{"meta":{"query_hash":"0ca3a5cb0134","filters":{"venue":"Canadian Journal of Health Technologies"},"cohort_total":660,"direct_labels_cover":1,"predictions_cover":660,"exported":660,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/0ca3a5cb0134","api":"https://metacan.xera.ac/api/v1/cohort?venue=Canadian+Journal+of+Health+Technologies"},"results":[{"id":"W3135045462","doi":"10.51731/cjht.2021.36","title":"Rapid Testing for the Diagnosis of Pulmonary Tuberculosis and Rifampicin Resistance: A Review of Cost-Effectiveness","year":2021,"lang":"en","type":"review","venue":"Canadian Journal of Health Technologies","topic":"Tuberculosis Research and Epidemiology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Generalizability theory; Sputum; Tuberculosis; Mycobacterium tuberculosis; Pulmonary tuberculosis; Rifampicin; Intensive care medicine; Pathology","score_opus":0.20062675631841173,"score_gpt":0.4380325216952149,"score_spread":0.23740576537680316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135045462","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000021665921,0.98110944,0.000036700974,0.015449517,0.00011814495,0.0029991071,0.00021343882,0.0000139334425,0.000038023045],"genre_scores_gemma":[0.00041742096,0.99793756,0.0006712505,0.0003801108,0.000025575415,0.00050264504,0.000021300204,0.00003416777,0.000009980365],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960065,0.00089128333,0.0019667577,0.00028798528,0.0002301432,0.00061732164],"domain_scores_gemma":[0.9879096,0.0085817985,0.001806298,0.00056768575,0.00095010514,0.00018449716],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.006014839,0.00030807345,0.0044463454,0.00072244945,0.00018678064,0.000010386608,0.00044554434,0.000391404,0.000012093479],"category_scores_gemma":[0.036453098,0.00018711248,0.0006029299,0.0010386991,0.00063478743,0.000060710383,0.000062422645,0.0010320562,2.477239e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011182099,0.000017204135,0.00084048946,0.23562592,0.000315271,0.000051726773,0.0000063472417,1.0280473e-7,2.3839902e-7,0.00008121446,0.0035146282,0.7595357],"study_design_scores_gemma":[0.00015883366,0.000393545,0.000649939,0.3091652,0.0006192189,0.0005765483,0.00014892292,9.663875e-7,0.0000055362084,0.000078443045,0.6881124,0.00009044706],"about_ca_topic_score_codex":0.0016190965,"about_ca_topic_score_gemma":0.00058031036,"teacher_disagreement_score":0.75944525,"about_ca_system_score_codex":0.00048928853,"about_ca_system_score_gemma":0.0069146627,"threshold_uncertainty_score":0.9987152},"labels":[],"label_agreement":null},{"id":"W3135402457","doi":"10.51731/cjht..24","title":"Canadian Medical Imaging Inventory, 2019–2020","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Radiation Dose and Imaging","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Medical imaging; Medical physics; Context (archaeology); Modalities; Medicine; Single-photon emission computed tomography; Population; Nuclear medicine; Radiology; Geography; Environmental health","score_opus":0.013393033885376455,"score_gpt":0.28849155671092835,"score_spread":0.2750985228255519,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135402457","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.045751493,0.17186017,0.000118374875,0.7785331,0.0010905,0.00013437339,0.000014908001,0.000086435546,0.0024106381],"genre_scores_gemma":[0.98343396,0.0016712738,0.00028982933,0.014211152,0.000073428295,0.0000015561413,0.000008432372,0.000019017687,0.00029134637],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982719,0.000055894983,0.0005774026,0.00014919283,0.00033376054,0.00061184354],"domain_scores_gemma":[0.99827904,0.000026802487,0.00021152438,0.00025983455,0.0002851687,0.00093764917],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071114954,0.00011614528,0.00037211066,0.00076931267,0.00023770097,0.000050038212,0.0002591333,0.00014170105,0.0007055972],"category_scores_gemma":[0.0024182578,0.00010883096,0.00009388159,0.0004966616,0.00014746867,0.00015131819,0.000015772534,0.00078404933,0.00004048735],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000027343365,0.000009552173,0.07754081,0.000055363806,0.000045518613,0.0068918886,0.00019489955,0.0000020951948,0.00002268032,0.00046147022,0.22866832,0.68610466],"study_design_scores_gemma":[0.00061809504,0.00006194406,0.019074457,0.0004967689,0.00001906547,0.007767078,0.003533871,0.00017802004,0.0004140024,0.00062433275,0.9670809,0.00013147603],"about_ca_topic_score_codex":0.17541292,"about_ca_topic_score_gemma":0.3522428,"teacher_disagreement_score":0.93768245,"about_ca_system_score_codex":0.0011705542,"about_ca_system_score_gemma":0.050618343,"threshold_uncertainty_score":0.95476377},"labels":[],"label_agreement":null},{"id":"W3135881593","doi":"10.51731/cjht..25","title":"Announcing the Canadian Journal of Health Technologies — A New Journal From CADTH","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Publication; Work (physics); Pandemic; Coronavirus disease 2019 (COVID-19); Public relations; Value (mathematics); Health care; Emerging technologies; Publishing; Political science; Medicine; Business; Computer science; Engineering; Advertising","score_opus":0.35191063936906997,"score_gpt":0.3938575603543826,"score_spread":0.04194692098531261,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135881593","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03055819,0.39037693,0.003042933,0.5726568,0.0026134555,0.00027742435,0.00023282302,0.000048555943,0.00019286905],"genre_scores_gemma":[0.97528726,0.004985424,0.007203232,0.011999157,0.00028993638,0.000005133204,0.0000087446015,0.00005679979,0.00016429955],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98893094,0.0006994266,0.00833373,0.00035434737,0.00027358136,0.0014079885],"domain_scores_gemma":[0.9851542,0.0007296161,0.011889074,0.0007899792,0.000825019,0.0006121034],"candidate_categories":["metaresearch","metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.028048037,0.00033573993,0.0021205917,0.002236427,0.0020757827,0.0005956995,0.0017479286,0.00048725455,0.00018538244],"category_scores_gemma":[0.021686265,0.00031260046,0.0003454,0.0009638484,0.0005074403,0.0007395339,0.00005582575,0.0022815906,0.00006863842],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00001833216,0.00005978084,0.09206169,0.0004463976,0.00073270546,0.0005674877,0.01623457,0.00075924315,0.000004646367,0.04512112,0.6003666,0.24362744],"study_design_scores_gemma":[0.0009100135,0.0003837931,0.013811761,0.000971203,0.000015301368,0.0021184182,0.054429125,0.0000534473,0.000027685992,0.11994989,0.80697215,0.00035723278],"about_ca_topic_score_codex":0.37893477,"about_ca_topic_score_gemma":0.6114,"teacher_disagreement_score":0.9447291,"about_ca_system_score_codex":0.006571951,"about_ca_system_score_gemma":0.07848624,"threshold_uncertainty_score":0.9999326},"labels":[],"label_agreement":null},{"id":"W3153217960","doi":"10.51731/cjht.2021.44","title":"Remote Monitoring Programs for Cardiac Conditions in Canada: An Environmental Scan","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cardiac Health and Mental Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Autonomy; Medicine; Medical emergency; Business; Environmental resource management; Political science; Environmental science","score_opus":0.03396781544573146,"score_gpt":0.31446787784871577,"score_spread":0.2805000624029843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3153217960","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95046973,0.03226434,0.000023047485,0.015089003,0.001135967,0.00073748827,0.00017518655,0.000026942345,0.000078304205],"genre_scores_gemma":[0.9963231,0.001276806,0.0017343988,0.00048771422,0.00005565172,0.000016139413,0.000062789644,0.000019130975,0.000024267887],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9981441,0.00006899456,0.00065667776,0.0001779929,0.00019381932,0.0007584288],"domain_scores_gemma":[0.9988963,0.00004566271,0.00022182449,0.00024333267,0.000073979245,0.0005189269],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052692584,0.00012513448,0.0005492545,0.00029337293,0.0002261069,0.00001255796,0.00009990625,0.00010547567,0.000007209557],"category_scores_gemma":[0.00015540722,0.00012699226,0.00009672233,0.0002428867,0.00007941154,0.000083120074,0.000010528459,0.00045396143,6.730077e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00002690096,0.0000314431,0.23480229,0.00035786245,0.000018730316,0.0003757495,0.00018843114,0.0000050775984,0.00011060709,0.000033953515,0.00071025395,0.7633387],"study_design_scores_gemma":[0.0026579776,0.0015277632,0.7455049,0.0018200468,0.00005638678,0.0018517417,0.06777806,0.000039133207,0.0032115493,0.00066519587,0.17454349,0.0003437336],"about_ca_topic_score_codex":0.83906835,"about_ca_topic_score_gemma":0.9121096,"teacher_disagreement_score":0.76299495,"about_ca_system_score_codex":0.007516994,"about_ca_system_score_gemma":0.045764945,"threshold_uncertainty_score":0.99629295},"labels":[],"label_agreement":null},{"id":"W3154216254","doi":"10.51731/cjht.2021.51","title":"Stereotactic Ablative Radiotherapy for the Treatment of Oligometastatic Cancer: A Clinical Review as Part of a Health Technology Assessment","year":2021,"lang":"en","type":"review","venue":"Canadian Journal of Health Technologies","topic":"Advanced Radiotherapy Techniques","field":"Physics and Astronomy","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; University of Calgary","funders":"","keywords":"SABR volatility model; Medicine; Ablative case; Radiation therapy; Adverse effect; Cancer; Radiosurgery; Medical physics; Clinical trial; Oncology; Internal medicine","score_opus":0.13397566216130063,"score_gpt":0.5108018768730298,"score_spread":0.37682621471172917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3154216254","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000004085649,0.9716648,0.014852582,0.009263572,0.00034809188,0.0033722094,0.00044913962,0.000037736376,0.000007809528],"genre_scores_gemma":[0.0000622331,0.9835541,0.015357019,0.00017686952,0.00004231215,0.0006911047,0.0000189044,0.00006555599,0.000031852254],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99449456,0.0006057353,0.003689723,0.0003622789,0.00020752137,0.0006401557],"domain_scores_gemma":[0.98981035,0.0010255255,0.007783693,0.00085945864,0.00041649578,0.000104486215],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017680593,0.0005040281,0.005775456,0.00076661486,0.00022591931,0.000017006827,0.00083476724,0.00023487592,0.00009045598],"category_scores_gemma":[0.0001368333,0.00031819055,0.0011269628,0.0010019249,0.0006148232,0.000071656315,0.000018807703,0.00073216954,1.6227729e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000029322027,0.000120103854,0.00017191711,0.0063989465,0.0022605087,0.0000046900695,0.000060644146,0.0000016653623,3.6291084e-8,0.0025794562,0.0009832314,0.98741585],"study_design_scores_gemma":[0.00040416548,0.0028395636,0.0000049909936,0.038236856,0.0004758256,0.00004269779,0.00055087294,0.0000023863934,0.0000045052375,0.00085355196,0.95639443,0.00019015538],"about_ca_topic_score_codex":0.0028839004,"about_ca_topic_score_gemma":0.0003048402,"teacher_disagreement_score":0.9872257,"about_ca_system_score_codex":0.0015582466,"about_ca_system_score_gemma":0.021576907,"threshold_uncertainty_score":0.99992704},"labels":[],"label_agreement":null},{"id":"W3155763117","doi":"10.51731/cjht.2021.56","title":"Tuberculosis Stigma and Racism, Colonialism, and Migration: A Rapid Qualitative Review","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Tuberculosis Research and Epidemiology","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tuberculosis; Stigma (botany); Racism; Indigenous; Colonialism; Genocide; Health care; Immigration; Criminology; Ethnic group; Political science; Medicine; Immigration policy; Gender studies; Sociology; Psychiatry; Law","score_opus":0.06564381358465378,"score_gpt":0.4024585395713658,"score_spread":0.336814725986712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3155763117","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.112299755,0.5128149,0.00002508997,0.37456226,0.00004853206,0.00015962102,0.000015170958,0.000016958016,0.000057769],"genre_scores_gemma":[0.64677954,0.34178632,0.0013603832,0.0099818045,0.000015497175,0.000011051333,0.00000837707,0.000009306677,0.00004769272],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981713,0.00046994942,0.00062900496,0.00017850993,0.0001398479,0.00041133273],"domain_scores_gemma":[0.99852246,0.0003549743,0.00024136664,0.000189498,0.00040420445,0.00028746677],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019988245,0.00011984798,0.00073904835,0.00031561442,0.00020486959,0.00001990162,0.00008114921,0.00014407879,0.000050473733],"category_scores_gemma":[0.0073833466,0.00009470044,0.00006591188,0.0003474184,0.00041107932,0.00008939454,0.00002730093,0.00051553635,0.0000024500434],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058533624,0.00003614735,0.011274907,0.0039762026,0.00030439137,0.0011619617,0.0035989543,3.208043e-7,0.00017043576,0.003411719,0.096095234,0.8799112],"study_design_scores_gemma":[0.0015980012,0.0022773603,0.05919959,0.007306883,0.00013487997,0.010392274,0.029994143,0.00001828239,0.00049664953,0.0062739854,0.8820122,0.0002957479],"about_ca_topic_score_codex":0.0027299982,"about_ca_topic_score_gemma":0.007816725,"teacher_disagreement_score":0.8796154,"about_ca_system_score_codex":0.00018164508,"about_ca_system_score_gemma":0.0025612917,"threshold_uncertainty_score":0.88390887},"labels":[],"label_agreement":null},{"id":"W3156120430","doi":"10.51731/cjht.2021.47","title":"A Call to Action on World Tuberculosis Day","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Tuberculosis Research and Epidemiology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tuberculosis; Poverty; Medicine; Infectious disease (medical specialty); Call to action; Disease; Public health; Health care; Global health; Environmental health; Economic growth; Family medicine; Nursing; Business; Pathology; Marketing","score_opus":0.07849117626467582,"score_gpt":0.38330438937751055,"score_spread":0.3048132131128347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3156120430","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.26952967,0.013961575,0.00017021222,0.71428174,0.00045924317,0.00022950832,0.000015069525,0.00007749241,0.0012754723],"genre_scores_gemma":[0.98476404,0.0008953414,0.0009727404,0.012825399,0.00004250411,0.0000081253875,0.000004506197,0.000014242536,0.0004730919],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99829084,0.00017337801,0.00050693034,0.00018312008,0.00018866835,0.00065707095],"domain_scores_gemma":[0.9986414,0.00017874369,0.00013693786,0.000320871,0.00029347706,0.00042862352],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010267652,0.000115178314,0.0005031657,0.001230506,0.0001635057,0.000018337358,0.00016322208,0.00013634807,0.00009252495],"category_scores_gemma":[0.0053137457,0.00009301425,0.00011344331,0.0007954979,0.00009378514,0.000052355674,0.000021958253,0.00081451156,0.00006106229],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000063637,0.00004696642,0.02597404,0.00010698167,0.000118086275,0.0011507163,0.00012758268,0.00004126383,0.00062455377,0.0010506653,0.22249028,0.74820524],"study_design_scores_gemma":[0.00050420593,0.0013890433,0.17059612,0.0005492974,0.00002106821,0.0010599396,0.0012501177,0.0000133375215,0.0043343552,0.0008871891,0.81926525,0.00013005052],"about_ca_topic_score_codex":0.0062674517,"about_ca_topic_score_gemma":0.05545055,"teacher_disagreement_score":0.7480752,"about_ca_system_score_codex":0.0009102001,"about_ca_system_score_gemma":0.0033648722,"threshold_uncertainty_score":0.961785},"labels":[],"label_agreement":null},{"id":"W3162401839","doi":"10.51731/cjht.2021.71","title":"Using Health Care Resources Wisely After the COVID-19 Pandemic: Recommendations to Reduce Low-Value Care","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Healthcare cost, quality, practices","field":"Health Professions","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pandemic; Health care; Medicine; Coronavirus disease 2019 (COVID-19); Business; Medical emergency; Nursing; Political science; Disease; Infectious disease (medical specialty)","score_opus":0.6379998547828083,"score_gpt":0.5730266786023779,"score_spread":0.06497317618043041,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3162401839","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23333304,0.12378786,0.0005356189,0.63851166,0.0018364519,0.0012613506,0.0003775946,0.00021525027,0.00014118302],"genre_scores_gemma":[0.86111873,0.0022573702,0.005515898,0.13062991,0.00018270864,0.0001056749,0.0000269313,0.00006602781,0.00009674446],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9891357,0.005793362,0.0023211397,0.00051500177,0.0004983306,0.001736474],"domain_scores_gemma":[0.99243087,0.0016023329,0.0019913868,0.0010766301,0.0016804766,0.0012183347],"candidate_categories":["metaresearch","metaepi_narrow","sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.005841626,0.0003385346,0.0008732725,0.0008804642,0.004951543,0.000093174094,0.0009952692,0.0005070853,0.0001630392],"category_scores_gemma":[0.013946136,0.00027581793,0.00015648428,0.0014174873,0.00034804028,0.00033420336,0.00022141873,0.003326667,0.000038962065],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00025779166,0.00005311723,0.16379066,0.0064706444,0.00015650844,0.00049913744,0.34466055,0.0003264033,0.000031290587,0.002311199,0.07337108,0.40807164],"study_design_scores_gemma":[0.00032798605,0.00016527397,0.0037811203,0.0010291517,0.000015661108,0.00022638841,0.35628194,0.0000020788148,0.000008801651,0.0004297129,0.6375522,0.00017968252],"about_ca_topic_score_codex":0.08892963,"about_ca_topic_score_gemma":0.30162394,"teacher_disagreement_score":0.6277857,"about_ca_system_score_codex":0.009865131,"about_ca_system_score_gemma":0.07372517,"threshold_uncertainty_score":0.9999694},"labels":[],"label_agreement":null},{"id":"W3166513740","doi":"10.51731/cjht.2021.69","title":"Using Health Care Resources Wisely During and Following the COVID-19 Pandemic","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Healthcare cost, quality, practices","field":"Health Professions","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Pandemic; Health care; Coronavirus disease 2019 (COVID-19); Value (mathematics); Diversity (politics); Public relations; 2019-20 coronavirus outbreak; Medicine; Business; Political science; Nursing; Computer science","score_opus":0.6511773294288565,"score_gpt":0.5520575918547119,"score_spread":0.0991197375741446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3166513740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5898244,0.20219101,0.000119261706,0.20647295,0.0007213313,0.0004496031,0.00003166793,0.0001347918,0.000055032557],"genre_scores_gemma":[0.96679676,0.0034258596,0.0011596088,0.028432237,0.000082238024,0.000015209906,0.000003221168,0.00004013199,0.000044716537],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.9923411,0.0037272077,0.0017445771,0.00036266755,0.00039923962,0.0014251937],"domain_scores_gemma":[0.99481744,0.0014963663,0.0019009917,0.00059512927,0.00045496915,0.00073508394],"candidate_categories":["metaresearch","sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0069544245,0.00024956212,0.0007957674,0.0005822443,0.006142003,0.00007177582,0.0005663062,0.00038992843,0.000030436071],"category_scores_gemma":[0.011907937,0.00019640471,0.00012461332,0.00074881496,0.0003635335,0.00033089632,0.00016353177,0.0028192517,0.0000050373505],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00005138345,0.000016301861,0.8230903,0.004866183,0.00014702574,0.00083399063,0.081684925,0.00004896575,0.0000725266,0.0011564798,0.0031309489,0.084900975],"study_design_scores_gemma":[0.0011014991,0.0001876108,0.035802778,0.0014560904,0.00003425374,0.0011048655,0.5102047,0.0000071034688,0.000014939713,0.0016823254,0.44811285,0.00029102678],"about_ca_topic_score_codex":0.06958521,"about_ca_topic_score_gemma":0.16040458,"teacher_disagreement_score":0.78728753,"about_ca_system_score_codex":0.0043432834,"about_ca_system_score_gemma":0.041645873,"threshold_uncertainty_score":0.99948126},"labels":[],"label_agreement":null},{"id":"W3169612600","doi":"10.51731/cjht.2021.77","title":"Treatment Programs for Substance Use Disorder","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Psychiatry; Mental health; Cannabis; Addiction; Ambulatory; Ambulatory care; Alcohol use disorder; Health care; Alcohol","score_opus":0.24766749046859404,"score_gpt":0.42142474319252654,"score_spread":0.1737572527239325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3169612600","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6782751,0.13201036,0.0012342015,0.1865496,0.0006671833,0.0009997482,0.00003668749,0.00009441417,0.0001327073],"genre_scores_gemma":[0.9929666,0.0018704779,0.004052959,0.00076338113,0.00001101571,0.000014552564,0.000009418947,0.000011022017,0.00030059708],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99911934,0.00002621193,0.0003362685,0.00009657419,0.000084931955,0.00033669497],"domain_scores_gemma":[0.9991603,0.00013342297,0.00020909015,0.00015552825,0.00020823158,0.00013345566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013739655,0.00008772878,0.00030388084,0.00012538605,0.00012501278,0.00003097521,0.00006713992,0.00007063877,0.00001428322],"category_scores_gemma":[0.00059053855,0.00006309404,0.000104648265,0.00018496792,0.000080148784,0.00012674733,0.0000035040978,0.00018038478,0.0000018302658],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057057412,0.000089911155,0.19410688,0.00010690831,0.00007550675,0.00025005612,0.00014724008,0.0000019284996,0.00001182993,0.00060787215,0.0006307395,0.80391407],"study_design_scores_gemma":[0.0014282973,0.0011784743,0.00854724,0.00013619111,0.000051729552,0.0004165517,0.0014577238,0.000037991747,0.00038067493,0.0005928184,0.985703,0.00006933494],"about_ca_topic_score_codex":0.00087094243,"about_ca_topic_score_gemma":0.0065771528,"teacher_disagreement_score":0.98507226,"about_ca_system_score_codex":0.00032286494,"about_ca_system_score_gemma":0.0019627705,"threshold_uncertainty_score":0.36702058},"labels":[],"label_agreement":null},{"id":"W3177066024","doi":"10.51731/cjht.2021.73","title":"Visual Examination Frequency for People Taking Ethambutol for Tuberculosis","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Drug-Induced Ocular Toxicity","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ethambutol; Guideline; Tuberculosis; Medicine; Visual acuity; Optometry; Family medicine; Isoniazid; Ophthalmology; Pathology","score_opus":0.04304806175371875,"score_gpt":0.3431754952297267,"score_spread":0.3001274334760079,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3177066024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8946462,0.019858085,0.019759124,0.06341084,0.0007705183,0.0011108483,0.0000764473,0.00013318179,0.00023470147],"genre_scores_gemma":[0.98452795,0.00011101774,0.014524673,0.0006612426,0.000042731674,0.000039406103,0.0000214214,0.000027332993,0.000044246153],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99849415,0.000055088592,0.0005798063,0.00018786355,0.00016821205,0.00051485834],"domain_scores_gemma":[0.99821424,0.00017168868,0.00050034607,0.00021244197,0.00076155737,0.00013972963],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010583848,0.00013373625,0.00050757005,0.00054091716,0.00027199753,0.00003401308,0.00014993249,0.00023991487,0.00001379146],"category_scores_gemma":[0.0057697156,0.00012844049,0.00017226154,0.00039720055,0.00006697071,0.0001297848,0.000012548504,0.00035745066,0.0000013855739],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000128550355,0.00006220859,0.008760734,0.0008335773,0.000118843906,0.0001246976,0.0006523371,0.0000071262675,0.0049579884,0.0024125604,0.0009958793,0.9810612],"study_design_scores_gemma":[0.010662374,0.0059404415,0.5101019,0.0043974393,0.00064906216,0.0060117333,0.04886318,0.0013392372,0.26039127,0.030636579,0.11960264,0.0014041002],"about_ca_topic_score_codex":0.001129207,"about_ca_topic_score_gemma":0.011274321,"teacher_disagreement_score":0.9796571,"about_ca_system_score_codex":0.00088381843,"about_ca_system_score_gemma":0.0048087244,"threshold_uncertainty_score":0.8530471},"labels":[],"label_agreement":null},{"id":"W3179543896","doi":"10.51731/cjht.2021.90","title":"Psychedelic-Assisted Psychotherapy for Post-Traumatic Stress Disorder, Anxiety Disorders, Mood Disorders, or Substance Use Disorders","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Psychedelics and Drug Studies","field":"Psychology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Psilocybin; Randomized controlled trial; Psychology; Psychotherapist; MDMA; Anxiety; Hallucinogen; Systematic review; Clinical psychology; Psychiatry; Mood; Medicine; MEDLINE","score_opus":0.051713275694359934,"score_gpt":0.34489962684650094,"score_spread":0.293186351152141,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3179543896","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4815708,0.2479691,0.022419423,0.2357873,0.0064094276,0.002557557,0.001468974,0.00053545577,0.0012819631],"genre_scores_gemma":[0.95408064,0.040555503,0.003343441,0.0010454069,0.000043945594,0.00019590663,0.000055052904,0.00012373737,0.000556353],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99574035,0.00022786316,0.0014931527,0.00070309767,0.0003171937,0.0015183213],"domain_scores_gemma":[0.99681056,0.00041363735,0.0010131719,0.0010294784,0.00047645796,0.00025671418],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00064766407,0.0005674175,0.0010417461,0.00069148745,0.00092384947,0.00016948921,0.0009582397,0.00044904478,0.00018900348],"category_scores_gemma":[0.00043405863,0.00048361794,0.0004414247,0.0011814263,0.000511732,0.000317749,0.000021072457,0.00074126647,0.000009495793],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036447647,0.0008338063,0.072221234,0.00031098636,0.0006600694,0.000014142367,0.008240627,0.000036928883,0.00001533668,0.009325124,0.018043892,0.8899334],"study_design_scores_gemma":[0.006484161,0.002185875,0.18612902,0.0006696641,0.00009982221,0.00017557507,0.13458084,0.000039982566,0.000019931831,0.03355878,0.6347942,0.0012621932],"about_ca_topic_score_codex":0.013056294,"about_ca_topic_score_gemma":0.83191276,"teacher_disagreement_score":0.88867116,"about_ca_system_score_codex":0.00024329107,"about_ca_system_score_gemma":0.0016334039,"threshold_uncertainty_score":0.9997615},"labels":[],"label_agreement":null},{"id":"W3180471204","doi":"10.51731/cjht.2021.82","title":"Smoke-Free Hospital Grounds","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Smoking Behavior and Cessation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Signage; Legislation; Government (linguistics); Smoking cessation; Mental health; Public health; Smoke; Business; Smoking ban; Medicine; Public relations; Medical emergency; Nursing; Environmental health; Psychology; Political science; Psychiatry; Geography; Advertising; Law","score_opus":0.03624678688214688,"score_gpt":0.3017801262302966,"score_spread":0.2655333393481497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3180471204","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9035146,0.014805409,0.00007595237,0.080404416,0.00070473057,0.000071345334,0.00000890978,0.000066410874,0.00034819098],"genre_scores_gemma":[0.99858874,0.00029535877,0.00036078625,0.0006381039,0.000022232958,0.000001868854,0.000005262744,0.000010534217,0.00007709652],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990663,0.0000230314,0.00034726752,0.000095211406,0.00017791083,0.00029030262],"domain_scores_gemma":[0.9990764,0.000017815773,0.00019881058,0.0003245445,0.0002817912,0.000100595615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003120419,0.000078664045,0.00025769498,0.0003255998,0.0001397783,0.00002922079,0.00017772574,0.00014089208,0.000059260386],"category_scores_gemma":[0.0007797163,0.000069798356,0.00007613786,0.0003180369,0.000112866,0.00008256743,0.000016630753,0.0004264107,0.0000012817633],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000098094315,0.000052392377,0.496553,0.00009306119,0.000044759512,0.0017213072,0.00045074202,9.0297385e-7,0.000055031935,0.0018555289,0.011948205,0.48721525],"study_design_scores_gemma":[0.0010621467,0.0009579186,0.8700247,0.00035279436,0.000049035087,0.0019023715,0.0063038785,8.267746e-7,0.002031186,0.004288776,0.11290012,0.00012626695],"about_ca_topic_score_codex":0.0019732348,"about_ca_topic_score_gemma":0.0012460883,"teacher_disagreement_score":0.48708898,"about_ca_system_score_codex":0.00046592113,"about_ca_system_score_gemma":0.0038683654,"threshold_uncertainty_score":0.68623143},"labels":[],"label_agreement":null},{"id":"W3181006784","doi":"10.51731/cjht.2021.78","title":"Models of Care for Chronic Pain","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pain Management and Opioid Use","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chronic pain; Psychosocial; Medicine; Referral; Chronic care; Health care; Medical prescription; Anxiety; Family medicine; Nursing; Physical therapy; Chronic disease; Psychiatry","score_opus":0.031072961903408396,"score_gpt":0.29213347293292324,"score_spread":0.26106051102951483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3181006784","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09945566,0.76230174,0.0314366,0.10419892,0.00055776845,0.000999975,0.000055306624,0.00011847505,0.00087554555],"genre_scores_gemma":[0.99410546,0.0013432712,0.0038679335,0.0005370929,0.00001805986,0.0000050064355,0.0000070063434,0.000009916821,0.00010627827],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99914473,0.000035857793,0.00036732433,0.00008063624,0.00009128729,0.00028014363],"domain_scores_gemma":[0.9991228,0.00006135558,0.00021990687,0.00019979943,0.0003308922,0.000065228785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005973548,0.00006907374,0.00034558505,0.00034169471,0.00008402072,0.000007173468,0.00013531727,0.00008415928,0.000010398157],"category_scores_gemma":[0.00066957786,0.00006070116,0.00010003225,0.00020361444,0.00007825454,0.000045994948,0.000011216641,0.00017007193,4.1134473e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029760999,0.00001974412,0.0065693296,0.0035697597,0.00011414478,0.00022542175,0.0008841822,0.00024489625,0.00013583145,0.0075227325,0.016772902,0.9639113],"study_design_scores_gemma":[0.003446536,0.004042414,0.008117762,0.003442515,0.00014677946,0.00008256259,0.053350657,0.001706665,0.0062717386,0.027912734,0.8911727,0.0003069266],"about_ca_topic_score_codex":0.0004199521,"about_ca_topic_score_gemma":0.0045508603,"teacher_disagreement_score":0.9636044,"about_ca_system_score_codex":0.00041461326,"about_ca_system_score_gemma":0.0045652865,"threshold_uncertainty_score":0.80986226},"labels":[],"label_agreement":null},{"id":"W3183002265","doi":"10.51731/cjht.2021.80","title":"An Overview of Direct-to-Patient Virtual Visits in Canada","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Telemedicine and Telehealth Implementation","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Health care; Videoconferencing; Phone; The Internet; Internet privacy; Health literacy; Language barrier; Business; Nursing; Medicine; Medical emergency; Political science; Computer science; Multimedia; World Wide Web","score_opus":0.055360567852470566,"score_gpt":0.35679364491870696,"score_spread":0.3014330770662364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3183002265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9310821,0.03244404,0.000032483957,0.0357792,0.0002974897,0.0002453697,0.000036998917,0.000013617309,0.000068676505],"genre_scores_gemma":[0.99452907,0.0007490066,0.0007317919,0.0039529963,0.000009997311,0.00000374313,0.000008888772,0.000009338104,0.000005184985],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.998267,0.0000718736,0.0008939106,0.00012187424,0.00025178835,0.00039353198],"domain_scores_gemma":[0.99884254,0.000048115744,0.00034837137,0.00022604749,0.00027601214,0.00025894513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003567851,0.00009292243,0.0005005108,0.0005524819,0.00005385056,0.000004479179,0.00012045096,0.0000505801,0.000056858513],"category_scores_gemma":[0.000541855,0.00008372406,0.000028831304,0.00067777967,0.000026175769,0.00006364308,0.000011428971,0.0002696807,6.626716e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020111664,0.000026406431,0.088559836,0.00020484942,0.000016525655,0.00063912047,0.000550972,0.000030005756,0.000105425504,0.00025937156,0.0045592654,0.9050281],"study_design_scores_gemma":[0.002233585,0.005790824,0.6764539,0.002076042,0.000035110672,0.00086469244,0.0520987,0.00003397776,0.010541328,0.00027602326,0.24935584,0.00024000517],"about_ca_topic_score_codex":0.88730055,"about_ca_topic_score_gemma":0.9890667,"teacher_disagreement_score":0.9047881,"about_ca_system_score_codex":0.0013837549,"about_ca_system_score_gemma":0.029822094,"threshold_uncertainty_score":0.9756779},"labels":[],"label_agreement":null},{"id":"W3183032369","doi":"10.51731/cjht.2021.74","title":"Single-Entry Models in Surgical Services","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Triage; Context (archaeology); Action plan; Operations management; Medicine; Health care; Quality management; Process management; Nova scotia; Quality (philosophy); Performance indicator; Medical emergency; Business; Management system; Engineering; Political science; Marketing; Management; Geography","score_opus":0.23486821773053165,"score_gpt":0.44678417177294555,"score_spread":0.2119159540424139,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3183032369","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7295602,0.051495213,0.0002583843,0.21680298,0.00044907074,0.00026692674,0.000012554555,0.00006317335,0.0010914694],"genre_scores_gemma":[0.99490595,0.0007441179,0.002362071,0.001909256,0.00002263482,0.0000024618153,0.000008944345,0.000009896783,0.00003464817],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981018,0.000088143264,0.0011748405,0.0001251082,0.00017682888,0.00033328854],"domain_scores_gemma":[0.9987236,0.00023467645,0.0004174989,0.00019571997,0.00030788544,0.00012060297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00097193127,0.000082804254,0.00037200027,0.00038438864,0.000059909195,0.000024325642,0.00012538371,0.00013395878,0.000056753557],"category_scores_gemma":[0.0012924785,0.00007469474,0.000065485554,0.00041103456,0.00006927656,0.00022386463,0.00002245833,0.0005550373,0.0000041907288],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006073729,0.00010449225,0.020969098,0.00026598177,0.000033811604,0.0047364156,0.00022865259,0.0001266652,0.000085630294,0.00088238117,0.0013396173,0.9711665],"study_design_scores_gemma":[0.0072460673,0.0016199333,0.029069083,0.00257553,0.00009356754,0.013131892,0.057345055,0.0012163479,0.0014291137,0.033688467,0.8521977,0.00038724134],"about_ca_topic_score_codex":0.007116033,"about_ca_topic_score_gemma":0.03052043,"teacher_disagreement_score":0.9707793,"about_ca_system_score_codex":0.0004523245,"about_ca_system_score_gemma":0.0040371,"threshold_uncertainty_score":0.9994957},"labels":[],"label_agreement":null},{"id":"W3186497210","doi":"10.51731/cjht.2021.99","title":"Palonosetron for Patients Undergoing High or Moderate Emetogenic Chemotherapy","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Nausea and vomiting management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Palonosetron; Aprepitant; Ondansetron; Granisetron; Medicine; Dexamethasone; Antiemetic; Chemotherapy-induced nausea and vomiting; Regimen; Nausea; Vomiting; Anesthesia; Pharmacology; Oncology; Internal medicine","score_opus":0.03695637737171747,"score_gpt":0.3024086123804909,"score_spread":0.2654522350087734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3186497210","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.903702,0.010622984,0.003251436,0.08093051,0.0006326259,0.00064217113,0.000028883876,0.00010502072,0.00008436124],"genre_scores_gemma":[0.9907956,0.00096810615,0.0060064076,0.0018674337,0.000023563984,0.00000757879,0.000011509346,0.000021246708,0.000298521],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988322,0.00002592201,0.00045811202,0.00013959434,0.00012349151,0.00042063044],"domain_scores_gemma":[0.99901325,0.00008328199,0.00029068044,0.00020459747,0.0003072152,0.0001009624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003112319,0.00011030004,0.00037529902,0.0003473159,0.00020042136,0.00003313678,0.00012621107,0.00009392551,0.000031782256],"category_scores_gemma":[0.0008404146,0.000086885,0.00008916807,0.0002476956,0.000048862163,0.00005906739,0.000013020257,0.00020549397,0.0000019957793],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004509179,0.00015687548,0.035936706,0.0009992837,0.00039690547,0.0003472629,0.00024105601,0.000032797136,0.000078846046,0.0027995957,0.02350945,0.9350503],"study_design_scores_gemma":[0.042962775,0.01953311,0.13886508,0.0045414204,0.0004529674,0.0007937228,0.01433176,0.0003010669,0.025700418,0.041090176,0.7101434,0.0012841212],"about_ca_topic_score_codex":0.00032530306,"about_ca_topic_score_gemma":0.0027164572,"teacher_disagreement_score":0.9337662,"about_ca_system_score_codex":0.00048588906,"about_ca_system_score_gemma":0.003405139,"threshold_uncertainty_score":0.604057},"labels":[],"label_agreement":null},{"id":"W3187821863","doi":"10.51731/cjht.2021.112","title":"Harm Reduction Interventions to Prevent Overdose Deaths","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Harm reduction; Psychological intervention; Opioid overdose; Public health; Medicine; Harm; Drug overdose; Environmental health; Poison control; Medical emergency; Psychiatry; Opioid; Psychology; Nursing; (+)-Naloxone; Social psychology","score_opus":0.04121654027972695,"score_gpt":0.3486309999741576,"score_spread":0.30741445969443065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3187821863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.63407123,0.11915687,0.0006628233,0.24396549,0.0010682946,0.0005881243,0.00003165318,0.00012504052,0.00033046794],"genre_scores_gemma":[0.99436516,0.0008875562,0.0038046658,0.00042842692,0.000015832964,0.000013299888,0.00000789349,0.000013997316,0.00046319125],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99889076,0.00003905821,0.0004966183,0.00013577996,0.00012697412,0.00031080123],"domain_scores_gemma":[0.99909294,0.000010670453,0.00019118674,0.00027182815,0.00025365222,0.00017969638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022260853,0.00009909115,0.0003011687,0.0005138867,0.00013394658,0.000022337394,0.00010773182,0.000080573205,0.000079531965],"category_scores_gemma":[0.0004842248,0.00008957235,0.00016317055,0.00039603337,0.0000461588,0.00006254898,0.000021246104,0.00027134517,0.000019373154],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039351053,0.00066459127,0.004502307,0.0010361306,0.0002812619,0.0013517885,0.0025765083,0.000047571095,0.0007709406,0.0022746096,0.03849875,0.9479562],"study_design_scores_gemma":[0.0046181832,0.010082622,0.13140327,0.014264987,0.00060649845,0.015143354,0.10778644,0.000010430719,0.06411046,0.013608049,0.63756436,0.00080132164],"about_ca_topic_score_codex":0.0014684522,"about_ca_topic_score_gemma":0.0013824016,"teacher_disagreement_score":0.9471549,"about_ca_system_score_codex":0.0009528724,"about_ca_system_score_gemma":0.0039463653,"threshold_uncertainty_score":0.7000683},"labels":[],"label_agreement":null},{"id":"W3190091345","doi":"10.51731/cjht.2021.96","title":"Implementation of Stereotactic Ablative Radiotherapy for the Treatment of Oligometastatic Cancer in Canada","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Ablative case; Radiation therapy; Radiosurgery; Medical physics; Prioritization; Stereotactic radiotherapy; Radiation oncology; Cancer; Radiology; Internal medicine; Business","score_opus":0.035829780523377236,"score_gpt":0.36926842939055116,"score_spread":0.3334386488671739,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3190091345","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.75375396,0.20486994,0.00007489461,0.040220708,0.00021801968,0.00066758454,0.00018759172,0.0000027196943,0.0000045912548],"genre_scores_gemma":[0.9794361,0.019851519,0.0004698007,0.00016098769,0.00000494826,0.00005913644,0.000002355758,0.000007027308,0.000008122276],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9991107,0.00002884445,0.00048468553,0.00007405071,0.00010364567,0.00019806965],"domain_scores_gemma":[0.9990098,0.00019904079,0.00042693972,0.00013897923,0.00018540522,0.000039833074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011617187,0.00007861225,0.00041591903,0.00017238274,0.00004165429,0.0000034327234,0.000058302892,0.00002157985,0.00005076571],"category_scores_gemma":[0.000033111945,0.000049421524,0.000063181804,0.00023672589,0.000048837494,0.000026921487,0.0000016597654,0.0000543135,2.022362e-8],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000040216044,0.000060689774,0.30193424,0.00020405951,0.00068973296,0.0000643193,0.0013554113,0.00010961298,0.00003188935,0.00011680003,0.0003809596,0.6950121],"study_design_scores_gemma":[0.008886402,0.004813833,0.8515974,0.0009469932,0.00040972375,0.00012393111,0.059151907,0.00008538297,0.037251655,0.0003857471,0.036205433,0.00014155098],"about_ca_topic_score_codex":0.94557655,"about_ca_topic_score_gemma":0.99351084,"teacher_disagreement_score":0.69487053,"about_ca_system_score_codex":0.0048003886,"about_ca_system_score_gemma":0.020720318,"threshold_uncertainty_score":0.99902},"labels":[],"label_agreement":null},{"id":"W3190144755","doi":"10.51731/cjht.2021.101","title":"Autologous Hematopoietic Stem Cell Transplantation for the Treatment of Multiple Sclerosis","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Multiple sclerosis; Hematopoietic stem cell transplantation; Randomized controlled trial; Transplantation; Disease; Clinical trial; Intensive care medicine; Stem cell; Oncology; Physical therapy; Internal medicine; Immunology","score_opus":0.0689390489209722,"score_gpt":0.2916260853727243,"score_spread":0.22268703645175209,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3190144755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4834284,0.2215643,0.012611463,0.28076786,0.0006594856,0.0008018826,0.00008757497,0.00005015165,0.000028912978],"genre_scores_gemma":[0.9902027,0.008592114,0.0009968412,0.00014241193,0.000008464649,0.000007162657,0.0000057088428,0.000005960334,0.00003860429],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992668,0.000023685247,0.00036979714,0.00006756986,0.00010425219,0.00016791694],"domain_scores_gemma":[0.9992123,0.00018445899,0.0002286744,0.00012798554,0.00018973571,0.000056835564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022815536,0.0000610806,0.00025408593,0.00013313639,0.00013913497,0.0000063351513,0.000063894775,0.00014939635,0.0000053685358],"category_scores_gemma":[0.000033346423,0.000035857807,0.000097044496,0.00016146415,0.0003009612,0.000016233036,0.0000014878063,0.00011626505,3.0826592e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003677697,0.00007074189,0.0008367657,0.000572616,0.000054052736,0.000044386157,0.001946518,0.000025090134,0.00095581985,0.00069402304,0.00020951973,0.9945537],"study_design_scores_gemma":[0.016205287,0.014594134,0.21585436,0.0041075186,0.0010857345,0.0033241329,0.06588004,0.0021992614,0.39898068,0.012451774,0.26478222,0.00053486193],"about_ca_topic_score_codex":0.0006648303,"about_ca_topic_score_gemma":0.0021066186,"teacher_disagreement_score":0.99401885,"about_ca_system_score_codex":0.00016046564,"about_ca_system_score_gemma":0.001919905,"threshold_uncertainty_score":0.3405829},"labels":[],"label_agreement":null},{"id":"W3192184107","doi":"10.51731/cjht.2021.113","title":"The Use of Cone Beam CT in Dental, Oral, and Maxillofacial Surgery, and Otolaryngology Settings","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Dental Radiography and Imaging","field":"Dentistry","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Otorhinolaryngology; Cone beam computed tomography; Dentistry; Respondent; Oral and maxillofacial surgery; Cone beam ct; Computed tomography; Orthodontics; Radiology; Surgery","score_opus":0.03325664436134857,"score_gpt":0.270137642137522,"score_spread":0.23688099777617344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3192184107","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93608356,0.058317795,0.000010905604,0.005132334,0.0003355901,0.00007147504,0.000026911655,0.000013469943,0.000007952974],"genre_scores_gemma":[0.99540377,0.004037505,0.00020406097,0.00032783757,0.0000020733482,0.000001544464,0.0000018526215,0.000007856096,0.000013521608],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988142,0.00007334682,0.00054754724,0.00012349979,0.00009555348,0.0003458382],"domain_scores_gemma":[0.99919873,0.00017264395,0.0003369502,0.00014483577,0.0000760582,0.000070801536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005654334,0.000095572104,0.00035620367,0.00048162698,0.00022522757,0.000096533644,0.00013912989,0.000065489934,0.000006170757],"category_scores_gemma":[0.0009573934,0.000079012316,0.00006015678,0.0003935266,0.0006380052,0.00022514384,0.000043956385,0.00035417228,5.411661e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001110776,0.000009999508,0.7587287,0.00006956515,0.00003397686,0.0018467014,0.000078975354,9.0216867e-7,0.00017476764,0.00023966977,0.0021807307,0.23662494],"study_design_scores_gemma":[0.0005587633,0.00010518773,0.73370457,0.00031520642,0.000018506553,0.014429843,0.0069212704,0.000012069699,0.0032134787,0.0013146249,0.23923115,0.0001753135],"about_ca_topic_score_codex":0.00888848,"about_ca_topic_score_gemma":0.024298297,"teacher_disagreement_score":0.23705043,"about_ca_system_score_codex":0.000071178496,"about_ca_system_score_gemma":0.0005789051,"threshold_uncertainty_score":0.9977114},"labels":[],"label_agreement":null},{"id":"W3193124833","doi":"10.51731/cjht.2021.118","title":"The Portable Neuromodulation Stimulator: Targeting Neuroplasticity for Balance or Gait Deficit","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Stroke Rehabilitation and Recovery","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Neuromodulation; Physical medicine and rehabilitation; Balance (ability); Gait; Neuroplasticity; Intervention (counseling); Rehabilitation; Medicine; Psychology; Physical therapy; Neuroscience; Psychiatry","score_opus":0.029255961482638954,"score_gpt":0.29496732474485393,"score_spread":0.265711363262215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3193124833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9082397,0.02766079,0.0041943192,0.057451773,0.0017209417,0.00051618885,0.000037244743,0.000092766306,0.000086278684],"genre_scores_gemma":[0.9963041,0.00045788827,0.0024451553,0.0005120532,0.00003075973,0.000004912415,0.000003859871,0.00001283296,0.0002284194],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99887395,0.000046819714,0.0005044749,0.000114739516,0.00012533678,0.00033469647],"domain_scores_gemma":[0.9984844,0.00056451035,0.00028989918,0.00015820816,0.00041620832,0.00008680404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045342656,0.00008288338,0.00026363792,0.00015494124,0.00040091953,0.000037027443,0.00009928865,0.000076693024,0.000015215512],"category_scores_gemma":[0.005990899,0.000052276115,0.000096567426,0.00024727266,0.000096834265,0.00006324078,0.000008489244,0.00027547093,0.0000015187884],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005681913,0.00011726488,0.41421852,0.0013612056,0.00024106714,0.00083292474,0.00042188456,0.0028784599,0.0023437717,0.004997901,0.055381335,0.5166375],"study_design_scores_gemma":[0.0023155133,0.0020494044,0.28063428,0.00063275854,0.00008365513,0.0015860628,0.0062230923,0.003925536,0.0016206609,0.002196438,0.6984832,0.00024939716],"about_ca_topic_score_codex":0.00016014758,"about_ca_topic_score_gemma":0.00059883564,"teacher_disagreement_score":0.6431019,"about_ca_system_score_codex":0.00018628572,"about_ca_system_score_gemma":0.0033681656,"threshold_uncertainty_score":0.7172099},"labels":[],"label_agreement":null},{"id":"W3193234131","doi":"10.51731/cjht.2021.98","title":"Initiation of Biologic Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis: A Budget Impact Analysis","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Antirheumatic drugs; Rheumatoid arthritis; Biosimilar; Medicine; Jurisdiction; Antirheumatic Agents; Drug; Physical therapy; Pharmacology; Internal medicine; Political science","score_opus":0.0309432461624803,"score_gpt":0.3287337595575248,"score_spread":0.29779051339504453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3193234131","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.57807845,0.39911592,0.009238843,0.012034493,0.0005088676,0.00032899095,0.00058810797,0.000068230474,0.000038070077],"genre_scores_gemma":[0.99034184,0.006738341,0.0026451699,0.0002009547,0.0000028961877,0.000006367828,0.000043749336,0.0000084576495,0.00001223862],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9980089,0.0002792848,0.00097090716,0.00019328814,0.00004457177,0.0005030609],"domain_scores_gemma":[0.99809355,0.0003560568,0.00079864985,0.00027583574,0.00040834886,0.000067536355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011924099,0.00016412455,0.000888416,0.00086563156,0.00023977083,0.000023740384,0.00028258923,0.0002876792,0.00012208542],"category_scores_gemma":[0.0022677416,0.0001257434,0.00046466576,0.00091536884,0.0003742768,0.00008551063,0.000027109183,0.00032566083,0.0000020603036],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026271882,0.00022897017,0.14933775,0.0006825502,0.0049491306,0.00010401335,0.000741884,0.00015069566,0.006272193,0.0058520543,0.004458847,0.8269592],"study_design_scores_gemma":[0.015404323,0.0073980675,0.5912684,0.007658178,0.0026506884,0.0017268455,0.036222503,0.0008103491,0.11769437,0.1291331,0.086975805,0.0030573527],"about_ca_topic_score_codex":0.0007868925,"about_ca_topic_score_gemma":0.0012104249,"teacher_disagreement_score":0.82390183,"about_ca_system_score_codex":0.00016257634,"about_ca_system_score_gemma":0.0021620917,"threshold_uncertainty_score":0.5127668},"labels":[],"label_agreement":null},{"id":"W3194380886","doi":"10.51731/cjht.2021.133","title":"Utilization Patterns of Disease-Modifying Antirheumatic Drugs for the Treatment of Rheumatoid Arthritis: Rationale for Improving the Harmonization of Coverage Criteria","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Adalimumab; Infliximab; Leflunomide; Antirheumatic drugs; Etanercept; Rheumatoid arthritis; Tocilizumab; Hydroxychloroquine; Sulfasalazine; Antirheumatic Agents; Internal medicine; Disease","score_opus":0.0609078350527339,"score_gpt":0.32256263847655364,"score_spread":0.26165480342381975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3194380886","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.34125358,0.37366867,0.2579002,0.023612961,0.00086152036,0.0014667,0.0012128192,0.000019451441,0.00000407019],"genre_scores_gemma":[0.9842633,0.014480575,0.0011060454,0.000079051664,0.00000346461,0.000019733776,0.000026173939,0.0000067454293,0.000014921196],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99893266,0.00011323278,0.00065130816,0.00008881577,0.000034943172,0.00017902063],"domain_scores_gemma":[0.9981963,0.0005579439,0.00066477957,0.00017780538,0.00038832548,0.000014844295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005152264,0.00008407353,0.00033688618,0.000111300724,0.00022192062,0.000011136266,0.00015901071,0.00009582226,0.000021596248],"category_scores_gemma":[0.00078739127,0.00005052069,0.0001302546,0.00012880156,0.00020058583,0.000046717967,0.000009509466,0.00006747537,6.3237415e-8],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013817858,0.000117519645,0.0029651502,0.000706515,0.0002520964,0.000001187068,0.0012580161,0.000056490844,0.007984367,0.0041672783,0.0003603501,0.98199284],"study_design_scores_gemma":[0.008952794,0.0045795874,0.024108846,0.0034598194,0.00034589073,0.000121852114,0.03935947,0.0023124616,0.83895963,0.02219079,0.05512737,0.00048147552],"about_ca_topic_score_codex":0.00035885177,"about_ca_topic_score_gemma":0.00043640748,"teacher_disagreement_score":0.98151135,"about_ca_system_score_codex":0.000068114634,"about_ca_system_score_gemma":0.0009027661,"threshold_uncertainty_score":0.2060174},"labels":[],"label_agreement":null},{"id":"W3196217705","doi":"10.51731/cjht.2021.126","title":"Barricaid Spinal Implant Device","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Spine and Intervertebral Disc Pathology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Horizon; Implant; Emerging technologies; Business; Medicine; Computer science; Surgery; Artificial intelligence; Physics","score_opus":0.049319214766096145,"score_gpt":0.3386718748373813,"score_spread":0.2893526600712852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3196217705","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6560062,0.15701655,0.00054976373,0.18316369,0.00093403476,0.00015317944,0.000020900492,0.0001040324,0.002051659],"genre_scores_gemma":[0.9932029,0.00044323463,0.0017255802,0.0044550532,0.000020777426,0.0000016492232,0.0000034768805,0.000009439593,0.00013784388],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99886817,0.00003833852,0.0004794557,0.000117140735,0.00009875677,0.00039812337],"domain_scores_gemma":[0.9991659,0.0000049900955,0.00020319027,0.00021726041,0.0002594095,0.00014924274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025614447,0.000096177195,0.00040874942,0.00037746143,0.000104654995,0.000014429707,0.0001571821,0.00012723269,0.0001261286],"category_scores_gemma":[0.000737482,0.0000768426,0.00010965986,0.00029741524,0.00011491664,0.00006723595,0.000019672729,0.000442573,0.000025468127],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026728698,0.000056647303,0.01502743,0.00034392605,0.00012177388,0.016982485,0.0001941719,0.0000012247426,0.0026252207,0.0041987426,0.08382919,0.87659246],"study_design_scores_gemma":[0.0017382532,0.00539371,0.331685,0.0015675699,0.0000815317,0.08574739,0.0096423505,0.000012766221,0.014551803,0.003115885,0.54616886,0.0002948669],"about_ca_topic_score_codex":0.0010701749,"about_ca_topic_score_gemma":0.002553184,"teacher_disagreement_score":0.8762976,"about_ca_system_score_codex":0.00023071564,"about_ca_system_score_gemma":0.004304505,"threshold_uncertainty_score":0.76360065},"labels":[],"label_agreement":null},{"id":"W3197948781","doi":"10.51731/cjht.2021.102","title":"Community Pharmacist–Led Medication Reviews","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacist; Medicine; Pharmacy; Context (archaeology); Psychological intervention; Community pharmacist; Nursing; Family medicine; Community pharmacy","score_opus":0.34578656031980903,"score_gpt":0.483134849641905,"score_spread":0.13734828932209597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3197948781","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13918212,0.38934004,0.0005171559,0.46689278,0.0012943657,0.0005223892,0.000014139871,0.00010164698,0.0021353553],"genre_scores_gemma":[0.97947013,0.012274951,0.0010528262,0.006989943,0.000016160506,0.000003412659,0.00000927692,0.000007821214,0.00017546635],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998527,0.00036318944,0.00063550565,0.000065690234,0.0001441535,0.00026445865],"domain_scores_gemma":[0.99870664,0.00014275283,0.0004831725,0.00027416617,0.00020238955,0.00019090765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017251006,0.00008679161,0.00042977036,0.00020793418,0.00025885014,0.000015942376,0.00018774053,0.00008216771,0.00014882247],"category_scores_gemma":[0.003779804,0.000067248875,0.00009418307,0.0002953145,0.00010995594,0.00011787233,0.000020281477,0.0011734111,0.00002693612],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032868495,0.000090906,0.02874892,0.00062809297,0.00007226494,0.0003034041,0.00044876806,6.339797e-7,0.0002351023,0.00028663003,0.034393452,0.93475896],"study_design_scores_gemma":[0.00069204514,0.00017937704,0.0043123392,0.0003351922,0.000049136408,0.00083425205,0.0012099022,0.00001983612,0.0010482644,0.0007150029,0.990546,0.00005864933],"about_ca_topic_score_codex":0.00076876074,"about_ca_topic_score_gemma":0.0009079691,"teacher_disagreement_score":0.95615256,"about_ca_system_score_codex":0.00034496275,"about_ca_system_score_gemma":0.002389689,"threshold_uncertainty_score":0.5097953},"labels":[],"label_agreement":null},{"id":"W3198687654","doi":"10.51731/cjht.2021.127","title":"Medications Containing Low-Dose Codeine for the Treatment of Pain and Coughs","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Respiratory and Cough-Related Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Codeine; Medicine; Medical prescription; Morphine; Narcotic; Pharmacology; Anesthesia","score_opus":0.055967485822450196,"score_gpt":0.353282770741035,"score_spread":0.2973152849185848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3198687654","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2714527,0.49588877,0.0023736272,0.22902526,0.00024165821,0.00082991016,0.000036708927,0.000034519355,0.00011684179],"genre_scores_gemma":[0.991648,0.007389787,0.00032172262,0.00048400924,0.000014727545,0.000020180636,0.0000028886773,0.000006908028,0.00011178164],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991269,0.0000747878,0.00037189107,0.00007822452,0.00011638154,0.00023181713],"domain_scores_gemma":[0.99871576,0.0004869284,0.0001882272,0.00019406012,0.00031408464,0.00010095488],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010001198,0.00006507097,0.00028182345,0.00017827233,0.00023872322,0.000010434823,0.000093901246,0.000091925554,0.000016399534],"category_scores_gemma":[0.0011067151,0.00003978718,0.000056736,0.00021514365,0.00029445667,0.000025717236,0.0000050433687,0.00019543563,3.1797163e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007076852,0.000056291712,0.004378896,0.00013783555,0.00021186178,0.00017828507,0.0006897301,0.000011484771,0.00016837698,0.0014342046,0.0016799414,0.9909823],"study_design_scores_gemma":[0.004408276,0.010791899,0.012796662,0.0010554208,0.00016764553,0.0006740102,0.040818658,0.0004979647,0.004015774,0.0020513828,0.92259353,0.00012880382],"about_ca_topic_score_codex":0.00043116428,"about_ca_topic_score_gemma":0.0019695847,"teacher_disagreement_score":0.99085355,"about_ca_system_score_codex":0.00018441041,"about_ca_system_score_gemma":0.004432291,"threshold_uncertainty_score":0.78626937},"labels":[],"label_agreement":null},{"id":"W3201529651","doi":"10.51731/cjht.2021.149","title":"Heart Function Clinics for Patients With Heart Failure","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Heart failure; Medicine; Guideline; Psychological intervention; Emergency medicine; Intensive care medicine; Internal medicine; Nursing","score_opus":0.19710736695482547,"score_gpt":0.3817221432970112,"score_spread":0.18461477634218573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3201529651","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.32411793,0.036865093,0.00976543,0.6252564,0.0020807842,0.0011102671,0.0005847912,0.00010980222,0.000109474415],"genre_scores_gemma":[0.9643373,0.00008045248,0.01801439,0.017314466,0.00007183352,0.000033567914,0.000034637393,0.000035408397,0.000077947785],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99598616,0.00012708579,0.0030040168,0.000282555,0.00007430983,0.0005258439],"domain_scores_gemma":[0.99649584,0.0004133103,0.0021327347,0.00036751878,0.00042601977,0.00016456336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006265201,0.00014297354,0.000942256,0.0005554724,0.00037695433,0.000076543714,0.0002131443,0.00020811864,0.000066805515],"category_scores_gemma":[0.0051844316,0.00015682759,0.00012764541,0.0002912116,0.000102588354,0.00034132067,0.000013360707,0.00032671017,0.00007470944],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036284982,0.0000927474,0.6727893,0.00057297247,0.000108952416,0.0000024191781,0.00032278796,0.0001335205,3.6570324e-7,0.028534511,0.29091373,0.0064924057],"study_design_scores_gemma":[0.000918716,0.0006820945,0.06720302,0.00015841733,0.0000054412176,0.000019088357,0.0023217495,0.000035466375,0.0000033638205,0.019347558,0.9091316,0.00017350454],"about_ca_topic_score_codex":0.0008658997,"about_ca_topic_score_gemma":0.0047676405,"teacher_disagreement_score":0.6402194,"about_ca_system_score_codex":0.0007943497,"about_ca_system_score_gemma":0.0031784847,"threshold_uncertainty_score":0.6395244},"labels":[],"label_agreement":null},{"id":"W3201749259","doi":"10.51731/cjht.2021.150","title":"Encorafenib in Combination With Binimetinib (Braftovi and Mektovi)","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Metastatic melanoma; Medicine; Business; Test (biology); Marketing; Melanoma; Economic growth; Economics; Cancer research; Health care","score_opus":0.012647135161659275,"score_gpt":0.23328943117980475,"score_spread":0.22064229601814547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3201749259","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9605218,0.032843094,0.0003156943,0.005866774,0.000094076895,0.000076499186,0.000007049596,0.000008269149,0.00026674586],"genre_scores_gemma":[0.99784666,0.00071421923,0.0011607835,0.00020506339,0.0000064748765,0.0000024562398,0.000008518933,0.0000070724027,0.00004873704],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993246,0.000050336334,0.0002342403,0.00012068107,0.000057095116,0.00021302639],"domain_scores_gemma":[0.99954325,0.000010258797,0.00014583366,0.00013511913,0.000108548484,0.000056992754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027465294,0.00007435134,0.00016205641,0.0001889446,0.0000653588,0.000017583445,0.00010640528,0.000112747904,0.0000041784415],"category_scores_gemma":[0.00024470553,0.000063412605,0.000018557543,0.00015994474,0.00009847004,0.000005262299,0.000018876935,0.00015052437,5.348352e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009716744,0.00010341164,0.17266273,0.00023472597,0.000085036685,0.0009302536,0.00045671308,0.000029308929,0.040688686,0.0058532814,0.0039669727,0.7748917],"study_design_scores_gemma":[0.004395593,0.0049052327,0.1079776,0.0005067329,0.000021368489,0.003096818,0.009454341,0.000017120714,0.26149037,0.0060435934,0.6014981,0.0005931095],"about_ca_topic_score_codex":0.00045910513,"about_ca_topic_score_gemma":0.009639872,"teacher_disagreement_score":0.7742986,"about_ca_system_score_codex":0.000037018926,"about_ca_system_score_gemma":0.0016702035,"threshold_uncertainty_score":0.5379275},"labels":[],"label_agreement":null},{"id":"W3202444222","doi":"10.51731/cjht.2021.157","title":"Pharyngeal Electrical Stimulation for the Treatment of Dysphagia Associated With Neurologic Conditions","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Dysphagia Assessment and Management","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dysphagia; Swallowing; Horizon; Stimulation; Medicine; Emerging technologies; Physical medicine and rehabilitation; Intensive care medicine; Computer science; Surgery; Artificial intelligence; Internal medicine; Physics","score_opus":0.06738108330130502,"score_gpt":0.3949480469823885,"score_spread":0.3275669636810835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3202444222","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7817935,0.055376086,0.01183562,0.14195283,0.0021678277,0.0052813264,0.00033303132,0.00029196852,0.0009678477],"genre_scores_gemma":[0.99779224,0.00070387096,0.00037382785,0.0006537626,0.000015953192,0.00009224751,0.00003132676,0.000012673483,0.00032407627],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99837923,0.0002191911,0.0006282901,0.00012461502,0.00014618518,0.0005024651],"domain_scores_gemma":[0.9975194,0.000984538,0.0007598804,0.00020232248,0.00046998463,0.000063884596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005187462,0.00011890918,0.00037272225,0.00024817523,0.0008389681,0.00001062786,0.00019042371,0.00013008226,0.00006950546],"category_scores_gemma":[0.00050152285,0.00007308379,0.00007694896,0.0004428429,0.00012593677,0.00007632851,0.000010057226,0.0003006915,0.0000018444674],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000392204,0.0011108962,0.41528848,0.00047393914,0.0025314777,0.00046353228,0.003404299,0.0020109816,0.0001804668,0.055625048,0.06179,0.4567287],"study_design_scores_gemma":[0.0081812395,0.0116251735,0.6199819,0.00032754178,0.0006738032,0.000037403155,0.012072273,0.0019118063,0.0003744344,0.011142016,0.33332735,0.00034507032],"about_ca_topic_score_codex":0.00058404607,"about_ca_topic_score_gemma":0.0071417848,"teacher_disagreement_score":0.45638362,"about_ca_system_score_codex":0.00062658254,"about_ca_system_score_gemma":0.0038211336,"threshold_uncertainty_score":0.6778527},"labels":[],"label_agreement":null},{"id":"W3203425821","doi":"10.51731/cjht.2021.168","title":"Nivolumab (Opdivo) in combination with Ipilimumab (Yervoy)","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ipilimumab; Nivolumab; Reimbursement; Medicine; Drug; Internal medicine; Oncology; Pharmacology; Immunotherapy; Cancer","score_opus":0.020374842019405787,"score_gpt":0.27163697770100426,"score_spread":0.2512621356815985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3203425821","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8158344,0.08293431,0.00014374891,0.100031026,0.00027463696,0.00022762775,0.000005851451,0.00005299964,0.0004953778],"genre_scores_gemma":[0.99731046,0.0010248708,0.0006521217,0.0008686843,0.0000044808835,0.000003150844,0.00000343739,0.000010444072,0.00012234408],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9989985,0.00003978107,0.00041135927,0.00010590087,0.00014233179,0.00030213394],"domain_scores_gemma":[0.9992991,0.000024078437,0.00021933187,0.00018841683,0.00020787954,0.00006119618],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039239178,0.000087640095,0.00031747675,0.0005387459,0.00008941129,0.000019416104,0.00011050681,0.00010542954,0.000051299678],"category_scores_gemma":[0.00016142405,0.0000708558,0.00005086232,0.00060512824,0.00014777065,0.0000833371,0.0000066299967,0.00036351028,0.0000017764195],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045352778,0.000088597604,0.036066245,0.00018423914,0.00008648649,0.0015693584,0.00044188628,0.0000053104,0.00041765845,0.0005065676,0.0029212977,0.9572588],"study_design_scores_gemma":[0.023443813,0.006356794,0.53325075,0.0039307824,0.00005855537,0.007971612,0.025001196,0.000039932238,0.008678913,0.0034159112,0.38737425,0.00047748326],"about_ca_topic_score_codex":0.004362132,"about_ca_topic_score_gemma":0.030361967,"teacher_disagreement_score":0.9567813,"about_ca_system_score_codex":0.0007744959,"about_ca_system_score_gemma":0.0058829375,"threshold_uncertainty_score":0.99975276},"labels":[],"label_agreement":null},{"id":"W3204294498","doi":"10.51731/cjht.2021.167","title":"Onasemnogene Abeparvovec (Zolgensma)","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Neurogenetic and Muscular Disorders Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"SMN1; SMA*; Spinal muscular atrophy; Medicine; Family medicine; Food and drug administration; Expert opinion; Intensive care medicine; Medical emergency","score_opus":0.039936633468162064,"score_gpt":0.32346405215871643,"score_spread":0.28352741869055437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3204294498","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5920747,0.29895368,0.00038310108,0.106523775,0.0003158626,0.00024386361,0.000012994676,0.00006355787,0.0014284876],"genre_scores_gemma":[0.9947396,0.0024564501,0.001266797,0.0011546141,0.000013401566,0.000002502278,0.0000036595445,0.000016049524,0.00034690456],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99871886,0.0000543444,0.0003859701,0.0001360433,0.00023416361,0.0004705942],"domain_scores_gemma":[0.99897045,0.0000262818,0.00013158313,0.00030542898,0.00036496186,0.00020132154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003444116,0.000093317954,0.00034303995,0.0003970154,0.00014745607,0.000020094716,0.00016735743,0.0001078421,0.00012849648],"category_scores_gemma":[0.00073866686,0.00008025899,0.00012334489,0.00041860825,0.00018182266,0.000029550767,0.000022513726,0.00042528627,0.000018908926],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022685928,0.00006867536,0.01477819,0.00023913565,0.00015038974,0.0067586284,0.00013870597,0.000006575813,0.003178264,0.0011256881,0.018165817,0.95536727],"study_design_scores_gemma":[0.0013566738,0.00076342566,0.026964944,0.0002977192,0.000039490486,0.00878526,0.0036758387,0.000009272233,0.033167873,0.0021795868,0.9225953,0.00016461531],"about_ca_topic_score_codex":0.0005938917,"about_ca_topic_score_gemma":0.0018269022,"teacher_disagreement_score":0.95520264,"about_ca_system_score_codex":0.00019071261,"about_ca_system_score_gemma":0.009464408,"threshold_uncertainty_score":0.99615103},"labels":[],"label_agreement":null},{"id":"W3206706106","doi":"10.51731/cjht.2021.170","title":"Bone Growth Stimulators for Treatment of Adults with Bone Disease or Injury","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Bone fractures and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Low-intensity pulsed ultrasound; Medicine; Context (archaeology); Radiography; Ultrasound; Nonunion; Stimulation; Bone healing; Therapeutic ultrasound; Bone growth; Surgery; Radiology; Internal medicine","score_opus":0.020846551201385385,"score_gpt":0.2969539266862987,"score_spread":0.2761073754849133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3206706106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9081889,0.06077842,0.00013306439,0.029850544,0.00013389446,0.0006376931,0.0002208981,0.00004194393,0.000014681628],"genre_scores_gemma":[0.99547285,0.0013142336,0.0027834743,0.00023889999,0.0000146035345,0.000017942866,0.000018881718,0.000020551477,0.00011855589],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99887925,0.000017059852,0.00046537613,0.00015042376,0.0001380752,0.00034981122],"domain_scores_gemma":[0.9986971,0.00005193281,0.00037142346,0.00025310618,0.00034722625,0.0002792045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000077037796,0.00015763889,0.00063104293,0.0003303019,0.00011163906,0.000009449247,0.00005845236,0.0000902378,0.00002145703],"category_scores_gemma":[0.0002529826,0.000093891984,0.0001202733,0.00025202704,0.00012597015,0.000052739742,0.000005867738,0.00009073215,6.3264656e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007129244,0.000939783,0.123990975,0.0012950423,0.0007770218,0.009193766,0.0006841663,0.000015224296,0.000041394796,0.0005899855,0.003406273,0.8519371],"study_design_scores_gemma":[0.06852371,0.10800027,0.4781161,0.012904455,0.00283562,0.007925404,0.01987781,0.00014346927,0.035891205,0.0078061083,0.25654572,0.0014301317],"about_ca_topic_score_codex":0.001951737,"about_ca_topic_score_gemma":0.0038015489,"teacher_disagreement_score":0.85050696,"about_ca_system_score_codex":0.0004669551,"about_ca_system_score_gemma":0.005623148,"threshold_uncertainty_score":0.99752223},"labels":[],"label_agreement":null},{"id":"W3209492902","doi":"10.51731/cjht.2021.180","title":"Celebrating Medical Librarians During Canadian Library Month","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Social Media in Health Education","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Coronavirus disease 2019 (COVID-19); Pandemic; Library science; Work (physics); Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); 2019-20 coronavirus outbreak; Medical library; Political science; Public relations; Medicine; Engineering; Computer science; Virology","score_opus":0.05334930675110122,"score_gpt":0.3290886376424987,"score_spread":0.27573933089139746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3209492902","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.30365652,0.04202321,0.000013626457,0.6419298,0.0062574577,0.00043873108,0.000019498782,0.0002244397,0.005436677],"genre_scores_gemma":[0.9942452,0.0020952192,0.0011424584,0.0020157322,0.00034010166,0.000028347113,0.0000052542778,0.00002576413,0.000101925405],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971424,0.00041837714,0.00071950466,0.0001784801,0.00046409536,0.0010771562],"domain_scores_gemma":[0.99751306,0.00053841947,0.00039745733,0.00021655273,0.00019687213,0.0011376236],"candidate_categories":["metaresearch","sts"],"consensus_categories":[],"category_scores_codex":[0.0012233085,0.00011832927,0.00033607433,0.0007264169,0.0018091763,0.00017922923,0.0007081572,0.00044564478,0.00077079167],"category_scores_gemma":[0.017100865,0.00012965147,0.00007123251,0.0011933888,0.00044074006,0.00064811145,0.000025586303,0.0008799458,0.000013548128],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000003918132,0.000025072422,0.15948452,0.00018322302,0.000034634526,0.0014016144,0.031818014,0.0000042918414,0.0000037929947,0.031414624,0.016650416,0.75897586],"study_design_scores_gemma":[0.00026539993,0.00006539865,0.0631088,0.0005357463,0.0000068145114,0.00012612296,0.09424027,0.0000040895334,0.00019578928,0.0061056153,0.8351131,0.00023285914],"about_ca_topic_score_codex":0.6569957,"about_ca_topic_score_gemma":0.9304945,"teacher_disagreement_score":0.81846267,"about_ca_system_score_codex":0.0012715134,"about_ca_system_score_gemma":0.13498288,"threshold_uncertainty_score":0.9994903},"labels":[],"label_agreement":null},{"id":"W3209734387","doi":"10.51731/cjht.2021.183","title":"Daunorubicin and Cytarabine Liposome (Vyxeos)","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Daunorubicin; Cytarabine; Reimbursement; Medicine; Myeloid leukemia; Drug; Vial; Leukemia; Intensive care medicine; Pharmacology; Internal medicine; Health care; Political science; Chemistry","score_opus":0.022976893449378248,"score_gpt":0.28637585964007134,"score_spread":0.2633989661906931,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3209734387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6806797,0.14301749,0.00012391916,0.17427723,0.00053747906,0.00016097094,0.000012932295,0.00008368507,0.0011066141],"genre_scores_gemma":[0.99466115,0.003085532,0.00049334107,0.0014634702,0.000023813329,0.000002593261,0.0000016006546,0.000010115613,0.0002583922],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991639,0.000026036549,0.0003325973,0.00010701917,0.00008712831,0.00028329212],"domain_scores_gemma":[0.9993132,0.00002374225,0.00014501305,0.00018413735,0.00019130095,0.00014264436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019477146,0.00008269139,0.00032589215,0.00033245207,0.00017514975,0.00002332811,0.000073172174,0.000085661166,0.000066175235],"category_scores_gemma":[0.00024153489,0.00006996591,0.000050301835,0.00032684504,0.00014761154,0.00007147852,0.000014650123,0.00040648846,0.0000050484996],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036033336,0.000054983677,0.10147715,0.00035961485,0.00015392744,0.002615783,0.00032734725,0.000007515018,0.003390331,0.0051609688,0.019314842,0.8671015],"study_design_scores_gemma":[0.0015687639,0.0011910376,0.11517968,0.0006659196,0.00007505292,0.014140006,0.003654715,0.0000031391899,0.010373327,0.0034839332,0.8494819,0.00018253259],"about_ca_topic_score_codex":0.001729581,"about_ca_topic_score_gemma":0.0052052876,"teacher_disagreement_score":0.866919,"about_ca_system_score_codex":0.00023458873,"about_ca_system_score_gemma":0.0036334973,"threshold_uncertainty_score":0.64456683},"labels":[],"label_agreement":null},{"id":"W3212825246","doi":"10.51731/cjht.2021.197","title":"Biologics in Plaque Psoriasis","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Ustekinumab; Biosimilar; Certolizumab pegol; Adalimumab; Infliximab; Etanercept; Secukinumab; Ixekizumab; Psoriasis; Dermatology; Internal medicine; Psoriatic arthritis; Tumor necrosis factor alpha","score_opus":0.039873739703723196,"score_gpt":0.3030348355283963,"score_spread":0.26316109582467306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212825246","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1743601,0.5970261,0.0009096835,0.22206876,0.0036568728,0.00024525338,0.00009249031,0.00012983513,0.0015108726],"genre_scores_gemma":[0.99413383,0.002148997,0.0023958455,0.0011318059,0.0000056943536,0.0000015833953,0.0000033808444,0.000006241999,0.00017263358],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985012,0.00026563852,0.0005751707,0.00014573096,0.000021810321,0.0004904387],"domain_scores_gemma":[0.99927276,0.00014352905,0.00022860989,0.00019241803,0.00013370291,0.000028990564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009303111,0.00010994535,0.00043482723,0.0004138433,0.00012229793,0.000013989984,0.0002997898,0.0004507179,0.00019314149],"category_scores_gemma":[0.0013397697,0.00008444222,0.000085985404,0.00047165793,0.0003243777,0.000043657565,0.000030433086,0.0007182751,0.000013057762],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027004653,0.000060611135,0.022967132,0.00005241879,0.000105260915,0.00058250455,0.00016704007,0.000004070273,0.0037803093,0.010112856,0.014603563,0.94753724],"study_design_scores_gemma":[0.00092098804,0.0004393856,0.017799603,0.00021445,0.000015557795,0.0011131815,0.004463279,0.0000012467867,0.040661752,0.016540024,0.9176074,0.00022309514],"about_ca_topic_score_codex":0.0010271637,"about_ca_topic_score_gemma":0.0063117975,"teacher_disagreement_score":0.94731414,"about_ca_system_score_codex":0.00018809034,"about_ca_system_score_gemma":0.0019571714,"threshold_uncertainty_score":0.3522131},"labels":[],"label_agreement":null},{"id":"W3215707621","doi":"10.51731/cjht.2021.214","title":"Adaptive Deep Brain Stimulation for the Treatment of Parkinson Disease and Essential Tremor","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Neurological disorders and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Deep brain stimulation; Essential tremor; Parkinson's disease; Physical medicine and rehabilitation; Neuroscience; Intervention (counseling); Medicine; Disease; Psychology; Psychiatry; Pathology","score_opus":0.0356514606983972,"score_gpt":0.30351253595561967,"score_spread":0.26786107525722247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215707621","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.77108365,0.13169543,0.0013278889,0.095094875,0.00011632732,0.0006045001,0.00004820034,0.00001717869,0.000011938183],"genre_scores_gemma":[0.9968578,0.002212429,0.0004320624,0.0004437146,0.000008733824,0.000010770443,0.0000045338043,0.0000054651136,0.000024448344],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.999422,0.000027446451,0.00022698069,0.00009486372,0.00006441204,0.00016425364],"domain_scores_gemma":[0.9993792,0.00017169293,0.00016021037,0.00011407232,0.00008885604,0.000085979176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000068121684,0.00007481404,0.0002375792,0.00009499983,0.00012803021,0.000007682241,0.000038932092,0.000044135624,0.000008040586],"category_scores_gemma":[0.0002686723,0.00004357705,0.00007707639,0.000097882585,0.00012262682,0.000023304809,0.0000036973634,0.000058241996,1.520283e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040120078,0.0001999763,0.02391675,0.00006268923,0.00017409855,0.0003308183,0.00023321579,0.000058922462,0.000030411666,0.00049724913,0.00040398652,0.9736907],"study_design_scores_gemma":[0.010463619,0.015778903,0.85572296,0.00026287342,0.0006916138,0.00017342805,0.005975409,0.0025567228,0.0014687309,0.03177745,0.074921034,0.00020725769],"about_ca_topic_score_codex":0.00036154693,"about_ca_topic_score_gemma":0.0017417177,"teacher_disagreement_score":0.97348344,"about_ca_system_score_codex":0.00009153988,"about_ca_system_score_gemma":0.0007049032,"threshold_uncertainty_score":0.17770205},"labels":[],"label_agreement":null},{"id":"W3216749353","doi":"10.51731/cjht.2021.209","title":"Canadian Trends and Projections in Prescription Drug Purchases: 2001–2023","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital; Women's College Hospital; Nova Scotia Health Authority; University of Calgary; Institute for Clinical Evaluative Sciences; Université Laval; Queen Elizabeth II Health Sciences Centre; University of British Columbia; Public Health Ontario; University of Toronto","funders":"","keywords":"Medical prescription; Pace; Audit; Prescription drug; Specialty; Business; Annual growth %; Medicine; Family medicine; Agricultural economics; Accounting; Pharmacology; Economics; Geography","score_opus":0.0745478460040486,"score_gpt":0.30158214108106585,"score_spread":0.22703429507701725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216749353","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.32538083,0.16633885,0.00007140917,0.4863225,0.0014836664,0.00025205972,0.00091315387,0.000048492584,0.019189019],"genre_scores_gemma":[0.99445605,0.0032452622,0.0001963549,0.0014797283,0.000015397456,0.0000069269036,0.00000579617,0.000010738533,0.0005837561],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99860233,0.000020701455,0.00066227093,0.00017251639,0.000014470228,0.0005277359],"domain_scores_gemma":[0.99928844,0.00002153416,0.00025730033,0.00015244407,0.00003836457,0.00024193953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006605949,0.00009451645,0.0003350518,0.0019236229,0.00017043031,0.00007987911,0.00017259597,0.000107780645,0.00016997449],"category_scores_gemma":[0.0003122745,0.000113985065,0.0000492223,0.0005771194,0.000087373664,0.00018530243,0.000016252281,0.0003869259,0.000018390103],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010124929,0.000070003785,0.2078938,0.00016515332,0.00010590904,0.0004113226,0.0018550133,0.0001851958,0.000009135655,0.22763342,0.103151225,0.45850968],"study_design_scores_gemma":[0.00037406577,0.0000513169,0.034744218,0.000049809725,0.0000023422585,0.00014871608,0.001078306,0.00033889478,0.000023273144,0.039848052,0.923182,0.00015897429],"about_ca_topic_score_codex":0.52341783,"about_ca_topic_score_gemma":0.904001,"teacher_disagreement_score":0.8200308,"about_ca_system_score_codex":0.0010502454,"about_ca_system_score_gemma":0.002161203,"threshold_uncertainty_score":0.4797558},"labels":[],"label_agreement":null},{"id":"W4200006876","doi":"10.51731/cjht.2021.221","title":"Lung-RADS Versus Pan-Canadian Early Detection of Lung Cancer Study Screening for Patients at High Risk of Lung Cancer","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lung cancer; Medicine; Lung cancer screening; Guideline; Lung; Radiology; National Lung Screening Trial; Medical physics; Oncology; Internal medicine; Pathology","score_opus":0.024937987854469667,"score_gpt":0.32986466822726823,"score_spread":0.3049266803727986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200006876","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.933044,0.060273413,0.000044215583,0.00392728,0.0010845572,0.0011176863,0.00047382203,0.000022901626,0.000012090261],"genre_scores_gemma":[0.99580926,0.0036040759,0.00023578119,0.000083265615,0.000041599018,0.0001502866,0.000010221733,0.000033827295,0.000031698306],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997893,0.00007852204,0.0008294648,0.00027572233,0.000309885,0.00061341666],"domain_scores_gemma":[0.9974068,0.000119954646,0.00094921805,0.00035232175,0.00088122167,0.00029050364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003483855,0.0002181623,0.000771722,0.00069607556,0.00033873323,0.000017220249,0.00019125878,0.0001850862,0.000063407424],"category_scores_gemma":[0.00042957623,0.00019248687,0.0001824893,0.00051880494,0.000113930866,0.00010625606,0.000028124976,0.00035439723,2.263492e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0002431528,0.00009568503,0.855718,0.00039934315,0.00094893813,0.00004623964,0.0005032676,0.00005049871,0.000011052254,0.000012359311,0.00081846485,0.14115296],"study_design_scores_gemma":[0.007331574,0.0029996678,0.97964287,0.0014763727,0.0010618584,0.000009305619,0.0015238978,0.00012581558,0.003007697,0.000019499137,0.0026172732,0.00018418157],"about_ca_topic_score_codex":0.68909943,"about_ca_topic_score_gemma":0.8709642,"teacher_disagreement_score":0.18186475,"about_ca_system_score_codex":0.005253607,"about_ca_system_score_gemma":0.0057630464,"threshold_uncertainty_score":0.99987334},"labels":[],"label_agreement":null},{"id":"W4200067059","doi":"10.51731/cjht.2021.185","title":"Risdiplam (Evrysdi)","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Neurogenetic and Muscular Disorders Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Family medicine; Spinal muscular atrophy; Physical therapy; Atrophy; Intensive care medicine; Pathology; Political science; Health care; Disease","score_opus":0.03575483784444124,"score_gpt":0.32543619014389263,"score_spread":0.2896813522994514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200067059","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5117552,0.31924853,0.00055095734,0.16511364,0.00040552448,0.00026978145,0.000008786319,0.00008015099,0.0025673625],"genre_scores_gemma":[0.99585074,0.0020632583,0.0009290336,0.0008042002,0.000009970553,0.0000019969596,0.0000019238314,0.000011823462,0.00032706177],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99894255,0.000047638212,0.0003243591,0.000105533945,0.00018644266,0.00039348772],"domain_scores_gemma":[0.9991667,0.000023482535,0.00010953489,0.00024729484,0.00029702391,0.00015595411],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032286465,0.00007232211,0.000283643,0.00036746962,0.0001295445,0.000017488816,0.00014293277,0.00009219507,0.00010675917],"category_scores_gemma":[0.00081141316,0.00006141342,0.00009564714,0.0003639854,0.00015459268,0.000028503226,0.000018241963,0.00044637683,0.000013245496],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015072118,0.00004824721,0.02120932,0.00022225601,0.000094278235,0.0050457753,0.00016924596,0.0000042953056,0.0007429309,0.0011489915,0.020777361,0.95052224],"study_design_scores_gemma":[0.0010950956,0.00062172994,0.031656,0.00027739807,0.000024681638,0.006975814,0.00476955,0.000007374331,0.008346949,0.0024788338,0.9436309,0.00011568128],"about_ca_topic_score_codex":0.00049669924,"about_ca_topic_score_gemma":0.0012116114,"teacher_disagreement_score":0.95040655,"about_ca_system_score_codex":0.00014133014,"about_ca_system_score_gemma":0.0077750813,"threshold_uncertainty_score":0.99784994},"labels":[],"label_agreement":null},{"id":"W4200081815","doi":"10.51731/cjht.2021.226","title":"Liraglutide (Saxenda)","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Liraglutide; Reimbursement; Medicine; Dyslipidemia; Overweight; Type 2 diabetes; Weight loss; Weight management; Obesity; Diabetes mellitus; Intervention (counseling); Family medicine; Physical therapy; Gerontology; Internal medicine; Health care; Nursing; Endocrinology; Political science","score_opus":0.027145564048585976,"score_gpt":0.27998161503450353,"score_spread":0.25283605098591755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200081815","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.30669662,0.29731825,0.00039353038,0.38064995,0.0012374265,0.00042858027,0.000015205247,0.0002632202,0.012997214],"genre_scores_gemma":[0.99418396,0.0009590849,0.0021467109,0.0016796499,0.000012340118,0.0000023537139,0.0000040070922,0.000009924584,0.0010019667],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99910337,0.000019413563,0.00031970927,0.00009193748,0.00011758771,0.00034796356],"domain_scores_gemma":[0.99934226,0.00001794638,0.00016022405,0.00021468937,0.00015532784,0.00010953525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000234147,0.00008257817,0.0003071412,0.00037120955,0.00010405242,0.00002088129,0.000101003745,0.000065339475,0.00007426985],"category_scores_gemma":[0.000313169,0.000068203284,0.00008287806,0.00027662618,0.00008372814,0.000056097764,0.000017227416,0.00021384105,0.000016926579],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000058574237,0.00003848722,0.015472945,0.00012856294,0.00015133525,0.0022984704,0.000090734626,0.00000202962,0.00004230794,0.004055177,0.031844214,0.94586986],"study_design_scores_gemma":[0.00075060845,0.00050814694,0.021173216,0.0003318764,0.00005616474,0.00045770564,0.0024645845,0.0000026130294,0.0022818325,0.0026216367,0.96927106,0.0000805371],"about_ca_topic_score_codex":0.0003521079,"about_ca_topic_score_gemma":0.0011720046,"teacher_disagreement_score":0.94578934,"about_ca_system_score_codex":0.00032694964,"about_ca_system_score_gemma":0.0026520547,"threshold_uncertainty_score":0.4704631},"labels":[],"label_agreement":null},{"id":"W4200199254","doi":"10.51731/cjht.2021.199","title":"Larotrectinib (Vitrakvi)","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Food and drug administration; Drug; Intensive care medicine; Family medicine; Pharmacology; Political science; Health care","score_opus":0.03795991233794819,"score_gpt":0.31802674102821643,"score_spread":0.2800668286902682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200199254","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.40902176,0.4113629,0.000050250048,0.1722622,0.00086498575,0.00022678557,0.000020200358,0.00011310122,0.006077825],"genre_scores_gemma":[0.99642605,0.0017572928,0.00068120606,0.00079439435,0.000014913303,0.000003693906,0.0000015038316,0.000007931777,0.0003130029],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991753,0.000021649688,0.00030859243,0.000095146665,0.00010294947,0.00029636399],"domain_scores_gemma":[0.99934185,0.000028502494,0.00014933405,0.00014536113,0.00024866636,0.00008631721],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017124576,0.00008470473,0.0003690354,0.00022544476,0.00018035599,0.000014970871,0.00007006811,0.000069786634,0.00006519583],"category_scores_gemma":[0.00044534518,0.00006523923,0.00009046677,0.0002944506,0.00010202386,0.000037438862,0.000012172045,0.00027120544,0.0000048642787],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025966032,0.000037290123,0.033173226,0.00008302276,0.00016449938,0.0020127194,0.00037411152,9.1464653e-7,0.000051115196,0.0004548974,0.010429751,0.9531925],"study_design_scores_gemma":[0.0013279517,0.0013420756,0.10053216,0.00042135772,0.000060430055,0.0038082462,0.009778245,0.0000012423253,0.0038286343,0.0020615729,0.8767079,0.0001301714],"about_ca_topic_score_codex":0.0015317848,"about_ca_topic_score_gemma":0.009561071,"teacher_disagreement_score":0.9530623,"about_ca_system_score_codex":0.00041658498,"about_ca_system_score_gemma":0.0043071746,"threshold_uncertainty_score":0.76407427},"labels":[],"label_agreement":null},{"id":"W4200232119","doi":"10.51731/cjht.2021.171","title":"Upadacitinib (Rinvoq)","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Methotrexate; Drug; Pharmacology; Internal medicine; Health care; Political science","score_opus":0.035849686157004616,"score_gpt":0.3000880696004551,"score_spread":0.26423838344345046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200232119","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4086684,0.45480835,0.00006033146,0.13112397,0.0007970158,0.00020370989,0.00003497817,0.000108311324,0.004194951],"genre_scores_gemma":[0.9949362,0.0025473267,0.0012836817,0.0009408392,0.0000142720555,0.0000025142422,0.0000036475865,0.000009665936,0.0002618456],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990766,0.000018571798,0.00034857087,0.00009660248,0.00011174629,0.0003479092],"domain_scores_gemma":[0.9992876,0.000021953028,0.00015905556,0.00018202465,0.0002397298,0.000109608336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001460573,0.000085810294,0.00036120054,0.0002231827,0.00019270585,0.00001439394,0.00007542365,0.00007675518,0.00008465741],"category_scores_gemma":[0.00044216609,0.0000710831,0.00008830454,0.00025181528,0.00011969642,0.00003975133,0.000014353258,0.00024620767,0.000012719065],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019133844,0.00005242807,0.05492119,0.000102902704,0.00018459787,0.008821901,0.00021402838,6.9948305e-7,0.000054615946,0.0025663034,0.013938363,0.9191238],"study_design_scores_gemma":[0.0025630102,0.0010315025,0.06913767,0.0007476612,0.000049060753,0.008897695,0.009901192,8.8057294e-7,0.0024035955,0.003450789,0.901677,0.00013994174],"about_ca_topic_score_codex":0.001490755,"about_ca_topic_score_gemma":0.0065919147,"teacher_disagreement_score":0.9189839,"about_ca_system_score_codex":0.00026839224,"about_ca_system_score_gemma":0.003042618,"threshold_uncertainty_score":0.53974736},"labels":[],"label_agreement":null},{"id":"W4200249070","doi":"10.51731/cjht.2021.225","title":"Pembrolizumab (Keytruda)","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Pembrolizumab; Medicine; Refractory (planetary science); Drug; Family medicine; Intensive care medicine; Internal medicine; Pharmacology; Political science; Cancer; Health care; Immunotherapy","score_opus":0.027838581508828623,"score_gpt":0.294519728736736,"score_spread":0.26668114722790737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200249070","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.40087813,0.39076093,0.00019043316,0.20491078,0.00096929236,0.00017557178,0.000014392491,0.0001100517,0.0019903902],"genre_scores_gemma":[0.9945876,0.0023513595,0.00068327965,0.002069912,0.000017121358,0.000001371801,0.0000020840812,0.0000105422005,0.00027674774],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990122,0.000028613847,0.0004124132,0.00009182173,0.00012859015,0.00032637507],"domain_scores_gemma":[0.99923766,0.000020660784,0.00020873158,0.00022633902,0.00021529525,0.00009130602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003008644,0.000082085826,0.0003133032,0.00033227846,0.00013274707,0.000020247278,0.00012681776,0.00011293413,0.00014971511],"category_scores_gemma":[0.0002891387,0.00006862413,0.00011572762,0.00036649738,0.000156993,0.0000509387,0.000008400169,0.00033250413,0.0000053408853],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013206704,0.00002058338,0.0062753307,0.00012317426,0.00010989291,0.0013021112,0.00019827465,7.5631726e-7,0.0008673556,0.00052125007,0.017265823,0.9731834],"study_design_scores_gemma":[0.0020053254,0.0006855013,0.03365567,0.00049432716,0.000023183582,0.006869439,0.0044568977,0.0000023528075,0.007095849,0.0011735138,0.9434216,0.00011635546],"about_ca_topic_score_codex":0.0015570681,"about_ca_topic_score_gemma":0.0029747803,"teacher_disagreement_score":0.97306705,"about_ca_system_score_codex":0.00044095502,"about_ca_system_score_gemma":0.00808721,"threshold_uncertainty_score":0.997536},"labels":[],"label_agreement":null},{"id":"W4200299004","doi":"10.51731/cjht.2021.216","title":"Thank You to Our Readers and Contributors","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Biomedical and Engineering Education","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Work (physics); Public relations; Engineering ethics; Library science; Political science; Medical education; Medicine; Computer science; Engineering","score_opus":0.013936325513447655,"score_gpt":0.23345826423553198,"score_spread":0.21952193872208434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200299004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.45220736,0.17580073,0.010667393,0.3548302,0.005388632,0.00020004027,0.00006148821,0.00062156323,0.00022258202],"genre_scores_gemma":[0.99804133,0.00045807587,0.0012361394,0.00021301353,0.000019313908,0.0000016299518,0.0000016305831,0.000008058652,0.000020800137],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99945146,0.000006697659,0.00019012911,0.000052088315,0.000054078646,0.00024556866],"domain_scores_gemma":[0.99968696,0.000010528192,0.000025817084,0.00008186469,0.000053398242,0.00014144748],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001662937,0.00006048985,0.00014523641,0.00022837547,0.000047014903,0.000019915264,0.00008783775,0.00006809868,0.0000030860049],"category_scores_gemma":[0.0002692456,0.000055761204,0.000016638864,0.00023665217,0.00002062074,0.000040718383,0.0000058616356,0.00020473065,0.000002961127],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000016399853,0.000005767474,0.0014918493,0.00039041275,0.00005038802,0.00012296556,0.00094227196,0.00057191565,0.00026826258,0.0006351178,0.059605706,0.9359137],"study_design_scores_gemma":[0.00029579602,0.0001379222,0.0191212,0.00047443085,0.000010842335,0.00056971953,0.01866931,0.00018757992,0.003698894,0.0015683091,0.9550032,0.0002627832],"about_ca_topic_score_codex":0.00038148483,"about_ca_topic_score_gemma":0.00067179237,"teacher_disagreement_score":0.93565094,"about_ca_system_score_codex":0.00016315587,"about_ca_system_score_gemma":0.00043323755,"threshold_uncertainty_score":0.22738759},"labels":[],"label_agreement":null},{"id":"W4200303884","doi":"10.51731/cjht.2021.152","title":"Encorafenib (Braftovi)","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Cetuximab; Drug class; Drug; Family medicine; Business; Pharmacology; Economic growth; Internal medicine; Economics; Cancer; Health care","score_opus":0.01682635852450084,"score_gpt":0.24471893124743535,"score_spread":0.2278925727229345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200303884","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.79715186,0.1771728,0.002177455,0.019531054,0.0011820329,0.00012784179,0.000040990493,0.000042198084,0.0025737556],"genre_scores_gemma":[0.9972534,0.00067780184,0.0011647472,0.00059316156,0.00003170672,0.0000016525,0.000010768117,0.000009428894,0.00025732533],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99916863,0.0000445492,0.00029510562,0.00012259305,0.00006720194,0.00030192846],"domain_scores_gemma":[0.9993083,0.0000065421264,0.00017661626,0.00025027507,0.00017318933,0.00008510401],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002398306,0.000083180086,0.00017367529,0.00012557129,0.00012004238,0.00002003737,0.00023544283,0.00014928171,0.000023003993],"category_scores_gemma":[0.00044709974,0.00007665499,0.00007040405,0.00012990918,0.00009042642,0.0000034685092,0.000028775523,0.00016805239,0.00000595892],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022189146,0.000044117034,0.0130200805,0.0001302421,0.00011459841,0.0011467816,0.00017392576,0.000026847812,0.1201329,0.0046262015,0.07118103,0.7893811],"study_design_scores_gemma":[0.00023750812,0.000344821,0.0022435666,0.000042554395,0.000004299894,0.0007961147,0.0011144775,8.979077e-7,0.110140964,0.0013849573,0.8835803,0.000109522574],"about_ca_topic_score_codex":0.0002774116,"about_ca_topic_score_gemma":0.0029404312,"teacher_disagreement_score":0.81239927,"about_ca_system_score_codex":0.000045829176,"about_ca_system_score_gemma":0.0036975872,"threshold_uncertainty_score":0.65593606},"labels":[],"label_agreement":null},{"id":"W4200307909","doi":"10.51731/cjht.2021.200","title":"Incobotulinumtoxina (Xeomin)","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Botulinum Toxin and Related Neurological Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Political science","score_opus":0.026164403066828188,"score_gpt":0.27842274531123146,"score_spread":0.25225834224440324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200307909","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4222561,0.18213987,0.00036256647,0.39024478,0.00095407903,0.00024064879,0.000009169236,0.0002066566,0.0035860932],"genre_scores_gemma":[0.99076784,0.0032469074,0.0012181598,0.0044734557,0.000011503079,0.0000013293441,0.0000023796376,0.000013498478,0.00026494317],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986652,0.00006169151,0.0005426242,0.00014742662,0.00014336698,0.00043969022],"domain_scores_gemma":[0.99906456,0.00005131952,0.00023392489,0.00024303017,0.00022596521,0.00018122068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030037083,0.00011799545,0.000442611,0.00032734298,0.00016069363,0.000018501534,0.00016954115,0.00029128342,0.00013285488],"category_scores_gemma":[0.0009887913,0.000089768415,0.00014097345,0.0005062243,0.00024698995,0.00005382019,0.000020875115,0.0009091023,0.000026533851],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006640125,0.00014112509,0.013978149,0.00026087166,0.0001683485,0.009736845,0.00025591074,0.000034224762,0.0009840346,0.003508631,0.024492443,0.94637305],"study_design_scores_gemma":[0.0027761166,0.0022235163,0.048677742,0.00059824414,0.00008204728,0.01149885,0.0050146887,0.000035002126,0.005769881,0.019220022,0.9037764,0.0003275074],"about_ca_topic_score_codex":0.00020826668,"about_ca_topic_score_gemma":0.00049325905,"teacher_disagreement_score":0.9460455,"about_ca_system_score_codex":0.00015065745,"about_ca_system_score_gemma":0.0039903154,"threshold_uncertainty_score":0.7078648},"labels":[],"label_agreement":null},{"id":"W4200446389","doi":"10.51731/cjht.2021.229","title":"Self-Sampling Devices for HPV Testing","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Sampling (signal processing); Cervical cancer screening; Medicine; Cancer screening; Cervical cancer; Test (biology); Cancer; Family medicine; Medical physics; Computer science; Internal medicine","score_opus":0.17188453703624765,"score_gpt":0.4087846352444208,"score_spread":0.23690009820817318,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200446389","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09268465,0.55728745,0.006614179,0.32611954,0.0012434789,0.0014790986,0.00008782844,0.0006055659,0.013878172],"genre_scores_gemma":[0.96573675,0.0003564236,0.032700907,0.0010863536,0.000054162032,0.0000075369894,0.0000030281485,0.000014114696,0.000040710845],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99884665,0.000019910105,0.00039149527,0.000117680254,0.00015035369,0.00047388175],"domain_scores_gemma":[0.99836564,0.00023963026,0.00015308309,0.00015920046,0.00091438426,0.00016803347],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006015202,0.000076479904,0.00032654277,0.00030880197,0.00024653808,0.000037952213,0.00015180539,0.00009873193,0.00009920706],"category_scores_gemma":[0.003024625,0.00006463153,0.0000743469,0.00044875484,0.00006683806,0.000052296196,0.000018615627,0.00041549685,0.0000023179655],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013256259,0.000013249992,0.008486346,0.00077186833,0.000036576603,0.00012630888,0.000083162595,0.0000052549753,0.000024510819,0.00046794847,0.0008286874,0.98914284],"study_design_scores_gemma":[0.001579829,0.001246184,0.1050816,0.0003585641,0.00005487147,0.0014406908,0.0066518085,0.00019596977,0.0014027253,0.005706342,0.8760971,0.00018430565],"about_ca_topic_score_codex":0.00094508566,"about_ca_topic_score_gemma":0.0065154373,"teacher_disagreement_score":0.98895854,"about_ca_system_score_codex":0.0004307503,"about_ca_system_score_gemma":0.0087122945,"threshold_uncertainty_score":0.9969074},"labels":[],"label_agreement":null},{"id":"W4200452605","doi":"10.51731/cjht.2021.222","title":"An Overview of Emerging Point-of-Care Tests for Differentiating Bacterial and Viral Infections","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Antibiotic Use and Resistance","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Point-of-care testing; Antibiotic resistance; Intensive care medicine; Point of care; Antimicrobial stewardship; Medicine; Antibiotics; Psychological intervention; Antibiotic Stewardship; Health care; Diagnostic test; Stewardship (theology); Risk analysis (engineering); Immunology; Biology; Pediatrics; Pathology; Nursing; Microbiology","score_opus":0.03145847286048498,"score_gpt":0.3149869575421082,"score_spread":0.2835284846816232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200452605","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81983393,0.1782436,0.000300253,0.0010060926,0.00044774468,0.000082907354,0.000060816183,0.000013736376,0.000010895723],"genre_scores_gemma":[0.9973629,0.0020506983,0.000522047,0.000027647315,0.000006268868,7.549818e-7,0.000012656015,0.000006082246,0.000010946703],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992081,0.00006402421,0.00041422798,0.000086946566,0.0000152081,0.00021148426],"domain_scores_gemma":[0.99920666,0.000065033804,0.0003915697,0.00012585423,0.00019307404,0.000017804276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015107414,0.000072816634,0.00033311272,0.00018823628,0.00018973758,0.0000071880595,0.00010967478,0.00014370371,0.00002490499],"category_scores_gemma":[0.00029248244,0.000062549254,0.000061320854,0.00010269576,0.0001815215,0.00006872664,0.000015537771,0.00016678369,2.7394304e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000082180035,0.00013233503,0.075930685,0.003247856,0.0003861109,0.00002656854,0.0038299162,0.000007196436,0.22110751,0.009195075,0.00081899675,0.68523556],"study_design_scores_gemma":[0.006024371,0.0075724083,0.2208604,0.0076295906,0.0003318474,0.0011203476,0.07652416,0.000009418026,0.554299,0.009015174,0.115788795,0.00082449603],"about_ca_topic_score_codex":0.00048805485,"about_ca_topic_score_gemma":0.0045932857,"teacher_disagreement_score":0.68441105,"about_ca_system_score_codex":0.000040799114,"about_ca_system_score_gemma":0.0008065229,"threshold_uncertainty_score":0.25631613},"labels":[],"label_agreement":null},{"id":"W4200599422","doi":"10.51731/cjht.2021.201","title":"Givosiran (Givlaari)","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Porphyrin Metabolism and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Family medicine; Political science; Health care","score_opus":0.011996671435491423,"score_gpt":0.24832633320240988,"score_spread":0.23632966176691844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200599422","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.47046384,0.50105363,0.0019620755,0.02314645,0.00092707656,0.00010417645,0.000032052027,0.00003320995,0.0022775235],"genre_scores_gemma":[0.9949498,0.002899658,0.00099441,0.0009785842,0.000022102075,0.0000013143688,0.000009472225,0.0000092817,0.00013535557],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99916565,0.000044867524,0.0002863733,0.00011971313,0.000071440896,0.0003119673],"domain_scores_gemma":[0.9993587,0.0000048772017,0.00016462027,0.00024503024,0.00014805942,0.00007871978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026661484,0.00008405634,0.00018029135,0.0001314137,0.00012612068,0.000022295191,0.00025123,0.0001321151,0.000021252376],"category_scores_gemma":[0.0004872514,0.00007838052,0.00007585773,0.0001589516,0.00012190885,0.0000041659077,0.00002610976,0.00015764614,0.0000038740427],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002112896,0.000046500445,0.015436962,0.000078289064,0.000107022635,0.0003174387,0.00015311071,0.000053347216,0.022798698,0.003632945,0.064591296,0.89276326],"study_design_scores_gemma":[0.00031936224,0.00012936951,0.00523867,0.000024381357,0.0000043667924,0.0002831833,0.0019130927,6.352668e-7,0.02446982,0.0021248152,0.9653836,0.000108686276],"about_ca_topic_score_codex":0.00046488162,"about_ca_topic_score_gemma":0.0028701467,"teacher_disagreement_score":0.9007923,"about_ca_system_score_codex":0.00002417694,"about_ca_system_score_gemma":0.0027805069,"threshold_uncertainty_score":0.49324998},"labels":[],"label_agreement":null},{"id":"W4200625024","doi":"10.51731/cjht.2021.145","title":"Durvalumab (Imfinzi)","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Durvalumab; Reimbursement; Carboplatin; Medicine; Etoposide; Authorization; Cisplatin; Intensive care medicine; Political science; Cancer; Surgery; Chemotherapy; Internal medicine; Law; Computer science; Computer security","score_opus":0.0508276305137164,"score_gpt":0.36922993545455696,"score_spread":0.31840230494084054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200625024","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.129577,0.43787163,0.0001518958,0.42816922,0.00068952166,0.00028568725,0.000021015509,0.00014430036,0.0030897022],"genre_scores_gemma":[0.9940083,0.0032383874,0.0011503141,0.0010931226,0.000025140465,0.0000041241146,0.0000016043632,0.00001296204,0.00046605253],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998651,0.00004938348,0.00041374387,0.0001205293,0.00025369247,0.00051163207],"domain_scores_gemma":[0.9987924,0.000049515347,0.00017593293,0.0002805528,0.000544695,0.00015690888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053716183,0.00009260227,0.00042686425,0.00043457694,0.00021017063,0.000023490213,0.00017484932,0.00008779616,0.000081304264],"category_scores_gemma":[0.0023703743,0.00007518045,0.000090983194,0.00046718115,0.0002591462,0.00006465328,0.00003411743,0.00056743296,0.000014312878],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003747986,0.000041520292,0.039409745,0.000590928,0.0002861063,0.0057580476,0.00057416566,0.0000042953766,0.0002607797,0.0021186345,0.10997295,0.84094536],"study_design_scores_gemma":[0.0013418383,0.0008433672,0.05655726,0.00084574067,0.000033645785,0.0037034797,0.008353382,0.0000043042505,0.003604748,0.0035460985,0.92102385,0.00014227441],"about_ca_topic_score_codex":0.0018385928,"about_ca_topic_score_gemma":0.005019839,"teacher_disagreement_score":0.86443126,"about_ca_system_score_codex":0.00089971017,"about_ca_system_score_gemma":0.012903446,"threshold_uncertainty_score":0.9926925},"labels":[],"label_agreement":null},{"id":"W4205118191","doi":"10.51731/cjht.2022.240","title":"Tucatinib (Tukysa)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Capecitabine; Trastuzumab; Pertuzumab; Medicine; Trastuzumab emtansine; Oncology; Internal medicine; Breast cancer; Cancer; Political science; Colorectal cancer","score_opus":0.08428908766939776,"score_gpt":0.38703315185344067,"score_spread":0.3027440641840429,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205118191","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.27710187,0.15944164,0.000102796264,0.5556741,0.0017116709,0.000891306,0.00008341288,0.00026132344,0.0047318856],"genre_scores_gemma":[0.99684167,0.0003178554,0.0006894852,0.0017192949,0.000022210788,0.000024272602,0.000002383307,0.00002089064,0.0003619281],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982708,0.00009953731,0.00049454387,0.00012518596,0.00041947706,0.00059045403],"domain_scores_gemma":[0.99899167,0.000054533743,0.0002558295,0.00033200707,0.00016135735,0.00020462235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014540955,0.000089629604,0.00034839477,0.00096257596,0.00045619832,0.000017777618,0.00046075945,0.00006213489,0.0006350797],"category_scores_gemma":[0.0008354833,0.0000823739,0.000077706594,0.0006509264,0.00020784141,0.00004003197,0.000059648868,0.0013047134,0.00001297581],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035243895,0.00003621535,0.020864494,0.0001759088,0.00004119192,0.0009388498,0.000631968,0.000020715648,0.00006649089,0.0011918959,0.13920315,0.8367939],"study_design_scores_gemma":[0.0004752898,0.0014344205,0.00675892,0.000100001394,0.000006837724,0.0020758454,0.00848246,0.000007998116,0.00023535528,0.0015740265,0.9787717,0.000077173],"about_ca_topic_score_codex":0.0054758587,"about_ca_topic_score_gemma":0.0014152686,"teacher_disagreement_score":0.83956856,"about_ca_system_score_codex":0.0017982105,"about_ca_system_score_gemma":0.014461689,"threshold_uncertainty_score":0.9911254},"labels":[],"label_agreement":null},{"id":"W4205164313","doi":"10.51731/cjht.2022.238","title":"Approaches to Evaluations of Virtual Care in Primary Care","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Telemedicine and Telehealth Implementation","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Health care; Scope (computer science); Quality (philosophy); Economic evaluation; Resource (disambiguation); Medicine; Nursing; Computer science; Political science","score_opus":0.12000296628863219,"score_gpt":0.35253272883362585,"score_spread":0.23252976254499366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205164313","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91562873,0.039396293,0.00013097917,0.043182302,0.00025927988,0.0009245767,0.000101389785,0.000032294916,0.00034415492],"genre_scores_gemma":[0.9973202,0.000055950113,0.0013042035,0.001193006,0.000011052441,0.000041736646,0.000054623004,0.000010308362,0.000008934665],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.99847114,0.00008788599,0.00071357726,0.000107986576,0.00030859376,0.00031083703],"domain_scores_gemma":[0.9991893,0.00003855474,0.00032403224,0.0001786274,0.00015759267,0.00011186445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062474963,0.00007987276,0.00036360126,0.001385731,0.0001848762,0.0000033194087,0.00017331082,0.000043232652,0.00004048893],"category_scores_gemma":[0.00023444327,0.000076123586,0.000042360818,0.00068130554,0.000060784594,0.000043278218,0.00003209434,0.00042882588,6.577968e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051105482,0.000018633915,0.058564983,0.00044046986,0.000013071031,0.000044724016,0.0132828355,0.0002268603,0.000019659283,0.0004322376,0.0015586274,0.9253468],"study_design_scores_gemma":[0.0024865982,0.008160743,0.28800887,0.00034127285,0.000038520437,0.00025623583,0.60249984,0.000007853279,0.0003456774,0.00025931332,0.09746573,0.00012935234],"about_ca_topic_score_codex":0.0037867916,"about_ca_topic_score_gemma":0.008990333,"teacher_disagreement_score":0.92521745,"about_ca_system_score_codex":0.0019762367,"about_ca_system_score_gemma":0.008217766,"threshold_uncertainty_score":0.9974047},"labels":[],"label_agreement":null},{"id":"W4205185159","doi":"10.51731/cjht.2021.124","title":"Fedratinib (Inrebic)","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Myelofibrosis; Reimbursement; Medicine; Ruxolitinib; Polycythemia vera; Disease; Essential thrombocythemia; Family medicine; Intensive care medicine; Internal medicine; Health care; Political science","score_opus":0.0371294891938039,"score_gpt":0.3059198913794901,"score_spread":0.26879040218568623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205185159","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.44549826,0.16855292,0.00022261468,0.38123494,0.0007067123,0.00039208026,0.000032273892,0.00011786744,0.0032423148],"genre_scores_gemma":[0.9936349,0.0016055969,0.002668516,0.0018255324,0.000019395711,0.000007510065,0.0000055595624,0.000011648976,0.00022134562],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988577,0.000045554403,0.000471544,0.00012884675,0.00014866018,0.0003477382],"domain_scores_gemma":[0.99896795,0.00005832223,0.00023135092,0.00022390114,0.00035745173,0.00016102029],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025493198,0.00011517404,0.00044684415,0.0002867216,0.00019430152,0.000031170668,0.000093041446,0.00010959683,0.00015273111],"category_scores_gemma":[0.00074804755,0.000088566034,0.00009937466,0.000288265,0.000104019644,0.000055714627,0.000011883635,0.0003420368,0.000019392324],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023927667,0.00013448096,0.110453315,0.00017106153,0.00022545847,0.0051901178,0.0004644308,0.000005986684,0.00011987424,0.007217847,0.028658008,0.8473355],"study_design_scores_gemma":[0.0027444013,0.002123719,0.11593555,0.0011178018,0.000085957516,0.0072244913,0.00680695,0.000010564974,0.024507292,0.005135916,0.8340577,0.00024966605],"about_ca_topic_score_codex":0.0006990108,"about_ca_topic_score_gemma":0.0041388725,"teacher_disagreement_score":0.84708583,"about_ca_system_score_codex":0.00038142584,"about_ca_system_score_gemma":0.0066669225,"threshold_uncertainty_score":0.99896437},"labels":[],"label_agreement":null},{"id":"W4205218195","doi":"10.51731/cjht.2021.189","title":"Elexacaftor-Tezacaftor-Ivacaftor and Ivacaftor (Trikafta)","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ivacaftor; Reimbursement; Cystic fibrosis; Medicine; Cystic fibrosis transmembrane conductance regulator; Drug; Regulator; Internal medicine; Pharmacology; Gene; Political science; Genetics; Biology","score_opus":0.025529726591794456,"score_gpt":0.3199476655061916,"score_spread":0.2944179389143971,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205218195","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7842721,0.20237665,0.00018382134,0.012403692,0.000045846926,0.00025655673,0.00003529043,0.00009854614,0.00032751233],"genre_scores_gemma":[0.9872466,0.0034666655,0.008109739,0.00068802695,0.00005961508,0.000008061042,0.000006371481,0.00003226626,0.00038267917],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99750584,0.00009842088,0.0007861942,0.00029643104,0.0004363183,0.0008768064],"domain_scores_gemma":[0.997905,0.0001905286,0.00035281014,0.00044362544,0.000605795,0.0005022485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007157243,0.00021839433,0.00075484364,0.0007650146,0.00028570063,0.00007821341,0.00029031993,0.00022501066,0.00012507118],"category_scores_gemma":[0.0042229113,0.00018984279,0.00012091323,0.000615585,0.00050228904,0.00021415003,0.000073519775,0.00091475353,0.000015794845],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001783009,0.00009480164,0.07017008,0.0010981614,0.00023607718,0.0044782856,0.00003588198,0.0000036355882,0.007288065,0.0029921136,0.026723806,0.8867008],"study_design_scores_gemma":[0.0015812827,0.0012629703,0.09613866,0.0009432632,0.00004058993,0.0050979517,0.0035416542,0.000012337066,0.009017619,0.0023831485,0.8797184,0.0002621024],"about_ca_topic_score_codex":0.0007462091,"about_ca_topic_score_gemma":0.0000908304,"teacher_disagreement_score":0.88643867,"about_ca_system_score_codex":0.0006743928,"about_ca_system_score_gemma":0.0076070447,"threshold_uncertainty_score":0.9980189},"labels":[],"label_agreement":null},{"id":"W4205459220","doi":"10.51731/cjht.2022.243","title":"Romosozumab (Evenity)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Medical and Biological Sciences","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Osteoporosis; Family medicine; Internal medicine; Political science; Health care","score_opus":0.04943136175459083,"score_gpt":0.29029929716573705,"score_spread":0.2408679354111462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205459220","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6546251,0.037843153,0.000095078125,0.30454654,0.00078885845,0.00023302391,0.000021748963,0.00010459014,0.0017418911],"genre_scores_gemma":[0.99714136,0.00008324896,0.00032987187,0.0022839159,0.000011638934,0.0000036453837,0.000001264949,0.0000022421918,0.00014283582],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989501,0.00006123946,0.00033599028,0.00008686711,0.00023280065,0.0003329812],"domain_scores_gemma":[0.99945754,0.00003622165,0.00019154507,0.00010127566,0.000048705144,0.00016471402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091856037,0.000056848006,0.0002500401,0.00027258595,0.00039888924,0.000007982078,0.00030478902,0.000049540715,0.000592134],"category_scores_gemma":[0.00073924323,0.0000349906,0.00006135632,0.00048175428,0.00025784262,0.000027292124,0.000038101454,0.0005778692,0.0000033568454],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019426257,0.000040901494,0.019526133,0.000029735593,0.0000140326465,0.00053292187,0.00006949481,0.0000035552173,0.000080227175,0.0023040634,0.013319077,0.9640604],"study_design_scores_gemma":[0.00039145135,0.002617799,0.021555226,0.000046158064,0.0000070507112,0.0016655669,0.003350718,0.000007291521,0.00009947602,0.013546807,0.95663625,0.00007623005],"about_ca_topic_score_codex":0.0014919468,"about_ca_topic_score_gemma":0.0005042605,"teacher_disagreement_score":0.9639842,"about_ca_system_score_codex":0.0002831349,"about_ca_system_score_gemma":0.0026327171,"threshold_uncertainty_score":0.64834523},"labels":[],"label_agreement":null},{"id":"W4205491995","doi":"10.51731/cjht.2022.245","title":"The Small House Model to Support Older Adults in Long-Term Care","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Geriatric Care and Nursing Homes","field":"Health Professions","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Generalizability theory; Autonomy; Context (archaeology); Consistency (knowledge bases); Long-term care; Flexibility (engineering); Replication (statistics); Interpersonal communication; Psychology; Public relations; Medicine; Social psychology; Computer science; Nursing; Political science; Economics; Management; Geography; Developmental psychology","score_opus":0.04307020147026734,"score_gpt":0.3537077130101118,"score_spread":0.3106375115398444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205491995","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.913588,0.031338498,0.0001259614,0.05163862,0.0019398765,0.001024693,0.00006235753,0.00014510771,0.00013686992],"genre_scores_gemma":[0.9980878,0.0003421937,0.0001616958,0.0010622977,0.000021405087,0.00009079195,0.000004493145,0.00003152187,0.00019779558],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.99763644,0.00023469243,0.0008162546,0.0001703584,0.00020421803,0.00093802804],"domain_scores_gemma":[0.9986918,0.00013753,0.00042018943,0.0003754889,0.00020692941,0.0001680914],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0011031869,0.00013279215,0.0003365375,0.00077788404,0.0020289,0.000017216855,0.0007567985,0.00012989088,0.000043803393],"category_scores_gemma":[0.00023291624,0.000104072686,0.0000728091,0.0005738795,0.00007412577,0.000048115056,0.000114389244,0.0014460529,0.0000115150215],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014390847,0.000028493185,0.088677,0.00036340256,0.000016856704,0.00032021647,0.058857966,0.00061389117,0.0000015085591,0.00030576458,0.059720844,0.7909502],"study_design_scores_gemma":[0.0025238341,0.0018946157,0.2603732,0.0010147078,0.000021668357,0.00015553333,0.6310964,0.0000413777,0.000014105914,0.0011373366,0.10126865,0.0004585207],"about_ca_topic_score_codex":0.010052042,"about_ca_topic_score_gemma":0.18284981,"teacher_disagreement_score":0.79049164,"about_ca_system_score_codex":0.0020341931,"about_ca_system_score_gemma":0.008292937,"threshold_uncertainty_score":0.9992703},"labels":[],"label_agreement":null},{"id":"W4205632133","doi":"10.51731/cjht.2021.187","title":"Brexucabtagene Autoleucel (Tecartus)","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Mantle cell lymphoma; Chimeric antigen receptor; Bruton's tyrosine kinase; Medicine; CD19; Lymphoma; Drug; Immunotherapy; Cell therapy; Oncology; Tyrosine kinase; Pharmacology; Immunology; Internal medicine; Cell; Antigen; Receptor; Cancer; Biology; Health care; Political science","score_opus":0.05133370576819875,"score_gpt":0.3399551668119211,"score_spread":0.2886214610437224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205632133","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.45144227,0.24815871,0.00035736483,0.2881648,0.0013007381,0.0005794724,0.00004278888,0.00033601862,0.009617839],"genre_scores_gemma":[0.99132526,0.0019395294,0.0014020939,0.0015761777,0.000042002386,0.000003916299,0.0000055906735,0.000029231438,0.003676175],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99830985,0.00007327688,0.0005312132,0.00016033318,0.00029606858,0.0006292793],"domain_scores_gemma":[0.99862975,0.000055230295,0.00019722056,0.0004322995,0.00043231534,0.00025319948],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00071283686,0.00012244201,0.00048346276,0.0006513828,0.00017738035,0.000038516595,0.0002484294,0.00017894598,0.0010848988],"category_scores_gemma":[0.0008457411,0.000108580214,0.00012358138,0.000692441,0.00022799247,0.00006601106,0.000029968105,0.00080178276,0.000022252983],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026320118,0.000030603904,0.003969183,0.00014488495,0.000087879474,0.0030547979,0.0001890315,0.000004107027,0.009563848,0.00055915274,0.013344038,0.96902615],"study_design_scores_gemma":[0.0009534638,0.0005818601,0.008816459,0.0003123181,0.000018023396,0.0050936756,0.0030774022,0.000011417996,0.023648921,0.00079990696,0.9565656,0.00012091366],"about_ca_topic_score_codex":0.002025114,"about_ca_topic_score_gemma":0.0038781767,"teacher_disagreement_score":0.9689052,"about_ca_system_score_codex":0.00072100526,"about_ca_system_score_gemma":0.01188798,"threshold_uncertainty_score":0.9998282},"labels":[],"label_agreement":null},{"id":"W4206026441","doi":"10.51731/cjht.2021.174","title":"Budesonide (Jorveza)","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Eosinophilic Esophagitis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Eosinophilic esophagitis; Budesonide; Medicine; Family medicine; Pathological; Intensive care medicine; Internal medicine; Asthma; Political science; Disease; Health care","score_opus":0.028695296492239186,"score_gpt":0.2956068445170824,"score_spread":0.26691154802484324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206026441","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.36767077,0.2842935,0.00022154952,0.34386662,0.0008318777,0.00022000809,0.000020549833,0.0001980155,0.0026771137],"genre_scores_gemma":[0.9931142,0.0009767072,0.003186938,0.0023621833,0.000026871236,0.0000017397583,0.0000026203452,0.000017206325,0.00031155205],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986563,0.000042491407,0.0005292879,0.00013047978,0.00018051248,0.0004609682],"domain_scores_gemma":[0.99878013,0.000047954076,0.00025553352,0.00033628618,0.00038754416,0.00019253505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004161901,0.00010705534,0.00044066587,0.00047663285,0.00014574092,0.000024644101,0.00018206131,0.00015448793,0.00011285221],"category_scores_gemma":[0.0016170824,0.00009714795,0.00010063978,0.000462443,0.00019689491,0.00007658434,0.00001898864,0.0005843691,0.000020298148],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012548659,0.00004322908,0.0624271,0.00027145265,0.00010416578,0.010757393,0.00029712173,0.0000032973624,0.00046425383,0.004169735,0.027076652,0.89437306],"study_design_scores_gemma":[0.0018777242,0.0012563283,0.1545427,0.0016364584,0.00006863677,0.027629578,0.006075789,0.000007145573,0.016467242,0.011089982,0.7790503,0.00029811505],"about_ca_topic_score_codex":0.0015176568,"about_ca_topic_score_gemma":0.0053363596,"teacher_disagreement_score":0.8940749,"about_ca_system_score_codex":0.0005195415,"about_ca_system_score_gemma":0.008976899,"threshold_uncertainty_score":0.9966413},"labels":[],"label_agreement":null},{"id":"W4206440127","doi":"10.51731/cjht.2021.173","title":"Venetoclax (Venclexta)","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Venetoclax; Reimbursement; Medicine; Cytarabine; Azacitidine; Drug; Intensive care medicine; Family medicine; Chemotherapy; Psychiatry; Internal medicine; Leukemia; Political science","score_opus":0.041498930668248404,"score_gpt":0.3312813472294035,"score_spread":0.2897824165611551,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206440127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4508348,0.22215179,0.0005309368,0.32187584,0.00067580777,0.00038241243,0.000022120814,0.00018390155,0.0033423693],"genre_scores_gemma":[0.9941258,0.0011869399,0.0027641226,0.0014233997,0.000026584705,0.0000026755474,0.0000034253378,0.000017076083,0.0004499952],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986196,0.000056366796,0.0004429146,0.00012592689,0.00021393427,0.0005412214],"domain_scores_gemma":[0.99878114,0.00004993898,0.00018504918,0.00033469344,0.00043984342,0.00020930581],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058008486,0.00009303929,0.00038610038,0.0005389445,0.00016273756,0.00002514211,0.00023720562,0.00015838195,0.00012262222],"category_scores_gemma":[0.0015793476,0.00008084089,0.0000913566,0.0005640811,0.0002120886,0.00006700828,0.000030627365,0.0008202853,0.000029384579],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029035858,0.000017737688,0.01020469,0.00024472122,0.000103661834,0.007961813,0.0002466179,0.000013539944,0.0009042421,0.002246964,0.05964709,0.9183799],"study_design_scores_gemma":[0.0011421688,0.0006997447,0.018927429,0.0005367763,0.000021855678,0.00876445,0.004875731,0.000035275727,0.008520304,0.0037837115,0.95255214,0.00014039439],"about_ca_topic_score_codex":0.0017099307,"about_ca_topic_score_gemma":0.0018104445,"teacher_disagreement_score":0.9182395,"about_ca_system_score_codex":0.002250645,"about_ca_system_score_gemma":0.034013364,"threshold_uncertainty_score":0.9714629},"labels":[],"label_agreement":null},{"id":"W4206540052","doi":"10.51731/cjht.2021.169","title":"Human Insulin (Entuzity KwikPen)","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Diabetes Management and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Glycemic; Human insulin; Insulin; Medicine; Diabetes mellitus; Drug; Subcutaneous injection; Drug class; Intensive care medicine; Pharmacology; Business; Internal medicine; Endocrinology; Political science; Law","score_opus":0.051685198503898896,"score_gpt":0.3460382872987443,"score_spread":0.2943530887948454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206540052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.62858593,0.13021733,0.00014320684,0.22714011,0.00071099546,0.00043367283,0.000011660266,0.00017667782,0.01258043],"genre_scores_gemma":[0.996353,0.00033137418,0.00044548704,0.0008031299,0.00002186978,0.0000018590285,0.0000039088936,0.000010683437,0.0020287232],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987505,0.000047651865,0.00040573164,0.000113712646,0.00021479961,0.00046758386],"domain_scores_gemma":[0.99910665,0.000017525037,0.00017296651,0.00026567467,0.00028336293,0.00015381898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068705226,0.000083465355,0.00033207703,0.00059145235,0.00022951495,0.000039992152,0.00021900208,0.000101403864,0.00021762673],"category_scores_gemma":[0.00058715953,0.00006884368,0.00008467929,0.00045544322,0.00018401079,0.00007734212,0.000042663756,0.00056077976,0.000021258744],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008763764,0.000082220286,0.026088879,0.00045322854,0.00013027468,0.0022477186,0.00012572324,0.000003261311,0.00022422822,0.007915216,0.05684915,0.90587133],"study_design_scores_gemma":[0.0013927289,0.0008587766,0.09742809,0.00062156527,0.000032734337,0.00018803573,0.0034431089,0.000008794975,0.0018027825,0.012042081,0.8820278,0.00015347208],"about_ca_topic_score_codex":0.00061128824,"about_ca_topic_score_gemma":0.0021034938,"teacher_disagreement_score":0.90571785,"about_ca_system_score_codex":0.0002928636,"about_ca_system_score_gemma":0.002853218,"threshold_uncertainty_score":0.50614864},"labels":[],"label_agreement":null},{"id":"W4206713533","doi":"10.51731/cjht.2021.119","title":"Patiromer (Veltassa)","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Potassium and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Hyperkalemia; Medicine; Kidney disease; Intensive care medicine; Renal function; Internal medicine; Economic growth; Health care","score_opus":0.020893355207893323,"score_gpt":0.27613870349549574,"score_spread":0.2552453482876024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206713533","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22828779,0.44139355,0.00036907403,0.32221943,0.0011094093,0.00019652084,0.000018389072,0.0001509448,0.006254916],"genre_scores_gemma":[0.99570733,0.0017929744,0.0007815754,0.0013987527,0.0000075034322,0.0000010182498,0.0000035958374,0.000010276285,0.00029698844],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990503,0.000028616774,0.00037441956,0.00008529642,0.000118688884,0.0003426388],"domain_scores_gemma":[0.99927545,0.000022448201,0.00018345754,0.00018164402,0.0002003193,0.00013669286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022087853,0.00007940002,0.0002995168,0.00036414177,0.00012220294,0.000012749271,0.00009946008,0.00017141108,0.00009630679],"category_scores_gemma":[0.00065182714,0.00006221514,0.00008293787,0.00036727948,0.00013928204,0.000044040546,0.000009181638,0.000500955,0.000015646407],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011692601,0.000047194007,0.018281749,0.00015445777,0.00013240728,0.0032961164,0.00026050725,0.000006639445,0.00024284485,0.0009616504,0.06204338,0.91456133],"study_design_scores_gemma":[0.001423299,0.0004366833,0.042584546,0.0005461401,0.000055452736,0.00543274,0.0072252136,0.000008456975,0.0017069816,0.0038179464,0.9366018,0.0001607133],"about_ca_topic_score_codex":0.00082026224,"about_ca_topic_score_gemma":0.0012787032,"teacher_disagreement_score":0.91440064,"about_ca_system_score_codex":0.00020101426,"about_ca_system_score_gemma":0.005823446,"threshold_uncertainty_score":0.9998126},"labels":[],"label_agreement":null},{"id":"W4206742742","doi":"10.51731/cjht.2022.242","title":"Renal Denervation for People With Hypertension","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Denervation; Horizon; Intervention (counseling); Medicine; Focus (optics); Information technology; Emerging technologies; Business; Computer science; Intensive care medicine; Nursing; Internal medicine; Artificial intelligence","score_opus":0.048663808432929556,"score_gpt":0.2672997802750063,"score_spread":0.21863597184207673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206742742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.43642637,0.1914741,0.001034268,0.3692919,0.00053524575,0.0009020366,0.00004395299,0.00014713005,0.0001449851],"genre_scores_gemma":[0.99314976,0.00015802956,0.0022849848,0.0042607076,0.000016309827,0.000026634389,0.0000052899186,0.0000119295055,0.000086385975],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99917483,0.000024166624,0.00028656263,0.00009538383,0.00016816868,0.0002509078],"domain_scores_gemma":[0.9991999,0.00005374801,0.00023413406,0.00013876136,0.00031627153,0.000057150817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041499265,0.00007614248,0.00043240737,0.00038793168,0.0006025206,0.000008144474,0.000101003265,0.000040632036,0.00001387806],"category_scores_gemma":[0.00016156118,0.000054465985,0.000053157317,0.00026213727,0.000058203197,0.00004488686,0.000019898569,0.00028460904,4.561089e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007313941,0.00013397103,0.043200433,0.0003975987,0.0006662547,0.0007733474,0.0013739493,0.00022796594,0.0009283469,0.0019431666,0.46613124,0.4834923],"study_design_scores_gemma":[0.001655597,0.0031450095,0.019981729,0.0001407928,0.00020218553,0.0038468295,0.0076084537,0.00004669582,0.0003811165,0.00075246947,0.9621291,0.00010999466],"about_ca_topic_score_codex":0.0014203357,"about_ca_topic_score_gemma":0.0030131117,"teacher_disagreement_score":0.55672336,"about_ca_system_score_codex":0.0000894019,"about_ca_system_score_gemma":0.0015891291,"threshold_uncertainty_score":0.46341625},"labels":[],"label_agreement":null},{"id":"W4206754378","doi":"10.51731/cjht.2022.237","title":"Azacitidine (Onureg)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Azacitidine; Medicine; Myeloid leukemia; Hematopoietic stem cell transplantation; Intensive care medicine; Transplantation; Family medicine; Internal medicine; Political science","score_opus":0.035742845196911094,"score_gpt":0.3107890114319356,"score_spread":0.27504616623502454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206754378","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.44835865,0.10711022,0.00032710374,0.44001812,0.0007634344,0.0006804734,0.000075835014,0.00024516706,0.002421021],"genre_scores_gemma":[0.99688536,0.00029634644,0.00077547214,0.0015667232,0.000018948936,0.000012584753,0.0000046560917,0.000019198718,0.00042071796],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984248,0.00008101985,0.00046235294,0.000120328485,0.00032976372,0.0005816835],"domain_scores_gemma":[0.9990618,0.00004757105,0.00025282954,0.0002889462,0.00016431768,0.0001845377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011589443,0.00009780942,0.00037691908,0.00119973,0.00050292886,0.000014611298,0.00041907933,0.000069004614,0.00035767094],"category_scores_gemma":[0.0006506542,0.000086199696,0.00008701994,0.0006744441,0.00021013177,0.000058650938,0.00006792205,0.001372568,0.000011063532],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001249307,0.000053699547,0.013264552,0.0001977181,0.00013248312,0.004383172,0.0005690184,0.00006888094,0.00042099014,0.0054554227,0.3192787,0.65605044],"study_design_scores_gemma":[0.0010635828,0.0017478957,0.0036479798,0.000072982606,0.000013546507,0.008816826,0.007812934,0.00003067879,0.0005483167,0.0024892963,0.97365004,0.000105907115],"about_ca_topic_score_codex":0.002882582,"about_ca_topic_score_gemma":0.0005788605,"teacher_disagreement_score":0.6559445,"about_ca_system_score_codex":0.0025469426,"about_ca_system_score_gemma":0.010784513,"threshold_uncertainty_score":0.9948234},"labels":[],"label_agreement":null},{"id":"W4207042641","doi":"10.51731/cjht.2022.246","title":"Adalimumab for the Treatment of Adults With Non-Infectious Uveitis","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Ocular Diseases and Behçet’s Syndrome","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Adalimumab; Medicine; Adverse effect; Uveitis; Placebo; Visual acuity; Clinical trial; Ophthalmology; Internal medicine; Pathology; Disease","score_opus":0.013442396937158168,"score_gpt":0.258994131870903,"score_spread":0.2455517349337448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4207042641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8922034,0.07335463,0.0003274608,0.032327138,0.00031951655,0.0011961301,0.00017857402,0.000043008586,0.000050142407],"genre_scores_gemma":[0.9984589,0.00097588834,0.00023814673,0.00018160786,0.00001188874,0.0000630696,0.0000046769483,0.000013406909,0.000052367322],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999164,0.000017589353,0.0002995149,0.00009129078,0.00015081387,0.00027682423],"domain_scores_gemma":[0.9992105,0.000053524942,0.0003013668,0.0002305181,0.000119968776,0.00008415892],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015632316,0.00009342566,0.00033519565,0.00026894026,0.0003590408,0.000007120672,0.00013915701,0.000035004163,0.00004962066],"category_scores_gemma":[0.00004627779,0.000054751217,0.00013291721,0.00022874943,0.00012424406,0.000023564024,0.00000740724,0.00014026281,3.4388893e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046657666,0.00029384645,0.023614667,0.00028264313,0.00040091897,0.0005395348,0.0010883536,0.0001685545,0.000013601278,0.00017217781,0.0029517575,0.97000736],"study_design_scores_gemma":[0.016376134,0.097667545,0.06143549,0.00076870405,0.00068019755,0.009200563,0.05044957,0.00023624081,0.0007399286,0.0009534617,0.76113456,0.00035761326],"about_ca_topic_score_codex":0.0066738054,"about_ca_topic_score_gemma":0.004890731,"teacher_disagreement_score":0.96964973,"about_ca_system_score_codex":0.00059500657,"about_ca_system_score_gemma":0.0024854562,"threshold_uncertainty_score":0.9999408},"labels":[],"label_agreement":null},{"id":"W4210372584","doi":"10.51731/cjht.2022.252","title":"Pembrolizumab (Keytruda)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pembrolizumab; Reimbursement; Medicine; Esophagus; Adenocarcinoma; Chemotherapy; Drug; Oncology; Internal medicine; General surgery; Intensive care medicine; Cancer; Pharmacology; Immunotherapy","score_opus":0.03679924395480353,"score_gpt":0.3275468292165374,"score_spread":0.29074758526173383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210372584","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2803736,0.5345637,0.00005210572,0.18221593,0.000512438,0.0006007851,0.00006523866,0.00014330076,0.0014728871],"genre_scores_gemma":[0.99843884,0.00036242386,0.00023053626,0.00072287995,0.000010188354,0.000018994673,0.0000032641547,0.00001113239,0.00020175555],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99878705,0.00005437311,0.00030691634,0.0000956188,0.00030280784,0.00045325194],"domain_scores_gemma":[0.999326,0.000022659975,0.00017607244,0.00020397549,0.000092095455,0.00017919659],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044168992,0.00007844078,0.00028269854,0.00065401033,0.00044198695,0.000012218164,0.0002215907,0.0000339261,0.0003269417],"category_scores_gemma":[0.00018017937,0.000065539316,0.00008184018,0.0003470676,0.00011627835,0.000041264328,0.000034376182,0.00065304287,0.0000067758456],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023530165,0.000088818066,0.051421728,0.0001595717,0.00014725984,0.00659714,0.00042348058,0.000032961805,0.00001265983,0.0028084829,0.033595074,0.90447754],"study_design_scores_gemma":[0.005594288,0.014536956,0.07987569,0.00017982499,0.00005034231,0.012708976,0.012666316,0.000018478126,0.00081473315,0.009032396,0.86429024,0.00023177771],"about_ca_topic_score_codex":0.004339293,"about_ca_topic_score_gemma":0.001145188,"teacher_disagreement_score":0.90424573,"about_ca_system_score_codex":0.0015846132,"about_ca_system_score_gemma":0.0072799274,"threshold_uncertainty_score":0.9983479},"labels":[],"label_agreement":null},{"id":"W4210408999","doi":"10.51731/cjht.2022.250","title":"Idecabtagene Vicleucel (Abecma)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Drug; Pharmacology; Intensive care medicine; Health care; Political science","score_opus":0.0544646208570626,"score_gpt":0.33944166122287556,"score_spread":0.28497704036581295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210408999","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6865142,0.1002418,0.00011263569,0.20816568,0.0008796541,0.00069115974,0.000046353583,0.00020810336,0.0031403971],"genre_scores_gemma":[0.99577945,0.00047110196,0.00044970817,0.0016752302,0.000022728751,0.000014280304,0.0000030334961,0.000025624273,0.0015588556],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998229,0.00010238528,0.0005027673,0.00013850705,0.00042266856,0.00060466584],"domain_scores_gemma":[0.998983,0.000051616167,0.0002514657,0.00035568964,0.00015409419,0.00020408354],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013975806,0.00010662687,0.0003964225,0.0010911936,0.00048929197,0.000021024827,0.00043884284,0.00006993335,0.0026740467],"category_scores_gemma":[0.00034709604,0.00009859243,0.000114811046,0.000676931,0.00018962154,0.000053923115,0.00006601331,0.0011165513,0.000011498694],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009327933,0.000040927196,0.006661861,0.00008058176,0.00007897709,0.0013021476,0.0004474084,0.000033580087,0.0043427185,0.0005025915,0.028130177,0.95828575],"study_design_scores_gemma":[0.0009556166,0.0016037389,0.005288924,0.000051178045,0.000010584598,0.0026070066,0.0067046625,0.000017332663,0.0025000575,0.0015237998,0.97863394,0.0001031492],"about_ca_topic_score_codex":0.004152498,"about_ca_topic_score_gemma":0.0014017356,"teacher_disagreement_score":0.9581826,"about_ca_system_score_codex":0.0015104045,"about_ca_system_score_gemma":0.0063928436,"threshold_uncertainty_score":0.99924},"labels":[],"label_agreement":null},{"id":"W4210818248","doi":"10.51731/cjht.2022.249","title":"Trientine hydrochloride (MAR-Trientine)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Trace Elements in Health","field":"Nursing","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Drug; Intensive care medicine; Pharmacology; Political science; Health care","score_opus":0.023178401082968866,"score_gpt":0.28176101977115875,"score_spread":0.2585826186881899,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210818248","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7267058,0.057694923,0.00030019024,0.2022266,0.011333758,0.0007801882,0.00013549025,0.00043268272,0.00039039142],"genre_scores_gemma":[0.99673426,0.00007535088,0.001089974,0.0018361041,0.000044048516,0.000020854824,0.0000074602253,0.000038573573,0.00015338961],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967382,0.00021430661,0.001209682,0.00025080756,0.00049077574,0.0010962094],"domain_scores_gemma":[0.99797046,0.00011704743,0.0011133937,0.00045688872,0.00014585548,0.0001963502],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0022617239,0.00019313017,0.0004896018,0.0014403063,0.0015094707,0.000048565424,0.00095827493,0.000091523725,0.00024995898],"category_scores_gemma":[0.0009060377,0.00019986069,0.00011980272,0.0010610224,0.00019667136,0.00018258466,0.00009247902,0.0013921816,0.000010861811],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019535485,0.000107171225,0.028831638,0.00019612485,0.000054612,0.00032809988,0.0015382261,0.00030185567,0.00008413713,0.0017631963,0.09739491,0.8692047],"study_design_scores_gemma":[0.00089395634,0.0011102282,0.0036590598,0.00006993768,0.000015230714,0.000506527,0.0063364697,0.00002898967,0.0007948394,0.0035444514,0.9828458,0.00019449787],"about_ca_topic_score_codex":0.0052223136,"about_ca_topic_score_gemma":0.002840806,"teacher_disagreement_score":0.8854509,"about_ca_system_score_codex":0.0019735207,"about_ca_system_score_gemma":0.0023832782,"threshold_uncertainty_score":0.99979043},"labels":[],"label_agreement":null},{"id":"W4210833548","doi":"10.51731/cjht.2022.253","title":"Zanubrutinib (Brukinsa)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Lymphoplasmacytic Lymphoma; Medicine; Family medicine; Waldenstrom macroglobulinemia; Political science; Lymphoma; Internal medicine; Health care","score_opus":0.04150092911836314,"score_gpt":0.31990717976881616,"score_spread":0.27840625065045305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210833548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6503365,0.15371841,0.00017345192,0.18766525,0.0020895668,0.0009931467,0.00006400983,0.0003217303,0.004637936],"genre_scores_gemma":[0.997746,0.00020642737,0.00042362104,0.0011909325,0.00002377551,0.0000110288665,0.0000030939211,0.000018468687,0.00037667013],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981805,0.00007976979,0.0005244532,0.00013247054,0.00044125883,0.0006415599],"domain_scores_gemma":[0.9989672,0.00006956367,0.00028356488,0.00035027103,0.00014228231,0.00018715468],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011961003,0.000098839184,0.00038042007,0.00095476775,0.0004801498,0.000017012151,0.0004442296,0.00007061631,0.0003585552],"category_scores_gemma":[0.000794983,0.00008818211,0.000098030825,0.00061679364,0.00023807718,0.000050063,0.00008166737,0.00097577745,0.000013007008],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00015345852,0.00007773229,0.0037821028,0.00031081133,0.00013661975,0.0041850917,0.0009162104,0.00013112038,0.00008558018,0.0039358395,0.15417409,0.83211136],"study_design_scores_gemma":[0.004129003,0.0014541274,0.0013703898,0.00009103569,0.000013059363,0.010658825,0.0065694298,0.00012687387,0.0002432956,0.0015985435,0.97364205,0.000103350794],"about_ca_topic_score_codex":0.009629705,"about_ca_topic_score_gemma":0.0010397115,"teacher_disagreement_score":0.832008,"about_ca_system_score_codex":0.021715516,"about_ca_system_score_gemma":0.07914543,"threshold_uncertainty_score":0.9969652},"labels":[],"label_agreement":null},{"id":"W4211162484","doi":"10.51731/cjht.2022.261","title":"Luspatercept (Reblozyl)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Blood groups and transfusion","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Vial; Erythropoietin; Anemia; Family medicine; Intensive care medicine; Surgery; Internal medicine; Political science; Health care","score_opus":0.020763465349534972,"score_gpt":0.25531746887963913,"score_spread":0.23455400353010417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211162484","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7877995,0.059753254,0.00019885931,0.15023778,0.0008130272,0.00031369083,0.00002707808,0.00012761485,0.0007292138],"genre_scores_gemma":[0.9978629,0.0002673946,0.00039516465,0.0013503789,0.000010409261,0.00000489984,0.0000026843686,0.000011578995,0.00009464369],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99902177,0.000038264487,0.000357689,0.00008805877,0.00017450904,0.0003197013],"domain_scores_gemma":[0.9994824,0.000012982293,0.0001645614,0.00017318885,0.00006465765,0.0001021965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048439568,0.00007504717,0.00028022774,0.0005451069,0.000408098,0.0000086078,0.00018550591,0.000052560845,0.000272686],"category_scores_gemma":[0.00006203999,0.00006383982,0.00007852112,0.00030138742,0.000084898755,0.000038761435,0.000020973155,0.0006530284,0.000003812472],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004594196,0.000059066082,0.020995809,0.00010808635,0.000054311855,0.0010505803,0.0007690564,0.000021894984,0.00019385206,0.0012040924,0.013222096,0.9622752],"study_design_scores_gemma":[0.0015464822,0.0028587629,0.03498497,0.00013606861,0.000041269508,0.0051248386,0.010881896,0.000014049825,0.0004515835,0.0026321702,0.94118464,0.00014326624],"about_ca_topic_score_codex":0.00386637,"about_ca_topic_score_gemma":0.0015674153,"teacher_disagreement_score":0.962132,"about_ca_system_score_codex":0.000332353,"about_ca_system_score_gemma":0.0019966261,"threshold_uncertainty_score":0.5844821},"labels":[],"label_agreement":null},{"id":"W4213234585","doi":"10.51731/cjht.2022.268","title":"Macitentan and Tadalafil (Opsynvi)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cardiovascular Issues in Pregnancy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tadalafil; Reimbursement; Medicine; Drug; Pharmacology; Internal medicine; Intensive care medicine; Erectile dysfunction; Health care; Political science","score_opus":0.019308314263558897,"score_gpt":0.2680454822482027,"score_spread":0.2487371679846438,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213234585","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.34510326,0.59410816,0.00017001813,0.057859797,0.0009259273,0.0004399024,0.00003789995,0.0001364904,0.0012185472],"genre_scores_gemma":[0.99724954,0.0009977246,0.00089204364,0.00065880985,0.0000115041885,0.000008166522,0.000002176321,0.00001580248,0.00016422787],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99886966,0.0000643004,0.00036718868,0.00012223457,0.00023905956,0.0003375595],"domain_scores_gemma":[0.999309,0.000021259824,0.00017912737,0.00029492308,0.00006917564,0.00012650654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007107084,0.0000919858,0.0003915388,0.0006054679,0.0003289885,0.000015638729,0.00019379819,0.000054391992,0.00010055897],"category_scores_gemma":[0.00027866845,0.000086853295,0.000113310074,0.0003042769,0.00018826204,0.000052925585,0.00006260155,0.00064020295,0.0000016849118],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002106446,0.000016066451,0.020701166,0.00014364578,0.00015975874,0.0037059365,0.0005643415,0.000014882683,0.000033789736,0.0015215492,0.0077434205,0.96537435],"study_design_scores_gemma":[0.0013055694,0.0010139147,0.016725,0.00027396012,0.000072288945,0.04915905,0.011490803,0.000010397799,0.00017304484,0.0031848755,0.9164279,0.00016321451],"about_ca_topic_score_codex":0.0011441248,"about_ca_topic_score_gemma":0.0004695088,"teacher_disagreement_score":0.96521115,"about_ca_system_score_codex":0.00056761265,"about_ca_system_score_gemma":0.0016787937,"threshold_uncertainty_score":0.35417747},"labels":[],"label_agreement":null},{"id":"W4213381093","doi":"10.51731/cjht.2022.265","title":"Temperature Management in Patients After Cardiac Arrest","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cardiac Arrest and Resuscitation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Targeted temperature management; Medicine; Hypothermia; Randomized controlled trial; Intensive care medicine; Clinical trial; Emergency medicine; Resuscitation; Internal medicine; Cardiopulmonary resuscitation; Return of spontaneous circulation","score_opus":0.006923285693652438,"score_gpt":0.2431828823527025,"score_spread":0.23625959665905005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213381093","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96691585,0.015261609,0.000001246641,0.013742985,0.0032779237,0.00041229985,0.000035029032,0.000027611524,0.00032544552],"genre_scores_gemma":[0.99912685,0.00019492795,0.00012813282,0.00044723976,0.000017822982,0.000027620328,0.000010915963,0.0000097106185,0.000036768277],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990094,0.000060759947,0.00032953252,0.00009824456,0.00021944362,0.00028262686],"domain_scores_gemma":[0.9995653,0.000010482943,0.00013568056,0.000157058,0.00006324845,0.00006821457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040498085,0.000078707366,0.0002658836,0.0007531015,0.00015448024,0.000012066237,0.000108043045,0.00005395057,0.00001929704],"category_scores_gemma":[0.000054910728,0.000068615016,0.000087923996,0.00041788144,0.000055900615,0.00004613984,0.000030595424,0.0005334348,0.0000022603333],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014174658,0.000049656883,0.77909404,0.00015863834,0.000087042295,0.0006494633,0.00054074003,0.000049779275,0.0000044524004,0.00020134998,0.017505297,0.20151779],"study_design_scores_gemma":[0.00067128515,0.00020237389,0.8256719,0.00009998452,0.000015005065,0.000003901698,0.003953896,5.630439e-7,0.0000074070654,0.00022646984,0.16908228,0.00006490172],"about_ca_topic_score_codex":0.00046555046,"about_ca_topic_score_gemma":0.0003669832,"teacher_disagreement_score":0.20145288,"about_ca_system_score_codex":0.0007669943,"about_ca_system_score_gemma":0.0006790853,"threshold_uncertainty_score":0.27980393},"labels":[],"label_agreement":null},{"id":"W4213428070","doi":"10.51731/cjht.2022.269","title":"An Overview of Smartphone Apps","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Mobile Health and mHealth Applications","field":"Health Professions","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"mHealth; Flexibility (engineering); Internet privacy; Mobile apps; App store; Health care; Computer science; World Wide Web; Medicine; Psychological intervention; Nursing","score_opus":0.13881431718338155,"score_gpt":0.45340942049109967,"score_spread":0.3145951033077181,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213428070","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21995115,0.61614335,0.0013621777,0.14789921,0.00456796,0.0066143074,0.0008357314,0.00050240086,0.002123736],"genre_scores_gemma":[0.9883284,0.005378887,0.0012177214,0.003992537,0.000033692628,0.0009137965,0.000018525021,0.00002865671,0.00008778163],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959088,0.0007476725,0.0018673018,0.00019593876,0.0003040325,0.0009762385],"domain_scores_gemma":[0.9965182,0.00022501891,0.0018938599,0.0006355654,0.0003329525,0.00039439916],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.003649258,0.0001432414,0.0006396904,0.00092562067,0.0023830957,0.0000041216936,0.00084158767,0.00016120666,0.0006776401],"category_scores_gemma":[0.00037877169,0.00013747714,0.00008396744,0.00092851155,0.00017406669,0.000109726396,0.0000676471,0.0016821241,0.000017196395],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005048027,0.00011175033,0.028487628,0.0015872602,0.000023082604,0.000023758606,0.0017705612,0.00011899532,0.00004404228,0.051917717,0.054740775,0.8611239],"study_design_scores_gemma":[0.0005786684,0.00075407256,0.011479666,0.0001842376,0.000007938308,0.000048570844,0.017471783,0.00001874136,0.0000136287645,0.0074560572,0.96188396,0.00010269741],"about_ca_topic_score_codex":0.015562531,"about_ca_topic_score_gemma":0.008445125,"teacher_disagreement_score":0.9071432,"about_ca_system_score_codex":0.0010371805,"about_ca_system_score_gemma":0.018215436,"threshold_uncertainty_score":0.9989157},"labels":[],"label_agreement":null},{"id":"W4214613706","doi":"10.51731/cjht.2022.271","title":"Estradiol (Imvexxy)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Family medicine; Gynecology; Political science","score_opus":0.25931164362329445,"score_gpt":0.4654075142819565,"score_spread":0.20609587065866203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214613706","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.40444335,0.030393492,0.0008323424,0.56127435,0.0014954482,0.00081358966,0.000049852624,0.00016571816,0.0005318765],"genre_scores_gemma":[0.9939319,0.000092100665,0.0020331084,0.0038394874,0.000020083431,0.00001261691,0.000006197527,0.000011199427,0.000053293985],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99832314,0.000088901004,0.00097170635,0.00009321682,0.00022782652,0.00029521858],"domain_scores_gemma":[0.99877065,0.00016655288,0.00061965134,0.00020103756,0.00013278786,0.00010932079],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017554112,0.00006993253,0.00028165642,0.0005129344,0.0003135094,0.000011727132,0.00020536513,0.00004250567,0.0003100201],"category_scores_gemma":[0.0031580348,0.000065203116,0.00007596827,0.00034480388,0.00009044865,0.00008721375,0.000027156719,0.0007996049,0.0000054257353],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041553787,0.0000314416,0.011494142,0.000038956274,0.000039721184,0.00045533775,0.00013582133,0.000051537423,0.00006420269,0.0007487755,0.043712236,0.9431863],"study_design_scores_gemma":[0.0009832864,0.0017020977,0.015028994,0.000039868264,0.000031282245,0.003431645,0.013115057,0.000030024918,0.00006166565,0.002798505,0.9626976,0.00007997445],"about_ca_topic_score_codex":0.006800605,"about_ca_topic_score_gemma":0.0014260968,"teacher_disagreement_score":0.9431063,"about_ca_system_score_codex":0.00076287636,"about_ca_system_score_gemma":0.0060730996,"threshold_uncertainty_score":0.9998132},"labels":[],"label_agreement":null},{"id":"W4214667444","doi":"10.51731/cjht.2022.270","title":"Emerging Drugs for Generalized Myasthenia Gravis","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Myasthenia Gravis and Thymoma","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"","keywords":"Myasthenia gravis; Tolerability; Medicine; Weakness; Thymectomy; Clinical trial; Muscle weakness; Disease; Intensive care medicine; Adverse effect; Internal medicine; Pediatrics; Surgery","score_opus":0.02277857378249926,"score_gpt":0.2957274180510737,"score_spread":0.27294884426857446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214667444","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7082538,0.06919431,0.00093661394,0.21884143,0.0012028662,0.0009996047,0.00013559974,0.00018310707,0.0002527],"genre_scores_gemma":[0.99449474,0.00012218968,0.0034107016,0.0015798529,0.000029202203,0.000041536237,0.000010507439,0.000028883267,0.0002823892],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984357,0.000055192704,0.00060454535,0.00014428173,0.00022101792,0.00053927785],"domain_scores_gemma":[0.9989961,0.000030781535,0.00041997342,0.00025284936,0.00015131103,0.00014897592],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096291397,0.00012980563,0.0004876445,0.00081091654,0.0007534306,0.000019084024,0.00030645958,0.0000607876,0.00014066667],"category_scores_gemma":[0.00019798512,0.000113865215,0.0001818517,0.00036584618,0.00009510649,0.000043852066,0.000032928136,0.00047542623,0.0000018182376],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018779685,0.000047458696,0.0033944892,0.0002394116,0.0001277006,0.00026970907,0.0021188117,0.000046652105,0.0002591729,0.01443819,0.040491972,0.93837863],"study_design_scores_gemma":[0.0017839024,0.0013181178,0.0010125724,0.000080506004,0.00004184507,0.0010958817,0.010332157,0.00006363249,0.0002138812,0.0103958,0.9735247,0.00013699324],"about_ca_topic_score_codex":0.0017196987,"about_ca_topic_score_gemma":0.00038248158,"teacher_disagreement_score":0.93824166,"about_ca_system_score_codex":0.0004990476,"about_ca_system_score_gemma":0.0025054193,"threshold_uncertainty_score":0.57948554},"labels":[],"label_agreement":null},{"id":"W4214668728","doi":"10.51731/cjht.2021.146","title":"Semaglutide (Rybelsus)","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Semaglutide; Reimbursement; Medicine; Metformin; Glycemic; Drug; Type 2 diabetes; Family medicine; Diabetes mellitus; Pharmacology; Political science; Health care; Endocrinology","score_opus":0.03820972258412177,"score_gpt":0.34213541595885694,"score_spread":0.3039256933747352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214668728","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.42817807,0.2893693,0.00005715032,0.27878243,0.001054491,0.0001906979,0.000018027597,0.000104846455,0.002245013],"genre_scores_gemma":[0.99483895,0.001295498,0.00086288777,0.0022505808,0.00002669609,0.0000024868377,0.0000029715275,0.000009207874,0.0007106907],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99914366,0.0000315111,0.0003250558,0.00008912396,0.00008309191,0.0003275408],"domain_scores_gemma":[0.9993231,0.000043071857,0.00016666073,0.0001479831,0.00019611372,0.00012303822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019619797,0.000079675294,0.0003294998,0.00030362408,0.000113537186,0.0000095803725,0.00008889738,0.000091217546,0.00022200609],"category_scores_gemma":[0.00028019366,0.00006731479,0.00008178003,0.00028688175,0.00011473283,0.00002836481,0.000010082463,0.00032592914,0.000012163892],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044399698,0.000082335595,0.045331616,0.00018031316,0.00021643727,0.0060528126,0.0003179813,0.0000048295046,0.0008284327,0.0012455792,0.08133364,0.86436164],"study_design_scores_gemma":[0.0014036819,0.00069732784,0.024251878,0.00019990209,0.000063345695,0.0045712446,0.0017513264,0.0000022559898,0.0067580403,0.0016608922,0.9585532,0.00008688118],"about_ca_topic_score_codex":0.0014614274,"about_ca_topic_score_gemma":0.0053236117,"teacher_disagreement_score":0.8772196,"about_ca_system_score_codex":0.00047378722,"about_ca_system_score_gemma":0.0070750415,"threshold_uncertainty_score":0.99855393},"labels":[],"label_agreement":null},{"id":"W4214842935","doi":"10.51731/cjht.2022.274","title":"Emerging Drugs for Amyotrophic Lateral Sclerosis","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Amyotrophic lateral sclerosis; Riluzole; Medicine; Drug development; Intensive care medicine; Disease; Drug; Pharmacology; Internal medicine","score_opus":0.05475330339128814,"score_gpt":0.31522112388974727,"score_spread":0.2604678204984591,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214842935","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8092947,0.019368775,0.00016063367,0.16974223,0.0005007501,0.00068376824,0.000058949656,0.00011358612,0.00007662161],"genre_scores_gemma":[0.9969216,0.0003716391,0.001169773,0.0011994997,0.000032344244,0.00006287583,0.000007150968,0.000032754222,0.00020233962],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978471,0.000088658955,0.0006471516,0.00018733903,0.00040062482,0.0008291217],"domain_scores_gemma":[0.9988819,0.000057010748,0.00034067905,0.0002837135,0.00023034961,0.00020637673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011330601,0.00014096161,0.0004853618,0.000981696,0.00088618184,0.000034471806,0.0004489727,0.000084196654,0.00020717343],"category_scores_gemma":[0.00033796031,0.00012259225,0.0001756475,0.00055685383,0.00018591396,0.0001007619,0.00008055401,0.0008830771,0.0000039936267],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030585943,0.000078651545,0.013374116,0.000361444,0.00019333512,0.00025101186,0.0016240166,0.0002517301,0.002274595,0.0015384239,0.032484367,0.94726247],"study_design_scores_gemma":[0.0059843506,0.007596993,0.12181892,0.0008234046,0.00008115729,0.0013803877,0.011009567,0.0005214806,0.00076718203,0.00907117,0.84035826,0.0005871551],"about_ca_topic_score_codex":0.003034153,"about_ca_topic_score_gemma":0.00025268568,"teacher_disagreement_score":0.9466753,"about_ca_system_score_codex":0.0014516431,"about_ca_system_score_gemma":0.003150242,"threshold_uncertainty_score":0.68158835},"labels":[],"label_agreement":null},{"id":"W4214854916","doi":"10.51731/cjht.2022.276","title":"Mecasermin (Increlex)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Orphan drug; Medicine; Basal (medicine); Growth hormone receptor; Drug; Growth hormone; Internal medicine; Pediatrics; Hormone; Pharmacology; Bioinformatics; Biology; Political science; Health care","score_opus":0.026084293684478944,"score_gpt":0.26119219399365445,"score_spread":0.2351079003091755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214854916","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8711532,0.06020732,0.000061933315,0.06635788,0.00071324885,0.00030740452,0.00003752537,0.00014051097,0.0010210144],"genre_scores_gemma":[0.9971784,0.00024240314,0.00043251686,0.0019408001,0.000015751848,0.000008761886,0.000005243489,0.000018758808,0.00015741681],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99840534,0.00007031594,0.000622034,0.00012677438,0.00027047948,0.0005050348],"domain_scores_gemma":[0.99903053,0.000036978672,0.00037058527,0.0002594456,0.00011935086,0.00018308638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007786547,0.0001234264,0.00043860835,0.0010003399,0.0005221045,0.000014306258,0.00031460566,0.000082461556,0.0001901945],"category_scores_gemma":[0.00040577448,0.00010970965,0.000118870346,0.00056830223,0.00013353351,0.00008209313,0.000044421733,0.000948361,0.000009053061],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015286096,0.0001160533,0.060135577,0.00022694597,0.00017197097,0.0041736043,0.0012207011,0.000026922758,0.0004963371,0.004222231,0.15652624,0.77253056],"study_design_scores_gemma":[0.0010222964,0.0026400394,0.02436455,0.000072310024,0.00003256899,0.0043514688,0.009264509,0.000014501123,0.000935392,0.0022969902,0.95483345,0.00017190858],"about_ca_topic_score_codex":0.0033245948,"about_ca_topic_score_gemma":0.00036893008,"teacher_disagreement_score":0.79830724,"about_ca_system_score_codex":0.00073800806,"about_ca_system_score_gemma":0.0046234434,"threshold_uncertainty_score":0.82017905},"labels":[],"label_agreement":null},{"id":"W4214889379","doi":"10.51731/cjht.2022.275","title":"Galcanezumab (Emgality)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Migraine; Medicine; Family medicine; Medical physics; Psychiatry; Political science; Health care","score_opus":0.04504464360644382,"score_gpt":0.3045848520118984,"score_spread":0.25954020840545455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214889379","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2586756,0.244552,0.000089376954,0.4875162,0.00035439432,0.0005136394,0.000051928197,0.00021823365,0.008028647],"genre_scores_gemma":[0.99644154,0.0003306455,0.00030469237,0.0018988734,0.00001543701,0.000008261276,0.0000019439503,0.000009972529,0.0009886461],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99884284,0.00004858511,0.00043714498,0.00009127891,0.00019636514,0.000383793],"domain_scores_gemma":[0.9993236,0.00002781752,0.00024540964,0.00019543983,0.00011408177,0.00009365598],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000676201,0.00008572507,0.00038130875,0.00068469264,0.0005472942,0.0000079908405,0.00019360735,0.000041086816,0.000197032],"category_scores_gemma":[0.00042091357,0.00007382371,0.00010559745,0.00040959407,0.0001380309,0.000032875825,0.00003878006,0.00066854095,0.0000035244157],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006622668,0.00006840781,0.041185442,0.00029916875,0.00020159618,0.001364368,0.0022249783,0.000016541153,0.00005507585,0.007742422,0.6961629,0.2506129],"study_design_scores_gemma":[0.00042192705,0.0009604081,0.010754508,0.000046125788,0.000017135273,0.0013808421,0.013316068,0.0000020494729,0.000051635714,0.0015257741,0.9714575,0.00006605093],"about_ca_topic_score_codex":0.0054020328,"about_ca_topic_score_gemma":0.0036463698,"teacher_disagreement_score":0.7377659,"about_ca_system_score_codex":0.000631926,"about_ca_system_score_gemma":0.0042807483,"threshold_uncertainty_score":0.81662935},"labels":[],"label_agreement":null},{"id":"W4220683091","doi":"10.51731/cjht.2022.280","title":"Osimertinib (Tagrisso)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Osimertinib; Reimbursement; Medicine; Oncology; Lung cancer; Exon; Drug; Adjuvant; Stage (stratigraphy); Internal medicine; Family medicine; Cancer; Pharmacology; Adenocarcinoma; Political science; Gene; Biology; Genetics","score_opus":0.025149900397469595,"score_gpt":0.3347979546627587,"score_spread":0.3096480542652891,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220683091","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.37436357,0.21766675,0.00022256061,0.40115836,0.0016774967,0.00081185007,0.00011562728,0.00023951486,0.0037442704],"genre_scores_gemma":[0.9978473,0.00010947831,0.00043533475,0.0012611265,0.000007927155,0.000013883369,0.000004761413,0.000008587117,0.00031157825],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99923307,0.000025538615,0.00029611983,0.0000692095,0.0001290601,0.00024698596],"domain_scores_gemma":[0.9994773,0.000016744205,0.00021373299,0.00013804766,0.00007117459,0.000082993385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023393602,0.000059762537,0.00020645937,0.00040836292,0.00041040272,0.000007856086,0.00012407245,0.000027985758,0.00019250016],"category_scores_gemma":[0.00010659805,0.00004886193,0.000058019938,0.00027066228,0.00006126,0.000035490153,0.000014331139,0.00032590234,0.0000038497437],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031302032,0.00007254442,0.03537369,0.00006233713,0.0002010317,0.00072404277,0.0011090788,0.00007828526,0.000041900723,0.0020003282,0.057238955,0.9030665],"study_design_scores_gemma":[0.00085033017,0.0011640548,0.020976346,0.000050746214,0.000051975745,0.001237822,0.00845911,0.0000054051134,0.00014000389,0.0013438017,0.9656543,0.000066112596],"about_ca_topic_score_codex":0.0036988035,"about_ca_topic_score_gemma":0.00049470755,"teacher_disagreement_score":0.9084153,"about_ca_system_score_codex":0.00083797565,"about_ca_system_score_gemma":0.0043392545,"threshold_uncertainty_score":0.7697651},"labels":[],"label_agreement":null},{"id":"W4220707728","doi":"10.51731/cjht.2022.296","title":"Nivolumab (Opdivo)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Nivolumab; Medicine; Adjuvant; Vial; Cancer drugs; Internal medicine; Cancer; Oncology; Intensive care medicine; General surgery; Health care; Political science","score_opus":0.03837833158930708,"score_gpt":0.32678229831197575,"score_spread":0.28840396672266866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220707728","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19469541,0.60207707,0.000058093116,0.20052662,0.00054620806,0.0006065724,0.00007270941,0.00014570446,0.0012716262],"genre_scores_gemma":[0.9982916,0.0003192647,0.00029927184,0.00076659175,0.00000926783,0.000017288885,0.0000031621378,0.000010170627,0.00028337172],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99885446,0.00005145481,0.00029601424,0.00009147827,0.00027461763,0.0004319534],"domain_scores_gemma":[0.9993576,0.00002061597,0.00016776785,0.00019522091,0.00009038485,0.00016844772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049076905,0.00007259965,0.00026576326,0.00060304074,0.00044103447,0.000011796661,0.0002146056,0.000032096963,0.00034050932],"category_scores_gemma":[0.00017637777,0.000061506675,0.00007612924,0.0003365079,0.00011354176,0.00004111301,0.00003426297,0.00061350624,0.000007891026],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009999216,0.00006850389,0.03910768,0.000105839135,0.000108146574,0.004490655,0.00028735196,0.000019209967,0.000008554709,0.0014178323,0.0393354,0.91495085],"study_design_scores_gemma":[0.0038403822,0.012271245,0.049574837,0.00015559632,0.00003998707,0.007367776,0.011823138,0.000014476158,0.0006714008,0.0072346353,0.90681624,0.00019028493],"about_ca_topic_score_codex":0.0064891586,"about_ca_topic_score_gemma":0.001653371,"teacher_disagreement_score":0.91476053,"about_ca_system_score_codex":0.0016165177,"about_ca_system_score_gemma":0.0068383035,"threshold_uncertainty_score":0.998792},"labels":[],"label_agreement":null},{"id":"W4220805300","doi":"10.51731/cjht.2022.294","title":"Chlormethine Gel (Ledaga)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Mycosis fungoides; Medicine; Dermatology; Family medicine; Lymphoma; Political science; Health care; Pathology","score_opus":0.043338427330568426,"score_gpt":0.33290281317614867,"score_spread":0.28956438584558025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220805300","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.59110135,0.120932356,0.0002260548,0.28417888,0.000544946,0.00079089275,0.000059644084,0.00017277167,0.001993084],"genre_scores_gemma":[0.9969292,0.00034155123,0.00046725498,0.0016858373,0.000011121996,0.000016119204,0.000004909933,0.000020177114,0.00052377867],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99828774,0.000097996824,0.00048859674,0.00013589015,0.0004272105,0.00056258513],"domain_scores_gemma":[0.99899966,0.000060086695,0.00025056768,0.00026922242,0.0002574358,0.00016300302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011287058,0.00011037113,0.0004175665,0.0011794931,0.00061866775,0.000019779316,0.0003661086,0.00006655096,0.0005057287],"category_scores_gemma":[0.0011733406,0.00009837627,0.000100996585,0.0006615474,0.00023579148,0.000050508766,0.000065379405,0.0010453992,0.000009529278],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002799591,0.00014723673,0.07016968,0.00027357438,0.0001983479,0.0047961785,0.001832416,0.00012498586,0.00048793797,0.0025760883,0.05588654,0.86322707],"study_design_scores_gemma":[0.0019350934,0.004084916,0.008192623,0.000110973226,0.00002307979,0.029123694,0.024690894,0.00012569307,0.00071835535,0.005675399,0.9250948,0.00022448883],"about_ca_topic_score_codex":0.00382931,"about_ca_topic_score_gemma":0.0021301,"teacher_disagreement_score":0.8692083,"about_ca_system_score_codex":0.0014877239,"about_ca_system_score_gemma":0.009507847,"threshold_uncertainty_score":0.99610734},"labels":[],"label_agreement":null},{"id":"W4220860894","doi":"10.51731/cjht.2022.290","title":"Electrospun Healing Fibres for the Management of Burns and Wounds","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Wound Healing and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Horizon; Operations management; Business; Health care; Medicine; Process management; Medical emergency; Knowledge management; Computer science; Engineering; Political science","score_opus":0.03278403749782005,"score_gpt":0.3111249747798966,"score_spread":0.27834093728207654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220860894","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4376761,0.34821013,0.0020231453,0.2097118,0.00056073687,0.001437003,0.00008475129,0.00008203075,0.00021428941],"genre_scores_gemma":[0.9958157,0.0014924794,0.002210677,0.00033603155,0.0000071785817,0.000025365878,0.0000023984217,0.000008621479,0.00010158006],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991733,0.000018911182,0.0003270139,0.00007697301,0.00012292076,0.00028091107],"domain_scores_gemma":[0.99944025,0.00006640271,0.00023521704,0.00014695642,0.00005828366,0.00005285904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059204595,0.000067929,0.00024148691,0.00023450263,0.0005499378,0.000009744064,0.00012419609,0.00003032351,0.000007464689],"category_scores_gemma":[0.000031440584,0.000046665453,0.00005321582,0.00017484944,0.00011673222,0.000018373028,0.00002023739,0.00024428486,1.0328948e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026122955,0.000097003045,0.020658102,0.0014975271,0.0010331576,0.0002565554,0.0012897432,0.00018697002,0.000050514915,0.020785214,0.0065576322,0.94732636],"study_design_scores_gemma":[0.006726745,0.01244773,0.058461554,0.0012448874,0.00061814906,0.0031131092,0.05826767,0.00024653538,0.0010369796,0.03294952,0.8245675,0.00031961716],"about_ca_topic_score_codex":0.0017310644,"about_ca_topic_score_gemma":0.0003194933,"teacher_disagreement_score":0.94700676,"about_ca_system_score_codex":0.00032308407,"about_ca_system_score_gemma":0.00077549857,"threshold_uncertainty_score":0.42297325},"labels":[],"label_agreement":null},{"id":"W4220871701","doi":"10.51731/cjht.2022.286","title":"Alpelisib (Piqray)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Fulvestrant; Medicine; Regimen; Family medicine; Metastatic breast cancer; Breast cancer; Oncology; Internal medicine; Cancer; Gynecology; Political science; Estrogen receptor; Health care","score_opus":0.024443423046101077,"score_gpt":0.29228039434484965,"score_spread":0.26783697129874856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220871701","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24462451,0.3965818,0.0015217363,0.35322034,0.0018196872,0.000679916,0.000080963866,0.00039448333,0.0010765694],"genre_scores_gemma":[0.99552864,0.00014176157,0.0017541872,0.0023644068,0.000018181887,0.000011701358,0.0000019435695,0.000019065536,0.00016013713],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99879175,0.00004460056,0.00041876247,0.00010653726,0.00021925746,0.00041906975],"domain_scores_gemma":[0.9991565,0.000026538635,0.0003408886,0.00024876907,0.00011535614,0.00011199414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004900216,0.00009743178,0.00035054056,0.00068164023,0.00038547334,0.000009078701,0.0002837391,0.000044293705,0.00024181424],"category_scores_gemma":[0.00019845,0.00008830191,0.000078128374,0.00043032688,0.00016931858,0.00007243564,0.00003215958,0.0007067811,0.0000041552375],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000062474115,0.000018674487,0.004884629,0.00005039332,0.000049790953,0.00046440458,0.00039275317,0.0000968382,0.00010165469,0.0012492258,0.0043228995,0.9883063],"study_design_scores_gemma":[0.0007659733,0.0008960784,0.006125647,0.000071854796,0.000010968554,0.0035729883,0.00873405,0.000004219696,0.00026834093,0.0046546864,0.9748058,0.00008940592],"about_ca_topic_score_codex":0.0014971367,"about_ca_topic_score_gemma":0.00051780697,"teacher_disagreement_score":0.9882169,"about_ca_system_score_codex":0.0011734545,"about_ca_system_score_gemma":0.0042613978,"threshold_uncertainty_score":0.75595367},"labels":[],"label_agreement":null},{"id":"W4220947098","doi":"10.51731/cjht.2022.282","title":"Vacuum-Induced Uterine Tamponade for Postpartum Hemorrhage","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Maternal and fetal healthcare","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Horizon; Medicine; Emerging technologies; Information technology; Business; Operations management; Obstetrics; Computer science; Engineering; Physics","score_opus":0.04756414374399462,"score_gpt":0.3256637272484906,"score_spread":0.27809958350449593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220947098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.79770756,0.016566338,0.00015668003,0.18339005,0.0010638824,0.0006771822,0.00020134162,0.000109561115,0.00012738798],"genre_scores_gemma":[0.99555653,0.00007909434,0.0010765069,0.0027162882,0.00003606212,0.000037136535,0.000011764733,0.000022272197,0.00046433476],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984533,0.000044925117,0.00059256674,0.00014417374,0.00020291877,0.0005621181],"domain_scores_gemma":[0.9989982,0.000036201403,0.00036436718,0.00022894026,0.00015428363,0.00021800962],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063003687,0.00013026861,0.00045369638,0.0005580414,0.0004888743,0.000013892974,0.00029084968,0.00007748348,0.00014185238],"category_scores_gemma":[0.0001481017,0.00011234822,0.0001210658,0.00024982053,0.000054801698,0.000055011635,0.000043814045,0.0006132822,0.000003035684],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007426135,0.00012474,0.0089804195,0.0036390137,0.00010767433,0.0051177256,0.0007926235,0.000008794536,0.001869169,0.0034919698,0.01269393,0.9624313],"study_design_scores_gemma":[0.0027032148,0.009819215,0.019824065,0.00030526743,0.00003939528,0.01917643,0.009133426,0.0001455214,0.0029505289,0.006539176,0.9290071,0.00035667358],"about_ca_topic_score_codex":0.004095924,"about_ca_topic_score_gemma":0.00096043036,"teacher_disagreement_score":0.96207464,"about_ca_system_score_codex":0.0006653762,"about_ca_system_score_gemma":0.002935841,"threshold_uncertainty_score":0.6191839},"labels":[],"label_agreement":null},{"id":"W4221003624","doi":"10.51731/cjht.2022.285","title":"2022 Health Technology Trends to Watch: Top 10 List","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Artificial Intelligence in Healthcare","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Ministry of Health; Alberta Health Services","funders":"","keywords":"Health care; Government (linguistics); Equity (law); Emerging technologies; Health technology; Business; Public relations; Knowledge management; Internet privacy; Computer science; Political science","score_opus":0.1581079539453819,"score_gpt":0.4694129010248179,"score_spread":0.311304947079436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221003624","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.084796935,0.03399159,0.00020122321,0.87438244,0.0038691924,0.0010645244,0.00027242812,0.00053215475,0.0008895144],"genre_scores_gemma":[0.98160154,0.00037605816,0.0009405369,0.012657209,0.00009185916,0.00029198482,0.000016011094,0.00007028648,0.0039545298],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9930559,0.0010008339,0.002606028,0.00046645643,0.00054976874,0.002321039],"domain_scores_gemma":[0.99590176,0.00030373043,0.0017067583,0.00090626825,0.0005840936,0.00059736404],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0045900666,0.0003085244,0.0010182083,0.003734247,0.0059029413,0.000020527908,0.0017752402,0.00038365353,0.0041214684],"category_scores_gemma":[0.0020318613,0.00030692713,0.00014289089,0.0040068324,0.00031771386,0.00013748647,0.00039846543,0.0041380143,0.00016551062],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000041432053,0.000030616528,0.025377547,0.00015827123,0.000021433043,0.00012173729,0.0044556954,0.00009527242,0.000011686843,0.0073119113,0.28051937,0.681855],"study_design_scores_gemma":[0.00015685038,0.0017384046,0.00070470705,0.0001986494,0.0000040077825,0.0001146128,0.106983125,0.000021754582,0.000054965443,0.0058301934,0.88397527,0.0002174419],"about_ca_topic_score_codex":0.06068095,"about_ca_topic_score_gemma":0.13996208,"teacher_disagreement_score":0.8968046,"about_ca_system_score_codex":0.0059802323,"about_ca_system_score_gemma":0.018300407,"threshold_uncertainty_score":0.9999383},"labels":[],"label_agreement":null},{"id":"W4221024616","doi":"10.51731/cjht.2022.283","title":"Artificial Intelligence for the Prediction of Sepsis in Adults","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Sepsis Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Horizon; Data science; Focus (optics); Computer science; Artificial intelligence; Intervention (counseling); Information technology; Emerging technologies; Decision support system; Knowledge management; Medicine; Nursing; Mathematics","score_opus":0.1396070954475354,"score_gpt":0.3522876855848396,"score_spread":0.21268059013730417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221024616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7516707,0.06412721,0.00075255014,0.18097794,0.0008122726,0.0013347024,0.00024746684,0.000037318478,0.000039827915],"genre_scores_gemma":[0.9987963,0.00055464037,0.0002795578,0.00028035502,0.000008477524,0.00006853216,0.0000034823308,0.0000055086325,0.0000031838267],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99908465,0.000025825975,0.0005063473,0.00007262827,0.0001206534,0.00018987237],"domain_scores_gemma":[0.9993261,0.00015852759,0.000261244,0.00013923028,0.00008189572,0.00003296591],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005202647,0.000054872267,0.00021679532,0.0004062389,0.00017285778,0.0000040546993,0.0001396681,0.000036196423,0.00003407461],"category_scores_gemma":[0.00040295513,0.000037949998,0.000072001065,0.00031028403,0.00008436897,0.00002266017,0.000012393608,0.00022980093,3.6658372e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010192741,0.00010116581,0.046005763,0.000082173916,0.000050818777,0.000031454576,0.0008014309,0.00032519925,0.000005895076,0.001458391,0.002355547,0.9486802],"study_design_scores_gemma":[0.0027062292,0.02285379,0.48743138,0.0024099986,0.0003014275,0.0010334816,0.2233981,0.0032697695,0.01209727,0.04282277,0.201316,0.00035978892],"about_ca_topic_score_codex":0.004068924,"about_ca_topic_score_gemma":0.0046825395,"teacher_disagreement_score":0.94832045,"about_ca_system_score_codex":0.00047160135,"about_ca_system_score_gemma":0.0011182025,"threshold_uncertainty_score":0.61510235},"labels":[],"label_agreement":null},{"id":"W4223528166","doi":"10.51731/cjht.2022.308","title":"Ketamine for Adults With Treatment-Resistant Depression or Post-Traumatic Stress Disorder","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Treatment of Major Depression","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Electroconvulsive therapy; Ketamine; Randomized controlled trial; Anesthesia; Medicine; Population; Major depressive disorder; Midazolam; Psychiatry; Internal medicine; Sedation","score_opus":0.02261003534631208,"score_gpt":0.2848191236407537,"score_spread":0.2622090882944416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4223528166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9447066,0.03459351,0.00014620743,0.018501414,0.00016772933,0.0014154973,0.00031519856,0.00012068918,0.00003311129],"genre_scores_gemma":[0.9967174,0.0002521798,0.0022700757,0.00017912553,0.000010787473,0.00017169904,0.000055403776,0.000038443595,0.0003048946],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.9983889,0.0000607028,0.0005306241,0.00022281916,0.00028781977,0.0005091237],"domain_scores_gemma":[0.9986374,0.0001271474,0.000524556,0.00036859803,0.00017179818,0.0001705379],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020436615,0.00021881696,0.0005645008,0.0006579091,0.0006080254,0.000019821658,0.00023719418,0.000079685065,0.00009515667],"category_scores_gemma":[0.00025633076,0.00012716983,0.0001027001,0.00028194135,0.0001085616,0.00009018461,0.000026293957,0.00027894625,9.329409e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055438015,0.00067215477,0.055301126,0.0007097407,0.0002880306,0.0012507737,0.0024296627,0.00013098987,0.0001240723,0.00004653949,0.0014826145,0.9320205],"study_design_scores_gemma":[0.052702744,0.14860459,0.22724715,0.0074552153,0.0009468559,0.0072129853,0.28101245,0.00029137227,0.0044175684,0.00035378512,0.2686434,0.0011118827],"about_ca_topic_score_codex":0.0077894777,"about_ca_topic_score_gemma":0.037006058,"teacher_disagreement_score":0.9309086,"about_ca_system_score_codex":0.0010773315,"about_ca_system_score_gemma":0.0027902229,"threshold_uncertainty_score":0.99881774},"labels":[],"label_agreement":null},{"id":"W4224215079","doi":"10.51731/cjht.2022.314","title":"Systemic Thrombolysis and Endovascular Therapy for Large Vessel Occlusion Acute Ischemic Stroke","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Thrombolysis; Medicine; Occlusion; Cardiology; Internal medicine; Ischemic stroke; Endovascular treatment; Stroke (engine); Ischemia; Radiology; Myocardial infarction","score_opus":0.015682566305057412,"score_gpt":0.26992432699642177,"score_spread":0.25424176069136434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224215079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8081376,0.15589638,0.002242198,0.031679865,0.00036606353,0.0011748952,0.00021713869,0.00011185741,0.00017399996],"genre_scores_gemma":[0.99256027,0.004290646,0.0014689445,0.001386966,0.000019130923,0.000055119282,0.000016547154,0.000027962462,0.0001744454],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983739,0.000046266287,0.0005419147,0.00021556606,0.00028176326,0.0005405488],"domain_scores_gemma":[0.9989197,0.000049929982,0.0004450656,0.0003499464,0.00011983654,0.00011551574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010461648,0.00016631358,0.00060508295,0.0006962505,0.0005563332,0.000019632384,0.0003310815,0.00009029527,0.00003586572],"category_scores_gemma":[0.0001408324,0.00014388404,0.00016657464,0.00027608208,0.00007930234,0.000069210284,0.00011511007,0.0005116331,7.321846e-7],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004889779,0.0001983189,0.031955473,0.0012493039,0.0038347475,0.0015161695,0.0025312514,0.00003336857,0.035032887,0.0011731861,0.49302518,0.42896113],"study_design_scores_gemma":[0.004236866,0.001577253,0.0017926965,0.00020443238,0.00022917827,0.0038978932,0.016187657,0.00009778721,0.004255507,0.000083271974,0.9672312,0.00020626742],"about_ca_topic_score_codex":0.00035203263,"about_ca_topic_score_gemma":0.00005085879,"teacher_disagreement_score":0.474206,"about_ca_system_score_codex":0.0007054139,"about_ca_system_score_gemma":0.0011652408,"threshold_uncertainty_score":0.58674204},"labels":[],"label_agreement":null},{"id":"W4224225208","doi":"10.51731/cjht.2022.313","title":"Rituximab for the Treatment of Primary Membranous Nephropathy","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Renal Diseases and Glomerulopathies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Nova Scotia Health Authority; Alberta Kidney Disease Network; Dalhousie University; University Health Network; University of Toronto; University of Calgary; Queen's University","funders":"Omeros Corporation","keywords":"Rituximab; Membranous nephropathy; Medicine; Cyclophosphamide; Tacrolimus; Internal medicine; Calcineurin; Nephrotic syndrome; Randomized controlled trial; Glomerulonephritis; Transplantation; Chemotherapy; Kidney; Lymphoma","score_opus":0.028530532914259162,"score_gpt":0.2749723424120416,"score_spread":0.24644180949778244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224225208","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24618353,0.6854251,0.00019101893,0.066233285,0.0005168614,0.0010249851,0.0002632386,0.000046197947,0.00011580816],"genre_scores_gemma":[0.99155444,0.007244528,0.0003354747,0.00069327006,0.000019334042,0.000055559714,0.000006108006,0.000012326258,0.000078973775],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990112,0.000034614357,0.00042564826,0.00008234309,0.00016469217,0.00028150377],"domain_scores_gemma":[0.9991391,0.000109139706,0.00033624843,0.00022922308,0.00011170666,0.00007463344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030234418,0.00009286029,0.0004565912,0.00032095806,0.00042373448,0.000007875202,0.00017919696,0.000033974364,0.000030211724],"category_scores_gemma":[0.00011506051,0.000056949877,0.00020249061,0.00022582697,0.00018183171,0.000027525723,0.000011583441,0.00014937724,5.176293e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002724967,0.00025704407,0.002015536,0.00033688883,0.00013630617,0.00016965954,0.00065342535,0.00006197305,0.000080093305,0.000567702,0.0041337074,0.9913152],"study_design_scores_gemma":[0.00318897,0.010402643,0.017815726,0.00010978382,0.00016458174,0.0007634763,0.010762355,0.00003210898,0.00040252472,0.0016415606,0.95461714,0.00009914244],"about_ca_topic_score_codex":0.0021643252,"about_ca_topic_score_gemma":0.00041837158,"teacher_disagreement_score":0.991216,"about_ca_system_score_codex":0.00065103924,"about_ca_system_score_gemma":0.0033490125,"threshold_uncertainty_score":0.5941004},"labels":[],"label_agreement":null},{"id":"W4224231288","doi":"10.51731/cjht.2022.306","title":"Estradiol and Progesterone (Bijuva)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Menopause: Health Impacts and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Estrogen; Progestogen; Medicine; Drug; Menopause; Gynecology; Vasomotor; Internal medicine; Endocrinology; Pharmacology; Political science","score_opus":0.050181892010300155,"score_gpt":0.31238240330216327,"score_spread":0.2622005112918631,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224231288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8104048,0.09227407,0.000011315058,0.09629498,0.00026988436,0.00051301596,0.000029237468,0.000061796774,0.00014092946],"genre_scores_gemma":[0.9973583,0.00042984437,0.000838362,0.0012494597,0.000008109023,0.000014494376,0.0000029238456,0.000013026328,0.0000854469],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988168,0.000051003382,0.00041552645,0.0001084111,0.00016640683,0.00044188826],"domain_scores_gemma":[0.9991866,0.000023901843,0.00029535752,0.00017321839,0.000049562314,0.00027136138],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005136514,0.00009995548,0.00035527415,0.0004706462,0.00045749915,0.000015331814,0.00011013302,0.00004962948,0.00004867002],"category_scores_gemma":[0.00014868166,0.0000805908,0.000009971031,0.00020341919,0.000111034686,0.000056644858,0.000021483305,0.00048645292,0.000001485128],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012869496,0.00010007142,0.0717091,0.0005081116,0.00014635005,0.0022764804,0.00071531313,0.000006202466,0.0001247791,0.0011993543,0.008006218,0.91507936],"study_design_scores_gemma":[0.008770938,0.042791363,0.16134882,0.00057814806,0.00015129523,0.03177926,0.008122463,0.000020950267,0.00028351857,0.005453538,0.74034256,0.00035713147],"about_ca_topic_score_codex":0.002819072,"about_ca_topic_score_gemma":0.00060801086,"teacher_disagreement_score":0.9147222,"about_ca_system_score_codex":0.0006362622,"about_ca_system_score_gemma":0.003873716,"threshold_uncertainty_score":0.6871806},"labels":[],"label_agreement":null},{"id":"W4224241935","doi":"10.51731/cjht.2022.304","title":"Triheptanoin (Dojolvi)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Metabolism and Genetic Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Calorie; Medicine; Family medicine; Business; Political science; Internal medicine","score_opus":0.011449612610456014,"score_gpt":0.24088423567639278,"score_spread":0.22943462306593676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224241935","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.66490096,0.316838,0.0007613025,0.01474096,0.0012084879,0.00023202518,0.00008366569,0.000027817312,0.0012068108],"genre_scores_gemma":[0.9977815,0.0007058722,0.00039204556,0.0008298626,0.000014404365,0.000008011136,0.000009956835,0.000010758803,0.00024757843],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99906397,0.00008006779,0.0003148549,0.00011605786,0.0001138781,0.00031117687],"domain_scores_gemma":[0.99943376,0.00000494011,0.00022067646,0.00022399866,0.000054492513,0.000062141145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005440833,0.0000808771,0.00016915453,0.00024290614,0.0003059615,0.000012938929,0.0004379213,0.000056158802,0.0000919383],"category_scores_gemma":[0.00018547298,0.0000794006,0.000071569375,0.00017774785,0.00010444396,0.000002110919,0.00005445325,0.00020742838,0.0000019577465],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039354287,0.000040492585,0.008402549,0.000035667308,0.00007156609,0.00006497946,0.00019321621,0.00039968637,0.0039019699,0.0017725907,0.117446095,0.86763185],"study_design_scores_gemma":[0.00031220596,0.00040668144,0.0018957095,0.000004587502,0.000004112836,0.00015514722,0.0032858502,0.0000017849721,0.0021883373,0.0012822073,0.9903722,0.000091177266],"about_ca_topic_score_codex":0.0006084691,"about_ca_topic_score_gemma":0.001203916,"teacher_disagreement_score":0.8729261,"about_ca_system_score_codex":0.000025270703,"about_ca_system_score_gemma":0.0019490377,"threshold_uncertainty_score":0.3457509},"labels":[],"label_agreement":null},{"id":"W4224246511","doi":"10.51731/cjht.2022.311","title":"Colchicine (Myinfla)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Antithrombotic; Medicine; Drug; Drug class; Colchicine; Intensive care medicine; Family medicine; Pharmacology; Internal medicine; Political science; Health care","score_opus":0.021402850192954282,"score_gpt":0.26422724025130406,"score_spread":0.24282439005834977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224246511","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.47882673,0.29045957,0.0004946404,0.22578217,0.0013316309,0.0011102197,0.000044574135,0.00022412198,0.0017263395],"genre_scores_gemma":[0.9967943,0.0003586624,0.0004732635,0.0021825053,0.000029905923,0.000015502377,0.0000031664838,0.000015950069,0.00012675037],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984779,0.00009068279,0.0005087187,0.0001134228,0.0003699767,0.00043932424],"domain_scores_gemma":[0.9990315,0.000015599326,0.00029085117,0.0003705498,0.00013196007,0.00015958339],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017015869,0.00009486339,0.0004923329,0.00066319376,0.0005388859,0.000010526871,0.00022758356,0.00005886482,0.00014577441],"category_scores_gemma":[0.00026819442,0.00008149257,0.00016948876,0.0004937299,0.00010219537,0.0000410038,0.000034706733,0.00083723245,0.000003903351],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050394312,0.00003576613,0.007735822,0.00021644802,0.00013806386,0.0012411586,0.00030438878,0.00006387664,0.00004204272,0.0022203333,0.018328473,0.9696232],"study_design_scores_gemma":[0.0011437869,0.001754249,0.014156382,0.00009540212,0.000029682156,0.005420501,0.0056357286,0.000007857398,0.00011164568,0.001392813,0.9701558,0.000096200165],"about_ca_topic_score_codex":0.0064636013,"about_ca_topic_score_gemma":0.0011283295,"teacher_disagreement_score":0.969527,"about_ca_system_score_codex":0.00089284,"about_ca_system_score_gemma":0.006765811,"threshold_uncertainty_score":0.9988649},"labels":[],"label_agreement":null},{"id":"W4224279217","doi":"10.51731/cjht.2022.312","title":"Inclisiran (Leqvio)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Familial hypercholesterolemia; Drug; Drug class; Statin; Ldl cholesterol; Physical therapy; Internal medicine; Intensive care medicine; Cholesterol; Pharmacology; Political science; Health care","score_opus":0.023769985502235004,"score_gpt":0.2676920870916604,"score_spread":0.24392210158942543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224279217","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5254008,0.32336602,0.00039047038,0.14674382,0.0013785367,0.00087974686,0.000044913726,0.00022173669,0.0015739426],"genre_scores_gemma":[0.9969882,0.0003372903,0.0005359489,0.001995397,0.00002859659,0.000012770231,0.0000029963157,0.000016252852,0.0000825552],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99844676,0.00010715893,0.0005036961,0.00012094091,0.00037537565,0.00044603823],"domain_scores_gemma":[0.9990373,0.000015712576,0.00027083524,0.00039871703,0.00011569403,0.00016174313],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019477042,0.00009385037,0.00045926668,0.0006681902,0.00058834587,0.000012605617,0.00026068895,0.00006358396,0.00013073126],"category_scores_gemma":[0.00028062373,0.00008139858,0.00019254813,0.0004763302,0.00010281291,0.00004890567,0.000044048957,0.00084886194,0.000004105188],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001876476,0.00002092389,0.0040844246,0.00010448791,0.000072704315,0.000605228,0.00023626482,0.000018827737,0.000011253056,0.0010378227,0.006080561,0.98770875],"study_design_scores_gemma":[0.0008236674,0.0014237327,0.011031606,0.00007222468,0.000021889706,0.004024643,0.005760172,0.0000045142974,0.00008468986,0.0014112457,0.97525346,0.000088122055],"about_ca_topic_score_codex":0.008056006,"about_ca_topic_score_gemma":0.0010311713,"teacher_disagreement_score":0.9876206,"about_ca_system_score_codex":0.000896875,"about_ca_system_score_gemma":0.00639393,"threshold_uncertainty_score":0.9992389},"labels":[],"label_agreement":null},{"id":"W4224283527","doi":"10.51731/cjht.2022.305","title":"Isatuximab (Sarclisa)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Carfilzomib; Medicine; Family medicine; Multiple myeloma; Political science; Internal medicine; Health care; Bortezomib","score_opus":0.05283725872536472,"score_gpt":0.3347017299084163,"score_spread":0.2818644711830516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224283527","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.72224593,0.11120322,0.00008449247,0.16340224,0.0006024585,0.00067096384,0.00010069427,0.00015664642,0.0015333608],"genre_scores_gemma":[0.9982133,0.00018796753,0.00072316494,0.000618385,0.000008249562,0.000012345941,0.0000059144895,0.000011221633,0.00021943761],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99872655,0.00006809808,0.0003321464,0.000097211625,0.00028982118,0.00048619587],"domain_scores_gemma":[0.9992176,0.000036305577,0.0002522509,0.0002164629,0.00009500373,0.00018237196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052882894,0.00008011253,0.00029849206,0.0007635191,0.000463773,0.000013470341,0.00023354233,0.00003931087,0.0002525015],"category_scores_gemma":[0.00045686626,0.00006695807,0.000080749596,0.0003471885,0.000132865,0.00004549941,0.00004061917,0.00064510095,0.000010467596],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009767093,0.000084674495,0.05691331,0.0000745473,0.000107544096,0.002696044,0.00024452293,0.000009246911,0.000039984734,0.0006661849,0.019582711,0.91948354],"study_design_scores_gemma":[0.0038968655,0.0037985553,0.07671001,0.00010534087,0.000023767152,0.005456534,0.0091517605,0.000042120253,0.00039541596,0.0034218817,0.89685214,0.00014562535],"about_ca_topic_score_codex":0.003690203,"about_ca_topic_score_gemma":0.00085067516,"teacher_disagreement_score":0.9193379,"about_ca_system_score_codex":0.0009832465,"about_ca_system_score_gemma":0.004799847,"threshold_uncertainty_score":0.8514722},"labels":[],"label_agreement":null},{"id":"W4224297523","doi":"10.51731/cjht.2022.301","title":"Robotic-Assisted Surgical Systems for Hip Arthroplasty","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Orthopaedic implants and arthroplasty","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Context (archaeology); Arthroplasty; Medicine; Hip arthroplasty; Randomized controlled trial; Surgical procedures; Psychological intervention; Evidence-based medicine; Physical therapy; Medical physics; Surgery; Nursing; Alternative medicine","score_opus":0.04069836747639381,"score_gpt":0.2880870641095675,"score_spread":0.2473886966331737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224297523","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.54314256,0.32218638,0.0027299523,0.11602281,0.011224308,0.0029732953,0.00053493335,0.0005024212,0.00068335945],"genre_scores_gemma":[0.9985917,0.00034107026,0.00035038183,0.00026969533,0.00005102535,0.00002971811,0.00001215758,0.000020326526,0.0003338905],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99827564,0.00007617487,0.0006715439,0.00014962164,0.00025312926,0.0005738805],"domain_scores_gemma":[0.99892354,0.000106808184,0.00043316305,0.00020346431,0.00014090067,0.00019211625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008764761,0.00013190127,0.00055319,0.0005429559,0.0007193943,0.000027392842,0.00014934869,0.00008682486,0.00007769489],"category_scores_gemma":[0.00025528116,0.000106829895,0.00013916606,0.00027082342,0.00017159621,0.000052906864,0.000028250559,0.0005682202,0.0000026917744],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025923617,0.00013122127,0.019923117,0.0005021452,0.00019214548,0.003909025,0.00025783788,0.000780526,0.000011573434,0.0047716107,0.068944745,0.90031683],"study_design_scores_gemma":[0.0017977731,0.001955684,0.0050325696,0.00013503658,0.000028365856,0.02031064,0.0049243183,0.0001423865,0.000006248336,0.000096448864,0.9654561,0.00011440356],"about_ca_topic_score_codex":0.00084951334,"about_ca_topic_score_gemma":0.00035726654,"teacher_disagreement_score":0.9002024,"about_ca_system_score_codex":0.00046266138,"about_ca_system_score_gemma":0.0034988786,"threshold_uncertainty_score":0.62068605},"labels":[],"label_agreement":null},{"id":"W4224310496","doi":"10.51731/cjht.2022.319","title":"Ravulizumab (Ultomiris)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Paroxysmal nocturnal hemoglobinuria; Medicine; Family medicine; Business; Political science; Health care; Internal medicine","score_opus":0.024986177415764328,"score_gpt":0.26288143086091187,"score_spread":0.23789525344514753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224310496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.50386375,0.44376704,0.00014983353,0.04555367,0.004613162,0.0006389225,0.00035452706,0.00031609612,0.00074298005],"genre_scores_gemma":[0.9992793,0.00005418935,0.00004472995,0.000345659,0.0000039131833,0.000020042078,0.00001325828,0.000010701198,0.00022816745],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984789,0.00026957816,0.0005886786,0.00012294734,0.00005356203,0.000486351],"domain_scores_gemma":[0.99904734,0.000071040675,0.00050689676,0.00026973995,0.000076790064,0.000028184108],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00071764353,0.00010664454,0.00032623447,0.00066970004,0.00086372433,0.00001295205,0.0007261502,0.00006228843,0.0015530792],"category_scores_gemma":[0.0002594275,0.000101689344,0.00009357601,0.00027049135,0.00018675275,0.000055813416,0.00008995081,0.000533786,0.00005147843],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008330108,0.00008345372,0.021679334,0.0000946839,0.00026399933,0.0002609701,0.0009793588,0.00011344908,0.0010577765,0.006586038,0.4887084,0.48008922],"study_design_scores_gemma":[0.0006749731,0.00045467447,0.0041766865,0.0000334154,0.000009963349,0.0010077388,0.010289114,5.8059214e-7,0.00044531294,0.0015743227,0.98122364,0.00010959903],"about_ca_topic_score_codex":0.0031666772,"about_ca_topic_score_gemma":0.0011665133,"teacher_disagreement_score":0.49541557,"about_ca_system_score_codex":0.00062455307,"about_ca_system_score_gemma":0.0025191377,"threshold_uncertainty_score":0.9993596},"labels":[],"label_agreement":null},{"id":"W4224312449","doi":"10.51731/cjht.2022.317","title":"Enablers for Remote Monitoring Programs for Cardiac Conditions: Lessons From the COVID-19 Pandemic","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Telemedicine and Telehealth Implementation","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Business; Telehealth; Reimbursement; Health care; Telemedicine; SAFER; Government (linguistics); Process management; Medicine; Medical emergency; Political science; Computer security; Computer science","score_opus":0.2054077679335343,"score_gpt":0.4365523792371471,"score_spread":0.23114461130361283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224312449","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21545695,0.061384495,0.00827605,0.7056055,0.0023220961,0.0051986594,0.001479298,0.00026370783,0.0000132725145],"genre_scores_gemma":[0.98985165,0.0006658572,0.0037392627,0.005041334,0.0001489724,0.00031102775,0.00018868971,0.000022683502,0.00003050675],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984593,0.00008229624,0.00060257973,0.00014823397,0.00019301577,0.0005146145],"domain_scores_gemma":[0.99835443,0.00054362364,0.0005163334,0.00021971579,0.00015498757,0.00021092968],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016363168,0.000106506246,0.00036720413,0.00029019194,0.0012935044,0.000018893836,0.00023872616,0.0000636262,0.000018160741],"category_scores_gemma":[0.0015657939,0.000082088154,0.00012185032,0.00028335117,0.0001268661,0.00005333119,0.000018149358,0.0004446123,2.858356e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009880746,0.000015097016,0.102698065,0.00026374598,0.00013616869,0.000019886034,0.0013747191,0.00002496304,0.000050013696,0.0004554738,0.075960875,0.8189022],"study_design_scores_gemma":[0.0017327743,0.0012762207,0.006489388,0.00009029959,0.00008471322,0.00014882193,0.049959328,0.000016528447,0.00004136036,0.0077200164,0.93236184,0.00007872069],"about_ca_topic_score_codex":0.018926369,"about_ca_topic_score_gemma":0.0028558555,"teacher_disagreement_score":0.85640097,"about_ca_system_score_codex":0.0014893388,"about_ca_system_score_gemma":0.0064644855,"threshold_uncertainty_score":0.9991679},"labels":[],"label_agreement":null},{"id":"W4224317855","doi":"10.51731/cjht.2022.315","title":"Emerging Multi-Cancer Early Detection Technologies","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Health care; Emerging technologies; Test (biology); Risk analysis (engineering); Cancer; Cancer screening; Clinical decision support system; Computer science; Medicine; Data science; Decision support system; Artificial intelligence; Political science","score_opus":0.01654254130916333,"score_gpt":0.27130229027534947,"score_spread":0.25475974896618614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224317855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.79803634,0.18424702,0.0037872677,0.012296084,0.0011061887,0.00025923928,0.00011372258,0.00011509843,0.00003902684],"genre_scores_gemma":[0.99615663,0.002860737,0.0006033181,0.00024003907,0.000020211766,0.00004009101,0.000003826188,0.000019209996,0.000055960118],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99892974,0.00003593254,0.00036293728,0.0001756902,0.00010641997,0.00038929138],"domain_scores_gemma":[0.9992233,0.000011433564,0.00036078328,0.00025618463,0.000105273255,0.00004305631],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035837648,0.00011854069,0.00019314636,0.00040374493,0.00053211267,0.00002772048,0.0004691739,0.00011388759,0.00001345167],"category_scores_gemma":[0.00031950942,0.00012369633,0.00008152102,0.00026945892,0.0001376602,0.0000056169656,0.00012683384,0.00039808278,0.000001028491],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030446143,0.000026398064,0.008203819,0.000027685213,0.000065254164,0.000037649435,0.00015991341,0.001193503,0.0144775,0.00015671393,0.0041998043,0.9714213],"study_design_scores_gemma":[0.0006441916,0.0011463381,0.0039064614,0.00003099171,0.000014353534,0.00017873809,0.0074171918,0.000052498897,0.042246055,0.00089355366,0.9432006,0.00026905412],"about_ca_topic_score_codex":0.0033271783,"about_ca_topic_score_gemma":0.0073048477,"teacher_disagreement_score":0.97115225,"about_ca_system_score_codex":0.00031457574,"about_ca_system_score_gemma":0.0013762319,"threshold_uncertainty_score":0.50441897},"labels":[],"label_agreement":null},{"id":"W4224321083","doi":"10.51731/cjht.2022.318","title":"Tirzepatide for Type 2 Diabetes Mellitus","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Metformin; Type 2 diabetes; Medicine; Type 2 Diabetes Mellitus; Diabetes mellitus; Glycemic; Liraglutide; Insulin; Endocrinology; Internal medicine; Clinical trial; Pharmacology","score_opus":0.039217028697575984,"score_gpt":0.29623674319022597,"score_spread":0.25701971449265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224321083","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.56476927,0.27452806,0.00011814891,0.15566307,0.0018892352,0.0016033805,0.0000754493,0.00023065269,0.0011227399],"genre_scores_gemma":[0.9963273,0.0003921828,0.0014282063,0.0014058497,0.000010956654,0.000038587412,0.000013696261,0.000014196653,0.00036905555],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99908084,0.00002145396,0.0003038584,0.00009005213,0.000121532175,0.00038224607],"domain_scores_gemma":[0.9994176,0.00004214978,0.0002120357,0.00015531093,0.00009665445,0.00007624486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045742615,0.00008237377,0.00029806703,0.0005120869,0.00028220765,0.00001227097,0.00016626448,0.000030588955,0.0000685597],"category_scores_gemma":[0.00020914548,0.000070926806,0.000078373036,0.00026755186,0.000059173097,0.00003884561,0.000025963373,0.0001831075,0.0000030882363],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029207513,0.000048752503,0.014369918,0.0001779568,0.00019080986,0.00006603151,0.0001187942,0.000022933546,0.000022994109,0.0023714239,0.07287081,0.90971035],"study_design_scores_gemma":[0.0007101873,0.0027238007,0.002350531,0.000054201115,0.000060988143,0.000017719201,0.0015994941,0.000026825988,0.00032264838,0.003006548,0.9890553,0.000071764596],"about_ca_topic_score_codex":0.00029948843,"about_ca_topic_score_gemma":0.00027585417,"teacher_disagreement_score":0.9161845,"about_ca_system_score_codex":0.0005422778,"about_ca_system_score_gemma":0.0011844134,"threshold_uncertainty_score":0.28923112},"labels":[],"label_agreement":null},{"id":"W4225002517","doi":"10.51731/cjht.2022.320","title":"Pertuzumab (Perjeta)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pertuzumab; Reimbursement; Trastuzumab; Medicine; Breast cancer; Oncology; Family medicine; Internal medicine; Cancer; Political science; Health care","score_opus":0.0735274290851781,"score_gpt":0.364587629344771,"score_spread":0.2910602002595929,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225002517","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24703893,0.22778709,0.00012854052,0.51876897,0.0014438101,0.0007952286,0.00007740951,0.00024886092,0.0037111882],"genre_scores_gemma":[0.9968634,0.00047510248,0.00049136014,0.0016955897,0.00002048702,0.000020198815,0.0000022266506,0.000021334696,0.00041028977],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99822336,0.0000992284,0.00047540944,0.00013389248,0.0004562066,0.00061188854],"domain_scores_gemma":[0.9990348,0.00004666316,0.00021279116,0.00033513125,0.00017030048,0.00020028371],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012595166,0.00009631079,0.0003758201,0.0009955862,0.0005306091,0.000019507761,0.00045855175,0.000067678586,0.00070231914],"category_scores_gemma":[0.0007181506,0.00008595147,0.0000935105,0.0005835826,0.00021726757,0.000046354202,0.00006342153,0.0013367538,0.000012375305],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050059523,0.000035381054,0.012928544,0.00017750931,0.000053637876,0.0017046967,0.0005993816,0.000032423104,0.000083131556,0.0011733432,0.10639037,0.8767715],"study_design_scores_gemma":[0.0005328892,0.0017785701,0.0039360076,0.000095256175,0.0000082579745,0.003087137,0.008224581,0.000020386287,0.00016749933,0.0010877787,0.9809788,0.000082828185],"about_ca_topic_score_codex":0.005897423,"about_ca_topic_score_gemma":0.0015189135,"teacher_disagreement_score":0.8766887,"about_ca_system_score_codex":0.0027229246,"about_ca_system_score_gemma":0.01434429,"threshold_uncertainty_score":0.9912435},"labels":[],"label_agreement":null},{"id":"W4225016550","doi":"10.51731/cjht.2022.321","title":"Harmonization of Public Coverage Policies for Biologic Drugs in the Treatment of Rheumatoid Arthritis","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"U.S. Department of Veterans Affairs","keywords":"Veterans Affairs; Medicine; Public administration; Political science; Internal medicine","score_opus":0.09433791284355138,"score_gpt":0.2939799318032812,"score_spread":0.19964201895972983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225016550","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8351662,0.110024385,0.00024803757,0.052758954,0.0002293225,0.0003580949,0.00092141767,0.000008183963,0.00028541102],"genre_scores_gemma":[0.97084373,0.02851571,0.00007883727,0.0005096886,0.0000049141872,0.000029427609,0.0000072335615,0.0000059746376,0.000004456616],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99873316,0.0000370173,0.0008514883,0.00008631067,0.000019207497,0.0002728002],"domain_scores_gemma":[0.9988456,0.000109383735,0.000838792,0.00014277581,0.00003090553,0.000032582582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009839056,0.000072353636,0.0004069933,0.00072452566,0.00014963873,0.000017488488,0.00033594403,0.000045540546,0.00003673693],"category_scores_gemma":[0.0001873999,0.00006422936,0.00009366394,0.00031551445,0.0001238722,0.00006494191,0.000012876316,0.00011268936,8.550645e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020038322,0.00021540785,0.0726715,0.000058057143,0.00007146811,0.0000036461922,0.004979141,0.00047886203,0.000009054757,0.5966421,0.0018987289,0.322952],"study_design_scores_gemma":[0.0012865671,0.001549647,0.009713904,0.000019914438,0.0000012578791,0.000030498337,0.004890561,0.00026177667,0.00019130137,0.1375092,0.84442174,0.00012363815],"about_ca_topic_score_codex":0.0046534254,"about_ca_topic_score_gemma":0.0012136772,"teacher_disagreement_score":0.84252304,"about_ca_system_score_codex":0.00043146012,"about_ca_system_score_gemma":0.0004504627,"threshold_uncertainty_score":0.7034618},"labels":[],"label_agreement":null},{"id":"W4226048218","doi":"10.51731/cjht.2022.300","title":"Trientine Hydrochloride (Waymade-Trientine)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Alcoholism and Thiamine Deficiency","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Drug; Pharmacology; Political science; Health care","score_opus":0.02498569634888081,"score_gpt":0.2713715913024547,"score_spread":0.24638589495357388,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4226048218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8861647,0.0565682,0.00019683239,0.05393832,0.0012855646,0.0003438366,0.000042284133,0.0001472748,0.0013129418],"genre_scores_gemma":[0.9980815,0.00018010742,0.0001785653,0.0008738462,0.000026032767,0.000010357235,0.0000098032315,0.000018523719,0.000621272],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99813235,0.00005359354,0.00069884193,0.00016860502,0.00035240894,0.0005941841],"domain_scores_gemma":[0.9988376,0.00003933677,0.00050009217,0.0003264231,0.00013340634,0.00016317275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011095153,0.00013927493,0.00048568507,0.0011290313,0.00064779166,0.000018342087,0.00037890676,0.000069099384,0.00019181485],"category_scores_gemma":[0.00069794286,0.000119700344,0.00013345116,0.0008880682,0.00018342807,0.00008301988,0.00006566008,0.00086584315,0.000010402196],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062708417,0.00043360554,0.09620261,0.0007723467,0.00030322382,0.0073873573,0.0036736955,0.00016517114,0.00069522206,0.023094138,0.16033761,0.70630795],"study_design_scores_gemma":[0.0017248738,0.0017318262,0.0069064163,0.00008134582,0.00004648925,0.003949863,0.0063730855,0.00002501244,0.0009065227,0.0014909473,0.9766009,0.0001627233],"about_ca_topic_score_codex":0.0013378211,"about_ca_topic_score_gemma":0.00013669443,"teacher_disagreement_score":0.81626326,"about_ca_system_score_codex":0.00047250855,"about_ca_system_score_gemma":0.0031778698,"threshold_uncertainty_score":0.5637405},"labels":[],"label_agreement":null},{"id":"W4226209919","doi":"10.51731/cjht.2021.182","title":"Budesonide-Glycopyrronium-Formoterol Fumarate Dihydrate (Breztri Aerosphere)","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Budesonide; Medicine; Formoterol; Reimbursement; Formoterol Fumarate; Inhalation; COPD; Bronchitis; Intensive care medicine; Anesthesia; Internal medicine","score_opus":0.02514401861931176,"score_gpt":0.2996405781778909,"score_spread":0.27449655955857916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4226209919","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.73934543,0.1768805,0.00039522068,0.07957707,0.0008058423,0.0006531732,0.00009209112,0.00021242874,0.0020382274],"genre_scores_gemma":[0.99504584,0.0019161265,0.0010975256,0.0008933222,0.000049490205,0.0000101678925,0.000014374799,0.000045763343,0.0009273846],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99701065,0.00012628004,0.00089429505,0.0003371479,0.0004707717,0.0011608689],"domain_scores_gemma":[0.99757,0.0000688264,0.0004304158,0.0006407483,0.00074657705,0.0005434539],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066463207,0.0002654381,0.00076489465,0.0005220825,0.00037272173,0.000086912616,0.0004343709,0.00026108493,0.0005371589],"category_scores_gemma":[0.0007867154,0.00023700634,0.00022741262,0.00086879736,0.0004907803,0.00024233085,0.000078018886,0.0012029771,0.000074180956],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019592424,0.00014459615,0.040988166,0.0013785578,0.0003202943,0.011595307,0.00030680548,0.00006423306,0.001439687,0.0015728701,0.016613463,0.9253801],"study_design_scores_gemma":[0.007919094,0.0022224355,0.29466477,0.0032848644,0.00023047978,0.013880201,0.016595023,0.0005163177,0.021881832,0.012447882,0.62521106,0.0011460205],"about_ca_topic_score_codex":0.0024893475,"about_ca_topic_score_gemma":0.0046637184,"teacher_disagreement_score":0.9242341,"about_ca_system_score_codex":0.002210549,"about_ca_system_score_gemma":0.017969746,"threshold_uncertainty_score":0.98759747},"labels":[],"label_agreement":null},{"id":"W4226349190","doi":"10.51731/cjht.2022.302","title":"Sacituzumab Govitecan (Trodelvy)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Metastatic breast cancer; Family medicine; Breast cancer; Cancer; Internal medicine; Political science; Health care","score_opus":0.028862155386624497,"score_gpt":0.27560738489170655,"score_spread":0.24674522950508204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4226349190","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.106390946,0.5909424,0.0038693834,0.28676802,0.0073088477,0.0007295176,0.00050137925,0.00044602455,0.003043482],"genre_scores_gemma":[0.9971491,0.00012539384,0.0007845521,0.0014514178,0.0000051506822,0.0000060786297,0.0000034499735,0.0000105083,0.00046431465],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99840415,0.00029104683,0.00054295297,0.00014687347,0.00005191365,0.0005630457],"domain_scores_gemma":[0.99919534,0.00007748062,0.00036940823,0.00024241721,0.000076915225,0.000038467042],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012705494,0.000121765275,0.00039181495,0.000568182,0.000849595,0.000014575467,0.0006215158,0.00015659691,0.00090798526],"category_scores_gemma":[0.0003336902,0.00010201163,0.00011910273,0.0004102472,0.00038033607,0.000046875517,0.00007560591,0.0010919916,0.0000115922285],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046570003,0.000045711313,0.001611079,0.000030106776,0.000145682,0.00011626094,0.0002251906,0.000022827993,0.0016419067,0.0114075,0.07024319,0.914464],"study_design_scores_gemma":[0.00041448316,0.0008087193,0.00085974275,0.000018352874,0.000014845357,0.0008657704,0.00308227,0.0000020405412,0.0019714336,0.0063281446,0.985507,0.00012718323],"about_ca_topic_score_codex":0.0019046556,"about_ca_topic_score_gemma":0.00084124453,"teacher_disagreement_score":0.91526383,"about_ca_system_score_codex":0.00051164936,"about_ca_system_score_gemma":0.0018807829,"threshold_uncertainty_score":0.9941802},"labels":[],"label_agreement":null},{"id":"W4226350874","doi":"10.51731/cjht.2021.195","title":"Risperidone for Extended-Release Injectable Suspension (Perseris)","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Risperidone; Suspension (topology); Medicine; Schizophrenia (object-oriented programming); Drug; Family medicine; Psychiatry; Political science; Health care; Law","score_opus":0.07352042089892238,"score_gpt":0.37762996240698504,"score_spread":0.3041095415080627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4226350874","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21541551,0.40695426,0.0009295551,0.37358588,0.0010833303,0.0005605327,0.00004202879,0.00011517794,0.0013137287],"genre_scores_gemma":[0.98703533,0.006719946,0.003317054,0.0026926163,0.000036812464,0.00000595055,0.0000034237094,0.00001356502,0.00017528211],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988216,0.000040257775,0.0004152467,0.00013331333,0.00012383692,0.00046571685],"domain_scores_gemma":[0.99883485,0.00014541934,0.00025056637,0.00017148361,0.0004035992,0.00019410095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005146317,0.00010460731,0.00042108446,0.00017588378,0.00033487647,0.000026885598,0.000107651955,0.00010384892,0.000107618296],"category_scores_gemma":[0.0024144817,0.000083845276,0.00010518428,0.00027928513,0.00012533391,0.000116642455,0.000023480574,0.00043837904,0.000005945582],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020369285,0.000089651134,0.0027475504,0.00042888388,0.00018455999,0.0009934554,0.00023653569,0.000007679865,0.0013331372,0.0014862603,0.044534396,0.9477542],"study_design_scores_gemma":[0.0011812488,0.00076201494,0.0027274096,0.00022615849,0.000068535184,0.0012212504,0.007539452,0.00004436207,0.0049341237,0.0014004824,0.9797917,0.00010323379],"about_ca_topic_score_codex":0.0012867983,"about_ca_topic_score_gemma":0.002329201,"teacher_disagreement_score":0.94765097,"about_ca_system_score_codex":0.00027835678,"about_ca_system_score_gemma":0.002744401,"threshold_uncertainty_score":0.48684496},"labels":[],"label_agreement":null},{"id":"W4229014886","doi":"10.51731/cjht.2022.326","title":"Cemiplimab (Libtayo)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Family medicine; Political science; Law","score_opus":0.021304337892339723,"score_gpt":0.25486189224374,"score_spread":0.2335575543514003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229014886","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.74729466,0.22294283,0.0009478429,0.026537046,0.0011837388,0.0002570896,0.000100535406,0.00006934359,0.00066690653],"genre_scores_gemma":[0.99862945,0.00023829317,0.0003399458,0.00062936,0.000019303645,0.000010697277,0.000006208148,0.000014486781,0.00011223592],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989518,0.00007641871,0.00034448106,0.00013382535,0.000121651836,0.00037182908],"domain_scores_gemma":[0.9993534,0.000010423128,0.00026332497,0.00022696977,0.00008958421,0.000056289125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006369541,0.00009688314,0.00019928005,0.00026244862,0.000547363,0.000012377022,0.00045582725,0.000062870735,0.000022124894],"category_scores_gemma":[0.00033111667,0.00009520518,0.000073918825,0.00019208253,0.00014049448,0.0000024323197,0.00010677271,0.00031304534,0.0000022297816],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000108272274,0.000109618275,0.022002587,0.00015832194,0.0004055724,0.0005848691,0.0015268537,0.0016356256,0.042550337,0.0020748295,0.18424878,0.74459434],"study_design_scores_gemma":[0.00030645935,0.0009603428,0.00097546785,0.000015478767,0.000005410151,0.00035734495,0.005941741,0.0000027376652,0.009535767,0.00073541526,0.9810221,0.00014169913],"about_ca_topic_score_codex":0.00046395705,"about_ca_topic_score_gemma":0.0006670974,"teacher_disagreement_score":0.7967734,"about_ca_system_score_codex":0.00016368151,"about_ca_system_score_gemma":0.0020741087,"threshold_uncertainty_score":0.4209929},"labels":[],"label_agreement":null},{"id":"W4230831017","doi":"10.51731/cjht.2021.125","title":"Dinutuximab (Unituxin)","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Irinotecan; Temozolomide; Drug; Refractory (planetary science); Intensive care medicine; Family medicine; Pharmacology; Internal medicine; Cancer; Chemotherapy; Health care; Political science","score_opus":0.040142133268399514,"score_gpt":0.3211656653900405,"score_spread":0.281023532121641,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230831017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7737658,0.07426556,0.00011427411,0.14946194,0.00034123423,0.00021538103,0.000020282363,0.00010653309,0.0017089702],"genre_scores_gemma":[0.9973837,0.00066615053,0.00090042414,0.0006405932,0.000008510754,0.000001955684,0.0000028691531,0.000010468094,0.00038532887],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99898964,0.000040633513,0.00027841303,0.00009748819,0.0001679174,0.00042593497],"domain_scores_gemma":[0.99914014,0.000025793935,0.0001234432,0.00022337175,0.0002775618,0.000209657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018101733,0.00007943462,0.00029826676,0.0004883234,0.00015023228,0.00002269185,0.00011971098,0.00006905968,0.0000680188],"category_scores_gemma":[0.0007417183,0.00006421702,0.00007535307,0.0004256859,0.0001286215,0.00006864718,0.000016823844,0.0004152668,0.000023336996],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033690274,0.00009463476,0.008089827,0.0001410583,0.00011867277,0.016710266,0.00008704911,8.022861e-7,0.00041701915,0.0009850496,0.008625502,0.9646964],"study_design_scores_gemma":[0.0066388953,0.0046125716,0.11792296,0.00127255,0.000073948555,0.028242825,0.006825959,0.000012431949,0.034123026,0.009252888,0.7907213,0.00030064557],"about_ca_topic_score_codex":0.00086723967,"about_ca_topic_score_gemma":0.002030922,"teacher_disagreement_score":0.96439576,"about_ca_system_score_codex":0.0003332557,"about_ca_system_score_gemma":0.0071502062,"threshold_uncertainty_score":0.99847835},"labels":[],"label_agreement":null},{"id":"W4236572722","doi":"10.51731/cjht.2021.158","title":"Pembrolizumab (Keytruda)","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Pembrolizumab; Microsatellite instability; Medicine; Drug; Colorectal cancer; Family medicine; Cancer; Political science; Internal medicine; Pharmacology; Health care","score_opus":0.03147129701916846,"score_gpt":0.2973980097060925,"score_spread":0.265926712686924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4236572722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.75446904,0.1552484,0.00019579391,0.08611866,0.0012646717,0.00017857416,0.000011265608,0.00009775557,0.002415831],"genre_scores_gemma":[0.9955622,0.0007172432,0.002289403,0.0011901557,0.000020810512,0.000002488537,0.0000015516002,0.0000150386095,0.00020113254],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987794,0.00003623917,0.00044551372,0.00012600057,0.00019293396,0.0004199042],"domain_scores_gemma":[0.9989221,0.000036547855,0.00021841603,0.00028657584,0.0003809498,0.00015542677],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025976656,0.000103631515,0.00038915782,0.00036686237,0.00012009608,0.00001926145,0.00017260485,0.00015188316,0.00020239362],"category_scores_gemma":[0.0011019628,0.00009078683,0.00009521779,0.0003900415,0.00017461143,0.000037992206,0.000019831316,0.0005072736,0.000011482806],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059630434,0.000035719004,0.03536487,0.00030074298,0.00011101353,0.0025746592,0.00042343987,0.000015967287,0.0011502133,0.001017528,0.02929192,0.9296543],"study_design_scores_gemma":[0.0020612916,0.0018716705,0.08223623,0.00076665205,0.000057202633,0.012686206,0.006520918,0.000011438875,0.029459022,0.006085878,0.85797036,0.00027316352],"about_ca_topic_score_codex":0.00077199715,"about_ca_topic_score_gemma":0.0032329177,"teacher_disagreement_score":0.92938113,"about_ca_system_score_codex":0.00065533316,"about_ca_system_score_gemma":0.01141808,"threshold_uncertainty_score":0.9941863},"labels":[],"label_agreement":null},{"id":"W4239689275","doi":"10.51731/cjht..29","title":"List of 2021 Health Technology Trends to Watch","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Telemedicine; Wearable computer; Health care; Health technology; Emerging technologies; Psychological intervention; Wearable technology; Biomedical technology; Business; Disruptive technology; Digital health; Medicine; Computer science; Internet privacy; Engineering; Nursing; Political science","score_opus":0.2160682696672634,"score_gpt":0.5024861054777943,"score_spread":0.2864178358105309,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239689275","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08767977,0.020318167,0.00083392794,0.89026165,0.00044584565,0.00022039025,0.00003918487,0.000049718547,0.00015134277],"genre_scores_gemma":[0.9802103,0.0007742671,0.013589676,0.005138554,0.000033083572,0.000007126373,0.000015072497,0.000018827037,0.0002131167],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969619,0.000097393175,0.0019762446,0.00020071352,0.0002452601,0.0005185087],"domain_scores_gemma":[0.9971979,0.00018046908,0.0010559477,0.00046852598,0.0008378421,0.00025926324],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0016016756,0.00012913634,0.00077003374,0.0011868689,0.00012962805,0.000013801508,0.00024282384,0.00018775066,0.00025495587],"category_scores_gemma":[0.008989976,0.00011873443,0.000112310794,0.001841392,0.00017709969,0.00009009818,0.000050624563,0.00068217807,0.000008526911],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002436272,0.000045431087,0.008666073,0.00010125052,0.000045923563,0.00020226467,0.00012673048,0.000005084515,0.0003444274,0.0006796621,0.036102552,0.95365626],"study_design_scores_gemma":[0.0014811285,0.002855465,0.015473614,0.00074142293,0.000046402227,0.0018080762,0.02014638,0.000007655447,0.0038325917,0.002185978,0.951262,0.00015930975],"about_ca_topic_score_codex":0.010024493,"about_ca_topic_score_gemma":0.032899525,"teacher_disagreement_score":0.95349693,"about_ca_system_score_codex":0.000663908,"about_ca_system_score_gemma":0.010920926,"threshold_uncertainty_score":0.9993577},"labels":[],"label_agreement":null},{"id":"W4245623554","doi":"10.51731/cjht.2021.120","title":"Dupilumab (Dupixent)","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Exhaled nitric oxide; Asthma; Dupilumab; Eosinophilic; Corticosteroid; Intensive care medicine; Internal medicine; Pathology; Health care","score_opus":0.02243943704668856,"score_gpt":0.2888968110201964,"score_spread":0.2664573739735078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4245623554","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5756331,0.33600995,0.0001850256,0.08603876,0.0006276171,0.00015855518,0.000018530904,0.00012424131,0.001204233],"genre_scores_gemma":[0.9970467,0.00046413048,0.00042638925,0.0018139472,0.000021320155,0.0000012518475,0.0000020864713,0.000010231709,0.00021391334],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99902874,0.000034625766,0.0003838453,0.00009426658,0.00013327453,0.00032526755],"domain_scores_gemma":[0.9991177,0.000020011834,0.00019046228,0.00021508754,0.00026389566,0.00019287168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018716112,0.00008214582,0.00031535327,0.000315399,0.00016098314,0.00001810099,0.00011600987,0.00009878001,0.000117487325],"category_scores_gemma":[0.0006839882,0.00006546484,0.00010647743,0.0002793248,0.0001560595,0.00005264181,0.000012491815,0.00031286207,0.000015877207],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016698643,0.000040891133,0.029359654,0.0001742108,0.000044433105,0.0043911473,0.0001044658,0.0000035765688,0.00012992455,0.0006688797,0.019674852,0.94539124],"study_design_scores_gemma":[0.00071679545,0.00045540754,0.050953474,0.00041525718,0.000024620262,0.002347196,0.005565693,0.0000021967228,0.0017351368,0.0008240322,0.9368656,0.000094547795],"about_ca_topic_score_codex":0.00025606115,"about_ca_topic_score_gemma":0.0008237686,"teacher_disagreement_score":0.9452967,"about_ca_system_score_codex":0.0002488523,"about_ca_system_score_gemma":0.010004633,"threshold_uncertainty_score":0.99560773},"labels":[],"label_agreement":null},{"id":"W4252977245","doi":"10.51731/cjht.2021.50","title":"Hybrid Closed-Loop Insulin Delivery Systems for People With Type 1 Diabetes","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Diabetes Management and Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Insulin; Hypoglycemia; Glycated hemoglobin; Medicine; Diabetes mellitus; Insulin delivery; Type 1 diabetes; Type 2 diabetes; Diabetes management; Insulin pump; Insulin pen; Blood Glucose Self-Monitoring; Pregnancy; Intensive care medicine; Internal medicine; Endocrinology; Continuous glucose monitoring","score_opus":0.026918641346176598,"score_gpt":0.2764264444354746,"score_spread":0.24950780308929799,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4252977245","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82153696,0.15596336,0.00009585153,0.021084085,0.00046291787,0.00050668913,0.000020491781,0.00006728036,0.00026238104],"genre_scores_gemma":[0.9966137,0.0016198948,0.0005457218,0.00036061628,0.000034842524,0.000014047546,0.000017260441,0.000022118531,0.0007718186],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986322,0.00004018153,0.00037727965,0.00014759864,0.00021000596,0.00059276074],"domain_scores_gemma":[0.998547,0.00009144874,0.0002076761,0.00025261304,0.00074911246,0.00015213007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006049454,0.00011445853,0.00048886635,0.00054646475,0.00018266581,0.00006316741,0.0002029568,0.000076765275,0.000019686977],"category_scores_gemma":[0.00063904084,0.00008440826,0.00006413119,0.00044882394,0.00011828005,0.00008619437,0.000025768406,0.00034088062,0.0000071237328],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016639868,0.00013185397,0.109662056,0.004298589,0.000706822,0.0011007931,0.00016811097,0.00012504705,0.0002303316,0.0015173341,0.10915874,0.7727339],"study_design_scores_gemma":[0.005039884,0.007691209,0.04102271,0.003846293,0.00023583273,0.00034934812,0.010154165,0.000984672,0.004317116,0.0015502879,0.9242698,0.000538685],"about_ca_topic_score_codex":0.00043276016,"about_ca_topic_score_gemma":0.0010145659,"teacher_disagreement_score":0.81511104,"about_ca_system_score_codex":0.00025303496,"about_ca_system_score_gemma":0.0038955645,"threshold_uncertainty_score":0.69105643},"labels":[],"label_agreement":null},{"id":"W4254385872","doi":"10.51731/cjht.2021.122","title":"Luspatercept (Reblozyl)","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Vial; Medicine; Anemia; Drug; Beta thalassemia; Thalassemia; Family medicine; Intensive care medicine; Internal medicine; Pharmacology; Health care; Political science","score_opus":0.017452272563012378,"score_gpt":0.2652066078259932,"score_spread":0.24775433526298082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4254385872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.43578118,0.2825022,0.00029650333,0.2764906,0.0010273667,0.00020110747,0.000010896874,0.00015471535,0.0035354344],"genre_scores_gemma":[0.99390733,0.0030271509,0.0008712452,0.00183745,0.000010452033,9.0281134e-7,0.0000029482953,0.000012472798,0.00033006602],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989135,0.000032275515,0.00043872427,0.00010118725,0.000119733966,0.0003945805],"domain_scores_gemma":[0.99920005,0.000015633212,0.00017798845,0.00021314503,0.00024215475,0.00015102471],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026630494,0.00009141787,0.00034729225,0.00034130836,0.00015372393,0.000017217999,0.00011748753,0.00019615417,0.00013060073],"category_scores_gemma":[0.00048232332,0.0000724053,0.00009904766,0.00036625678,0.00015066554,0.00004626334,0.000013683491,0.000542506,0.00001875183],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012926242,0.000037386304,0.011029294,0.0001917355,0.00008622048,0.0033503822,0.0005158485,0.000011368331,0.00021600132,0.0008195834,0.024277614,0.9594516],"study_design_scores_gemma":[0.0013401408,0.00064263324,0.015762404,0.0008266753,0.00004706297,0.00783075,0.020035455,0.000013812835,0.00227935,0.00259586,0.94844854,0.00017733288],"about_ca_topic_score_codex":0.0011677674,"about_ca_topic_score_gemma":0.0015006028,"teacher_disagreement_score":0.9592743,"about_ca_system_score_codex":0.00024950108,"about_ca_system_score_gemma":0.0054576076,"threshold_uncertainty_score":0.96815616},"labels":[],"label_agreement":null},{"id":"W4280537120","doi":"10.51731/cjht.2022.337","title":"Clinical Classification and Interventions for Post–COVID-19 Condition: A Scoping Review","year":2022,"lang":"en","type":"review","venue":"Canadian Journal of Health Technologies","topic":"Long-Term Effects of COVID-19","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Psychological intervention; Coronavirus disease 2019 (COVID-19); Medicine; Quality of life (healthcare); MEDLINE; 2019-20 coronavirus outbreak; Nursing; Disease; Pathology; Political science","score_opus":0.3130877014900466,"score_gpt":0.5501135969586873,"score_spread":0.23702589546864072,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280537120","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000021421886,0.9188172,0.00054087664,0.07451288,0.0005423173,0.0052798,0.00018494268,0.000102771155,0.000017021619],"genre_scores_gemma":[0.000027722883,0.9908537,0.0011090232,0.0072102826,0.000056841764,0.00044393985,0.00022095755,0.000045234345,0.00003227697],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99550414,0.0005665449,0.0028549517,0.00038789425,0.00022729365,0.00045918836],"domain_scores_gemma":[0.9929433,0.0025493691,0.0031183849,0.00058440364,0.00022762123,0.0005769231],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00505885,0.00031686635,0.003144399,0.001425435,0.0005081221,0.00004567188,0.000497689,0.0004080048,0.00018755601],"category_scores_gemma":[0.03363885,0.00026401575,0.0011831123,0.0004952153,0.00041598585,0.00012077097,0.000067368164,0.0013939145,0.0000048285356],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004347605,0.000013769584,0.000036189314,0.3873907,0.00008770203,0.00008328863,0.000007635575,2.4629552e-8,4.978147e-9,0.0002867587,0.0074502374,0.60463935],"study_design_scores_gemma":[0.00034643756,0.00090649637,0.000030743024,0.37072167,0.0006263908,0.00146396,0.000101041245,3.0604298e-7,9.522091e-9,0.00024252856,0.625441,0.000119388606],"about_ca_topic_score_codex":0.00029212984,"about_ca_topic_score_gemma":0.0011388611,"teacher_disagreement_score":0.6179908,"about_ca_system_score_codex":0.00199689,"about_ca_system_score_gemma":0.035859346,"threshold_uncertainty_score":0.9999812},"labels":[],"label_agreement":null},{"id":"W4280551961","doi":"10.51731/cjht.2022.329","title":"Somatrogon (Ngenla)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Drug; Intensive care medicine; Family medicine; Pharmacology; Political science; Health care","score_opus":0.08723218125982363,"score_gpt":0.37803992502831396,"score_spread":0.29080774376849033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280551961","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17602193,0.32864022,0.000051359944,0.49149007,0.00088686764,0.00026482402,0.000023522069,0.0001048678,0.0025163228],"genre_scores_gemma":[0.9953678,0.0011632614,0.00031482277,0.0030516116,0.000014942786,0.000005697909,8.044297e-7,0.0000073407077,0.00007369238],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990444,0.000056828,0.00031582243,0.000071932365,0.00017259932,0.00033842446],"domain_scores_gemma":[0.99939597,0.000058306057,0.00025908265,0.000114885675,0.00006226856,0.0001094655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069336954,0.00006569394,0.0002595784,0.0002638624,0.0005795868,0.000010933274,0.00017765793,0.00003163901,0.0002597625],"category_scores_gemma":[0.0003678453,0.000054175554,0.000066408495,0.000261996,0.00009930948,0.000055999833,0.000043218708,0.0006948345,0.0000053782405],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007089827,0.000039999402,0.012412746,0.00009734009,0.00011865626,0.00075256714,0.00030741876,0.000013366958,0.00006533563,0.0013493373,0.03951179,0.9452605],"study_design_scores_gemma":[0.0003608619,0.00073863094,0.0045105903,0.00002207703,0.00002261114,0.0012602016,0.0055587185,0.0000079108895,0.00009592731,0.0011778397,0.9861963,0.000048340087],"about_ca_topic_score_codex":0.0013711592,"about_ca_topic_score_gemma":0.00032549803,"teacher_disagreement_score":0.9466845,"about_ca_system_score_codex":0.00045723372,"about_ca_system_score_gemma":0.0016421503,"threshold_uncertainty_score":0.44577715},"labels":[],"label_agreement":null},{"id":"W4280593482","doi":"10.51731/cjht.2022.330","title":"An Overview of New and Emerging Technologies for Early Diagnosis of Alzheimer Disease","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cholinesterase and Neurodegenerative Diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Disease; Biomarker; Medicine; Cognitive decline; Amyloid beta; Amyloid (mycology); Alzheimer's disease; Bioinformatics; Neuroscience; Pathology; Dementia; Psychology; Biology","score_opus":0.11877353355568293,"score_gpt":0.3797878448533067,"score_spread":0.26101431129762376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280593482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7039916,0.28083715,0.000022480817,0.014587802,0.00006949387,0.0002983725,0.00015387661,0.000037839738,0.0000013954696],"genre_scores_gemma":[0.9939973,0.005153171,0.00046648277,0.00031091977,0.00000919366,0.000035430967,0.0000069265648,0.000015381162,0.00000524636],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99886495,0.000041258485,0.0005450508,0.00014775373,0.00015523986,0.00024572303],"domain_scores_gemma":[0.99889004,0.000059168873,0.00046600416,0.00026996635,0.00015879996,0.00015599444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024104942,0.00011752564,0.0004802466,0.0006840529,0.00017296117,0.000008035382,0.00020315114,0.0000438235,0.000017570708],"category_scores_gemma":[0.0004950577,0.0001030758,0.00011089886,0.00032952544,0.00018492255,0.00010513369,0.00003877662,0.00020948298,6.414504e-8],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025344384,0.00017137146,0.35248613,0.00073231565,0.00017056898,0.00014575505,0.00065991667,0.00005744674,0.00054179516,0.0013735405,0.0052527646,0.6381549],"study_design_scores_gemma":[0.0069806688,0.014723701,0.72381836,0.0026157307,0.0014965679,0.00042264475,0.034161583,0.00014526187,0.06784462,0.016741242,0.13018607,0.00086356763],"about_ca_topic_score_codex":0.001190451,"about_ca_topic_score_gemma":0.0002432674,"teacher_disagreement_score":0.6372914,"about_ca_system_score_codex":0.00006112395,"about_ca_system_score_gemma":0.0018940407,"threshold_uncertainty_score":0.4203309},"labels":[],"label_agreement":null},{"id":"W4280598676","doi":"10.51731/cjht.2022.331","title":"Daratumumab (Darzalex SC)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Daratumumab; Reimbursement; Medicine; Bortezomib; Dexamethasone; Family medicine; Internal medicine; Multiple myeloma; Political science; Health care","score_opus":0.016960740101297875,"score_gpt":0.27010467136470573,"score_spread":0.25314393126340784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280598676","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7627475,0.18388645,0.00018211281,0.050515585,0.0011453148,0.00041602974,0.0001856009,0.000081460305,0.00083994213],"genre_scores_gemma":[0.99726707,0.00080862606,0.00046659127,0.001150992,0.00001933451,0.000031490406,0.00001966955,0.000022120912,0.00021411336],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986322,0.000100071265,0.00042867966,0.00019716646,0.00016082478,0.00048106056],"domain_scores_gemma":[0.9990279,0.000016530646,0.00040039094,0.00036988797,0.000081032915,0.0001042302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043642803,0.00015205987,0.00027796734,0.0003554609,0.0006381622,0.0000244902,0.00060039083,0.000105128864,0.00007404876],"category_scores_gemma":[0.00028348103,0.00014512251,0.00012354083,0.00023504978,0.00016483337,0.0000061699575,0.00011461163,0.0003530375,0.000005432204],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010015912,0.00020649823,0.15033197,0.00008518622,0.000500205,0.0006637302,0.0004788625,0.00054655876,0.0030657745,0.002192413,0.23790836,0.6039203],"study_design_scores_gemma":[0.0006953483,0.0014299907,0.009969719,0.00002368794,0.000017145387,0.00053967664,0.0039570024,0.0000020066625,0.0057840794,0.0005748148,0.9767905,0.00021605231],"about_ca_topic_score_codex":0.0015185073,"about_ca_topic_score_gemma":0.0024402933,"teacher_disagreement_score":0.7388821,"about_ca_system_score_codex":0.00038334326,"about_ca_system_score_gemma":0.002192423,"threshold_uncertainty_score":0.5917924},"labels":[],"label_agreement":null},{"id":"W4281481605","doi":"10.51731/cjht.2022.341","title":"An Overview of Continuous Learning Artificial Intelligence-Enabled Medical Devices","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Applications of artificial intelligence; Artificial intelligence; Health care; Computer science; Knowledge management; Political science","score_opus":0.2523961664306744,"score_gpt":0.4510323125373515,"score_spread":0.19863614610667707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281481605","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8315588,0.089648515,0.0010630804,0.075889505,0.0011918826,0.00041174033,0.000008677531,0.00010031199,0.00012744014],"genre_scores_gemma":[0.99724644,0.001376073,0.00042147574,0.00085952156,0.00004792822,0.000010820221,0.0000070584583,0.000013845947,0.00001685566],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.9974197,0.00024497733,0.0012766487,0.00015100562,0.0004673222,0.0004403481],"domain_scores_gemma":[0.99825954,0.00015034946,0.0007359505,0.00022438662,0.00037878798,0.00025095377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002623324,0.000109076995,0.00052048586,0.00074243563,0.00051210774,0.00001753914,0.00039646626,0.00013859288,0.00069580285],"category_scores_gemma":[0.0018818668,0.00009980344,0.0000893139,0.00065164693,0.000237886,0.00010547266,0.000027385426,0.0011379656,0.0000049325104],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000040877807,0.00007342701,0.017344067,0.00019792511,0.00002128907,0.00010099098,0.0016389204,0.00016642801,0.000031257805,0.0036516127,0.0003388271,0.97639436],"study_design_scores_gemma":[0.00017180562,0.017226426,0.009497352,0.00214095,0.00012829683,0.004373208,0.60178596,0.0024800326,0.00947834,0.0638029,0.2882859,0.0006288523],"about_ca_topic_score_codex":0.016409794,"about_ca_topic_score_gemma":0.006814337,"teacher_disagreement_score":0.9757655,"about_ca_system_score_codex":0.00045472206,"about_ca_system_score_gemma":0.008997141,"threshold_uncertainty_score":0.99662095},"labels":[],"label_agreement":null},{"id":"W4281718991","doi":"10.51731/cjht.2022.356","title":"Utilization of Old- Versus New-Generation Biologics for Plaque Psoriasis for Public and Private Payers in Canada","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Institute for Health Information","funders":"","keywords":"Biosimilar; Medicine; Formulary; Ustekinumab; Generic drug; Orphan drug; Family medicine; Infliximab; Pharmacology; Drug; Internal medicine","score_opus":0.1329166001152631,"score_gpt":0.31660010990601506,"score_spread":0.18368350979075196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281718991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.72102296,0.096399404,0.015901381,0.1577425,0.0057205986,0.0019510412,0.001191777,0.000047080044,0.000023252815],"genre_scores_gemma":[0.995627,0.00043026335,0.0035409862,0.0003234506,0.000006774426,0.000017721419,0.00002674807,0.000005916915,0.000021173157],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99894744,0.00011642878,0.0004714715,0.00012134465,0.000026338626,0.000316992],"domain_scores_gemma":[0.9992091,0.00022059312,0.00035868055,0.00009539945,0.00008608881,0.000030105835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079694396,0.000083797066,0.00029812794,0.00032579203,0.0002292428,0.000006915,0.00019999359,0.00013043637,0.000020353149],"category_scores_gemma":[0.001001823,0.000071449074,0.000039435632,0.0002355554,0.00010424524,0.000039453214,0.000024744366,0.00022139867,2.5595018e-8],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031490807,0.000022323931,0.008477156,0.000086945416,0.00012228401,0.0000033761853,0.00013534403,0.00007443608,0.002421099,0.020248437,0.01758616,0.9505075],"study_design_scores_gemma":[0.006090859,0.0039793067,0.0050073448,0.000051536957,0.000054999142,0.00006992416,0.009457819,0.000377835,0.027008792,0.009163026,0.9383936,0.0003449931],"about_ca_topic_score_codex":0.24745373,"about_ca_topic_score_gemma":0.7804248,"teacher_disagreement_score":0.95016253,"about_ca_system_score_codex":0.00060796173,"about_ca_system_score_gemma":0.004628594,"threshold_uncertainty_score":0.82109267},"labels":[],"label_agreement":null},{"id":"W4281773966","doi":"10.51731/cjht.2022.350","title":"Lorlatinib (Lorbrena)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Drug; Family medicine; Intensive care medicine; Political science; Pharmacology; Health care","score_opus":0.0271931516960458,"score_gpt":0.33553377938504764,"score_spread":0.30834062768900183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281773966","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3134336,0.1966852,0.00037194838,0.47881642,0.0020757122,0.0009375424,0.00015706349,0.0002749295,0.0072476054],"genre_scores_gemma":[0.99772704,0.00009014866,0.0006515424,0.0011856181,0.000009030313,0.000013486048,0.0000055858395,0.000008803999,0.00030874382],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992628,0.000023864055,0.00027493678,0.00006823622,0.00013269552,0.00023747003],"domain_scores_gemma":[0.999483,0.00001766095,0.00020834077,0.00013959152,0.00007179467,0.00007965011],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022310053,0.000059413524,0.00020505302,0.00044096762,0.0003959014,0.000008773957,0.000117970914,0.00002663308,0.00018408858],"category_scores_gemma":[0.0001000677,0.000049455735,0.00005610791,0.00027941444,0.00006619259,0.000038768,0.0000144555115,0.00032303727,0.0000035566438],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026262083,0.000056350003,0.024295531,0.00006685965,0.0001641871,0.0007270913,0.0010736178,0.00010045731,0.000020195654,0.002919657,0.05148361,0.9190662],"study_design_scores_gemma":[0.0009099863,0.0012342971,0.01248816,0.0000559905,0.000043855944,0.00133602,0.008201354,0.0000070696474,0.0000684625,0.0019244079,0.9736664,0.000063976004],"about_ca_topic_score_codex":0.0023908322,"about_ca_topic_score_gemma":0.00075566495,"teacher_disagreement_score":0.9221828,"about_ca_system_score_codex":0.0008640417,"about_ca_system_score_gemma":0.004818508,"threshold_uncertainty_score":0.85478264},"labels":[],"label_agreement":null},{"id":"W4281779657","doi":"10.51731/cjht.2022.357","title":"Self-Collection of Nose and Throat Swab Samples for SARS-CoV-2 Antigen Testing","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"SARS-CoV-2 detection and testing","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Throat; Nose; Medicine; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Sampling (signal processing); Coronavirus disease 2019 (COVID-19); Dermatology; Surgery; Internal medicine; Infectious disease (medical specialty); Disease","score_opus":0.10906093829135867,"score_gpt":0.33203393979504237,"score_spread":0.2229730015036837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281779657","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98349756,0.010026327,0.0004768198,0.004973815,0.00029904718,0.00044345815,0.000021004496,0.00015301311,0.0001089377],"genre_scores_gemma":[0.9835285,0.00006124098,0.015639944,0.0007133823,0.000017839537,0.000015499925,0.0000010643897,0.000018378329,0.00000417476],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99879044,0.00004602598,0.000546895,0.00014115316,0.00014545137,0.00033003668],"domain_scores_gemma":[0.9987758,0.00023122183,0.0005655467,0.0001403565,0.00025084286,0.00003623102],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081366295,0.000110322646,0.00039429837,0.00083358894,0.0006360982,0.000014783869,0.00012349908,0.00007403394,0.0000024517365],"category_scores_gemma":[0.0022477275,0.000105622414,0.00006457943,0.000678809,0.000111182904,0.00006757762,0.000029206267,0.00039525915,2.2740782e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019819308,0.00015192736,0.19997552,0.0015044739,0.00028674433,0.00019429935,0.0027321356,0.0000236399,0.18065864,0.0007483835,0.006154531,0.6073715],"study_design_scores_gemma":[0.004761139,0.009346777,0.04507287,0.0008327176,0.00015993744,0.009939838,0.020934727,0.0016107684,0.6599036,0.0063856365,0.24052082,0.00053119095],"about_ca_topic_score_codex":0.0058067897,"about_ca_topic_score_gemma":0.0021216485,"teacher_disagreement_score":0.6068403,"about_ca_system_score_codex":0.00042951448,"about_ca_system_score_gemma":0.0019965195,"threshold_uncertainty_score":0.8778168},"labels":[],"label_agreement":null},{"id":"W4281800226","doi":"10.51731/cjht.2022.343","title":"Enfortumab Vedotin (Padcev)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Urothelial cancer; Drug; Anticancer drug; Internal medicine; Oncology; Cancer; Pharmacology; Political science","score_opus":0.3542821329863515,"score_gpt":0.4064495632101858,"score_spread":0.052167430223834355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281800226","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14869677,0.18277927,0.002092639,0.65739036,0.0040445845,0.0008653754,0.00072837196,0.00020810528,0.0031945128],"genre_scores_gemma":[0.9873663,0.00019912019,0.0012955593,0.010775724,0.00004084954,0.000037755653,0.000008071515,0.000025784959,0.0002508053],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99447805,0.00026214062,0.0042505274,0.0002454843,0.00010988468,0.000653903],"domain_scores_gemma":[0.9949428,0.00027228362,0.0041245436,0.0004239196,0.000072115814,0.00016435518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018338833,0.00014259499,0.000934674,0.0014387235,0.0008946713,0.00005260715,0.0007920948,0.000098280165,0.00071995595],"category_scores_gemma":[0.0039912285,0.00018412275,0.00013282258,0.0004194346,0.00013424386,0.00026900182,0.00006212198,0.00067999196,0.00017594252],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001799726,0.000082329716,0.07218299,0.00044806598,0.00015113477,0.00008276706,0.004682051,0.0013006477,0.0000012136115,0.4361058,0.4336206,0.051324416],"study_design_scores_gemma":[0.00040711585,0.0003177543,0.006277686,0.00004083568,0.000001967243,0.00016518362,0.011709991,0.00013258326,0.0000027416722,0.04629182,0.9344605,0.00019178931],"about_ca_topic_score_codex":0.016168822,"about_ca_topic_score_gemma":0.0026703984,"teacher_disagreement_score":0.83866954,"about_ca_system_score_codex":0.0027817737,"about_ca_system_score_gemma":0.004061933,"threshold_uncertainty_score":0.9903826},"labels":[],"label_agreement":null},{"id":"W4281872990","doi":"10.51731/cjht.2022.346","title":"Bimekizumab (Bimzelx)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Plaque psoriasis; Family medicine; Psoriasis; Intensive care medicine; Dermatology; Political science; Health care","score_opus":0.024982866814554368,"score_gpt":0.24319567992768074,"score_spread":0.21821281311312637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281872990","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5559705,0.41393524,0.00005648045,0.02460512,0.003950167,0.0002862096,0.00020311598,0.00020042172,0.0007927682],"genre_scores_gemma":[0.99877185,0.00027355566,0.00009831702,0.00029052419,0.0000053515537,0.000015362393,0.0000160263,0.00001155255,0.00051748246],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998727,0.00020096249,0.00042271265,0.00012462336,0.000041135172,0.0004835503],"domain_scores_gemma":[0.9992771,0.000056589808,0.0003627854,0.00022213455,0.0000555193,0.00002584018],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005667607,0.00012016858,0.00032267362,0.0006797737,0.0009111831,0.000010409429,0.0004955717,0.00011305819,0.0006060093],"category_scores_gemma":[0.00011956236,0.00010678389,0.00010359255,0.0003297248,0.00016529755,0.00005593685,0.000048174945,0.00047849945,0.00005335099],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003348629,0.000029204273,0.002735944,0.000010148356,0.00013446844,0.0001322216,0.0003334413,0.000013114826,0.00038110465,0.0013804412,0.020992268,0.97382414],"study_design_scores_gemma":[0.001007287,0.000846418,0.003952251,0.000019947829,0.000027757938,0.001469232,0.00539527,3.400202e-7,0.0024471355,0.0018552409,0.98283875,0.00014036617],"about_ca_topic_score_codex":0.0025903026,"about_ca_topic_score_gemma":0.0010446564,"teacher_disagreement_score":0.9736838,"about_ca_system_score_codex":0.00046179342,"about_ca_system_score_gemma":0.0020511472,"threshold_uncertainty_score":0.7008175},"labels":[],"label_agreement":null},{"id":"W4281919354","doi":"10.51731/cjht.2022.351","title":"Systemic Thrombolysis by Alteplase for Acute Ischemic Stroke","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Neurological Disorders and Treatments","field":"Neuroscience","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Agency for Drugs and Technologies in Health","funders":"","keywords":"Medicine; Thrombolysis; Stroke (engine); Significant difference; Pediatrics; Internal medicine; Myocardial infarction","score_opus":0.02880504133659749,"score_gpt":0.28438681696450346,"score_spread":0.25558177562790596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281919354","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9508932,0.019698584,0.0003353137,0.0261613,0.00057687145,0.0006277833,0.0014007448,0.00013585544,0.00017032593],"genre_scores_gemma":[0.9971629,0.0004613055,0.000078192534,0.002056659,0.00000294683,0.00006706586,0.000003906095,0.00001497729,0.00015208808],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99852246,0.00009604104,0.00043000164,0.00023694243,0.00018707274,0.00052745367],"domain_scores_gemma":[0.9990824,0.00014001317,0.00043856993,0.00020893206,0.00003285868,0.00009721025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024169248,0.00013411854,0.0003610673,0.00030640923,0.0008158485,0.00003261841,0.0006161521,0.000059104335,0.000040148076],"category_scores_gemma":[0.00038304087,0.00011212776,0.00012290261,0.00030182168,0.00014083277,0.00008796488,0.000050193088,0.0004015473,0.0000035515336],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027490171,0.000427049,0.0052821822,0.00019915214,0.00032687257,0.0016074413,0.0005094532,0.0003225539,0.16356608,0.0036935606,0.4634487,0.36034203],"study_design_scores_gemma":[0.005461375,0.0101354,0.00028882344,0.00009496994,0.00024358876,0.0038126328,0.006931098,0.00022402241,0.1288764,0.013920339,0.82913375,0.0008776197],"about_ca_topic_score_codex":0.0003929048,"about_ca_topic_score_gemma":0.00008598107,"teacher_disagreement_score":0.36568502,"about_ca_system_score_codex":0.0003043976,"about_ca_system_score_gemma":0.0006900261,"threshold_uncertainty_score":0.62749296},"labels":[],"label_agreement":null},{"id":"W4282562487","doi":"10.51731/cjht.2022.358","title":"Pemigatinib (Pemazyre)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pneumocystis jirovecii pneumonia detection and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Family medicine; Drug; Political science; Pharmacology; Health care","score_opus":0.02520408554022498,"score_gpt":0.2769138192359095,"score_spread":0.25170973369568456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282562487","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7503472,0.04895354,0.00017539071,0.19658099,0.0014097353,0.0005867722,0.00006027316,0.00029161034,0.001594462],"genre_scores_gemma":[0.9981139,0.000106823354,0.0003568513,0.0011527746,0.00000858104,0.000015944039,0.0000024718868,0.000013028823,0.00022964313],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988253,0.00005864304,0.00045020186,0.00010924802,0.00022013148,0.00033647395],"domain_scores_gemma":[0.9992137,0.000031218602,0.000328201,0.00021036215,0.000079382065,0.00013713761],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044298044,0.00009801738,0.0003335931,0.00063361943,0.00048490713,0.000011274007,0.00016786852,0.00004599062,0.00018690512],"category_scores_gemma":[0.00023468802,0.00008546056,0.0001006573,0.00036594126,0.00012476709,0.000037006135,0.000025768824,0.0006032459,0.000009573442],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008649998,0.00013829049,0.025154896,0.00011956132,0.00017900307,0.0033217156,0.000864717,0.00011726705,0.0005657545,0.0013867068,0.014083152,0.9539824],"study_design_scores_gemma":[0.0016294492,0.0032797467,0.028624233,0.000099392404,0.00003851698,0.014455217,0.0099926395,0.000022327782,0.0009167252,0.0019725505,0.9388212,0.00014801782],"about_ca_topic_score_codex":0.0014014809,"about_ca_topic_score_gemma":0.0005762679,"teacher_disagreement_score":0.9538344,"about_ca_system_score_codex":0.0010382687,"about_ca_system_score_gemma":0.0028716512,"threshold_uncertainty_score":0.50941855},"labels":[],"label_agreement":null},{"id":"W4282963206","doi":"10.51731/cjht.2022.361","title":"Utilization of Cholinesterase Inhibitors for Alzheimer Disease in Canada","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Galantamine; Donepezil; Rivastigmine; Cholinesterase; Medicine; Dementia; Formulary; Disease; Gerontology; Pharmacology; Internal medicine","score_opus":0.19897771612527607,"score_gpt":0.40317106518684337,"score_spread":0.2041933490615673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282963206","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8852476,0.050210588,0.000049325292,0.06296843,0.0006893283,0.0006691986,0.00013017864,0.000011355473,0.000024004083],"genre_scores_gemma":[0.9984618,0.0001176413,0.0001167285,0.0012651788,0.000006219995,0.000011599822,0.000008519574,0.0000069067823,0.0000054391016],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99902284,0.000043995104,0.0004927243,0.00006672448,0.0001583289,0.00021537449],"domain_scores_gemma":[0.9992393,0.00009891593,0.00035107252,0.000098380806,0.00008120191,0.00013112744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035315775,0.000059913527,0.00023590558,0.00034030998,0.00009246006,0.0000029740452,0.00010703736,0.000018334482,0.000030226982],"category_scores_gemma":[0.0005534987,0.000052935506,0.000041506988,0.00026321172,0.000036616097,0.00006399505,0.000014222256,0.00027331934,7.447208e-8],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002788985,0.000051945703,0.76282233,0.00024223805,0.000037184138,0.00017871159,0.00014602974,0.00064672483,0.0000074869267,0.0002345459,0.003648874,0.23170504],"study_design_scores_gemma":[0.0043330938,0.0011988641,0.20455611,0.00039077934,0.00018966557,0.00014453016,0.008915486,0.0029512811,0.00083074224,0.0011552576,0.77507335,0.0002608336],"about_ca_topic_score_codex":0.5639769,"about_ca_topic_score_gemma":0.5717133,"teacher_disagreement_score":0.7714245,"about_ca_system_score_codex":0.0006622876,"about_ca_system_score_gemma":0.011653711,"threshold_uncertainty_score":0.9939493},"labels":[],"label_agreement":null},{"id":"W4282977469","doi":"10.51731/cjht.2022.362","title":"Alpha1-Proteinase Inhibitor (Human) (Zemaira)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Proteinase inhibitor; Drug; Medicine; Intensive care medicine; Pharmacology; Chemistry; Health care; Political science; Enzyme","score_opus":0.13544595912281798,"score_gpt":0.39591952761530447,"score_spread":0.2604735684924865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282977469","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.73656297,0.060704447,0.000050351762,0.19964968,0.0010413002,0.00071449333,0.000038367165,0.0001437767,0.0010946507],"genre_scores_gemma":[0.99647814,0.00008515109,0.00039929594,0.0027933305,0.000023752971,0.000012819584,0.000003830121,0.000014449582,0.00018922976],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985089,0.00010312789,0.0005507509,0.000117709074,0.00029157495,0.00042794654],"domain_scores_gemma":[0.9989803,0.00006367036,0.00045253264,0.00021441697,0.00008890259,0.00020018738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087958947,0.00010838497,0.0003627682,0.0005628568,0.0006138134,0.000017831291,0.00024642373,0.000058142083,0.00042047838],"category_scores_gemma":[0.000524983,0.00009282585,0.00010769529,0.0003377322,0.00013672221,0.000120515186,0.000054143904,0.0011010515,0.0000089899995],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003656905,0.00037891726,0.10434572,0.0006485902,0.00028305248,0.0050296276,0.0009716559,0.00006084799,0.00096197554,0.011450692,0.09561535,0.77988786],"study_design_scores_gemma":[0.0010827517,0.0019175942,0.0031504403,0.00007695496,0.000032374934,0.0010408362,0.003421251,0.000015174845,0.0005349376,0.0016286119,0.9869914,0.000107673935],"about_ca_topic_score_codex":0.0012826654,"about_ca_topic_score_gemma":0.0003366456,"teacher_disagreement_score":0.891376,"about_ca_system_score_codex":0.0006165814,"about_ca_system_score_gemma":0.0023114004,"threshold_uncertainty_score":0.47835818},"labels":[],"label_agreement":null},{"id":"W4283122442","doi":"10.51731/cjht.2022.363","title":"Prasterone (Intrarosa)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Phytochemistry and Bioactive Compounds","field":"Materials Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Drug class; Family medicine; Drug; Gynecology; Political science; Pharmacology; Health care","score_opus":0.025356679755541955,"score_gpt":0.25199272577962206,"score_spread":0.2266360460240801,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283122442","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.957182,0.016383167,0.00020195224,0.02466704,0.00088205794,0.00009973824,0.00007171105,0.00008172109,0.0004306248],"genre_scores_gemma":[0.99918604,0.000018549586,0.00038575556,0.00032824994,0.000011745135,0.0000065153513,0.0000011937329,0.0000050264753,0.000056941342],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990197,0.000068367386,0.00031167222,0.00010043496,0.00015535718,0.0003444976],"domain_scores_gemma":[0.99934775,0.000025396379,0.000340455,0.00016316987,0.0000593823,0.0000638407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071517867,0.00007266598,0.00018778465,0.00016916296,0.00055925647,0.00003472982,0.00056680385,0.000034036955,0.00031400114],"category_scores_gemma":[0.00013572512,0.00006609466,0.000028187216,0.00019763781,0.00017664854,0.00010204009,0.000058041103,0.00035047243,0.000006215784],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007773293,0.00010482125,0.0029502201,0.00014631159,0.000033294862,0.00057701115,0.0008793048,0.000182286,0.6947205,0.002211914,0.052908473,0.24520811],"study_design_scores_gemma":[0.0004407598,0.0013249397,0.0020349713,0.00006156216,0.0000069636967,0.0016697702,0.0082029775,0.000006603621,0.2549681,0.010492628,0.7205306,0.00026009686],"about_ca_topic_score_codex":0.00053990335,"about_ca_topic_score_gemma":0.00022710396,"teacher_disagreement_score":0.66762215,"about_ca_system_score_codex":0.0004552802,"about_ca_system_score_gemma":0.0018811185,"threshold_uncertainty_score":0.4301405},"labels":[],"label_agreement":null},{"id":"W4283271171","doi":"10.51731/cjht.2022.364","title":"Tralokinumab (Adtralza)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Medical prescription; Family medicine; Atopic dermatitis; Nursing; Dermatology; Political science; Health care","score_opus":0.02398316503482601,"score_gpt":0.28358858184129304,"score_spread":0.25960541680646704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283271171","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.54453254,0.19556499,0.000064889624,0.2558895,0.0010214419,0.00034400105,0.00005879251,0.0002030578,0.002320776],"genre_scores_gemma":[0.9974444,0.00011607298,0.0001875368,0.0020614176,0.000006316479,0.000007404007,0.000003364258,0.000008629958,0.00016486936],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99899733,0.00006137892,0.00036848764,0.000081819155,0.00014252616,0.0003484691],"domain_scores_gemma":[0.99940526,0.000028794773,0.00021125315,0.00017806617,0.000058688216,0.00011795395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033017565,0.00007479054,0.00031157114,0.000582065,0.00040991424,0.000007444982,0.00023309198,0.000056070086,0.00028257802],"category_scores_gemma":[0.00025503009,0.00006693175,0.00009348586,0.00027007388,0.00017280265,0.000048020207,0.000017930637,0.0005659901,0.0000055105],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012376625,0.00011355758,0.11387047,0.00019250078,0.00014398122,0.0063761696,0.00056931126,0.000042539923,0.000025208254,0.0032745986,0.47480184,0.40046605],"study_design_scores_gemma":[0.00092697603,0.00061641337,0.04957759,0.00006832423,0.00003208121,0.012143211,0.006454039,0.0000064646997,0.00015651406,0.0057203798,0.9241921,0.00010592803],"about_ca_topic_score_codex":0.0005138809,"about_ca_topic_score_gemma":0.00028417754,"teacher_disagreement_score":0.45291182,"about_ca_system_score_codex":0.00031437684,"about_ca_system_score_gemma":0.0039955117,"threshold_uncertainty_score":0.7087866},"labels":[],"label_agreement":null},{"id":"W4283529023","doi":"10.51731/cjht.2022.372","title":"Health System Readiness Report: The Availability of Privately Funded IV Infusion Clinics in Canada","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Scope (computer science); Business; Scale (ratio); Medicine; Tracking (education); Healthcare system; Medical emergency; Family medicine; Health care; Political science; Psychology; Geography; Computer science","score_opus":0.244985086455644,"score_gpt":0.3822351515037907,"score_spread":0.1372500650481467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283529023","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.640875,0.040447973,0.00020006807,0.31467885,0.0020251193,0.0010689249,0.00048579014,0.00003777616,0.00018050324],"genre_scores_gemma":[0.99563956,0.0002541692,0.00038119513,0.0035991191,0.000019907442,0.000041360832,0.000010251677,0.000019453038,0.000034973527],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.988451,0.00088905316,0.009419269,0.0003457216,0.00020640105,0.0006885502],"domain_scores_gemma":[0.9869413,0.0007974431,0.01106837,0.0008688938,0.00015241589,0.00017161407],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.043712854,0.00016940587,0.0015994897,0.00083830266,0.0006415214,0.000019471627,0.0009506639,0.00009816042,0.00005725264],"category_scores_gemma":[0.0063936403,0.00017283077,0.00010263939,0.0007624493,0.00015513999,0.00016549265,0.00010054347,0.00085670565,0.0000065354384],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00003822433,0.00006634527,0.88221496,0.0024030707,0.000076131,0.00013825587,0.0027921863,0.0024872005,2.9302072e-7,0.040311094,0.039897364,0.029574864],"study_design_scores_gemma":[0.0013069735,0.0006071749,0.4044904,0.00066973397,0.000005686819,0.00096202956,0.08693099,0.0015782124,0.0000038688154,0.013961145,0.48899084,0.0004929414],"about_ca_topic_score_codex":0.9656748,"about_ca_topic_score_gemma":0.9611857,"teacher_disagreement_score":0.47772455,"about_ca_system_score_codex":0.015316309,"about_ca_system_score_gemma":0.03202454,"threshold_uncertainty_score":0.9884637},"labels":[],"label_agreement":null},{"id":"W4284892562","doi":"10.51731/cjht.2022.384","title":"Platform, Basket, and Umbrella Trial Designs: Stakeholder Perspectives of Novel Therapeutics","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Science, Research, and Medicine","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact; Telus (Canada); Canadian Agency for Drugs and Technologies in Health; University of Manitoba; University of Toronto","funders":"","keywords":"Clinical trial; Protocol (science); Stakeholder engagement; Medicine; Alternative medicine; Stakeholder; Medical physics; Engineering ethics; Public relations; Engineering; Internal medicine; Political science; Pathology","score_opus":0.3202342750032946,"score_gpt":0.3883024218095185,"score_spread":0.06806814680622392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4284892562","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.889107,0.08139518,0.00036287322,0.027884074,0.000330409,0.0005848402,0.00002483381,0.000029862198,0.00028093168],"genre_scores_gemma":[0.9969109,0.0016895249,0.0007157884,0.0005329168,0.000025073523,0.0000066356315,7.89373e-7,0.000009885128,0.00010846327],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.9985154,0.000042311724,0.00045512876,0.00013705861,0.0004387583,0.0004112979],"domain_scores_gemma":[0.99901146,0.00012251633,0.0003023844,0.00019742029,0.00020439686,0.00016183247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001794327,0.00009573559,0.00041114585,0.00090659753,0.00030913853,0.000010713424,0.0002545616,0.00006530614,0.00005090149],"category_scores_gemma":[0.00057879306,0.000072276925,0.00005385458,0.0005095969,0.0006521835,0.00006592618,0.000033399454,0.00066341733,1.780264e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0076130163,0.00067163666,0.010584349,0.00057715207,0.00037559003,0.00055869535,0.027403874,0.000044792687,0.004990357,0.007244814,0.007024629,0.9329111],"study_design_scores_gemma":[0.06414415,0.027931219,0.014602636,0.00058725197,0.00013298713,0.0034975363,0.7435897,0.00021401547,0.001918675,0.0024415464,0.14058787,0.00035242536],"about_ca_topic_score_codex":0.0017775636,"about_ca_topic_score_gemma":0.00045308823,"teacher_disagreement_score":0.93255866,"about_ca_system_score_codex":0.0003918874,"about_ca_system_score_gemma":0.0054699536,"threshold_uncertainty_score":0.9703463},"labels":[],"label_agreement":null},{"id":"W4285090912","doi":"10.51731/cjht.2022.388","title":"Fostamatinib (Tavalisse)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Family medicine; Drug; Political science; Pharmacology; Health care; Law","score_opus":0.038057505034988996,"score_gpt":0.3107436991759175,"score_spread":0.2726861941409285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285090912","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.56768084,0.23746638,0.00002920311,0.18930641,0.00095350086,0.0005063064,0.00006965466,0.00013737075,0.0038503178],"genre_scores_gemma":[0.9983576,0.0003083058,0.00028419148,0.0008513173,0.000007634283,0.00001557421,0.0000020333957,0.000008339509,0.00016503257],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991198,0.000031184485,0.00032831196,0.000078576864,0.0001601635,0.00028194155],"domain_scores_gemma":[0.99946773,0.000023980412,0.00022318542,0.00013126446,0.00008618347,0.00006764193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032455215,0.000077245706,0.00031800926,0.00038522985,0.0005160402,0.000009193283,0.00013160912,0.00002614155,0.00016234926],"category_scores_gemma":[0.00017098755,0.00006128671,0.00007337942,0.00027498294,0.0000932422,0.0000306629,0.00003346897,0.00034132603,0.0000019405304],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010303782,0.00004790303,0.022711903,0.000073455165,0.00014306299,0.0007672843,0.0013495387,0.000011956083,0.000013963462,0.0010636704,0.029618822,0.94409543],"study_design_scores_gemma":[0.0009691561,0.004328117,0.02891583,0.00007055996,0.000031987624,0.0015744021,0.022091113,0.0000037294797,0.000099694415,0.0019499424,0.9398729,0.00009257008],"about_ca_topic_score_codex":0.0032318614,"about_ca_topic_score_gemma":0.0019145859,"teacher_disagreement_score":0.9440028,"about_ca_system_score_codex":0.0008788011,"about_ca_system_score_gemma":0.002529874,"threshold_uncertainty_score":0.4885629},"labels":[],"label_agreement":null},{"id":"W4285394931","doi":"10.51731/cjht.2022.390","title":"Diacetylmorphine for Adults With Opioid Dependence","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Buprenorphine; Hydromorphone; Methadone; Medicine; Opioid; Opioid use disorder; Guideline; Anesthesia; Agonist; Pharmacology; Internal medicine","score_opus":0.01574886368000027,"score_gpt":0.2653063064427987,"score_spread":0.2495574427627984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285394931","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8237648,0.085604966,0.00060281286,0.08771923,0.00041036113,0.0015108949,0.00015587061,0.0001383202,0.00009274571],"genre_scores_gemma":[0.99500614,0.0003089112,0.0038243295,0.00064377213,0.000008849707,0.000103328486,0.00001402261,0.000022014956,0.000068608606],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988139,0.00002322936,0.0003646913,0.00014981146,0.0002183607,0.00042995042],"domain_scores_gemma":[0.99910855,0.00004420031,0.00031433877,0.0002543301,0.00015601325,0.00012258919],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003278853,0.00012417474,0.0003668678,0.0004813539,0.0003926549,0.000011275133,0.00023966543,0.000045427652,0.00005028076],"category_scores_gemma":[0.0001935926,0.00009594326,0.000072562565,0.0003066959,0.000094182666,0.00005474711,0.00002345803,0.00039134533,0.000001517097],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013055626,0.0003560342,0.09105148,0.0011377432,0.0003779881,0.0015387848,0.005861135,0.00023996347,0.00006767258,0.0021875636,0.02072092,0.87515515],"study_design_scores_gemma":[0.016860697,0.045120914,0.052492294,0.0015459703,0.00027236095,0.009061904,0.14030059,0.00014868307,0.0020459634,0.0052390173,0.72616374,0.0007478581],"about_ca_topic_score_codex":0.0031458512,"about_ca_topic_score_gemma":0.0026862775,"teacher_disagreement_score":0.8744073,"about_ca_system_score_codex":0.0007793967,"about_ca_system_score_gemma":0.0048878198,"threshold_uncertainty_score":0.86707824},"labels":[],"label_agreement":null},{"id":"W4285596414","doi":"10.51731/cjht.2022.392","title":"Trace Amine-Associated Receptor 1 Agonists for Schizophrenia","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Receptor Mechanisms and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Antipsychotic; Medicine; Partial agonist; Agonist; Pharmacology; Clinical trial; Dopamine receptor D2; Schizophrenia (object-oriented programming); Internal medicine; Psychiatry; Dopamine; Receptor","score_opus":0.01674535363351529,"score_gpt":0.2506839181679237,"score_spread":0.2339385645344084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285596414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9351109,0.050128166,0.002699201,0.009984416,0.0013145278,0.000414175,0.00026931215,0.00004436732,0.000034922876],"genre_scores_gemma":[0.9970971,0.000191977,0.0021373066,0.00026539975,0.000029370245,0.00003100509,0.000044143,0.000022385366,0.00018134696],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99883914,0.00007500966,0.0004034723,0.00016080287,0.00011627053,0.00040530204],"domain_scores_gemma":[0.9991859,0.000016860311,0.0004184589,0.00016759489,0.0001344342,0.0000767502],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083964935,0.00011376201,0.00023920748,0.0002113191,0.0006086633,0.00002613602,0.00041760397,0.000120680095,0.0000643607],"category_scores_gemma":[0.0004539341,0.000114136754,0.0001270656,0.00016555007,0.00006209825,0.0000042874476,0.000038323455,0.0002712644,8.0167604e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034139102,0.00011394671,0.0011920322,0.00010176624,0.00031081826,0.000037433925,0.00039136675,0.0007346335,0.32153693,0.0023209876,0.110466875,0.56245184],"study_design_scores_gemma":[0.0010692747,0.0024509437,0.00018392869,0.000036593225,0.000011609961,0.000096524185,0.002961738,0.000026206742,0.06319462,0.0017560087,0.927968,0.00024451327],"about_ca_topic_score_codex":0.00037404883,"about_ca_topic_score_gemma":0.00071286695,"teacher_disagreement_score":0.8175012,"about_ca_system_score_codex":0.00021764365,"about_ca_system_score_gemma":0.0017387521,"threshold_uncertainty_score":0.46814075},"labels":[],"label_agreement":null},{"id":"W4285597427","doi":"10.51731/cjht.2022.391","title":"Selpercatinib (Retevmo)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Family medicine; Drug; Political science; Health care; Pharmacology","score_opus":0.026523375509340825,"score_gpt":0.33789754651757126,"score_spread":0.31137417100823045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285597427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.44237646,0.18757546,0.00018032087,0.36196962,0.0015300261,0.0008345792,0.0001398962,0.00024247592,0.0051511535],"genre_scores_gemma":[0.9974328,0.00012985301,0.0008067209,0.0013102719,0.0000076150313,0.00001658766,0.00000565297,0.000009103382,0.00028139498],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992544,0.000027054097,0.0002821414,0.000070401235,0.00012894333,0.00023703124],"domain_scores_gemma":[0.99948883,0.000017241993,0.00018752796,0.00014765114,0.00007995744,0.00007880065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024525778,0.000059822152,0.00020340402,0.00040693968,0.00041033336,0.000008099625,0.00012856036,0.00002841307,0.00020394598],"category_scores_gemma":[0.000108921224,0.000049937848,0.000054899876,0.00027442005,0.0000648993,0.00003705276,0.000013862373,0.0003302372,0.0000036088625],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023784753,0.000060067905,0.027227756,0.000079398465,0.00017769211,0.000614756,0.0019201316,0.00006520154,0.000036294223,0.0027770307,0.04952756,0.9174903],"study_design_scores_gemma":[0.0008783481,0.0012981733,0.014886521,0.00005670792,0.000048792666,0.0017016589,0.014040195,0.0000064354895,0.000083116014,0.0015419903,0.96538657,0.00007150755],"about_ca_topic_score_codex":0.002846508,"about_ca_topic_score_gemma":0.00062501465,"teacher_disagreement_score":0.91741884,"about_ca_system_score_codex":0.000986028,"about_ca_system_score_gemma":0.0055199214,"threshold_uncertainty_score":0.9792104},"labels":[],"label_agreement":null},{"id":"W4285801062","doi":"10.51731/cjht.2022.397","title":"Improving Access to Primary Care","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Primary Care and Health Outcomes","field":"Health Professions","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Primary care; Psychological intervention; Incentive; Nursing; Health care; Medicine; Family medicine; Political science","score_opus":0.06777947422113127,"score_gpt":0.4033509992311163,"score_spread":0.335571525009985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285801062","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14220944,0.17545584,0.0010431908,0.6482349,0.0117495805,0.0037718199,0.0005575348,0.00078454526,0.01619316],"genre_scores_gemma":[0.89764076,0.00020467812,0.001198997,0.100312255,0.0000714682,0.0001684461,0.000019990955,0.000045884015,0.00033752437],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99662745,0.00041516393,0.001189144,0.00021954691,0.0003453969,0.0012032932],"domain_scores_gemma":[0.99779063,0.00020979544,0.00090509997,0.00043969086,0.0003553959,0.0002993626],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0016331719,0.00016914586,0.0006061756,0.0013800848,0.0036731826,0.000027067572,0.0014393192,0.00014559699,0.00031999996],"category_scores_gemma":[0.0004930519,0.00015932391,0.00009902184,0.00078867364,0.00006814539,0.00025142054,0.00049002824,0.0021215698,0.00002643941],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000036155256,0.000008342976,0.04385226,0.0010836676,0.000016422873,0.00014102149,0.0040006107,0.00003615924,0.000015308475,0.00063489407,0.19672094,0.7534542],"study_design_scores_gemma":[0.00042327243,0.0004628252,0.029740386,0.0001024539,0.000007499744,0.000043481177,0.033870753,6.722568e-7,0.000009434231,0.00062765967,0.93455094,0.00016059486],"about_ca_topic_score_codex":0.025658233,"about_ca_topic_score_gemma":0.019807655,"teacher_disagreement_score":0.7554313,"about_ca_system_score_codex":0.009598205,"about_ca_system_score_gemma":0.044487584,"threshold_uncertainty_score":0.9980783},"labels":[],"label_agreement":null},{"id":"W4286685301","doi":"10.51731/cjht.2022.403","title":"Nivolumab (Opdivo)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Nivolumab; Medicine; Oncology; Drug; Esophageal adenocarcinoma; Internal medicine; Gastroesophageal Junction; Adenocarcinoma; Intensive care medicine; Pharmacology; Cancer; Political science; Immunotherapy","score_opus":0.03897734126157233,"score_gpt":0.22951305929578625,"score_spread":0.19053571803421393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4286685301","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.29770356,0.5535782,0.0021054212,0.113004096,0.005495412,0.00045847867,0.0007573351,0.00017959451,0.026717909],"genre_scores_gemma":[0.99766654,0.0004104042,0.00027447968,0.0012326991,0.000018969618,0.00000875963,0.0000016634854,0.00001589798,0.00037058795],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.998486,0.000015269625,0.0008540915,0.00014792292,0.000029612966,0.00046713187],"domain_scores_gemma":[0.9986578,0.00001851,0.00097002817,0.00023320649,0.000036359743,0.000084052015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001105481,0.000097614444,0.0004532248,0.0008004404,0.0005729912,0.000040381143,0.00058453705,0.0000642482,0.00060307473],"category_scores_gemma":[0.00027842153,0.000120009994,0.00010587237,0.000277122,0.00013647728,0.00019973543,0.00004784146,0.0004917229,0.000056363875],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019500252,0.000036843274,0.049806956,0.00004308531,0.00006904839,0.00009834747,0.0010004723,0.0003978501,0.0000015040214,0.4649213,0.08423616,0.39936894],"study_design_scores_gemma":[0.0002893788,0.0003053014,0.0065952265,0.000008853327,0.0000011126898,0.00009342831,0.0013927631,0.000017880047,0.0000066901307,0.099523805,0.8916406,0.00012492941],"about_ca_topic_score_codex":0.009247745,"about_ca_topic_score_gemma":0.0013620697,"teacher_disagreement_score":0.80740446,"about_ca_system_score_codex":0.0011228604,"about_ca_system_score_gemma":0.0012799883,"threshold_uncertainty_score":0.99734974},"labels":[],"label_agreement":null},{"id":"W4289525250","doi":"10.51731/cjht.2022.406","title":"Models of Care for People Re-Entering the Community After Incarceration","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Geriatric Care and Nursing Homes","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Health care; Community service; Service delivery framework; Medicine; Service (business); Nursing; Gerontology; Political science; Business; Public relations","score_opus":0.0677947611427661,"score_gpt":0.3676326857130322,"score_spread":0.2998379245702661,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4289525250","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.917787,0.037706133,0.0013041607,0.040222082,0.0013699674,0.0010236762,0.00023893116,0.000057789817,0.00029024621],"genre_scores_gemma":[0.9991805,0.0000932338,0.00023117405,0.00031237002,0.000016382694,0.000111201276,0.00000937381,0.000011820136,0.000033935892],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.99838024,0.00050523627,0.00058449194,0.000058427944,0.00012992081,0.00034166937],"domain_scores_gemma":[0.9985823,0.00026868482,0.0005389605,0.000290296,0.00028078273,0.000038965096],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0014249126,0.000073908035,0.0003041137,0.00032927986,0.0028013056,0.0000073427796,0.0004139983,0.00007491257,0.000034166715],"category_scores_gemma":[0.00021878259,0.000057453806,0.00008189371,0.00026078793,0.000070619295,0.000077214936,0.00008115434,0.0010684686,3.1958146e-7],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005605278,0.00006146814,0.024048056,0.0035080318,0.00010066988,0.000013902549,0.5518506,0.0027052339,0.000044432392,0.0033291394,0.0692405,0.3445374],"study_design_scores_gemma":[0.00052064634,0.0008985225,0.008711645,0.00024133806,0.000020632944,0.000015378444,0.9177322,0.00010189657,0.000030059598,0.0080445735,0.063592464,0.00009064245],"about_ca_topic_score_codex":0.029220497,"about_ca_topic_score_gemma":0.11054126,"teacher_disagreement_score":0.3658816,"about_ca_system_score_codex":0.0007933281,"about_ca_system_score_gemma":0.0023710027,"threshold_uncertainty_score":0.9984969},"labels":[],"label_agreement":null},{"id":"W4291001560","doi":"10.51731/cjht.2022.412","title":"Understanding the Portrait of Dementia Care in Canada: A CADTH Panel of Experts","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Health, Medicine and Society","field":"Health Professions","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dementia; Portrait; Health care; Medicine; Gerontology; Disease; Panel discussion; Nursing; Family medicine; Political science; Business; Geography","score_opus":0.18976275944799337,"score_gpt":0.35774223045434494,"score_spread":0.16797947100635158,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4291001560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8525885,0.080334745,0.00016932812,0.063801564,0.0012588504,0.00096089736,0.00015535361,0.000022007765,0.000708801],"genre_scores_gemma":[0.9971327,0.00047179122,0.000076542194,0.0022636,0.000010563856,0.000020995902,0.0000028045472,0.000011900473,0.000009095511],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.9969068,0.00059490453,0.0013464477,0.0001075128,0.00037721673,0.0006671041],"domain_scores_gemma":[0.99798626,0.00036781922,0.001120361,0.00025624104,0.00015553928,0.00011379678],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023822198,0.0001027121,0.00051855895,0.00035464257,0.00096244586,0.0000014296978,0.00048609218,0.00014079305,0.00010757927],"category_scores_gemma":[0.0005879585,0.000076997625,0.00005986567,0.000573992,0.00015772627,0.000041354167,0.000055771976,0.001792832,1.0434806e-7],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000054907698,0.00003358743,0.63193816,0.002504768,0.00016095162,0.00031855388,0.23780309,0.0004558984,0.000029505203,0.011073586,0.06577414,0.049852848],"study_design_scores_gemma":[0.00048224517,0.00023876017,0.024364712,0.00033339986,0.000010497479,0.00001808795,0.9417443,0.0000094616325,0.000007512377,0.0007794518,0.031951055,0.000060491187],"about_ca_topic_score_codex":0.9491312,"about_ca_topic_score_gemma":0.9903061,"teacher_disagreement_score":0.7039412,"about_ca_system_score_codex":0.006225878,"about_ca_system_score_gemma":0.10284775,"threshold_uncertainty_score":0.99758905},"labels":[],"label_agreement":null},{"id":"W4291002011","doi":"10.51731/cjht.2022.415","title":"Normal Immunoglobulin (Human) 10% and Recombinant Human Hyaluronidase (HyQvia)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Antifungal resistance and susceptibility","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Hyaluronidase; Recombinant DNA; Antibody; Medicine; Drug; Human immunodeficiency virus (HIV); Immunology; Pharmacology; Chemistry; Enzyme; Political science; Biochemistry","score_opus":0.028845260575301228,"score_gpt":0.3002388141577398,"score_spread":0.27139355358243855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4291002011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9505329,0.03172396,0.000011162978,0.016865171,0.00018353993,0.0002207916,0.000016439168,0.000057768662,0.00038823028],"genre_scores_gemma":[0.9982893,0.00016523257,0.00014065864,0.0003957596,0.000009663597,0.0000066845287,0.000007149607,0.000013942985,0.00097164663],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9983835,0.00009302444,0.0006270871,0.00017682985,0.00022708556,0.00049246434],"domain_scores_gemma":[0.9990186,0.000028748182,0.00035243723,0.00032078882,0.00012303944,0.00015636669],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011650373,0.00013320263,0.00046096215,0.00044036188,0.0011751025,0.000024786388,0.00025449556,0.00008166938,0.0004731072],"category_scores_gemma":[0.00025749812,0.000118933305,0.00009207724,0.00024945434,0.0003246043,0.00008726427,0.000066907036,0.000850392,0.000004747867],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043596313,0.00035858664,0.35763046,0.0009217366,0.00022407745,0.0038092025,0.0017632301,0.000014182974,0.0030353183,0.007009535,0.048634164,0.57616353],"study_design_scores_gemma":[0.0030665055,0.009019714,0.5154628,0.00039870947,0.0000696364,0.0022286247,0.022087444,0.000009395617,0.00058687123,0.00700692,0.43964797,0.00041538617],"about_ca_topic_score_codex":0.0044924547,"about_ca_topic_score_gemma":0.0038156523,"teacher_disagreement_score":0.57574815,"about_ca_system_score_codex":0.0007381073,"about_ca_system_score_gemma":0.0019378631,"threshold_uncertainty_score":0.90380573},"labels":[],"label_agreement":null},{"id":"W4291002222","doi":"10.51731/cjht.2022.414","title":"An Overview of Comprehensive Genomic Profiling Technologies to Inform Cancer Care","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Profiling (computer programming); Emerging technologies; Clinical trial; Health care; Medicine; Data science; Computer science; Pathology; Political science","score_opus":0.0449433329869874,"score_gpt":0.33271092312586953,"score_spread":0.28776759013888215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4291002222","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7226253,0.27230534,0.000057841426,0.0040312395,0.0003117782,0.00027741698,0.00034375666,0.000025411926,0.000021903223],"genre_scores_gemma":[0.99206674,0.005888269,0.001357196,0.00058847235,0.00001401688,0.00004061953,0.000021854792,0.000018114284,0.000004742508],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988374,0.000028488708,0.0004814019,0.00017297085,0.00012060234,0.0003591405],"domain_scores_gemma":[0.9988322,0.0000129572145,0.0004079524,0.00038420415,0.0002905713,0.00007211284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001752006,0.00013360594,0.00031476564,0.00040768858,0.0003084744,0.000017141088,0.0006941276,0.00010757267,0.000009691732],"category_scores_gemma":[0.0001128106,0.0001366169,0.00007652896,0.000317256,0.0001298859,0.000006032627,0.00017671664,0.00027112063,5.001621e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001240243,0.000039973118,0.01983994,0.0005512803,0.0001516191,0.000050631057,0.0012695418,0.01718318,0.06563652,0.0029823252,0.0047177817,0.8874532],"study_design_scores_gemma":[0.0006158291,0.0036389623,0.0047744056,0.00012351337,0.000025210153,0.000121393816,0.061346874,0.000019250469,0.083817676,0.00086246355,0.84426206,0.0003923447],"about_ca_topic_score_codex":0.003036305,"about_ca_topic_score_gemma":0.005243522,"teacher_disagreement_score":0.8870608,"about_ca_system_score_codex":0.00042224242,"about_ca_system_score_gemma":0.0033650054,"threshold_uncertainty_score":0.5969375},"labels":[],"label_agreement":null},{"id":"W4291152226","doi":"10.51731/cjht.2022.416","title":"Ospemifene (Osphena)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Genitourinary system; Menopause; Urinary incontinence; Drug class; Gynecology; Intensive care medicine; Drug; Family medicine; Internal medicine; Surgery; Psychiatry; Political science","score_opus":0.007426298641069915,"score_gpt":0.22763024574935395,"score_spread":0.22020394710828403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4291152226","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7734533,0.21115246,0.00017754138,0.01375183,0.0007016523,0.00016369288,0.000021701298,0.00003348067,0.0005443448],"genre_scores_gemma":[0.99857515,0.0005308685,0.00027975655,0.00042126866,0.000014288257,0.000005713302,0.000007716717,0.00001217296,0.00015307016],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99915767,0.00007116234,0.0002540967,0.00010600632,0.0000990932,0.00031195424],"domain_scores_gemma":[0.99946725,0.000006390776,0.0002187012,0.00018980878,0.00004808132,0.00006973523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004721284,0.000080960446,0.00015116137,0.00015622935,0.00036936434,0.000010681653,0.00036004584,0.00009197887,0.000025365121],"category_scores_gemma":[0.00012534595,0.00007422772,0.00007400838,0.00016855328,0.000095083866,0.0000023847788,0.000058804428,0.00038774122,0.0000026714406],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011994889,0.000088942514,0.011666149,0.000079131365,0.00031051584,0.0006337573,0.00031741316,0.0015874718,0.034409817,0.0027430726,0.19095197,0.7570918],"study_design_scores_gemma":[0.00046891035,0.0018431039,0.0007590283,0.00001854064,0.000008816357,0.0011396084,0.0018358836,0.000007196862,0.017513413,0.0009917916,0.975251,0.00016269412],"about_ca_topic_score_codex":0.00039030585,"about_ca_topic_score_gemma":0.00014080685,"teacher_disagreement_score":0.784299,"about_ca_system_score_codex":0.000117119336,"about_ca_system_score_gemma":0.0016159923,"threshold_uncertainty_score":0.30269185},"labels":[],"label_agreement":null},{"id":"W4292714772","doi":"10.51731/cjht.2022.425","title":"Reflections on the Canadian Bleeding Disorders Registry: Lessons Learned and Future Perspectives","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Procurement; Disease; Modalities; Medicine; Epidemiology; Product (mathematics); Family medicine; Intensive care medicine; Business; Pathology; Sociology","score_opus":0.1100831696613066,"score_gpt":0.4017112021239375,"score_spread":0.2916280324626309,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292714772","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07149308,0.020503849,7.6470997e-7,0.903616,0.00016962152,0.00024362083,0.000022958617,0.00003245444,0.003917622],"genre_scores_gemma":[0.9957255,0.0030426616,0.00005605504,0.00059605343,0.000042476026,0.000016148382,0.0000020926652,0.00001225867,0.0005067661],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989404,0.00008689829,0.00018003373,0.00013837815,0.00020405458,0.00045020704],"domain_scores_gemma":[0.99932754,0.000061273306,0.00011249176,0.00020767302,0.00007863835,0.00021240582],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0006512647,0.00009510956,0.0001980045,0.0008425567,0.002600614,0.000042186373,0.00019680781,0.00007912463,0.00009653861],"category_scores_gemma":[0.0003347701,0.00006338479,0.000055466717,0.00053467136,0.00032110422,0.000034897068,0.000020125764,0.0012292735,0.0000014868716],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000116203046,0.000101337275,0.018900031,0.0001036523,0.0003870885,0.0007798029,0.015431207,0.00003185736,0.00007296994,0.15508386,0.04494583,0.76404613],"study_design_scores_gemma":[0.00037759083,0.0010772883,0.00926141,0.000057171284,0.000017868537,0.00048082884,0.24438998,0.0000062470044,0.000019383508,0.004917099,0.73931426,0.000080893],"about_ca_topic_score_codex":0.20579642,"about_ca_topic_score_gemma":0.68678945,"teacher_disagreement_score":0.9242324,"about_ca_system_score_codex":0.0017793977,"about_ca_system_score_gemma":0.006384953,"threshold_uncertainty_score":0.9992479},"labels":[],"label_agreement":null},{"id":"W4293206881","doi":"10.51731/cjht.2022.428","title":"Ripretinib (Qinlock)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Gastrointestinal Tumor Research and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Regorafenib; Reimbursement; Sunitinib; Medicine; Imatinib; GiST; Drug; Family medicine; Intensive care medicine; Pharmacology; Internal medicine; Stromal cell; Political science; Cancer; Colorectal cancer; Health care","score_opus":0.03815395286686855,"score_gpt":0.31151360899872066,"score_spread":0.2733596561318521,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293206881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6891275,0.07039793,0.00012639616,0.23708251,0.0003791691,0.0006640826,0.000060511757,0.00016881492,0.0019930652],"genre_scores_gemma":[0.99810165,0.00006484074,0.0012354982,0.0004131599,0.0000064842225,0.000012050378,0.000003061188,0.000009650797,0.00015357755],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99881166,0.000059782822,0.00032582085,0.000089690904,0.0002535232,0.00045950332],"domain_scores_gemma":[0.99929756,0.000033910375,0.00019098155,0.00018170834,0.00010829512,0.00018753874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057878654,0.00007772504,0.00026119177,0.0005592355,0.0003741229,0.000011435843,0.00020425531,0.000018429353,0.00022460698],"category_scores_gemma":[0.00057483336,0.000063787505,0.00007712145,0.00030302687,0.00012641253,0.00002868724,0.0000359301,0.0006689153,0.00000858865],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022420137,0.00020824755,0.16279757,0.00020325906,0.00015037731,0.015665041,0.0004164267,0.000046684378,0.00013143466,0.0030810193,0.05045313,0.7666226],"study_design_scores_gemma":[0.0026959616,0.015416337,0.061173867,0.00032661724,0.00003742834,0.044109512,0.015366163,0.000027217835,0.00068564445,0.0057828054,0.8541938,0.00018462838],"about_ca_topic_score_codex":0.002464921,"about_ca_topic_score_gemma":0.00044608556,"teacher_disagreement_score":0.8037407,"about_ca_system_score_codex":0.0008393031,"about_ca_system_score_gemma":0.0043789707,"threshold_uncertainty_score":0.7768106},"labels":[],"label_agreement":null},{"id":"W4293207290","doi":"10.51731/cjht.2022.427","title":"Amifampridine phosphate (Firdapse)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Myasthenia Gravis and Thymoma","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Drug; Drug class; Family medicine; Political science; Pharmacology; Health care; Law","score_opus":0.02205549360723137,"score_gpt":0.26410860124144964,"score_spread":0.24205310763421828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293207290","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6688558,0.14779878,0.00020840816,0.18036643,0.0011786313,0.00045400695,0.000065001885,0.00019531326,0.00087765837],"genre_scores_gemma":[0.99730027,0.00029257862,0.0005189282,0.0015886272,0.0000129224545,0.0000076890265,0.0000037271934,0.000017528222,0.00025771774],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986723,0.000045190805,0.0004961816,0.00011335085,0.000229847,0.00044313204],"domain_scores_gemma":[0.99911964,0.000021771253,0.00035087878,0.000256147,0.00010159749,0.0001499552],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007448334,0.000105842926,0.0003982176,0.00061470363,0.00045053376,0.000014359187,0.00028394858,0.00005176388,0.00032867727],"category_scores_gemma":[0.00020068097,0.000090625,0.000102660786,0.00042356335,0.00011667517,0.000044879645,0.000040705527,0.00069265795,0.000008130834],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009546938,0.000067429486,0.020025356,0.00012874637,0.000099941135,0.002179306,0.0006144169,0.000044478973,0.00020114852,0.009687831,0.026843062,0.9400128],"study_design_scores_gemma":[0.0009461768,0.0017627635,0.00998297,0.00009015009,0.000020050451,0.0038374136,0.004828785,0.000026542673,0.00038011363,0.0033940808,0.97461253,0.00011839924],"about_ca_topic_score_codex":0.002989509,"about_ca_topic_score_gemma":0.00040619244,"teacher_disagreement_score":0.9477695,"about_ca_system_score_codex":0.0005515649,"about_ca_system_score_gemma":0.0029697446,"threshold_uncertainty_score":0.52681994},"labels":[],"label_agreement":null},{"id":"W4293724035","doi":"10.51731/cjht.2022.431","title":"Faricimab (Vabysmo)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Macular degeneration; Medicine; Drug; Public health; Optometry; Drug treatment; Ophthalmology; Internal medicine; Pharmacology; Pathology","score_opus":0.3579371651390985,"score_gpt":0.40850366225846313,"score_spread":0.05056649711936462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293724035","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0271197,0.5632382,0.0016230019,0.40330553,0.0019441854,0.0004313971,0.00035075942,0.000108205524,0.0018790007],"genre_scores_gemma":[0.9867691,0.00018088438,0.00040891516,0.012366694,0.0000060893412,0.0000327717,0.0000055663004,0.000022092325,0.00020791269],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99481493,0.00028189516,0.003940567,0.00024073807,0.000102266065,0.00061958504],"domain_scores_gemma":[0.99539346,0.00025482412,0.0038383426,0.0004042528,0.000070695074,0.000038405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017313546,0.00013385885,0.00091295096,0.0014497752,0.00090423576,0.000053124488,0.00076592003,0.00009262485,0.0006058926],"category_scores_gemma":[0.0034846487,0.00017170089,0.00012470272,0.00046258737,0.00012613744,0.0002517136,0.000060400413,0.00065339805,0.00016660578],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020858868,0.00013385522,0.020744972,0.00056168693,0.000219632,0.000112846334,0.006669779,0.0018199054,0.000001745927,0.43541265,0.16326286,0.3710392],"study_design_scores_gemma":[0.00030708863,0.00017904355,0.0043243077,0.00002444114,0.0000015815193,0.00013486516,0.0085825445,0.00009631828,0.0000014488991,0.043153655,0.9430472,0.00014749356],"about_ca_topic_score_codex":0.01289255,"about_ca_topic_score_gemma":0.00036498293,"teacher_disagreement_score":0.9596494,"about_ca_system_score_codex":0.002713476,"about_ca_system_score_gemma":0.002798216,"threshold_uncertainty_score":0.99368066},"labels":[],"label_agreement":null},{"id":"W4294193007","doi":"10.51731/cjht.2022.434","title":"Current Utilization Patterns of Glucagon-Like Peptide-1 Receptor Agonists","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Institute for Health Information","funders":"","keywords":"Formulary; Reimbursement; Business; Drug; Pharmacology; Medicine; Health care; Economic growth; Economics","score_opus":0.048603727892597356,"score_gpt":0.3054348629377528,"score_spread":0.2568311350451554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294193007","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85116154,0.115877315,0.00044929626,0.02880166,0.0022948352,0.00086027215,0.00012505059,0.00012673668,0.000303304],"genre_scores_gemma":[0.99714595,0.0021176194,0.00023080649,0.0002538611,0.000010133048,0.000017714872,0.000034931356,0.000013284526,0.00017568254],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987924,0.000046719768,0.0005006112,0.000113245005,0.00023067079,0.00031636987],"domain_scores_gemma":[0.9990908,0.000017607808,0.00047674577,0.00021806918,0.00010906748,0.0000877155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039969757,0.000104309605,0.00034555132,0.0006901594,0.00019515038,0.000010186869,0.0002067841,0.00003462714,0.0001649288],"category_scores_gemma":[0.00009186562,0.00009316217,0.000088872606,0.0002931011,0.00006533972,0.000055353943,0.00004879322,0.00028095054,0.000003235178],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023357417,0.000112903566,0.0524303,0.00033423415,0.00009955073,0.00004493486,0.00032186293,0.000020840633,0.000020902942,0.00095895,0.020652993,0.92497915],"study_design_scores_gemma":[0.0008933177,0.0015446763,0.019892028,0.00031247656,0.000058446018,0.000038862683,0.0045048497,0.000009545824,0.00046564473,0.00042550656,0.97175896,0.000095683856],"about_ca_topic_score_codex":0.0009738294,"about_ca_topic_score_gemma":0.0005760878,"teacher_disagreement_score":0.95110595,"about_ca_system_score_codex":0.0006955924,"about_ca_system_score_gemma":0.0012905679,"threshold_uncertainty_score":0.3799043},"labels":[],"label_agreement":null},{"id":"W4294292647","doi":"10.51731/cjht.2022.433","title":"Cemiplimab (Libtayo)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Lung cancer; Oncology; Family medicine; Political science; Health care","score_opus":0.023578534964492186,"score_gpt":0.3292358113351322,"score_spread":0.30565727637064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294292647","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.29590788,0.25779524,0.00042742817,0.43579778,0.0019295239,0.0009286968,0.00015885958,0.00030033148,0.0067542526],"genre_scores_gemma":[0.9978112,0.00013021451,0.0005474313,0.0011498246,0.000007663746,0.000014569857,0.0000052325877,0.000009382053,0.00032449485],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992524,0.000021978014,0.00027346052,0.0000706707,0.00013006493,0.0002514292],"domain_scores_gemma":[0.99949527,0.000015479902,0.00019320521,0.0001469398,0.000070072085,0.000079025216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021221272,0.000060359107,0.00020757726,0.00043937628,0.000414592,0.000008868895,0.000127445,0.000028486018,0.00016626721],"category_scores_gemma":[0.000084606814,0.000050582094,0.000057127363,0.0002755543,0.00006483506,0.00003928058,0.000016517679,0.00033330248,0.0000036017484],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035536952,0.00007839685,0.023096733,0.00008359095,0.00019333822,0.000990722,0.0011944585,0.00008252417,0.00003608756,0.0037134353,0.04893882,0.92155635],"study_design_scores_gemma":[0.0010923552,0.0012742599,0.010912551,0.00005490948,0.000051367548,0.0018374954,0.010492169,0.0000059239314,0.00010220543,0.002273587,0.9718326,0.00007060796],"about_ca_topic_score_codex":0.0024442675,"about_ca_topic_score_gemma":0.0005726,"teacher_disagreement_score":0.92289376,"about_ca_system_score_codex":0.0011194842,"about_ca_system_score_gemma":0.0052625486,"threshold_uncertainty_score":0.93355346},"labels":[],"label_agreement":null},{"id":"W4295095326","doi":"10.51731/cjht.2022.439","title":"Post-Market Drug Evaluation","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cornerstone; Government (linguistics); Work (physics); Key (lock); Drug; Business; Risk analysis (engineering); Public relations; Data science; Computer science; Medicine; Engineering; Political science; Computer security; Pharmacology; Geography","score_opus":0.26796293488843287,"score_gpt":0.4061658416834237,"score_spread":0.1382029067949908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295095326","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14537029,0.15830162,0.00040478303,0.6880002,0.002758203,0.0010430397,0.0006850387,0.00010571117,0.0033311148],"genre_scores_gemma":[0.98695594,0.00014933416,0.000794156,0.011602706,0.000036507176,0.000073260904,0.00001385964,0.00002335829,0.0003508644],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9943458,0.0007147711,0.0039262865,0.00026493374,0.00018959603,0.0005586095],"domain_scores_gemma":[0.9946398,0.00036897804,0.0041928226,0.00042282595,0.00023278061,0.00014277316],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.048608106,0.00013743364,0.0007990462,0.0015691264,0.00089808786,0.000058823833,0.00068703707,0.00007845131,0.002028949],"category_scores_gemma":[0.008422384,0.00017657805,0.0001230479,0.0004014987,0.000109177825,0.00034455344,0.000052448107,0.00057367067,0.00011181675],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025824624,0.00008323786,0.03590947,0.0003693214,0.00015273655,0.000026419784,0.0066105784,0.0014727615,0.0000017606569,0.08681971,0.7858439,0.08268425],"study_design_scores_gemma":[0.00072260905,0.0003075113,0.0143847,0.000059413735,0.000006575164,0.00014267467,0.028413897,0.0011428636,0.0000031657237,0.06871626,0.8858292,0.00027112543],"about_ca_topic_score_codex":0.014985694,"about_ca_topic_score_gemma":0.004888435,"teacher_disagreement_score":0.8415857,"about_ca_system_score_codex":0.00392593,"about_ca_system_score_gemma":0.0052134227,"threshold_uncertainty_score":0.9999301},"labels":[],"label_agreement":null},{"id":"W4295743166","doi":"10.51731/cjht.2022.443","title":"Letter to the Editor Regarding CADTH rapid review: Systemic Thrombolysis by Alteplase for Acute Ischemic Stroke","year":2022,"lang":"en","type":"letter","venue":"Canadian Journal of Health Technologies","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Thrombolysis; Medicine; Stroke (engine); Acute stroke; Ischemic stroke; Intensive care medicine; Tissue plasminogen activator; Cardiology; Internal medicine; Ischemia; Myocardial infarction; Engineering","score_opus":0.018517441139092254,"score_gpt":0.2782553962394906,"score_spread":0.2597379551003983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295743166","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006881173,0.2223422,0.0004533562,0.7685386,0.0045266384,0.0024821823,0.0012836611,0.000106368854,0.00019818278],"genre_scores_gemma":[0.000495724,0.02241575,0.0009791175,0.96531177,0.0058023715,0.0005834253,0.0003655647,0.0001555539,0.0038907363],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99534947,0.00016761266,0.0016695511,0.0005852297,0.0008671704,0.0013609402],"domain_scores_gemma":[0.9959765,0.00027944313,0.0018149379,0.0013698231,0.00035519476,0.0002041154],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.001995697,0.00058714976,0.0020478985,0.0011468125,0.00057292427,0.00006489365,0.0017498669,0.0006595673,0.0001465254],"category_scores_gemma":[0.0012282892,0.0004218479,0.000627666,0.00057912606,0.00019358227,0.000098262026,0.00019959957,0.0048263203,0.000017692078],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024521756,0.0000050009885,0.000012992937,0.0028579354,0.0010433893,0.00048719297,0.00006078264,0.0000012179502,0.00009052218,7.917144e-7,0.98059,0.014825657],"study_design_scores_gemma":[0.00057049445,0.0006945097,9.664911e-7,0.0044847946,0.0013008999,0.0012048973,0.00061803503,0.0000021280266,0.00027659876,0.0000021225599,0.99052054,0.00032400986],"about_ca_topic_score_codex":0.0007002232,"about_ca_topic_score_gemma":0.00007443498,"teacher_disagreement_score":0.19992644,"about_ca_system_score_codex":0.003108506,"about_ca_system_score_gemma":0.0026935479,"threshold_uncertainty_score":0.99982333},"labels":[],"label_agreement":null},{"id":"W4295745635","doi":"10.51731/cjht.2022.441","title":"Dostarlimab (Jemperli)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Microsatellite instability; Medicine; Oncology; Internal medicine; Regimen; Quality of life (healthcare); Disease; Clinical trial; Endometrial cancer; Cancer; Gynecology; Biology","score_opus":0.027585593118772716,"score_gpt":0.28097659240452916,"score_spread":0.2533909992857564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295745635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8353719,0.079412006,0.000048118265,0.08245513,0.0014041268,0.0003397746,0.00003197689,0.00010397804,0.00083299517],"genre_scores_gemma":[0.9973277,0.00017072285,0.00082025386,0.0015253442,0.000011617484,0.000012145153,0.0000019189058,0.000015988997,0.00011430432],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99871576,0.000057702542,0.000428645,0.000113249596,0.00026567857,0.00041894463],"domain_scores_gemma":[0.9992343,0.000032822118,0.0002653188,0.00023458835,0.000115608396,0.000117362586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006163479,0.000096026495,0.0003271999,0.00063194084,0.00036446744,0.000011430256,0.0002972147,0.000060514187,0.00051121775],"category_scores_gemma":[0.0003385569,0.000086792665,0.000082505016,0.00041227328,0.00016873151,0.00003053148,0.000045839395,0.00076756155,0.000004461642],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013659362,0.000059903537,0.053071115,0.00016738952,0.000107590844,0.0010673912,0.0015705521,0.00017106906,0.00064293743,0.0007534531,0.05834456,0.88390744],"study_design_scores_gemma":[0.0009111201,0.0034431468,0.019303337,0.00007456974,0.000021902579,0.0033374033,0.011550506,0.000010279242,0.0012970088,0.0018919545,0.95801175,0.00014703447],"about_ca_topic_score_codex":0.0025346128,"about_ca_topic_score_gemma":0.0012252864,"teacher_disagreement_score":0.8996672,"about_ca_system_score_codex":0.0014397898,"about_ca_system_score_gemma":0.007138689,"threshold_uncertainty_score":0.9984899},"labels":[],"label_agreement":null},{"id":"W4295972090","doi":"10.51731/cjht.2022.442","title":"Avalglucosidase Alfa (Nexviazyme)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Family medicine; Vial; Political science; Health care","score_opus":0.036770565799471355,"score_gpt":0.3129541320836914,"score_spread":0.27618356628422003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295972090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5785455,0.19932841,0.00019068457,0.21897075,0.00063272496,0.0006903161,0.000051547588,0.00018686784,0.0014032052],"genre_scores_gemma":[0.9977358,0.0003019836,0.0002954342,0.0013255689,0.000011715201,0.000015357811,0.0000047055337,0.000020440752,0.00028902022],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998235,0.000104193045,0.00048919086,0.00013847901,0.00042971288,0.0006034263],"domain_scores_gemma":[0.9990132,0.0000430555,0.00025846888,0.00029538872,0.00018440519,0.00020552507],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009794645,0.000107101696,0.00037814002,0.0010524612,0.0006050566,0.0000207104,0.00043158614,0.00006962729,0.00049412163],"category_scores_gemma":[0.00078953616,0.00009676674,0.00010984275,0.0006529411,0.00020311221,0.00006646916,0.00007290629,0.0011301981,0.00001600807],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011532438,0.00010621102,0.022382712,0.00019181457,0.00010177408,0.0038629046,0.0007085202,0.00005247539,0.00022839173,0.0012654659,0.06076803,0.9102164],"study_design_scores_gemma":[0.0018168918,0.003078448,0.010164688,0.000113923496,0.000022900205,0.004957234,0.016543804,0.00004795796,0.00077187485,0.003928042,0.9583492,0.00020498438],"about_ca_topic_score_codex":0.0056572366,"about_ca_topic_score_gemma":0.0012271664,"teacher_disagreement_score":0.9100114,"about_ca_system_score_codex":0.0012238754,"about_ca_system_score_gemma":0.0066506593,"threshold_uncertainty_score":0.9989807},"labels":[],"label_agreement":null},{"id":"W4295972175","doi":"10.51731/cjht.2022.445","title":"Cenegermin (OXERVATE)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Ocular Infections and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Family medicine; Keratitis; Ophthalmology; Political science; Health care","score_opus":0.02495012981780162,"score_gpt":0.28234762652661577,"score_spread":0.2573974967088142,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295972175","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89549637,0.047413047,0.000102719205,0.05475197,0.00072149857,0.0002802341,0.000028723167,0.00010823948,0.0010972127],"genre_scores_gemma":[0.9987003,0.00012526245,0.00047749197,0.0004921668,0.00000460734,0.0000070980454,0.0000028490078,0.000008487729,0.00018171621],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992733,0.000033309643,0.00026789863,0.00006650092,0.000113637296,0.00024537765],"domain_scores_gemma":[0.9995206,0.000011781292,0.00017417505,0.00015694358,0.00006108331,0.0000754357],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028922103,0.00006118741,0.00021143837,0.00053018326,0.00041514612,0.0000081793905,0.00009960651,0.000034211032,0.00012714752],"category_scores_gemma":[0.000098550605,0.000052184023,0.000071167946,0.0003171166,0.00005853101,0.00003402427,0.00001729551,0.0003468703,0.0000072977605],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019968942,0.00010636918,0.18186198,0.000062551684,0.00013806284,0.0020790517,0.00020957897,0.000046842837,0.00004038175,0.001392936,0.010349215,0.80369306],"study_design_scores_gemma":[0.00083517784,0.0014213248,0.035767026,0.000054163313,0.000028069442,0.004432996,0.0025454503,0.000005989191,0.00032386326,0.0016842316,0.9528271,0.00007459517],"about_ca_topic_score_codex":0.002953746,"about_ca_topic_score_gemma":0.0006699863,"teacher_disagreement_score":0.9424779,"about_ca_system_score_codex":0.0006799108,"about_ca_system_score_gemma":0.002209013,"threshold_uncertainty_score":0.44652},"labels":[],"label_agreement":null},{"id":"W4296106206","doi":"10.51731/cjht.2022.438","title":"Response to Letter to Editor From the Canadian Stroke Consortium","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Stroke (engine); Thrombolysis; Acute stroke; Medicine; Systematic review; MEDLINE; Tissue plasminogen activator; Political science; Engineering; Psychiatry; Internal medicine","score_opus":0.019552516331999434,"score_gpt":0.2689430503336739,"score_spread":0.24939053400167444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296106206","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19461772,0.0025100266,0.00007981599,0.7983391,0.003045916,0.0006286383,0.00036716153,0.000051450454,0.00036014474],"genre_scores_gemma":[0.89507234,0.000007647234,0.0012109675,0.102390744,0.0004793809,0.000046337183,0.000005438641,0.000023290775,0.00076386513],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979547,0.00016048993,0.00051989197,0.00020566954,0.00042136677,0.000737827],"domain_scores_gemma":[0.9983571,0.00018180558,0.00020874263,0.0005707376,0.00013868023,0.00054290326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016114006,0.00015088807,0.00035667943,0.0010135726,0.00077094237,0.000045837893,0.0007846013,0.000086586675,0.00022850992],"category_scores_gemma":[0.0017443936,0.00011958532,0.00008196842,0.00050462387,0.0001216238,0.000030309391,0.00012797362,0.0010052393,0.00003646134],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014298792,0.0000047734575,0.0043318425,0.0000045342454,0.000055799814,0.0004425394,0.0005575772,0.000029952145,0.00019357592,0.000023896511,0.971788,0.022424547],"study_design_scores_gemma":[0.00035010683,0.00062199315,0.012980592,0.000051311206,0.000021700173,0.00009170334,0.0065474357,0.0000017859102,0.00021915566,0.000024979734,0.97898823,0.0001010316],"about_ca_topic_score_codex":0.4085763,"about_ca_topic_score_gemma":0.5527757,"teacher_disagreement_score":0.7004546,"about_ca_system_score_codex":0.0035313347,"about_ca_system_score_gemma":0.007869626,"threshold_uncertainty_score":0.9977548},"labels":[],"label_agreement":null},{"id":"W4296633325","doi":"10.51731/cjht.2022.453","title":"Zanubrutinib (Brukinsa)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Family medicine; Political science; Health care","score_opus":0.04150092911836314,"score_gpt":0.31990717976881616,"score_spread":0.27840625065045305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296633325","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6503365,0.15371841,0.00017345192,0.18766525,0.0020895668,0.0009931467,0.00006400983,0.0003217303,0.004637936],"genre_scores_gemma":[0.997746,0.00020642737,0.00042362104,0.0011909325,0.00002377551,0.0000110288665,0.0000030939211,0.000018468687,0.00037667013],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981805,0.00007976979,0.0005244532,0.00013247054,0.00044125883,0.0006415599],"domain_scores_gemma":[0.9989672,0.00006956367,0.00028356488,0.00035027103,0.00014228231,0.00018715468],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011961003,0.000098839184,0.00038042007,0.00095476775,0.0004801498,0.000017012151,0.0004442296,0.00007061631,0.0003585552],"category_scores_gemma":[0.000794983,0.00008818211,0.000098030825,0.00061679364,0.00023807718,0.000050063,0.00008166737,0.00097577745,0.000013007008],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00015345852,0.00007773229,0.0037821028,0.00031081133,0.00013661975,0.0041850917,0.0009162104,0.00013112038,0.00008558018,0.0039358395,0.15417409,0.83211136],"study_design_scores_gemma":[0.004129003,0.0014541274,0.0013703898,0.00009103569,0.000013059363,0.010658825,0.0065694298,0.00012687387,0.0002432956,0.0015985435,0.97364205,0.000103350794],"about_ca_topic_score_codex":0.009629705,"about_ca_topic_score_gemma":0.0010397115,"teacher_disagreement_score":0.832008,"about_ca_system_score_codex":0.021715516,"about_ca_system_score_gemma":0.07914543,"threshold_uncertainty_score":0.9969652},"labels":[],"label_agreement":null},{"id":"W4296755162","doi":"10.51731/cjht.2022.452","title":"Vagus Nerve Stimulation for the Treatment of Post–COVID-19 Condition","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Vagus Nerve Stimulation Research","field":"Neuroscience","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Vagus nerve stimulation; Neurostimulation; Vagus nerve; Telemedicine; Medicine; Coronavirus disease 2019 (COVID-19); Intensive care medicine; Neuroscience; Health care; Stimulation; Psychology; Disease; Internal medicine","score_opus":0.14003503661401626,"score_gpt":0.40596641072547324,"score_spread":0.26593137411145695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296755162","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7526684,0.019951524,0.0068732044,0.21572188,0.0009536715,0.0026993603,0.000935139,0.00014081996,0.000056003988],"genre_scores_gemma":[0.9989116,0.000118459015,0.00013683144,0.0006810188,0.00000910794,0.00006253354,0.000006431853,0.000010330705,0.000063667256],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985471,0.00021150822,0.00047759892,0.00014250852,0.0002905191,0.0003307998],"domain_scores_gemma":[0.99792296,0.0010686545,0.0005175275,0.00024091284,0.00015040852,0.000099531375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069435424,0.0000879473,0.00020724088,0.0006594977,0.0011489044,0.00002586895,0.00043329492,0.000043888223,0.00012315011],"category_scores_gemma":[0.0027203867,0.0000645866,0.000104876584,0.00049547764,0.0002262768,0.00008917479,0.000019959018,0.00019240046,0.0000012634838],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046893256,0.00032484558,0.009187626,0.00027978834,0.00007775931,0.00022961582,0.0041481876,0.26095757,0.009015586,0.02687094,0.009087569,0.67935157],"study_design_scores_gemma":[0.007699118,0.025776355,0.02601347,0.000063957596,0.000077139746,0.00091266487,0.020239413,0.02272838,0.034733087,0.044627152,0.8165932,0.0005360359],"about_ca_topic_score_codex":0.0043310286,"about_ca_topic_score_gemma":0.0015193374,"teacher_disagreement_score":0.80750567,"about_ca_system_score_codex":0.0013810219,"about_ca_system_score_gemma":0.0035117208,"threshold_uncertainty_score":0.883656},"labels":[],"label_agreement":null},{"id":"W4297168865","doi":"10.51731/cjht.2022.454","title":"Elexacaftor-Tezacaftor-Ivacaftor and Ivacaftor (Trikafta)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ivacaftor; Reimbursement; Medicine; Cystic fibrosis; Internal medicine; Health care; Cystic fibrosis transmembrane conductance regulator","score_opus":0.023544233250175982,"score_gpt":0.3075235823898118,"score_spread":0.28397934913963585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297168865","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86388385,0.12425999,0.00008047009,0.010824306,0.0000566344,0.00047499724,0.0000794174,0.0001200676,0.0002202419],"genre_scores_gemma":[0.99522513,0.000883856,0.0027847774,0.00070732436,0.000040966544,0.00003336291,0.000006246888,0.000034649845,0.0002836684],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99731827,0.00013973984,0.0007661599,0.0002737957,0.0006142998,0.0008877091],"domain_scores_gemma":[0.9983522,0.00016803975,0.00045157122,0.00039375023,0.000220174,0.00041421782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001237447,0.00020769537,0.0006713506,0.0012916125,0.0007399937,0.000047455844,0.00048684972,0.00010768211,0.00025995064],"category_scores_gemma":[0.0016903859,0.00018829378,0.00011166024,0.0006518283,0.0004601152,0.00017130846,0.00015437944,0.0013420273,0.0000073671104],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004969725,0.00013210531,0.076172404,0.00072735484,0.00022527635,0.0020953633,0.00007394796,0.00003234256,0.0027671228,0.003231894,0.05770408,0.8563411],"study_design_scores_gemma":[0.0012858529,0.0028447043,0.04365645,0.00017298774,0.00002464405,0.0030745943,0.005129851,0.000020889745,0.00058737793,0.0016746994,0.9413241,0.00020381644],"about_ca_topic_score_codex":0.0015832111,"about_ca_topic_score_gemma":0.000033391414,"teacher_disagreement_score":0.88362,"about_ca_system_score_codex":0.0013376425,"about_ca_system_score_gemma":0.0049587362,"threshold_uncertainty_score":0.8796585},"labels":[],"label_agreement":null},{"id":"W4298003152","doi":"10.51731/cjht.2022.456","title":"Delayed Tuberculin Skin Testing","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Tuberculosis Research and Epidemiology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Tuberculin; Guideline; Tuberculosis; Skin test; Disease; Intensive care medicine; Internal medicine; Pathology","score_opus":0.06370473140508465,"score_gpt":0.3398150714843604,"score_spread":0.27611034007927576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4298003152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6812125,0.062089738,0.00013647207,0.25476724,0.00038764437,0.00035604334,0.000037729827,0.00013834838,0.0008743251],"genre_scores_gemma":[0.99441504,0.00018581365,0.002198005,0.003092226,0.000020378244,0.000013554395,0.000004857964,0.000014286133,0.000055863107],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99809027,0.00020510945,0.0006350784,0.0001373027,0.0002200401,0.0007121859],"domain_scores_gemma":[0.99885076,0.00022128734,0.00028357992,0.000236106,0.00018067886,0.00022757369],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00207953,0.00010071613,0.00046088954,0.0008716895,0.0005373823,0.000010054219,0.00032046385,0.00008177812,0.00014103543],"category_scores_gemma":[0.004625327,0.000086288914,0.00009220881,0.0006570942,0.00017408132,0.000047901074,0.000059606304,0.0012562408,0.000009374993],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000077863115,0.00004143055,0.051514123,0.000080948965,0.00011927611,0.0013553147,0.0003122897,0.0002773126,0.00019380044,0.0005887572,0.072684325,0.8727546],"study_design_scores_gemma":[0.0012342299,0.005070732,0.058550525,0.00012464408,0.000029415143,0.012100968,0.008479114,0.00042113513,0.00019992751,0.0037449626,0.9098395,0.00020480514],"about_ca_topic_score_codex":0.015865382,"about_ca_topic_score_gemma":0.0019644003,"teacher_disagreement_score":0.8725498,"about_ca_system_score_codex":0.0009094108,"about_ca_system_score_gemma":0.0049691,"threshold_uncertainty_score":0.9906881},"labels":[],"label_agreement":null},{"id":"W4298144359","doi":"10.51731/cjht.2022.458","title":"Selpercatinib (Retevmo)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Science, Research, and Medicine","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lenvatinib; Reimbursement; Medicine; Sorafenib; Drug; Thyroid cancer; Thyroid carcinoma; Oncology; Intensive care medicine; Internal medicine; Family medicine; Thyroid; Pharmacology; Political science; Health care","score_opus":0.058540830483123155,"score_gpt":0.34950562165247157,"score_spread":0.2909647911693484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4298144359","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6233477,0.09313192,0.00009442285,0.27871203,0.0011444391,0.00050800294,0.000022724731,0.00014120479,0.0028975368],"genre_scores_gemma":[0.996043,0.0004261879,0.00044289563,0.002637085,0.000022554126,0.00000940703,0.000002076373,0.000009266285,0.0004075191],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99839836,0.000061707666,0.00041274654,0.00012182159,0.00046094964,0.0005444314],"domain_scores_gemma":[0.9990747,0.000047742844,0.000202147,0.0002552504,0.00017099512,0.00024918924],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018307182,0.000079369245,0.000324766,0.0010298053,0.0005142305,0.000010229312,0.0003986411,0.000047699785,0.00034061653],"category_scores_gemma":[0.0010261708,0.00006219121,0.00006328871,0.0007690193,0.00033581295,0.000053402517,0.000040058087,0.0008838976,0.000006356307],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041140986,0.0000379812,0.02468748,0.00011403355,0.0000321027,0.00108828,0.0016898453,0.000011235152,0.0003031824,0.0011851644,0.06127241,0.90953714],"study_design_scores_gemma":[0.0010586366,0.0026409992,0.02465926,0.00013016345,0.000013667873,0.0041086418,0.03901079,0.000026513102,0.00035809202,0.0011813287,0.9267134,0.00009850521],"about_ca_topic_score_codex":0.0033950224,"about_ca_topic_score_gemma":0.00071769435,"teacher_disagreement_score":0.90943867,"about_ca_system_score_codex":0.0006965771,"about_ca_system_score_gemma":0.008471617,"threshold_uncertainty_score":0.9971494},"labels":[],"label_agreement":null},{"id":"W4298144373","doi":"10.51731/cjht.2022.457","title":"Cannabis for Opioid Use Disorder","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cannabis; Opioid use disorder; Psychiatry; Craving; Medicine; Opioid; Opioid-Related Disorders; Guideline; Addiction; Opioid epidemic","score_opus":0.034688417354724825,"score_gpt":0.3194146966780997,"score_spread":0.28472627932337485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4298144373","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.30835706,0.062614106,0.00048643828,0.625972,0.0008199194,0.00127945,0.0002847309,0.00010050138,0.0000858327],"genre_scores_gemma":[0.991244,0.00027071938,0.00058844325,0.0020757744,0.000026205462,0.00015709104,0.000014168238,0.00003461749,0.0055889385],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984406,0.000046558253,0.00046187037,0.00014403401,0.00028245393,0.00062444917],"domain_scores_gemma":[0.99897844,0.000014693532,0.00023182838,0.0002702176,0.00031381001,0.0001909975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081046735,0.000107938555,0.00037048012,0.0008629731,0.0006756063,0.000038519007,0.0003000923,0.000067968074,0.00014324844],"category_scores_gemma":[0.00086591986,0.000094456205,0.00015142316,0.00045822954,0.00017912919,0.00008262517,0.000048167392,0.00066406664,0.0000010600261],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008405511,0.00004091023,0.00936259,0.00016878385,0.000041532625,0.00014415194,0.00030088954,0.00004065798,0.000037402202,0.0011457148,0.6210984,0.3675349],"study_design_scores_gemma":[0.0007477503,0.0015545762,0.009337996,0.000032981698,0.000011485382,0.00058837194,0.0049400353,0.000023055647,0.00007490758,0.0008325827,0.9817715,0.00008473516],"about_ca_topic_score_codex":0.0145227695,"about_ca_topic_score_gemma":0.0060296655,"teacher_disagreement_score":0.68288696,"about_ca_system_score_codex":0.0009796306,"about_ca_system_score_gemma":0.008834649,"threshold_uncertainty_score":0.9967843},"labels":[],"label_agreement":null},{"id":"W4301396928","doi":"10.51731/cjht.2022.462","title":"Internet-Delivered Cognitive Behavioural Therapy for the Management of Chronic Non-Cancer Pain","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Digital Mental Health Interventions","field":"Psychology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Multidisciplinary approach; Chronic pain; Cognition; Psychotherapist; Medicine; Cancer pain; Health care; The Internet; Psychology; Alternative medicine; Psychiatry","score_opus":0.0831387336667072,"score_gpt":0.38138037753319115,"score_spread":0.29824164386648394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4301396928","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4540793,0.4443575,0.0064910105,0.079631336,0.007653924,0.005182238,0.001643363,0.00012151081,0.0008397962],"genre_scores_gemma":[0.99803346,0.00026372628,0.00008119404,0.00056173577,0.000009605492,0.00054073456,0.000006507218,0.000018787847,0.00048426437],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99846184,0.00012327198,0.0006750399,0.0001381396,0.00014129955,0.00046037827],"domain_scores_gemma":[0.9988111,0.0001530267,0.0006769978,0.00019105116,0.000110512934,0.000057281897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012496791,0.00011350793,0.00024957777,0.0003137469,0.00031358254,0.000016152466,0.00063605123,0.000047851743,0.0004030072],"category_scores_gemma":[0.000022130218,0.000090240756,0.00016145679,0.00025722428,0.00021904176,0.000056435987,0.000057049994,0.000372719,0.0000031618122],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012501806,0.000106083164,0.0012744862,0.00010257916,0.00025578935,0.000028506036,0.00051289727,0.000007412237,7.048703e-7,0.0027834978,0.007961056,0.986842],"study_design_scores_gemma":[0.014823829,0.060845174,0.1720916,0.004716317,0.00031922013,0.00045786912,0.23238225,0.00034906517,0.0011571947,0.016720293,0.49511224,0.0010249355],"about_ca_topic_score_codex":0.0076794247,"about_ca_topic_score_gemma":0.0035625165,"teacher_disagreement_score":0.985817,"about_ca_system_score_codex":0.00083264196,"about_ca_system_score_gemma":0.0006308426,"threshold_uncertainty_score":0.99892855},"labels":[],"label_agreement":null},{"id":"W4301397008","doi":"10.51731/cjht.2022.461","title":"Lisocabtagene Maraleucel (Breyanzi)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Lymphoma; Follicular lymphoma; Medicine; Drug; Chimeric antigen receptor; Diffuse large B-cell lymphoma; Oncology; Internal medicine; Cancer research; Cancer; Immunotherapy; Pharmacology; Political science","score_opus":0.05164566627031014,"score_gpt":0.3287784616090058,"score_spread":0.27713279533869567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4301397008","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.59899104,0.13985647,0.00011487785,0.25469986,0.0011241611,0.00086065056,0.000069823924,0.0002401833,0.004042976],"genre_scores_gemma":[0.9939781,0.000697534,0.00045979908,0.0016967141,0.000027735856,0.000016844891,0.0000044932594,0.000027649934,0.0030911341],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99820554,0.00011293557,0.00050793594,0.00014117584,0.0004060827,0.000626325],"domain_scores_gemma":[0.9989812,0.000051960735,0.00026061662,0.00036062178,0.00014853013,0.00019710051],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012985385,0.00011284232,0.00041914324,0.0011431605,0.00048616537,0.000022031483,0.00044809605,0.00007867423,0.003057219],"category_scores_gemma":[0.00032176435,0.00010428134,0.00012844552,0.0006575149,0.00020577808,0.000054182106,0.000068489724,0.0012296649,0.000010844422],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011891676,0.000050503666,0.013745516,0.00011149119,0.000093370756,0.0014889943,0.0003767608,0.000035098732,0.0019476421,0.00056213845,0.05492865,0.9265409],"study_design_scores_gemma":[0.00086128473,0.0016520713,0.007843613,0.000051842562,0.000010752781,0.0026519063,0.004809611,0.000014552259,0.0008778138,0.0011348762,0.9799902,0.000101480895],"about_ca_topic_score_codex":0.003894157,"about_ca_topic_score_gemma":0.0012316558,"teacher_disagreement_score":0.92643946,"about_ca_system_score_codex":0.0014909133,"about_ca_system_score_gemma":0.005987073,"threshold_uncertainty_score":0.99964803},"labels":[],"label_agreement":null},{"id":"W4304811002","doi":"10.51731/cjht.2022.464","title":"Lenvatinib and Pembrolizumab (Lenvima and Keytruda)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"European Organisation for Research and Treatment of Cancer; Eisai Canada; Eisai; Memorial Sloan-Kettering Cancer Center","keywords":"Pembrolizumab; Lenvatinib; Reimbursement; Medicine; Internal medicine; Systemic therapy; Oncology; Intensive care medicine; Immunotherapy; Cancer; Political science","score_opus":0.024963822927379118,"score_gpt":0.2793609517246027,"score_spread":0.25439712879722354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4304811002","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7775239,0.1685153,0.0000033435736,0.053218845,0.00011713516,0.00015320536,0.000018201243,0.000027499382,0.00042261966],"genre_scores_gemma":[0.99697286,0.0022272721,0.00018863664,0.00049652887,0.0000062616064,0.000011595691,8.6136794e-7,0.000007238879,0.00008872558],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999291,0.000023605595,0.00023816826,0.00009999606,0.000110877634,0.00023634905],"domain_scores_gemma":[0.99960697,0.000029269779,0.00015178353,0.000087798086,0.000044443284,0.0000797212],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021404352,0.00008236226,0.0003053754,0.0003097869,0.00050869695,0.000011766164,0.000060871313,0.000030127469,0.000034170716],"category_scores_gemma":[0.00012022825,0.00006649876,0.000027099019,0.00014290659,0.00018840043,0.000034573342,0.000046787005,0.00030098658,2.3004577e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001164866,0.00002060645,0.085866444,0.00010046806,0.0001002354,0.00038699005,0.0010159656,0.0000012003344,0.000013375137,0.00081795343,0.004191221,0.9073691],"study_design_scores_gemma":[0.0030553462,0.006207138,0.39681447,0.00012910378,0.00006575482,0.005473524,0.02483489,0.000011674759,0.00006452358,0.0029969285,0.56017435,0.00017231579],"about_ca_topic_score_codex":0.0022316142,"about_ca_topic_score_gemma":0.0017814229,"teacher_disagreement_score":0.90719676,"about_ca_system_score_codex":0.00033794454,"about_ca_system_score_gemma":0.0009879665,"threshold_uncertainty_score":0.39125368},"labels":[],"label_agreement":null},{"id":"W4304889388","doi":"10.51731/cjht.2022.466","title":"Cariprazine (Vraylar)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Family medicine; Political science; Health care; Law","score_opus":0.08329596807437746,"score_gpt":0.3756888814833445,"score_spread":0.29239291340896706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4304889388","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.115538225,0.3184959,0.000059680886,0.5612136,0.00096922414,0.00028398828,0.000033873643,0.00009885714,0.0033066384],"genre_scores_gemma":[0.99457365,0.0011932292,0.0003033256,0.0037922107,0.000014366354,0.0000057636908,0.000001213902,0.0000075943767,0.000108671185],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998991,0.00006208701,0.0003430835,0.00007758972,0.00018250124,0.000343718],"domain_scores_gemma":[0.99933255,0.0000651827,0.00026607455,0.00013140234,0.00008327248,0.00012152541],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008343142,0.00007072562,0.00028524097,0.00028984717,0.0005689382,0.000011094829,0.00018602746,0.00003362116,0.00028622645],"category_scores_gemma":[0.0006057467,0.000057935602,0.00006280021,0.0003303609,0.00011193062,0.000059410515,0.000047901944,0.00084256683,0.00000512998],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007948547,0.000044913108,0.012691868,0.000091192276,0.00012329093,0.0011967284,0.00032374053,0.00001685476,0.000068586356,0.0012804376,0.05889644,0.92518646],"study_design_scores_gemma":[0.0004200834,0.0007537764,0.003968857,0.000020935639,0.000024196279,0.001390415,0.00442169,0.000008198178,0.00006715296,0.0007603026,0.9881137,0.000050720526],"about_ca_topic_score_codex":0.002635045,"about_ca_topic_score_gemma":0.0007043424,"teacher_disagreement_score":0.9292172,"about_ca_system_score_codex":0.00047796543,"about_ca_system_score_gemma":0.0018515006,"threshold_uncertainty_score":0.43758705},"labels":[],"label_agreement":null},{"id":"W4306165741","doi":"10.51731/cjht.2022.467","title":"Selinexor (Xpovio)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Dexamethasone; Multiple myeloma; Drug; Drug class; Family medicine; Intensive care medicine; Pharmacology; Health care; Political science; Internal medicine","score_opus":0.039031156922889484,"score_gpt":0.33490013292492893,"score_spread":0.29586897600203943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306165741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.44382617,0.19572236,0.000047219477,0.35653007,0.0018796464,0.0004918771,0.00006870524,0.00016449452,0.0012694777],"genre_scores_gemma":[0.9961692,0.00036461753,0.00028922522,0.0026805187,0.000021858566,0.000013710616,0.0000042795255,0.000009494338,0.00044708158],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99914694,0.000043009863,0.0003192107,0.000077948134,0.0001147977,0.00029808172],"domain_scores_gemma":[0.99947405,0.000025636227,0.0002153633,0.00012297342,0.000068834546,0.000093167764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036585747,0.000071271985,0.00027136935,0.00052226643,0.00030249465,0.0000054808957,0.0001591943,0.000039950533,0.0005602605],"category_scores_gemma":[0.00007264603,0.00006183172,0.00006916968,0.0002904309,0.00008563565,0.000028339327,0.000020474634,0.00049446267,0.0000050388026],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013139025,0.00011318327,0.02605373,0.00008305234,0.00015029503,0.0015788941,0.0005807216,0.000045947814,0.00019921715,0.0007704274,0.22037916,0.749914],"study_design_scores_gemma":[0.001032612,0.0017710758,0.004176842,0.000021281649,0.00003169122,0.0020531134,0.0023474037,0.0000061949904,0.00021492032,0.0007055588,0.9875836,0.000055757042],"about_ca_topic_score_codex":0.0028847794,"about_ca_topic_score_gemma":0.0012401651,"teacher_disagreement_score":0.7672044,"about_ca_system_score_codex":0.0008715238,"about_ca_system_score_gemma":0.004569148,"threshold_uncertainty_score":0.8105473},"labels":[],"label_agreement":null},{"id":"W4306861656","doi":"10.51731/cjht.2022.476","title":"The Vital Role of Medical Librarians in a Time of Information Overload","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Health Sciences Research and Education","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Information overload; Nature versus nurture; Health information; Field (mathematics); Medical information; Value (mathematics); Medical library; Knowledge management; Public relations; Library science; Political science; Computer science; Health care; World Wide Web; Sociology","score_opus":0.03755430122874671,"score_gpt":0.3850373701056179,"score_spread":0.3474830688768712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306861656","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8002098,0.012830304,0.000039722196,0.18445307,0.0008415482,0.0006944567,0.00007415504,0.000024336932,0.00083256245],"genre_scores_gemma":[0.9988659,0.00046729075,0.00006543285,0.00052385614,0.00001089159,0.000027759752,0.0000031810796,0.0000030865801,0.000032612712],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99700624,0.00046072283,0.001155936,0.000050529245,0.0007673443,0.0005592032],"domain_scores_gemma":[0.99818563,0.00052134035,0.0008106074,0.00017055163,0.0001459701,0.00016590186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006989847,0.00005025746,0.00022115571,0.00076368527,0.0008593689,0.000009354522,0.0009799997,0.00011127361,0.0002737368],"category_scores_gemma":[0.0033526064,0.000036068966,0.00003198191,0.00085888663,0.00025250413,0.000291459,0.000101718295,0.0011707902,0.000008493778],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000107285035,0.00006659356,0.13116881,0.00050744804,0.000017178732,0.000011045222,0.032290574,0.000057189318,0.000030109164,0.011932809,0.078023784,0.74578714],"study_design_scores_gemma":[0.00071204547,0.00096153375,0.085558526,0.00042859954,0.0000017418192,0.000032998953,0.2785093,0.00043160946,0.000044557746,0.010863541,0.6223688,0.00008671749],"about_ca_topic_score_codex":0.025013559,"about_ca_topic_score_gemma":0.0073011466,"teacher_disagreement_score":0.7457005,"about_ca_system_score_codex":0.00055038003,"about_ca_system_score_gemma":0.030602643,"threshold_uncertainty_score":0.981479},"labels":[],"label_agreement":null},{"id":"W4307130134","doi":"10.51731/cjht.2022.478","title":"Ruxolitinib (Jakavi)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Ruxolitinib; Medicine; Family medicine; Drug; Pharmacology; Internal medicine; Political science; Health care; Myelofibrosis","score_opus":0.04092840541870764,"score_gpt":0.3241599007891345,"score_spread":0.28323149537042686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307130134","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.71043634,0.13973027,0.00008739248,0.14376242,0.001043467,0.00074548286,0.00006325112,0.00024170267,0.0038896909],"genre_scores_gemma":[0.99775726,0.00023304157,0.0003783924,0.0011759006,0.000018857465,0.00001321289,0.0000035146752,0.000017999982,0.0004018205],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982113,0.000080035235,0.0005162977,0.00012525561,0.00040769376,0.0006593886],"domain_scores_gemma":[0.9990011,0.00006884527,0.00025661485,0.00033176463,0.0001459853,0.00019568531],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011578188,0.00009396411,0.0003686019,0.00067480974,0.0004459771,0.000016582508,0.00041410004,0.00006742492,0.00039949003],"category_scores_gemma":[0.0007601783,0.00008399049,0.00009496721,0.00053113594,0.000231564,0.000048907037,0.00007591292,0.0009516916,0.000013600473],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0001643261,0.00008999217,0.003829691,0.00044133153,0.00015503385,0.007780482,0.0013518215,0.00012860326,0.00008668637,0.008292952,0.12713735,0.8505417],"study_design_scores_gemma":[0.0042530047,0.0014460568,0.0011745491,0.00010664674,0.000013741452,0.012389868,0.010789312,0.00010875169,0.0002467051,0.0026992336,0.9666614,0.00011071881],"about_ca_topic_score_codex":0.009471004,"about_ca_topic_score_gemma":0.0007792936,"teacher_disagreement_score":0.850431,"about_ca_system_score_codex":0.023272179,"about_ca_system_score_gemma":0.078700304,"threshold_uncertainty_score":0.997125},"labels":[],"label_agreement":null},{"id":"W4307544781","doi":"10.51731/cjht.2022.480","title":"Upadacitinib (Rinvoq)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Atopic dermatitis; Drug; Intensive care medicine; Pharmacology; Health care; Dermatology; Political science","score_opus":0.027848523310344625,"score_gpt":0.2896456162540784,"score_spread":0.26179709294373377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307544781","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.47608104,0.2538043,0.00008497826,0.26349425,0.0012486486,0.0004147695,0.00007920177,0.00025336444,0.00453948],"genre_scores_gemma":[0.9967845,0.0001350677,0.00020983107,0.0026886475,0.000006854844,0.000007798848,0.0000037730717,0.000008342333,0.00015519977],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990268,0.00006016711,0.00036699278,0.00007989872,0.00014059967,0.0003255884],"domain_scores_gemma":[0.99936867,0.000035681907,0.00022640597,0.0001813868,0.00006913032,0.00011870431],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035444216,0.000071267365,0.0002950184,0.0005571006,0.00042581817,0.000007097445,0.00022196292,0.00005210486,0.00031063237],"category_scores_gemma":[0.00038201283,0.00006394404,0.00008117688,0.00025210527,0.00017987181,0.000041938405,0.000026806954,0.0005379383,0.000006841742],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011190659,0.00009371348,0.16987821,0.000207534,0.00012558806,0.006138325,0.00041654598,0.000027994982,0.000019621524,0.0043179803,0.46688506,0.35177752],"study_design_scores_gemma":[0.00074014696,0.0004721847,0.03590033,0.00006909833,0.000023563382,0.009772308,0.0072455537,0.000005384638,0.00012847435,0.0061444705,0.93940675,0.00009172946],"about_ca_topic_score_codex":0.0006774493,"about_ca_topic_score_gemma":0.0003657825,"teacher_disagreement_score":0.52070343,"about_ca_system_score_codex":0.00026836066,"about_ca_system_score_gemma":0.0039964826,"threshold_uncertainty_score":0.70895886},"labels":[],"label_agreement":null},{"id":"W4307750735","doi":"10.51731/cjht.2022.479","title":"Sodium Phenylbutyrate-Ursodoxicoltaurine (Albrioza)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Phenylbutyrate; Medicine; Amyotrophic lateral sclerosis; Family medicine; Intensive care medicine; Physical therapy; Internal medicine; Political science","score_opus":0.04368086776676324,"score_gpt":0.30455680359388193,"score_spread":0.2608759358271187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307750735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7172018,0.039384782,0.00008967027,0.24100132,0.00066394516,0.00060593715,0.000046746263,0.00017798864,0.00082777557],"genre_scores_gemma":[0.99704134,0.00036949848,0.0005006224,0.0013793915,0.00002726744,0.000020872674,0.0000047410754,0.000025575162,0.00063071435],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99782187,0.00011980898,0.0006149892,0.00017155029,0.0005005555,0.00077120046],"domain_scores_gemma":[0.99882114,0.000039677896,0.00033427993,0.00034088228,0.00020545443,0.0002585375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010989313,0.00013673714,0.00048268502,0.0008930091,0.00064139575,0.000030387191,0.0005086937,0.00008626861,0.0007184399],"category_scores_gemma":[0.00042491578,0.0001167627,0.00011598061,0.0006624928,0.00025484018,0.00009136609,0.00010959644,0.0013112931,0.000016377478],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003805741,0.00021839493,0.04523468,0.00037420975,0.00025391314,0.0038722216,0.0009021274,0.0001603454,0.004347855,0.002643466,0.10178085,0.83983135],"study_design_scores_gemma":[0.0021594528,0.0039058577,0.07654512,0.0001730757,0.00002552199,0.0033796632,0.004705205,0.000062812804,0.0010210375,0.0026526668,0.90511435,0.0002552103],"about_ca_topic_score_codex":0.0047504264,"about_ca_topic_score_gemma":0.0009298538,"teacher_disagreement_score":0.8395762,"about_ca_system_score_codex":0.0016495372,"about_ca_system_score_gemma":0.0058992314,"threshold_uncertainty_score":0.99973637},"labels":[],"label_agreement":null},{"id":"W4308203378","doi":"10.51731/cjht.2022.492","title":"Robotic Surgical Systems for Orthopedics","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Hip and Femur Fractures","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; Alberta Health Services","funders":"","keywords":"Orthopedic surgery; Medicine; Joint replacement; Arthroplasty; Learning curve; Knee replacement; Medical physics; Physical therapy; Surgery; Computer science","score_opus":0.037791713216540714,"score_gpt":0.3081298103642984,"score_spread":0.27033809714775764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308203378","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16641268,0.6096198,0.0039176517,0.21134084,0.00513426,0.002120536,0.00014241267,0.00033355085,0.0009782875],"genre_scores_gemma":[0.9985074,0.000352188,0.00025592375,0.0005312734,0.000041708092,0.000022513927,0.0000062227227,0.00001462943,0.00026817358],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99881256,0.000049753155,0.00046968725,0.000093251525,0.00018476875,0.0003900124],"domain_scores_gemma":[0.9992,0.00008548123,0.00028475275,0.00016714039,0.000120896286,0.00014176845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085065,0.00008490609,0.0004088277,0.0005172691,0.00042131942,0.000015724809,0.00018794053,0.00008039062,0.000039092443],"category_scores_gemma":[0.00035705973,0.00006831483,0.000100316975,0.00024266544,0.000093895855,0.00003195121,0.000016598833,0.0005786781,0.000001355854],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004233012,0.00018075768,0.0618926,0.0016158549,0.00037733157,0.0070996853,0.0016073883,0.007793487,0.000016277687,0.020191139,0.2597523,0.6390499],"study_design_scores_gemma":[0.0007349463,0.0012406582,0.0011561366,0.00007493755,0.000024711067,0.0041605234,0.0052493443,0.00013897037,0.000006096242,0.00037580435,0.98676634,0.00007151169],"about_ca_topic_score_codex":0.0014746651,"about_ca_topic_score_gemma":0.00031331807,"teacher_disagreement_score":0.83209467,"about_ca_system_score_codex":0.00045504348,"about_ca_system_score_gemma":0.0035629633,"threshold_uncertainty_score":0.6320544},"labels":[],"label_agreement":null},{"id":"W4308495322","doi":"10.51731/cjht.2022.489","title":"Rapid Syphilis Testing","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Syphilis Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Syphilis; Point-of-care testing; Medicine; Point of care; Psychological intervention; Health care; Test (biology); Human immunodeficiency virus (HIV); Family medicine; Nursing; Immunology","score_opus":0.08241587287447642,"score_gpt":0.2993597272150131,"score_spread":0.21694385434053665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308495322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.56860024,0.25178158,0.000013202236,0.17666805,0.000718858,0.00050716725,0.00004676867,0.00018829491,0.0014758504],"genre_scores_gemma":[0.99747163,0.00028252366,0.00083886523,0.0013255762,0.000014237349,0.000021660338,0.0000028746576,0.00001311895,0.00002954052],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99884456,0.000047683232,0.00043478757,0.00011048505,0.00019644547,0.00036604475],"domain_scores_gemma":[0.99913937,0.000098608,0.0003082081,0.0002153003,0.00012063362,0.00011789751],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006013619,0.0000948531,0.00034324237,0.00061631924,0.00048534118,0.000013721258,0.00018616048,0.000042092426,0.00018952711],"category_scores_gemma":[0.00084068126,0.00007955183,0.00008063845,0.00048015316,0.000092346374,0.000040544328,0.000031286636,0.00045618898,0.000003909949],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008481805,0.000058810027,0.06873243,0.000038946197,0.000055641558,0.00082266156,0.00019093786,0.00001840185,0.000010610199,0.0003809285,0.011311141,0.918371],"study_design_scores_gemma":[0.0015666714,0.0047937604,0.11147304,0.00027576208,0.00006414699,0.006052941,0.010003571,0.000020555695,0.00037159014,0.002461968,0.86273944,0.00017656107],"about_ca_topic_score_codex":0.0033974694,"about_ca_topic_score_gemma":0.00047349103,"teacher_disagreement_score":0.9181945,"about_ca_system_score_codex":0.0009318217,"about_ca_system_score_gemma":0.0031180123,"threshold_uncertainty_score":0.553122},"labels":[],"label_agreement":null},{"id":"W4308495428","doi":"10.51731/cjht.2022.491","title":"Mogamulizumab (Poteligeo)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Refractory (planetary science); Drug; Vial; Intensive care medicine; Family medicine; Pharmacology; Political science; Health care","score_opus":0.04859463929211724,"score_gpt":0.333019264260428,"score_spread":0.2844246249683108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308495428","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5264457,0.13544194,0.0001603766,0.33147565,0.0011039989,0.0008967125,0.000054514243,0.00026759863,0.0041534994],"genre_scores_gemma":[0.99665725,0.00042266268,0.00039364534,0.0012452625,0.000015222478,0.000011962099,0.0000025037039,0.000021039148,0.0012304328],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983879,0.000088790766,0.00045297,0.00012182534,0.00039053021,0.00055800925],"domain_scores_gemma":[0.99908936,0.00004642,0.00023075537,0.00031714898,0.00014768788,0.00016864885],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010485917,0.000096714844,0.00036667523,0.0010959409,0.00049216335,0.000017978873,0.00039704348,0.00006699117,0.0021510192],"category_scores_gemma":[0.00037812104,0.0000886195,0.000109407374,0.00059852295,0.00017566526,0.000045416873,0.0000572482,0.0011681049,0.000010304776],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010024847,0.00003141774,0.0043399427,0.000059477294,0.00006104539,0.0012563653,0.0005133024,0.00005067908,0.0007248427,0.0005249957,0.025125718,0.96721196],"study_design_scores_gemma":[0.00083835155,0.0016743378,0.0023988988,0.000045987956,0.0000075205257,0.0031091676,0.0073204865,0.000019739602,0.00090082944,0.0014254929,0.98217696,0.00008222942],"about_ca_topic_score_codex":0.006671861,"about_ca_topic_score_gemma":0.001538729,"teacher_disagreement_score":0.9671297,"about_ca_system_score_codex":0.0015946062,"about_ca_system_score_gemma":0.0067485766,"threshold_uncertainty_score":0.9999428},"labels":[],"label_agreement":null},{"id":"W4309408407","doi":"10.51731/cjht.2022.496","title":"Nusinersen (Spinraza)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Neurogenetic and Muscular Disorders Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; SMA*; Medicine; Intrathecal; Spinal muscular atrophy; Food and drug administration; Family medicine; Intensive care medicine; Surgery; Political science; Medical emergency; Pathology; Computer science; Disease; Health care","score_opus":0.036934496013959386,"score_gpt":0.3159404689860767,"score_spread":0.2790059729721173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309408407","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6041612,0.15168543,0.00024945775,0.2406916,0.0005560045,0.00060233416,0.000019510004,0.00010730892,0.0019271274],"genre_scores_gemma":[0.99807984,0.00030833736,0.0003086503,0.0010579533,0.000006696994,0.0000077744135,0.0000017650481,0.000012542498,0.00021646629],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989271,0.000059044545,0.0002860303,0.00009151389,0.0002650588,0.00037122474],"domain_scores_gemma":[0.9994321,0.000013824229,0.00013730387,0.00020547607,0.00009813867,0.000113168615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005011714,0.00006521614,0.00023539735,0.00067103707,0.000341445,0.000009713081,0.0002339222,0.000035666708,0.00018738768],"category_scores_gemma":[0.0002527141,0.000058234196,0.000080725,0.0004161758,0.00014081156,0.000021919477,0.000041518633,0.0005915249,0.0000046437995],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042460677,0.000060035763,0.013568441,0.00012594002,0.000078031015,0.0021253699,0.0002959048,0.000060761366,0.00031682444,0.0012778388,0.046235576,0.93581283],"study_design_scores_gemma":[0.0006846846,0.0012194164,0.0089241825,0.000032624986,0.0000111197,0.0031552499,0.007148869,0.0000133716185,0.00018766787,0.0008477421,0.9777056,0.000069474816],"about_ca_topic_score_codex":0.0013753759,"about_ca_topic_score_gemma":0.00031021502,"teacher_disagreement_score":0.93574333,"about_ca_system_score_codex":0.0003069984,"about_ca_system_score_gemma":0.0049119596,"threshold_uncertainty_score":0.87136054},"labels":[],"label_agreement":null},{"id":"W4309585197","doi":"10.51731/cjht.2022.499","title":"Faricimab (Vabysmo)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Macular degeneration; Family medicine; Drug; Optometry; Ophthalmology; Political science; Pharmacology; Law","score_opus":0.02466755399370983,"score_gpt":0.29017029338089645,"score_spread":0.2655027393871866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309585197","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.28135282,0.65307397,0.000040389627,0.06342543,0.00041198998,0.00029371877,0.000052881143,0.00008585453,0.0012629629],"genre_scores_gemma":[0.9986323,0.00020134113,0.00007012384,0.000925424,8.9532074e-7,0.000007840617,0.0000043333926,0.000009164074,0.00014853785],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991138,0.00003322697,0.00030040278,0.00008067513,0.00017409756,0.00029780163],"domain_scores_gemma":[0.9995118,0.000014438458,0.00021837304,0.00016403174,0.00006358783,0.000027762106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020891684,0.000073809424,0.00025353458,0.00043129284,0.00035166688,0.000009976378,0.00015676246,0.000029922701,0.00016630306],"category_scores_gemma":[0.00013094101,0.000060503353,0.00009355576,0.00027207128,0.000072638955,0.000031846703,0.00002354095,0.00034081252,0.0000057401535],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003815918,0.000050240946,0.007935567,0.000041963816,0.00005582894,0.0014022081,0.00007989327,0.000010971504,0.000004940141,0.00050068775,0.0017527601,0.98812675],"study_design_scores_gemma":[0.0007561958,0.0012435177,0.064739436,0.000053157284,0.000035594272,0.0019803485,0.0033728036,0.0000064494748,0.000025703024,0.001922465,0.9258016,0.00006277685],"about_ca_topic_score_codex":0.0027198086,"about_ca_topic_score_gemma":0.000030812156,"teacher_disagreement_score":0.988064,"about_ca_system_score_codex":0.0006576623,"about_ca_system_score_gemma":0.002684616,"threshold_uncertainty_score":0.47623932},"labels":[],"label_agreement":null},{"id":"W4309585704","doi":"10.51731/cjht.2022.498","title":"Prostate-Specific Membrane Antigen PET-CT Imaging for the Staging of Prostate Cancer in Canada","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Prostate cancer; Staffing; Context (archaeology); Glutamate carboxypeptidase II; PET-CT; Medical physics; Nuclear medicine; Cancer; Positron emission tomography; Nursing; Internal medicine","score_opus":0.03150406660229012,"score_gpt":0.31069015037118786,"score_spread":0.27918608376889775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309585704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.66109586,0.22176948,0.000009634074,0.1146061,0.0005042613,0.0015274578,0.0004373541,0.00001907296,0.00003077677],"genre_scores_gemma":[0.9902647,0.009108581,0.00009992605,0.00025163323,0.000008790872,0.00012814277,0.000007942004,0.000021727865,0.00010854],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99818385,0.000056952893,0.000591055,0.00015832827,0.00033749433,0.00067234074],"domain_scores_gemma":[0.9989819,0.000121459714,0.00037989908,0.00022796287,0.00019390412,0.00009489427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089899753,0.0001279653,0.00041687678,0.0005514584,0.00043310056,0.000016301066,0.00032775066,0.000007407836,0.000059810383],"category_scores_gemma":[0.000092438655,0.000088532266,0.00006263327,0.0005831974,0.00018072872,0.00006840945,0.000042419033,0.00058853644,1.0099941e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00037064456,0.000029690635,0.45645973,0.00051653193,0.00011946945,0.0022739167,0.0011060694,0.0011694934,0.00028963978,0.000095691255,0.0075785266,0.5299906],"study_design_scores_gemma":[0.008726709,0.0012779942,0.12194608,0.0013654004,0.00006616648,0.0018713573,0.15231125,0.0012010452,0.012107478,0.0008497539,0.6977864,0.00049039174],"about_ca_topic_score_codex":0.849597,"about_ca_topic_score_gemma":0.7979102,"teacher_disagreement_score":0.69020784,"about_ca_system_score_codex":0.0040508425,"about_ca_system_score_gemma":0.02902415,"threshold_uncertainty_score":0.9997724},"labels":[],"label_agreement":null},{"id":"W4310214325","doi":"10.51731/cjht.2022.510","title":"Asciminib (Scemblix)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Myeloid leukemia; Drug; Family medicine; Pharmacology; Internal medicine; Political science; Health care","score_opus":0.03483540550133837,"score_gpt":0.2954047634783444,"score_spread":0.260569357977006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310214325","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7343896,0.11315837,0.00006045883,0.14806236,0.0012381269,0.0006009397,0.000055939454,0.00022265133,0.0022115351],"genre_scores_gemma":[0.99748325,0.00020639914,0.0006910439,0.0012038652,0.000012358934,0.000012851252,0.0000049670025,0.00001659163,0.0003686418],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99864304,0.0000529948,0.00046897732,0.000121605655,0.00025692035,0.00045645615],"domain_scores_gemma":[0.99910945,0.000036034427,0.0003376746,0.00029664012,0.00008120321,0.00013900886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055427745,0.00010621224,0.00037277196,0.00079573574,0.00041497295,0.000011275202,0.00028160168,0.000060530718,0.00036956364],"category_scores_gemma":[0.00031859896,0.00009377231,0.00009344611,0.00043833946,0.00012403376,0.000049682065,0.00004248226,0.00070984865,0.0000115883295],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000064695574,0.00007560908,0.015485338,0.000120683246,0.00015479987,0.003920031,0.00064155395,0.00005528476,0.000055733643,0.0011855148,0.0707494,0.9074913],"study_design_scores_gemma":[0.0020728982,0.0020814557,0.008956179,0.00010176888,0.000035731984,0.008341032,0.0069058426,0.000015446578,0.00027123705,0.0013146473,0.96978635,0.00011744279],"about_ca_topic_score_codex":0.0035170317,"about_ca_topic_score_gemma":0.0009668367,"teacher_disagreement_score":0.9073739,"about_ca_system_score_codex":0.004307551,"about_ca_system_score_gemma":0.012762776,"threshold_uncertainty_score":0.99951476},"labels":[],"label_agreement":null},{"id":"W4310215188","doi":"10.51731/cjht.2022.508","title":"Cariprazine (Vraylar)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Bipolar disorder; Mania; Psychiatry; Depression (economics); Bipolar I disorder; Medicine; Psychology; Clinical psychology; Lithium (medication)","score_opus":0.023222157234161444,"score_gpt":0.2766494257988006,"score_spread":0.25342726856463915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310215188","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17210704,0.62488383,0.000119183824,0.19960703,0.00075440714,0.0004440024,0.00006562973,0.00015592056,0.0018629493],"genre_scores_gemma":[0.9985218,0.0003675738,0.00038019332,0.00056995207,0.000005782905,0.000008720926,0.0000049268046,0.000010341303,0.00013073276],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991169,0.00003748854,0.0003064382,0.00008112045,0.00015635183,0.00030172785],"domain_scores_gemma":[0.99945533,0.000013083928,0.00017622951,0.0001930428,0.000063794585,0.000098513505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034663896,0.0000773933,0.00026612537,0.00050102605,0.00036339727,0.000007923687,0.00015488853,0.00004129398,0.0001505676],"category_scores_gemma":[0.0001051834,0.00006535117,0.000074875345,0.00029483947,0.00007810403,0.00003184124,0.000023944182,0.000507104,0.0000050372328],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029124147,0.00008546825,0.117437966,0.00006330652,0.00011887777,0.0005310296,0.0004388834,0.000012995024,0.000030965108,0.0014410701,0.010513388,0.8692969],"study_design_scores_gemma":[0.000972808,0.0016493595,0.05689095,0.000032948727,0.000034343473,0.0029365416,0.004718877,0.000003969701,0.00009726893,0.0016281888,0.9309601,0.00007465185],"about_ca_topic_score_codex":0.0046011936,"about_ca_topic_score_gemma":0.004490813,"teacher_disagreement_score":0.9204467,"about_ca_system_score_codex":0.0006377901,"about_ca_system_score_gemma":0.0031252713,"threshold_uncertainty_score":0.69556594},"labels":[],"label_agreement":null},{"id":"W4310215203","doi":"10.51731/cjht.2022.507","title":"Dostarlimab (Jemperli)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Regimen; Family medicine; Drug; Internal medicine; Pharmacology; Political science; Health care; Law","score_opus":0.03632230262593499,"score_gpt":0.30076741970064014,"score_spread":0.26444511707470514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310215203","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.54840225,0.23095042,0.000057641908,0.21581578,0.0015739619,0.0005871565,0.00009275285,0.00018219322,0.0023378658],"genre_scores_gemma":[0.99754006,0.00029343093,0.00027022968,0.0017178947,0.000013532333,0.000010610996,0.0000038126868,0.000009862599,0.00014058365],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989236,0.000048217298,0.0003736071,0.00009151471,0.00022186506,0.00034118607],"domain_scores_gemma":[0.9993874,0.000034809902,0.00021648942,0.00016029835,0.0000767069,0.00012428786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004331779,0.000080466656,0.00033495185,0.0006670989,0.00035060244,0.000009852386,0.00019375412,0.00004085078,0.00048092983],"category_scores_gemma":[0.00024074235,0.000064138636,0.00009469105,0.00060972536,0.000087487664,0.000038319024,0.000028684868,0.0004891167,0.0000055177215],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014915642,0.000077517136,0.026803726,0.00007745902,0.00010971918,0.00103793,0.0003413544,0.000014289595,0.000034544006,0.0011945486,0.007994287,0.9621655],"study_design_scores_gemma":[0.002845799,0.0040055923,0.016855268,0.000066497334,0.000039297534,0.0017766326,0.0071254885,0.0000021413125,0.0003368227,0.0029677507,0.963867,0.00011169487],"about_ca_topic_score_codex":0.004949715,"about_ca_topic_score_gemma":0.00069333403,"teacher_disagreement_score":0.9620538,"about_ca_system_score_codex":0.0010940372,"about_ca_system_score_gemma":0.0034036937,"threshold_uncertainty_score":0.74825215},"labels":[],"label_agreement":null},{"id":"W4311150483","doi":"10.51731/cjht.2022.512","title":"Canadian Trends in Estimated Pharmaceutical Drug Purchases and Projections: 2023","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Business; Audit; Annual growth %; Specialty; Private sector; Agricultural economics; Medicine; Accounting; Economics; Economic growth; Family medicine","score_opus":0.11798662010314265,"score_gpt":0.34642342254702213,"score_spread":0.22843680244387948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311150483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.44272834,0.1872669,0.000022645634,0.35969174,0.0013327686,0.00039547423,0.0016227202,0.00007511541,0.0068642832],"genre_scores_gemma":[0.9965386,0.0010750428,0.00011364261,0.0020554469,0.000010793107,0.00002211211,0.0000069396438,0.0000140825105,0.00016334136],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983707,0.000034792512,0.0007609639,0.00019164322,0.000024880414,0.00061701384],"domain_scores_gemma":[0.99923795,0.00003882256,0.0003001662,0.00013517114,0.0000184231,0.0002694753],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011312452,0.00011590397,0.00038763965,0.003238026,0.00042144093,0.000056343182,0.00032025058,0.00006143071,0.00052258465],"category_scores_gemma":[0.00018132341,0.00014114103,0.00005293797,0.00077443465,0.00013483754,0.00013375311,0.00004327577,0.0007083123,0.000013340008],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032176653,0.00009071203,0.16217197,0.00008933747,0.000106894826,0.00038554255,0.0015211597,0.0010939859,0.0000029380187,0.17013194,0.060363054,0.6040103],"study_design_scores_gemma":[0.00061382685,0.00012650389,0.012449106,0.0000191378,0.0000030943409,0.00024618147,0.0011862727,0.0022879888,0.000008763598,0.02901044,0.9538424,0.00020626542],"about_ca_topic_score_codex":0.42060557,"about_ca_topic_score_gemma":0.38922948,"teacher_disagreement_score":0.89347935,"about_ca_system_score_codex":0.0016941138,"about_ca_system_score_gemma":0.001364097,"threshold_uncertainty_score":0.6219155},"labels":[],"label_agreement":null},{"id":"W4311150526","doi":"10.51731/cjht.2022.523","title":"Atezolizumab (Tecentriq)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Atezolizumab; Carboplatin; Medicine; Intensive care medicine; Family medicine; Political science; Cancer; Surgery; Internal medicine; Chemotherapy; Health care; Law","score_opus":0.037319562789226685,"score_gpt":0.3405334726099894,"score_spread":0.3032139098207627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311150526","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.18205239,0.38084117,0.00009027114,0.43310532,0.0010370858,0.00075927394,0.000053476415,0.00022688389,0.0018341405],"genre_scores_gemma":[0.9974727,0.0011118392,0.00024920443,0.0008801564,0.000013066772,0.000017343184,0.0000017087175,0.000013128821,0.00024086169],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985017,0.00006349743,0.00040029347,0.00010824283,0.00036146506,0.000564777],"domain_scores_gemma":[0.99919575,0.000035949866,0.0002385458,0.00022993443,0.00016696617,0.00013286546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072822446,0.000088408,0.0003656064,0.00080464187,0.00061164616,0.000013307186,0.0003150338,0.00003740889,0.00020026753],"category_scores_gemma":[0.000663876,0.00007487671,0.00007964046,0.00053035974,0.00021110653,0.00004781265,0.000083151295,0.00085190294,0.0000063048274],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011221694,0.000042429234,0.027022148,0.00022921443,0.00017615574,0.0018993942,0.0007669364,0.000029541252,0.000042391013,0.001392342,0.14394163,0.8243456],"study_design_scores_gemma":[0.00093457976,0.0015063743,0.007832944,0.00008685425,0.000013464803,0.0016962722,0.007264,0.000008369918,0.00016634782,0.001388051,0.97902375,0.000079000376],"about_ca_topic_score_codex":0.0047818082,"about_ca_topic_score_gemma":0.0009712979,"teacher_disagreement_score":0.8350821,"about_ca_system_score_codex":0.0024241062,"about_ca_system_score_gemma":0.007282041,"threshold_uncertainty_score":0.99834573},"labels":[],"label_agreement":null},{"id":"W4311618837","doi":"10.51731/cjht.2022.525","title":"Pembrolizumab (Keytruda)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Pembrolizumab; Medicine; Breast cancer; Stage (stratigraphy); Family medicine; Oncology; Cancer; Internal medicine; Health care; Political science","score_opus":0.029407668507255985,"score_gpt":0.2953782050532903,"score_spread":0.2659705365460343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311618837","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.634436,0.22712323,0.000020627447,0.1335964,0.0008598752,0.00037149803,0.000042618674,0.000117252894,0.003432478],"genre_scores_gemma":[0.998385,0.0004325964,0.00014423627,0.0007828624,0.000009301697,0.000016496744,0.00000152346,0.000008911436,0.00021904487],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990859,0.000028733577,0.00030650216,0.00008737237,0.0001762113,0.00031525933],"domain_scores_gemma":[0.9994803,0.00001919146,0.00020361888,0.00014048084,0.00008251978,0.00007387222],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024618517,0.00008245843,0.000333529,0.00044640803,0.0005595626,0.000008570737,0.00014445228,0.000029550258,0.0001644602],"category_scores_gemma":[0.000127292,0.00006680522,0.00008192559,0.00029028126,0.000108144784,0.00003001462,0.000035742207,0.0003962495,0.000002136851],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017374402,0.00005592021,0.033915225,0.000073192525,0.00017604695,0.0011881894,0.0009994894,0.000017848579,0.000013224894,0.0012914824,0.031280234,0.9308154],"study_design_scores_gemma":[0.001457523,0.004008652,0.0493831,0.000056531742,0.00003589326,0.002647316,0.01380227,0.0000044166345,0.00006868742,0.0017157645,0.9267205,0.000099347446],"about_ca_topic_score_codex":0.003338941,"about_ca_topic_score_gemma":0.0021870488,"teacher_disagreement_score":0.93071604,"about_ca_system_score_codex":0.001186943,"about_ca_system_score_gemma":0.0031526035,"threshold_uncertainty_score":0.55925834},"labels":[],"label_agreement":null},{"id":"W4311705407","doi":"10.51731/cjht.2022.516","title":"Subtypes of Post–COVID-19 Condition: A Review of the Emerging Evidence","year":2022,"lang":"en","type":"review","venue":"Canadian Journal of Health Technologies","topic":"Fibromyalgia and Chronic Fatigue Syndrome Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Disease; Medicine; Coronavirus disease 2019 (COVID-19); Chronic condition; Intensive care medicine; Multiple sclerosis; Chronic fatigue syndrome; Pathology; Immunology; Psychiatry; Infectious disease (medical specialty)","score_opus":0.15117052414923002,"score_gpt":0.436791541482021,"score_spread":0.285621017332791,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311705407","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000014346442,0.96524906,0.000003901803,0.033384092,0.00022542346,0.0009776484,0.00008610986,0.000018670875,0.000040764906],"genre_scores_gemma":[0.0004315353,0.99914855,0.00006910635,0.0002069258,0.000005922853,0.000028059507,0.000014256191,0.000025005258,0.00007064564],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99646086,0.00047982522,0.0017499619,0.00019718126,0.0006495768,0.00046260405],"domain_scores_gemma":[0.9958178,0.00052381586,0.0023611991,0.0007662789,0.00032369778,0.00020723486],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0025830027,0.00023385399,0.0023384714,0.0009764258,0.00023663827,0.000006619927,0.0010773011,0.00021335573,0.0011697375],"category_scores_gemma":[0.0101535125,0.00014787812,0.00070509256,0.0014195333,0.0006107972,0.00006504862,0.00011420487,0.001519698,0.000002962733],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000028224358,0.000007878646,0.000025858271,0.5573922,0.000104698935,0.0001005768,0.00004196163,1.7760871e-7,2.3846366e-7,0.0001506858,0.0071089803,0.43506396],"study_design_scores_gemma":[0.0000872508,0.0004569514,0.000019961624,0.34043482,0.00020358023,0.0020455266,0.0003694439,8.735845e-8,0.0000016867538,0.00007446432,0.6562382,0.00006800752],"about_ca_topic_score_codex":0.002621898,"about_ca_topic_score_gemma":0.00014619328,"teacher_disagreement_score":0.6491292,"about_ca_system_score_codex":0.0019151946,"about_ca_system_score_gemma":0.06536478,"threshold_uncertainty_score":0.99974334},"labels":[],"label_agreement":null},{"id":"W4311719624","doi":"10.51731/cjht.2022.520","title":"Pembrolizumab in Combination With Lenvatinib (Keytruda and Lenvima)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lenvatinib; Pembrolizumab; Medicine; Reimbursement; Internal medicine; Oncology; Sorafenib; Cancer; Immunotherapy; Hepatocellular carcinoma","score_opus":0.02804367635266003,"score_gpt":0.2806465541397167,"score_spread":0.25260287778705665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311719624","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92471355,0.028141845,0.000017524446,0.046351906,0.000103329294,0.0002694935,0.00001163736,0.000026447231,0.00036429084],"genre_scores_gemma":[0.99891716,0.00028223364,0.00023734133,0.0004941831,0.0000037247655,0.000014152609,0.0000030526412,0.0000074554428,0.00004070904],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.999193,0.00004158224,0.00027999104,0.0000904311,0.00016592721,0.00022904719],"domain_scores_gemma":[0.99956805,0.00003893777,0.00018400456,0.00009139306,0.00004684644,0.00007077584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030044795,0.00007109029,0.00027985385,0.0007320182,0.00016349688,0.000008423916,0.00008558458,0.00003439468,0.000053044812],"category_scores_gemma":[0.00013675797,0.000054313467,0.00002094397,0.0005394677,0.000091412745,0.00005219674,0.000017131799,0.00038540392,4.5872235e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004686522,0.00010476848,0.2126067,0.00012985128,0.000048302445,0.0006645125,0.00038891993,0.000017857736,0.000012117302,0.002133951,0.00048419498,0.78294015],"study_design_scores_gemma":[0.031979736,0.023320626,0.7415349,0.0005593758,0.00007296219,0.004771528,0.018118912,0.00003170568,0.00035935186,0.01148299,0.16742174,0.00034619131],"about_ca_topic_score_codex":0.0049910084,"about_ca_topic_score_gemma":0.003389258,"teacher_disagreement_score":0.78259397,"about_ca_system_score_codex":0.0006985928,"about_ca_system_score_gemma":0.00138727,"threshold_uncertainty_score":0.7544945},"labels":[],"label_agreement":null},{"id":"W4311969069","doi":"10.51731/cjht.2022.522","title":"Tepotinib (Tepmetko)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Family medicine; Health care; Political science","score_opus":0.02609199232944256,"score_gpt":0.33716446812680095,"score_spread":0.3110724757973584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311969069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.39249486,0.21269496,0.00041141993,0.38378313,0.0021435677,0.0010091863,0.00012156036,0.0002922085,0.007049102],"genre_scores_gemma":[0.99747175,0.00010339342,0.00092122436,0.001186296,0.000008376759,0.000014412208,0.000004760208,0.000009297523,0.00028048936],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99920976,0.0000270342,0.00030270463,0.00007191387,0.00013696098,0.000251626],"domain_scores_gemma":[0.9994565,0.000018299119,0.00021967245,0.00014596747,0.00007613504,0.00008342292],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027071655,0.00006161003,0.00021676609,0.00049487123,0.00041573585,0.000009283467,0.00012937313,0.00002825617,0.00018567404],"category_scores_gemma":[0.00013156552,0.00005101306,0.000060522863,0.00030376925,0.00006800333,0.000035576315,0.000015450238,0.00034018586,0.0000036449806],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019046733,0.00005394994,0.021675626,0.000052682004,0.00014665817,0.00069866277,0.00091032934,0.00004029312,0.000018885463,0.0017349032,0.034727734,0.93992126],"study_design_scores_gemma":[0.0009180619,0.0012423933,0.014527687,0.000052937976,0.00005049239,0.0018748834,0.012411166,0.0000039997467,0.000085856635,0.0021771656,0.9665883,0.00006704052],"about_ca_topic_score_codex":0.003067644,"about_ca_topic_score_gemma":0.00057590345,"teacher_disagreement_score":0.9398542,"about_ca_system_score_codex":0.00092654413,"about_ca_system_score_gemma":0.0053087426,"threshold_uncertainty_score":0.94174814},"labels":[],"label_agreement":null},{"id":"W4312063023","doi":"10.51731/cjht.2022.524","title":"Semaglutide (Wegovy)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Reimbursement; Overweight; Semaglutide; Dyslipidemia; Obesity; Type 2 diabetes; Weight loss; Body mass index; Comorbidity; Obstructive sleep apnea; Diabetes mellitus; Physical therapy; Internal medicine; Health care; Endocrinology","score_opus":0.02399447771287723,"score_gpt":0.2672215931424719,"score_spread":0.2432271154295947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312063023","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5807449,0.12862779,0.00008980386,0.28260225,0.0012502183,0.00081303064,0.0000326821,0.00029302266,0.005546273],"genre_scores_gemma":[0.9968409,0.00012705888,0.0006244717,0.0015989712,0.0000070421747,0.000012619512,0.0000032203127,0.000010296469,0.0007754132],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99906313,0.00002943272,0.00031041368,0.00008255264,0.00016695386,0.00034749735],"domain_scores_gemma":[0.9994453,0.000020445987,0.00021398428,0.00018654756,0.000047712572,0.00008601079],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043917238,0.0000774834,0.00026904233,0.00066293345,0.00029583782,0.000010796398,0.00018238368,0.000026302687,0.00016858385],"category_scores_gemma":[0.0001404239,0.00006673869,0.000073677154,0.00030363156,0.000072424424,0.0000297501,0.000039389837,0.00031281993,0.000007398943],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018048704,0.000056738416,0.02636235,0.00009006017,0.00014513699,0.0009466245,0.0002040897,0.00003136832,0.000015903472,0.0034095794,0.07848604,0.89023405],"study_design_scores_gemma":[0.00063655816,0.0012329434,0.011317352,0.000049822927,0.00003612005,0.00026746874,0.0041734194,0.000005207124,0.000095656156,0.0015876308,0.98053265,0.00006520056],"about_ca_topic_score_codex":0.0011102732,"about_ca_topic_score_gemma":0.0005089653,"teacher_disagreement_score":0.90204656,"about_ca_system_score_codex":0.0007525973,"about_ca_system_score_gemma":0.0015499633,"threshold_uncertainty_score":0.27495682},"labels":[],"label_agreement":null},{"id":"W4312116747","doi":"10.51731/cjht.2022.530","title":"Post‒COVID-19 Condition Treatment and Management Rapid Scoping Review","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Long-Term Effects of COVID-19","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Psychological intervention; Coronavirus disease 2019 (COVID-19); Medical diagnosis; Intensive care medicine; MEDLINE; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Psychiatry; Pathology; Disease; Infectious disease (medical specialty)","score_opus":0.03501929585761541,"score_gpt":0.36177684109723995,"score_spread":0.3267575452396245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312116747","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016977035,0.5951089,0.00009504278,0.38481128,0.00024561037,0.0024236976,0.000040001254,0.00012619304,0.00017218909],"genre_scores_gemma":[0.77634144,0.16288093,0.0011097564,0.059259024,0.000022009775,0.0002080787,0.00003651731,0.00003226349,0.00010998554],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984754,0.00015891921,0.000562198,0.00019388756,0.00021177356,0.00039787783],"domain_scores_gemma":[0.99866486,0.00015526323,0.0004506896,0.00030812502,0.00006352818,0.00035756687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001066016,0.00015745522,0.0005619314,0.0008502861,0.00055425765,0.000020867661,0.00019243488,0.000050837567,0.0001833344],"category_scores_gemma":[0.0008631606,0.0001337935,0.00009308044,0.00029464666,0.00015253619,0.00008659148,0.00005331124,0.0002976798,0.0000032338232],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013198772,0.00010547536,0.0057026483,0.060989093,0.00036061692,0.006355163,0.0006649379,0.000038054,0.000043532884,0.0024316101,0.021831566,0.9013453],"study_design_scores_gemma":[0.008204402,0.015693001,0.007634336,0.06285214,0.0006187211,0.012984081,0.008134454,0.000010682287,0.0001855747,0.002999706,0.8800178,0.0006650744],"about_ca_topic_score_codex":0.0021927347,"about_ca_topic_score_gemma":0.0013061713,"teacher_disagreement_score":0.90068024,"about_ca_system_score_codex":0.00289765,"about_ca_system_score_gemma":0.0051910556,"threshold_uncertainty_score":0.920871},"labels":[],"label_agreement":null},{"id":"W4312116758","doi":"10.51731/cjht.2022.528","title":"Selpercatinib (Retevmo)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Medullary thyroid cancer; Family medicine; Disease; Thyroid cancer; Cancer; Intensive care medicine; Internal medicine; Health care; Political science","score_opus":0.3815832281513177,"score_gpt":0.4162456149719361,"score_spread":0.034662386820618396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312116758","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12198157,0.1790774,0.0013080928,0.6906562,0.0027998716,0.00069586455,0.00060085993,0.00016916945,0.0027109878],"genre_scores_gemma":[0.9845753,0.00021416096,0.0017908622,0.013093508,0.000034962148,0.000041500134,0.0000069091975,0.00002498307,0.00021781283],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9947386,0.00031235948,0.004010562,0.00024209887,0.000100113524,0.0005962747],"domain_scores_gemma":[0.9953839,0.00028402262,0.0036892376,0.00041668932,0.00007655713,0.00014959245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019035932,0.00013259484,0.00088511175,0.0012856472,0.00088186894,0.000047182955,0.00077368564,0.00009334631,0.0007928052],"category_scores_gemma":[0.0040444876,0.00017044765,0.00012027447,0.0004309683,0.0001290731,0.00024756812,0.000054666947,0.0006456633,0.00018094784],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014155375,0.000079124526,0.07531627,0.0004637328,0.00015406263,0.00005808691,0.0077193426,0.0009949732,0.0000020339598,0.37220266,0.4945653,0.04843023],"study_design_scores_gemma":[0.00034506616,0.00028713682,0.0060468903,0.00003627702,0.0000018055317,0.00015889137,0.015486483,0.00011343314,0.0000025447139,0.044380378,0.93295586,0.00018524294],"about_ca_topic_score_codex":0.010047458,"about_ca_topic_score_gemma":0.0017124108,"teacher_disagreement_score":0.8625937,"about_ca_system_score_codex":0.0024058588,"about_ca_system_score_gemma":0.003139148,"threshold_uncertainty_score":0.9965447},"labels":[],"label_agreement":null},{"id":"W4313202305","doi":"10.51731/cjht.2022.531","title":"Nivolumab (Opdivo)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Nivolumab; Medicine; Drug; Adjuvant; Oncology; Internal medicine; Cancer; Pharmacology; Immunotherapy; Political science","score_opus":0.030712421897495686,"score_gpt":0.29070101617694755,"score_spread":0.25998859427945187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313202305","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.41696537,0.30435625,0.00019945436,0.26845706,0.0024877053,0.0009871019,0.0001786458,0.00034166235,0.006026773],"genre_scores_gemma":[0.9975039,0.0001796858,0.00030212582,0.0016343893,0.000012434746,0.0000117305335,0.00000250443,0.000012721181,0.00034050763],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990362,0.000037781203,0.0003214699,0.00008994967,0.00018478573,0.0003298064],"domain_scores_gemma":[0.9994307,0.000012598808,0.00019650537,0.00018705524,0.00007016363,0.00010293622],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002964033,0.00008046446,0.00028443174,0.00047261748,0.0003967653,0.000009613187,0.00019308268,0.00004067784,0.0003304747],"category_scores_gemma":[0.00008767348,0.00007047202,0.000078080855,0.00028543477,0.000088527944,0.00004049541,0.000023250377,0.000463977,0.000006448027],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000078003424,0.00006401161,0.025736496,0.0000721192,0.00012167135,0.001065802,0.00054665946,0.000015937314,0.000030722334,0.0008157444,0.048252314,0.92320055],"study_design_scores_gemma":[0.0017630672,0.0030584435,0.014370776,0.00006967522,0.00003862698,0.0031545819,0.006776036,0.000004048174,0.00027091758,0.0028303734,0.9675561,0.00010734232],"about_ca_topic_score_codex":0.0062060338,"about_ca_topic_score_gemma":0.001057111,"teacher_disagreement_score":0.9230932,"about_ca_system_score_codex":0.00094992673,"about_ca_system_score_gemma":0.005222593,"threshold_uncertainty_score":0.93817085},"labels":[],"label_agreement":null},{"id":"W4313202375","doi":"10.51731/cjht.2022.532","title":"Abemaciclib (Verzenio)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Family medicine; Breast cancer; Disease; Internal medicine; Oncology; Drug; Cancer; Pharmacology; Health care; Political science","score_opus":0.025378513830842764,"score_gpt":0.2975466509263467,"score_spread":0.2721681370955039,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313202375","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.33290577,0.3676483,0.0012613344,0.2938876,0.0019418225,0.0007271415,0.000093676084,0.00045151377,0.0010828432],"genre_scores_gemma":[0.9961506,0.00013042885,0.0014790678,0.002020645,0.000015701606,0.000012134211,0.0000019639974,0.000019228546,0.00017019533],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99878174,0.000044609118,0.0004226345,0.00010786157,0.00022101232,0.0004221243],"domain_scores_gemma":[0.99916714,0.000026263067,0.0003479878,0.00024382876,0.00010310537,0.00011167387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046870147,0.00009863815,0.0003551085,0.00063327176,0.00040460523,0.000008941166,0.00027715784,0.000043952852,0.00026399473],"category_scores_gemma":[0.00016685508,0.000089987196,0.000081675214,0.0004234388,0.00017328265,0.000074679636,0.000033445653,0.0007001894,0.0000046398495],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007147799,0.000020579093,0.006119993,0.000059509322,0.00005531777,0.00049839646,0.00041696426,0.00008333021,0.00012523589,0.0012493199,0.0034043784,0.9878955],"study_design_scores_gemma":[0.00091100275,0.00094641314,0.005880783,0.000073219875,0.000012537342,0.004506955,0.007982656,0.000005129905,0.0003678957,0.0052599637,0.973954,0.00009940596],"about_ca_topic_score_codex":0.0011115422,"about_ca_topic_score_gemma":0.00038119362,"teacher_disagreement_score":0.98779607,"about_ca_system_score_codex":0.0011735833,"about_ca_system_score_gemma":0.0039384225,"threshold_uncertainty_score":0.69865924},"labels":[],"label_agreement":null},{"id":"W4313287828","doi":"10.51731/cjht.2022.526","title":"Atezolizumab (Tecentriq)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Lung Health Foundation","keywords":"Reimbursement; Atezolizumab; Medicine; Adjuvant; Oncology; Adjuvant chemotherapy; Lung cancer; Internal medicine; Drug; Cancer; Intensive care medicine; Pharmacology; Immunotherapy; Political science","score_opus":0.03595807640146948,"score_gpt":0.23053323532801037,"score_spread":0.1945751589265409,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313287828","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2533238,0.61115885,0.0022507804,0.10800505,0.00507699,0.00047187533,0.0005874105,0.0001709454,0.018954296],"genre_scores_gemma":[0.99773085,0.0007250518,0.00022890687,0.0010293807,0.000016851776,0.000008206464,0.0000019935674,0.000015984944,0.00024274347],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99840736,0.00001560831,0.00089219894,0.00014884931,0.00003093228,0.00050501985],"domain_scores_gemma":[0.99861914,0.000018370049,0.0010085677,0.0002274045,0.00003782893,0.00008868551],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096895994,0.00010166674,0.0004611016,0.0008064678,0.0005513328,0.000040559982,0.000574114,0.00006518294,0.00061708037],"category_scores_gemma":[0.00028730274,0.00012209949,0.00010570892,0.00030341395,0.00012784265,0.0001849987,0.000048195587,0.00048460808,0.000059727154],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000247008,0.000036563903,0.04682934,0.00004036638,0.00006745212,0.00011687518,0.0008452468,0.00038537927,0.0000011882499,0.43737194,0.054470953,0.45981],"study_design_scores_gemma":[0.00032321137,0.00025755365,0.004830626,0.000009088331,0.0000011155287,0.000108906555,0.0009628775,0.000024908923,0.000009654778,0.08378362,0.9095659,0.00012249287],"about_ca_topic_score_codex":0.008099146,"about_ca_topic_score_gemma":0.0007813866,"teacher_disagreement_score":0.85509497,"about_ca_system_score_codex":0.0013168649,"about_ca_system_score_gemma":0.0012708491,"threshold_uncertainty_score":0.998506},"labels":[],"label_agreement":null},{"id":"W4313649019","doi":"10.51731/cjht.2023.534","title":"Pralsetinib (Gavreto)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Family medicine; Political science; Health care","score_opus":0.0401246982092405,"score_gpt":0.37572661462384405,"score_spread":0.3356019164146036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313649019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.47132552,0.057499133,0.00010396503,0.46435446,0.0012641368,0.00069640874,0.000060292823,0.0006056713,0.0040904153],"genre_scores_gemma":[0.997759,0.00057584635,0.00046756683,0.0005991287,0.0000129786495,0.0000065390004,0.0000071155373,0.00001014478,0.00056169],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99922764,0.000013204175,0.0002910401,0.00006946112,0.00009783232,0.00030080567],"domain_scores_gemma":[0.9994616,0.000025427633,0.00016436883,0.00014124604,0.00011040298,0.00009698545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025516262,0.00006406885,0.00021689908,0.00058447104,0.00015096828,0.0000127715575,0.00009349777,0.000066403554,0.000034591358],"category_scores_gemma":[0.0002997206,0.000048296435,0.000053334064,0.0004930357,0.00008469616,0.000048894704,0.000006267393,0.00019016567,0.000045624045],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011288725,0.000016338321,0.031568285,0.00011467734,0.00013135973,0.0007295468,0.00068144675,0.000011080188,0.000026670183,0.001589168,0.10692095,0.8581992],"study_design_scores_gemma":[0.00097068184,0.00076010654,0.10038863,0.00034845524,0.00005175626,0.000568752,0.00571159,0.000008510044,0.00021028281,0.003443178,0.8874522,0.0000858728],"about_ca_topic_score_codex":0.0015251796,"about_ca_topic_score_gemma":0.0011098371,"teacher_disagreement_score":0.8581133,"about_ca_system_score_codex":0.00032472002,"about_ca_system_score_gemma":0.0037332133,"threshold_uncertainty_score":0.662256},"labels":[],"label_agreement":null},{"id":"W4315853248","doi":"10.51731/cjht.2023.538","title":"Lurbinectedin (Zepzelca)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Quality of life (healthcare); Disease; Lung cancer; Oncology; Intensive care medicine; Clinical trial; Cancer; Overall survival; Internal medicine; Stage (stratigraphy); Surgery","score_opus":0.06750447713632651,"score_gpt":0.38564942484924675,"score_spread":0.31814494771292023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4315853248","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.34305996,0.09505163,0.000057875353,0.5573166,0.0010158581,0.00061514374,0.000030426945,0.00080142816,0.0020511092],"genre_scores_gemma":[0.996274,0.0024776803,0.00024246928,0.00045524476,0.000030734594,0.000008494837,0.0000023097766,0.000016156659,0.00049290614],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998564,0.00002908773,0.00039251865,0.00010980821,0.0002665523,0.0006380291],"domain_scores_gemma":[0.99911046,0.000068246125,0.00016913019,0.00022245377,0.00027030878,0.00015938036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007856586,0.00009679397,0.0003881731,0.0013491913,0.00021805888,0.000017686572,0.00023291375,0.00008969151,0.000030296764],"category_scores_gemma":[0.0021640495,0.00007457288,0.000074707765,0.0011552658,0.0002645718,0.00006510487,0.000034236462,0.00053609593,0.000058284357],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034500288,0.000012787399,0.04556524,0.00043112796,0.00016325417,0.0017662232,0.0005522494,0.000008229302,0.00017351599,0.00088011235,0.45169333,0.49871942],"study_design_scores_gemma":[0.0011867903,0.0014088459,0.15619339,0.00079293805,0.000023902106,0.0007774017,0.0071937772,0.000026486368,0.00074369734,0.003490168,0.82800704,0.0001555942],"about_ca_topic_score_codex":0.0026467922,"about_ca_topic_score_gemma":0.00237787,"teacher_disagreement_score":0.65321404,"about_ca_system_score_codex":0.00069101946,"about_ca_system_score_gemma":0.00460657,"threshold_uncertainty_score":0.8171858},"labels":[],"label_agreement":null},{"id":"W4316037650","doi":"10.51731/cjht.2023.539","title":"Faricimab (Vabysmo)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Diabetic macular edema; Medicine; Family medicine; Political science; Diabetes mellitus; Diabetic retinopathy; Health care","score_opus":0.04056564087290863,"score_gpt":0.3272458019378994,"score_spread":0.2866801610649908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4316037650","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.52304417,0.37937048,0.00004032481,0.09492355,0.00046411811,0.00032997248,0.000032521108,0.0003355388,0.0014593211],"genre_scores_gemma":[0.9984122,0.00088904664,0.000048632377,0.0004085861,0.000001377217,0.0000029166104,0.000005171077,0.000010209238,0.00022184962],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99911046,0.000015252673,0.00030133952,0.00008015985,0.0001272147,0.00036559018],"domain_scores_gemma":[0.9995257,0.00002134586,0.00016165788,0.00016408651,0.00009346671,0.000033727625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019295418,0.000079633,0.00026690227,0.0006367092,0.0001345778,0.0000139876765,0.00011811729,0.000069357906,0.000027001899],"category_scores_gemma":[0.00030124956,0.00005931671,0.00009102057,0.00050663284,0.00009163573,0.000041502157,0.000010287848,0.00019504591,0.00007372202],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015217979,0.000014402454,0.008815779,0.00007250792,0.000048147926,0.0014508258,0.000053003456,0.000002529664,0.0000063665184,0.00030570047,0.0029034307,0.9863121],"study_design_scores_gemma":[0.00078519405,0.0006641078,0.33800212,0.00029819203,0.000039259874,0.0006764058,0.0019462173,0.000014502056,0.00007730995,0.0033645793,0.6540547,0.000077398945],"about_ca_topic_score_codex":0.0017711825,"about_ca_topic_score_gemma":0.000051325074,"teacher_disagreement_score":0.98623466,"about_ca_system_score_codex":0.00024696128,"about_ca_system_score_gemma":0.0018444225,"threshold_uncertainty_score":0.32719263},"labels":[],"label_agreement":null},{"id":"W4316095980","doi":"10.51731/cjht.2023.540","title":"Identifying Overused Lab Tests in Hospital Settings: A Delphi Study","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Healthcare cost, quality, practices","field":"Health Professions","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Canadian Blood Services; Canadian Association of Emergency Physicians","keywords":"Medicine; Medical laboratory; Test (biology); Medical diagnosis; Health care; Nursing; Pathology","score_opus":0.5239739004730818,"score_gpt":0.5427200456900964,"score_spread":0.018746145217014565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4316095980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8470815,0.0071425843,0.000014848365,0.14207114,0.0016970938,0.0014424965,0.00003093516,0.00041694794,0.00010245001],"genre_scores_gemma":[0.99632627,0.0006395409,0.00029282135,0.002468499,0.000056395966,0.00008458999,0.000003966548,0.000049952738,0.00007797996],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9929533,0.0020486459,0.0023651097,0.0003699871,0.00051363296,0.0017493282],"domain_scores_gemma":[0.9950985,0.0015857635,0.0019065985,0.00058868865,0.00050799095,0.00031247403],"candidate_categories":["metaresearch","sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.012886914,0.00025641054,0.0008028237,0.0026088606,0.0013052142,0.000054262786,0.0009190124,0.00042341618,0.00004706273],"category_scores_gemma":[0.01611194,0.00024320142,0.00008047747,0.0024787576,0.00017921661,0.00061646075,0.00017181164,0.003249522,0.00021751772],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023849612,0.00013723804,0.8604091,0.0010914722,0.00005324843,0.0014116026,0.039881725,0.00000804519,0.000010965387,0.0005353361,0.02156431,0.07487312],"study_design_scores_gemma":[0.0012323397,0.00089955836,0.5442673,0.0018693106,0.000011520315,0.000022822684,0.40763175,0.000012469979,0.0000046281657,0.0034872238,0.040303603,0.00025748255],"about_ca_topic_score_codex":0.058798514,"about_ca_topic_score_gemma":0.19306943,"teacher_disagreement_score":0.36775005,"about_ca_system_score_codex":0.0020679077,"about_ca_system_score_gemma":0.011280827,"threshold_uncertainty_score":0.99999493},"labels":[],"label_agreement":null},{"id":"W4316805821","doi":"10.51731/cjht.2023.541","title":"Pembrolizumab (Keytruda)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Vial; Pembrolizumab; Medicine; Reimbursement; Nephrectomy; Renal cell carcinoma; Adjuvant; Resection; Surgery; Internal medicine; Kidney; Cancer; Immunotherapy","score_opus":0.07187227101914873,"score_gpt":0.37928811297744913,"score_spread":0.3074158419583004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4316805821","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84900457,0.018385878,0.00008767445,0.1286845,0.0002893772,0.00027194322,0.000008185407,0.00021658365,0.0030512966],"genre_scores_gemma":[0.9969276,0.0013890001,0.00045540967,0.0004452852,0.000018598226,0.0000053425133,0.0000026298974,0.000011584449,0.0007445116],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986686,0.00004519774,0.00042476476,0.00009285403,0.00019675611,0.00057184265],"domain_scores_gemma":[0.99915844,0.000094220704,0.00017232452,0.00021915036,0.0001799625,0.00017590691],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000933193,0.00008095596,0.00048807473,0.0011343352,0.00019723567,0.000011596783,0.00021016445,0.00015491851,0.00008204315],"category_scores_gemma":[0.0012944774,0.00006302075,0.00007165135,0.00068030105,0.00028829873,0.00004518721,0.000018835588,0.000509287,0.00011578892],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000087672175,0.000026812264,0.31178918,0.0003094011,0.00014897616,0.0028277482,0.0006008544,0.0000035013884,0.000079658545,0.0031318679,0.116061434,0.5649329],"study_design_scores_gemma":[0.002535829,0.0026346494,0.5098101,0.00057223084,0.000059051323,0.0033947283,0.008871649,0.00014314799,0.00019507311,0.010086072,0.4615272,0.00017025514],"about_ca_topic_score_codex":0.0017433157,"about_ca_topic_score_gemma":0.0010210531,"teacher_disagreement_score":0.56476265,"about_ca_system_score_codex":0.0003739236,"about_ca_system_score_gemma":0.0070574675,"threshold_uncertainty_score":0.9985716},"labels":[],"label_agreement":null},{"id":"W4317508600","doi":"10.51731/cjht.2023.543","title":"Ruxolitinib (Jakavi)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Ruxolitinib; Medicine; Family medicine; Drug; Refractory (planetary science); Intensive care medicine; Internal medicine; Pharmacology; Health care; Political science","score_opus":0.04997393762946757,"score_gpt":0.3201934607321535,"score_spread":0.27021952310268593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317508600","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82990587,0.018228455,0.0004883265,0.1457921,0.0009876664,0.000530549,0.000038326478,0.00067410036,0.0033546158],"genre_scores_gemma":[0.99803776,0.0006927487,0.0006282419,0.00042983404,0.000013217085,0.0000033163979,0.0000068131053,0.00001402659,0.00017404594],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988313,0.000026094249,0.00048020124,0.00008512817,0.00015900968,0.00041827728],"domain_scores_gemma":[0.99932396,0.00006505429,0.00018711193,0.00017326807,0.00011947386,0.00013113742],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006372652,0.00008060635,0.00030279384,0.0006738908,0.000112887195,0.000012306706,0.00013881968,0.00011658883,0.00004269888],"category_scores_gemma":[0.00034874567,0.00006834319,0.000063909465,0.0005734692,0.00011109187,0.000047340123,0.000004716552,0.00029962475,0.00009776447],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054784072,0.000034200137,0.067252815,0.0019570757,0.00014511963,0.0050972593,0.0033240598,0.000023775021,0.00073891965,0.009998475,0.058539607,0.8528339],"study_design_scores_gemma":[0.0033937197,0.0018262162,0.23020633,0.0034675323,0.000104509534,0.010158732,0.03178218,0.000078232806,0.008627799,0.014336752,0.6955739,0.00044407145],"about_ca_topic_score_codex":0.0007465284,"about_ca_topic_score_gemma":0.0004432223,"teacher_disagreement_score":0.8523898,"about_ca_system_score_codex":0.00019256516,"about_ca_system_score_gemma":0.0025017215,"threshold_uncertainty_score":0.44379467},"labels":[],"label_agreement":null},{"id":"W4317608316","doi":"10.51731/cjht.2023.545","title":"Tafasitamab (Minjuvi)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Lenalidomide; Medicine; Refractory (planetary science); Lymphoma; Intensive care medicine; Oncology; Internal medicine; Political science; Health care; Multiple myeloma","score_opus":0.04215647556844165,"score_gpt":0.325645451494131,"score_spread":0.28348897592568933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317608316","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7261208,0.084144525,0.000017845092,0.1855878,0.0007715311,0.0003300041,0.000025287634,0.00033573105,0.0026664762],"genre_scores_gemma":[0.99769247,0.0013932745,0.00014202001,0.00036874195,0.00001356633,0.0000059626514,0.0000020187856,0.000009313549,0.00037264166],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99911577,0.0000123138425,0.00030318173,0.00008444464,0.00011733457,0.00036696802],"domain_scores_gemma":[0.999484,0.000028908731,0.00014767093,0.00013458625,0.00011878935,0.00008604341],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025597285,0.000086141066,0.00033964825,0.0006310305,0.00020430416,0.000011633912,0.00010454613,0.00006574577,0.000025973097],"category_scores_gemma":[0.00030151126,0.0000631331,0.00007523987,0.0005398848,0.00012780342,0.000039335886,0.000014970661,0.00021126863,0.00003143447],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033119468,0.000013665628,0.029100388,0.00008181198,0.00011988661,0.00094542775,0.0004982152,0.0000021244334,0.000017112998,0.0004424294,0.053016067,0.91572976],"study_design_scores_gemma":[0.0013100061,0.002444997,0.2782983,0.00036165636,0.000048542115,0.0007591664,0.011657902,0.000007690084,0.0003507109,0.0029068824,0.70171493,0.00013923185],"about_ca_topic_score_codex":0.0018502227,"about_ca_topic_score_gemma":0.0032418184,"teacher_disagreement_score":0.9155905,"about_ca_system_score_codex":0.0004343528,"about_ca_system_score_gemma":0.001880042,"threshold_uncertainty_score":0.33351138},"labels":[],"label_agreement":null},{"id":"W4317830857","doi":"10.51731/cjht.2023.547","title":"Empagliflozin (Jardiance)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Empagliflozin; Medicine; Drug class; Family medicine; Drug; Intensive care medicine; Health care; Pharmacology; Political science","score_opus":0.03664097978150487,"score_gpt":0.30055596266128615,"score_spread":0.26391498287978127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317830857","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.64934164,0.059367165,0.00008816269,0.28205872,0.0014168873,0.0007405296,0.000019106883,0.00081808714,0.006149729],"genre_scores_gemma":[0.9967658,0.0010492607,0.00039274155,0.0007741576,0.000015329128,0.0000059763456,0.0000051165503,0.000012605726,0.000979016],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99900734,0.000014933506,0.00031971253,0.00008829489,0.0001264671,0.00044323632],"domain_scores_gemma":[0.99943656,0.000021203452,0.00015751465,0.00019851416,0.00007441953,0.00011178125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042843446,0.00008813601,0.00031617287,0.0009608354,0.000115042094,0.000018136756,0.0001425547,0.000067310495,0.00003095066],"category_scores_gemma":[0.00021880028,0.00007005796,0.00008446205,0.0006033234,0.0000943665,0.00006195423,0.0000159015,0.000186257,0.00012383526],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000067402066,0.000012818834,0.022245374,0.00011692481,0.0001231034,0.0006861434,0.00015019967,0.000006808428,0.000009553381,0.001178165,0.1358991,0.83956504],"study_design_scores_gemma":[0.0007643344,0.00068108947,0.08191112,0.00031415,0.000044053828,0.000071489936,0.0028168573,0.000010778414,0.00022779376,0.0025579962,0.9105084,0.000091941445],"about_ca_topic_score_codex":0.00055952324,"about_ca_topic_score_gemma":0.0007790368,"teacher_disagreement_score":0.8394731,"about_ca_system_score_codex":0.00028743292,"about_ca_system_score_gemma":0.0011362392,"threshold_uncertainty_score":0.28568807},"labels":[],"label_agreement":null},{"id":"W4317884461","doi":"10.51731/cjht.2023.549","title":"Abrocitinib (Cibinqo)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Atopic dermatitis; Refractory (planetary science); Drug; Family medicine; Dermatology; Pharmacology; Health care; Political science","score_opus":0.34411209858443714,"score_gpt":0.507443061392487,"score_spread":0.16333096280804982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317884461","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3993518,0.00934615,0.0005749345,0.5878934,0.0011307257,0.000607588,0.000028298786,0.0004667731,0.00060028245],"genre_scores_gemma":[0.9952893,0.00041966088,0.0014188723,0.0026911418,0.000033238106,0.000005083568,0.000010498455,0.000014453303,0.00011771013],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99825126,0.00004390152,0.0010415675,0.0000999031,0.00018181709,0.00038154455],"domain_scores_gemma":[0.9985964,0.00028744087,0.00051917264,0.00020579535,0.00026293064,0.00012831991],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0017799358,0.00007727723,0.00030389562,0.0007611856,0.00013691549,0.000017274644,0.00015423259,0.00010332211,0.000073266376],"category_scores_gemma":[0.009428661,0.00006617508,0.00007831391,0.00067015557,0.00011951026,0.00011463622,0.000016565895,0.0004644957,0.000097883014],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018843983,0.000008250245,0.0079717105,0.00006769527,0.000030365829,0.00032035535,0.00011042279,0.0000062735085,0.00008158674,0.00047858627,0.09112678,0.89977914],"study_design_scores_gemma":[0.0012718331,0.0009382516,0.0697197,0.00026925717,0.000035334382,0.0008202919,0.013115176,0.000044337616,0.00022655219,0.0071494435,0.9063012,0.00010863659],"about_ca_topic_score_codex":0.0043640425,"about_ca_topic_score_gemma":0.00303486,"teacher_disagreement_score":0.8996705,"about_ca_system_score_codex":0.00027537986,"about_ca_system_score_gemma":0.0037481927,"threshold_uncertainty_score":0.9989153},"labels":[],"label_agreement":null},{"id":"W4317934516","doi":"10.51731/cjht.2023.553","title":"Cabozantinib (Cabometyx)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cabozantinib; Reimbursement; Medicine; Refractory (planetary science); Drug; Intensive care medicine; Family medicine; Oncology; Medical physics; Internal medicine; Cancer; Pharmacology; Political science; Health care","score_opus":0.45878445805100243,"score_gpt":0.4447541549510803,"score_spread":0.014030303099922148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317934516","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22291063,0.08184411,0.0011630793,0.68731827,0.0029690787,0.0006072152,0.000374975,0.00044549626,0.0023671545],"genre_scores_gemma":[0.99035937,0.0012101206,0.0012841477,0.0065700044,0.0000656778,0.000016665648,0.000009137796,0.000033779725,0.0004511069],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9944622,0.0001542999,0.0042554275,0.00025406913,0.00008280541,0.0007911983],"domain_scores_gemma":[0.9956364,0.0004138659,0.0032162094,0.00043035112,0.00011583271,0.00018731035],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.019086108,0.00015135191,0.0010401425,0.0024249326,0.00038633167,0.000075807,0.0006245437,0.00020290933,0.00014923849],"category_scores_gemma":[0.009212372,0.00017811537,0.00013170883,0.0010146489,0.00017297087,0.00034692878,0.000029969126,0.0004040861,0.0016654514],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000006494422,0.000027083574,0.08446482,0.0006506167,0.00013578965,0.00007847583,0.0029299087,0.00017250555,0.0000021917544,0.21755077,0.6184076,0.07557371],"study_design_scores_gemma":[0.0004004036,0.00014370632,0.032446574,0.0001531225,0.000002003159,0.000060343515,0.00701004,0.00012673758,0.0000090958265,0.055546023,0.9038862,0.00021578175],"about_ca_topic_score_codex":0.009278725,"about_ca_topic_score_gemma":0.0033759242,"teacher_disagreement_score":0.7674487,"about_ca_system_score_codex":0.00074944703,"about_ca_system_score_gemma":0.0022564172,"threshold_uncertainty_score":0.99913347},"labels":[],"label_agreement":null},{"id":"W4317934829","doi":"10.51731/cjht.2023.551","title":"Trastuzumab Deruxtecan (Enhertu)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Trastuzumab; Reimbursement; Medicine; Regimen; Adjuvant; Oncology; Breast cancer; Internal medicine; Human Epidermal Growth Factor Receptor 2; Metastatic breast cancer; Cancer; Health care","score_opus":0.10286531305846934,"score_gpt":0.398326580389078,"score_spread":0.2954612673306086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317934829","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4534305,0.07818354,0.00028851244,0.4622791,0.0013700528,0.00093901774,0.00005155147,0.00089609943,0.0025616023],"genre_scores_gemma":[0.99657834,0.001651867,0.0005112512,0.00070659065,0.0000343797,0.000010789737,0.0000032276985,0.000030926112,0.00047264638],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979847,0.00005862126,0.0005687961,0.0001560058,0.00036351054,0.0008683832],"domain_scores_gemma":[0.998843,0.00007875373,0.00019698631,0.00034753606,0.00024115283,0.00029254146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012865202,0.0001256626,0.0004479542,0.0015642556,0.00022855078,0.00003117623,0.00039489398,0.00017437682,0.00011679921],"category_scores_gemma":[0.0013587706,0.00010568794,0.00009811665,0.0012958992,0.00030268822,0.000064057094,0.000026637737,0.0008709455,0.000109812805],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001695462,0.000010002983,0.007698179,0.00021004921,0.000039021477,0.0011076189,0.00032599355,0.0000066025386,0.00008385337,0.00029446595,0.0763762,0.91383106],"study_design_scores_gemma":[0.00091086404,0.0016173312,0.040787008,0.00078299496,0.000015904803,0.0013449255,0.007961091,0.000036219943,0.0012374488,0.004319933,0.94081736,0.00016893017],"about_ca_topic_score_codex":0.0054456326,"about_ca_topic_score_gemma":0.0065215207,"teacher_disagreement_score":0.91366214,"about_ca_system_score_codex":0.0012033251,"about_ca_system_score_gemma":0.010888831,"threshold_uncertainty_score":0.9947185},"labels":[],"label_agreement":null},{"id":"W4318067260","doi":"10.51731/cjht.2023.554","title":"Maribavir (Livtencity)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Refractory (planetary science); Intensive care medicine; Family medicine; Health care; Political science; Biology","score_opus":0.07485179050639802,"score_gpt":0.3509333658957975,"score_spread":0.2760815753893995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318067260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.74606705,0.040329948,0.00008535913,0.2079182,0.00061445404,0.00053846656,0.000036911206,0.0005164248,0.0038932157],"genre_scores_gemma":[0.9968907,0.001524541,0.00021368494,0.00056556595,0.00002081874,0.000003828971,0.0000028672944,0.000016050912,0.0007619434],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99857926,0.000029851955,0.0004326595,0.00010760757,0.00023863971,0.0006120008],"domain_scores_gemma":[0.9991603,0.000049099985,0.0001491074,0.00023993883,0.0002016915,0.00019989326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00097163825,0.000089916524,0.00035849365,0.0017392687,0.00021376708,0.000029521909,0.00024901124,0.00013898208,0.000100147554],"category_scores_gemma":[0.0007812886,0.00007159124,0.00009370718,0.0011974864,0.00020191069,0.000071748436,0.000028295675,0.00063188333,0.00016473704],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002428398,0.00001222961,0.021728894,0.00013674032,0.000041020296,0.0012152588,0.00015619549,0.0000029624623,0.0001446938,0.0012378792,0.045256298,0.9300435],"study_design_scores_gemma":[0.00046633783,0.0005095448,0.06592593,0.00019534951,0.000007635021,0.00044790772,0.0017187279,0.000023498365,0.00042668753,0.0023905286,0.92780566,0.00008217624],"about_ca_topic_score_codex":0.005473267,"about_ca_topic_score_gemma":0.004690845,"teacher_disagreement_score":0.9299614,"about_ca_system_score_codex":0.0003983007,"about_ca_system_score_gemma":0.004937539,"threshold_uncertainty_score":0.8758982},"labels":[],"label_agreement":null},{"id":"W4318817604","doi":"10.51731/cjht.2023.556","title":"Lutetium (¹⁷⁷Lu) Oxodotreotide (Lutathera)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Health Canada","keywords":"Reimbursement; Lutetium; Medicine; Neuroendocrine tumors; Somatostatin receptor; Medical physics; Somatostatin; Intensive care medicine; Internal medicine; Political science; Chemistry; Health care","score_opus":0.0492802878119603,"score_gpt":0.35629339758249134,"score_spread":0.30701310977053103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318817604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5484909,0.036477003,0.000058902155,0.41159862,0.0008016421,0.0006086072,0.000029789102,0.0007592721,0.0011752527],"genre_scores_gemma":[0.99596083,0.0016917607,0.0006135606,0.00092522753,0.000023815028,0.000007393658,0.0000026401506,0.000030574465,0.00074420974],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99808013,0.000057609643,0.00050939556,0.00015711287,0.00031234298,0.00088341406],"domain_scores_gemma":[0.99888176,0.00010212528,0.0002392611,0.0003161309,0.00019902222,0.00026172653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000509461,0.00013298387,0.0004327757,0.0015491801,0.00019507445,0.00002722189,0.00035310167,0.000021334201,0.000043164597],"category_scores_gemma":[0.0018641317,0.00010805183,0.00010014465,0.0010325733,0.00029715264,0.00012137643,0.000033829954,0.0007132867,0.000102895494],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009634283,0.00004698227,0.037317377,0.0006080963,0.000121230616,0.053368565,0.00035244745,0.00006265448,0.0009971206,0.0012662545,0.14076279,0.76500016],"study_design_scores_gemma":[0.0011719329,0.0017407747,0.029847907,0.00047425795,0.000014741461,0.0116008725,0.0043019443,0.000027490338,0.00412511,0.0066407886,0.9398688,0.00018535774],"about_ca_topic_score_codex":0.0011042876,"about_ca_topic_score_gemma":0.0019562265,"teacher_disagreement_score":0.799106,"about_ca_system_score_codex":0.00033532668,"about_ca_system_score_gemma":0.003258019,"threshold_uncertainty_score":0.5779586},"labels":[],"label_agreement":null},{"id":"W4319082132","doi":"10.51731/cjht.2023.558","title":"Cariprazine (Vraylar)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Risperidone; Schizophrenia (object-oriented programming); Psychiatry; Placebo; Clinical trial; Medicine; Psychology; Alternative medicine; Internal medicine; Pathology","score_opus":0.05148672534158338,"score_gpt":0.33917598324148673,"score_spread":0.28768925789990335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319082132","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6994267,0.04730333,0.00002996799,0.25186217,0.00034611922,0.00033042234,0.00002284229,0.00029983313,0.00037860833],"genre_scores_gemma":[0.99758416,0.0011192769,0.0008261106,0.00022958081,0.000014950191,0.0000055181295,0.0000059234676,0.000011197846,0.00020326172],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9988777,0.000025830042,0.00031036514,0.00008943755,0.00019232565,0.0005043389],"domain_scores_gemma":[0.9992515,0.000041147483,0.000119767494,0.00021954559,0.00014663728,0.0002213973],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005085293,0.00008255319,0.00028969484,0.0010929343,0.00015452119,0.000016983267,0.00015365625,0.000083517494,0.000034695102],"category_scores_gemma":[0.0008010315,0.000060590108,0.00007495478,0.00072599284,0.00013054049,0.000047687598,0.000015024078,0.00037342787,0.000108053275],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015768588,0.000018514973,0.020526873,0.00008732444,0.000099234276,0.0039862366,0.000105939376,0.00000309678,0.00004427777,0.0016117297,0.037205026,0.93615407],"study_design_scores_gemma":[0.005903697,0.0043793987,0.4802242,0.0007404264,0.0000600907,0.0040282314,0.0059586857,0.000055946584,0.0019640701,0.02035446,0.47607023,0.0002605763],"about_ca_topic_score_codex":0.0024113772,"about_ca_topic_score_gemma":0.005616864,"teacher_disagreement_score":0.9358935,"about_ca_system_score_codex":0.00039265092,"about_ca_system_score_gemma":0.005372258,"threshold_uncertainty_score":0.9530155},"labels":[],"label_agreement":null},{"id":"W4319438676","doi":"10.51731/cjht.2023.561","title":"Pembrolizumab (Keytruda)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Pembrolizumab; Medicine; Vial; Family medicine; Internal medicine; Cancer; Political science","score_opus":0.42098361643813637,"score_gpt":0.4337388593827365,"score_spread":0.01275524294460012,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319438676","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21514499,0.07743656,0.0012671519,0.69939077,0.002644516,0.00058269897,0.00026778653,0.00045666395,0.0028088498],"genre_scores_gemma":[0.99231315,0.0008878997,0.00074827723,0.0055809617,0.000059016787,0.000015983955,0.0000073030656,0.000030282137,0.00035715676],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9947939,0.0001482543,0.0039554625,0.0002457239,0.00008452669,0.0007721458],"domain_scores_gemma":[0.99597776,0.00034627423,0.0029554476,0.00042783708,0.00010305463,0.00018960454],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.014679532,0.0001479347,0.0009762135,0.0021160531,0.00039409127,0.00007259527,0.00062001066,0.00020353288,0.00014822884],"category_scores_gemma":[0.0072562476,0.0001761459,0.00012941855,0.00074956456,0.00016766854,0.00033290865,0.00002879478,0.0004049543,0.001659856],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010534369,0.000024282914,0.06045563,0.00067913334,0.00012146846,0.00008129966,0.0031076504,0.00028583175,0.0000014975732,0.30490312,0.5857923,0.044537246],"study_design_scores_gemma":[0.0006071364,0.00021679775,0.03654069,0.00018502408,0.0000024065278,0.000101701575,0.008028533,0.0002749493,0.0000062682966,0.110910006,0.84286845,0.00025803866],"about_ca_topic_score_codex":0.007478884,"about_ca_topic_score_gemma":0.0033399693,"teacher_disagreement_score":0.7771681,"about_ca_system_score_codex":0.0011498656,"about_ca_system_score_gemma":0.0024097138,"threshold_uncertainty_score":0.9991304},"labels":[],"label_agreement":null},{"id":"W4319438804","doi":"10.51731/cjht.2023.559","title":"Dupilumab (Dupixent)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Medical prescription; Atopic dermatitis; Dermatology; Drug; Reimbursement; Methotrexate; Azathioprine; Disease; Family medicine; Surgery; Pharmacology; Internal medicine; Health care","score_opus":0.032088891347487436,"score_gpt":0.3086995705365656,"score_spread":0.27661067918907817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319438804","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7023091,0.085792966,0.000045521243,0.20831107,0.00093043776,0.00027616107,0.000020820315,0.00054357114,0.0017704071],"genre_scores_gemma":[0.9980046,0.00063793326,0.00010726542,0.000989809,0.000009486824,0.0000028436586,0.000004157718,0.000009405532,0.0002344719],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990012,0.000028322671,0.00037289507,0.00008128718,0.00010796127,0.00040833242],"domain_scores_gemma":[0.99934536,0.000046031684,0.00017274408,0.00019176384,0.000102120764,0.0001419816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003196969,0.000078402496,0.00031653003,0.0008711268,0.00017913639,0.000011052495,0.00017529391,0.00012165984,0.000052398376],"category_scores_gemma":[0.0008384236,0.00006417143,0.00008200794,0.0004951624,0.0002178411,0.000057033674,0.000012900781,0.00031041406,0.00011162064],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036574194,0.00002369728,0.13707769,0.000240218,0.000085360974,0.004418029,0.00021203927,0.0000060876855,0.000014857755,0.0011084154,0.54942524,0.30735177],"study_design_scores_gemma":[0.0011148431,0.00034708824,0.31797484,0.00045643005,0.000036321013,0.0038573884,0.0044819685,0.000018828727,0.00032479168,0.008743078,0.66250604,0.00013836092],"about_ca_topic_score_codex":0.0003634335,"about_ca_topic_score_gemma":0.0004881558,"teacher_disagreement_score":0.3072134,"about_ca_system_score_codex":0.0001397772,"about_ca_system_score_gemma":0.0029908314,"threshold_uncertainty_score":0.5305606},"labels":[],"label_agreement":null},{"id":"W4319438907","doi":"10.51731/cjht.2023.562","title":"Specialized Clinics and Health Care Professional Resources for Post–COVID-19 Condition in Canada","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Specialty; Referral; Jurisdiction; Health care; Medicine; Family medicine; Nursing; Political science","score_opus":0.3371586172653225,"score_gpt":0.4733619029530325,"score_spread":0.13620328568771,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319438907","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2687576,0.05725307,0.00017974369,0.6696776,0.0014452406,0.0011083267,0.0014742784,0.000057080746,0.000047017405],"genre_scores_gemma":[0.95488435,0.001334212,0.0011381321,0.04230765,0.00008451581,0.00007118664,0.00008064619,0.000029464696,0.000069849586],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9948473,0.00023403489,0.0038697724,0.0002909699,0.000089974674,0.00066795497],"domain_scores_gemma":[0.99538034,0.0008305317,0.0030985568,0.00022342968,0.000117675525,0.00034945557],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013324258,0.0001430794,0.0010246729,0.0013707093,0.0005197764,0.000040672046,0.00031122053,0.0001548922,0.00003482781],"category_scores_gemma":[0.008099244,0.00016758403,0.000062493775,0.00040371917,0.00010995462,0.00018039926,0.000025468093,0.0003455044,0.000013881298],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000073709365,0.0000271503,0.33453315,0.005301578,0.00008513544,0.000055025394,0.020278884,0.000489101,2.6706678e-7,0.0688766,0.5164588,0.053820606],"study_design_scores_gemma":[0.0014272118,0.00027710313,0.12570062,0.000311755,0.0000017093085,0.000026250784,0.09552494,0.00018601108,4.3676607e-7,0.02230992,0.75401175,0.00022231818],"about_ca_topic_score_codex":0.86148083,"about_ca_topic_score_gemma":0.9812122,"teacher_disagreement_score":0.6861267,"about_ca_system_score_codex":0.007394531,"about_ca_system_score_gemma":0.034346454,"threshold_uncertainty_score":0.9964159},"labels":[],"label_agreement":null},{"id":"W4319438997","doi":"10.51731/cjht.2023.560","title":"Tezepelumab (Tezspire)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Asthma; Family medicine; Political science; Health care; Internal medicine","score_opus":0.1247266686164449,"score_gpt":0.4093796100074597,"score_spread":0.2846529413910148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319438997","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20640141,0.11481783,0.000051140967,0.6725719,0.0009191344,0.00031064116,0.000014455176,0.0003941379,0.004519345],"genre_scores_gemma":[0.99348414,0.00429363,0.00019568866,0.0018121507,0.00002228977,0.0000023363382,0.0000010368615,0.000009292782,0.00017942322],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99894595,0.00002786814,0.00035949386,0.00008094811,0.00014125346,0.00044449538],"domain_scores_gemma":[0.99930483,0.00010029071,0.00020927249,0.00013136635,0.0001099406,0.0001442763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073896046,0.000078391466,0.00030229051,0.0004359591,0.00024164963,0.00001714916,0.00015405047,0.000080427264,0.00005910745],"category_scores_gemma":[0.0011942323,0.000058708352,0.00006667515,0.0005900671,0.00015364253,0.0000793773,0.000021213591,0.0004709515,0.00008119717],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020456791,0.000009529437,0.00835296,0.000110334135,0.00006488292,0.00063007046,0.00014640379,0.000002271884,0.00003175999,0.0006587909,0.053778812,0.9361937],"study_design_scores_gemma":[0.00038835473,0.00036940817,0.020590544,0.00012451828,0.000019644933,0.0003751778,0.0025574288,0.000015155816,0.0001717128,0.0015464068,0.9737844,0.000057246933],"about_ca_topic_score_codex":0.0014717785,"about_ca_topic_score_gemma":0.0007758634,"teacher_disagreement_score":0.9361365,"about_ca_system_score_codex":0.00020027986,"about_ca_system_score_gemma":0.001380039,"threshold_uncertainty_score":0.244813},"labels":[],"label_agreement":null},{"id":"W4319599123","doi":"10.51731/cjht.2023.565","title":"Entrectinib (Rozlytrek)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Oncology; Internal medicine; Drug; Receptor tyrosine kinase; Intensive care medicine; Family medicine; Pharmacology; Receptor; Health care","score_opus":0.057363275288919775,"score_gpt":0.2583792644691913,"score_spread":0.20101598918027153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319599123","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.45764297,0.272336,0.0015005395,0.22440098,0.00788465,0.0005650803,0.0005129687,0.0007336681,0.03442312],"genre_scores_gemma":[0.9966187,0.001966743,0.00016995812,0.0005327667,0.00003324301,0.000003385846,0.000003059522,0.000017407068,0.00065474806],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99842536,0.0000080797145,0.0008435214,0.00014748705,0.000020762098,0.000554789],"domain_scores_gemma":[0.9988544,0.00003805903,0.00074503565,0.00021312847,0.00004843908,0.00010096192],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010057406,0.000105449464,0.00046402137,0.0011412958,0.00020872412,0.000052305655,0.0003927243,0.00013397378,0.00020249192],"category_scores_gemma":[0.00076501834,0.00011580091,0.00010440792,0.00050858915,0.0001460931,0.00021679935,0.0000190254,0.00028799247,0.0011324172],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008954512,0.00001319871,0.071904965,0.00006466384,0.00006881398,0.000103358245,0.0009503975,0.000092491944,0.0000019472545,0.26291057,0.19544375,0.4684369],"study_design_scores_gemma":[0.00022548363,0.00009742907,0.01894517,0.000037226284,0.0000010763212,0.000029621939,0.0008559736,0.00001997259,0.000024895964,0.11215057,0.86749053,0.000122032056],"about_ca_topic_score_codex":0.0040806797,"about_ca_topic_score_gemma":0.0024661482,"teacher_disagreement_score":0.6720468,"about_ca_system_score_codex":0.00038381264,"about_ca_system_score_gemma":0.00076502154,"threshold_uncertainty_score":0.9996453},"labels":[],"label_agreement":null},{"id":"W4319752050","doi":"10.51731/cjht.2023.570","title":"Cariprazine (Vraylar)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Bipolar disorder; Mania; Psychiatry; Medicine; Depression (economics); Political science; Lithium (medication); Health care","score_opus":0.12154661428356324,"score_gpt":0.40884815167057953,"score_spread":0.2873015373870163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319752050","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.18743756,0.13475285,0.000049443566,0.67306495,0.00090698217,0.00026541267,0.000017349657,0.00032039615,0.0031850133],"genre_scores_gemma":[0.9923898,0.005441683,0.0002183628,0.0017471992,0.000022875654,0.0000022319243,0.0000015070863,0.000008765132,0.00016757194],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99899507,0.000028591998,0.0003440694,0.00007710067,0.0001335174,0.00042166535],"domain_scores_gemma":[0.99930567,0.00009613416,0.00019709079,0.0001314593,0.000122142,0.0001474965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077106105,0.000076292774,0.00030022033,0.000427899,0.00021833855,0.000015540038,0.0001403221,0.0000777115,0.000046960162],"category_scores_gemma":[0.001389355,0.000056807014,0.000061113824,0.00061462953,0.0001411208,0.00007745762,0.000020989048,0.00048320496,0.000065217035],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027744918,0.000011279266,0.012307486,0.00013723355,0.00009274411,0.0010802643,0.00018789743,0.0000034033287,0.00007715145,0.00068496977,0.0837462,0.90164363],"study_design_scores_gemma":[0.0003711166,0.00034318268,0.020164846,0.0000991131,0.000022698272,0.00040565687,0.0021782059,0.000015683352,0.00017115481,0.001128643,0.9750465,0.0000531744],"about_ca_topic_score_codex":0.0017115733,"about_ca_topic_score_gemma":0.0011653827,"teacher_disagreement_score":0.90159047,"about_ca_system_score_codex":0.0001800422,"about_ca_system_score_gemma":0.0012733963,"threshold_uncertainty_score":0.25873983},"labels":[],"label_agreement":null},{"id":"W4319981881","doi":"10.51731/cjht.2023.571","title":"Sotrovimab for the Treatment of COVID-19","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Coronavirus disease 2019 (COVID-19); Observational study; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); 2019-20 coronavirus outbreak; Clinical study; Medicine; Internal medicine; Virology; Disease","score_opus":0.13221696115913442,"score_gpt":0.4217765383629842,"score_spread":0.2895595772038497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319981881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.46646446,0.11803472,0.001336071,0.41090676,0.0006349722,0.0020492878,0.00012757863,0.00027758945,0.00016855363],"genre_scores_gemma":[0.9840412,0.0010026627,0.00022503233,0.014565947,0.000035702455,0.000057091584,0.000001565379,0.000018865701,0.000051892257],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99880874,0.000027647966,0.00040446428,0.000104873834,0.00018277577,0.00047150473],"domain_scores_gemma":[0.99878865,0.0004561501,0.0002136502,0.00030051894,0.00016864334,0.00007239599],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006810008,0.00009602704,0.00036646926,0.0007823004,0.00025740569,0.000013322382,0.000275902,0.00010216001,0.000004151902],"category_scores_gemma":[0.0015438512,0.000057338562,0.00015291545,0.00057859917,0.00030083407,0.00002872786,0.000009842204,0.0001686655,0.0000073557335],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002548195,0.00008314982,0.022969387,0.0006012892,0.0002547443,0.00040111924,0.0016371409,0.000011100999,0.0005998102,0.0016710047,0.030246604,0.9412698],"study_design_scores_gemma":[0.0014223334,0.0026039148,0.0015852997,0.000049629212,0.000027019447,0.0001239392,0.0058623822,0.000060240618,0.004339491,0.0021763428,0.9817028,0.000046573492],"about_ca_topic_score_codex":0.007830717,"about_ca_topic_score_gemma":0.0055970973,"teacher_disagreement_score":0.95145625,"about_ca_system_score_codex":0.000945129,"about_ca_system_score_gemma":0.010329111,"threshold_uncertainty_score":0.9987762},"labels":[],"label_agreement":null},{"id":"W4320036799","doi":"10.51731/cjht.2023.572","title":"Design, Rationale, and Preliminary Results of the Canadian Homozygous Familial Hypercholesterolemia Registry: 2008 to 2022 Update","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Familial hypercholesterolemia; Medicine; Patient registry; Orphan drug; Disease; Atherosclerotic cardiovascular disease; Disease registry; Apheresis; Pediatrics; Intensive care medicine; Cholesterol; Family medicine; Internal medicine; Bioinformatics","score_opus":0.0310804090823588,"score_gpt":0.2634483542726371,"score_spread":0.23236794519027829,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4320036799","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.58020145,0.03609777,0.00024540751,0.37923583,0.0008473968,0.0025908505,0.0004520695,0.000112220296,0.0002169905],"genre_scores_gemma":[0.99574256,0.0012593362,0.00084413687,0.0017953026,0.00004139294,0.000019501285,0.000009879282,0.000019643883,0.0002682682],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981692,0.00013891765,0.00061921636,0.00018794522,0.0003562798,0.00052848173],"domain_scores_gemma":[0.9984536,0.000044358392,0.0002789799,0.00057870586,0.00026185965,0.0003824629],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019452006,0.00013250858,0.0004342441,0.00078456564,0.00044387134,0.000023531755,0.00032240408,0.00018993611,0.000003561726],"category_scores_gemma":[0.0011628164,0.000097411925,0.00009868429,0.0008685022,0.00023265032,0.00005819968,0.000040836097,0.00054960116,0.000005470491],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005236384,0.000019683923,0.003639427,0.0005682957,0.00021067778,0.001487726,0.0014058886,0.0005424531,0.00018975974,0.00027265414,0.19400924,0.7971305],"study_design_scores_gemma":[0.0029662403,0.0028906388,0.21259597,0.0012230563,0.00008549373,0.004816581,0.0040009115,0.00007692321,0.0010011131,0.0010587602,0.7689798,0.00030454522],"about_ca_topic_score_codex":0.27300775,"about_ca_topic_score_gemma":0.42997447,"teacher_disagreement_score":0.796826,"about_ca_system_score_codex":0.00061282096,"about_ca_system_score_gemma":0.011932406,"threshold_uncertainty_score":0.99366903},"labels":[],"label_agreement":null},{"id":"W4320918436","doi":"10.51731/cjht.2023.573","title":"Pegvaliase (Palynziq)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Metabolism and Genetic Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Phenylalanine; Medicine; Blood concentration; Drug; Internal medicine; Pharmacology; Chemistry; Biochemistry","score_opus":0.02057033651950258,"score_gpt":0.27688851353246663,"score_spread":0.25631817701296405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4320918436","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86830056,0.10565204,0.0005036086,0.023415962,0.0010547765,0.00018257121,0.00004389134,0.000077616474,0.000769002],"genre_scores_gemma":[0.9958607,0.003012028,0.0002847341,0.00043859598,0.000023028599,0.0000029649175,0.000014146339,0.000012329514,0.0003514901],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990866,0.000037994763,0.00030071626,0.00011645268,0.00008549459,0.00037274076],"domain_scores_gemma":[0.999422,0.0000063766583,0.00016496982,0.00024169497,0.00008306051,0.000081856895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051017833,0.0000871975,0.00016813484,0.00033064984,0.00012831904,0.000017634251,0.0003347362,0.00011699713,0.000014815489],"category_scores_gemma":[0.0004295716,0.000077581724,0.00006784769,0.0002991205,0.00013178599,0.0000026100165,0.000027186425,0.00011942809,0.000025710055],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013980088,0.00001198853,0.009529834,0.00006906515,0.000059628033,0.000076582524,0.00016376769,0.00013639664,0.0024553018,0.0006401634,0.24018116,0.74666214],"study_design_scores_gemma":[0.00026545062,0.00019285128,0.010414557,0.000024158066,0.0000050924114,0.000058597147,0.0018375625,0.0000040195655,0.003663176,0.0016423381,0.98178506,0.00010713533],"about_ca_topic_score_codex":0.00054777786,"about_ca_topic_score_gemma":0.0017814178,"teacher_disagreement_score":0.746555,"about_ca_system_score_codex":0.000008946173,"about_ca_system_score_gemma":0.0012856182,"threshold_uncertainty_score":0.3163691},"labels":[],"label_agreement":null},{"id":"W4321496229","doi":"10.51731/cjht.2023.575","title":"Wastewater Surveillance for Communicable Diseases","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"SARS-CoV-2 detection and testing","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université du Québec à Montréal","funders":"","keywords":"Wastewater; Population; Environmental health; Epidemiological surveillance; Medicine; Epidemiology; Environmental science; Environmental engineering; Pathology","score_opus":0.07479812435245925,"score_gpt":0.3358515198332107,"score_spread":0.26105339548075146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321496229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93617964,0.01858567,0.00009619548,0.043608043,0.000501568,0.00033967762,0.000041660707,0.00047335567,0.00017421566],"genre_scores_gemma":[0.99827766,0.0001175568,0.0005947737,0.00089972996,0.000016534334,0.000009239132,0.0000037147563,0.000015235122,0.00006553134],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990722,0.000029430019,0.00035158332,0.00007848199,0.00008302188,0.0003852827],"domain_scores_gemma":[0.99918276,0.00016955336,0.00018992247,0.00023815178,0.00015392424,0.00006570322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005094812,0.00007778302,0.00031355995,0.0005526615,0.00025652492,0.000020470823,0.00017985856,0.00007231033,0.00000483309],"category_scores_gemma":[0.001708118,0.00006281704,0.000077323144,0.00041733315,0.000115591756,0.00004811677,0.000016995336,0.00023540386,0.0000110696665],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014870455,0.000051634426,0.15391022,0.0011183588,0.00018730744,0.00052275497,0.00052711024,0.000037046044,0.007188925,0.000676991,0.08771027,0.7479207],"study_design_scores_gemma":[0.002120931,0.0013321532,0.029638842,0.00062746287,0.000027609023,0.0009003022,0.006742142,0.0004078153,0.028840082,0.004756608,0.9243604,0.0002456685],"about_ca_topic_score_codex":0.0011682679,"about_ca_topic_score_gemma":0.0018896483,"teacher_disagreement_score":0.83665013,"about_ca_system_score_codex":0.00017296396,"about_ca_system_score_gemma":0.0010814513,"threshold_uncertainty_score":0.25616047},"labels":[],"label_agreement":null},{"id":"W4321496367","doi":"10.51731/cjht.2023.576","title":"Ozanimod (Zeposia)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Ulcerative colitis; Family medicine; Internal medicine; Political science; Health care","score_opus":0.01615046927160108,"score_gpt":0.2630801344444975,"score_spread":0.24692966517289644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321496367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98210835,0.009069737,0.000114172486,0.0077387504,0.00040224247,0.00012761274,0.000023208415,0.00008018685,0.00033575718],"genre_scores_gemma":[0.9990665,0.00029938002,0.00013694662,0.00030772813,0.000024055047,0.000004095362,0.000008755252,0.00001463252,0.00013795249],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990848,0.000039238836,0.00029985476,0.000109494606,0.000083931576,0.0003826991],"domain_scores_gemma":[0.99936146,0.0000053497893,0.0001853582,0.00024281371,0.000104416395,0.000100594465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042000946,0.000086903914,0.00012895615,0.00032743358,0.00015694197,0.000019556746,0.000334544,0.00013323511,0.000007428685],"category_scores_gemma":[0.0003884387,0.000082559905,0.000069952446,0.00019848692,0.00012524355,0.00000431216,0.00003066642,0.00014787071,0.000030984887],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013783768,0.00003953395,0.09220654,0.00036999534,0.00024792465,0.004882255,0.00040905317,0.0005423937,0.015236512,0.004819127,0.32661858,0.55449027],"study_design_scores_gemma":[0.0006708161,0.00050332583,0.21665904,0.0001089754,0.0000119558945,0.00031122737,0.002488081,0.000023627465,0.0061541838,0.0031283523,0.76962155,0.00031889995],"about_ca_topic_score_codex":0.00019455086,"about_ca_topic_score_gemma":0.001553705,"teacher_disagreement_score":0.5541713,"about_ca_system_score_codex":0.00006314185,"about_ca_system_score_gemma":0.0020797001,"threshold_uncertainty_score":0.3689299},"labels":[],"label_agreement":null},{"id":"W4321597293","doi":"10.51731/cjht.2023.577","title":"Pitolisant Hydrochloride (Wakix)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Plant-based Medicinal Research","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Narcolepsy; Cataplexy; Medicine; Psychiatry; Political science; Modafinil; Health care","score_opus":0.2579957923937001,"score_gpt":0.5011647147126034,"score_spread":0.2431689223189033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321597293","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82461363,0.036187183,0.00008710195,0.13250546,0.0036161155,0.0004478369,0.00013110078,0.000477648,0.0019339243],"genre_scores_gemma":[0.9946491,0.0029472837,0.000065122666,0.0018254046,0.00006484012,0.00001116306,0.0000080266545,0.000019735025,0.0004093105],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974771,0.00023824594,0.0006433333,0.00016877174,0.0002822551,0.0011902972],"domain_scores_gemma":[0.9982957,0.0005641533,0.00032656227,0.00021776865,0.00018451,0.00041128695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033842584,0.00016203588,0.00042209058,0.0012112763,0.00047178633,0.000020215637,0.0007764564,0.00035712874,0.00024409856],"category_scores_gemma":[0.002550264,0.00013892395,0.00008747586,0.0009994481,0.00051493885,0.000103947685,0.000046068915,0.0020227646,0.00034266745],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001277087,0.000032372056,0.01097926,0.00020577856,0.00012869915,0.0044446774,0.000619056,0.0002481441,0.0017739126,0.0021085287,0.28077343,0.69855845],"study_design_scores_gemma":[0.0007360623,0.00044547845,0.004313503,0.00013041093,0.000019038634,0.0005487341,0.0025945383,0.00020609464,0.0069060107,0.003382911,0.98056746,0.00014973467],"about_ca_topic_score_codex":0.0017994511,"about_ca_topic_score_gemma":0.0023140248,"teacher_disagreement_score":0.69979405,"about_ca_system_score_codex":0.00050371175,"about_ca_system_score_gemma":0.005198258,"threshold_uncertainty_score":0.92214864},"labels":[],"label_agreement":null},{"id":"W4321790146","doi":"10.51731/cjht.2023.581","title":"Dalbavancin (Xydalba)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Bacterial Identification and Susceptibility Testing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Streptococcus anginosus; Dalbavancin; Streptococcus dysgalactiae; Microbiology; Streptococcus; Medicine; Enterococcus faecalis; Clindamycin; Enterococcus; Streptococcus pyogenes; Staphylococcus aureus; Vancomycin; Linezolid; Streptococcus agalactiae; Antibiotics; Biology; Bacteria","score_opus":0.03387587921961897,"score_gpt":0.291212006580458,"score_spread":0.257336127360839,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321790146","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97941625,0.0050022835,0.00022144802,0.014353166,0.00064070104,0.00010258434,0.00001379711,0.00007759476,0.00017215515],"genre_scores_gemma":[0.99900246,0.00020138206,0.00030268636,0.00020605486,0.000023365636,0.000001916793,0.000015030464,0.000008695805,0.00023839022],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99919444,0.000040202947,0.00033187275,0.00011014354,0.000058015892,0.00026532664],"domain_scores_gemma":[0.9993902,0.000010637294,0.00019413707,0.00022539703,0.00012217411,0.000057459936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068153534,0.00006403813,0.00012878916,0.00024051708,0.00014864985,0.000029438543,0.00026471136,0.00010380362,0.000009962152],"category_scores_gemma":[0.0011462382,0.000060834678,0.000046581157,0.0002579601,0.00008867211,0.0000042973165,0.000023633054,0.00012026948,0.000022132675],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016489743,0.000018342638,0.035246897,0.00011033586,0.000049808343,0.00005520089,0.00026624728,0.000051017974,0.18050033,0.0009402382,0.10804576,0.67469937],"study_design_scores_gemma":[0.00033097985,0.00036890004,0.070743285,0.000070542614,0.0000046951523,0.0001259234,0.0027138987,0.000016410004,0.023073778,0.0019781846,0.9003778,0.00019557124],"about_ca_topic_score_codex":0.00049574696,"about_ca_topic_score_gemma":0.0032807682,"teacher_disagreement_score":0.79233205,"about_ca_system_score_codex":0.000045813907,"about_ca_system_score_gemma":0.0010202682,"threshold_uncertainty_score":0.24807662},"labels":[],"label_agreement":null},{"id":"W4321850144","doi":"10.51731/cjht.2023.583","title":"Edaravone Oral Suspension (Radicava)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Edaravone; Amyotrophic lateral sclerosis; Suspension (topology); Medicine; Intensive care medicine; Pharmacology; Internal medicine; Political science; Disease; Health care","score_opus":0.09077613698380728,"score_gpt":0.35837008768806955,"score_spread":0.2675939507042623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321850144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7916113,0.00880696,0.000035343724,0.19843678,0.0003238006,0.0002801123,0.0000068049576,0.0002532436,0.00024563752],"genre_scores_gemma":[0.997291,0.0012882302,0.00049189205,0.00054630643,0.00002208665,0.0000028547297,0.0000047633794,0.000019805873,0.00033301653],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9982213,0.00006244944,0.0004956868,0.00013710525,0.00035022796,0.0007332463],"domain_scores_gemma":[0.9989905,0.000048054142,0.00019212822,0.00028007053,0.00022493093,0.0002643433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010708679,0.00010962373,0.0004332772,0.0011715079,0.00022924657,0.00002548483,0.00028097729,0.00016920092,0.00010144347],"category_scores_gemma":[0.0009785729,0.00008230438,0.000084449974,0.001010089,0.00030904374,0.000086254695,0.000038946982,0.00071503414,0.0001412781],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007134374,0.000024534625,0.016458465,0.00017472524,0.000074731375,0.0025142217,0.0003028904,0.000015510721,0.002785936,0.0009995955,0.12738797,0.84919006],"study_design_scores_gemma":[0.0021167567,0.0026513627,0.59625703,0.0010782061,0.000027075483,0.001790856,0.0033274768,0.00016523628,0.001461058,0.0055784443,0.3852718,0.00027474287],"about_ca_topic_score_codex":0.0033933928,"about_ca_topic_score_gemma":0.0014987538,"teacher_disagreement_score":0.84891534,"about_ca_system_score_codex":0.0005557739,"about_ca_system_score_gemma":0.0032948744,"threshold_uncertainty_score":0.58449656},"labels":[],"label_agreement":null},{"id":"W4321850145","doi":"10.51731/cjht.2023.584","title":"Dental Sealants for the Prevention of Dental Caries","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Dental Health and Care Utilization","field":"Dentistry","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Sealant; Dentistry; Medicine; Molar; Materials science","score_opus":0.042477260995364606,"score_gpt":0.34320494903714555,"score_spread":0.30072768804178096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321850145","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9726417,0.021383446,0.000994296,0.0016413593,0.002377478,0.0006050845,0.00019233047,0.00010946306,0.00005480753],"genre_scores_gemma":[0.99914414,0.00039278308,0.000066329805,0.0000926854,0.00002038554,0.000014932692,0.00002307157,0.000012741538,0.00023296235],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986825,0.000045080793,0.00058099633,0.00009355733,0.00020383055,0.0003940478],"domain_scores_gemma":[0.99899316,0.00012500638,0.0004888985,0.00016615454,0.0001580286,0.000068741654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073380035,0.00008798095,0.00023028087,0.00039981515,0.0003504807,0.000031704134,0.00036871395,0.00011772807,0.000016921278],"category_scores_gemma":[0.00042616,0.00006746635,0.000114042356,0.0004650306,0.00017733875,0.000118416516,0.000024642271,0.00018289809,0.000014529288],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008853935,0.000027786446,0.18675932,0.00075359415,0.00008770497,0.000103791026,0.00038944613,0.00006615027,0.000097432654,0.003621792,0.039276328,0.76872814],"study_design_scores_gemma":[0.0027522,0.0018770226,0.71129894,0.0010893838,0.00011420974,0.0017899175,0.13127762,0.00057307293,0.006906559,0.015672555,0.12622726,0.00042127154],"about_ca_topic_score_codex":0.0028972235,"about_ca_topic_score_gemma":0.08359057,"teacher_disagreement_score":0.76830685,"about_ca_system_score_codex":0.00024373828,"about_ca_system_score_gemma":0.0012222703,"threshold_uncertainty_score":0.9331315},"labels":[],"label_agreement":null},{"id":"W4322628486","doi":"10.51731/cjht.2023.588","title":"Mepolizumab (Nucala)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Sinusitis and nasal conditions","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Mepolizumab; Medicine; Nasal administration; Sinusitis; Intensive care medicine; Family medicine; Surgery; Internal medicine; Pharmacology; Health care; Political science","score_opus":0.05100338439174335,"score_gpt":0.3310257490628313,"score_spread":0.28002236467108793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322628486","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8580535,0.019481644,0.0000701404,0.119375765,0.00068453996,0.00021482108,0.000037673744,0.00039818764,0.0016837032],"genre_scores_gemma":[0.99854803,0.00024629149,0.00019735716,0.00073255907,0.00001934685,0.0000024689498,0.0000054016687,0.000010767817,0.00023775485],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990988,0.000017767094,0.00033495403,0.00007080811,0.00011834437,0.00035934654],"domain_scores_gemma":[0.9993903,0.00003684225,0.00015218067,0.00016259131,0.00012948754,0.00012859536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003206366,0.000066941866,0.00025840767,0.0010282644,0.00019526409,0.000014065277,0.00012720581,0.00009530843,0.00006376911],"category_scores_gemma":[0.0005545914,0.000055557437,0.00007276842,0.0006936488,0.0001354279,0.00005225537,0.000009924538,0.00032026542,0.000064222484],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021341135,0.000023613093,0.042418424,0.00017714441,0.00009653671,0.0037545406,0.00039991701,0.0000064369037,0.00017549934,0.009769468,0.34218186,0.6009752],"study_design_scores_gemma":[0.0011979593,0.0011998075,0.4827425,0.00063081837,0.00003482645,0.0042374814,0.0060406034,0.000021411328,0.00055645674,0.0064988337,0.49666685,0.0001724656],"about_ca_topic_score_codex":0.001543399,"about_ca_topic_score_gemma":0.0015103387,"teacher_disagreement_score":0.6008027,"about_ca_system_score_codex":0.0002526983,"about_ca_system_score_gemma":0.002846968,"threshold_uncertainty_score":0.5050399},"labels":[],"label_agreement":null},{"id":"W4322628564","doi":"10.51731/cjht.2023.586","title":"Guselkumab (Tremfya)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Psoriatic arthritis; Antirheumatic drugs; Drug; Methotrexate; Family medicine; Rheumatoid arthritis; Antirheumatic Agents; Surgery; Pharmacology; Internal medicine; Health care; Political science","score_opus":0.14677292511683313,"score_gpt":0.4164534900742946,"score_spread":0.2696805649574615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322628564","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19245438,0.12118678,0.000041647214,0.6808902,0.00087111467,0.00026711592,0.00001458738,0.0003795077,0.0038946904],"genre_scores_gemma":[0.99266154,0.0053910376,0.00020019429,0.001544797,0.000020662605,0.000002173903,0.0000010669404,0.000008972844,0.00016956725],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989939,0.000027688115,0.00033796785,0.00007702287,0.00013561135,0.00042781918],"domain_scores_gemma":[0.9993201,0.00010540485,0.00019615049,0.00013138211,0.00010962793,0.00013736941],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006777442,0.00007496928,0.00028912447,0.000444905,0.00024088362,0.000016723194,0.00015140984,0.00007541541,0.000056098146],"category_scores_gemma":[0.0011526601,0.000056186385,0.0000635562,0.000598644,0.00014243781,0.00007696992,0.000020236632,0.00045275965,0.00007691312],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002422363,0.000011320956,0.0064543784,0.00012013094,0.000086420056,0.00070837233,0.0001816794,0.0000028791658,0.000047351365,0.00077266624,0.08448151,0.9071091],"study_design_scores_gemma":[0.00037227338,0.0003314339,0.01468097,0.00011379155,0.000021690024,0.00037478845,0.0026879522,0.000014035498,0.00023667494,0.001492732,0.97961944,0.000054221626],"about_ca_topic_score_codex":0.0011976525,"about_ca_topic_score_gemma":0.0008592623,"teacher_disagreement_score":0.90705484,"about_ca_system_score_codex":0.00019553538,"about_ca_system_score_gemma":0.0012755481,"threshold_uncertainty_score":0.22912143},"labels":[],"label_agreement":null},{"id":"W4322726485","doi":"10.51731/cjht.2022.589","title":"Point-of-Care Tests for Pancreatitis","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pancreatitis; Endoscopic retrograde cholangiopancreatography; Point of care; Medicine; Acute pancreatitis; Point (geometry); Test (biology); Point-of-care testing; Health care; Service (business); Intensive care medicine; Business; Pathology; Internal medicine; Political science; Biology; Mathematics; Marketing","score_opus":0.041378879018475076,"score_gpt":0.3270817336030432,"score_spread":0.2857028545845681,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322726485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91496104,0.05001267,0.0009805276,0.031581152,0.00085747923,0.0006719413,0.00007418274,0.00036880825,0.0004922169],"genre_scores_gemma":[0.9981671,0.00033590692,0.0012786798,0.00011391754,0.00002019443,0.000011439532,0.0000044725975,0.000010631044,0.000057669025],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992392,0.000012113165,0.0003227671,0.000077077326,0.000090949616,0.00025789882],"domain_scores_gemma":[0.9992229,0.00007855371,0.00022422374,0.0001297269,0.00027326704,0.00007134019],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000292693,0.000064311665,0.00030373776,0.0006926262,0.00011105234,0.000006957312,0.000091281625,0.00009389177,0.0000058793344],"category_scores_gemma":[0.0010160474,0.000055667875,0.00008830346,0.00049242505,0.00008188169,0.00004008544,0.0000072604926,0.00017787999,0.0000022641489],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021049143,0.0000035876242,0.012490803,0.00049385603,0.00003233922,0.00006683001,0.00041108087,0.000010518964,0.00008247764,0.00022741195,0.009748819,0.9762218],"study_design_scores_gemma":[0.005270658,0.049398504,0.32860488,0.004632643,0.00017794999,0.0028384738,0.049136862,0.00020191995,0.022616131,0.010826431,0.525772,0.0005235837],"about_ca_topic_score_codex":0.0023731922,"about_ca_topic_score_gemma":0.005277774,"teacher_disagreement_score":0.9756982,"about_ca_system_score_codex":0.000261052,"about_ca_system_score_gemma":0.0017417251,"threshold_uncertainty_score":0.35875726},"labels":[],"label_agreement":null},{"id":"W4323360573","doi":"10.51731/cjht.2022.590","title":"2023 Watch List: Top 10 Precision Medicine Technologies and Issues","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; York University; Hospital for Sick Children; University of Toronto; SickKids Foundation; Cancer Care Ontario","funders":"","keywords":"Precision medicine; Health care; Scope (computer science); Equity (law); Health equity; Mental health; Medicine; Computer science; Political science","score_opus":0.3294868882497334,"score_gpt":0.4438877261962957,"score_spread":0.1144008379465623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323360573","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08268279,0.155579,0.00018078198,0.7591682,0.00086746016,0.0004152294,0.00010616077,0.0004042907,0.00059609907],"genre_scores_gemma":[0.97176874,0.019903274,0.0019558677,0.0029180648,0.00011836447,0.00004391585,0.000018329361,0.000051092393,0.0032223647],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99486643,0.00014054566,0.003770203,0.00037614675,0.00011901303,0.00072766864],"domain_scores_gemma":[0.9960615,0.0006649878,0.0024455858,0.00052927906,0.0001528653,0.00014580112],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.016078204,0.00021098499,0.0012845242,0.0019914745,0.00044051762,0.00007371143,0.0006712248,0.0003609652,0.00022581461],"category_scores_gemma":[0.018163396,0.00021100022,0.00007163707,0.000936049,0.0005065502,0.00037581119,0.00008263082,0.000478574,0.0004367313],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009351718,0.0000123407835,0.02321193,0.00052948593,0.00006484834,0.000038552353,0.002088905,0.00002284914,0.000004320252,0.040836178,0.81261486,0.12056636],"study_design_scores_gemma":[0.00043392405,0.00038268004,0.008501892,0.00046636863,0.000003668044,0.000061783445,0.023952277,0.00013688595,0.000018619108,0.117266096,0.8485569,0.00021890293],"about_ca_topic_score_codex":0.013411195,"about_ca_topic_score_gemma":0.005079266,"teacher_disagreement_score":0.88908595,"about_ca_system_score_codex":0.0006832678,"about_ca_system_score_gemma":0.00075503555,"threshold_uncertainty_score":0.9931586},"labels":[],"label_agreement":null},{"id":"W4323569680","doi":"10.51731/cjht.2022.591","title":"Automatic Stop Orders for Opioids","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Observational study; Medical prescription; Opioid; Context (archaeology); Medicine; Adverse effect; Pharmacology; Internal medicine","score_opus":0.03600269691823518,"score_gpt":0.32803725950607904,"score_spread":0.2920345625878439,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323569680","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7614161,0.031746276,0.00032663785,0.20366709,0.0008043438,0.0012038538,0.0000473275,0.0006508936,0.00013753095],"genre_scores_gemma":[0.9959979,0.0004785164,0.002735094,0.00055517023,0.000011047566,0.000036129,0.000012729678,0.000025347468,0.00014803794],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987569,0.000018083898,0.00046018694,0.00011353454,0.00013273857,0.0005185938],"domain_scores_gemma":[0.99918276,0.00007741962,0.00022478381,0.00023927834,0.00015038661,0.00012536465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004279764,0.00011843869,0.0004022549,0.000984489,0.00018826069,0.000016935805,0.00017924079,0.00011377779,0.000024398902],"category_scores_gemma":[0.00078499666,0.00009641504,0.000106243366,0.0005663687,0.00010991999,0.000051492585,0.00001066664,0.00020856982,0.000026531528],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013484739,0.00002998499,0.0074244756,0.00063981576,0.00011832743,0.0001778749,0.00092771597,0.000015784895,0.000016556045,0.0010050451,0.045472834,0.9441581],"study_design_scores_gemma":[0.0066082203,0.007452287,0.10118502,0.0019547946,0.00020918672,0.0007313066,0.05768635,0.0016777407,0.00071289367,0.017162576,0.80412084,0.0004987858],"about_ca_topic_score_codex":0.0015662741,"about_ca_topic_score_gemma":0.000832113,"teacher_disagreement_score":0.9436593,"about_ca_system_score_codex":0.00047869355,"about_ca_system_score_gemma":0.0044039497,"threshold_uncertainty_score":0.7812418},"labels":[],"label_agreement":null},{"id":"W4323925622","doi":"10.51731/cjht.2022.594","title":"Dexamethasone Intravitreal Implant (Ozurdex)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Diabetic macular edema; Medicine; Dexamethasone; Implant; Drug; Intensive care medicine; Ophthalmology; Pharmacology; Surgery; Internal medicine; Diabetic retinopathy; Diabetes mellitus; Health care; Political science; Endocrinology","score_opus":0.035897500427676775,"score_gpt":0.3247893953953579,"score_spread":0.28889189496768114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323925622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9279686,0.021842713,0.00003015189,0.048982147,0.0003453191,0.00024880827,0.000057635716,0.00020291578,0.0003217017],"genre_scores_gemma":[0.99777377,0.0013774853,0.00033749346,0.0003457409,0.000014642794,0.00000422803,0.0000133341955,0.000013849143,0.00011944553],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99885184,0.000026361146,0.00038036387,0.000107604246,0.00015121208,0.00048263636],"domain_scores_gemma":[0.9992381,0.000044561253,0.00020435196,0.00019158526,0.0000974907,0.00022395971],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029368734,0.00010852894,0.00035910695,0.00068655645,0.0001432692,0.000017393451,0.00014016723,0.000093787356,0.000027385253],"category_scores_gemma":[0.00033853817,0.00008061707,0.00009947502,0.000481529,0.000120942765,0.000046726105,0.000013179602,0.000259953,0.00004882321],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000062006686,0.000031594125,0.056705024,0.00014192167,0.0001273727,0.0054045273,0.00013106782,0.0000037293319,0.000041501447,0.0005809409,0.02408421,0.9126861],"study_design_scores_gemma":[0.0024025303,0.0031727117,0.787639,0.00087867863,0.00013740936,0.0065675895,0.0054827016,0.000030139356,0.00051001454,0.0076647243,0.18527466,0.00023981852],"about_ca_topic_score_codex":0.0046918923,"about_ca_topic_score_gemma":0.0011649907,"teacher_disagreement_score":0.91244626,"about_ca_system_score_codex":0.00029287688,"about_ca_system_score_gemma":0.0021537906,"threshold_uncertainty_score":0.7092769},"labels":[],"label_agreement":null},{"id":"W4324149309","doi":"10.51731/cjht.2022.596","title":"Pembrolizumab (Keytruda)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pembrolizumab; Reimbursement; Medicine; Bevacizumab; Test (biology); Family medicine; Intensive care medicine; Chemotherapy; Cancer; Internal medicine; Health care; Immunotherapy; Political science","score_opus":0.038417204387254815,"score_gpt":0.3117376367690041,"score_spread":0.2733204323817493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4324149309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7166063,0.08047093,0.000054745855,0.19996922,0.0010615438,0.00030841847,0.000017413622,0.00041128136,0.0011001534],"genre_scores_gemma":[0.99646455,0.0021123716,0.00013623963,0.0009581945,0.00001713191,0.0000027312444,0.0000024630215,0.0000128994125,0.00029339292],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989492,0.000019841222,0.00040119622,0.00008311081,0.000140389,0.0004062119],"domain_scores_gemma":[0.99938554,0.000026318006,0.00020637254,0.00019686723,0.00009649765,0.00008842427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005281416,0.00008349108,0.00028743068,0.0009062113,0.00015521508,0.000015796273,0.00017525417,0.00011018229,0.000057708497],"category_scores_gemma":[0.0002266633,0.000066642104,0.00010258137,0.000729328,0.0001786456,0.000051129413,0.0000087703565,0.00029864532,0.000027883409],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014941081,0.0000074337304,0.0065322123,0.00011173048,0.000076394834,0.00047123551,0.0002618195,0.0000019262056,0.00030590527,0.00029773952,0.059211314,0.9325729],"study_design_scores_gemma":[0.0018702062,0.0010870118,0.08801529,0.00043220748,0.00001630513,0.0014903153,0.004551306,0.0000112185635,0.000990849,0.0015524658,0.8998606,0.0001222089],"about_ca_topic_score_codex":0.0024403597,"about_ca_topic_score_gemma":0.0015300225,"teacher_disagreement_score":0.93245065,"about_ca_system_score_codex":0.00037038923,"about_ca_system_score_gemma":0.0033715025,"threshold_uncertainty_score":0.59809005},"labels":[],"label_agreement":null},{"id":"W4327621571","doi":"10.51731/cjht.2023.597","title":"Eptinezumab (Vyepti)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Migraine; Drug class; Medicine; Family medicine; Drug; Psychiatry; Political science; Health care; Law","score_opus":0.06256858349756063,"score_gpt":0.3386118358547654,"score_spread":0.2760432523572048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4327621571","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.40989617,0.090478994,0.00010008687,0.4927551,0.00027778416,0.00047709685,0.000020792117,0.0006544967,0.0053394767],"genre_scores_gemma":[0.99548066,0.0016312279,0.00033754524,0.00086571515,0.000029657484,0.0000040357127,0.000002569014,0.000012785757,0.0016357799],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988551,0.000017875022,0.00043063797,0.00008921077,0.00013650142,0.00047064724],"domain_scores_gemma":[0.99932164,0.00004006849,0.00018537095,0.00018507105,0.00016041638,0.00010743186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055426406,0.000094784,0.00039606765,0.0009248709,0.00021576797,0.000010194138,0.00014449569,0.00009540501,0.00004454936],"category_scores_gemma":[0.0008730315,0.00007330039,0.000103012004,0.0006510281,0.00016497458,0.00004228758,0.000018515515,0.00039306667,0.00007502233],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014606734,0.000010268217,0.018321387,0.0002255401,0.00008382765,0.000652347,0.0008995616,0.0000026366695,0.000051978703,0.0014906955,0.76007116,0.21817596],"study_design_scores_gemma":[0.0005346001,0.0006664018,0.056913618,0.00029993887,0.000018886094,0.000562738,0.0110720005,0.000008184714,0.0001360259,0.0023546175,0.9273443,0.00008867991],"about_ca_topic_score_codex":0.0018306031,"about_ca_topic_score_gemma":0.0038020685,"teacher_disagreement_score":0.5855845,"about_ca_system_score_codex":0.00019546722,"about_ca_system_score_gemma":0.0022704857,"threshold_uncertainty_score":0.40277442},"labels":[],"label_agreement":null},{"id":"W4327698971","doi":"10.51731/cjht.2023.599","title":"Formulary Management of Targeted Immune Modulators in Ulcerative Colitis","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Golimumab; Medicine; Ulcerative colitis; Infliximab; Biosimilar; Tofacitinib; Adalimumab; Ustekinumab; Formulary; Vedolizumab; Pharmacology; Immunology; Internal medicine; Rheumatoid arthritis; Disease","score_opus":0.02723269619042964,"score_gpt":0.29722217123173855,"score_spread":0.26998947504130894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4327698971","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86706877,0.0946342,0.0005145531,0.03411687,0.0016558575,0.0008077191,0.00017432083,0.00018603691,0.00084168743],"genre_scores_gemma":[0.99739826,0.0013541651,0.0009504332,0.000095151714,0.0000015576359,0.0000044681983,0.0000058165124,0.000007778463,0.0001823805],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99846846,0.00015484123,0.00072433986,0.00011908577,0.000037411195,0.0004958908],"domain_scores_gemma":[0.99933976,0.00006391933,0.0003139754,0.00018149245,0.00007550305,0.000025349396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011744461,0.00011190258,0.00046628187,0.0008744666,0.00010779696,0.0000056999625,0.00032485905,0.0002507247,0.0000620111],"category_scores_gemma":[0.00013517642,0.00009138333,0.00009047228,0.0008295226,0.00032813312,0.000056424302,0.00004427115,0.0004128388,0.0000090419035],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014660934,0.0000654423,0.007916734,0.00044377413,0.0005598015,0.00050808024,0.00076391274,0.000046661753,0.0021895445,0.023360768,0.00658306,0.95741564],"study_design_scores_gemma":[0.0034924636,0.001702502,0.756194,0.0016552516,0.00006968332,0.00025673694,0.028075421,0.00005536764,0.057508122,0.041547354,0.108893536,0.00054958224],"about_ca_topic_score_codex":0.0013952315,"about_ca_topic_score_gemma":0.0016012318,"teacher_disagreement_score":0.956866,"about_ca_system_score_codex":0.00017551384,"about_ca_system_score_gemma":0.0003961453,"threshold_uncertainty_score":0.37265038},"labels":[],"label_agreement":null},{"id":"W4328121497","doi":"10.51731/cjht.2023.600","title":"An Overview of Clinical Applications of Virtual and Augmented Reality","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Stroke Rehabilitation and Recovery","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba","funders":"","keywords":"Psychological intervention; Anxiety; Mental health; Medicine; Intervention (counseling); Virtual reality; Health care; Autism spectrum disorder; Psychiatry; Autism; Computer science; Human–computer interaction","score_opus":0.17253962374510123,"score_gpt":0.4711807475025072,"score_spread":0.298641123757406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4328121497","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9592125,0.019922245,0.00027689972,0.019907312,0.00016327055,0.00033642972,0.000060503124,0.000052507316,0.00006833125],"genre_scores_gemma":[0.9937111,0.00559109,0.0005282847,0.00012389084,0.000010206185,0.000003986471,0.000004831842,0.0000048957713,0.000021671478],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9987104,0.00007551424,0.000879989,0.000084149025,0.000111201836,0.00013877837],"domain_scores_gemma":[0.9987867,0.00019700246,0.00048840034,0.00021404684,0.00019816545,0.00011567145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013133019,0.000051362782,0.00045126607,0.00050974486,0.000045927383,0.0000026053763,0.00010075112,0.00011305973,0.000009661013],"category_scores_gemma":[0.00089333364,0.000040529212,0.00008291408,0.00042831135,0.00036102848,0.00004126103,0.0000091479915,0.00021136658,0.0000010115236],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028182661,0.000048302893,0.13732718,0.00047021036,0.00004617968,0.0000066474236,0.00014494456,0.000004811443,0.00008222048,0.0031778167,0.0020131636,0.85665035],"study_design_scores_gemma":[0.0008059179,0.002120422,0.9327186,0.00048199663,0.000028416289,0.00005655791,0.0075027444,0.000045971752,0.00018777224,0.0021734703,0.05382382,0.000054315187],"about_ca_topic_score_codex":0.0012258728,"about_ca_topic_score_gemma":0.00071192894,"teacher_disagreement_score":0.85659605,"about_ca_system_score_codex":0.00005354546,"about_ca_system_score_gemma":0.0016213455,"threshold_uncertainty_score":0.28761974},"labels":[],"label_agreement":null},{"id":"W4353076861","doi":"10.51731/cjht.2023.603","title":"Pembrolizumab (Keytruda)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pembrolizumab; Reimbursement; Medicine; Chemotherapy; Oncology; Disease; Internal medicine; Breast cancer; Test (biology); Family medicine; Cancer; Health care; Immunotherapy; Political science","score_opus":0.038417204387254815,"score_gpt":0.3117376367690041,"score_spread":0.2733204323817493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4353076861","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7166063,0.08047093,0.000054745855,0.19996922,0.0010615438,0.00030841847,0.000017413622,0.00041128136,0.0011001534],"genre_scores_gemma":[0.99646455,0.0021123716,0.00013623963,0.0009581945,0.00001713191,0.0000027312444,0.0000024630215,0.0000128994125,0.00029339292],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989492,0.000019841222,0.00040119622,0.00008311081,0.000140389,0.0004062119],"domain_scores_gemma":[0.99938554,0.000026318006,0.00020637254,0.00019686723,0.00009649765,0.00008842427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005281416,0.00008349108,0.00028743068,0.0009062113,0.00015521508,0.000015796273,0.00017525417,0.00011018229,0.000057708497],"category_scores_gemma":[0.0002266633,0.000066642104,0.00010258137,0.000729328,0.0001786456,0.000051129413,0.0000087703565,0.00029864532,0.000027883409],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014941081,0.0000074337304,0.0065322123,0.00011173048,0.000076394834,0.00047123551,0.0002618195,0.0000019262056,0.00030590527,0.00029773952,0.059211314,0.9325729],"study_design_scores_gemma":[0.0018702062,0.0010870118,0.08801529,0.00043220748,0.00001630513,0.0014903153,0.004551306,0.0000112185635,0.000990849,0.0015524658,0.8998606,0.0001222089],"about_ca_topic_score_codex":0.0024403597,"about_ca_topic_score_gemma":0.0015300225,"teacher_disagreement_score":0.93245065,"about_ca_system_score_codex":0.00037038923,"about_ca_system_score_gemma":0.0033715025,"threshold_uncertainty_score":0.59809005},"labels":[],"label_agreement":null},{"id":"W4360949189","doi":"10.51731/cjht.2023.607","title":"Living With Type 2 Diabetes","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Diabetes Management and Education","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Diabetes Canada","keywords":"Reimbursement; Psychosocial; Medicine; Quality of life (healthcare); Type 2 diabetes; Polypharmacy; Type 1 diabetes; Diabetes mellitus; Nursing; Gerontology; Intensive care medicine; Psychiatry; Health care; Political science","score_opus":0.02818776541507773,"score_gpt":0.2793533771637474,"score_spread":0.2511656117486697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4360949189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9600311,0.0076736794,0.000006915522,0.030862624,0.00038787522,0.00011580247,6.864408e-7,0.00016153777,0.00075980404],"genre_scores_gemma":[0.99863774,0.00024675432,0.0002651989,0.00043253828,0.00001626288,0.0000020738312,0.000002417368,0.00001030016,0.00038670533],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9992981,0.000012495389,0.00019268255,0.00006368768,0.00009356466,0.00033946504],"domain_scores_gemma":[0.9994987,0.000039027764,0.00014270908,0.00013224472,0.00011826454,0.00006902792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004813158,0.000059981052,0.00018250567,0.0007705674,0.000101909434,0.000021160215,0.000107901215,0.000043457032,0.000028116616],"category_scores_gemma":[0.00038529476,0.000044816446,0.00002154295,0.0007693335,0.000075437776,0.00007491955,0.000009649907,0.00017087399,0.000036860005],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000032759874,0.000012023272,0.45250472,0.00023809588,0.00006658693,0.000041479565,0.00036563643,0.000010204679,0.00002591404,0.00034124075,0.0513773,0.49501354],"study_design_scores_gemma":[0.00028730018,0.0015663882,0.74915355,0.0014034446,0.000043958276,0.000028007964,0.010003751,0.00004156656,0.0001312318,0.001049441,0.23615663,0.00013473116],"about_ca_topic_score_codex":0.0001956457,"about_ca_topic_score_gemma":0.0003503447,"teacher_disagreement_score":0.4948788,"about_ca_system_score_codex":0.00014118692,"about_ca_system_score_gemma":0.0012385997,"threshold_uncertainty_score":0.21972226},"labels":[],"label_agreement":null},{"id":"W4361205476","doi":"10.51731/cjht.2023.608","title":"Formulary Management of Biologics in Plaque Psoriasis","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ustekinumab; Biosimilar; Medicine; Formulary; Plaque psoriasis; Biologic Agents; Infliximab; Psoriasis; Family medicine; Tumor necrosis factor alpha; Internal medicine; Dermatology; Disease","score_opus":0.04817312372920696,"score_gpt":0.31702777676995286,"score_spread":0.2688546530407459,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361205476","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6961749,0.19351313,0.00089152204,0.10266907,0.0034117212,0.0009298552,0.00019682493,0.00033947203,0.0018734882],"genre_scores_gemma":[0.9938541,0.004223338,0.0016073064,0.00017787021,0.0000023265561,0.000003338168,0.0000041991184,0.000006304915,0.0001211851],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998609,0.000119581964,0.00064853125,0.000118080134,0.00002913768,0.00047568872],"domain_scores_gemma":[0.9993448,0.000097349985,0.00029551034,0.00018339888,0.000057051395,0.000021836482],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013502327,0.00010419246,0.00041481797,0.0008835017,0.000084648505,0.0000046507375,0.00039947894,0.00032382374,0.00004107743],"category_scores_gemma":[0.00017798685,0.00007789869,0.00008507933,0.0007826695,0.00030480514,0.000039335493,0.00004890192,0.00040657353,0.000012723817],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004862782,0.000036677917,0.01207357,0.00025692672,0.0002077778,0.00026484593,0.00014981008,0.0000131050265,0.00089071185,0.014822554,0.010800539,0.96043485],"study_design_scores_gemma":[0.0034587653,0.0023803446,0.16302955,0.0016476811,0.000087530556,0.00040310505,0.022343611,0.00001910515,0.037010282,0.0761947,0.6927955,0.0006298238],"about_ca_topic_score_codex":0.0007229564,"about_ca_topic_score_gemma":0.00080021017,"teacher_disagreement_score":0.959805,"about_ca_system_score_codex":0.000118571355,"about_ca_system_score_gemma":0.0003346157,"threshold_uncertainty_score":0.31766164},"labels":[],"label_agreement":null},{"id":"W4361268230","doi":"10.51731/cjht.2023.612","title":"Brolucizumab (Beovu)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Diabetic macular edema; Medicine; Drug; Family medicine; Political science; Pharmacology; Diabetes mellitus; Diabetic retinopathy; Health care","score_opus":0.03906193496694753,"score_gpt":0.3253698351831276,"score_spread":0.2863079002161801,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361268230","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.861042,0.04792984,0.000024562618,0.08898133,0.0004014602,0.00027504878,0.000029294828,0.0002839446,0.0010324806],"genre_scores_gemma":[0.9981678,0.0010181041,0.00015928548,0.0003645096,0.000009990736,0.0000029685743,0.0000054140373,0.000011254427,0.00026068554],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9990803,0.000016177655,0.00031100897,0.000083405124,0.00013182516,0.0003772686],"domain_scores_gemma":[0.9993772,0.00002142345,0.00016456426,0.00017709931,0.00009534508,0.0001643998],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019084537,0.000080442005,0.00027021408,0.00063052465,0.000136078,0.000014567322,0.00012259014,0.00007197958,0.000033210043],"category_scores_gemma":[0.00031302488,0.00006102398,0.00009439997,0.00046414175,0.00009446779,0.00004469846,0.000010157947,0.0001979102,0.000086658925],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047081823,0.00002705753,0.08242279,0.00017208156,0.00010819076,0.0033658333,0.00011176464,0.0000056412005,0.0000142563895,0.00084331963,0.03358654,0.87929547],"study_design_scores_gemma":[0.0015419413,0.0016539557,0.68536925,0.0006133533,0.000060690538,0.0014531178,0.0031924117,0.000023699386,0.00015162931,0.006172892,0.2996342,0.00013287131],"about_ca_topic_score_codex":0.0018451491,"about_ca_topic_score_gemma":0.0004512765,"teacher_disagreement_score":0.87916255,"about_ca_system_score_codex":0.00026788612,"about_ca_system_score_gemma":0.002221856,"threshold_uncertainty_score":0.39414772},"labels":[],"label_agreement":null},{"id":"W4361283772","doi":"10.51731/cjht.2023.610","title":"Darolutamide (Nubeqa)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Docetaxel; Prostate cancer; Medicine; Drug; Drug class; Family medicine; Cancer; Pharmacology; Political science; Internal medicine; Health care","score_opus":0.06536889916657437,"score_gpt":0.3642351572893772,"score_spread":0.2988662581228029,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361283772","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6617738,0.0759788,0.000030420755,0.2596406,0.00056989276,0.00039334266,0.000025475292,0.00035101696,0.0012366759],"genre_scores_gemma":[0.99591994,0.0026939723,0.00015344605,0.0003147585,0.000015838319,0.0000052702776,0.000005629984,0.000012684063,0.0008784773],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99888736,0.00002223006,0.00030475375,0.0000891407,0.00017597566,0.00052053353],"domain_scores_gemma":[0.999375,0.000034453235,0.0001234715,0.00018075357,0.00013680692,0.00014952385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005375515,0.000077825236,0.00028174755,0.0010363674,0.00017872709,0.000016931923,0.00016497765,0.00009008936,0.00002924007],"category_scores_gemma":[0.0003572631,0.000056389,0.00006738685,0.0007314262,0.0001941349,0.000057908237,0.000016054459,0.00037078687,0.000060798615],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052312917,0.000015244912,0.031880327,0.000204544,0.00009849038,0.0023797336,0.00033218175,0.0000070212022,0.00021605485,0.00044812265,0.07348886,0.8908771],"study_design_scores_gemma":[0.0028242888,0.002261757,0.1840581,0.0008753897,0.000036169215,0.0012519823,0.009172295,0.000045154797,0.0042155813,0.008323395,0.7867271,0.00020878304],"about_ca_topic_score_codex":0.001401095,"about_ca_topic_score_gemma":0.00090154895,"teacher_disagreement_score":0.89066833,"about_ca_system_score_codex":0.00049871556,"about_ca_system_score_gemma":0.0045394083,"threshold_uncertainty_score":0.8052715},"labels":[],"label_agreement":null},{"id":"W4362698908","doi":"10.51731/cjht.2023.615","title":"Low-Level Laser Treatment for Lower Back Pain","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Laser Applications in Dentistry and Medicine","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chronic pain; Low back pain; Medicine; Health care; Physical therapy; Alternative medicine; Pathology","score_opus":0.08412602082015072,"score_gpt":0.3493078580773847,"score_spread":0.265181837257234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362698908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5301504,0.01525672,0.011520363,0.4356713,0.002423018,0.003248269,0.00044200572,0.0005690911,0.00071880914],"genre_scores_gemma":[0.9923775,0.0007429293,0.0020717517,0.0013743449,0.00006429503,0.00006069432,0.00003801911,0.000020104122,0.0032503358],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989444,0.000023600169,0.00041949106,0.000119878765,0.00009962654,0.00039301306],"domain_scores_gemma":[0.99911034,0.000122758,0.0001811408,0.0002793816,0.00015245544,0.00015390696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083323586,0.0001061511,0.00033466512,0.00044143066,0.00015431127,0.0000098369665,0.00014863755,0.00011852046,0.000055938646],"category_scores_gemma":[0.0006778459,0.00007801532,0.000095360054,0.00041575075,0.00013847374,0.000036152785,0.0000072637713,0.00015950314,0.000056491423],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004386788,0.000059526945,0.0021182378,0.0003037079,0.00008116548,0.0002674503,0.00014860764,0.000010082412,0.00008710548,0.00023794817,0.19610474,0.8005376],"study_design_scores_gemma":[0.0022027644,0.0023949796,0.0053629684,0.00056706386,0.000042137755,0.00035092724,0.0025574623,0.00004184864,0.004013643,0.0018223923,0.98053247,0.000111354755],"about_ca_topic_score_codex":0.00030192218,"about_ca_topic_score_gemma":0.0007871177,"teacher_disagreement_score":0.8004262,"about_ca_system_score_codex":0.0004544312,"about_ca_system_score_gemma":0.0020169797,"threshold_uncertainty_score":0.35780352},"labels":[],"label_agreement":null},{"id":"W4364378002","doi":"10.51731/cjht.2023.616","title":"Belimumab (Benlysta)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Belimumab; Reimbursement; Vial; Lupus nephritis; Medicine; Family medicine; Drug; Pharmacology; Internal medicine; Political science; Chemistry; Immunology","score_opus":0.11443310875397324,"score_gpt":0.3097521052128289,"score_spread":0.1953189964588557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4364378002","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3322343,0.16190349,0.0005756452,0.47773436,0.0034006895,0.0004164156,0.000652696,0.0004963466,0.02258607],"genre_scores_gemma":[0.9958449,0.0021348984,0.00012060327,0.0017086485,0.000022481976,0.0000029702687,0.0000025298486,0.000015466278,0.00014749984],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984864,0.000009794315,0.00080864236,0.00013149648,0.000018475894,0.0005452129],"domain_scores_gemma":[0.9990952,0.000040826122,0.0005007112,0.00020240314,0.000031463223,0.00012941315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010565044,0.00009323055,0.00039552106,0.0012115239,0.00018464892,0.000050986207,0.00043168955,0.000110147565,0.00010974892],"category_scores_gemma":[0.00039377538,0.0001028444,0.0000960376,0.0005181478,0.000118913485,0.00012834238,0.000026960786,0.00031396034,0.0006434631],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000059621134,0.000014245081,0.014736054,0.00009130451,0.000082226135,0.000094673014,0.0005039897,0.000157589,0.0000046548384,0.6485941,0.10224702,0.23346817],"study_design_scores_gemma":[0.0002283288,0.00007244617,0.0049543763,0.00001858953,0.0000010095467,0.000026543548,0.00030643784,0.00018324888,0.000025576723,0.19058649,0.8034953,0.00010163591],"about_ca_topic_score_codex":0.0021085169,"about_ca_topic_score_gemma":0.00086869835,"teacher_disagreement_score":0.7012483,"about_ca_system_score_codex":0.000314862,"about_ca_system_score_gemma":0.0005877073,"threshold_uncertainty_score":0.8270631},"labels":[],"label_agreement":null},{"id":"W4365513626","doi":"10.51731/cjht.2023.618","title":"Dupilumab (Dupixent)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dupilumab; Reimbursement; Atopic dermatitis; Medicine; Medical prescription; Drug; Family medicine; Intensive care medicine; Dermatology; Psychiatry; Pharmacology; Health care; Political science","score_opus":0.032088891347487436,"score_gpt":0.3086995705365656,"score_spread":0.27661067918907817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365513626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7023091,0.085792966,0.000045521243,0.20831107,0.00093043776,0.00027616107,0.000020820315,0.00054357114,0.0017704071],"genre_scores_gemma":[0.9980046,0.00063793326,0.00010726542,0.000989809,0.000009486824,0.0000028436586,0.000004157718,0.000009405532,0.0002344719],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990012,0.000028322671,0.00037289507,0.00008128718,0.00010796127,0.00040833242],"domain_scores_gemma":[0.99934536,0.000046031684,0.00017274408,0.00019176384,0.000102120764,0.0001419816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003196969,0.000078402496,0.00031653003,0.0008711268,0.00017913639,0.000011052495,0.00017529391,0.00012165984,0.000052398376],"category_scores_gemma":[0.0008384236,0.00006417143,0.00008200794,0.0004951624,0.0002178411,0.000057033674,0.000012900781,0.00031041406,0.00011162064],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036574194,0.00002369728,0.13707769,0.000240218,0.000085360974,0.004418029,0.00021203927,0.0000060876855,0.000014857755,0.0011084154,0.54942524,0.30735177],"study_design_scores_gemma":[0.0011148431,0.00034708824,0.31797484,0.00045643005,0.000036321013,0.0038573884,0.0044819685,0.000018828727,0.00032479168,0.008743078,0.66250604,0.00013836092],"about_ca_topic_score_codex":0.0003634335,"about_ca_topic_score_gemma":0.0004881558,"teacher_disagreement_score":0.3072134,"about_ca_system_score_codex":0.0001397772,"about_ca_system_score_gemma":0.0029908314,"threshold_uncertainty_score":0.5305606},"labels":[],"label_agreement":null},{"id":"W4366348155","doi":"10.51731/cjht.2023.619","title":"Lurbinectedin (Zepzelca)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Inhalation and Respiratory Drug Delivery","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Health Canada","keywords":"Reimbursement; Medicine; Family medicine; Political science; Health care","score_opus":0.0440627496326552,"score_gpt":0.30769963027935077,"score_spread":0.26363688064669555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366348155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8093421,0.023305729,0.000090875656,0.16272593,0.0013672264,0.0003146981,0.000012923003,0.00063273736,0.0022078296],"genre_scores_gemma":[0.99776393,0.0003146888,0.00014555645,0.0012482295,0.000026393664,0.0000016169733,0.00000271834,0.000011358863,0.00048548976],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99903035,0.000025834464,0.0003929316,0.00007538644,0.00014172155,0.00033377923],"domain_scores_gemma":[0.99932015,0.000028533292,0.0001913436,0.00015120905,0.00019358649,0.000115204704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051445345,0.00007412418,0.0002557036,0.0012297123,0.00016314634,0.000012489206,0.00012390064,0.00012128607,0.00005278551],"category_scores_gemma":[0.00057650835,0.00005795403,0.00006941499,0.0007511342,0.00012244724,0.00005414021,0.000009526253,0.00036209438,0.00010278256],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027542384,0.000019432795,0.019815495,0.000244856,0.00007391564,0.002009314,0.0005121864,0.000049862796,0.00048992387,0.001442047,0.25985923,0.7154562],"study_design_scores_gemma":[0.001039105,0.0006374857,0.036345467,0.0004443294,0.000019184641,0.0010047967,0.0054056123,0.00010367479,0.0017035826,0.0006627856,0.95248157,0.00015241922],"about_ca_topic_score_codex":0.00033070578,"about_ca_topic_score_gemma":0.00036776153,"teacher_disagreement_score":0.7153038,"about_ca_system_score_codex":0.00021463573,"about_ca_system_score_gemma":0.002738101,"threshold_uncertainty_score":0.48572734},"labels":[],"label_agreement":null},{"id":"W4366416036","doi":"10.51731/cjht.2023.622","title":"Dupilumab (Dupixent)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Dupilumab; Medicine; Asthma; Family medicine; Intensive care medicine; Immunology; Health care; Political science","score_opus":0.12354451478203543,"score_gpt":0.40744865768828953,"score_spread":0.2839041429062541,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366416036","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.25161758,0.12189662,0.000046067198,0.6214106,0.0009970126,0.00029498112,0.000014422068,0.00035886207,0.003363859],"genre_scores_gemma":[0.99290854,0.0051308298,0.00016532253,0.0015824904,0.000020264077,0.0000022866018,0.000001167853,0.000008601057,0.00018052584],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989672,0.000027895148,0.0003504704,0.000078037236,0.00013880713,0.00043761163],"domain_scores_gemma":[0.9993215,0.000099768855,0.00020461067,0.00012582919,0.000105652114,0.0001426306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070015166,0.00007536028,0.0002903202,0.0004169099,0.00024662208,0.000017600949,0.00014809075,0.00007338373,0.00006450068],"category_scores_gemma":[0.001147417,0.000056773708,0.00006540757,0.000557579,0.00014632082,0.00007755561,0.000021885488,0.00045280156,0.00008278554],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030996325,0.00001213896,0.010794226,0.0001363791,0.000086000975,0.00077089184,0.00018605232,0.000003237076,0.000033257016,0.00083900406,0.07574406,0.9113638],"study_design_scores_gemma":[0.00042454095,0.00034781345,0.022763152,0.000120251745,0.00001958181,0.00036079218,0.0027490633,0.000015063804,0.00014629595,0.0014665485,0.9715322,0.000054668122],"about_ca_topic_score_codex":0.0012763287,"about_ca_topic_score_gemma":0.00079751527,"teacher_disagreement_score":0.91130906,"about_ca_system_score_codex":0.00021221502,"about_ca_system_score_gemma":0.0013142853,"threshold_uncertainty_score":0.23314857},"labels":[],"label_agreement":null},{"id":"W4366583939","doi":"10.51731/cjht.2023.624","title":"Lemborexant (Dayvigo)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Sleep and related disorders","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Family medicine; Political science; Health care","score_opus":0.03488945574877507,"score_gpt":0.32283845210793494,"score_spread":0.2879489963591599,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366583939","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.55623937,0.20916106,0.0002658328,0.20610352,0.008570539,0.0004702747,0.000031829695,0.0012344694,0.017923113],"genre_scores_gemma":[0.9981877,0.000759312,0.00005651759,0.0005030115,0.000012565887,0.0000047199997,0.000002488406,0.00001789228,0.00045579634],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99859977,0.00006202805,0.00046777603,0.0001227523,0.000103343,0.000644316],"domain_scores_gemma":[0.9992467,0.0000593146,0.00026803688,0.00025296464,0.00007177628,0.000101170466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063952315,0.000103812126,0.0002499472,0.0012043264,0.00022565977,0.000018290857,0.00041831454,0.00024506348,0.00022180416],"category_scores_gemma":[0.00023161902,0.00008452575,0.000080022546,0.00091474643,0.0002122198,0.000047673853,0.000014242219,0.00053862523,0.000435505],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007315383,0.000015364354,0.005302047,0.00001539056,0.00017010272,0.0005931021,0.001676156,0.000025769903,0.000004718777,0.008783853,0.18750815,0.795898],"study_design_scores_gemma":[0.0010218087,0.00045041725,0.025400892,0.000124911,0.000025822275,0.00041793188,0.04790538,0.000009740246,0.000030962976,0.016791685,0.9076054,0.00021500954],"about_ca_topic_score_codex":0.0054451833,"about_ca_topic_score_gemma":0.0018728311,"teacher_disagreement_score":0.795683,"about_ca_system_score_codex":0.00012673695,"about_ca_system_score_gemma":0.0009838417,"threshold_uncertainty_score":0.8231524},"labels":[],"label_agreement":null},{"id":"W4366768571","doi":"10.51731/cjht.2023.629","title":"Anifrolumab (Saphnelo)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Drug; Family medicine; Autoantibody; Intensive care medicine; Immunology; Pharmacology; Political science; Health care; Antibody","score_opus":0.05748737273041901,"score_gpt":0.34252555837844345,"score_spread":0.2850381856480244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366768571","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83810484,0.04573629,0.00007559081,0.11289438,0.0007408405,0.0005133438,0.000014092821,0.0004955565,0.0014250692],"genre_scores_gemma":[0.9978415,0.0009343546,0.0002526059,0.00023528987,0.000022985714,0.0000061352894,0.0000024113485,0.000022177743,0.0006825543],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99823284,0.000051693973,0.00059014786,0.00012444981,0.00031782317,0.00068302336],"domain_scores_gemma":[0.99887973,0.00007970442,0.00024476493,0.00033688417,0.00026200133,0.00019691224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013814548,0.00010236249,0.00045738544,0.0016879323,0.00018172115,0.000024541621,0.00031984184,0.0001556786,0.00004913498],"category_scores_gemma":[0.0015107131,0.00008173778,0.00009296922,0.0011367754,0.00019543852,0.00006544154,0.000026796899,0.00052133866,0.00016518803],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043669304,0.000021824872,0.24677937,0.0013024344,0.00014518485,0.0039155767,0.0015024273,0.0000068480435,0.00023504565,0.0014801814,0.22399838,0.520569],"study_design_scores_gemma":[0.0036577273,0.002232644,0.05839624,0.004148992,0.0000375308,0.08620435,0.055720087,0.00013591505,0.0011337232,0.008721992,0.77921647,0.0003943302],"about_ca_topic_score_codex":0.0019590303,"about_ca_topic_score_gemma":0.0012993178,"teacher_disagreement_score":0.5552181,"about_ca_system_score_codex":0.00058747747,"about_ca_system_score_gemma":0.0056252535,"threshold_uncertainty_score":0.99789584},"labels":[],"label_agreement":null},{"id":"W4366769075","doi":"10.51731/cjht.2023.628","title":"Tebentafusp (Kimmtrak)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Ocular Oncology and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Family medicine; Drug; Political science; Pharmacology; Law","score_opus":0.038676213736566545,"score_gpt":0.3310579482046647,"score_spread":0.2923817344680982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366769075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8241436,0.033372518,0.000032059645,0.13976961,0.0007648757,0.00029877902,0.000013511378,0.0003171431,0.0012879197],"genre_scores_gemma":[0.9982291,0.0005723358,0.00031693955,0.0005603193,0.000010098323,0.0000030159715,0.0000047275526,0.000009804638,0.00029366303],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99911743,0.0000253515,0.00030561356,0.00008139577,0.000094894,0.00037529808],"domain_scores_gemma":[0.99946207,0.00002929273,0.00016145379,0.0001662449,0.00007356036,0.00010737142],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037335887,0.00007822565,0.00029404365,0.0007375558,0.00016807058,0.000007181234,0.00012338266,0.00014010993,0.00003820959],"category_scores_gemma":[0.00030030968,0.00006104326,0.00007487251,0.00046416474,0.00015135776,0.000046192312,0.000009955583,0.0003087718,0.00011197037],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025213585,0.00004001747,0.17780292,0.000099557175,0.00018430938,0.00463574,0.00024010213,0.000003946481,0.000041605064,0.0012096661,0.03381386,0.781903],"study_design_scores_gemma":[0.0023452663,0.0023458025,0.3434021,0.00040956953,0.00007892002,0.0028844962,0.0049936245,0.000010693601,0.0010327008,0.007855441,0.63448614,0.00015524898],"about_ca_topic_score_codex":0.00080312253,"about_ca_topic_score_gemma":0.0012599706,"teacher_disagreement_score":0.7817478,"about_ca_system_score_codex":0.00031163104,"about_ca_system_score_gemma":0.0024237824,"threshold_uncertainty_score":0.4299686},"labels":[],"label_agreement":null},{"id":"W4366987390","doi":"10.51731/cjht.2023.631","title":"Lumasiran (Oxlumo)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Kidney Stones and Urolithiasis Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Primary hyperoxaluria; Medicine; Family medicine; Intensive care medicine; Internal medicine; Political science; Health care","score_opus":0.04658851933332053,"score_gpt":0.32063157609817267,"score_spread":0.27404305676485213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366987390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.75542414,0.027669197,0.000027153888,0.21389382,0.0007454294,0.0003268051,0.000024940995,0.00041553608,0.0014729614],"genre_scores_gemma":[0.99762523,0.0005671959,0.00033328877,0.00092440477,0.000013792812,0.000003050198,0.000004727684,0.000015138373,0.00051317876],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988936,0.000020138026,0.0003898232,0.00009655991,0.00014745862,0.0004523758],"domain_scores_gemma":[0.9992755,0.000022499777,0.00019352538,0.0002155849,0.00010285715,0.00019002397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038719043,0.00009676049,0.00035866327,0.00083786953,0.00017293889,0.000013760117,0.0001481501,0.00010772454,0.000026553795],"category_scores_gemma":[0.0004249565,0.00007427103,0.0000935944,0.00057213416,0.0001151666,0.00005185311,0.000011394197,0.00028173337,0.00006956838],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024709707,0.0000311932,0.2051372,0.00015263457,0.0001312554,0.0013978486,0.00042588764,0.0000037368752,0.000050214858,0.0010113484,0.05378764,0.7378463],"study_design_scores_gemma":[0.0010783856,0.0008251362,0.3684408,0.00027330863,0.000032140637,0.0011643729,0.0028365538,0.000011863626,0.0002329442,0.0018579555,0.6231504,0.00009610982],"about_ca_topic_score_codex":0.0017602831,"about_ca_topic_score_gemma":0.00042169748,"teacher_disagreement_score":0.73775023,"about_ca_system_score_codex":0.0002726044,"about_ca_system_score_gemma":0.0023532626,"threshold_uncertainty_score":0.4174587},"labels":[],"label_agreement":null},{"id":"W4366987477","doi":"10.51731/cjht.2023.630","title":"Caplacizumab (Cablivi)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Placebo; Clinical trial; Disease; Quality of life (healthcare); Intensive care medicine; Internal medicine; Oncology; Alternative medicine; Pathology","score_opus":0.038920565652946666,"score_gpt":0.28553241571776977,"score_spread":0.2466118500648231,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366987477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.75105256,0.19528812,0.000107215295,0.046514902,0.0044361856,0.0005504507,0.00021804652,0.0009749903,0.00085754227],"genre_scores_gemma":[0.9991533,0.00021076025,0.000025580337,0.0001409208,0.000005750117,0.0000074016407,0.000016360782,0.000011580754,0.00042834727],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985448,0.000118037045,0.0005634176,0.00012028728,0.000039770744,0.0006136642],"domain_scores_gemma":[0.99912906,0.00010688342,0.00035202803,0.00026935837,0.00010837722,0.000034280918],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006605322,0.00011374438,0.00033187636,0.001097856,0.0003437669,0.000018966337,0.00052649254,0.0001400751,0.0003019866],"category_scores_gemma":[0.0005808881,0.00009928848,0.00008452139,0.0005324104,0.00022921871,0.00007733489,0.000038739694,0.00030295874,0.0005901182],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022295075,0.000020930505,0.022999963,0.00015461494,0.00018916596,0.00024224639,0.00054242753,0.000028570776,0.0010024024,0.0043425313,0.6201153,0.3503396],"study_design_scores_gemma":[0.00071191875,0.00032650353,0.027168963,0.00024280822,0.000013491876,0.00050044165,0.007919103,0.000001520248,0.0013992467,0.0034069493,0.95813984,0.00016919723],"about_ca_topic_score_codex":0.0029904104,"about_ca_topic_score_gemma":0.003535107,"teacher_disagreement_score":0.3501704,"about_ca_system_score_codex":0.0002468039,"about_ca_system_score_gemma":0.0018806736,"threshold_uncertainty_score":0.7584972},"labels":[],"label_agreement":null},{"id":"W4367024202","doi":"10.51731/cjht.2021.218","title":"Chlormethine Gel (Ledaga)","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Mycosis fungoides; Medicine; Dermatology; Cutaneous T-cell lymphoma; Lymphoma; Clinical trial; Internal medicine","score_opus":0.04797523497754828,"score_gpt":0.3494243519555125,"score_spread":0.3014491169779642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367024202","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.45265925,0.22127478,0.0005720422,0.3214266,0.00042547178,0.00039059544,0.000023594559,0.00013675386,0.0030909071],"genre_scores_gemma":[0.99421805,0.0016596167,0.0016288587,0.001688479,0.000017591616,0.0000033397446,0.000005187128,0.000019242885,0.0007596054],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99843746,0.00006592646,0.00050310924,0.00014867424,0.00029002846,0.0005547898],"domain_scores_gemma":[0.9984213,0.00006924505,0.00018948351,0.0003080523,0.00080921006,0.0002027192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000607337,0.00011682732,0.00047689068,0.0006519868,0.00021075526,0.000034831643,0.00020392056,0.0001532373,0.0002208086],"category_scores_gemma":[0.003306394,0.000099291196,0.00011052444,0.0006199912,0.00026035783,0.00006500301,0.00002823788,0.0006773617,0.000022577078],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008753127,0.000100925456,0.06379526,0.0004351092,0.00020869669,0.011289042,0.0008068851,0.000010522726,0.0014583847,0.0023509176,0.023273284,0.89618343],"study_design_scores_gemma":[0.0033469324,0.0022295008,0.028062582,0.0010377007,0.00005555795,0.07047365,0.022294713,0.00009480594,0.02166584,0.011558211,0.838772,0.0004084819],"about_ca_topic_score_codex":0.0016380602,"about_ca_topic_score_gemma":0.0065809116,"teacher_disagreement_score":0.89577496,"about_ca_system_score_codex":0.00068515143,"about_ca_system_score_gemma":0.015383775,"threshold_uncertainty_score":0.9901981},"labels":[],"label_agreement":null},{"id":"W4367052365","doi":"10.51731/cjht.2023.633","title":"Pembrolizumab (Keytruda)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pembrolizumab; Reimbursement; Medicine; Vial; Drug; Package insert; Intensive care medicine; Internal medicine; Cancer; Pharmacology; Health care; Political science; Immunotherapy","score_opus":0.04594901997250975,"score_gpt":0.318084219682552,"score_spread":0.2721351997100423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367052365","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90316117,0.024694739,0.00004656677,0.06928043,0.0011427901,0.00025882482,0.000011239323,0.00030083733,0.0011033886],"genre_scores_gemma":[0.9980645,0.00065236964,0.00046352044,0.0005577352,0.000021065103,0.0000050072254,0.0000018558561,0.000018598843,0.00021531261],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99869436,0.000025151594,0.00043337847,0.00011406327,0.00021060863,0.00052245945],"domain_scores_gemma":[0.9991667,0.000046521778,0.00021595682,0.00024933292,0.00017092896,0.00015053786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004557106,0.00010540653,0.00035709993,0.0009996187,0.00014039026,0.000015037487,0.0002384209,0.00014818383,0.00007819449],"category_scores_gemma":[0.0008638658,0.00008816959,0.000084423176,0.0007757628,0.00019865263,0.00003814478,0.000020703626,0.00045566473,0.00005975559],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000064874184,0.000012426663,0.035392985,0.00026246576,0.00007425849,0.00089738856,0.000538063,0.00003908139,0.0003909808,0.00055928115,0.09668406,0.8650841],"study_design_scores_gemma":[0.0018938963,0.002921981,0.21023935,0.0006606805,0.000039646697,0.0027166205,0.0065662465,0.000053679512,0.0040766755,0.0079119755,0.7626366,0.00028265058],"about_ca_topic_score_codex":0.0012085879,"about_ca_topic_score_gemma":0.0016613961,"teacher_disagreement_score":0.86480147,"about_ca_system_score_codex":0.0005504423,"about_ca_system_score_gemma":0.0047746,"threshold_uncertainty_score":0.84699357},"labels":[],"label_agreement":null},{"id":"W4367298040","doi":"10.51731/cjht.2023.635","title":"Durvalumab (Imfinzi)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Durvalumab; Reimbursement; Gemcitabine; Medicine; Chemotherapy; Drug; Intensive care medicine; Oncology; Internal medicine; Cancer; Pharmacology; Political science; Health care; Immunotherapy","score_opus":0.06131565145675124,"score_gpt":0.25897425253254247,"score_spread":0.19765860107579122,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367298040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.54849356,0.2532502,0.0017738502,0.16167313,0.005834229,0.00049788563,0.00045815916,0.00060993776,0.027409032],"genre_scores_gemma":[0.99680144,0.0019027786,0.00019958585,0.0005873815,0.000030538173,0.0000038870508,0.0000022525317,0.000018815917,0.00045331527],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99833053,0.000008572061,0.00090953166,0.0001519249,0.000023812161,0.00057565264],"domain_scores_gemma":[0.9988074,0.00003095086,0.00076278526,0.00024224647,0.000054390293,0.00010226214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012094511,0.000109678396,0.00049743574,0.0011856297,0.00023185009,0.000056304143,0.0004506541,0.00014583534,0.00010963746],"category_scores_gemma":[0.0007473481,0.000121322846,0.00010859852,0.0005275759,0.00017485495,0.00025333522,0.00002169989,0.0002971546,0.00064389576],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009579752,0.000013025978,0.06459663,0.0000842443,0.00007103864,0.00012047118,0.00077749207,0.00014533209,0.0000022620864,0.37878358,0.123407796,0.43198857],"study_design_scores_gemma":[0.00028082673,0.00014607947,0.04860454,0.000044032753,0.0000012287845,0.00003474593,0.00070138014,0.0000387755,0.000018399696,0.16120353,0.78877956,0.00014689955],"about_ca_topic_score_codex":0.004819845,"about_ca_topic_score_gemma":0.0018286393,"teacher_disagreement_score":0.6653718,"about_ca_system_score_codex":0.00044351022,"about_ca_system_score_gemma":0.0009460226,"threshold_uncertainty_score":0.8276192},"labels":[],"label_agreement":null},{"id":"W4367315644","doi":"10.51731/cjht.2023.636","title":"Berotralstat (Orladeyo)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Family medicine; Hereditary angioedema; Political science; Health care","score_opus":0.051064160185393434,"score_gpt":0.3160557353830847,"score_spread":0.26499157519769123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367315644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6778231,0.080310546,0.00011624054,0.23874454,0.0011113146,0.00043810895,0.00002900695,0.00066411495,0.0007629834],"genre_scores_gemma":[0.9970466,0.0010580836,0.00034806653,0.00082773255,0.000034764493,0.0000033839428,0.000007747655,0.000019301327,0.0006543026],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99858445,0.000023701477,0.00054556434,0.00011913548,0.0001785111,0.00054862973],"domain_scores_gemma":[0.9991304,0.000056924924,0.0002688532,0.00022140439,0.00014140096,0.00018101597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054062594,0.00011736548,0.00039191364,0.00096953526,0.0002255756,0.000023738176,0.00018620561,0.000134373,0.000060801758],"category_scores_gemma":[0.0004905425,0.0000991657,0.00011471923,0.00074387173,0.00018006332,0.00009804675,0.000013834117,0.0003114932,0.000059221486],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023854218,0.000017384771,0.06698056,0.0002073262,0.00008018744,0.0007030919,0.000850277,0.000033276814,0.00008394604,0.0034893558,0.076788686,0.85074204],"study_design_scores_gemma":[0.0012194817,0.0008572776,0.29022485,0.00073139253,0.000040878236,0.0011166363,0.0055690594,0.00009462937,0.0012768048,0.011485143,0.68714637,0.00023750543],"about_ca_topic_score_codex":0.0026485357,"about_ca_topic_score_gemma":0.0022221692,"teacher_disagreement_score":0.8505045,"about_ca_system_score_codex":0.00023657334,"about_ca_system_score_gemma":0.002503332,"threshold_uncertainty_score":0.44408035},"labels":[],"label_agreement":null},{"id":"W4367315717","doi":"10.51731/cjht.2023.634","title":"Deferiprone (Ferriprox)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Academic Publishing and Open Access","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Deferiprone; Medicine; Drug; Family medicine; Intensive care medicine; Political science; Pharmacology; Health care; Thalassemia; Internal medicine","score_opus":0.18781634468781483,"score_gpt":0.4288984082819613,"score_spread":0.24108206359414647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367315717","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5000307,0.04549426,0.0016731157,0.44236225,0.0040275175,0.00037274638,0.000058306538,0.00065310154,0.0053279963],"genre_scores_gemma":[0.9976726,0.00022276572,0.00030534802,0.0008517911,0.000023312099,0.0000030767508,0.0000012391508,0.000010200084,0.0009096528],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99702686,0.00014573628,0.0011492746,0.0002235523,0.00079253264,0.00066205626],"domain_scores_gemma":[0.9977336,0.00039778693,0.0008091253,0.00045889616,0.0004198762,0.00018070087],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.010301456,0.00011225289,0.00042727336,0.0022969304,0.00044825373,0.0005695228,0.0035245055,0.00022186685,0.00007979106],"category_scores_gemma":[0.02030907,0.00007821238,0.00009159955,0.0036264597,0.00026499588,0.00092882913,0.00011835895,0.00079688,0.00028651243],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000020718542,0.0000016524109,0.011245732,0.0000039957404,0.000005821204,0.00006367922,0.00023636874,0.00003098824,0.0000037573545,0.0019192215,0.28742862,0.6990581],"study_design_scores_gemma":[0.00015504124,0.000092667084,0.024671914,0.00005855022,0.0000020448485,0.00012606908,0.010758916,0.000060897062,0.00008864019,0.13112578,0.83274835,0.00011109731],"about_ca_topic_score_codex":0.0024911903,"about_ca_topic_score_gemma":0.0021807402,"teacher_disagreement_score":0.698947,"about_ca_system_score_codex":0.00023269845,"about_ca_system_score_gemma":0.0036085423,"threshold_uncertainty_score":0.9879433},"labels":[],"label_agreement":null},{"id":"W4375951830","doi":"10.51731/cjht.2023.638","title":"Objective Assessment System for Cognitive Function","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Delphi Technique in Research","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cognition; Rehabilitation; Service (business); Function (biology); Horizon; Time horizon; Knowledge management; Information technology; Health care; Computer science; Medicine; Business; Marketing; Political science; Physical therapy","score_opus":0.16686765054654018,"score_gpt":0.4814488522793862,"score_spread":0.31458120173284604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4375951830","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19792807,0.036546204,0.13825636,0.53657377,0.013915397,0.014825371,0.0007606476,0.009247316,0.051946882],"genre_scores_gemma":[0.99898833,0.00017057403,0.0005093085,0.00006781023,0.000033367694,0.00008553184,0.0000025888053,0.00001189994,0.00013059091],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.99831843,0.00020573175,0.0003738167,0.00012727648,0.00033087478,0.0006438882],"domain_scores_gemma":[0.99825203,0.00049018464,0.00031815574,0.00010375876,0.00072276493,0.00011308523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048132176,0.00007627461,0.00023068706,0.0011317809,0.0010540334,0.0000765964,0.0003807403,0.00017356788,0.000007810546],"category_scores_gemma":[0.002338427,0.00007248065,0.0000745277,0.0010595612,0.00039062777,0.00015880883,0.000019564763,0.00037315156,0.000011694252],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029393514,0.000011327481,0.0033139477,0.00020441902,0.000081798105,0.00009415402,0.002655799,0.000009330987,0.000018588707,0.07937572,0.029928856,0.8842767],"study_design_scores_gemma":[0.0006086396,0.0012732387,0.015578382,0.00091465923,0.000029236247,0.000030059487,0.6767218,0.00006170736,0.00028010618,0.03921892,0.2650434,0.00023981658],"about_ca_topic_score_codex":0.0141400825,"about_ca_topic_score_gemma":0.022741139,"teacher_disagreement_score":0.88403684,"about_ca_system_score_codex":0.001617273,"about_ca_system_score_gemma":0.008339229,"threshold_uncertainty_score":0.99728256},"labels":[],"label_agreement":null},{"id":"W4376114963","doi":"10.51731/cjht.2023.640","title":"Olaparib (Lynparza)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Olaparib; Reimbursement; Medicine; Oncology; Germline; Internal medicine; BRCA mutation; Adjuvant; Drug; Human Epidermal Growth Factor Receptor 2; Chemotherapy; Breast cancer; Gynecology; Cancer; Pharmacology; Political science; Genetics; Biology","score_opus":0.06684353766478728,"score_gpt":0.3530063722913855,"score_spread":0.2861628346265982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376114963","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4335095,0.071291775,0.0004483238,0.48774603,0.0021418068,0.0005783745,0.00005129909,0.0010509576,0.0031819346],"genre_scores_gemma":[0.99611294,0.0013386226,0.00046545808,0.0017542075,0.00003182628,0.000007151451,0.000003869233,0.00001759444,0.00026833641],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99875015,0.000029083143,0.00047687744,0.00010206859,0.00017788868,0.0004639329],"domain_scores_gemma":[0.9991394,0.000043377815,0.0002688854,0.00024040244,0.00016496233,0.0001429635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006678274,0.00009387394,0.00034570092,0.0010624701,0.0001704974,0.000016391716,0.00018882922,0.00012617052,0.000075507145],"category_scores_gemma":[0.00037809229,0.00008124526,0.00008192173,0.0008251901,0.0002001972,0.0000707672,0.0000096985295,0.0004393972,0.00009037116],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045057037,0.000017572049,0.015891923,0.00018516608,0.00009038772,0.0009140553,0.00050409534,0.00002687297,0.00050179905,0.0030338624,0.28879535,0.68999386],"study_design_scores_gemma":[0.0012287252,0.0006619479,0.02084637,0.00050980295,0.000012012292,0.0010189604,0.0027160307,0.00001716361,0.0024891065,0.008081855,0.9622969,0.000121124394],"about_ca_topic_score_codex":0.0008094752,"about_ca_topic_score_gemma":0.0006535354,"teacher_disagreement_score":0.68987274,"about_ca_system_score_codex":0.00050985394,"about_ca_system_score_gemma":0.0037667234,"threshold_uncertainty_score":0.66820055},"labels":[],"label_agreement":null},{"id":"W4376143644","doi":"10.51731/cjht.2023.644","title":"Amivantamab (Rybrevant)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Epidermal growth factor receptor; Oncology; Drug; Chemotherapy; Disease; Lung cancer; Internal medicine; Intensive care medicine; Cancer; Pharmacology; Political science; Health care","score_opus":0.03132594971319125,"score_gpt":0.3619167096172947,"score_spread":0.33059075990410347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376143644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.46833634,0.08237584,0.00021837675,0.44264787,0.0015020217,0.0007188691,0.000072027535,0.0007123052,0.0034163517],"genre_scores_gemma":[0.99772984,0.0009006958,0.00037621564,0.00051920966,0.000012379782,0.0000043932814,0.000006297071,0.000010717335,0.00044023854],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99921495,0.000012045113,0.00029236998,0.00007204694,0.00009912224,0.00030949403],"domain_scores_gemma":[0.99947685,0.00002532391,0.00015086925,0.00014880026,0.000102426595,0.000095725125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020492532,0.000068041314,0.00023384635,0.00067883695,0.00015611498,0.0000125473425,0.00009945988,0.000060996263,0.000025575104],"category_scores_gemma":[0.00021038135,0.000051128074,0.000058374422,0.00048993307,0.000085496824,0.00005187651,0.000007093049,0.00019023893,0.00005118346],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010978093,0.000016927132,0.021569192,0.00013249215,0.00013954414,0.0010551623,0.0005398888,0.000011758999,0.000040454543,0.001190562,0.08359196,0.8917011],"study_design_scores_gemma":[0.0014553586,0.0009534367,0.10778712,0.0005089853,0.00008328041,0.0011186253,0.0077795205,0.000017393158,0.00035531286,0.0043520583,0.87547225,0.00011667656],"about_ca_topic_score_codex":0.001676602,"about_ca_topic_score_gemma":0.0012127052,"teacher_disagreement_score":0.8915844,"about_ca_system_score_codex":0.00042687153,"about_ca_system_score_gemma":0.0033871753,"threshold_uncertainty_score":0.6008704},"labels":[],"label_agreement":null},{"id":"W4376144093","doi":"10.51731/cjht.2023.641","title":"Privately Operated Medical Imaging Facilities Across Canada","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Radiation Dose and Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Metropolitan area; Medical imaging; Payment; Positron emission tomography; Census; Nuclear medicine; Computed tomography; Medicine; Medical physics; Single-photon emission computed tomography; Business; Radiology; Finance; Environmental health","score_opus":0.02660114225238389,"score_gpt":0.31861868320395953,"score_spread":0.2920175409515756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376144093","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.70661145,0.017776825,0.00006659826,0.27424082,0.00067769934,0.00015401302,0.000048940925,0.00021168952,0.00021194898],"genre_scores_gemma":[0.9964088,0.0005799274,0.00005310777,0.002581315,0.000022920816,0.0000027985823,0.000009706741,0.000013646438,0.00032772974],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981991,0.000034907578,0.00058828114,0.00011960658,0.0003912354,0.00066685386],"domain_scores_gemma":[0.99911773,0.000057753175,0.00018195466,0.00018848738,0.00018219707,0.00027188772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00084050995,0.00011280467,0.00035718264,0.00030393706,0.0003179726,0.000045117285,0.00028926658,0.00007817207,0.00008703184],"category_scores_gemma":[0.0022045786,0.000094177136,0.00004502221,0.0006732733,0.00019980776,0.00013862703,0.000025716434,0.0005375816,0.000013297377],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000070371552,0.000003849136,0.044958778,0.00010614848,0.000038136557,0.0019496465,0.0006938385,0.000022921922,0.000020211959,0.000090012654,0.080968805,0.8711406],"study_design_scores_gemma":[0.00083939737,0.00008320536,0.05782724,0.00045311174,0.00000675577,0.0015874439,0.03049051,0.0008349014,0.0007813599,0.00017759104,0.9067597,0.00015883204],"about_ca_topic_score_codex":0.65388304,"about_ca_topic_score_gemma":0.6469837,"teacher_disagreement_score":0.8709818,"about_ca_system_score_codex":0.00072836917,"about_ca_system_score_gemma":0.017633304,"threshold_uncertainty_score":0.9879358},"labels":[],"label_agreement":null},{"id":"W4376644329","doi":"10.51731/cjht.2023.649","title":"Extrapolating Clinical Evidence Within Economic Evaluations","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Hospital for Sick Children; University of Ottawa; Canadian Agency for Drugs and Technologies in Health; Western University","funders":"","keywords":"Extrapolation; Econometrics; Computer science; Economics; Statistics; Mathematics","score_opus":0.7121975685384159,"score_gpt":0.5586665753917054,"score_spread":0.15353099314671048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376644329","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.43067318,0.079252414,0.002789462,0.4796094,0.0054221107,0.0009520683,0.0002364806,0.00039538086,0.00066951424],"genre_scores_gemma":[0.99176794,0.0013356335,0.003072783,0.003477284,0.00012756941,0.000025098057,0.0000060219613,0.000032078868,0.00015558602],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9902129,0.00051317475,0.008108026,0.00037662077,0.00009482923,0.0006944467],"domain_scores_gemma":[0.99103725,0.0020237898,0.006024506,0.0005477888,0.00012656307,0.00024007964],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.06209833,0.00017310378,0.0011767658,0.0016826077,0.00055074476,0.00011224258,0.00072385714,0.0002615881,0.00016386746],"category_scores_gemma":[0.029810252,0.00020797005,0.00019906826,0.0005086376,0.00027522122,0.00069989346,0.000039680253,0.00061220577,0.0018013865],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015736978,0.000037692007,0.4580359,0.00064263557,0.00025286624,0.000038506623,0.005253451,0.004908223,0.0000026373252,0.21079734,0.24708813,0.07292688],"study_design_scores_gemma":[0.0018136265,0.0011898018,0.3184564,0.0025397877,0.000027989045,0.00022142613,0.031826165,0.021389699,0.000015421405,0.29774666,0.32358742,0.0011855896],"about_ca_topic_score_codex":0.007448087,"about_ca_topic_score_gemma":0.007887469,"teacher_disagreement_score":0.56109476,"about_ca_system_score_codex":0.0016620189,"about_ca_system_score_gemma":0.005967991,"threshold_uncertainty_score":0.9996672},"labels":[],"label_agreement":null},{"id":"W4376876736","doi":"10.51731/cjht.2023.650","title":"Overview of Health Technology Assessment Processes for Time-Limited Recommendations","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Health technology; Context (archaeology); Interim; Excellence; Agency (philosophy); Business; Health care; Medicine; Waiver; Inclusion (mineral); Political science; Geography","score_opus":0.528444175915969,"score_gpt":0.5012615904239898,"score_spread":0.027182585491979272,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376876736","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009890884,0.09561577,0.004665583,0.8866504,0.0006389982,0.0011832429,0.0009918966,0.00022479479,0.00013846518],"genre_scores_gemma":[0.9314421,0.020273967,0.034375485,0.012663647,0.00007857211,0.00038217162,0.00020988398,0.00011729879,0.00045690362],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9930272,0.00019487814,0.0056759194,0.00029860463,0.00007160605,0.0007318],"domain_scores_gemma":[0.9915812,0.00079885416,0.0066721626,0.00044105249,0.0003800476,0.00012670808],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.019086616,0.00017487608,0.0015368169,0.0032240513,0.00048369888,0.000037859965,0.0006210933,0.00023242338,0.000066263165],"category_scores_gemma":[0.009638001,0.00020566782,0.000119493554,0.0017465285,0.00018645945,0.00028418438,0.00003719024,0.00031937598,0.000088016226],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009810189,0.00013221706,0.040629126,0.008441852,0.00030205544,0.000003571096,0.0016710368,0.00017559883,0.00000387942,0.29281056,0.46701044,0.18880984],"study_design_scores_gemma":[0.000918382,0.0008803101,0.01114503,0.0012833158,0.0000072677117,0.000033784545,0.011391212,0.00044446942,0.00001708224,0.14404584,0.8295163,0.00031704042],"about_ca_topic_score_codex":0.002040802,"about_ca_topic_score_gemma":0.0021262723,"teacher_disagreement_score":0.92155117,"about_ca_system_score_codex":0.0013769136,"about_ca_system_score_gemma":0.0077422117,"threshold_uncertainty_score":0.99870425},"labels":[],"label_agreement":null},{"id":"W4377096713","doi":"10.51731/cjht.2023.655","title":"Lutetium (¹⁷⁷Lu) Vipivotide Tetraxetan (Pluvicto)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Cabazitaxel; Prostate cancer; Medicine; Taxane; Oncology; Clinical trial; Drug; Internal medicine; Cancer; Androgen deprivation therapy; Pharmacology; Political science; Breast cancer; Health care","score_opus":0.05330637484045283,"score_gpt":0.3480798382205606,"score_spread":0.2947734633801078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377096713","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.49933067,0.095425196,0.000069502756,0.39776394,0.0015785808,0.00092554645,0.00007406387,0.0007664522,0.004066044],"genre_scores_gemma":[0.99388117,0.0043024234,0.00024209288,0.00040477756,0.000031154206,0.000008500766,0.000009988492,0.000022524302,0.0010973805],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983315,0.00003632075,0.0004584874,0.00014462604,0.00026244923,0.000766627],"domain_scores_gemma":[0.9990443,0.00005691225,0.00018176592,0.00026885953,0.00020493445,0.00024325163],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006711725,0.00013136883,0.00041091512,0.0022686091,0.00024811825,0.000029561048,0.00025859667,0.00013536311,0.000060373146],"category_scores_gemma":[0.0004524883,0.00009686007,0.000107748274,0.0011741531,0.00027111755,0.00008737041,0.00002359974,0.0005775538,0.000091119444],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001264471,0.000053797627,0.075180545,0.0005997664,0.00028522636,0.0057054753,0.00084581034,0.0000150964615,0.0008961702,0.0012979816,0.17739648,0.7375972],"study_design_scores_gemma":[0.0025707558,0.002062532,0.13625084,0.0008991028,0.00004591672,0.0011741526,0.00782665,0.00003590101,0.004609828,0.004210626,0.84006536,0.00024833198],"about_ca_topic_score_codex":0.0019686902,"about_ca_topic_score_gemma":0.0015655819,"teacher_disagreement_score":0.73734885,"about_ca_system_score_codex":0.0007215683,"about_ca_system_score_gemma":0.0059970235,"threshold_uncertainty_score":0.9996381},"labels":[],"label_agreement":null},{"id":"W4377099138","doi":"10.51731/cjht.2023.653","title":"Finerenone (Kerendia)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Kidney disease; Intensive care medicine; Renal function; Disease; Myocardial infarction; Emergency medicine; Health care; Internal medicine","score_opus":0.48365951493252024,"score_gpt":0.4412437580011146,"score_spread":0.042415756931405646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377099138","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15440015,0.09259054,0.00142212,0.7450174,0.0027192936,0.00054082146,0.00041350315,0.00043782135,0.0024583307],"genre_scores_gemma":[0.9921371,0.0010173732,0.0011165336,0.005101846,0.00006433902,0.000016682041,0.000013092771,0.00002986839,0.00050318596],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9950726,0.00013310996,0.00377705,0.00022997572,0.00007276747,0.0007144664],"domain_scores_gemma":[0.996116,0.00037334667,0.0028481963,0.00039579952,0.000089037276,0.00017762056],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.013948512,0.0001401828,0.0009473141,0.002038486,0.00033591408,0.000063748266,0.00055117713,0.00018604893,0.00019130227],"category_scores_gemma":[0.00705048,0.00016587839,0.0001136844,0.0007421581,0.0001476689,0.0002814044,0.000027237484,0.00037573374,0.0017558133],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000051052693,0.000022570319,0.049264636,0.00050389284,0.000109336375,0.00006345742,0.0020423012,0.0002364241,0.0000017101631,0.1902175,0.7057457,0.05178738],"study_design_scores_gemma":[0.00045410954,0.00019209318,0.03882125,0.00017814123,0.0000023511707,0.00006323474,0.005560393,0.00021525979,0.0000068394015,0.09188339,0.8623765,0.00024643296],"about_ca_topic_score_codex":0.008181301,"about_ca_topic_score_gemma":0.004407558,"teacher_disagreement_score":0.8377369,"about_ca_system_score_codex":0.0008746137,"about_ca_system_score_gemma":0.001976517,"threshold_uncertainty_score":0.9990214},"labels":[],"label_agreement":null},{"id":"W4377099143","doi":"10.51731/cjht.2023.654","title":"Pegcetacoplan (Empaveli)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Paroxysmal nocturnal hemoglobinuria; Family medicine; Intensive care medicine; Political science; Internal medicine; Health care","score_opus":0.13707269510445716,"score_gpt":0.41165148832113124,"score_spread":0.2745787932166741,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377099143","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24734321,0.117175244,0.000054789052,0.6298467,0.001055674,0.00029791403,0.00002501363,0.00037587393,0.003825597],"genre_scores_gemma":[0.99333584,0.0046398556,0.00017199294,0.0016538588,0.000023132687,0.000001972601,0.000001936216,0.000008461613,0.00016293855],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99899465,0.00002806809,0.00033824932,0.00007666121,0.00013300907,0.00042938726],"domain_scores_gemma":[0.9993256,0.00010600676,0.00019684706,0.000121089295,0.00009998958,0.00015051609],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071085984,0.00007674838,0.0002990999,0.00042848085,0.00023225273,0.000017042477,0.00014556952,0.00007529738,0.000050049897],"category_scores_gemma":[0.00103516,0.00005692938,0.00006090978,0.00052641885,0.00013507044,0.0000713924,0.000018806133,0.00045994294,0.00007686781],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003192306,0.000011250325,0.02591278,0.00017431955,0.00010409223,0.001070432,0.00029625665,0.000004024074,0.000059500504,0.0006759629,0.0842076,0.8874518],"study_design_scores_gemma":[0.00036444145,0.00033989825,0.03332563,0.00010276982,0.000021603968,0.0005161307,0.0032684421,0.000016133117,0.0002092552,0.0011771034,0.96060014,0.000058456473],"about_ca_topic_score_codex":0.0010183168,"about_ca_topic_score_gemma":0.00058369193,"teacher_disagreement_score":0.8873934,"about_ca_system_score_codex":0.00016077136,"about_ca_system_score_gemma":0.0013076443,"threshold_uncertainty_score":0.23215127},"labels":[],"label_agreement":null},{"id":"W4379422197","doi":"10.51731/cjht.2023.664","title":"An Overview of Pharmacogenomic Testing for Psychiatric Disorders","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Pharmacogenomics; Generalizability theory; Medicine; Guideline; Genetic testing; Health care; Personalized medicine; Test (biology); Psychiatry; Psychology; Bioinformatics; Pharmacology","score_opus":0.32274797548898837,"score_gpt":0.507439021635251,"score_spread":0.18469104614626264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379422197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.76508594,0.21838723,0.00020964406,0.01137706,0.003410933,0.0007566185,0.00036687823,0.00020353851,0.00020215215],"genre_scores_gemma":[0.98596364,0.01162377,0.0014373391,0.00082318863,0.00006811638,0.00002346922,0.000009080788,0.000032689815,0.00001867939],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99784636,0.00021329748,0.00089414854,0.00019034633,0.00011344889,0.0007424079],"domain_scores_gemma":[0.9982489,0.00032439936,0.00075548113,0.00019606373,0.00023460799,0.00024059151],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022204586,0.00018976879,0.000489589,0.0011315467,0.0004013312,0.000014476134,0.00073431386,0.00022097456,0.000050245213],"category_scores_gemma":[0.0004028711,0.00018159655,0.00014943298,0.0011170462,0.00023982266,0.0001065245,0.000026704258,0.00058644416,0.0000103166285],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044596047,0.00006085109,0.015273938,0.0003327137,0.00010528356,0.000012351887,0.0003140616,0.0012872946,0.0077577145,0.0011389925,0.0062244246,0.96744776],"study_design_scores_gemma":[0.0030466348,0.0010596814,0.011501464,0.000081931736,0.00022002177,0.00007246419,0.0016387,0.0034612035,0.010375015,0.026415616,0.9417024,0.00042486712],"about_ca_topic_score_codex":0.00047982135,"about_ca_topic_score_gemma":0.00038799623,"teacher_disagreement_score":0.9670229,"about_ca_system_score_codex":0.00009860576,"about_ca_system_score_gemma":0.0020507898,"threshold_uncertainty_score":0.7405293},"labels":[],"label_agreement":null},{"id":"W4379881935","doi":"10.51731/cjht.2023.665","title":"Hybrid Operating Room Suites","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Surgical Simulation and Training","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Operating theater; Suite; Neurosurgery; Cardiothoracic surgery; Medical physics; Surgery; Vascular surgery; Cardiac surgery","score_opus":0.06293747887892315,"score_gpt":0.3345494473028057,"score_spread":0.2716119684238826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379881935","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9378977,0.00861571,0.00006341968,0.051576007,0.00030051547,0.00013409872,0.0000059355434,0.00030458297,0.0011020239],"genre_scores_gemma":[0.9987207,0.00011459811,0.00028372632,0.00074387074,0.000017305738,0.0000012366933,0.000003920494,0.000009332532,0.00010528466],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990699,0.000022300392,0.000378776,0.00007461723,0.00011876588,0.00033558995],"domain_scores_gemma":[0.99938923,0.00014067971,0.00013598811,0.00010528908,0.00010707415,0.0001217216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000621135,0.000066344386,0.00025077356,0.0005663467,0.00019417012,0.000024329935,0.00010107031,0.000052346648,0.00006966941],"category_scores_gemma":[0.001787556,0.00005212094,0.00005656649,0.0003853601,0.000061533225,0.00005610223,0.000009596382,0.00031220765,0.000030164558],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000059061167,0.0000053324347,0.040993344,0.00004905861,0.000026375403,0.00081915676,0.00020009807,0.0001617205,0.000020947575,0.0009264933,0.0030217979,0.95376974],"study_design_scores_gemma":[0.0031407354,0.0008951785,0.1643397,0.0009691206,0.00002417836,0.0013183705,0.011266097,0.001500496,0.0011601978,0.003968201,0.8111586,0.00025914365],"about_ca_topic_score_codex":0.00052819133,"about_ca_topic_score_gemma":0.00025349326,"teacher_disagreement_score":0.95351064,"about_ca_system_score_codex":0.00013276245,"about_ca_system_score_gemma":0.0012321887,"threshold_uncertainty_score":0.21858497},"labels":[],"label_agreement":null},{"id":"W4380090156","doi":"10.51731/cjht.2023.666","title":"Ravulizumab (Ultomiris)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Thrombotic microangiopathy; Medicine; Drug; Intensive care medicine; Family medicine; Pharmacology; Political science; Health care; Internal medicine","score_opus":0.038824719566165525,"score_gpt":0.2936630351160758,"score_spread":0.25483831554991027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380090156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.75353366,0.18430723,0.00012061689,0.055381194,0.004202298,0.0005826532,0.00017751794,0.0009943214,0.0007004842],"genre_scores_gemma":[0.9991955,0.00023944177,0.000031166222,0.00015482701,0.0000060045777,0.000007548554,0.000015994417,0.000011918047,0.00033755947],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99852765,0.00012481112,0.0005901434,0.00012219144,0.000039263225,0.0005959645],"domain_scores_gemma":[0.99910265,0.00010445805,0.0003762095,0.00027014563,0.00011234662,0.000034185967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006638764,0.00011500624,0.00034325404,0.0009883968,0.00033299107,0.000018111119,0.0005487973,0.00014330437,0.00025943777],"category_scores_gemma":[0.0005929118,0.0000997307,0.00009110105,0.0005025771,0.00023522985,0.00007282247,0.00003958365,0.0003070235,0.00064322277],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024441497,0.000017643677,0.01758925,0.000118808515,0.00016598869,0.00019695559,0.00047742596,0.000019274283,0.0009956303,0.002967062,0.54918814,0.4282394],"study_design_scores_gemma":[0.0007775098,0.00027075846,0.027400471,0.00020350711,0.0000121789635,0.00038569095,0.00664844,0.0000014480719,0.0014695803,0.0030300515,0.9596507,0.00014967052],"about_ca_topic_score_codex":0.0020487027,"about_ca_topic_score_gemma":0.0019097041,"teacher_disagreement_score":0.42808974,"about_ca_system_score_codex":0.00023653047,"about_ca_system_score_gemma":0.0017367057,"threshold_uncertainty_score":0.8267542},"labels":[],"label_agreement":null},{"id":"W4380152961","doi":"10.51731/cjht.2023.668","title":"Brexucabtagene Autoleucel (Tecartus)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Refractory (planetary science); Chimeric antigen receptor; Drug; Intensive care medicine; Family medicine; Pharmacology; Internal medicine; Political science; Cancer; Immunotherapy","score_opus":0.06782205487796064,"score_gpt":0.3562780262120117,"score_spread":0.2884559713340511,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380152961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.70435095,0.044417933,0.0000955645,0.24323179,0.0012285473,0.0008506382,0.00004450161,0.0010079477,0.004772155],"genre_scores_gemma":[0.99341905,0.0016831702,0.0002964643,0.0007359206,0.000040514507,0.000007215902,0.000006284055,0.00003417086,0.0037772073],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981899,0.000051823423,0.00051781675,0.00014598387,0.0003215438,0.0007729142],"domain_scores_gemma":[0.99890715,0.00006949723,0.00019514124,0.00037906982,0.00020346633,0.00024565402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012089869,0.00012439126,0.00044560965,0.0016679728,0.0002054969,0.000030443167,0.0003367253,0.00017486486,0.00044066913],"category_scores_gemma":[0.0006745132,0.00010562077,0.00011027952,0.0013192331,0.00025748112,0.000066148925,0.000031211504,0.000725033,0.00010577532],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003027891,0.000012020778,0.0042172647,0.0001352812,0.00006397068,0.0012043855,0.00025033244,0.0000101078585,0.003674461,0.00033880275,0.043765757,0.94629735],"study_design_scores_gemma":[0.0009136066,0.0009182039,0.02270704,0.00028118416,0.000013255218,0.0012385043,0.0031949894,0.000050443952,0.0038437939,0.0010752392,0.9656342,0.00012950192],"about_ca_topic_score_codex":0.0031043324,"about_ca_topic_score_gemma":0.0020965394,"teacher_disagreement_score":0.9461678,"about_ca_system_score_codex":0.0006129533,"about_ca_system_score_gemma":0.0052366415,"threshold_uncertainty_score":0.9289577},"labels":[],"label_agreement":null},{"id":"W4380203508","doi":"10.51731/cjht.2023.667","title":"Axicabtagene Ciloleucel (Yescarta)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chemoimmunotherapy; Reimbursement; Medicine; Lymphoma; Drug; Refractory (planetary science); Oncology; Intensive care medicine; Internal medicine; Pharmacology; Health care; Rituximab; Political science","score_opus":0.07583853752595779,"score_gpt":0.35787496221602544,"score_spread":0.2820364246900676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380203508","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.72605664,0.053098537,0.00009259111,0.21407883,0.0008835432,0.0006527331,0.000029211224,0.00062262703,0.004485315],"genre_scores_gemma":[0.993377,0.0026225115,0.00025432627,0.0005653551,0.00003953986,0.000006270495,0.0000044909057,0.000028101922,0.003102456],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99829316,0.000049062044,0.00048175262,0.00013857333,0.0003136997,0.0007237371],"domain_scores_gemma":[0.9989392,0.000067667585,0.00017686967,0.0003609667,0.0002130609,0.00024224218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011629545,0.00011525494,0.0004230015,0.0015174673,0.0001968858,0.000027081627,0.00031895985,0.00015931927,0.0004375858],"category_scores_gemma":[0.0006653689,0.00009713814,0.00012273935,0.0010957804,0.00023984493,0.000058777077,0.000027889666,0.00068182976,0.00011617785],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032314212,0.000011798885,0.0052556726,0.00014239589,0.00006186638,0.0010613168,0.00025411192,0.000006826075,0.0039479164,0.00025263982,0.037794784,0.9511784],"study_design_scores_gemma":[0.0011514898,0.0016920936,0.022370834,0.0004057593,0.000016762755,0.0011554596,0.0054980805,0.000038311508,0.0069623883,0.002325226,0.9582193,0.00016432525],"about_ca_topic_score_codex":0.0016102922,"about_ca_topic_score_gemma":0.0016542585,"teacher_disagreement_score":0.95101404,"about_ca_system_score_codex":0.00052247907,"about_ca_system_score_gemma":0.0043157474,"threshold_uncertainty_score":0.7655951},"labels":[],"label_agreement":null},{"id":"W4380610182","doi":"10.51731/cjht.2023.669","title":"Deep Brain Stimulation Surgery Programs in Canada","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Neurological disorders and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Deep brain stimulation; Medicine; Movement disorders; Thalamic stimulator; Stimulation; Essential tremor; Population; Dyskinesia; Parkinson's disease; Disease; Neuroscience; Psychiatry; Psychology; Internal medicine","score_opus":0.06529880742081656,"score_gpt":0.2862933284433369,"score_spread":0.22099452102252032,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380610182","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90938556,0.004960862,0.000014527188,0.08516819,0.00016502858,0.0002183694,0.0000023483913,0.000054764638,0.000030344583],"genre_scores_gemma":[0.9982774,0.00019499818,0.00005537046,0.0014318487,0.000003095666,0.0000057439042,0.000008805114,0.0000075792395,0.000015105085],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989475,0.000034439596,0.00039095743,0.00009293775,0.00013052364,0.0004036186],"domain_scores_gemma":[0.99947476,0.00012373053,0.00015403223,0.000106940475,0.000042770982,0.00009778941],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028226487,0.00007818489,0.0003139543,0.0005335115,0.0000664658,0.0000078810335,0.00007522774,0.00006292138,0.000010181815],"category_scores_gemma":[0.00062493444,0.000060604325,0.000042927953,0.0006898733,0.000044923298,0.000036493177,0.000007142882,0.00024071783,0.0000035602975],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009408851,0.000010225164,0.50261295,0.000029213386,0.000008636457,0.0012971706,0.000025993435,0.000067937486,8.5163146e-7,0.000022239932,0.003428654,0.49248672],"study_design_scores_gemma":[0.00059361296,0.00037760162,0.9830927,0.00016814873,0.0000062011313,0.00008066192,0.0018352345,0.000316958,0.000008958641,0.0041035125,0.009337156,0.00007923673],"about_ca_topic_score_codex":0.8024375,"about_ca_topic_score_gemma":0.97943914,"teacher_disagreement_score":0.49240747,"about_ca_system_score_codex":0.0006483501,"about_ca_system_score_gemma":0.006449737,"threshold_uncertainty_score":0.99918276},"labels":[],"label_agreement":null},{"id":"W4381856846","doi":"10.51731/cjht.2023.670","title":"Mavacamten (Camzyos)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cardiomyopathy and Myosin Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Bristol-Myers Squibb","keywords":"Reimbursement; Medicine; Family medicine; Drug; Political science; Pharmacology; Law; Health care","score_opus":0.04622634454255619,"score_gpt":0.31361005498168254,"score_spread":0.26738371043912634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381856846","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5215646,0.16728635,0.0001385967,0.3021778,0.002030795,0.00052449957,0.0000445262,0.00086739694,0.0053654527],"genre_scores_gemma":[0.99644744,0.0023077806,0.00022356723,0.0006315386,0.000031676376,0.000004004675,0.000002089642,0.000012201739,0.00033971336],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989274,0.000021543974,0.0003760099,0.0000927611,0.00014238851,0.00043989823],"domain_scores_gemma":[0.9993149,0.000039489045,0.00016926046,0.00019939564,0.00017289711,0.00010407747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065756094,0.00009204297,0.00042795244,0.0008879126,0.00020726235,0.000014241966,0.00014418492,0.00009842928,0.0000124465505],"category_scores_gemma":[0.0007034527,0.00007327413,0.00011855209,0.0006723948,0.00020345623,0.0000553552,0.000024918781,0.00033962686,0.000050087343],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023669603,0.0000083392215,0.02488554,0.00019615877,0.00013250635,0.0018783133,0.0005866472,0.0000056263307,0.00007745462,0.0015716004,0.19261028,0.77802384],"study_design_scores_gemma":[0.00062929373,0.0005092787,0.1134093,0.00035811582,0.000036643552,0.0016807857,0.010218205,0.0000039075744,0.00028401188,0.0030004575,0.86975896,0.0001110303],"about_ca_topic_score_codex":0.0011121432,"about_ca_topic_score_gemma":0.00064592884,"teacher_disagreement_score":0.77791286,"about_ca_system_score_codex":0.00022263794,"about_ca_system_score_gemma":0.0016384659,"threshold_uncertainty_score":0.29880324},"labels":[],"label_agreement":null},{"id":"W4382682016","doi":"10.51731/cjht.2023.675","title":"Rapid HIV Self-Testing","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Human immunodeficiency virus (HIV); Fingerstick; Medicine; Test (biology); Hiv test; Immunology; Environmental health; Population; Biology; Diabetes mellitus","score_opus":0.051113276834115345,"score_gpt":0.28879388868164285,"score_spread":0.2376806118475275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382682016","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6627955,0.25389716,0.00006483332,0.077473454,0.0014372632,0.00058518804,0.00020314727,0.0014330306,0.0021104387],"genre_scores_gemma":[0.9984097,0.0008217133,0.0003463556,0.00008629412,0.000005019532,0.0000070277897,0.000019804182,0.000010351706,0.00029371725],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986798,0.00010371767,0.00035033785,0.00010922706,0.00003572352,0.00072120473],"domain_scores_gemma":[0.9993057,0.00015864856,0.00018602991,0.00017904403,0.0001230608,0.00004749697],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00068733824,0.00009867818,0.00025557505,0.00080201635,0.00042022538,0.000016978136,0.00033037423,0.00015116706,0.00008040337],"category_scores_gemma":[0.0007922516,0.00007824521,0.00005463002,0.00059246167,0.00017898816,0.000060149116,0.000028721714,0.0004503059,0.0012960262],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00000944877,0.000019674497,0.013686049,0.00003762308,0.00015959125,0.00051778485,0.00035367886,0.0000038527483,0.0005542116,0.00028244834,0.07756398,0.90681165],"study_design_scores_gemma":[0.0010014741,0.00077187765,0.026303206,0.00012157436,0.000010636979,0.0009306863,0.0030958734,0.0000025810666,0.0020631938,0.0011167106,0.96445674,0.0001254636],"about_ca_topic_score_codex":0.0012856978,"about_ca_topic_score_gemma":0.0005559354,"teacher_disagreement_score":0.9066862,"about_ca_system_score_codex":0.00024226123,"about_ca_system_score_gemma":0.0023784926,"threshold_uncertainty_score":0.99948156},"labels":[],"label_agreement":null},{"id":"W4384030746","doi":"10.51731/cjht.2023.687","title":"Crisantaspase Recombinant (Rylaze)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Regimen; Lymphoblastic Leukemia; Recombinant DNA; Drug; Lymphoma; Intensive care medicine; Pharmacology; Leukemia; Internal medicine; Political science; Biology; Health care","score_opus":0.13544321487633465,"score_gpt":0.4133315752594893,"score_spread":0.2778883603831547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384030746","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22166094,0.10334014,0.00003792528,0.67103857,0.001613189,0.00030094813,0.000014104631,0.0003036711,0.0016905061],"genre_scores_gemma":[0.98794264,0.00987462,0.00019546239,0.001787201,0.000018028823,0.00000298047,0.0000016331014,0.000010302486,0.00016715462],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988562,0.000038238322,0.00040017246,0.00009086752,0.00013293742,0.00048158356],"domain_scores_gemma":[0.9992183,0.00012272697,0.00023449122,0.00014349142,0.000110790264,0.00017020766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008838667,0.000086856235,0.00033370053,0.00044584036,0.00026693853,0.000017497694,0.00015451638,0.00007994553,0.00006348002],"category_scores_gemma":[0.0013131141,0.0000637352,0.000071011505,0.00056545506,0.00014516871,0.000082988176,0.00002395954,0.0005136804,0.000073481555],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037483376,0.000018305363,0.007430532,0.00015208492,0.00007417819,0.0013513706,0.00018850267,0.0000016376988,0.00003313825,0.00065612723,0.14811704,0.8419396],"study_design_scores_gemma":[0.0004664298,0.00050534,0.013030813,0.00017354362,0.000025918707,0.0005294376,0.003607508,0.000015570582,0.00029316504,0.002314808,0.9789694,0.000068046036],"about_ca_topic_score_codex":0.0021667946,"about_ca_topic_score_gemma":0.00088053965,"teacher_disagreement_score":0.84187156,"about_ca_system_score_codex":0.00020813184,"about_ca_system_score_gemma":0.0012515974,"threshold_uncertainty_score":0.32755598},"labels":[],"label_agreement":null},{"id":"W4384068853","doi":"10.51731/cjht.2023.684","title":"Nivolumab (Opdivo)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Nivolumab; Biosimilar; Medicine; Oncology; Chemotherapy; Drug; Lung cancer; Intensive care medicine; Cancer; Internal medicine; Family medicine; Immunotherapy; Pharmacology; Political science; Health care","score_opus":0.05628373340307806,"score_gpt":0.25281661706094033,"score_spread":0.19653288365786226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384068853","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5316637,0.2726675,0.0019640448,0.15709189,0.0057857097,0.00048449097,0.000449676,0.0006234137,0.029269546],"genre_scores_gemma":[0.9968865,0.0017401365,0.00019662616,0.00058064,0.000028969096,0.000003483565,0.0000020320715,0.000017846329,0.0005437916],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984,0.000007303908,0.0008558901,0.00014708667,0.000021994889,0.0005677421],"domain_scores_gemma":[0.998857,0.000026761463,0.00072894635,0.00023377442,0.000052339692,0.000101175865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00102655,0.000104958046,0.00047585074,0.001165135,0.00022945719,0.00005570547,0.00044697418,0.00014284822,0.00010914638],"category_scores_gemma":[0.0006154762,0.000117806834,0.00010321489,0.00050308154,0.00017034844,0.0002583782,0.00002176717,0.00028931556,0.00063311076],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00000830739,0.000011458813,0.056243695,0.00007395185,0.000061000566,0.000103649414,0.00069503824,0.00010014467,0.0000019637812,0.308076,0.13792565,0.49669915],"study_design_scores_gemma":[0.00028314602,0.00015861604,0.033841334,0.000042589607,0.0000011522019,0.000031775297,0.00078045117,0.000036864672,0.000017956192,0.15395285,0.81070936,0.00014391098],"about_ca_topic_score_codex":0.0060608895,"about_ca_topic_score_gemma":0.0021674077,"teacher_disagreement_score":0.6727837,"about_ca_system_score_codex":0.0004426192,"about_ca_system_score_gemma":0.0008957697,"threshold_uncertainty_score":0.91622925},"labels":[],"label_agreement":null},{"id":"W4384298936","doi":"10.51731/cjht.2023.691","title":"Xylazine Test Strips for Drug Checking","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Veterinary Pharmacology and Anesthesia","field":"Veterinary","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Xylazine; Adulterant; Tranquilizer; Medicine; Drug; Pharmacology; Toxicology; Ketamine; Anesthesia; Biology","score_opus":0.12249321699272242,"score_gpt":0.3783318420089495,"score_spread":0.25583862501622706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384298936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9249052,0.009530128,0.00008488985,0.06373192,0.00072708336,0.0003810879,0.000064748376,0.0004500298,0.000124934],"genre_scores_gemma":[0.9984756,0.00022822713,0.00049830484,0.00048412147,0.00003868748,0.000020470361,0.000005851977,0.000023706834,0.00022499604],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99856275,0.00006329661,0.0005107957,0.00014503094,0.00008193756,0.00063618564],"domain_scores_gemma":[0.99897605,0.00030495677,0.00034773184,0.0001743312,0.0000997996,0.00009711876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012840735,0.00013904965,0.00033655905,0.00073175953,0.0005364419,0.000026116888,0.00048034693,0.00013228341,0.00003669789],"category_scores_gemma":[0.00063137437,0.00012660294,0.000101026984,0.00042027727,0.00016597469,0.00014023484,0.000026502186,0.0004838644,0.00004698237],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030160075,0.00009900984,0.026829438,0.0009563019,0.00018580398,0.010623278,0.0019115837,0.00008038509,0.007124651,0.002211766,0.34957266,0.6001035],"study_design_scores_gemma":[0.0010637954,0.00301998,0.026244009,0.0002974644,0.000024346635,0.004833433,0.0054402114,0.00015452695,0.0007620247,0.004980635,0.9528688,0.00031078365],"about_ca_topic_score_codex":0.00033389745,"about_ca_topic_score_gemma":0.00034620767,"teacher_disagreement_score":0.6032961,"about_ca_system_score_codex":0.0001904554,"about_ca_system_score_gemma":0.0010764314,"threshold_uncertainty_score":0.5162718},"labels":[],"label_agreement":null},{"id":"W4384342683","doi":"10.51731/cjht.2023.690","title":"Caplacizumab (Cablivi)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Sanofi","keywords":"Reimbursement; Medicine; Drug; Intensive care medicine; Family medicine; Pharmacology; Political science; Health care","score_opus":0.038920565652946666,"score_gpt":0.28553241571776977,"score_spread":0.2466118500648231,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384342683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.75105256,0.19528812,0.000107215295,0.046514902,0.0044361856,0.0005504507,0.00021804652,0.0009749903,0.00085754227],"genre_scores_gemma":[0.9991533,0.00021076025,0.000025580337,0.0001409208,0.000005750117,0.0000074016407,0.000016360782,0.000011580754,0.00042834727],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985448,0.000118037045,0.0005634176,0.00012028728,0.000039770744,0.0006136642],"domain_scores_gemma":[0.99912906,0.00010688342,0.00035202803,0.00026935837,0.00010837722,0.000034280918],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006605322,0.00011374438,0.00033187636,0.001097856,0.0003437669,0.000018966337,0.00052649254,0.0001400751,0.0003019866],"category_scores_gemma":[0.0005808881,0.00009928848,0.00008452139,0.0005324104,0.00022921871,0.00007733489,0.000038739694,0.00030295874,0.0005901182],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022295075,0.000020930505,0.022999963,0.00015461494,0.00018916596,0.00024224639,0.00054242753,0.000028570776,0.0010024024,0.0043425313,0.6201153,0.3503396],"study_design_scores_gemma":[0.00071191875,0.00032650353,0.027168963,0.00024280822,0.000013491876,0.00050044165,0.007919103,0.000001520248,0.0013992467,0.0034069493,0.95813984,0.00016919723],"about_ca_topic_score_codex":0.0029904104,"about_ca_topic_score_gemma":0.003535107,"teacher_disagreement_score":0.3501704,"about_ca_system_score_codex":0.0002468039,"about_ca_system_score_gemma":0.0018806736,"threshold_uncertainty_score":0.7584972},"labels":[],"label_agreement":null},{"id":"W4384405989","doi":"10.51731/cjht.2023.693","title":"Individuals’ Access to Medical Imaging Results via Patient Portals","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Radiology practices and education","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Patient portal; Health care; Medical emergency; Health information; Medical imaging; Information sharing; Medicine; Business; World Wide Web; Computer science; Political science; Radiology","score_opus":0.056162133225843514,"score_gpt":0.38937245162847517,"score_spread":0.33321031840263166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384405989","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4647465,0.004622576,0.000054084543,0.5291628,0.0008585774,0.00020420911,0.000011342769,0.0001004037,0.0002394654],"genre_scores_gemma":[0.9927915,0.00046109402,0.0002864696,0.0063592046,0.00004135184,0.00000696668,0.000013034778,0.0000111120235,0.000029292285],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99835557,0.00005544115,0.0006962908,0.00014461145,0.00027452796,0.00047356414],"domain_scores_gemma":[0.99859643,0.00012265731,0.00046005336,0.00023126522,0.00016070118,0.00042889905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016288847,0.00009101457,0.00030603836,0.0011788915,0.00018414934,0.000036514073,0.0003292618,0.0001298545,0.000051714058],"category_scores_gemma":[0.0068795183,0.00007362509,0.00004547327,0.0007375244,0.0001125414,0.00018999721,0.00003859176,0.0005070884,0.00003686052],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020113052,0.000012511963,0.060535982,0.000032158674,0.000028656652,0.0005388635,0.0007445014,0.00001027792,0.0000071366844,0.00003378497,0.18987449,0.7481615],"study_design_scores_gemma":[0.00065635843,0.0006051299,0.32740915,0.0005389865,0.00002653951,0.0027735012,0.008843653,0.00005107224,0.00018771918,0.001053589,0.6577116,0.00014272105],"about_ca_topic_score_codex":0.002759789,"about_ca_topic_score_gemma":0.0011998082,"teacher_disagreement_score":0.7480188,"about_ca_system_score_codex":0.00026425216,"about_ca_system_score_gemma":0.0049063135,"threshold_uncertainty_score":0.87035894},"labels":[],"label_agreement":null},{"id":"W4385128883","doi":"10.51731/cjht.2023.696","title":"An Overview of Emerging Trends and Technologies in Ulcerative Colitis","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Vedolizumab; Medicine; Ustekinumab; Tofacitinib; Ulcerative colitis; Adalimumab; Inflammatory bowel disease; Internal medicine; Intensive care medicine; Biologic Agents; Infliximab; Disease","score_opus":0.028245657557853323,"score_gpt":0.31947360643540945,"score_spread":0.29122794887755615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385128883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97601926,0.019365389,0.000013084075,0.004283776,0.00007624887,0.0000885314,0.000046711084,0.000055945366,0.000051034454],"genre_scores_gemma":[0.9956523,0.0040829238,0.00016847528,0.00004833138,0.0000049126256,0.000007032686,0.000009085747,0.000010877417,0.000016051146],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99896073,0.00007295455,0.00041172194,0.00014612832,0.00007463938,0.0003338173],"domain_scores_gemma":[0.99936306,0.000009336016,0.00025232803,0.00023824442,0.00008260081,0.000054405158],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005273963,0.00010706977,0.00023387467,0.0009380455,0.00008446328,0.000013310119,0.0002788744,0.00017101303,0.000004004753],"category_scores_gemma":[0.00030189048,0.00010278301,0.000040528772,0.00047167158,0.00028056276,0.000013070832,0.000041007374,0.00017035038,6.0598705e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008018791,0.0000213332,0.077446885,0.00029392313,0.000049452254,0.0005843299,0.0006226374,0.00011819069,0.001961638,0.0029949995,0.0018641471,0.91396224],"study_design_scores_gemma":[0.00096876477,0.0009069753,0.9362316,0.00042034715,0.00001218074,0.00012457422,0.02509097,0.000081118924,0.006652979,0.005124283,0.024058636,0.0003275382],"about_ca_topic_score_codex":0.00044018182,"about_ca_topic_score_gemma":0.016522959,"teacher_disagreement_score":0.9136347,"about_ca_system_score_codex":0.00006234845,"about_ca_system_score_gemma":0.000797915,"threshold_uncertainty_score":0.9220199},"labels":[],"label_agreement":null},{"id":"W4385143328","doi":"10.51731/cjht.2023.697","title":"Selumetinib (Koselugo)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Selumetinib; Neurofibromatosis; Medicine; Family medicine; Health care; Political science; Cancer; Pathology; Internal medicine","score_opus":0.056215157197167076,"score_gpt":0.3495927522428396,"score_spread":0.2933775950456725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385143328","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86845225,0.011114657,0.000018828408,0.1184773,0.0003262238,0.0003447854,0.000019945803,0.0003567317,0.0008892685],"genre_scores_gemma":[0.99823004,0.00069956004,0.00027076263,0.00032501668,0.000009801249,0.0000042042943,0.0000030709455,0.000013828921,0.0004437144],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988041,0.000034754776,0.00031750716,0.000097263655,0.00019644282,0.00054992654],"domain_scores_gemma":[0.99927294,0.000049790215,0.00013825572,0.00019473847,0.00013180941,0.0002124428],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004324226,0.00008386204,0.00028009652,0.001149207,0.00016195973,0.000017468457,0.0001651564,0.00007292281,0.000035770172],"category_scores_gemma":[0.0007644267,0.000064287226,0.00007261956,0.0007816338,0.0001376503,0.000054287917,0.00001622078,0.00037579326,0.00015574426],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004521205,0.000032927725,0.023106357,0.0001555838,0.00010937504,0.005911717,0.00014110896,0.0000032431844,0.00019919257,0.00039458647,0.06759632,0.90230435],"study_design_scores_gemma":[0.002910862,0.004489714,0.21942352,0.00063726126,0.00003316398,0.0035853593,0.0035494568,0.00002839455,0.00473722,0.0047997525,0.7556068,0.00019851587],"about_ca_topic_score_codex":0.0009045986,"about_ca_topic_score_gemma":0.00069483416,"teacher_disagreement_score":0.90210587,"about_ca_system_score_codex":0.00022992183,"about_ca_system_score_gemma":0.002952668,"threshold_uncertainty_score":0.5237906},"labels":[],"label_agreement":null},{"id":"W4385360042","doi":"10.51731/cjht.2023.700","title":"Fostemsavir (Rukobia)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Human immunodeficiency virus (HIV); Regimen; Family medicine; Drug; Intensive care medicine; Pharmacology; Political science; Surgery; Health care; Law","score_opus":0.0469626711215796,"score_gpt":0.3081190507480522,"score_spread":0.2611563796264726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385360042","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4561149,0.033024773,0.000043209653,0.5067837,0.00084416545,0.00054335495,0.000017909297,0.0005975061,0.0020304841],"genre_scores_gemma":[0.99356025,0.00075444195,0.0006162224,0.0003573871,0.000013878055,0.00000654826,0.0000074805425,0.000015310769,0.0046685054],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988591,0.000020704856,0.00042101045,0.00009801703,0.00015460838,0.00044652805],"domain_scores_gemma":[0.99935454,0.000035908564,0.00018786592,0.00017692886,0.00010436249,0.0001404062],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047489267,0.00010128329,0.00034422657,0.0010446273,0.0001726211,0.000015233244,0.00014293274,0.00009940442,0.000026859796],"category_scores_gemma":[0.00028175904,0.00007951401,0.000073232775,0.00066315674,0.000099112054,0.000054347576,0.000014889199,0.0002639413,0.00015232293],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015051493,0.000021217802,0.051308803,0.00013373351,0.00012790415,0.0020856084,0.0008208399,0.000002753343,0.00003353431,0.00072007946,0.1876164,0.7571141],"study_design_scores_gemma":[0.0010643548,0.00036953395,0.04053336,0.0005095186,0.000028233608,0.00081116514,0.006620086,0.00000951841,0.000645234,0.001954967,0.94731915,0.00013489158],"about_ca_topic_score_codex":0.0005074319,"about_ca_topic_score_gemma":0.0013525975,"teacher_disagreement_score":0.75970274,"about_ca_system_score_codex":0.0004097019,"about_ca_system_score_gemma":0.0032273885,"threshold_uncertainty_score":0.57252485},"labels":[],"label_agreement":null},{"id":"W4385457285","doi":"10.51731/cjht.2023.704","title":"Emergency Care Follow-Up for Children and Adolescents With Suicide Attempts or Ideation","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Suicide and Self-Harm Studies","field":"Psychology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Emergency department; Psychological intervention; Medicine; Suicide attempt; Suicidal ideation; Suicide prevention; Harm; Family medicine; Psychiatry; Medical emergency; Poison control; Psychology","score_opus":0.04573004631640684,"score_gpt":0.33967454473677566,"score_spread":0.29394449842036885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385457285","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95164096,0.03977811,0.00011995885,0.006833611,0.0008219399,0.00054000266,0.00007335993,0.00015419174,0.00003785095],"genre_scores_gemma":[0.99839497,0.0010923682,0.000101151076,0.00017093512,0.000025640004,0.000030024936,0.000011601657,0.000023016584,0.0001502762],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986958,0.000040270417,0.00043393293,0.00018844048,0.00010576199,0.0005358238],"domain_scores_gemma":[0.9991878,0.00003570161,0.00030097066,0.00018477795,0.00020366271,0.00008703263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029784974,0.00014799254,0.0003331156,0.0006202523,0.0003837733,0.000016630524,0.0002256516,0.00012291936,0.000020032552],"category_scores_gemma":[0.00020936433,0.00010752279,0.00005336733,0.00044230575,0.000096171105,0.00007509133,0.000018065159,0.00021335915,0.000010176497],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018457552,0.000006726844,0.8284012,0.00014899854,0.00014382513,0.000064774256,0.0037102145,0.0000030811766,0.0000034842449,0.00021501668,0.03295986,0.13415825],"study_design_scores_gemma":[0.0015233689,0.0011104919,0.9604433,0.00016565529,0.000039153158,0.00012907133,0.032493293,8.700151e-7,0.000023942914,0.0006602146,0.0032334868,0.00017713675],"about_ca_topic_score_codex":0.0067287884,"about_ca_topic_score_gemma":0.048387963,"teacher_disagreement_score":0.13398111,"about_ca_system_score_codex":0.00012696857,"about_ca_system_score_gemma":0.0004834041,"threshold_uncertainty_score":0.9998855},"labels":[],"label_agreement":null},{"id":"W4385457407","doi":"10.51731/cjht.2023.703","title":"Difelikefalin (Korsuva)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Kidney disease; Placebo; Quality of life (healthcare); Intensive care medicine; Randomized controlled trial; Hemodialysis; Dialysis; Clinical trial; Physical therapy; Internal medicine; Alternative medicine; Pathology","score_opus":0.0353784729194209,"score_gpt":0.3163723597125678,"score_spread":0.28099388679314685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385457407","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.67296666,0.079579115,0.00006155471,0.24436837,0.00100789,0.00025767097,0.000023600844,0.00053553603,0.0011995761],"genre_scores_gemma":[0.9977932,0.000690853,0.00014342088,0.0011482057,0.000013205931,0.000002970121,0.0000044211374,0.000009781197,0.00019395762],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989931,0.000032408392,0.0003823215,0.00008153755,0.00010917029,0.0004014715],"domain_scores_gemma":[0.9993326,0.00005519789,0.00017199497,0.00019051327,0.00010230819,0.00014738129],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003588969,0.000079743055,0.00032630656,0.00087978214,0.00016398603,0.000010092051,0.00017704048,0.00012969317,0.000035367782],"category_scores_gemma":[0.0009634165,0.000064229745,0.0000820091,0.00051289157,0.0002206619,0.00005268935,0.000012746451,0.00031304726,0.000090956455],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003790312,0.000024900244,0.16245133,0.00025706168,0.00008704249,0.004560701,0.00029010372,0.000007969705,0.00002201908,0.00093169825,0.5340034,0.29732588],"study_design_scores_gemma":[0.001025157,0.000352257,0.27830157,0.0005067149,0.000039444672,0.0033400878,0.0049650325,0.000026637697,0.00043978338,0.0101536475,0.70069337,0.000156281],"about_ca_topic_score_codex":0.00041874652,"about_ca_topic_score_gemma":0.00053355604,"teacher_disagreement_score":0.3248265,"about_ca_system_score_codex":0.00010941084,"about_ca_system_score_gemma":0.0026069833,"threshold_uncertainty_score":0.46246764},"labels":[],"label_agreement":null},{"id":"W4385507009","doi":"10.51731/cjht.2023.705","title":"Palovarotene (Sohonos)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Environmental Science and Water Management","field":"Environmental Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Fibrodysplasia ossificans progressiva; Reimbursement; Myositis ossificans; Heterotopic ossification; Medicine; Family medicine; Surgery; Political science; Health care","score_opus":0.018139003928827516,"score_gpt":0.22989192398204505,"score_spread":0.21175292005321755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385507009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9072961,0.0022154585,0.00039803213,0.08432003,0.0006503018,0.000324907,0.000007737888,0.0002562805,0.0045311004],"genre_scores_gemma":[0.9983481,0.00031454148,0.00038655233,0.00054605945,0.000004055556,0.0000031203467,9.958197e-7,0.0000064126075,0.00039016947],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99883753,0.00002616358,0.00030159394,0.00013069075,0.00020728684,0.0004967371],"domain_scores_gemma":[0.9995407,0.000011927605,0.00016299923,0.00018929972,0.0000033144045,0.00009179124],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00080191804,0.00008195539,0.00014245122,0.00023477917,0.0002526819,0.000027425811,0.0005327575,0.0000488236,0.00032947306],"category_scores_gemma":[0.000058886282,0.00006537888,0.000043114735,0.00063217594,0.00032610673,0.00018891942,0.00010170466,0.0001539544,0.0009502358],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000016471652,0.0000094869765,0.11725713,0.000011488382,0.000008398494,0.0002000223,0.00039525522,0.0012458583,0.00024174771,0.00021796314,0.059997465,0.82041353],"study_design_scores_gemma":[0.00016076112,0.00021589691,0.33571747,0.000035761215,0.000003339441,0.00004290086,0.00261035,0.000055049346,0.0005986858,0.009058549,0.6513522,0.00014899041],"about_ca_topic_score_codex":0.0054146,"about_ca_topic_score_gemma":0.0028772429,"teacher_disagreement_score":0.8202645,"about_ca_system_score_codex":0.0004113963,"about_ca_system_score_gemma":0.000081405204,"threshold_uncertainty_score":0.9998276},"labels":[],"label_agreement":null},{"id":"W4385552853","doi":"10.51731/cjht.2023.706","title":"Ciltacabtagene Autoleucel (Carvykti)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Drug; Refractory (planetary science); Antibody therapy; Intensive care medicine; Pharmacology; Antibody; Immunology; Health care; Monoclonal antibody; Political science","score_opus":0.0766381167478992,"score_gpt":0.36080694697566534,"score_spread":0.2841688302277662,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385552853","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.69311696,0.05023756,0.000119854456,0.2497808,0.0010406511,0.00076571346,0.000040084684,0.0008695309,0.0040288707],"genre_scores_gemma":[0.9929139,0.0020516186,0.00035978816,0.000716465,0.000041870597,0.000007052909,0.000005589965,0.000033946064,0.003869744],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981405,0.000052505144,0.00052898255,0.00014854735,0.00034494174,0.0007845046],"domain_scores_gemma":[0.9988563,0.00007371006,0.00020447897,0.00037689664,0.00023960398,0.00024898077],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012719514,0.00012629456,0.00045972367,0.0017217865,0.00020902693,0.00003010469,0.00035645964,0.0001871214,0.00046518137],"category_scores_gemma":[0.0007881792,0.000107061205,0.00012947718,0.0012365481,0.00024181497,0.00006678007,0.000032784126,0.0007674705,0.000114961775],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032654672,0.000011464834,0.0057937982,0.00014071244,0.00007458132,0.0013529338,0.00025379617,0.000012453224,0.003368208,0.0003301485,0.04686354,0.9417657],"study_design_scores_gemma":[0.0010099204,0.0009587053,0.026227707,0.00029502867,0.000014748444,0.0011452363,0.0032735004,0.00007110045,0.0047805565,0.0020648525,0.96001565,0.00014300938],"about_ca_topic_score_codex":0.002686121,"about_ca_topic_score_gemma":0.0016565348,"teacher_disagreement_score":0.9416227,"about_ca_system_score_codex":0.0007153464,"about_ca_system_score_gemma":0.005581207,"threshold_uncertainty_score":0.99008214},"labels":[],"label_agreement":null},{"id":"W4385699997","doi":"10.51731/cjht.2023.711","title":"Cost-Effectiveness of an RSVpreF Vaccine for Prevention of Respiratory Syncytial Virus Outcomes in Infants","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Respiratory viral infections research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immunization; Medicine; Pregnancy; Cost effectiveness; Pediatrics; Immunology; Antibody; Biology","score_opus":0.16878689120907156,"score_gpt":0.47053173141393045,"score_spread":0.3017448402048589,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385699997","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99525476,0.0022298007,0.00018750591,0.0006284844,0.00018599602,0.0013982947,0.00004753312,0.0000471772,0.000020471385],"genre_scores_gemma":[0.99955976,0.00010313463,0.00017945435,0.00004128189,0.000009448437,0.000070751026,0.000004681469,0.000018827162,0.000012659691],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9979746,0.000284846,0.00095745287,0.0001494521,0.00022665499,0.00040703386],"domain_scores_gemma":[0.9983639,0.00028133698,0.0004868804,0.00032691285,0.00043116117,0.00010978079],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031468673,0.000118334785,0.00075282046,0.0028095143,0.000081956365,0.000007830376,0.00024201702,0.00019645362,0.000009840007],"category_scores_gemma":[0.0030771112,0.00010052411,0.00011779583,0.0010756864,0.00014159358,0.00019594554,0.000025464615,0.00039635279,0.000001706251],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000929446,0.00022126893,0.3965161,0.0021279284,0.00014515046,0.00012999447,0.0001690509,0.000308166,0.015293032,0.00044775158,0.00033528398,0.5833768],"study_design_scores_gemma":[0.0035058185,0.006421263,0.92255294,0.0010678973,0.000021054308,0.000032221342,0.0008558396,0.000054892695,0.059480947,0.0019766223,0.0039243945,0.00010610639],"about_ca_topic_score_codex":0.0030066816,"about_ca_topic_score_gemma":0.009640258,"teacher_disagreement_score":0.58327067,"about_ca_system_score_codex":0.00053102704,"about_ca_system_score_gemma":0.0029357586,"threshold_uncertainty_score":0.537949},"labels":[],"label_agreement":null},{"id":"W4385783269","doi":"10.51731/cjht.2023.712","title":"Artificial Intelligence in Prehospital Emergency Health Care","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Triage; Health care; Staffing; Artificial intelligence; Conversation; Computer science; Medical emergency; Medicine; Nursing; Psychology","score_opus":0.16465164067272786,"score_gpt":0.43723823429574343,"score_spread":0.27258659362301557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385783269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7007836,0.0664466,0.0005539557,0.228094,0.002912622,0.0008068126,0.000017309889,0.00022873716,0.00015636592],"genre_scores_gemma":[0.99615204,0.002894316,0.00041271385,0.00041040409,0.00006020234,0.000013558172,0.000012211008,0.000017406921,0.000027139793],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.99730045,0.00007080525,0.001465564,0.00019064591,0.0002076239,0.0007649035],"domain_scores_gemma":[0.9987406,0.00005214693,0.0004295609,0.00025805485,0.00030253042,0.00021709815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010751138,0.00013385371,0.0004322653,0.0016084838,0.00026262924,0.000016103613,0.00024170638,0.00016776471,0.00005784848],"category_scores_gemma":[0.001117714,0.00012550877,0.0000869489,0.0016170001,0.00013411665,0.000115552786,0.000016363058,0.0006428134,0.00007451268],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014199994,0.000018619725,0.022280144,0.00024763946,0.000006792152,0.00007317982,0.0075665405,0.000045358956,0.0000041572616,0.0010980694,0.0031936811,0.9654516],"study_design_scores_gemma":[0.00009289091,0.0064642793,0.10760932,0.0025994899,0.000022410608,0.0004864584,0.715822,0.00040190807,0.0041137277,0.08807054,0.07362876,0.0006882439],"about_ca_topic_score_codex":0.020875093,"about_ca_topic_score_gemma":0.03784962,"teacher_disagreement_score":0.9647634,"about_ca_system_score_codex":0.0011115262,"about_ca_system_score_gemma":0.008349245,"threshold_uncertainty_score":0.9972725},"labels":[],"label_agreement":null},{"id":"W4385876561","doi":"10.51731/cjht.2023.713","title":"Hyperbaric Oxygen Therapy: An Emerging Therapy for Post–COVID-19 Condition","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Diabetic Foot Ulcer Assessment and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Coronavirus disease 2019 (COVID-19); Hyperbaric oxygen; Medicine; Intensive care medicine; Adverse effect; Randomized controlled trial; Oxygen therapy; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Clinical trial; Internal medicine; Surgery; Disease","score_opus":0.0762789059156902,"score_gpt":0.3845148688191601,"score_spread":0.3082359629034699,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385876561","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6083131,0.020588193,0.0010116756,0.3670265,0.00075577263,0.0015053737,0.000041486433,0.0005110088,0.00024690115],"genre_scores_gemma":[0.98761153,0.003168857,0.00070500985,0.008158969,0.000036787824,0.000049158585,0.000060389033,0.00002751982,0.00018178982],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99868923,0.000040915766,0.00042344898,0.00016314648,0.00017520797,0.0005080675],"domain_scores_gemma":[0.99903166,0.000058299378,0.00026026825,0.0002492367,0.00016780724,0.00023274458],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010499922,0.00013424868,0.00034217897,0.0011883804,0.00030490407,0.000041302883,0.000247804,0.00010071171,0.00006354635],"category_scores_gemma":[0.0002888419,0.00010863795,0.00009958927,0.0005133161,0.000104418745,0.0001396722,0.000011871263,0.00020242862,0.000007571668],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009692536,0.00005301136,0.0027943882,0.00021310539,0.0001649979,0.0001391002,0.0009045052,0.000031663403,0.00035947692,0.0024610956,0.047393624,0.9453881],"study_design_scores_gemma":[0.0028786068,0.003818718,0.029000727,0.00010288927,0.000023206945,0.00007769837,0.014943339,0.000080386606,0.0002494313,0.009442623,0.9392079,0.00017446569],"about_ca_topic_score_codex":0.001433372,"about_ca_topic_score_gemma":0.00080449204,"teacher_disagreement_score":0.9452136,"about_ca_system_score_codex":0.00040371393,"about_ca_system_score_gemma":0.002870948,"threshold_uncertainty_score":0.50929385},"labels":[],"label_agreement":null},{"id":"W4385876563","doi":"10.51731/cjht.2023.714","title":"Utilization of Opioid Agonist Therapies in Canada","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Buprenorphine; (+)-Naloxone; Methadone; Opioid use disorder; Medicine; Population; Opioid; Agonist; Public health; Pharmacology; Internal medicine; Environmental health","score_opus":0.03982585123833438,"score_gpt":0.2987935455343681,"score_spread":0.2589676942960337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385876563","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92584044,0.040965248,0.000012012862,0.032540657,0.00024636087,0.00024022245,0.000026699941,0.000038732927,0.00008965087],"genre_scores_gemma":[0.9967015,0.0029016049,0.0001644139,0.00018165426,0.000002921136,0.0000045629877,0.000009097461,0.000010354393,0.000023889337],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99896026,0.000024580904,0.0004819772,0.000077352306,0.00015317055,0.00030264544],"domain_scores_gemma":[0.9993874,0.00003452447,0.00024388066,0.0001686786,0.00010461672,0.00006092162],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022195715,0.00008380147,0.0003388249,0.0007171944,0.000057760128,0.0000049998253,0.0001313071,0.000056215657,0.000014568227],"category_scores_gemma":[0.00022244047,0.00006988846,0.00003360169,0.0007027683,0.000076515666,0.000035628666,0.000008470484,0.00017986045,0.0000017242523],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022994218,0.000026770129,0.42221066,0.00040559896,0.00006224959,0.0004103003,0.0017454684,0.00006038936,0.000049765076,0.0005509787,0.0056049167,0.5688499],"study_design_scores_gemma":[0.0013425432,0.00075048755,0.8791544,0.00089703134,0.000020968135,0.00010886677,0.058515884,0.00008247322,0.0022338443,0.0022915204,0.054463852,0.0001381542],"about_ca_topic_score_codex":0.9282429,"about_ca_topic_score_gemma":0.97432387,"teacher_disagreement_score":0.56871176,"about_ca_system_score_codex":0.0012248609,"about_ca_system_score_gemma":0.021553788,"threshold_uncertainty_score":0.9839931},"labels":[],"label_agreement":null},{"id":"W4385966998","doi":"10.51731/cjht.2023.715","title":"Risankizumab (Skyrizi)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Pharmacotherapy; Intensive care medicine; Drug; Physical therapy; Internal medicine; Pharmacology; Health care","score_opus":0.0153356177688009,"score_gpt":0.2638520298573586,"score_spread":0.2485164120885577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385966998","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9811956,0.010420899,0.000098947356,0.0071690422,0.00048551516,0.00013558436,0.00003216337,0.0000902427,0.00037200373],"genre_scores_gemma":[0.9989557,0.00037980324,0.00013783005,0.00032060442,0.000027495806,0.0000041767794,0.000011248072,0.000015505722,0.00014761002],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99901,0.00004485262,0.00032422252,0.000116620366,0.000090625384,0.0004136418],"domain_scores_gemma":[0.9993232,0.000006654129,0.00020353003,0.00026772445,0.00009562482,0.00010326865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046523527,0.00009459526,0.0001404849,0.0003648352,0.00017175476,0.00002004557,0.00036455007,0.00014289653,0.000012958317],"category_scores_gemma":[0.00045966168,0.000088790184,0.00007655754,0.00021637634,0.0001504686,0.0000046507535,0.000033606513,0.00016602721,0.00003965192],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011847779,0.000026076636,0.04876392,0.00025097904,0.00018115353,0.0032881512,0.00031071846,0.0003376887,0.0043416996,0.0024561984,0.35312024,0.5868047],"study_design_scores_gemma":[0.0006851894,0.00039242816,0.14646864,0.0000909732,0.000010731766,0.00024118631,0.0023728362,0.000017379667,0.003676775,0.00316004,0.8426031,0.00028072746],"about_ca_topic_score_codex":0.00022365099,"about_ca_topic_score_gemma":0.0015261574,"teacher_disagreement_score":0.58652395,"about_ca_system_score_codex":0.00007590118,"about_ca_system_score_gemma":0.0023741818,"threshold_uncertainty_score":0.42116964},"labels":[],"label_agreement":null},{"id":"W4386162778","doi":"10.51731/cjht.2023.720","title":"Deucravacitinib (Sotyktu)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Plaque psoriasis; Medicine; Psoriasis; Dermatology; Clinical trial; Intensive care medicine; Internal medicine","score_opus":0.036647230691082354,"score_gpt":0.2688750822448455,"score_spread":0.23222785155376316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386162778","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83149487,0.13896401,0.000056168832,0.024767889,0.0030084457,0.00024184212,0.00011606246,0.0005385595,0.00081214827],"genre_scores_gemma":[0.9978706,0.001123359,0.00008191259,0.00016586199,0.000008778894,0.0000062117233,0.00002283914,0.000012808298,0.00070761406],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99871194,0.00009853462,0.0004355144,0.00012322767,0.000029911991,0.0006008445],"domain_scores_gemma":[0.9993048,0.00009145722,0.00027624457,0.00020948687,0.00008497133,0.000033066364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058636384,0.00012867426,0.00033531783,0.0008856433,0.0003578232,0.000014605036,0.00037148214,0.000250816,0.000107310516],"category_scores_gemma":[0.00031522664,0.000106064734,0.00009829624,0.00053093414,0.00021280562,0.00006898389,0.000020562695,0.00028051634,0.00056880247],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014245831,0.000009501449,0.006449139,0.00002153846,0.0001290324,0.00016180552,0.00029156407,0.0000031939687,0.0007578463,0.0011570491,0.0370073,0.9539978],"study_design_scores_gemma":[0.0011412047,0.0005125467,0.041119214,0.00013340161,0.000034980578,0.00061739434,0.0046711857,6.22956e-7,0.009102233,0.0039808247,0.938476,0.0002103859],"about_ca_topic_score_codex":0.001332967,"about_ca_topic_score_gemma":0.0017946393,"teacher_disagreement_score":0.9537874,"about_ca_system_score_codex":0.00014399835,"about_ca_system_score_gemma":0.0012908201,"threshold_uncertainty_score":0.7310995},"labels":[],"label_agreement":null},{"id":"W4386251552","doi":"10.51731/cjht.2023.724","title":"Upadacitinib (Rinvoq)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Antirheumatic drugs; Ankylosing spondylitis; Drug; Drug class; Intensive care medicine; Pharmacology; Disease; Internal medicine; Antirheumatic Agents; Health care","score_opus":0.04937382254902658,"score_gpt":0.31749931197059955,"score_spread":0.268125489421573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386251552","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7641217,0.09893273,0.000018042096,0.13277388,0.0009067561,0.00037173237,0.000043947588,0.00042004624,0.0024111518],"genre_scores_gemma":[0.996699,0.0022943127,0.00025693144,0.00043643106,0.0000143098605,0.0000050133344,0.000004320624,0.000011845772,0.00027788553],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990057,0.000012883886,0.00033907435,0.00008744258,0.00012198872,0.00043293557],"domain_scores_gemma":[0.99944276,0.000027954618,0.0001572686,0.00015835337,0.000107512446,0.000106159976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025632992,0.000087279725,0.00033141213,0.0006085141,0.00022529147,0.000011233821,0.00010420837,0.000074885225,0.0000326704],"category_scores_gemma":[0.00034660602,0.000069032096,0.000078284174,0.0005010293,0.0001361907,0.000039905968,0.000014985157,0.00022114452,0.00006628677],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021713546,0.000019010638,0.05726859,0.000093654526,0.00012876598,0.003209312,0.00028359937,0.0000017863525,0.000019341362,0.00147123,0.048339684,0.8891433],"study_design_scores_gemma":[0.002320266,0.0015871834,0.1735911,0.00063470186,0.000033498534,0.001875258,0.009820038,0.0000040734117,0.00032544407,0.00442523,0.8052405,0.00014267152],"about_ca_topic_score_codex":0.0023345607,"about_ca_topic_score_gemma":0.0033946545,"teacher_disagreement_score":0.88900065,"about_ca_system_score_codex":0.00022542717,"about_ca_system_score_gemma":0.0012654312,"threshold_uncertainty_score":0.3529173},"labels":[],"label_agreement":null},{"id":"W4386254370","doi":"10.51731/cjht.2023.723","title":"Avacopan (Tavneos)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Rituximab; Microscopic polyangiitis; Granulomatosis with polyangiitis; Prednisone; Internal medicine; Vasculitis; Quality of life (healthcare); Anti-neutrophil cytoplasmic antibody; Clinical trial; ANCA-Associated Vasculitis; Disease","score_opus":0.028708038472559826,"score_gpt":0.2930848554154779,"score_spread":0.2643768169429181,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386254370","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.419366,0.07800486,0.00014153558,0.49566582,0.001657955,0.00042764054,0.00004006313,0.00078259886,0.0039135334],"genre_scores_gemma":[0.99675363,0.00174049,0.00023151997,0.0007526794,0.000016282142,0.0000026961304,0.00000606827,0.000011532746,0.00048507735],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99907565,0.000018337978,0.00035495343,0.00007409433,0.00010926601,0.0003677194],"domain_scores_gemma":[0.9994111,0.000022122544,0.0001491073,0.00017198244,0.00011403097,0.00013163367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034094107,0.000068822046,0.0002546673,0.00091071345,0.00021190397,0.000013130328,0.00013162947,0.00013656284,0.000058954738],"category_scores_gemma":[0.00027386763,0.000053342526,0.000094569215,0.0006238228,0.0001275168,0.00004515008,0.000008799813,0.00045692004,0.00012488705],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000006335868,0.000016198574,0.0064522126,0.00013719761,0.00015033837,0.0022878137,0.00035105218,0.000024048315,0.00010658528,0.0046562506,0.21090817,0.7749038],"study_design_scores_gemma":[0.0010118886,0.0006847766,0.06472678,0.00064220035,0.000041909723,0.0025940023,0.0054244185,0.00002677318,0.00023418556,0.009297229,0.91518897,0.00012688676],"about_ca_topic_score_codex":0.0010031097,"about_ca_topic_score_gemma":0.000615778,"teacher_disagreement_score":0.7747769,"about_ca_system_score_codex":0.00019299303,"about_ca_system_score_gemma":0.0023127815,"threshold_uncertainty_score":0.41027752},"labels":[],"label_agreement":null},{"id":"W4386331644","doi":"10.51731/cjht.2023.726","title":"Vericiguat (Verquvo)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Decompensation; Medicine; Heart failure; Intensive care medicine; Diuretic; Ejection fraction; Drug class; Drug; Internal medicine; Health care; Pharmacology; Political science","score_opus":0.2190525147232995,"score_gpt":0.4353519264052075,"score_spread":0.21629941168190797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386331644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.65270835,0.03434237,0.00008299467,0.30812716,0.0014762172,0.00038812723,0.000014652277,0.00038932177,0.002470816],"genre_scores_gemma":[0.9965873,0.0010615089,0.00019433496,0.0019458372,0.000012874455,0.0000014314523,0.0000021551468,0.000009390632,0.00018520377],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989946,0.000030025634,0.00036355708,0.00007334909,0.00015310383,0.00038538582],"domain_scores_gemma":[0.9993022,0.00010325964,0.00021755176,0.00014560802,0.000084262516,0.00014713411],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055359356,0.00007447337,0.00027513193,0.00058243354,0.0001327099,0.000014237646,0.00014634177,0.00007914346,0.000054319557],"category_scores_gemma":[0.0010279625,0.00005689687,0.00007156635,0.0005810891,0.000106991014,0.00010281506,0.00001472779,0.00044105385,0.000092011025],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005704347,0.000023051825,0.10433358,0.0002623079,0.00008662729,0.0011414073,0.00034251015,0.0000151401355,0.00007629425,0.001190268,0.050175365,0.8422964],"study_design_scores_gemma":[0.0006613849,0.0005768531,0.045388807,0.00017385052,0.000026367634,0.00038864242,0.0022301876,0.00009999479,0.0002808284,0.0015598808,0.94853073,0.00008248146],"about_ca_topic_score_codex":0.0007188842,"about_ca_topic_score_gemma":0.00019725146,"teacher_disagreement_score":0.89835536,"about_ca_system_score_codex":0.00018535147,"about_ca_system_score_gemma":0.0014799521,"threshold_uncertainty_score":0.26253715},"labels":[],"label_agreement":null},{"id":"W4386331753","doi":"10.51731/cjht.2023.727","title":"Atogepant (Qulipta)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Migraine; Medicine; Drug class; Family medicine; Drug; Psychiatry; Political science; Health care","score_opus":0.06980154237411829,"score_gpt":0.3372905315972303,"score_spread":0.26748898922311204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386331753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.47769043,0.10938307,0.00006438858,0.4091553,0.00027979855,0.0003517129,0.000018895518,0.0005166967,0.002539687],"genre_scores_gemma":[0.9952986,0.0023940578,0.00029289143,0.0009121418,0.000025656242,0.0000030571834,0.0000020516388,0.000011559596,0.0010599727],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988932,0.000017240935,0.00040632713,0.00008573509,0.00013601189,0.00046151067],"domain_scores_gemma":[0.99935704,0.00003559406,0.00017278438,0.00017678649,0.00014474613,0.00011306556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005656649,0.00008895761,0.00038952817,0.0008362121,0.00021266963,0.0000091454185,0.00013688343,0.000089360976,0.000027940416],"category_scores_gemma":[0.0007759588,0.00006782392,0.0001009896,0.00059876224,0.00015670172,0.000038365913,0.000018289098,0.00036055077,0.000060748982],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013218573,0.0000106166135,0.0373085,0.0002397619,0.00010471578,0.0009224914,0.0009526908,0.0000018379172,0.00007393872,0.0016567915,0.75817096,0.20054448],"study_design_scores_gemma":[0.00037752787,0.00050751143,0.07631259,0.00026483694,0.000018309458,0.00050494506,0.009401523,0.0000072671037,0.00016016049,0.0019117744,0.91045827,0.00007529219],"about_ca_topic_score_codex":0.002277712,"about_ca_topic_score_gemma":0.004802333,"teacher_disagreement_score":0.51760817,"about_ca_system_score_codex":0.00017695525,"about_ca_system_score_gemma":0.0023984222,"threshold_uncertainty_score":0.42546982},"labels":[],"label_agreement":null},{"id":"W4386569541","doi":"10.51731/cjht.2023.732","title":"Dapagliflozin","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dapagliflozin; Reimbursement; Medicine; Kidney disease; Intensive care medicine; Renal function; Drug; Disease; Internal medicine; Pharmacology; Endocrinology; Diabetes mellitus; Economic growth; Health care; Economics","score_opus":0.03969015294780756,"score_gpt":0.2983118014589129,"score_spread":0.25862164851110536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386569541","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.59633154,0.05004282,0.00008275824,0.34463307,0.001194776,0.00066740083,0.000013771724,0.00082494196,0.006208923],"genre_scores_gemma":[0.9973054,0.0006577388,0.0003573272,0.0006444601,0.000010103032,0.000004167471,0.0000045358315,0.000010041308,0.0010062131],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999173,0.000011701377,0.00027506155,0.000070695845,0.000105844294,0.0003636855],"domain_scores_gemma":[0.99953365,0.000018489967,0.0001325108,0.00016638672,0.000060541814,0.000088390596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037746064,0.00007082136,0.00024799028,0.00092668826,0.000096475764,0.000014195103,0.00012548271,0.000055146404,0.000026048489],"category_scores_gemma":[0.0002024998,0.000055052344,0.000059915295,0.00051107846,0.00007885407,0.000048789912,0.00001432893,0.00015558406,0.00008857321],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000052349465,0.000012027635,0.014864832,0.00009590085,0.00009013339,0.0005946861,0.00011076833,0.000004172277,0.000014054185,0.0019570591,0.12118013,0.861071],"study_design_scores_gemma":[0.00070521317,0.00073808496,0.045939732,0.0002512278,0.00003665325,0.00007509688,0.0027006336,0.000013076368,0.00025501987,0.0031049112,0.94610506,0.000075276],"about_ca_topic_score_codex":0.00051747554,"about_ca_topic_score_gemma":0.00055827195,"teacher_disagreement_score":0.8609957,"about_ca_system_score_codex":0.00022683424,"about_ca_system_score_gemma":0.00094293326,"threshold_uncertainty_score":0.22449695},"labels":[],"label_agreement":null},{"id":"W4386569617","doi":"10.51731/cjht.2023.731","title":"Telephone Triage Services in Canada","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Emergency and Acute Care Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Triage; Health care; Hotline; Medicine; Nursing; Medical emergency; Business; Political science; Telecommunications; Computer science","score_opus":0.022015028654886196,"score_gpt":0.2801131795225354,"score_spread":0.2580981508676492,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386569617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8407841,0.07394338,0.0000021620172,0.0837696,0.0008156846,0.00018376822,0.000026878166,0.00007180084,0.00040263092],"genre_scores_gemma":[0.99379694,0.005159033,0.000066740344,0.00088847283,0.000013870654,0.0000037352709,0.0000034591596,0.000008758193,0.000058964593],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987728,0.00002254911,0.0005083419,0.000091211274,0.00014898874,0.0004561004],"domain_scores_gemma":[0.99943656,0.000041515057,0.00018086741,0.00014548248,0.000109440145,0.000086112945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003949545,0.00009343759,0.00040501778,0.00068745273,0.00011481787,0.0000048142597,0.000177728,0.000059504444,0.000021026884],"category_scores_gemma":[0.00027484112,0.00007582322,0.000041717445,0.00095533393,0.00005493891,0.00004936808,0.000017326842,0.00035368762,0.000005547463],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038821043,0.000012490671,0.2885481,0.0008416261,0.00011885496,0.005017632,0.0012862311,0.00003609279,0.000071189505,0.00020928988,0.14405096,0.55976874],"study_design_scores_gemma":[0.0014309728,0.00041854114,0.40789717,0.001207273,0.000022511249,0.0003406673,0.08468355,0.000033137367,0.0005339469,0.001317793,0.50189364,0.0002207539],"about_ca_topic_score_codex":0.9506565,"about_ca_topic_score_gemma":0.99591434,"teacher_disagreement_score":0.55954796,"about_ca_system_score_codex":0.0008605508,"about_ca_system_score_gemma":0.009890441,"threshold_uncertainty_score":0.99572253},"labels":[],"label_agreement":null},{"id":"W4386688264","doi":"10.51731/cjht.2023.734","title":"Trastuzumab Deruxtecan (Enhertu)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Trastuzumab; Medicine; Reimbursement; Metastatic breast cancer; Oncology; Chemotherapy; Breast cancer; Internal medicine; Disease; Adjuvant; Cancer; Intensive care medicine; Health care","score_opus":0.10286531305846934,"score_gpt":0.398326580389078,"score_spread":0.2954612673306086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386688264","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4534305,0.07818354,0.00028851244,0.4622791,0.0013700528,0.00093901774,0.00005155147,0.00089609943,0.0025616023],"genre_scores_gemma":[0.99657834,0.001651867,0.0005112512,0.00070659065,0.0000343797,0.000010789737,0.0000032276985,0.000030926112,0.00047264638],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979847,0.00005862126,0.0005687961,0.0001560058,0.00036351054,0.0008683832],"domain_scores_gemma":[0.998843,0.00007875373,0.00019698631,0.00034753606,0.00024115283,0.00029254146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012865202,0.0001256626,0.0004479542,0.0015642556,0.00022855078,0.00003117623,0.00039489398,0.00017437682,0.00011679921],"category_scores_gemma":[0.0013587706,0.00010568794,0.00009811665,0.0012958992,0.00030268822,0.000064057094,0.000026637737,0.0008709455,0.000109812805],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001695462,0.000010002983,0.007698179,0.00021004921,0.000039021477,0.0011076189,0.00032599355,0.0000066025386,0.00008385337,0.00029446595,0.0763762,0.91383106],"study_design_scores_gemma":[0.00091086404,0.0016173312,0.040787008,0.00078299496,0.000015904803,0.0013449255,0.007961091,0.000036219943,0.0012374488,0.004319933,0.94081736,0.00016893017],"about_ca_topic_score_codex":0.0054456326,"about_ca_topic_score_gemma":0.0065215207,"teacher_disagreement_score":0.91366214,"about_ca_system_score_codex":0.0012033251,"about_ca_system_score_gemma":0.010888831,"threshold_uncertainty_score":0.9947185},"labels":[],"label_agreement":null},{"id":"W4386751852","doi":"10.51731/cjht.2023.736","title":"Somatropin for Short Stature","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Idiopathic short stature; Guideline; Short stature; Medicine; Growth hormone; Context (archaeology); Somatropin; Pediatrics; Growth hormone treatment; Small for gestational age; Hormone; Endocrinology; Intensive care medicine; Gestational age; Biology; Pregnancy; Pathology","score_opus":0.05128207835179631,"score_gpt":0.3225026465746606,"score_spread":0.2712205682228643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386751852","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8471345,0.034721103,0.00057783694,0.11479674,0.001098216,0.00082594476,0.000101061785,0.0004830645,0.00026155336],"genre_scores_gemma":[0.9971933,0.00087942975,0.0009498404,0.00075868133,0.000036061567,0.000010822882,0.000018252354,0.000024067765,0.00012956643],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99856186,0.000015522824,0.0005326296,0.00012377246,0.00015237482,0.0006138364],"domain_scores_gemma":[0.9991736,0.00005346615,0.00016249991,0.00021440977,0.00021592935,0.00018009426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043287847,0.00012650187,0.0004316409,0.0010368633,0.00020444223,0.000019556997,0.00020448137,0.00020576673,0.000007564868],"category_scores_gemma":[0.00068097556,0.00010041824,0.00013532511,0.00060035253,0.00012149268,0.000090177135,0.0000125453425,0.00043986648,0.0000126235045],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008271117,0.000024219986,0.04789534,0.00058884243,0.00014803415,0.00046125677,0.0005853863,0.0000069714733,0.0004833188,0.0022356755,0.32656345,0.6209248],"study_design_scores_gemma":[0.0011472121,0.0023300939,0.13459247,0.00040540524,0.000049982074,0.000469777,0.006988406,0.000042115153,0.0022161836,0.006220348,0.84530497,0.00023302951],"about_ca_topic_score_codex":0.000452512,"about_ca_topic_score_gemma":0.0005777743,"teacher_disagreement_score":0.6206918,"about_ca_system_score_codex":0.00026667668,"about_ca_system_score_gemma":0.0028819789,"threshold_uncertainty_score":0.5112507},"labels":[],"label_agreement":null},{"id":"W4386777097","doi":"10.51731/cjht.2023.737","title":"Foslevodopa-Foscarbidopa (Vyalev)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Dyskinesia; Levodopa; Medicine; Disease; Drug; Parkinson's disease; Intensive care medicine; Psychiatry; Political science; Internal medicine; Health care","score_opus":0.042815861914998116,"score_gpt":0.3039787385316636,"score_spread":0.2611628766166655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386777097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8725045,0.05686204,0.00014326282,0.06676881,0.0010571972,0.00048222824,0.00007330084,0.0005960271,0.0015126336],"genre_scores_gemma":[0.99789125,0.00082961336,0.00046165226,0.00046955273,0.00001756641,0.000006910954,0.00000673004,0.000019674997,0.00029707942],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987227,0.000028031882,0.00038374166,0.00013981636,0.00018777385,0.0005379532],"domain_scores_gemma":[0.99912983,0.000028401268,0.00022661495,0.00025493428,0.000116990486,0.00024324175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038690932,0.00012899822,0.00038805118,0.0010064774,0.00019493673,0.000019307794,0.00018179155,0.000108275315,0.000042646312],"category_scores_gemma":[0.0003317192,0.0001042627,0.000118392105,0.00061875203,0.000097602286,0.00006575864,0.000017790207,0.00027820695,0.00010546463],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042187618,0.000051799507,0.030545939,0.00019744472,0.00019480933,0.005424233,0.00018529255,0.0000066258335,0.0001231123,0.0018952013,0.033538666,0.9277947],"study_design_scores_gemma":[0.0020794778,0.0014146776,0.17223981,0.0006251411,0.000093119874,0.0013278979,0.0034958555,0.000044689787,0.0013009784,0.011656692,0.80550104,0.00022062431],"about_ca_topic_score_codex":0.0012336803,"about_ca_topic_score_gemma":0.00070086546,"teacher_disagreement_score":0.92757404,"about_ca_system_score_codex":0.00037887928,"about_ca_system_score_gemma":0.0026700029,"threshold_uncertainty_score":0.47364706},"labels":[],"label_agreement":null},{"id":"W4386890226","doi":"10.51731/cjht.2023.739","title":"Optimizing the Use of Iodinated Contrast Media: Conservation Strategies Used Across Canada During the 2022 Shortage","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Advanced X-ray and CT Imaging","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Economic shortage; Contrast (vision); Dosing; Medicine; Iodinated contrast media; Iodinated contrast; Adverse effect; Sustainability; Radiology; Computed tomography; Computer science; Pharmacology","score_opus":0.03422663134946923,"score_gpt":0.25090922571688146,"score_spread":0.21668259436741222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386890226","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9801439,0.007336374,0.00079635537,0.010764225,0.00050131977,0.00017294173,0.00009892954,0.00017891341,0.0000070497185],"genre_scores_gemma":[0.9991477,0.00056520395,0.0001335584,0.00010739655,0.000009895598,0.0000067535334,0.0000038086555,0.000018422188,0.0000072296452],"study_design_codex":"simulation_or_modeling","study_design_gemma":"qualitative","domain_scores_codex":[0.99866426,0.00004033468,0.0005135632,0.00007646878,0.00017661897,0.0005287454],"domain_scores_gemma":[0.9990638,0.00031868066,0.00022491137,0.00022205959,0.000119221986,0.00005136551],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044383534,0.00012978121,0.0002583976,0.00012568333,0.00049322064,0.00007954413,0.0004010348,0.00006662065,0.0000048055585],"category_scores_gemma":[0.0003795842,0.0000884059,0.000039053488,0.00064172636,0.00024200995,0.00031369313,0.0000213407,0.0005743879,3.914262e-7],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000259709,0.0000068991562,0.01503594,0.0005516415,0.00028761348,0.0006670267,0.01144798,0.87431204,0.003689302,0.0014079864,0.0093454,0.083222196],"study_design_scores_gemma":[0.0022119433,0.00018292917,0.18256217,0.001526698,0.000072500414,0.00057066017,0.59114265,0.039760258,0.022872303,0.0024900022,0.15542209,0.0011857712],"about_ca_topic_score_codex":0.18152314,"about_ca_topic_score_gemma":0.85045594,"teacher_disagreement_score":0.8345518,"about_ca_system_score_codex":0.0003628783,"about_ca_system_score_gemma":0.0012806394,"threshold_uncertainty_score":0.82392716},"labels":[],"label_agreement":null},{"id":"W4387139635","doi":"10.51731/cjht.2023.745","title":"Difelikefalin (Korsuva)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Kidney disease; Family medicine; Intensive care medicine; Political science; Internal medicine; Health care","score_opus":0.0353784729194209,"score_gpt":0.3163723597125678,"score_spread":0.28099388679314685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387139635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.67296666,0.079579115,0.00006155471,0.24436837,0.00100789,0.00025767097,0.000023600844,0.00053553603,0.0011995761],"genre_scores_gemma":[0.9977932,0.000690853,0.00014342088,0.0011482057,0.000013205931,0.000002970121,0.0000044211374,0.000009781197,0.00019395762],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989931,0.000032408392,0.0003823215,0.00008153755,0.00010917029,0.0004014715],"domain_scores_gemma":[0.9993326,0.00005519789,0.00017199497,0.00019051327,0.00010230819,0.00014738129],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003588969,0.000079743055,0.00032630656,0.00087978214,0.00016398603,0.000010092051,0.00017704048,0.00012969317,0.000035367782],"category_scores_gemma":[0.0009634165,0.000064229745,0.0000820091,0.00051289157,0.0002206619,0.00005268935,0.000012746451,0.00031304726,0.000090956455],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003790312,0.000024900244,0.16245133,0.00025706168,0.00008704249,0.004560701,0.00029010372,0.000007969705,0.00002201908,0.00093169825,0.5340034,0.29732588],"study_design_scores_gemma":[0.001025157,0.000352257,0.27830157,0.0005067149,0.000039444672,0.0033400878,0.0049650325,0.000026637697,0.00043978338,0.0101536475,0.70069337,0.000156281],"about_ca_topic_score_codex":0.00041874652,"about_ca_topic_score_gemma":0.00053355604,"teacher_disagreement_score":0.3248265,"about_ca_system_score_codex":0.00010941084,"about_ca_system_score_gemma":0.0026069833,"threshold_uncertainty_score":0.46246764},"labels":[],"label_agreement":null},{"id":"W4387219070","doi":"10.51731/cjht.2023.746","title":"Perspectives and Experiences Regarding the Impacts of Emergency Department Overcrowding: A Rapid Qualitative Review","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Emergency and Acute Care Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Overcrowding; Emergency department; Harm; Medicine; Health care; Dignity; Burnout; Nursing; Psychology; Medical emergency; Social psychology; Clinical psychology; Political science","score_opus":0.07338817551188323,"score_gpt":0.40818421945540106,"score_spread":0.3347960439435178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387219070","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.29523224,0.64263135,0.0000047326175,0.061496947,0.00020688947,0.00021860136,0.00000923559,0.000027676146,0.00017236595],"genre_scores_gemma":[0.70494723,0.29480943,0.000053006836,0.00015112561,0.000008903937,0.000011954651,6.391141e-7,0.0000045151896,0.000013187297],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.99878716,0.00009949151,0.0005441351,0.00010903257,0.00016399432,0.0002962032],"domain_scores_gemma":[0.9990412,0.00009400097,0.00037292077,0.0001482635,0.0002731676,0.00007044573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013082927,0.00010577049,0.00045058568,0.0002828894,0.0002743656,0.000004273684,0.00013548085,0.00004132134,0.000030672894],"category_scores_gemma":[0.0027486426,0.00006245172,0.00010287669,0.0006274342,0.0003062155,0.0000776542,0.000027387681,0.00021188194,7.76135e-7],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054237087,0.00003547845,0.007756363,0.0051131444,0.0007413553,0.00020253519,0.545426,5.3804405e-7,0.00016342607,0.008467905,0.29975128,0.13228774],"study_design_scores_gemma":[0.00016139694,0.0006057916,0.0033491775,0.0024703993,0.00004528504,0.00007779831,0.9688013,5.6703067e-7,0.0002335783,0.0010828952,0.023099389,0.000072381205],"about_ca_topic_score_codex":0.00053222326,"about_ca_topic_score_gemma":0.0004992279,"teacher_disagreement_score":0.42337534,"about_ca_system_score_codex":0.000116579,"about_ca_system_score_gemma":0.0006559869,"threshold_uncertainty_score":0.32905805},"labels":[],"label_agreement":null},{"id":"W4387402610","doi":"10.51731/cjht.2023.748","title":"Budesonide Extended Release for Ulcerative Colitis","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Budesonide; Ulcerative colitis; Medicine; Internal medicine; Adverse effect; Placebo; Randomized controlled trial; Clinical trial; Corticosteroid; Gastroenterology; Disease; Alternative medicine; Pathology","score_opus":0.017084894008127578,"score_gpt":0.2815914837279059,"score_spread":0.2645065897197783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387402610","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9805983,0.004325317,0.0010341434,0.0123526575,0.00052063604,0.0006233124,0.0002695767,0.00010890839,0.00016716735],"genre_scores_gemma":[0.99843127,0.00029566864,0.0005227614,0.00042348538,0.00003566966,0.000032000484,0.000028581839,0.00001979747,0.0002107777],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989158,0.000053576117,0.0003477617,0.00014595648,0.000075284224,0.00046160622],"domain_scores_gemma":[0.9991793,0.000019005449,0.0002316767,0.00022659636,0.00020866499,0.00013472798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051561097,0.000108230066,0.00017089842,0.00028789495,0.00023762995,0.000024438496,0.00027961793,0.00014522458,0.0000064162086],"category_scores_gemma":[0.0011026264,0.000105003826,0.000098176366,0.0001583456,0.00015855912,0.000006112092,0.000022477587,0.00013056937,0.000008893058],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009919167,0.000054181495,0.008711837,0.00063564774,0.00034156695,0.002399896,0.00078067987,0.00040581805,0.0040707337,0.011403426,0.32065526,0.64954907],"study_design_scores_gemma":[0.002209651,0.001483728,0.30369383,0.00023369062,0.000031976375,0.00025737728,0.0075809103,0.00010936245,0.009868903,0.014479672,0.6594948,0.0005560704],"about_ca_topic_score_codex":0.00020648359,"about_ca_topic_score_gemma":0.0073093027,"teacher_disagreement_score":0.64899296,"about_ca_system_score_codex":0.00011741358,"about_ca_system_score_gemma":0.0029954796,"threshold_uncertainty_score":0.5313852},"labels":[],"label_agreement":null},{"id":"W4387775935","doi":"10.51731/cjht.2023.752","title":"Semaglutide for Type 2 Diabetes (2 mg)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Semaglutide; Discontinuation; Medicine; Placebo; Adverse effect; Diabetes mellitus; Type 2 diabetes; Glycemic; Internal medicine; Randomized controlled trial; Dulaglutide; Endocrinology; Exenatide; Alternative medicine; Liraglutide","score_opus":0.05726240410101599,"score_gpt":0.3232356622110811,"score_spread":0.2659732581100651,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387775935","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8035866,0.041733276,0.00003971764,0.15174527,0.0010681348,0.00087707327,0.000024569268,0.0004435708,0.0004817636],"genre_scores_gemma":[0.9965174,0.0005622598,0.0010642819,0.0008139654,0.000022112912,0.000015369536,0.000013103059,0.00001794094,0.0009735683],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99901694,0.000010491132,0.00029795791,0.00009194249,0.00008974682,0.00049294165],"domain_scores_gemma":[0.99936736,0.00007395948,0.00015889488,0.00016917856,0.00013644905,0.000094191484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004613665,0.00009061225,0.00031352649,0.0007654874,0.00012818289,0.000016433441,0.00013413467,0.00006771893,0.000013641202],"category_scores_gemma":[0.0006141838,0.00007171415,0.00007784876,0.00049065374,0.00007885141,0.000037594928,0.000014295031,0.000121800185,0.000031208754],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012733264,0.000018994226,0.034792624,0.00041354174,0.00020839534,0.00010214268,0.000100123645,0.000007596346,0.00007697233,0.0017871181,0.17192619,0.79055357],"study_design_scores_gemma":[0.00097572466,0.0017296864,0.032178797,0.00035669765,0.00007732735,0.000012847239,0.001412528,0.000042712323,0.0008190997,0.004826777,0.9574601,0.0001077231],"about_ca_topic_score_codex":0.00016481114,"about_ca_topic_score_gemma":0.000438952,"teacher_disagreement_score":0.79044586,"about_ca_system_score_codex":0.00022611854,"about_ca_system_score_gemma":0.0009359679,"threshold_uncertainty_score":0.29244182},"labels":[],"label_agreement":null},{"id":"W4387814323","doi":"10.51731/cjht.2023.758","title":"Use of MRI and CT in Private Imaging Facilities in Canada (2021-2023)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Radiology practices and education","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Payment; Business; Government (linguistics); Coronavirus disease 2019 (COVID-19); Private insurance; Finance; Private sector; Health care; Medicine; Health insurance; Economic growth; Economics","score_opus":0.04931627375963663,"score_gpt":0.29953974809018835,"score_spread":0.2502234743305517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387814323","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92738956,0.010432991,0.0000020716252,0.061840314,0.00019797056,0.00009914971,0.000011943362,0.000007145995,0.000018822408],"genre_scores_gemma":[0.9967416,0.0028086507,0.00019167394,0.0001913403,0.0000042269576,0.0000021830147,0.000002349396,0.0000043198374,0.000053674397],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990755,0.000043450767,0.0004295159,0.000081534854,0.00007085594,0.0002991979],"domain_scores_gemma":[0.99941623,0.00013904354,0.00022244047,0.000116575684,0.000043924694,0.0000617939],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052482024,0.000061666324,0.00028353347,0.00086775894,0.000039344864,0.000007951426,0.00007541152,0.000029776478,0.000010332901],"category_scores_gemma":[0.0010393537,0.00005537546,0.000013371013,0.00044538855,0.000108632354,0.00014523894,0.00001066758,0.00033942537,5.923839e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010035212,0.000003206377,0.8772118,0.00012106466,0.000008413831,0.0004216201,0.00038792074,0.00006821555,0.000018146427,0.000095920266,0.0033713821,0.118282296],"study_design_scores_gemma":[0.00030617084,0.000078796416,0.8839938,0.00035774382,0.000004875287,0.0004348173,0.026707891,0.00016917603,0.00007410848,0.0005752935,0.087235644,0.00006168351],"about_ca_topic_score_codex":0.9583835,"about_ca_topic_score_gemma":0.9681489,"teacher_disagreement_score":0.11822061,"about_ca_system_score_codex":0.0007643412,"about_ca_system_score_gemma":0.0075380956,"threshold_uncertainty_score":0.99808824},"labels":[],"label_agreement":null},{"id":"W4387821300","doi":"10.51731/cjht.2023.760","title":"Cost-Effectiveness of Nirsevimab for the Prevention of Respiratory Syncytial Virus Infection in Infants","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Respiratory viral infections research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Generalizability theory; Cost effectiveness; Economic evaluation; Population; Medicine; Environmental health; Immunization; Economic cost; Cost–benefit analysis; Demography; Immunology; Biology; Antibody; Psychology; Economics","score_opus":0.17974875024272932,"score_gpt":0.4554738111971024,"score_spread":0.2757250609543731,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387821300","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99032146,0.0058630286,0.00090944197,0.00083158346,0.0002979763,0.0016788547,0.000021448257,0.000039181083,0.000037053087],"genre_scores_gemma":[0.9991391,0.00065711467,0.000036052956,0.00003165726,0.000013393871,0.00009872453,0.0000017705821,0.000013502905,0.000008701042],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99835026,0.00026288646,0.0007447098,0.00010978162,0.00020598076,0.0003263737],"domain_scores_gemma":[0.99833256,0.0004710753,0.0004596217,0.00025878768,0.0004260273,0.00005194729],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004061132,0.000091448404,0.0004455449,0.0019040803,0.00013798839,0.000008443645,0.00016588406,0.00016279952,0.0000074667796],"category_scores_gemma":[0.003453742,0.00006835098,0.00012009703,0.001398907,0.0003247838,0.00012427568,0.000022677848,0.00043782848,0.0000021578264],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061698473,0.0001010037,0.23048183,0.0019822277,0.0001357926,0.00003989421,0.00017145784,0.00095388346,0.008130217,0.00057343655,0.0008339267,0.75597936],"study_design_scores_gemma":[0.002723157,0.004333813,0.9115612,0.0018742844,0.000037186437,0.00005526073,0.0007714418,0.00014311261,0.056096524,0.0020665375,0.020232208,0.000105272666],"about_ca_topic_score_codex":0.0067835995,"about_ca_topic_score_gemma":0.011139466,"teacher_disagreement_score":0.7558741,"about_ca_system_score_codex":0.00057326583,"about_ca_system_score_gemma":0.0035687985,"threshold_uncertainty_score":0.9998303},"labels":[],"label_agreement":null},{"id":"W4387821399","doi":"10.51731/cjht.2023.756","title":"Equity in Health Technology Assessment","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Redress; Equity (law); Health equity; Health care; Psychological intervention; Health technology; Business; Public relations; Public economics; Actuarial science; Political science; Medicine; Nursing; Economic growth; Economics","score_opus":0.5030334889143961,"score_gpt":0.5219491030484097,"score_spread":0.018915614134013548,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387821399","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05851237,0.050701633,0.0013487813,0.8863145,0.001139704,0.0006515104,0.00013885477,0.00028105205,0.00091161],"genre_scores_gemma":[0.98912275,0.0018220362,0.0027051014,0.006143047,0.000026424636,0.00003695297,0.000007911295,0.000027680931,0.000108088316],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99203163,0.00025905384,0.006087085,0.00034125097,0.000106322535,0.0011746791],"domain_scores_gemma":[0.9946289,0.00030624532,0.0042778435,0.00049918477,0.000087550034,0.00020026504],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.03505481,0.00017625571,0.0014099948,0.0052181073,0.00034954725,0.000059206013,0.00079942093,0.00028382143,0.000069266454],"category_scores_gemma":[0.005544101,0.00021497201,0.00009324833,0.0018063718,0.00021969968,0.0002978064,0.000087396504,0.00076472916,0.0003393181],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000004003301,0.000052102532,0.20824118,0.0011039451,0.00005735096,0.00006517986,0.0013615926,0.00052206666,0.0000010099271,0.59779245,0.08731445,0.10348468],"study_design_scores_gemma":[0.0009555484,0.00054495677,0.12065724,0.00073153165,0.0000012205111,0.000086251115,0.02283312,0.00067774573,0.0000035627718,0.3076875,0.54545504,0.0003663154],"about_ca_topic_score_codex":0.016063727,"about_ca_topic_score_gemma":0.017863752,"teacher_disagreement_score":0.93061036,"about_ca_system_score_codex":0.004649013,"about_ca_system_score_gemma":0.00726846,"threshold_uncertainty_score":0.999172},"labels":[],"label_agreement":null},{"id":"W4387845563","doi":"10.51731/cjht.2023.761","title":"Emergency Department Overcrowding in Canada: Multistakeholder Dialogue","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Emergency and Acute Care Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Overcrowding; Emergency department; Accountability; Burnout; Health care; Medicine; Distress; Nursing; Medical emergency; Psychology; Political science","score_opus":0.05736666045693938,"score_gpt":0.3012940200363951,"score_spread":0.24392735957945572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387845563","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8811302,0.07599105,0.00001581181,0.04020906,0.0018340098,0.00030266782,0.00007441362,0.00008142214,0.00036131483],"genre_scores_gemma":[0.99110675,0.008438142,0.00006957365,0.00028427705,0.000017183555,0.000008793087,0.000009108539,0.000012501246,0.000053663305],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998384,0.000029293371,0.00068162667,0.00012763661,0.00018129835,0.0005961709],"domain_scores_gemma":[0.9993782,0.00003227374,0.00019389825,0.00015998393,0.00012301438,0.000112617454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004025819,0.00012570403,0.00041445057,0.00062540744,0.00016539963,0.0000037487985,0.00015398857,0.000066477965,0.00003584912],"category_scores_gemma":[0.0006465506,0.00010799292,0.00006392606,0.00078167784,0.000055531145,0.00005607174,0.000021621445,0.0003663567,0.0000049641317],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016612801,0.00001563352,0.4363169,0.00029057713,0.00010963227,0.0031487516,0.00076983584,0.00005558364,0.000046507714,0.000373386,0.3205888,0.23826776],"study_design_scores_gemma":[0.0010083936,0.00034022305,0.6438034,0.0006848408,0.00003085417,0.00025189263,0.025749372,0.00003989097,0.0004045289,0.0010766012,0.3263112,0.00029878656],"about_ca_topic_score_codex":0.8625449,"about_ca_topic_score_gemma":0.9917311,"teacher_disagreement_score":0.23796898,"about_ca_system_score_codex":0.0016246596,"about_ca_system_score_gemma":0.007932547,"threshold_uncertainty_score":0.9976916},"labels":[],"label_agreement":null},{"id":"W4387845984","doi":"10.51731/cjht.2023.762","title":"Avacopan (Tavneos)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Microscopic polyangiitis; Granulomatosis with polyangiitis; Vasculitis; Intensive care medicine; Proteinase 3; Internal medicine; Political science; Health care","score_opus":0.028708038472559826,"score_gpt":0.2930848554154779,"score_spread":0.2643768169429181,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387845984","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.419366,0.07800486,0.00014153558,0.49566582,0.001657955,0.00042764054,0.00004006313,0.00078259886,0.0039135334],"genre_scores_gemma":[0.99675363,0.00174049,0.00023151997,0.0007526794,0.000016282142,0.0000026961304,0.00000606827,0.000011532746,0.00048507735],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99907565,0.000018337978,0.00035495343,0.00007409433,0.00010926601,0.0003677194],"domain_scores_gemma":[0.9994111,0.000022122544,0.0001491073,0.00017198244,0.00011403097,0.00013163367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034094107,0.000068822046,0.0002546673,0.00091071345,0.00021190397,0.000013130328,0.00013162947,0.00013656284,0.000058954738],"category_scores_gemma":[0.00027386763,0.000053342526,0.000094569215,0.0006238228,0.0001275168,0.00004515008,0.000008799813,0.00045692004,0.00012488705],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000006335868,0.000016198574,0.0064522126,0.00013719761,0.00015033837,0.0022878137,0.00035105218,0.000024048315,0.00010658528,0.0046562506,0.21090817,0.7749038],"study_design_scores_gemma":[0.0010118886,0.0006847766,0.06472678,0.00064220035,0.000041909723,0.0025940023,0.0054244185,0.00002677318,0.00023418556,0.009297229,0.91518897,0.00012688676],"about_ca_topic_score_codex":0.0010031097,"about_ca_topic_score_gemma":0.000615778,"teacher_disagreement_score":0.7747769,"about_ca_system_score_codex":0.00019299303,"about_ca_system_score_gemma":0.0023127815,"threshold_uncertainty_score":0.41027752},"labels":[],"label_agreement":null},{"id":"W4387972807","doi":"10.51731/cjht.2023.770","title":"Ravulizumab (Ultomiris)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Myasthenia Gravis and Thymoma","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Myasthenia gravis; Medicine; Drug; Family medicine; Pharmacology; Political science; Internal medicine; Law; Health care","score_opus":0.038404020202156816,"score_gpt":0.31029660472795734,"score_spread":0.2718925845258005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387972807","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7890447,0.0272397,0.00008959312,0.18100233,0.0006831183,0.000310259,0.000018016903,0.00041845522,0.0011938172],"genre_scores_gemma":[0.998135,0.00056092674,0.000361283,0.0005695276,0.000019475217,0.000002596895,0.0000032984117,0.000015728208,0.00033222095],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988082,0.000024316014,0.0004483178,0.00009688281,0.00015325335,0.00046901056],"domain_scores_gemma":[0.9992234,0.00003137702,0.00022243771,0.00023237024,0.00013532849,0.00015507727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057888625,0.000095290954,0.00037308648,0.0009937291,0.00016312057,0.000018099643,0.00020068546,0.000119868746,0.00005289627],"category_scores_gemma":[0.0004925984,0.000073951,0.00009186331,0.00067391363,0.00013447824,0.000049295722,0.00001427133,0.00039267895,0.000102660146],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028851928,0.00001114992,0.0116529,0.00013101602,0.00005099602,0.0015123021,0.00034399214,0.000003236843,0.000076922006,0.0029959152,0.07124704,0.9119457],"study_design_scores_gemma":[0.001136445,0.00089312723,0.07108899,0.00041220308,0.000019212397,0.002140863,0.0041213734,0.00003050966,0.00043606514,0.0070487275,0.91254234,0.00013012694],"about_ca_topic_score_codex":0.0014321008,"about_ca_topic_score_gemma":0.0009156348,"teacher_disagreement_score":0.9118155,"about_ca_system_score_codex":0.00022125036,"about_ca_system_score_gemma":0.0025236753,"threshold_uncertainty_score":0.44768918},"labels":[],"label_agreement":null},{"id":"W4388131049","doi":"10.51731/cjht.2023.772","title":"Dupilumab (Dupixent)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Atopic dermatitis; Medical prescription; Dupilumab; Population; Disease; Pediatrics; Dermatology; Family medicine; Internal medicine; Pharmacology","score_opus":0.032088891347487436,"score_gpt":0.3086995705365656,"score_spread":0.27661067918907817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388131049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7023091,0.085792966,0.000045521243,0.20831107,0.00093043776,0.00027616107,0.000020820315,0.00054357114,0.0017704071],"genre_scores_gemma":[0.9980046,0.00063793326,0.00010726542,0.000989809,0.000009486824,0.0000028436586,0.000004157718,0.000009405532,0.0002344719],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990012,0.000028322671,0.00037289507,0.00008128718,0.00010796127,0.00040833242],"domain_scores_gemma":[0.99934536,0.000046031684,0.00017274408,0.00019176384,0.000102120764,0.0001419816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003196969,0.000078402496,0.00031653003,0.0008711268,0.00017913639,0.000011052495,0.00017529391,0.00012165984,0.000052398376],"category_scores_gemma":[0.0008384236,0.00006417143,0.00008200794,0.0004951624,0.0002178411,0.000057033674,0.000012900781,0.00031041406,0.00011162064],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036574194,0.00002369728,0.13707769,0.000240218,0.000085360974,0.004418029,0.00021203927,0.0000060876855,0.000014857755,0.0011084154,0.54942524,0.30735177],"study_design_scores_gemma":[0.0011148431,0.00034708824,0.31797484,0.00045643005,0.000036321013,0.0038573884,0.0044819685,0.000018828727,0.00032479168,0.008743078,0.66250604,0.00013836092],"about_ca_topic_score_codex":0.0003634335,"about_ca_topic_score_gemma":0.0004881558,"teacher_disagreement_score":0.3072134,"about_ca_system_score_codex":0.0001397772,"about_ca_system_score_gemma":0.0029908314,"threshold_uncertainty_score":0.5305606},"labels":[],"label_agreement":null},{"id":"W4388203943","doi":"10.51731/cjht.2023.765","title":"Deucravacitinib (Sotyktu)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Plaque psoriasis; Family medicine; Psoriasis; Intensive care medicine; Dermatology; Political science; Health care","score_opus":0.45862118258732837,"score_gpt":0.44120919426623084,"score_spread":0.017411988321097527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388203943","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.18005328,0.07573264,0.001882653,0.7352522,0.0026904114,0.00063012965,0.00037651302,0.0004839279,0.0028982293],"genre_scores_gemma":[0.9899383,0.00090679724,0.0012639612,0.0073967054,0.000065023996,0.000017342178,0.000009975269,0.000031816235,0.0003700455],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.994625,0.00015277643,0.0041277623,0.00024430008,0.00007797325,0.0007722021],"domain_scores_gemma":[0.99588126,0.00040710423,0.0030051495,0.00040501507,0.00010769119,0.00019379226],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.01750353,0.00014675574,0.000955153,0.0020205944,0.00038535538,0.00007345861,0.00060458353,0.00020168569,0.00014841837],"category_scores_gemma":[0.008659489,0.00017518779,0.00012402094,0.0007440447,0.00017301213,0.00032067214,0.000027464908,0.00039309662,0.0018571917],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000063161183,0.000022567383,0.06962305,0.0006026708,0.00011861489,0.00007698817,0.0027994802,0.0002098818,0.0000018525736,0.2812377,0.59307986,0.052221023],"study_design_scores_gemma":[0.00039104396,0.000163464,0.029079784,0.00017465086,0.0000019844426,0.00006973916,0.007781535,0.00017877611,0.0000076208657,0.09990345,0.8620229,0.00022507005],"about_ca_topic_score_codex":0.0068169646,"about_ca_topic_score_gemma":0.0034415226,"teacher_disagreement_score":0.809885,"about_ca_system_score_codex":0.0009549961,"about_ca_system_score_gemma":0.0021906404,"threshold_uncertainty_score":0.99979675},"labels":[],"label_agreement":null},{"id":"W4388205527","doi":"10.51731/cjht.2023.768","title":"Interventions Intended to Alleviate Emergency Department Overcrowding","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Emergency and Acute Care Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Overcrowding; Emergency department; Psychological intervention; Medicine; Health care; Medical emergency; Nursing; Political science","score_opus":0.07940633953554911,"score_gpt":0.3793811944753877,"score_spread":0.2999748549398386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388205527","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5225892,0.12311343,0.00067022076,0.3466248,0.0041278955,0.00084526907,0.000089012756,0.0005588009,0.0013813542],"genre_scores_gemma":[0.9917565,0.007105373,0.0003231118,0.00042246756,0.000021786636,0.000015395051,0.00000627919,0.0000138749465,0.00033522764],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985363,0.00002536314,0.00070058036,0.0001247387,0.00013554173,0.00047749208],"domain_scores_gemma":[0.9992017,0.000015593512,0.00019175066,0.00018251558,0.0002516031,0.00015682324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053218345,0.00011631593,0.0003613146,0.0009860953,0.00026280028,0.0000075789394,0.0001883184,0.00006606313,0.000093372364],"category_scores_gemma":[0.0010883526,0.00009694046,0.0002169836,0.0008289317,0.000057420075,0.0000610632,0.000048659265,0.0002799783,0.000054799697],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031956683,0.000039190847,0.019398415,0.0009208073,0.00033368822,0.0006304726,0.0015725216,0.000021961061,0.00014968768,0.0030763806,0.7145867,0.2592382],"study_design_scores_gemma":[0.0011868303,0.002988831,0.15991883,0.0041761794,0.00015150709,0.00043367912,0.04092387,0.000010632962,0.0009931787,0.008203661,0.780566,0.00044682398],"about_ca_topic_score_codex":0.0006390064,"about_ca_topic_score_gemma":0.004795476,"teacher_disagreement_score":0.46916726,"about_ca_system_score_codex":0.00030321022,"about_ca_system_score_gemma":0.00060410897,"threshold_uncertainty_score":0.3953117},"labels":[],"label_agreement":null},{"id":"W4388224263","doi":"10.51731/cjht.2023.773","title":"Roflumilast (Zoryve)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Roflumilast; Reimbursement; Intertriginous; Medicine; Psoriasis; Plaque psoriasis; Family medicine; Dermatology; Internal medicine; Political science; COPD; Health care; Disease","score_opus":0.0316320951458392,"score_gpt":0.26019278478805236,"score_spread":0.22856068964221316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388224263","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8071661,0.16291462,0.000042733813,0.024941333,0.0034263853,0.00022891696,0.00009730275,0.0005145056,0.000668103],"genre_scores_gemma":[0.9976356,0.001167145,0.00005058968,0.00014630625,0.000008750919,0.000005705421,0.00001809902,0.000012530707,0.000955274],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987855,0.00009205686,0.0004056801,0.00011908492,0.000028523009,0.00056914124],"domain_scores_gemma":[0.9993534,0.0000750077,0.00025533742,0.00020558551,0.00007933229,0.000031326996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053561316,0.00012412104,0.00032455058,0.0008689578,0.00035605062,0.000013193752,0.0003553576,0.0002388988,0.00009870905],"category_scores_gemma":[0.00025002277,0.000102079954,0.00009549656,0.0005229805,0.00020959227,0.00006927709,0.000021208336,0.00027672548,0.00059137854],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014722137,0.00001121722,0.00790758,0.000023651257,0.00013899237,0.00016406023,0.00036358263,0.000004412763,0.0011891876,0.0006852302,0.05986591,0.9296315],"study_design_scores_gemma":[0.0009920844,0.00046931268,0.04494511,0.00012345616,0.000031461674,0.00048336003,0.0044607944,5.341826e-7,0.009701954,0.0021364726,0.93646586,0.00018962035],"about_ca_topic_score_codex":0.0013541053,"about_ca_topic_score_gemma":0.0019547495,"teacher_disagreement_score":0.9294418,"about_ca_system_score_codex":0.00016020793,"about_ca_system_score_gemma":0.001250651,"threshold_uncertainty_score":0.76011723},"labels":[],"label_agreement":null},{"id":"W4388231839","doi":"10.51731/cjht.2023.774","title":"Tisagenlecleucel (Kymriah)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Refractory (planetary science); Food and drug administration; Drug; Intensive care medicine; Medical emergency; Pharmacology; Political science; Health care","score_opus":0.07828658743759795,"score_gpt":0.36425421196518165,"score_spread":0.28596762452758373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388231839","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6587977,0.05058518,0.00011262694,0.28256747,0.0011293826,0.0007705214,0.000027506785,0.00073769724,0.0052719726],"genre_scores_gemma":[0.9930691,0.0019760625,0.0002993019,0.0006697023,0.000037773163,0.000005433189,0.000003961051,0.000029473527,0.0039091543],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984479,0.000046584686,0.00044579493,0.00012040766,0.0002722802,0.0006670587],"domain_scores_gemma":[0.99906266,0.00006923151,0.00016560315,0.0003138099,0.0001838243,0.0002048801],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011321743,0.000100913625,0.0003732432,0.0014555288,0.00018159772,0.000026335241,0.0002948803,0.00014566822,0.00054942025],"category_scores_gemma":[0.0007393461,0.00008514285,0.000100311925,0.0010811083,0.00021704037,0.000058003618,0.000024747907,0.00063969824,0.00014815117],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027749025,0.000008786188,0.0042086733,0.000097872864,0.000050833376,0.0010232696,0.00023944123,0.000004533175,0.0018284272,0.00032481435,0.056679673,0.9355059],"study_design_scores_gemma":[0.00094556005,0.0009300045,0.024539348,0.0002705241,0.000011543118,0.0011077208,0.003590792,0.000029656134,0.0027981296,0.0034176807,0.9622409,0.0001181613],"about_ca_topic_score_codex":0.0023837644,"about_ca_topic_score_gemma":0.0018480405,"teacher_disagreement_score":0.9353878,"about_ca_system_score_codex":0.0005156325,"about_ca_system_score_gemma":0.004288062,"threshold_uncertainty_score":0.7606838},"labels":[],"label_agreement":null},{"id":"W4388293257","doi":"10.51731/cjht.2023.776","title":"Buprenorphine-Naloxone Film Versus Tablets for Opioid Use Disorder","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Buprenorphine; Opioid use disorder; Medicine; (+)-Naloxone; Sublingual administration; Methadone; Substance abuse; Psychiatry; Opioid; Anesthesia; Internal medicine","score_opus":0.049734694388451496,"score_gpt":0.31446750619373415,"score_spread":0.26473281180528263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388293257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8112313,0.06261634,0.00094269455,0.1198642,0.0022960738,0.0018841056,0.00038716182,0.0006690894,0.00010899007],"genre_scores_gemma":[0.99288577,0.002620801,0.003345019,0.00040751527,0.000031347958,0.000066450055,0.00008686013,0.000053401378,0.0005028301],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99822855,0.000024127321,0.000583815,0.00020157245,0.00019764052,0.00076429144],"domain_scores_gemma":[0.998644,0.00021207336,0.00030765854,0.00038147892,0.00025610402,0.00019866628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003701403,0.00019964678,0.0005410577,0.0010436928,0.00028194653,0.000043468815,0.00024544026,0.00017458956,0.000033235254],"category_scores_gemma":[0.0015393135,0.00016729283,0.0001505092,0.0007286328,0.00014292133,0.00015349333,0.000026092663,0.00033746465,0.000032854885],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087365403,0.00026225942,0.08067085,0.0013981276,0.0008544695,0.001009691,0.0021955261,0.00030410878,0.00016972182,0.002426555,0.16516665,0.7446684],"study_design_scores_gemma":[0.007947439,0.004603502,0.06724624,0.0006065152,0.00014964414,0.00018702244,0.009066511,0.00020547946,0.0003783988,0.0023193955,0.906954,0.00033588236],"about_ca_topic_score_codex":0.0058715786,"about_ca_topic_score_gemma":0.0056481645,"teacher_disagreement_score":0.7443325,"about_ca_system_score_codex":0.0005023034,"about_ca_system_score_gemma":0.0032838604,"threshold_uncertainty_score":0.8876109},"labels":[],"label_agreement":null},{"id":"W4388584866","doi":"10.51731/cjht.2023.781","title":"Is Canada Prepared for the Surge of Dementia?","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dementia; Medicine; Health care; Disease; Intensive care medicine; Pathology","score_opus":0.4215623356377443,"score_gpt":0.42275789423132526,"score_spread":0.0011955585935809476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388584866","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11358651,0.100507304,0.0015509916,0.7791553,0.0022337327,0.0011186077,0.0015670022,0.00006784614,0.00021268168],"genre_scores_gemma":[0.9935624,0.0006886415,0.00035495477,0.00518252,0.00002751287,0.000034498345,0.000005865138,0.000016344828,0.00012729158],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99594784,0.00007213861,0.0032430834,0.00016090518,0.00007578436,0.0005002783],"domain_scores_gemma":[0.9951787,0.0011617987,0.0030498875,0.0003713111,0.0001469105,0.00009137967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012390225,0.00010001777,0.000701739,0.0005664843,0.00035116574,0.000023735842,0.00053980795,0.00009394455,0.00006560206],"category_scores_gemma":[0.006274804,0.000096775555,0.00010655216,0.0003835708,0.000109474844,0.00011955841,0.000020105497,0.0001566746,0.00001847971],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000058545256,0.0000069044204,0.05876085,0.0005256255,0.00021829068,0.0000032958771,0.0012526981,0.00022014578,4.8547173e-7,0.025106424,0.9058903,0.008009112],"study_design_scores_gemma":[0.00035379958,0.00010057106,0.029923256,0.00011055995,0.000007817724,0.000010174105,0.009942718,0.00064780435,0.000026805923,0.016042212,0.9427012,0.00013305893],"about_ca_topic_score_codex":0.65977836,"about_ca_topic_score_gemma":0.7623553,"teacher_disagreement_score":0.87997586,"about_ca_system_score_codex":0.0008208151,"about_ca_system_score_gemma":0.006767188,"threshold_uncertainty_score":0.9988635},"labels":[],"label_agreement":null},{"id":"W4388730911","doi":"10.51731/cjht.2023.782","title":"Belzutifan (Welireg)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Disease; Renal cell carcinoma; Intensive care medicine; General surgery; Family medicine; Oncology; Internal medicine; Health care; Political science","score_opus":0.020255065632725184,"score_gpt":0.2776337747908749,"score_spread":0.25737870915814975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388730911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.67293364,0.27810884,0.00043410115,0.041222017,0.0059602894,0.00030283933,0.00007727601,0.0001725768,0.00078840903],"genre_scores_gemma":[0.99054784,0.007824744,0.00027098207,0.00061218324,0.00021454554,0.0000052257947,0.0000148594845,0.000018704386,0.0004908967],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998976,0.000031038417,0.00031805248,0.00013382651,0.00009131504,0.00044977],"domain_scores_gemma":[0.9992983,0.0000071028376,0.00019659377,0.00025755478,0.00013909809,0.00010138277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004669435,0.00010048975,0.00020937026,0.00036451538,0.00017759322,0.000020111374,0.00034697904,0.00016504215,0.00000884987],"category_scores_gemma":[0.00041480138,0.000091923444,0.00007639553,0.00039005972,0.00014789788,0.0000044506887,0.00003307875,0.00019212953,0.000015930143],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012396359,0.0000066161583,0.0012772535,0.000043039265,0.000048277736,0.000019152398,0.000114148614,0.000038217375,0.007873491,0.0005167884,0.20727372,0.7827769],"study_design_scores_gemma":[0.00021178927,0.00017262131,0.004046894,0.000029572566,0.000004874144,0.00009957584,0.00083901914,0.0000015703746,0.0043490394,0.00067941117,0.9894711,0.00009452575],"about_ca_topic_score_codex":0.0011248447,"about_ca_topic_score_gemma":0.00457966,"teacher_disagreement_score":0.78268236,"about_ca_system_score_codex":0.0000489063,"about_ca_system_score_gemma":0.0022221305,"threshold_uncertainty_score":0.39419642},"labels":[],"label_agreement":null},{"id":"W4388764420","doi":"10.51731/cjht.2023.784","title":"Upadacitinib (Rinvoq)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Ulcerative colitis; Drug; Family medicine; Intensive care medicine; Pharmacology; Internal medicine; Health care; Political science","score_opus":0.4912516269531884,"score_gpt":0.445118357760833,"score_spread":0.046133269192355386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388764420","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13717942,0.074290186,0.0014399852,0.7793034,0.002699377,0.0006284054,0.00037413923,0.0004891769,0.0035959186],"genre_scores_gemma":[0.9898575,0.0009313764,0.0011869329,0.007445115,0.00006579169,0.000018199073,0.000009587938,0.00003167482,0.00045385503],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99476993,0.00014160553,0.0040308777,0.00023861567,0.000077303506,0.0007416714],"domain_scores_gemma":[0.99600196,0.00038604537,0.0029250248,0.00039981568,0.0000998113,0.00018736036],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.016818263,0.0001418543,0.0009327663,0.0019111132,0.00037213645,0.000069761234,0.00058253366,0.00018934782,0.00015337822],"category_scores_gemma":[0.0077696573,0.00016857633,0.00012364048,0.0007074645,0.0001687266,0.00032387034,0.0000272607,0.00038275647,0.0016269825],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000005581082,0.000020473473,0.05775266,0.00058687286,0.00010327279,0.00006837835,0.0024066076,0.0002016585,0.0000014775057,0.33466604,0.5615791,0.04260783],"study_design_scores_gemma":[0.0003829166,0.00015195241,0.02436419,0.00017297086,0.0000017846813,0.000064218024,0.007878222,0.00016672486,0.0000073790993,0.11486252,0.85173064,0.00021647455],"about_ca_topic_score_codex":0.009385166,"about_ca_topic_score_gemma":0.004547347,"teacher_disagreement_score":0.85267806,"about_ca_system_score_codex":0.00095476356,"about_ca_system_score_gemma":0.0021189323,"threshold_uncertainty_score":0.9991504},"labels":[],"label_agreement":null},{"id":"W4388865013","doi":"10.51731/cjht.2023.786","title":"Emergency Department Overcrowding: An Environmental Scan of Contributing Factors and a Summary of Systematic Review Evidence on Interventions","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Emergency and Acute Care Studies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Dalhousie University","funders":"","keywords":"Overcrowding; Emergency department; Psychological intervention; Mental health; Interdependence; Medicine; Health care; Medical emergency; Nursing; Psychiatry; Political science","score_opus":0.09846319209688296,"score_gpt":0.3700545313891586,"score_spread":0.27159133929227564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388865013","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.49253145,0.5041747,0.0000074632276,0.0025913434,0.00012895874,0.00045859476,0.00007833244,0.00001896455,0.0000102034255],"genre_scores_gemma":[0.84045976,0.15943934,0.000019306777,0.000049983417,0.000002706831,0.000007261762,0.0000063557145,0.0000056401236,0.000009623651],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99833554,0.00008144417,0.0010680056,0.00009903772,0.00016695214,0.00024902527],"domain_scores_gemma":[0.99884766,0.0000870301,0.00071365264,0.0001920957,0.000077558725,0.000082010614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009958746,0.000109255554,0.00078769826,0.00035949473,0.00012831863,0.000002071061,0.0001346734,0.000047861322,0.000015184854],"category_scores_gemma":[0.0018165968,0.000079193946,0.00016385225,0.00026159477,0.00013167644,0.00007690259,0.000030576237,0.0001675823,5.4171034e-7],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034700744,0.00013098415,0.40762347,0.5671192,0.00074947794,0.00014419983,0.0012899315,0.0000026235566,0.00063835754,0.0006222533,0.011843881,0.009800937],"study_design_scores_gemma":[0.00050406903,0.0048484528,0.17548893,0.7851713,0.00083885324,0.00013429242,0.029641686,0.000006387233,0.002179327,0.0003876788,0.0005478401,0.00025119926],"about_ca_topic_score_codex":0.0003578938,"about_ca_topic_score_gemma":0.00060605834,"teacher_disagreement_score":0.34792832,"about_ca_system_score_codex":0.00019602341,"about_ca_system_score_gemma":0.00025034952,"threshold_uncertainty_score":0.32294354},"labels":[],"label_agreement":null},{"id":"W4388942633","doi":"10.51731/cjht.2023.789","title":"Implications of ChatGPT on Radiology Workflow","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Radiology practices and education","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Workflow; Burnout; Medicine; Patient safety; Patient care; Interventional radiology; Medical diagnosis; Productivity; Overtime; Radiology; Medical physics; Health care; Nursing; Computer science","score_opus":0.06568450223921185,"score_gpt":0.36595350241913344,"score_spread":0.3002690001799216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388942633","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6059892,0.010083603,0.000059196205,0.3823029,0.0005977834,0.0001836601,0.000008690725,0.000077838165,0.0006970904],"genre_scores_gemma":[0.9968616,0.0017545255,0.00048079249,0.0007706177,0.000026133694,0.000005707485,0.0000064850287,0.000007670956,0.000086513166],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99912214,0.00004401527,0.00040489488,0.0000866977,0.00005359709,0.00028863933],"domain_scores_gemma":[0.9989762,0.00014972509,0.00042042174,0.0002486098,0.00012433718,0.00008075751],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063582824,0.00006420931,0.00030488908,0.00090343243,0.000118801385,0.000003936683,0.00015935126,0.00014439273,0.000023833389],"category_scores_gemma":[0.0010592741,0.000052298816,0.00005441711,0.0005542731,0.00019367771,0.000046907593,0.000005653886,0.00034279187,0.000019985762],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003993359,0.000031089432,0.06308368,0.000089049194,0.00008054814,0.000046093952,0.0005444816,0.00006235798,0.00019522176,0.0070602964,0.07417937,0.85458785],"study_design_scores_gemma":[0.00053718546,0.0017659196,0.7058705,0.0002697894,0.000035010566,0.0015707095,0.004300377,0.000018453848,0.00030850532,0.013209585,0.27201894,0.00009501082],"about_ca_topic_score_codex":0.00053797284,"about_ca_topic_score_gemma":0.0002963189,"teacher_disagreement_score":0.85449284,"about_ca_system_score_codex":0.0001979031,"about_ca_system_score_gemma":0.002071374,"threshold_uncertainty_score":0.36745286},"labels":[],"label_agreement":null},{"id":"W4388998480","doi":"10.51731/cjht.2023.790","title":"Nelarabine (Atriance)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Drug; Family medicine; Intensive care medicine; Psychiatry; Political science; Health care","score_opus":0.04358283942503465,"score_gpt":0.330934496541233,"score_spread":0.28735165711619837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388998480","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.47223935,0.045998383,0.0008241561,0.47676295,0.0011716769,0.0007361035,0.000035274283,0.0007690482,0.0014630437],"genre_scores_gemma":[0.9969225,0.0010848326,0.00069158553,0.0006538281,0.000035893947,0.0000039882293,0.0000040296113,0.000020794821,0.0005825325],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998364,0.000035700334,0.00050899736,0.00012173942,0.00028150316,0.0006880894],"domain_scores_gemma":[0.9989508,0.000098925826,0.00021195656,0.0002861316,0.00023869492,0.00021349319],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009957087,0.00010276589,0.00040359303,0.0013789068,0.00017215109,0.00002005029,0.00030601592,0.0001577574,0.000049428723],"category_scores_gemma":[0.0020818473,0.00008084393,0.0000857254,0.001279194,0.00025152857,0.0000763473,0.000029381652,0.0005560806,0.00014561483],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006518475,0.000014810358,0.010276318,0.00029047893,0.000099057215,0.0040210458,0.00030615038,0.000031837935,0.00019969765,0.00124411,0.22281958,0.76063174],"study_design_scores_gemma":[0.004155424,0.0019363229,0.04797034,0.0008938915,0.000036850113,0.004489586,0.0062252637,0.00039505676,0.0011851726,0.0062460876,0.92621887,0.00024713675],"about_ca_topic_score_codex":0.0019634468,"about_ca_topic_score_gemma":0.0006046503,"teacher_disagreement_score":0.7603846,"about_ca_system_score_codex":0.0013446251,"about_ca_system_score_gemma":0.01210336,"threshold_uncertainty_score":0.9934971},"labels":[],"label_agreement":null},{"id":"W4388998485","doi":"10.51731/cjht.2023.791","title":"Emergency Department Overcrowding in Canada","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Emergency and Acute Care Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Jewish General Hospital; Dalhousie University","keywords":"Overcrowding; Health care; Emergency department; Population; Medicine; Business; Nursing; Environmental health; Political science; Law","score_opus":0.032649997697894916,"score_gpt":0.3018785889419661,"score_spread":0.2692285912440712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388998485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85752535,0.0852495,0.00000746832,0.054882087,0.0014582049,0.00019653467,0.000027187996,0.000063332795,0.0005903171],"genre_scores_gemma":[0.9891487,0.010430239,0.00005650139,0.00028381852,0.000011806976,0.000004985917,0.0000033195763,0.000008618137,0.00005205409],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986856,0.00001973,0.00055547495,0.00009377657,0.000155168,0.00049025216],"domain_scores_gemma":[0.9995086,0.000021001311,0.00015370538,0.00012891159,0.000099172554,0.000088572335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034718946,0.000094252144,0.00032834877,0.00056413776,0.00013111431,0.0000026133432,0.00013219133,0.00004694952,0.00004100543],"category_scores_gemma":[0.0004578644,0.00008017844,0.000049592236,0.00078350556,0.00003661588,0.000044470737,0.000017853818,0.0002958942,0.0000044142216],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011058214,0.000007787189,0.41431004,0.00022940106,0.00007572207,0.0020225937,0.000432732,0.000038054895,0.000027626069,0.00042474412,0.357949,0.22447126],"study_design_scores_gemma":[0.0007128525,0.00039692948,0.45452502,0.0007215254,0.000024619358,0.00027617713,0.033860795,0.000029626488,0.0004829745,0.0020093466,0.50670856,0.00025155983],"about_ca_topic_score_codex":0.84903187,"about_ca_topic_score_gemma":0.98901063,"teacher_disagreement_score":0.2242197,"about_ca_system_score_codex":0.0014284473,"about_ca_system_score_gemma":0.008901531,"threshold_uncertainty_score":0.9967171},"labels":[],"label_agreement":null},{"id":"W4389196199","doi":"10.51731/cjht.2023.793","title":"Zanubrutinib (Brukinsa)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Family medicine; Political science; Health care","score_opus":0.06634469539270238,"score_gpt":0.35787450985986713,"score_spread":0.29152981446716475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389196199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7672953,0.046841536,0.00011059954,0.17926581,0.0015051095,0.0007145364,0.000025240484,0.00080244977,0.0034394348],"genre_scores_gemma":[0.99758524,0.000932612,0.00030117884,0.00054126675,0.00003737876,0.000004218625,0.0000037940579,0.000021047459,0.0005732892],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981961,0.000036738365,0.0005258609,0.00013161416,0.00032282178,0.0007868224],"domain_scores_gemma":[0.9989012,0.00010257138,0.00021004732,0.00035040904,0.00020864648,0.00022712085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011054997,0.000106617634,0.0004003896,0.0014090629,0.00018429292,0.000023826236,0.00033513582,0.00016317812,0.000058877544],"category_scores_gemma":[0.0018226005,0.000086465276,0.00009540033,0.0011471743,0.00030014172,0.00006527311,0.00003579186,0.00055971317,0.00016521108],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00004924507,0.000017947972,0.0033740443,0.00042982952,0.00009445559,0.0034719447,0.00048886053,0.000024341782,0.00008848386,0.001935986,0.19978188,0.79024297],"study_design_scores_gemma":[0.0059866784,0.0010864078,0.011542301,0.00070649333,0.00002009725,0.0051241294,0.005310069,0.00039815408,0.0010168396,0.003891508,0.96473956,0.00017774488],"about_ca_topic_score_codex":0.0062690815,"about_ca_topic_score_gemma":0.0017190591,"teacher_disagreement_score":0.7900652,"about_ca_system_score_codex":0.008291746,"about_ca_system_score_gemma":0.055787567,"threshold_uncertainty_score":0.9955152},"labels":[],"label_agreement":null},{"id":"W4389196223","doi":"10.51731/cjht.2023.794","title":"Cenobamate (Xcopri)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Epilepsy; Family medicine; Psychiatry; Political science; Health care","score_opus":0.054626572332850426,"score_gpt":0.3494819304024781,"score_spread":0.2948553580696277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389196223","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7113631,0.04165655,0.000032856482,0.24432151,0.0003674912,0.00039679816,0.00002620919,0.00038547764,0.0014499992],"genre_scores_gemma":[0.99707276,0.0019917795,0.00030901845,0.00028933465,0.0000108161175,0.000004435692,0.0000045468455,0.000010929873,0.00030640446],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988496,0.000025148407,0.0003135134,0.000082640654,0.000173826,0.0005553192],"domain_scores_gemma":[0.9992984,0.00003688683,0.00012540501,0.00019853792,0.00012960921,0.0002111489],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053281384,0.00007639737,0.00027972067,0.0009015736,0.00016061122,0.000016237445,0.00014843623,0.00007909096,0.000041582178],"category_scores_gemma":[0.00052405015,0.000056085082,0.000067747394,0.00057855475,0.00013324086,0.000044999728,0.000014752206,0.0003330541,0.00014397963],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030786574,0.000024799785,0.10050698,0.00019335253,0.00011195697,0.0038896385,0.00019816341,0.0000044536096,0.0000579106,0.0012596528,0.05765252,0.83606976],"study_design_scores_gemma":[0.0021621552,0.0031797441,0.34148115,0.00082873827,0.000030334322,0.0017862624,0.0060623204,0.000028402705,0.0018916879,0.01050125,0.6318692,0.00017877974],"about_ca_topic_score_codex":0.0019443966,"about_ca_topic_score_gemma":0.0014818767,"teacher_disagreement_score":0.835891,"about_ca_system_score_codex":0.00036791404,"about_ca_system_score_gemma":0.0033035334,"threshold_uncertainty_score":0.5860326},"labels":[],"label_agreement":null},{"id":"W4389388127","doi":"10.51731/cjht.2023.797","title":"Technologies to Increase Freedom for People Living With Dementia","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Aging, Elder Care, and Social Issues","field":"Health Professions","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dementia; Gerontology; Mood; Long-term care; Activities of daily living; Medicine; Quality of life (healthcare); Population; Psychology; Disease; Psychiatry; Nursing; Environmental health","score_opus":0.038576442582911624,"score_gpt":0.3544173313489428,"score_spread":0.3158408887660312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389388127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88136643,0.018460277,0.0040849163,0.08903205,0.0015253616,0.0022345788,0.00012502763,0.002460881,0.00071047095],"genre_scores_gemma":[0.9957153,0.0003268951,0.0022773026,0.00123182,0.000049891223,0.00016212065,0.0000044273643,0.000041764146,0.00019046529],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.99745256,0.00013342159,0.00075334776,0.00022810654,0.00020926738,0.0012233171],"domain_scores_gemma":[0.99781287,0.00060647517,0.0005875219,0.0003517094,0.00048135006,0.0001600606],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0016844893,0.0001994589,0.0006191713,0.0013194787,0.0019075793,0.000029818308,0.00069237535,0.0003359464,0.000019511921],"category_scores_gemma":[0.0035463716,0.00016266931,0.00008616694,0.0012192783,0.00018527258,0.00015496397,0.00010927966,0.0007676965,0.00004286623],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059093247,0.00003185656,0.58759266,0.0014699387,0.0003141483,0.0001244591,0.050469883,0.00007851652,0.000037604335,0.008725792,0.16407304,0.18702303],"study_design_scores_gemma":[0.0007894809,0.0010575025,0.049755223,0.0025341446,0.00006444338,0.000018825594,0.71800685,0.000030008805,0.000046552377,0.010657628,0.21660855,0.000430809],"about_ca_topic_score_codex":0.022377549,"about_ca_topic_score_gemma":0.16411759,"teacher_disagreement_score":0.667537,"about_ca_system_score_codex":0.0004951148,"about_ca_system_score_gemma":0.0038130595,"threshold_uncertainty_score":0.9993918},"labels":[],"label_agreement":null},{"id":"W4389675176","doi":"10.51731/cjht.2023.800","title":"Artificial Intelligence–Enhanced Rapid Response Electroencephalography for the Identification of Nonconvulsive Seizure","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"EEG and Brain-Computer Interfaces","field":"Neuroscience","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Electroencephalography; Medicine; Epilepsy; Intensive care; Intensive care unit; Intensive care medicine; Medical emergency; Psychiatry","score_opus":0.05747205686476836,"score_gpt":0.3278756556508445,"score_spread":0.2704035987860761,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389675176","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88636935,0.004816296,0.037583306,0.068883546,0.0013517261,0.0007365939,0.00008393856,0.00016503964,0.000010234019],"genre_scores_gemma":[0.99904716,0.00044094445,0.0001519432,0.0002939639,0.000017487957,0.000020052921,7.037169e-7,0.000009627211,0.000018134855],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99817747,0.00017083835,0.0008553473,0.00018652517,0.00016600172,0.00044381828],"domain_scores_gemma":[0.99749607,0.0012244693,0.0007683077,0.0002643441,0.00020020505,0.000046610938],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001954742,0.00010814142,0.0002417845,0.0009054857,0.00039394898,0.00005772851,0.0008714848,0.00008814506,0.0000047852513],"category_scores_gemma":[0.003375492,0.00007695697,0.00012298378,0.0012676563,0.0004911614,0.00012235227,0.000021961408,0.00030038448,0.0000053140707],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020960547,0.000014815347,0.000026781885,0.000056225224,0.000020318777,0.000019895422,0.0020593111,0.00046461725,0.24716963,0.002766529,0.0021881056,0.7450042],"study_design_scores_gemma":[0.00006080862,0.00084994116,0.0005754267,0.000083487605,0.000007793199,0.000053722968,0.0060668173,0.00073485775,0.96070427,0.023142979,0.007625753,0.00009412592],"about_ca_topic_score_codex":0.00012281442,"about_ca_topic_score_gemma":0.0003918888,"teacher_disagreement_score":0.74491006,"about_ca_system_score_codex":0.00008571775,"about_ca_system_score_gemma":0.0010000692,"threshold_uncertainty_score":0.4041023},"labels":[],"label_agreement":null},{"id":"W4389675210","doi":"10.51731/cjht.2023.798","title":"Dupilumab (Dupixent)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dupilumab; Reimbursement; Medicine; Medical prescription; Atopic dermatitis; Syringe; Pharmacy; Dermatology; Family medicine; Intensive care medicine; Pharmacology; Psychiatry; Health care","score_opus":0.032088891347487436,"score_gpt":0.3086995705365656,"score_spread":0.27661067918907817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389675210","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7023091,0.085792966,0.000045521243,0.20831107,0.00093043776,0.00027616107,0.000020820315,0.00054357114,0.0017704071],"genre_scores_gemma":[0.9980046,0.00063793326,0.00010726542,0.000989809,0.000009486824,0.0000028436586,0.000004157718,0.000009405532,0.0002344719],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990012,0.000028322671,0.00037289507,0.00008128718,0.00010796127,0.00040833242],"domain_scores_gemma":[0.99934536,0.000046031684,0.00017274408,0.00019176384,0.000102120764,0.0001419816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003196969,0.000078402496,0.00031653003,0.0008711268,0.00017913639,0.000011052495,0.00017529391,0.00012165984,0.000052398376],"category_scores_gemma":[0.0008384236,0.00006417143,0.00008200794,0.0004951624,0.0002178411,0.000057033674,0.000012900781,0.00031041406,0.00011162064],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036574194,0.00002369728,0.13707769,0.000240218,0.000085360974,0.004418029,0.00021203927,0.0000060876855,0.000014857755,0.0011084154,0.54942524,0.30735177],"study_design_scores_gemma":[0.0011148431,0.00034708824,0.31797484,0.00045643005,0.000036321013,0.0038573884,0.0044819685,0.000018828727,0.00032479168,0.008743078,0.66250604,0.00013836092],"about_ca_topic_score_codex":0.0003634335,"about_ca_topic_score_gemma":0.0004881558,"teacher_disagreement_score":0.3072134,"about_ca_system_score_codex":0.0001397772,"about_ca_system_score_gemma":0.0029908314,"threshold_uncertainty_score":0.5305606},"labels":[],"label_agreement":null},{"id":"W4389937533","doi":"10.51731/cjht.2023.802","title":"Artificial Intelligence Decision Support Tools for End-of-Life Care Planning Conversations","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Advance care planning; Palliative care; End-of-life care; Optimism; Psychological intervention; Quality of life (healthcare); Medicine; Nudge theory; Psychology; Nursing; Social psychology","score_opus":0.36450220059285143,"score_gpt":0.47032201141076235,"score_spread":0.10581981081791092,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389937533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86334777,0.014406653,0.0431822,0.0738761,0.0032965404,0.0013996535,0.00012873388,0.00023084757,0.00013149423],"genre_scores_gemma":[0.99614763,0.0002869883,0.0030988725,0.0003374211,0.00005536428,0.000016505943,0.000034885445,0.000013192093,0.000009150001],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.9981315,0.000023388387,0.0011107465,0.00013319131,0.00018040866,0.00042074607],"domain_scores_gemma":[0.9978333,0.0006553071,0.00044851587,0.00020507861,0.0006832952,0.00017446774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008437507,0.00009752313,0.00036417198,0.001007699,0.00028711386,0.000028024935,0.00019617799,0.00017174515,0.00004650746],"category_scores_gemma":[0.0061421683,0.00008986414,0.00010117956,0.0006465461,0.00020032555,0.0001473801,0.0000113570995,0.00028494446,0.000019518395],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050655857,0.00000780851,0.0049064416,0.00021971924,0.00001379598,0.000016197695,0.0040829177,0.0001958462,0.000023595378,0.0015262584,0.0026465228,0.98631024],"study_design_scores_gemma":[0.00013843656,0.004418434,0.011586325,0.0023072935,0.000085118154,0.00018948708,0.73619926,0.0009162348,0.02834404,0.07450227,0.14090642,0.0004066932],"about_ca_topic_score_codex":0.0021283189,"about_ca_topic_score_gemma":0.0020894876,"teacher_disagreement_score":0.98590356,"about_ca_system_score_codex":0.00036466194,"about_ca_system_score_gemma":0.009718003,"threshold_uncertainty_score":0.995896},"labels":[],"label_agreement":null},{"id":"W4389950523","doi":"10.51731/cjht.2023.801","title":"Early Intervention Programs for Adolescents and Young Adults With Eating Disorders","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Eating Disorders and Behaviors","field":"Psychology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Intervention (counseling); Eating disorders; Psychological intervention; Young adult; Medicine; MEDLINE; Gerontology; Psychology; Psychiatry","score_opus":0.02341429607863432,"score_gpt":0.31158700291537383,"score_spread":0.2881727068367395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389950523","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99314094,0.004035383,0.0002869486,0.001548407,0.0003510206,0.00046864184,0.0000074692566,0.00012998945,0.000031231935],"genre_scores_gemma":[0.99942243,0.000059282447,0.00035235105,0.00002290849,0.0000060788648,0.000044473163,0.0000052545406,0.000018385874,0.00006884836],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9989832,0.000032070515,0.0003369641,0.00014163903,0.00007468875,0.0004314525],"domain_scores_gemma":[0.99941456,0.000015473177,0.0003233565,0.000114291186,0.00007169673,0.000060646133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035142692,0.00009970614,0.00018780971,0.00041079326,0.00022486525,0.00004083876,0.00016184304,0.00010010962,0.0000035627947],"category_scores_gemma":[0.000077719145,0.000081317594,0.000050665458,0.00031578683,0.00014411937,0.00007049132,0.000010643055,0.00022704306,0.0000025327222],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022866487,0.000017492244,0.48777077,0.00008050687,0.000008870303,0.0000074864492,0.0010609407,3.8557283e-7,4.12724e-7,0.00006129774,0.0002721632,0.5106968],"study_design_scores_gemma":[0.0018540754,0.0034490377,0.93874925,0.002035064,0.000018268587,0.000057391306,0.049821313,0.000014100657,0.0000015077293,0.0012646007,0.0025680978,0.00016730424],"about_ca_topic_score_codex":0.013611265,"about_ca_topic_score_gemma":0.041502234,"teacher_disagreement_score":0.5105295,"about_ca_system_score_codex":0.00005793233,"about_ca_system_score_gemma":0.000118793236,"threshold_uncertainty_score":0.9929572},"labels":[],"label_agreement":null},{"id":"W4390051729","doi":"10.51731/cjht.2023.807","title":"Perspectives and Experiences Regarding the Creation of Arteriovenous Fistulas for Hemodialysis Access: A Rapid Qualitative Review","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Organ Donation and Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Coaching; Psychological intervention; Health care; Nursing; Medicine; Hemodialysis; Agency (philosophy); End stage renal disease; Psychology; Medical education; Surgery","score_opus":0.07332529046648495,"score_gpt":0.40626458094094714,"score_spread":0.3329392904744622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390051729","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.482116,0.25792634,0.0015733135,0.25680736,0.00015029043,0.0010925931,0.00004561101,0.00008243109,0.00020606339],"genre_scores_gemma":[0.97651356,0.022899365,0.00024728724,0.0002838548,0.0000066309976,0.000023547464,0.00000505343,0.0000045206302,0.00001620139],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.9992976,0.000066203196,0.00033875275,0.000074318225,0.000101771795,0.00012135839],"domain_scores_gemma":[0.9991551,0.00018625187,0.0003213798,0.00008020539,0.00022603222,0.00003104052],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009324798,0.00005456376,0.0002753152,0.00036056136,0.00016292365,0.00001646681,0.000092607384,0.000034512945,0.000011724802],"category_scores_gemma":[0.0010441081,0.000035966073,0.00005523493,0.00042355628,0.00020334155,0.000104213555,0.0000040580458,0.00008608644,3.031092e-7],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000091708825,0.000030252053,0.0013132975,0.004678496,0.00027075442,0.000030006639,0.39743802,0.0000036518838,0.00012383412,0.0054366775,0.004667122,0.58591616],"study_design_scores_gemma":[0.00079584995,0.0007265392,0.008548565,0.0026983663,0.00012353415,0.00013743636,0.97445846,0.000029531771,0.0010307393,0.0025758054,0.0087903,0.000084872794],"about_ca_topic_score_codex":0.00031258477,"about_ca_topic_score_gemma":0.00038051023,"teacher_disagreement_score":0.58583134,"about_ca_system_score_codex":0.000081183556,"about_ca_system_score_gemma":0.00055770436,"threshold_uncertainty_score":0.1466654},"labels":[],"label_agreement":null},{"id":"W4390059465","doi":"10.51731/cjht.2023.808","title":"Screening for Colorectal Cancer in Individuals Younger Than 50 Years","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Colorectal cancer; Incidence (geometry); Colonoscopy; Retrospective cohort study; Cohort; Cancer; Colorectal cancer screening; Cohort study; Demography; Internal medicine","score_opus":0.05186125323701863,"score_gpt":0.3356508133531266,"score_spread":0.28378956011610795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390059465","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96989673,0.013316016,0.00025502444,0.015344845,0.0005001906,0.000422136,0.000060323768,0.00016678641,0.000037921272],"genre_scores_gemma":[0.9985059,0.0003590062,0.0007730961,0.0001957456,0.00003722339,0.000050640585,0.000004588814,0.000018739256,0.000055052522],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.998783,0.000026980084,0.00041013584,0.00013767998,0.00015527685,0.00048692222],"domain_scores_gemma":[0.9994031,0.00007609879,0.00023191283,0.00009784126,0.00009275894,0.00009825053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085581373,0.00009825886,0.00035913842,0.0014032247,0.000121662924,0.000021891057,0.00014067399,0.0001593126,0.000012488715],"category_scores_gemma":[0.00046312454,0.00009309995,0.00008810648,0.0008751109,0.0000921983,0.00009802164,0.000015537964,0.0004050914,0.0000023607986],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000299912,0.000007952289,0.16398713,0.000100440615,0.00006102883,0.00008546283,0.0006592791,0.00015832034,0.0001295556,0.000069668706,0.0044733244,0.8299679],"study_design_scores_gemma":[0.0014623781,0.002423344,0.9368757,0.00073708955,0.000023839702,0.00019985411,0.004078904,0.00018058164,0.0008363701,0.0008646836,0.052167326,0.00014991716],"about_ca_topic_score_codex":0.0124035925,"about_ca_topic_score_gemma":0.028609155,"teacher_disagreement_score":0.829818,"about_ca_system_score_codex":0.00047224827,"about_ca_system_score_gemma":0.0019237164,"threshold_uncertainty_score":0.9941729},"labels":[],"label_agreement":null},{"id":"W4390059615","doi":"10.51731/cjht.2023.804","title":"Setmelanotide (Imcivree)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Genetic and Kidney Cyst Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Proprotein convertase; Medicine; Kexin; Drug; Obesity; Orphan drug; Internal medicine; Pediatrics; Intensive care medicine; Family medicine; Bioinformatics; Pharmacology; Biology; Health care; Political science","score_opus":0.01622868157685836,"score_gpt":0.2618929886096289,"score_spread":0.24566430703277053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390059615","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92517287,0.049988806,0.00035985842,0.02295188,0.000648584,0.00017358825,0.00007974836,0.000093556744,0.00053108047],"genre_scores_gemma":[0.99807936,0.0008863877,0.00023420126,0.0005012729,0.00002372364,0.0000031026354,0.000020121232,0.000012136627,0.00023969218],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99912524,0.000032966956,0.00027700455,0.00011285832,0.00008045933,0.00037147792],"domain_scores_gemma":[0.9994145,0.0000075208613,0.00015214857,0.00021607002,0.000084792904,0.00012494266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030083442,0.00008802721,0.00015238581,0.00028134862,0.00013698703,0.000016558797,0.0003064328,0.00011152398,0.000010358477],"category_scores_gemma":[0.00046582808,0.00007801471,0.00007208948,0.0002364032,0.00012278317,0.0000023943192,0.0000282058,0.0001089813,0.0000281051],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003466721,0.00002667218,0.029655704,0.00015011331,0.00014627833,0.00029812052,0.0001828505,0.00022243259,0.01518347,0.00036004029,0.62396324,0.3297764],"study_design_scores_gemma":[0.00037539948,0.00056475616,0.030052288,0.000066571476,0.000009233269,0.00016257627,0.0022796341,0.0000062889526,0.014386566,0.0022610517,0.9496576,0.0001780037],"about_ca_topic_score_codex":0.0004063738,"about_ca_topic_score_gemma":0.00080641033,"teacher_disagreement_score":0.3295984,"about_ca_system_score_codex":0.000033409942,"about_ca_system_score_gemma":0.0020885642,"threshold_uncertainty_score":0.37050232},"labels":[],"label_agreement":null},{"id":"W4390113947","doi":"10.51731/cjht.2023.806","title":"Andexanet Alfa (Ondexxya)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rivaroxaban; Apixaban; Medicine; Observational study; Intensive care medicine; Prothrombin complex concentrate; Internal medicine; Warfarin","score_opus":0.12907333391532777,"score_gpt":0.3707171932327033,"score_spread":0.24164385931737553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390113947","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.36101896,0.02740568,0.00027246235,0.6052865,0.0015691002,0.0006126452,0.000014713703,0.0007583847,0.0030616054],"genre_scores_gemma":[0.9973509,0.0007028939,0.00028113966,0.0005312515,0.000053131545,4.2982234e-7,0.000006033321,0.000010378652,0.0010638697],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99903786,0.000019683413,0.0003910708,0.00007690975,0.00014482198,0.00032962317],"domain_scores_gemma":[0.99941206,0.000045687088,0.0002145133,0.00015709958,0.000079364945,0.000091305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056190207,0.0000765551,0.00030162043,0.0009979614,0.00013953549,0.000018848508,0.0001252052,0.00008562387,0.00006094898],"category_scores_gemma":[0.0005094936,0.00006130752,0.00008270211,0.00063791306,0.00008367845,0.00006949855,0.000015667949,0.00019264944,0.000063989835],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028421271,0.000001739817,0.23340052,0.00017259236,0.00009308322,0.0004985407,0.00019262293,0.000046572717,0.00006140388,0.0039103706,0.10982994,0.6517642],"study_design_scores_gemma":[0.00057716866,0.0002695857,0.13719076,0.00010305105,0.00001808865,0.00011882189,0.002004749,0.00003501779,0.00011513595,0.003062183,0.8564316,0.00007384431],"about_ca_topic_score_codex":0.00050988863,"about_ca_topic_score_gemma":0.0005358727,"teacher_disagreement_score":0.74660164,"about_ca_system_score_codex":0.00014748872,"about_ca_system_score_gemma":0.000980647,"threshold_uncertainty_score":0.2500048},"labels":[],"label_agreement":null},{"id":"W4390908813","doi":"10.51731/cjht.2024.816","title":"Endobronchial Valves for the Management of Severe Emphysema","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Randomized controlled trial; Evidence-based medicine; Quality of life (healthcare); Evidence-based practice; Systematic review; Intensive care medicine; Clinical trial; MEDLINE; Surgery; Alternative medicine; Internal medicine; Pathology; Nursing","score_opus":0.031266743592285345,"score_gpt":0.33279344402821964,"score_spread":0.3015267004359343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390908813","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12968767,0.6945127,0.0013757148,0.16786131,0.0016516505,0.002676276,0.00030422566,0.00018622821,0.0017442136],"genre_scores_gemma":[0.9964891,0.0017954028,0.0012278558,0.00009603052,0.00004303579,0.00002604689,0.000002966194,0.00001944329,0.00030013887],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987356,0.000025253734,0.0004261249,0.00014040027,0.00024339168,0.00042920193],"domain_scores_gemma":[0.99918365,0.00014020699,0.00013276399,0.0002832845,0.0001514522,0.00010861666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005418164,0.000109052744,0.00029580842,0.0004315362,0.00016277624,0.00002510364,0.0003293435,0.00007113642,0.000047362504],"category_scores_gemma":[0.00010836127,0.00007153447,0.00019186974,0.00034093243,0.0003437951,0.00006979109,0.000036331825,0.00035610437,0.000003497317],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006643258,0.000021283713,0.0010071322,0.0046053287,0.00051088945,0.00038075732,0.00018041051,0.000023706421,0.000020172705,0.01610618,0.008827009,0.9682507],"study_design_scores_gemma":[0.0026234088,0.0014992761,0.18546276,0.005732763,0.0005365579,0.0018133488,0.029265592,0.00054259936,0.0008453209,0.052071065,0.71926755,0.00033977436],"about_ca_topic_score_codex":0.0008008273,"about_ca_topic_score_gemma":0.00037041883,"teacher_disagreement_score":0.96791095,"about_ca_system_score_codex":0.00067092647,"about_ca_system_score_gemma":0.0039789584,"threshold_uncertainty_score":0.7058501},"labels":[],"label_agreement":null},{"id":"W4390918971","doi":"10.51731/cjht.2024.815","title":"Average Volume of MRI Exams Conducted per Hour Across Canada","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Radiation Dose and Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Workflow; Volume (thermodynamics); Mri scan; Medical physics; Variety (cybernetics); Medicine; Magnetic resonance imaging; Computer science; Statistics; Radiology; Database; Artificial intelligence; Mathematics; Physics","score_opus":0.021059491304500234,"score_gpt":0.29591242062202966,"score_spread":0.2748529293175294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390918971","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.79273975,0.09209562,0.00040633144,0.11297245,0.0011350589,0.00020532263,0.00009423688,0.00009857061,0.00025267043],"genre_scores_gemma":[0.997962,0.0004897118,0.00020714506,0.0008970428,0.00002902763,0.0000014748875,0.0000043444625,0.000016530747,0.0003927114],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986636,0.000026664073,0.00056735944,0.00011825845,0.00020168803,0.00042244865],"domain_scores_gemma":[0.999252,0.0000377648,0.0002114476,0.00019921303,0.00014798246,0.00015157253],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042347878,0.0001069518,0.00037934817,0.00027778264,0.00012159141,0.000036511196,0.00018808506,0.00008968737,0.00011257598],"category_scores_gemma":[0.0003442183,0.00008916988,0.00006449554,0.00036527566,0.00015028131,0.00014219669,0.000011512486,0.0005291185,0.0000052664136],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012182023,0.000010840331,0.022340521,0.0005673494,0.00016310003,0.0012698439,0.0014176911,0.000099621946,0.0003780934,0.00024520783,0.1122629,0.86123264],"study_design_scores_gemma":[0.00054954307,0.00033306604,0.040599674,0.00091788854,0.00002560805,0.0014626684,0.008390065,0.0004987489,0.0033258037,0.00022376401,0.94350934,0.00016383782],"about_ca_topic_score_codex":0.552673,"about_ca_topic_score_gemma":0.4771293,"teacher_disagreement_score":0.86106884,"about_ca_system_score_codex":0.00077679794,"about_ca_system_score_gemma":0.011945848,"threshold_uncertainty_score":0.9936555},"labels":[],"label_agreement":null},{"id":"W4390975747","doi":"10.51731/cjht.2024.817","title":"Ketamine for Adults With Treatment-Resistant Depression or Posttraumatic Stress Disorder: A 2023 Update","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Treatment of Major Depression","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ketamine; Suicidal ideation; Depression (economics); Psychiatry; Mental health; Psychology; Dissociative; Treatment-resistant depression; Hallucinogen; Clinical psychology; Placebo; Medicine; Psychotherapist; Major depressive disorder; Suicide prevention; Poison control; Alternative medicine; Medical emergency","score_opus":0.023666098261682037,"score_gpt":0.30075208039739043,"score_spread":0.2770859821357084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390975747","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7263978,0.22676897,0.0007796227,0.042783547,0.0003984765,0.0019815245,0.00043043855,0.00037728387,0.000082338236],"genre_scores_gemma":[0.993898,0.002277472,0.0030430574,0.00009721598,0.000022189673,0.000077625176,0.000048846057,0.000048392387,0.00048723986],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983564,0.000033776498,0.0005752607,0.0002725798,0.00021715052,0.0005448401],"domain_scores_gemma":[0.99890155,0.00014997464,0.00026557472,0.00035006163,0.00013079369,0.00020207868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018771368,0.00026229786,0.00059428276,0.00078549766,0.00022658106,0.00006393551,0.00018744697,0.00015700306,0.00004358527],"category_scores_gemma":[0.00021649715,0.00013929838,0.00011963071,0.00036596175,0.00013936173,0.00015417155,0.000012829336,0.00024777322,0.000008779165],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019065172,0.0001830185,0.008669911,0.0017871216,0.00034300043,0.0020610313,0.00048857427,0.000013752317,0.00006453947,0.00010021628,0.0036946193,0.9806877],"study_design_scores_gemma":[0.032205015,0.072173364,0.05246073,0.075058535,0.0018277669,0.008025978,0.030143796,0.0016077005,0.0104822675,0.0017127093,0.7128929,0.0014092781],"about_ca_topic_score_codex":0.0028181977,"about_ca_topic_score_gemma":0.028763035,"teacher_disagreement_score":0.97927845,"about_ca_system_score_codex":0.0007058883,"about_ca_system_score_gemma":0.0027417946,"threshold_uncertainty_score":0.9889595},"labels":[],"label_agreement":null},{"id":"W4391134430","doi":"10.51731/cjht.2024.819","title":"Axicabtagene Ciloleucel (Yescarta)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.05406790230311775,"score_gpt":0.35301510937500535,"score_spread":0.2989472070718876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391134430","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20296691,0.5629997,0.00046295518,0.22378992,0.0015567001,0.0005904535,0.000031228665,0.0005054221,0.0070966803],"genre_scores_gemma":[0.9933316,0.0029771097,0.0004560526,0.00049528945,0.00005783306,0.0000047087005,0.000002071215,0.000029584076,0.0026457203],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99848443,0.000041462627,0.00046914467,0.00015582421,0.0002768254,0.00057230785],"domain_scores_gemma":[0.9991676,0.00006726041,0.00008638309,0.000300864,0.00015731787,0.00022055497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092624937,0.00012097912,0.00038054463,0.0012350387,0.00013019789,0.00006741134,0.0002640119,0.00015994172,0.0007511813],"category_scores_gemma":[0.0003344078,0.00009614057,0.00014309818,0.000621105,0.00023986596,0.00008268209,0.000018552844,0.000904006,0.000057674828],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018474144,0.000009276335,0.0007093625,0.0003025295,0.00007884435,0.0014551822,0.00022223695,0.0000017462514,0.0029044508,0.00076371094,0.019625913,0.97390825],"study_design_scores_gemma":[0.00034696725,0.0011242805,0.001443966,0.0007979722,0.000019119396,0.0021530795,0.0017242358,0.000039853523,0.0047934474,0.0019482335,0.9855056,0.00010327391],"about_ca_topic_score_codex":0.0015264945,"about_ca_topic_score_gemma":0.0013434807,"teacher_disagreement_score":0.973805,"about_ca_system_score_codex":0.0007630841,"about_ca_system_score_gemma":0.006613403,"threshold_uncertainty_score":0.9990182},"labels":[],"label_agreement":null},{"id":"W4391257731","doi":"10.51731/cjht.2024.822","title":"Tremelimumab (Imjudo) in Combination With Durvalumab (Imfinzi)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tremelimumab; Durvalumab; Medicine; Internal medicine; Nivolumab; Cancer; Immunotherapy","score_opus":0.03239914303394808,"score_gpt":0.24205544899604506,"score_spread":0.20965630596209697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391257731","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.50598663,0.40758625,0.003378093,0.070907265,0.0018850602,0.0004296168,0.00012857566,0.00017163211,0.0095268935],"genre_scores_gemma":[0.9979254,0.0013172252,0.00031989484,0.00026046368,0.000016396807,0.0000059259346,0.0000018682563,0.00002069594,0.00013209964],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985046,0.000010713735,0.0008413688,0.00018822886,0.000028887154,0.00042624597],"domain_scores_gemma":[0.9992998,0.000034287354,0.00038034882,0.00017338146,0.000044877546,0.00006729671],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091622083,0.00012463426,0.00046361526,0.0014393298,0.00009921157,0.00011403618,0.00028548774,0.0001367631,0.00006257575],"category_scores_gemma":[0.00020683289,0.00012211261,0.000062699975,0.00047153333,0.00015250381,0.00044369462,0.000009795914,0.00042205624,0.00006164405],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026371177,0.000032099648,0.042451702,0.00018310409,0.00005528018,0.00021872243,0.0010260813,0.00014143986,0.0000011563598,0.4575299,0.005326999,0.49300715],"study_design_scores_gemma":[0.0014230445,0.0010984592,0.09102024,0.0007308401,0.0000052566584,0.00018852197,0.0015140238,0.00048715234,0.00004100486,0.2490902,0.6539925,0.0004088027],"about_ca_topic_score_codex":0.0076271784,"about_ca_topic_score_gemma":0.012568991,"teacher_disagreement_score":0.6486654,"about_ca_system_score_codex":0.0010535157,"about_ca_system_score_gemma":0.0013711005,"threshold_uncertainty_score":0.9989811},"labels":[],"label_agreement":null},{"id":"W4391449146","doi":"10.51731/cjht.2024.824","title":"Somapacitan (Sogroya)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Coconut Research and Applications","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.029090092646117484,"score_gpt":0.308740247536233,"score_spread":0.2796501548901155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391449146","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1948254,0.46586174,0.0010423189,0.31717685,0.00041475132,0.00019147864,0.0001456795,0.0008821539,0.019459633],"genre_scores_gemma":[0.99866694,0.00051940256,0.0002466943,0.000053989763,0.000030782892,0.000008217013,0.0000020063949,0.000010256135,0.00046168664],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990966,0.0000075942075,0.00028822297,0.00009971928,0.000115176066,0.00039271015],"domain_scores_gemma":[0.99947613,0.00005989924,0.00007060137,0.0001986177,0.00006879144,0.00012594336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002622661,0.00007286849,0.0001430792,0.00036611193,0.00018022026,0.0000994246,0.00036995803,0.00008926095,0.00029206695],"category_scores_gemma":[0.00022035635,0.000060909766,0.000065490254,0.00028592977,0.00017392547,0.000079681915,0.000013673668,0.00054355816,0.000029419296],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[9.2192687e-7,0.0000028731667,0.00029882442,0.0001696067,0.00001953503,0.00012258705,0.00008581235,8.033719e-7,0.0008187149,0.008785313,0.017794257,0.97190076],"study_design_scores_gemma":[0.000062763174,0.000036193916,0.00014588903,0.0002625197,0.0000031529867,0.00021056703,0.002832576,0.000026835014,0.003441827,0.01622588,0.97668093,0.00007088307],"about_ca_topic_score_codex":0.0015412197,"about_ca_topic_score_gemma":0.002550099,"teacher_disagreement_score":0.9718299,"about_ca_system_score_codex":0.0003403761,"about_ca_system_score_gemma":0.0032965627,"threshold_uncertainty_score":0.5847961},"labels":[],"label_agreement":null},{"id":"W4391716904","doi":"10.51731/cjht.2024.826","title":"Elexacaftor-Tezacaftor-Ivacaftor and Ivacaftor (Trikafta)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ivacaftor; Medicine; Cystic fibrosis; Reimbursement; Combination therapy; Cystic fibrosis transmembrane conductance regulator; Pharmacology; Internal medicine; Health care","score_opus":0.023704979657390646,"score_gpt":0.33266858670483407,"score_spread":0.3089636070474434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391716904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.615134,0.371145,0.00027246185,0.012411182,0.000081500366,0.00037313876,0.000043402277,0.00024751716,0.0002917742],"genre_scores_gemma":[0.9918792,0.0036790422,0.003614139,0.00032496362,0.00008716013,0.000011578399,0.0000037734337,0.000041602878,0.00035850084],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99761146,0.00006194268,0.0007498364,0.000302808,0.00041977566,0.0008541928],"domain_scores_gemma":[0.99856865,0.00023440148,0.00018240813,0.00033371104,0.0002320424,0.00044877175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009422892,0.00023145399,0.0006372395,0.0014902168,0.00022472841,0.00014490115,0.00032241544,0.0002211468,0.000090687754],"category_scores_gemma":[0.0018467909,0.0001834177,0.00012539883,0.0006603613,0.0005609712,0.0002937914,0.000052498584,0.0010764976,0.00003407367],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000095424206,0.00002556702,0.009563719,0.0015987669,0.00017267204,0.0020068728,0.000032202995,0.000001875614,0.0018174436,0.004031943,0.03358461,0.9470689],"study_design_scores_gemma":[0.00056910043,0.0014643593,0.021973813,0.0017651464,0.000038235365,0.0027474465,0.0014257815,0.000054994063,0.0013587394,0.0029017848,0.96549714,0.00020343575],"about_ca_topic_score_codex":0.0010561618,"about_ca_topic_score_gemma":0.0000430484,"teacher_disagreement_score":0.94686544,"about_ca_system_score_codex":0.00082021224,"about_ca_system_score_gemma":0.0053163846,"threshold_uncertainty_score":0.94310385},"labels":[],"label_agreement":null},{"id":"W4391723447","doi":"10.51731/cjht.2024.825","title":"Ibrutinib (Imbruvica)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ibrutinib; Venetoclax; Reimbursement; Medicine; Drug; Chronic lymphocytic leukemia; Oncology; Family medicine; Internal medicine; Leukemia; Pharmacology; Political science; Health care","score_opus":0.0390365717984071,"score_gpt":0.34989368745113497,"score_spread":0.3108571156527279,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391723447","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.18337178,0.5811719,0.00052731525,0.22598231,0.0016596828,0.00059536815,0.000023693898,0.00061568536,0.0060523143],"genre_scores_gemma":[0.9973099,0.000988809,0.0006353989,0.00045080393,0.00003993939,0.0000032954154,0.0000015864695,0.000021954776,0.0005483012],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984516,0.000031181586,0.00050103274,0.00014716032,0.00027308022,0.00059596996],"domain_scores_gemma":[0.999165,0.00010594621,0.000092230795,0.0002854598,0.00014440689,0.0002069702],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008678401,0.00010786409,0.00035185905,0.0010305296,0.00011600373,0.00006290012,0.0002722554,0.0001610236,0.000114440605],"category_scores_gemma":[0.0008384292,0.00008169538,0.00011079003,0.0006084571,0.0003061324,0.00008883488,0.000023247903,0.0007349266,0.00009133389],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000025248968,0.000012323926,0.00035138358,0.000910882,0.00011091556,0.0057370635,0.0003541793,0.0000049115483,0.00007107213,0.0056376783,0.07631732,0.910467],"study_design_scores_gemma":[0.0015673363,0.0006800531,0.0005898941,0.0013660683,0.00002178524,0.008537379,0.0015322694,0.00040404627,0.0008084309,0.0030222328,0.98136747,0.00010301581],"about_ca_topic_score_codex":0.0045400783,"about_ca_topic_score_gemma":0.0010698978,"teacher_disagreement_score":0.91036403,"about_ca_system_score_codex":0.011717651,"about_ca_system_score_gemma":0.083804004,"threshold_uncertainty_score":0.9920762},"labels":[],"label_agreement":null},{"id":"W4391723502","doi":"10.51731/cjht.2024.827","title":"Mirikizumab (Omvoh)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Dosing; Syringe; Ulcerative colitis; Tofacitinib; Vial; Drug; Intensive care medicine; Family medicine; Pharmacology; Internal medicine; Political science; Health care","score_opus":0.01076456973361453,"score_gpt":0.25980991371157675,"score_spread":0.2490453439779622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391723502","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7527027,0.22599785,0.0007519908,0.01784835,0.0014244011,0.00020944467,0.000056019293,0.0001196328,0.00088957377],"genre_scores_gemma":[0.9988155,0.000396226,0.00026090533,0.00030984683,0.000037161186,0.0000031437075,0.000005257618,0.00001667419,0.00015530096],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99914044,0.000035175042,0.0003029434,0.00012724816,0.00007562778,0.00031855018],"domain_scores_gemma":[0.99951315,0.000006054699,0.0000911391,0.0002146417,0.00008078766,0.00009420124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003467326,0.00009599893,0.00012113246,0.00028724814,0.00010474904,0.000048666174,0.00029168904,0.00013844448,0.000019477091],"category_scores_gemma":[0.00023165681,0.00008489512,0.00008689597,0.000114739785,0.00014504624,0.0000062760155,0.000020776424,0.00020496122,0.000020720086],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000087851484,0.000017378266,0.0032334314,0.0005012512,0.00019015807,0.0041100387,0.00022623058,0.00005567575,0.002242738,0.0062698424,0.1655147,0.8175507],"study_design_scores_gemma":[0.00015620555,0.00020782981,0.012709262,0.00016004576,0.0000093779145,0.0004197155,0.00059252774,0.00001295733,0.0021103558,0.0018742984,0.9816018,0.00014564171],"about_ca_topic_score_codex":0.00019652145,"about_ca_topic_score_gemma":0.0015135368,"teacher_disagreement_score":0.81740505,"about_ca_system_score_codex":0.00010992497,"about_ca_system_score_gemma":0.0036643695,"threshold_uncertainty_score":0.6500434},"labels":[],"label_agreement":null},{"id":"W4391840542","doi":"10.51731/cjht.2024.829","title":"Cabozantinib (Cabometyx)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cabozantinib; Reimbursement; Medicine; Nivolumab; Renal cell carcinoma; Drug; Oncology; Intensive care medicine; Internal medicine; Pharmacology; Cancer; Immunotherapy; Political science","score_opus":0.04342577596772945,"score_gpt":0.25924637735701594,"score_spread":0.2158206013892865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391840542","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0726567,0.8438585,0.0033002037,0.05899727,0.0042176004,0.00017934164,0.00023960252,0.00019152132,0.016359286],"genre_scores_gemma":[0.99568254,0.0028394721,0.00046296098,0.00053312536,0.000048669965,0.0000028419977,0.0000011519004,0.00002153241,0.00040768652],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983941,0.0000069329667,0.0009232577,0.0001770571,0.000021035634,0.0004776559],"domain_scores_gemma":[0.9992235,0.00003555806,0.00039782948,0.00020259038,0.000044289,0.000096281125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000988621,0.000119739976,0.0004785028,0.0011539052,0.00014886935,0.00014893197,0.00038033782,0.00014855799,0.00018422167],"category_scores_gemma":[0.00040653883,0.00012345373,0.00012935555,0.00039330585,0.00017877574,0.00037840946,0.000014809712,0.00040389222,0.00026684196],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000027350306,0.0000056817066,0.006203618,0.000098468656,0.00005159664,0.000089070476,0.00036276592,0.000010427233,0.0000013421411,0.42799643,0.029093677,0.5360842],"study_design_scores_gemma":[0.00010729924,0.000111994865,0.004218337,0.00011187383,0.0000018411135,0.00007881807,0.00031585761,0.000029338546,0.000029575674,0.10298197,0.89189047,0.00012263907],"about_ca_topic_score_codex":0.005324263,"about_ca_topic_score_gemma":0.0013553927,"teacher_disagreement_score":0.92302585,"about_ca_system_score_codex":0.0004157035,"about_ca_system_score_gemma":0.0013820421,"threshold_uncertainty_score":0.8048729},"labels":[],"label_agreement":null},{"id":"W4392110465","doi":"10.51731/cjht.2024.839","title":"Timing of Antibiotic Therapy for Neisseria Gonorrhoeae Infection","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Reproductive tract infections research","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Gonorrhea; Neisseria gonorrhoeae; Medicine; Antibiotic resistance; Antibiotics; Antibiotic therapy; Empiric therapy; Intensive care medicine; Internal medicine; Family medicine; Microbiology; Biology; Alternative medicine; Pathology","score_opus":0.05951706191556892,"score_gpt":0.3567738861029935,"score_spread":0.29725682418742455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392110465","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.768829,0.2185292,0.0017825695,0.007671403,0.0023439236,0.0005180038,0.000029443441,0.00013416243,0.00016229293],"genre_scores_gemma":[0.99775064,0.0019414317,0.00014631137,0.000020066724,0.0000119607275,0.0000055390105,0.000004345673,0.000014108115,0.000105606756],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989822,0.000081872065,0.0004291463,0.00014648843,0.000013274883,0.00034705517],"domain_scores_gemma":[0.99924034,0.00015483281,0.00018577179,0.00019314302,0.00020983476,0.000016088794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009722303,0.00009442387,0.00027352254,0.0011012359,0.00020793715,0.000025076237,0.0001751216,0.00018706001,0.00006201076],"category_scores_gemma":[0.0005724861,0.00007714026,0.00010629189,0.00037081083,0.00029315866,0.00014269148,0.000009477633,0.00046017353,0.00002039063],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038635746,0.00003298672,0.0054253303,0.00024514584,0.00020719007,0.0000028664697,0.00024594765,0.000029703913,0.03687962,0.0019036501,0.004118014,0.95087093],"study_design_scores_gemma":[0.0007531892,0.0029783784,0.0438613,0.00056366937,0.000023376057,0.001015254,0.0011678643,0.000017629745,0.16416566,0.004483147,0.7807614,0.00020910798],"about_ca_topic_score_codex":0.004024012,"about_ca_topic_score_gemma":0.00078152784,"teacher_disagreement_score":0.9506618,"about_ca_system_score_codex":0.00023996661,"about_ca_system_score_gemma":0.0020203206,"threshold_uncertainty_score":0.60831296},"labels":[],"label_agreement":null},{"id":"W4392198582","doi":"10.51731/cjht.2024.840","title":"Cost-Effectiveness of Respiratory Syncytial Virus Vaccines for Adults","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Respiratory viral infections research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Economic evaluation; Medicine; Cost effectiveness; Vaccination; Generalizability theory; Economic cost; Cost-effectiveness analysis; Willingness to pay; Health care; Cost–benefit analysis; Incremental cost-effectiveness ratio; Economic impact analysis; Environmental health; Immunology; Psychology; Economic growth; Biology","score_opus":0.12123472138849099,"score_gpt":0.43188661654562244,"score_spread":0.31065189515713143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392198582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8338831,0.15402938,0.0029839957,0.004802146,0.0012395754,0.0025363697,0.00012675348,0.00021808872,0.00018055578],"genre_scores_gemma":[0.9992322,0.0002600352,0.00021807595,0.000119912875,0.00004667882,0.00007412293,0.0000020164084,0.00002794627,0.000019055278],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99835855,0.00014281781,0.00068256806,0.00017997173,0.00019666227,0.0004394037],"domain_scores_gemma":[0.99843615,0.00036683556,0.00018923848,0.00027114,0.0005940929,0.00014256864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020058835,0.0001361636,0.00053942524,0.0017595072,0.0001495477,0.000032588152,0.00022269181,0.00020043727,0.000022640445],"category_scores_gemma":[0.00211617,0.0001084256,0.00016407401,0.000705609,0.00021877217,0.00015569084,0.000018319091,0.00055982,0.000006474548],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065064133,0.000054267002,0.0070209075,0.005970654,0.00020122899,0.00036193183,0.00016412482,0.000034130066,0.0046163914,0.002466047,0.005579342,0.97288036],"study_design_scores_gemma":[0.004341288,0.014253073,0.043318007,0.010898069,0.0001177004,0.0008644776,0.0025196588,0.00018814833,0.14676045,0.004247724,0.7720901,0.00040135736],"about_ca_topic_score_codex":0.0020366525,"about_ca_topic_score_gemma":0.0019521966,"teacher_disagreement_score":0.972479,"about_ca_system_score_codex":0.0007899623,"about_ca_system_score_gemma":0.0069078985,"threshold_uncertainty_score":0.998722},"labels":[],"label_agreement":null},{"id":"W4392233481","doi":"10.51731/cjht.2024.843","title":"Photon-Counting CT: High Resolution, Less Radiation","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Advanced X-ray and CT Imaging","field":"Engineering","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medical physics; Medicine; Photon counting; Nuclear medicine; Photon; Optics; Physics","score_opus":0.01203413001560574,"score_gpt":0.23713297620603022,"score_spread":0.22509884619042447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392233481","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.28797418,0.62813836,0.05688959,0.019174283,0.00481488,0.00027281442,0.00004370674,0.0018827472,0.00080941705],"genre_scores_gemma":[0.9973288,0.0014056943,0.0011003591,0.000081514016,0.000036003057,0.0000033691974,0.000002169463,0.000023027273,0.000019030129],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990368,0.000012578023,0.00038310562,0.00008647031,0.00009256288,0.0003884796],"domain_scores_gemma":[0.99966186,0.000038308157,0.00007506469,0.00012133237,0.00004847762,0.0000549508],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003707143,0.0001038512,0.00018253326,0.000590102,0.00017901386,0.00007415117,0.00019341001,0.000052224692,0.000009799212],"category_scores_gemma":[0.000121623016,0.000101843274,0.00004076514,0.0003987097,0.00006684057,0.00032537137,0.000006431464,0.00048960187,0.000009181143],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[8.7797827e-7,0.0000014533082,0.00033900142,0.0002490277,0.00002735488,0.00019421979,0.00025373712,0.011402753,0.00009587951,0.0044522164,0.0050874995,0.977896],"study_design_scores_gemma":[0.00029029418,0.000087083004,0.0021793176,0.0013390259,0.000020844567,0.0008563379,0.0055310396,0.014798605,0.0051053944,0.024067394,0.94531447,0.00041016837],"about_ca_topic_score_codex":0.0011978742,"about_ca_topic_score_gemma":0.0009176304,"teacher_disagreement_score":0.97748584,"about_ca_system_score_codex":0.0005879229,"about_ca_system_score_gemma":0.000580145,"threshold_uncertainty_score":0.4153048},"labels":[],"label_agreement":null},{"id":"W4392239323","doi":"10.51731/cjht.2024.842","title":"Polatuzumab Vedotin (Polivy)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Rituximab; Prednisone; Lymphoma; Internal medicine; Doxorubicin; Cyclophosphamide; Oncology; Chemotherapy; Political science","score_opus":0.023820182957066567,"score_gpt":0.3022941830101228,"score_spread":0.2784740000530562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392239323","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.27950025,0.5773185,0.000045685,0.14020436,0.00096344127,0.0002411555,0.000017883107,0.00023875771,0.0014699666],"genre_scores_gemma":[0.99716806,0.0016274118,0.0004478894,0.00058958115,0.000026770183,0.0000044415037,0.0000019899846,0.000013620147,0.000120241],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99901485,0.000017080178,0.0003816801,0.00011160178,0.00012266266,0.00035214398],"domain_scores_gemma":[0.9994644,0.000046569436,0.00009645413,0.00017742552,0.000070513786,0.00014465509],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020526157,0.00010638534,0.00031138118,0.00073326856,0.00010850273,0.00004725513,0.00011835213,0.00010754399,0.00004293264],"category_scores_gemma":[0.00018570908,0.00007559657,0.000112027396,0.000319978,0.00010876991,0.00006786708,0.000009269942,0.00026987304,0.00004474751],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00000847146,0.000030560448,0.010872192,0.0002159642,0.00013551104,0.0026852933,0.00028632302,0.0000013215423,0.000017639211,0.008541512,0.029555604,0.9476496],"study_design_scores_gemma":[0.0007177127,0.0012483064,0.039469745,0.0015533824,0.000067602654,0.0032624053,0.0018189424,0.000023890534,0.0009399374,0.0037742541,0.9470058,0.00011798288],"about_ca_topic_score_codex":0.004523864,"about_ca_topic_score_gemma":0.0013560784,"teacher_disagreement_score":0.94753164,"about_ca_system_score_codex":0.0011354515,"about_ca_system_score_gemma":0.005859298,"threshold_uncertainty_score":0.99977654},"labels":[],"label_agreement":null},{"id":"W4392239670","doi":"10.51731/cjht.2024.841","title":"General Ultrasound Examination Volumes per Sonographer 8-Hour Workday","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Ultrasound in Clinical Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Sonographer; Staffing; Medicine; Ultrasound; Economic shortage; Physical examination; Physical therapy; Nursing; Radiology","score_opus":0.038221375877079,"score_gpt":0.33891159690041023,"score_spread":0.3006902210233312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392239670","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80117846,0.10614011,0.0045956727,0.0845229,0.0011334856,0.0005187062,0.00004049884,0.0004894886,0.0013806936],"genre_scores_gemma":[0.99105406,0.0014207927,0.0059792534,0.00070921367,0.00008747264,0.000015801135,0.000009276123,0.000026878439,0.0006972676],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984477,0.00005176073,0.00069499784,0.00019399368,0.00019440155,0.00041712337],"domain_scores_gemma":[0.99882203,0.00033150567,0.00018902341,0.00028244892,0.00020519938,0.0001698041],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009938938,0.00013578554,0.0003434566,0.0007217381,0.00019421565,0.00009348652,0.00024092336,0.00022521721,0.0002370461],"category_scores_gemma":[0.0009732601,0.00010934321,0.00015339893,0.0006445071,0.00034492585,0.00014586769,0.000009147566,0.0007840742,0.000058438483],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000005353732,0.000040251587,0.033832923,0.00017716977,0.00012520062,0.00006657714,0.00046565314,0.000007315151,0.00038105625,0.0057772864,0.035043463,0.92407775],"study_design_scores_gemma":[0.0003212329,0.0005513624,0.2020878,0.00055933266,0.00007226752,0.00094217004,0.002443162,0.00005435639,0.00023188331,0.011472592,0.7810782,0.00018561492],"about_ca_topic_score_codex":0.00078036316,"about_ca_topic_score_gemma":0.0011300216,"teacher_disagreement_score":0.92389214,"about_ca_system_score_codex":0.0004089038,"about_ca_system_score_gemma":0.0021935373,"threshold_uncertainty_score":0.44588867},"labels":[],"label_agreement":null},{"id":"W4392294844","doi":"10.51731/cjht.2024.844","title":"Working Together for Better Health: A United Effort to Support the National Strategy for Drugs for Rare Diseases in Canada","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rare disease; Government (linguistics); Orphan drug; Business; Investment (military); Medicine; Disease; Economic growth; Political science; Bioinformatics; Economics","score_opus":0.3593393142149555,"score_gpt":0.4259854495159906,"score_spread":0.06664613530103508,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392294844","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.028200395,0.031561855,0.008667372,0.92220837,0.0017216405,0.0035688241,0.003966839,0.00004937062,0.000055315064],"genre_scores_gemma":[0.9475315,0.00008124179,0.0025709367,0.04881527,0.00015091554,0.0006163165,0.00007824249,0.000041855987,0.00011372071],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99595094,0.000064820815,0.002887038,0.00028464725,0.0000907614,0.0007217899],"domain_scores_gemma":[0.9969314,0.0014584947,0.0010796022,0.00017338363,0.00016562053,0.00019152489],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009291561,0.00015522113,0.000714843,0.0011938312,0.00036576737,0.00011593274,0.00043510992,0.000095606054,0.000022394737],"category_scores_gemma":[0.002686984,0.00015023605,0.00012469926,0.00042925132,0.0000498645,0.00016072243,0.000012787655,0.00022200785,0.0000053537183],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00004248268,0.00001739188,0.019040955,0.0018475339,0.00012962738,0.000003685359,0.002042615,0.0020486142,9.119271e-8,0.08741113,0.79968786,0.08772804],"study_design_scores_gemma":[0.0004762343,0.00030241816,0.003364323,0.00038621714,0.0000035953194,0.000009463304,0.0063753105,0.0021207933,0.0000010432794,0.042613853,0.94417274,0.00017398714],"about_ca_topic_score_codex":0.4236468,"about_ca_topic_score_gemma":0.8596526,"teacher_disagreement_score":0.91933113,"about_ca_system_score_codex":0.0056443987,"about_ca_system_score_gemma":0.021464882,"threshold_uncertainty_score":0.99817276},"labels":[],"label_agreement":null},{"id":"W4392517675","doi":"10.51731/cjht.2024.850","title":"2024 Watch List: Top 10 Technologies and Issues Related to Caring for Children and Youth With Medical Complexity","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Child and Adolescent Health","field":"Health Professions","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Health care; Service (business); Psychology; Public relations; Nursing; Medicine; Business; Political science; Marketing","score_opus":0.051200532128178294,"score_gpt":0.37804314311212683,"score_spread":0.3268426109839485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392517675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5378927,0.0935126,0.00019728136,0.36551264,0.0006187171,0.0013020566,0.00024001903,0.0006231591,0.000100838195],"genre_scores_gemma":[0.99461174,0.0028585864,0.0012317672,0.0007898881,0.000045873363,0.000007213917,0.000014255382,0.00003375833,0.0004069401],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976315,0.00009923715,0.00082873396,0.0003422945,0.0002306292,0.00086760335],"domain_scores_gemma":[0.99884236,0.00022322178,0.00021913415,0.00025018916,0.00015333573,0.00031175528],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014797957,0.00022216237,0.0005871139,0.00062785874,0.0009623128,0.000056852412,0.00035207457,0.0004575469,0.000044401277],"category_scores_gemma":[0.0012439353,0.00015736898,0.00004244861,0.00049342605,0.0004957607,0.00012565662,0.00011986675,0.0016414732,0.0000054453167],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009698444,0.000026330817,0.08663149,0.0018992709,0.00016160417,0.00011472783,0.01854615,0.0000027009573,0.0000037517352,0.024631489,0.05777261,0.8101129],"study_design_scores_gemma":[0.0046434733,0.004924256,0.14994764,0.047610894,0.00020152975,0.0015564689,0.35778388,0.00020860297,0.00015495854,0.056458637,0.374935,0.0015746503],"about_ca_topic_score_codex":0.010798443,"about_ca_topic_score_gemma":0.0239455,"teacher_disagreement_score":0.80853826,"about_ca_system_score_codex":0.00034559664,"about_ca_system_score_gemma":0.0031303272,"threshold_uncertainty_score":0.99578875},"labels":[],"label_agreement":null},{"id":"W4392706460","doi":"10.51731/cjht.2024.852","title":"Andexanet Alfa (Ondexxya)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rivaroxaban; Reimbursement; Apixaban; Medicine; Intensive care medicine; Internal medicine; Health care; Warfarin; Political science","score_opus":0.09033240018256643,"score_gpt":0.3655339634611459,"score_spread":0.2752015632785795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392706460","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07821839,0.32526278,0.0013427008,0.58691406,0.00261921,0.0005160183,0.000014706492,0.0005718253,0.004540302],"genre_scores_gemma":[0.9971696,0.0008198765,0.00052370044,0.00047169076,0.00008029284,3.2745723e-7,0.0000027887083,0.000011199739,0.00092053047],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991297,0.000016584614,0.00038061803,0.00008674814,0.00012733974,0.0002589781],"domain_scores_gemma":[0.9995803,0.000045642904,0.000102751204,0.00013023238,0.000058133824,0.000082900435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044522432,0.00008043664,0.00027058067,0.0008058915,0.000091368674,0.000048134974,0.00010312745,0.00008598245,0.00010632501],"category_scores_gemma":[0.0002519604,0.000060657938,0.0000968293,0.00035533708,0.00008369851,0.00009894896,0.000010275576,0.000257131,0.00003101079],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014905253,0.0000012659135,0.029204255,0.00034816377,0.000111292684,0.0006431308,0.00015618184,0.000010693249,0.0000417711,0.0112830745,0.051864356,0.9063209],"study_design_scores_gemma":[0.00022525906,0.00023699063,0.012021094,0.0002767908,0.000027606186,0.00030066475,0.00081362744,0.000048765636,0.00010495767,0.0033982478,0.98248464,0.00006133948],"about_ca_topic_score_codex":0.0004876471,"about_ca_topic_score_gemma":0.0004370233,"teacher_disagreement_score":0.9306203,"about_ca_system_score_codex":0.0002178712,"about_ca_system_score_gemma":0.0015243384,"threshold_uncertainty_score":0.27041107},"labels":[],"label_agreement":null},{"id":"W4392706467","doi":"10.51731/cjht.2024.854","title":"Reprocessed Single-Use Semicritical and Critical Medical Devices","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Medical Device Sterilization and Disinfection","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Bioburden; Medical device; Single use; Medicine; Medical emergency; Patient safety; Risk analysis (engineering); Business; Operations management; Health care; Surgery; Engineering","score_opus":0.032269279161308076,"score_gpt":0.31307223649321736,"score_spread":0.2808029573319093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392706467","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20109156,0.5561251,0.009461208,0.22727123,0.0047092503,0.00020343358,0.00003509988,0.0005631622,0.00053993845],"genre_scores_gemma":[0.99759847,0.00057890825,0.000090364876,0.0016510474,0.000013243193,0.0000018181861,0.0000054790667,0.000009053125,0.000051611067],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987914,0.00011498929,0.0005009244,0.00017227036,0.00006899953,0.00035140594],"domain_scores_gemma":[0.9991327,0.0004631536,0.00005676743,0.000105977175,0.00013723041,0.00010416661],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007031622,0.00010139165,0.00025757324,0.0004132439,0.00018427066,0.00009107833,0.00015168132,0.0003791243,0.00038201216],"category_scores_gemma":[0.008131222,0.00007921483,0.000040834384,0.00024471537,0.00078878854,0.00021110493,0.000023123475,0.0005950937,0.000033381595],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028079037,0.000055771816,0.0043007066,0.0010993303,0.00008984502,0.00057397154,0.00048823663,2.734797e-7,0.0017180325,0.04870472,0.022139259,0.92080176],"study_design_scores_gemma":[0.00046725123,0.0006324566,0.0034290282,0.0020210408,0.000038617676,0.0064614187,0.0026288629,0.000033877353,0.0018796645,0.006074509,0.9761151,0.00021818277],"about_ca_topic_score_codex":0.0005314476,"about_ca_topic_score_gemma":0.0012916528,"teacher_disagreement_score":0.95397586,"about_ca_system_score_codex":0.000087191125,"about_ca_system_score_gemma":0.0016352056,"threshold_uncertainty_score":0.97344196},"labels":[],"label_agreement":null},{"id":"W4392850800","doi":"10.51731/cjht.2024.856","title":"Upadacitinib (Rinvoq)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Drug; Intensive care medicine; Family medicine; Pharmacology; Health care; Political science","score_opus":0.01283136766829396,"score_gpt":0.2641328023146,"score_spread":0.25130143464630605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392850800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.77670807,0.20257315,0.0009279212,0.016360002,0.0015033735,0.00023566053,0.00007760702,0.00014069678,0.0014735549],"genre_scores_gemma":[0.998746,0.00041427047,0.0002711325,0.00034234044,0.000042048792,0.000003345455,0.0000058652945,0.000016363107,0.00015863562],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991413,0.00003404213,0.00030795287,0.00012598695,0.000075332,0.00031539102],"domain_scores_gemma":[0.9995207,0.0000067077585,0.00009193543,0.000203964,0.000080109174,0.0000965435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003763528,0.00009448861,0.00011896412,0.00026778533,0.00010263483,0.000047936883,0.00027856292,0.0001304687,0.000020751468],"category_scores_gemma":[0.00024758137,0.00008384119,0.000085117965,0.0001094866,0.00014693862,0.0000062741274,0.000020427024,0.00020261796,0.000017380007],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055046312,0.000018662166,0.008743816,0.00061382534,0.0002100038,0.0045556757,0.00023798156,0.00006980728,0.0043616467,0.012712011,0.14784779,0.82057375],"study_design_scores_gemma":[0.00016244786,0.00020495139,0.008859796,0.0001811188,0.000009141098,0.00039273401,0.00072822283,0.00001257051,0.0028915163,0.0026357856,0.9837652,0.00015650707],"about_ca_topic_score_codex":0.00023357503,"about_ca_topic_score_gemma":0.0018450873,"teacher_disagreement_score":0.8359174,"about_ca_system_score_codex":0.00008606956,"about_ca_system_score_gemma":0.003365644,"threshold_uncertainty_score":0.5970508},"labels":[],"label_agreement":null},{"id":"W4393004377","doi":"10.51731/cjht.2024.859","title":"Optune (NovoTTF-200A)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science; Environmental science","score_opus":0.030041368006209396,"score_gpt":0.31045276515305475,"score_spread":0.2804113971468454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393004377","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21722353,0.52208376,0.0001163091,0.25785127,0.0010943328,0.00028498218,0.00002295206,0.00024798617,0.0010749203],"genre_scores_gemma":[0.99738276,0.0014036222,0.000598979,0.0004855522,0.000021830705,0.000005531713,0.000002139508,0.000014458623,0.000085121625],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990251,0.00001443263,0.00037232836,0.00011121941,0.00012717285,0.0003497318],"domain_scores_gemma":[0.99946207,0.000041667576,0.00009250229,0.00017718629,0.00008667316,0.00013988095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029530912,0.000102297236,0.0003113459,0.0008182194,0.00010022675,0.00004478597,0.00011510517,0.00010165382,0.00006147253],"category_scores_gemma":[0.00018685237,0.00007336035,0.00010474388,0.00038317413,0.00010953788,0.000066522,0.000008315362,0.0003326542,0.0000417099],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000052878813,0.000032113938,0.008285592,0.00020787519,0.00013183907,0.0048292233,0.0001566076,0.0000026236373,0.00008441172,0.004489548,0.048954405,0.9328205],"study_design_scores_gemma":[0.000557132,0.0010171352,0.017302297,0.0014042837,0.0000644829,0.0031017426,0.0013985932,0.000029659861,0.0018415143,0.0029587895,0.9702148,0.000109575994],"about_ca_topic_score_codex":0.0018095865,"about_ca_topic_score_gemma":0.0011688616,"teacher_disagreement_score":0.9327109,"about_ca_system_score_codex":0.000513596,"about_ca_system_score_gemma":0.0031046316,"threshold_uncertainty_score":0.55074835},"labels":[],"label_agreement":null},{"id":"W4393004755","doi":"10.51731/cjht.2024.861","title":"Formulary Management of Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Formulary; Glucagon-like peptide-1; Pharmacology; Chemistry; Glucagon-like peptide 1 receptor; Receptor; Endocrinology; Internal medicine; Medicine; Diabetes mellitus; Type 2 diabetes; Agonist","score_opus":0.014926110689431131,"score_gpt":0.25872166032681004,"score_spread":0.2437955496373789,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393004755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.76337606,0.20769452,0.00014777954,0.025474347,0.0011323706,0.00082308694,0.00003637493,0.00019403541,0.0011214508],"genre_scores_gemma":[0.98826003,0.008947921,0.002016509,0.00022383039,0.000015192487,0.00001132352,0.000014318891,0.00002326862,0.00048762799],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985553,0.000015206362,0.0006289991,0.00018561429,0.00019487563,0.0004199905],"domain_scores_gemma":[0.999339,0.000020576328,0.00019642491,0.00022555239,0.00006859312,0.00014985944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041820674,0.00017578561,0.00045425294,0.00080506026,0.00009792649,0.00003733091,0.00014644678,0.000103437575,0.000024989067],"category_scores_gemma":[0.000013652306,0.00014117538,0.0001180083,0.00032961692,0.00021003786,0.00014239026,0.00002675715,0.0002545684,0.0000071070576],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039926388,0.00006124875,0.0046126544,0.0034781266,0.0006902716,0.0011919539,0.00041338126,0.0000010422779,0.0001344811,0.0035808184,0.017506573,0.9682895],"study_design_scores_gemma":[0.0018812686,0.0023544475,0.013892457,0.006446943,0.00048573056,0.00019960616,0.006365735,0.000022678836,0.006171325,0.0022100403,0.9596704,0.0002993197],"about_ca_topic_score_codex":0.0005459151,"about_ca_topic_score_gemma":0.0003898837,"teacher_disagreement_score":0.9679902,"about_ca_system_score_codex":0.00032813166,"about_ca_system_score_gemma":0.00058327604,"threshold_uncertainty_score":0.57569647},"labels":[],"label_agreement":null},{"id":"W4393876948","doi":"10.51731/cjht.2024.865","title":"Ibrutinib (Imbruvica)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ibrutinib; Medicine; Internal medicine; Leukemia","score_opus":0.0390365717984071,"score_gpt":0.34989368745113497,"score_spread":0.3108571156527279,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393876948","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.18337178,0.5811719,0.00052731525,0.22598231,0.0016596828,0.00059536815,0.000023693898,0.00061568536,0.0060523143],"genre_scores_gemma":[0.9973099,0.000988809,0.0006353989,0.00045080393,0.00003993939,0.0000032954154,0.0000015864695,0.000021954776,0.0005483012],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984516,0.000031181586,0.00050103274,0.00014716032,0.00027308022,0.00059596996],"domain_scores_gemma":[0.999165,0.00010594621,0.000092230795,0.0002854598,0.00014440689,0.0002069702],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008678401,0.00010786409,0.00035185905,0.0010305296,0.00011600373,0.00006290012,0.0002722554,0.0001610236,0.000114440605],"category_scores_gemma":[0.0008384292,0.00008169538,0.00011079003,0.0006084571,0.0003061324,0.00008883488,0.000023247903,0.0007349266,0.00009133389],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000025248968,0.000012323926,0.00035138358,0.000910882,0.00011091556,0.0057370635,0.0003541793,0.0000049115483,0.00007107213,0.0056376783,0.07631732,0.910467],"study_design_scores_gemma":[0.0015673363,0.0006800531,0.0005898941,0.0013660683,0.00002178524,0.008537379,0.0015322694,0.00040404627,0.0008084309,0.0030222328,0.98136747,0.00010301581],"about_ca_topic_score_codex":0.0045400783,"about_ca_topic_score_gemma":0.0010698978,"teacher_disagreement_score":0.91036403,"about_ca_system_score_codex":0.011717651,"about_ca_system_score_gemma":0.083804004,"threshold_uncertainty_score":0.9920762},"labels":[],"label_agreement":null},{"id":"W4393902627","doi":"10.51731/cjht.2024.866","title":"Calaspargase Pegol (Asparlas)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Mediterranean and Iberian flora and fauna","field":"Agricultural and Biological Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.029404317920824062,"score_gpt":0.23292624826558128,"score_spread":0.2035219303447572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393902627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5516226,0.2868003,0.000061869025,0.15532273,0.0035931293,0.0002509205,0.0001084564,0.00039671073,0.0018432635],"genre_scores_gemma":[0.99876916,0.0005082948,0.000052014017,0.00039398822,0.00009327013,0.0000018513465,0.0000054705806,0.00000107691,0.00017486997],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99898076,0.000038206803,0.00035769306,0.00012431493,0.000114552306,0.00038448145],"domain_scores_gemma":[0.9995981,0.00006812706,0.00009434678,0.000047861533,0.00005286193,0.00013869962],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032808507,0.00010189841,0.00021469544,0.00010033502,0.00019385593,0.00011262628,0.0003160621,0.00011201248,0.0003484239],"category_scores_gemma":[0.00012501131,0.000037252903,0.00009126855,0.0003869147,0.00012086865,0.00013578734,0.000011672374,0.00031911355,0.000057014215],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000026244954,0.00000452495,0.00029707287,0.000028713366,0.00000961422,0.0003008069,0.000110971196,2.9880852e-7,0.00049276795,0.001318239,0.03140178,0.96603256],"study_design_scores_gemma":[0.00005173878,0.00037389953,0.005011481,0.00020577418,0.0000050852777,0.0004291331,0.0011824983,0.000023917375,0.00021555128,0.0037687034,0.9886222,0.000110049274],"about_ca_topic_score_codex":0.0015662322,"about_ca_topic_score_gemma":0.004333541,"teacher_disagreement_score":0.96592253,"about_ca_system_score_codex":0.00008651113,"about_ca_system_score_gemma":0.00035537523,"threshold_uncertainty_score":0.38149974},"labels":[],"label_agreement":null},{"id":"W4393991885","doi":"10.51731/cjht.2024.868","title":"Efgartigimod Alfa (Vyvgart)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Nematode management and characterization studies","field":"Agricultural and Biological Sciences","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.02504345589370992,"score_gpt":0.23338023896011686,"score_spread":0.20833678306640693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393991885","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.710539,0.09401652,0.00007587643,0.1921176,0.001100484,0.0002060936,0.00003617969,0.00039569061,0.0015125459],"genre_scores_gemma":[0.9986429,0.00069590315,0.00003144036,0.00038205262,0.000028936303,0.000002799075,0.000003642874,7.7880605e-7,0.00021154391],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99923,0.00002189811,0.00030067938,0.0000951431,0.00009551021,0.0002567161],"domain_scores_gemma":[0.9997222,0.00004459565,0.00010235645,0.000033356508,0.00005549285,0.00004202735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029426985,0.00007825545,0.00016909976,0.000090105634,0.00022578375,0.00012207152,0.00022700013,0.000050614773,0.00010705161],"category_scores_gemma":[0.000058443064,0.000029468725,0.00006127022,0.00039502376,0.00007769432,0.00013586422,0.000021510297,0.00014787423,0.000031435255],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000013287747,0.0000038981557,0.0018856007,0.000034863082,0.000022543172,0.000058269197,0.00009008187,6.2066357e-7,0.0006451527,0.003691279,0.01517594,0.9783904],"study_design_scores_gemma":[0.000029340115,0.00013226215,0.014592639,0.00013190795,0.0000049265436,0.000033543183,0.0017407316,0.000008072784,0.00024181254,0.004167825,0.97883874,0.00007818065],"about_ca_topic_score_codex":0.000484675,"about_ca_topic_score_gemma":0.004469161,"teacher_disagreement_score":0.97831225,"about_ca_system_score_codex":0.000059632825,"about_ca_system_score_gemma":0.00010296354,"threshold_uncertainty_score":0.24938966},"labels":[],"label_agreement":null},{"id":"W4394606699","doi":"10.51731/cjht.2024.869","title":"Renal Denervation for Uncontrolled Hypertension","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Denervation; Medicine; Resistant hypertension; Internal medicine; Cardiology; Blood pressure","score_opus":0.061873099196899366,"score_gpt":0.3025412099882627,"score_spread":0.24066811079136335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394606699","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.031852733,0.68220973,0.0016865734,0.28242636,0.0009896677,0.00049177237,0.000015769647,0.00019141675,0.0001359674],"genre_scores_gemma":[0.9937946,0.0009703435,0.001824761,0.0031491704,0.000059265014,0.0000101025735,0.000002895233,0.000013876229,0.00017498797],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99907607,0.000016895525,0.00042013932,0.0001099349,0.000112423935,0.00026453074],"domain_scores_gemma":[0.99921197,0.00012301576,0.0001130849,0.0001225142,0.00036197944,0.00006746689],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005289183,0.000091615955,0.00050316885,0.00055990805,0.00018558395,0.000028347053,0.00007709409,0.00011626098,0.000006177547],"category_scores_gemma":[0.0005125594,0.00006219642,0.00012244322,0.00021550905,0.00007834133,0.000073961055,0.000007659844,0.00024962798,0.000003612674],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000093075694,0.000014974464,0.0005815029,0.00037523767,0.0004079003,0.0005022856,0.00016711261,0.000006506681,0.001084113,0.002024292,0.2506387,0.7441043],"study_design_scores_gemma":[0.0010834845,0.00079339376,0.0017725362,0.00088569784,0.0002868068,0.0012300471,0.00085371325,0.00022647814,0.0007580781,0.003513659,0.98851293,0.00008319254],"about_ca_topic_score_codex":0.00071440445,"about_ca_topic_score_gemma":0.0011484947,"teacher_disagreement_score":0.96194184,"about_ca_system_score_codex":0.00007107739,"about_ca_system_score_gemma":0.0017670798,"threshold_uncertainty_score":0.3134724},"labels":[],"label_agreement":null},{"id":"W4394922115","doi":"10.51731/cjht.2024.872","title":"Evinacumab (Evkeeza)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Family medicine; Drug; Pharmacology; Political science","score_opus":0.023581426086268297,"score_gpt":0.29115975924483933,"score_spread":0.26757833315857105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394922115","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0732361,0.8010696,0.0010905563,0.12135615,0.0012213272,0.00040927352,0.000011504911,0.00030857412,0.001296919],"genre_scores_gemma":[0.99552214,0.0028015978,0.000772406,0.00065276626,0.00006683058,0.0000046110945,0.0000014600249,0.000020760255,0.00015741796],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99865216,0.00003931966,0.00047360084,0.00013736602,0.00025102473,0.0004465193],"domain_scores_gemma":[0.99923015,0.000021645666,0.00009974978,0.00033817423,0.00013499249,0.00017531017],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012564062,0.00010994875,0.00045696608,0.0007564286,0.00014123783,0.00004734306,0.00016141847,0.00014409324,0.00004360077],"category_scores_gemma":[0.0003201433,0.00008156299,0.0002389538,0.00046624037,0.00012573242,0.0000937939,0.000011111732,0.0006372136,0.000029892966],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000005220697,0.000005222735,0.00038499644,0.00054648705,0.00009831768,0.0011125314,0.00011091912,0.0000011696674,0.000011250501,0.0025017655,0.010599011,0.98462313],"study_design_scores_gemma":[0.000283668,0.0006224117,0.003386565,0.0012347167,0.00004258902,0.0047288053,0.0011866733,0.000016209468,0.00024018032,0.002116091,0.9860547,0.000087363886],"about_ca_topic_score_codex":0.0037676576,"about_ca_topic_score_gemma":0.0009729429,"teacher_disagreement_score":0.98453575,"about_ca_system_score_codex":0.0006533197,"about_ca_system_score_gemma":0.008455487,"threshold_uncertainty_score":0.9971657},"labels":[],"label_agreement":null},{"id":"W4395081939","doi":"10.51731/cjht.2024.873","title":"Glofitamab (Columvi)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Vial; Medicine; Refractory (planetary science); Lymphoma; Follicular lymphoma; Drug; Intensive care medicine; Internal medicine; Pharmacology; Health care; Political science","score_opus":0.05172994418768404,"score_gpt":0.35660408707546454,"score_spread":0.3048741428877805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395081939","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.18935224,0.4806813,0.00034935176,0.31992745,0.0016477423,0.00069730566,0.000027184084,0.0005368732,0.0067805494],"genre_scores_gemma":[0.99505883,0.001592043,0.00048207893,0.0005076203,0.00004579316,0.000004499839,0.0000013185024,0.000025660504,0.00228217],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99863964,0.000034854886,0.00042536223,0.00013228889,0.0002402121,0.0005276313],"domain_scores_gemma":[0.9992641,0.00006446863,0.00007748206,0.00025782024,0.00015238822,0.00018374703],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008342358,0.00010068425,0.00033594065,0.0011165441,0.00011821059,0.00007252395,0.00024102056,0.00014577675,0.00077178143],"category_scores_gemma":[0.00038936248,0.00008172615,0.00011988414,0.00063020806,0.00023090586,0.00008479289,0.000015995056,0.0008502168,0.000056048848],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018021885,0.00000763986,0.0012945164,0.00025860788,0.0000686457,0.0015063824,0.00016130859,0.0000010264596,0.00060511124,0.0011142421,0.028909191,0.96605533],"study_design_scores_gemma":[0.00033294904,0.0008312458,0.002723834,0.000671247,0.000014049959,0.0023826975,0.0014465201,0.000039429,0.0010449721,0.0026892398,0.98774284,0.00008097284],"about_ca_topic_score_codex":0.0031363901,"about_ca_topic_score_gemma":0.0023751708,"teacher_disagreement_score":0.96597433,"about_ca_system_score_codex":0.0009422469,"about_ca_system_score_gemma":0.007344601,"threshold_uncertainty_score":0.99828285},"labels":[],"label_agreement":null},{"id":"W4395464611","doi":"10.51731/cjht.2024.875","title":"Sacituzumab Govitecan (Trodelvy)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Immunohistochemistry; Medicine; Human Epidermal Growth Factor Receptor 2; Oncology; Metastatic breast cancer; Internal medicine; Family medicine; Cancer; Breast cancer; Political science","score_opus":0.060535617426535994,"score_gpt":0.3863126043444558,"score_spread":0.3257769869179198,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395464611","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0825678,0.5120998,0.0016446878,0.39631313,0.0020028863,0.00068153447,0.000065336775,0.0006385277,0.003986293],"genre_scores_gemma":[0.9964776,0.0014810578,0.00084507646,0.0006589232,0.000057534773,0.000007915099,0.0000018699851,0.00003265887,0.00043737225],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981483,0.000045490477,0.00056918844,0.00018601691,0.00034304408,0.00070791616],"domain_scores_gemma":[0.9990177,0.00006646314,0.0001067289,0.00034340954,0.0001979806,0.0002677004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010556588,0.00013488086,0.0004169039,0.0014345456,0.000167252,0.000083905135,0.0003407404,0.0001823246,0.00017455465],"category_scores_gemma":[0.0007020153,0.00010781803,0.000119009914,0.0008052276,0.0003194364,0.000102653044,0.000022853357,0.001243236,0.000065704124],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014782215,0.000007990403,0.0012849807,0.0006335129,0.00005934299,0.001832208,0.00024958642,0.0000048860798,0.00009554523,0.003547158,0.06497012,0.9272999],"study_design_scores_gemma":[0.00029504462,0.0009501741,0.0014074277,0.001506293,0.000017760736,0.0022600696,0.001481062,0.000078021905,0.0007395687,0.0044656885,0.9866872,0.00011171385],"about_ca_topic_score_codex":0.0059511685,"about_ca_topic_score_gemma":0.0042243944,"teacher_disagreement_score":0.92718816,"about_ca_system_score_codex":0.002106987,"about_ca_system_score_gemma":0.016153267,"threshold_uncertainty_score":0.9894242},"labels":[],"label_agreement":null},{"id":"W4395685966","doi":"10.51731/cjht.2024.876","title":"Olaparib (Lynparza)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Olaparib; Medicine; Computer science; Physics; Nuclear magnetic resonance","score_opus":0.041689355697901456,"score_gpt":0.34693427468736254,"score_spread":0.3052449189894611,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395685966","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06560873,0.5816785,0.0017015889,0.3439282,0.0026466995,0.00035194398,0.000037270253,0.0005702446,0.0034768162],"genre_scores_gemma":[0.99569994,0.0015653244,0.0008838553,0.001545886,0.00004867048,0.0000053792196,0.000001734452,0.000018983104,0.00023021996],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99887925,0.00002435752,0.000463699,0.000115626164,0.00015569669,0.00036137848],"domain_scores_gemma":[0.99938434,0.000043355005,0.00012545219,0.00019797073,0.00011950813,0.00012936842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005248,0.000098806704,0.00030891973,0.00085130666,0.0001099688,0.000043297685,0.0001544566,0.00012671942,0.00013439056],"category_scores_gemma":[0.00018232656,0.00008035343,0.00009646107,0.00045007534,0.00020024895,0.000102061655,0.000006263591,0.0005924846,0.000042656447],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002075815,0.000011364949,0.0015798623,0.00034437774,0.00009779446,0.001069901,0.00036469573,0.0000052617843,0.000302717,0.008180299,0.121116325,0.86690664],"study_design_scores_gemma":[0.0003788922,0.00047330395,0.0012609367,0.0011589745,0.000015206277,0.0021757723,0.00087196304,0.000019764808,0.0018476803,0.0073481975,0.9843676,0.00008167189],"about_ca_topic_score_codex":0.0007734823,"about_ca_topic_score_gemma":0.00052946515,"teacher_disagreement_score":0.9300912,"about_ca_system_score_codex":0.0007637004,"about_ca_system_score_gemma":0.0059393314,"threshold_uncertainty_score":0.9996961},"labels":[],"label_agreement":null},{"id":"W4396514034","doi":"10.51731/cjht.2024.878","title":"Vutrisiran (Amvuttra)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Syringe; Stage (stratigraphy); Family medicine; Intensive care medicine; Political science; Psychiatry; Health care","score_opus":0.01796420021912586,"score_gpt":0.2907013560597264,"score_spread":0.27273715584060054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396514034","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.37609643,0.558829,0.00076650025,0.06185525,0.0013380423,0.00029264356,0.00007347119,0.00014994203,0.0005987212],"genre_scores_gemma":[0.9942694,0.0043107746,0.00056704634,0.00056801987,0.000040074392,0.000009332142,0.000008771238,0.00002477757,0.00020182936],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988091,0.000042587482,0.00041210532,0.0001992672,0.0001023773,0.00043456268],"domain_scores_gemma":[0.99936706,0.000025679617,0.00014817003,0.0002794171,0.00007256611,0.000107083906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003539629,0.00015613025,0.00025217788,0.00041391494,0.00013905288,0.00006378054,0.00037007648,0.0002097769,0.000020168198],"category_scores_gemma":[0.00027618418,0.0001295609,0.00014361602,0.00023224992,0.00016769698,0.000008982577,0.000027247937,0.0002571915,0.000019648793],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001635117,0.000038452188,0.02743476,0.00020948391,0.00037533522,0.0005299778,0.00021759354,0.000028269407,0.0024513204,0.002158802,0.11508811,0.8514515],"study_design_scores_gemma":[0.0003253327,0.00080473186,0.00630194,0.0002248122,0.000029109278,0.00042424246,0.0014124529,0.0000039497645,0.019543417,0.001312549,0.9694002,0.00021726474],"about_ca_topic_score_codex":0.0010435431,"about_ca_topic_score_gemma":0.0022876987,"teacher_disagreement_score":0.85431206,"about_ca_system_score_codex":0.00018474259,"about_ca_system_score_gemma":0.0019407675,"threshold_uncertainty_score":0.528334},"labels":[],"label_agreement":null},{"id":"W4396514095","doi":"10.51731/cjht.2024.879","title":"Niraparib and Abiraterone Acetate (Akeega)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Abiraterone acetate; Reimbursement; Medicine; Abiraterone; Prostate cancer; Asymptomatic; Internal medicine; Oncology; Chemotherapy; Cancer; Gynecology; Political science; Androgen deprivation therapy; Health care","score_opus":0.03726430238214361,"score_gpt":0.32689288200919125,"score_spread":0.28962857962704763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396514095","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.30526718,0.4924323,0.00056570524,0.19977583,0.0009098756,0.00024471464,0.000026149288,0.0002603374,0.0005179172],"genre_scores_gemma":[0.9937544,0.004029912,0.00076818094,0.0012286934,0.00002845496,0.000004933899,0.0000013264453,0.000017751778,0.00016636039],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99898595,0.000025122756,0.00042043987,0.00012602018,0.00011675827,0.00032573976],"domain_scores_gemma":[0.9994758,0.00003246783,0.0001209753,0.00015165968,0.000085910586,0.00013320835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004857211,0.000103479964,0.00032180414,0.0007022275,0.00011143949,0.00005449415,0.00009591186,0.00010923396,0.000044301043],"category_scores_gemma":[0.00009049045,0.00008317687,0.00004963451,0.00029701254,0.00028073776,0.000116784424,0.000008032921,0.00047918965,0.00001196142],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032238648,0.000008139172,0.002329145,0.0004971431,0.000106318934,0.0008586407,0.0006024425,0.0000033127653,0.0008267361,0.0030365326,0.02927177,0.96242756],"study_design_scores_gemma":[0.0009863364,0.0009826482,0.006075661,0.0017817568,0.000031132964,0.0042590387,0.0016076257,0.00003905575,0.0037047933,0.010295065,0.97008395,0.00015296023],"about_ca_topic_score_codex":0.00069012935,"about_ca_topic_score_gemma":0.00064418,"teacher_disagreement_score":0.9622746,"about_ca_system_score_codex":0.00038150643,"about_ca_system_score_gemma":0.002388537,"threshold_uncertainty_score":0.4237162},"labels":[],"label_agreement":null},{"id":"W4396514411","doi":"10.51731/cjht.2024.877","title":"Artificial Intelligence for Patient Flow","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Healthcare Operations and Scheduling Optimization","field":"Health Professions","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Overcrowding; Emergency department; Psychological intervention; Health care; Medical emergency; Medicine; Workflow; Acute care; Health information technology; Computer science; Nursing","score_opus":0.1340610564882069,"score_gpt":0.4347832521283983,"score_spread":0.3007221956401914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396514411","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015648216,0.06446206,0.63562214,0.2743557,0.007286027,0.0017914913,0.00017853582,0.00037446237,0.00028134335],"genre_scores_gemma":[0.9649255,0.00040997798,0.033545937,0.0009074665,0.00006968662,0.000059672515,0.000010388162,0.000020568883,0.00005075493],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980312,0.000139659,0.0010920437,0.00013276545,0.00009990405,0.0005044558],"domain_scores_gemma":[0.9988093,0.0002934902,0.0002115613,0.00015069918,0.00042863056,0.00010633015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014889705,0.000092932045,0.00023458194,0.0005923403,0.0010295281,0.00004244723,0.00017144697,0.0002154956,0.00006712098],"category_scores_gemma":[0.0013157784,0.00007554384,0.00006259792,0.0003965627,0.000070727045,0.00013079305,0.0000111455865,0.0006689602,0.000029856436],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000005270417,0.000004319324,0.000079023135,0.00026686137,0.000009633118,0.000012245501,0.002264167,0.0012508334,0.000003063448,0.025752634,0.005276477,0.9650755],"study_design_scores_gemma":[0.00007250154,0.0010850319,0.00009553794,0.0022135146,0.000015654918,0.00004541027,0.0376449,0.049506534,0.00017318092,0.064886995,0.84400713,0.00025361456],"about_ca_topic_score_codex":0.0015477438,"about_ca_topic_score_gemma":0.0059995796,"teacher_disagreement_score":0.9648219,"about_ca_system_score_codex":0.00058764644,"about_ca_system_score_gemma":0.009533432,"threshold_uncertainty_score":0.9960816},"labels":[],"label_agreement":null},{"id":"W4396568439","doi":"10.51731/cjht.2024.881","title":"Belumosudil (Rezurock)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Environmental science","score_opus":0.026215156772497517,"score_gpt":0.30275199556516397,"score_spread":0.27653683879266644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396568439","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21260768,0.6270717,0.0002529162,0.15536375,0.0014943931,0.00040240926,0.000026659545,0.00051194336,0.002268585],"genre_scores_gemma":[0.9967264,0.0013928879,0.00084592,0.0005063783,0.000030029112,0.0000037809132,0.000002761368,0.000022015498,0.00046981528],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99878246,0.000019747162,0.000458427,0.0001374851,0.00016076607,0.0004411369],"domain_scores_gemma":[0.9993586,0.00004668015,0.00011791961,0.00023652744,0.00008896358,0.00015132365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033706275,0.00012319931,0.00035215373,0.0007560715,0.00011666654,0.00003265612,0.0001699784,0.00013289954,0.00011603718],"category_scores_gemma":[0.0002847898,0.0000951138,0.00010590077,0.00035336186,0.00014089992,0.00008491212,0.000013518306,0.00056267146,0.00008571474],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008779229,0.000012213766,0.002483685,0.000355255,0.00014069858,0.0032281275,0.00025066143,0.0000030795293,0.000043996028,0.0014063121,0.04484255,0.9472246],"study_design_scores_gemma":[0.00073613285,0.000842815,0.0046830727,0.0013477359,0.000059724844,0.005784939,0.0012062037,0.0000394857,0.00066284783,0.0025538474,0.98196775,0.00011544312],"about_ca_topic_score_codex":0.0026569578,"about_ca_topic_score_gemma":0.0016136857,"teacher_disagreement_score":0.9471092,"about_ca_system_score_codex":0.0025287624,"about_ca_system_score_gemma":0.012557245,"threshold_uncertainty_score":0.9930406},"labels":[],"label_agreement":null},{"id":"W4396597402","doi":"10.51731/cjht.2024.882","title":"Nivolumab and Relatlimab (Opdualag)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Nivolumab; Medicine; Internal medicine; Cancer; Immunotherapy","score_opus":0.020883726419394413,"score_gpt":0.2905325456342415,"score_spread":0.2696488192148471,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396597402","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19664255,0.67526793,0.00007372021,0.12653044,0.0006302989,0.00015235007,0.00000974217,0.0001439776,0.00054898474],"genre_scores_gemma":[0.99340796,0.0053125885,0.00037222647,0.00063012267,0.000015567006,0.0000014881085,7.944872e-7,0.0000123849195,0.0002468902],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992109,0.000015696094,0.0003323661,0.00009666577,0.00008875956,0.00025560614],"domain_scores_gemma":[0.9996391,0.000030332763,0.00008325238,0.00012426212,0.000047973477,0.00007509476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045194672,0.00007931881,0.00023105166,0.0005584503,0.00010653899,0.00004362572,0.00008074337,0.00011211234,0.000033578086],"category_scores_gemma":[0.0001072714,0.00006089711,0.00006261236,0.00027766815,0.00022314712,0.00007936019,0.000007140483,0.00038342393,0.000004155731],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049335944,0.000004347952,0.0012738633,0.00021826685,0.0000824344,0.00034602135,0.00028400918,1.2996257e-7,0.00018721036,0.00083333603,0.01743248,0.9792886],"study_design_scores_gemma":[0.0007559644,0.0009981373,0.010715871,0.0012802265,0.000030016383,0.004085099,0.00246871,0.000016969378,0.00032214032,0.0019513412,0.97727937,0.00009613276],"about_ca_topic_score_codex":0.0023446095,"about_ca_topic_score_gemma":0.0011868434,"teacher_disagreement_score":0.97919244,"about_ca_system_score_codex":0.00035032284,"about_ca_system_score_gemma":0.002602121,"threshold_uncertainty_score":0.4616051},"labels":[],"label_agreement":null},{"id":"W4396613915","doi":"10.51731/cjht.2024.884","title":"Anticytokine Therapy and Corticosteroids for Cytokine Release Syndrome and for Neurotoxicity Following T-Cell Engager or CAR T-Cell Therapy","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cytokine release syndrome; Medicine; Anakinra; Internal medicine; Oncology; Chimeric antigen receptor; T cell; Immunology; Immune system","score_opus":0.07920129161709988,"score_gpt":0.3448582712694659,"score_spread":0.265656979652366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396613915","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87773067,0.10511212,0.00045215897,0.014038456,0.00029774796,0.0021660724,0.00007363846,0.00010612861,0.000023006627],"genre_scores_gemma":[0.9848395,0.012412043,0.0011378498,0.0007226895,0.000039543273,0.00008415658,0.0000051832353,0.00007871161,0.00068029953],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99800056,0.00008391208,0.0006287268,0.00034475245,0.0002196442,0.00072240713],"domain_scores_gemma":[0.99849933,0.0005697972,0.00016950116,0.00030097348,0.00016129672,0.00029910862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012835179,0.00026080932,0.00071859156,0.0008496209,0.00033644604,0.00013305352,0.0002038699,0.0002103973,0.000035126326],"category_scores_gemma":[0.00043549307,0.0001876294,0.00018993982,0.00036744273,0.00023254787,0.00014238022,0.000021604506,0.0006032559,6.537602e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016275503,0.000110028064,0.003163271,0.0018278921,0.0002704979,0.0022999402,0.00075316284,0.000002323133,0.15963075,0.00006986661,0.002730633,0.8275141],"study_design_scores_gemma":[0.020631528,0.034796704,0.0071882475,0.001796729,0.00016570839,0.0072974926,0.0035189048,0.00091116794,0.12818721,0.0018418975,0.7928316,0.0008328463],"about_ca_topic_score_codex":0.00047683204,"about_ca_topic_score_gemma":0.00022942817,"teacher_disagreement_score":0.82668126,"about_ca_system_score_codex":0.0002519262,"about_ca_system_score_gemma":0.0022244668,"threshold_uncertainty_score":0.76513046},"labels":[],"label_agreement":null},{"id":"W4396801928","doi":"10.51731/cjht.2024.890","title":"Inclisiran (Leqvio)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Statin; Internal medicine; Atherosclerotic cardiovascular disease; Clinical trial; Cause of death; Drug; Adverse effect; Disease; Cholesterol; Quality of life (healthcare); Pharmacology","score_opus":0.023971632236052604,"score_gpt":0.29090637191898483,"score_spread":0.26693473968293224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396801928","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.119800694,0.76287293,0.0010740254,0.11262494,0.0013912847,0.00043870177,0.000014649669,0.00034142245,0.0014413717],"genre_scores_gemma":[0.9964597,0.001799407,0.0007296682,0.0008078417,0.00006928128,0.000003727287,0.0000016754587,0.000020195082,0.00010849137],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986639,0.000041506944,0.0004912468,0.00013606621,0.00024071446,0.00042653727],"domain_scores_gemma":[0.99925315,0.000023224016,0.00009401679,0.0003288878,0.00012302911,0.00017767705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014182995,0.000106493964,0.00043213664,0.0007897817,0.00014635055,0.00004642626,0.0001611495,0.00014732432,0.00003838092],"category_scores_gemma":[0.00031164178,0.00007894559,0.00022051457,0.00048373052,0.00012962073,0.000092020186,0.000012484481,0.0006558307,0.000024451703],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004461117,0.000005020464,0.00058564695,0.00042763527,0.000086968466,0.00093980314,0.00014621225,0.0000011052203,0.000011263536,0.0021945934,0.0052722166,0.9903251],"study_design_scores_gemma":[0.00031207292,0.00064306066,0.00480167,0.0010665419,0.000035817007,0.0034604657,0.001267857,0.000013741696,0.00022124001,0.0026227136,0.9854685,0.000086310654],"about_ca_topic_score_codex":0.0050401306,"about_ca_topic_score_gemma":0.0013874854,"teacher_disagreement_score":0.9902388,"about_ca_system_score_codex":0.000506767,"about_ca_system_score_gemma":0.006937589,"threshold_uncertainty_score":0.99869215},"labels":[],"label_agreement":null},{"id":"W4396827093","doi":"10.51731/cjht.2024.893","title":"Odevixibat (Bylvay)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Family medicine; Political science; Health care","score_opus":0.037984929529660115,"score_gpt":0.3380933450141672,"score_spread":0.3001084154845071,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396827093","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02408939,0.69287986,0.0016069362,0.277195,0.0013316815,0.0002246227,0.000012673862,0.00031751092,0.0023423037],"genre_scores_gemma":[0.9956369,0.0024240531,0.00046625675,0.0010893294,0.000024863437,0.000002415101,0.0000015864139,0.000010445992,0.00034418132],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990897,0.000018015047,0.00037333436,0.000083083316,0.0001271134,0.0003087364],"domain_scores_gemma":[0.99943525,0.000039402552,0.00010205941,0.0001752385,0.000077088356,0.00017095622],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005010704,0.00007577112,0.0002447214,0.0007249555,0.00008262924,0.000023699773,0.00014089058,0.000107428066,0.000078540346],"category_scores_gemma":[0.0007499466,0.00005525059,0.00007499213,0.00035465398,0.00014552663,0.0000993814,0.0000059601416,0.000479579,0.000034250854],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000040695318,0.000005630227,0.000978715,0.00030091952,0.00004054452,0.00050891563,0.0002669084,5.806658e-7,0.00003489085,0.0028604327,0.040224444,0.95477396],"study_design_scores_gemma":[0.0002360972,0.0003898767,0.0053379466,0.0032756436,0.00002513459,0.0025059863,0.0010631221,0.000019629933,0.0005376199,0.0034298568,0.9831121,0.00006697035],"about_ca_topic_score_codex":0.0004933939,"about_ca_topic_score_gemma":0.00028060024,"teacher_disagreement_score":0.9715475,"about_ca_system_score_codex":0.00034051164,"about_ca_system_score_gemma":0.0069678235,"threshold_uncertainty_score":0.99866176},"labels":[],"label_agreement":null},{"id":"W4396957301","doi":"10.51731/cjht.2024.894","title":"Point-of-Care Tests for COVID-19 and Influenza in Canada","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"SARS-CoV-2 detection and testing","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Point-of-care testing; Intensive care medicine; Diagnostic test; Point of care; Test (biology); Emergency medicine; Pathology","score_opus":0.07325829680857208,"score_gpt":0.36639433975587743,"score_spread":0.29313604294730533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396957301","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8662188,0.11241403,0.00013162829,0.020446805,0.00032487855,0.00031533488,0.000029641182,0.000060473652,0.000058407873],"genre_scores_gemma":[0.9951307,0.000058595353,0.00084648764,0.003936132,0.000008879291,0.0000055547475,5.1074454e-7,0.000010507206,0.0000026448824],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99909496,0.000015311996,0.00044399546,0.00010101213,0.00008535136,0.0002593664],"domain_scores_gemma":[0.9993127,0.00023477546,0.0001393782,0.00009941203,0.000106926724,0.00010678899],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033246956,0.00007914479,0.00028553998,0.0007334054,0.00007180905,0.000013251549,0.000081040474,0.0000730002,0.0000028661123],"category_scores_gemma":[0.0033409856,0.00006842888,0.0000315454,0.00036114393,0.00008097221,0.000049922917,0.000008269799,0.00031513578,2.090738e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005705303,0.0000062374324,0.14883202,0.005009821,0.000052842573,0.0011156457,0.0014189758,0.000018933786,0.00082035793,0.00087417144,0.005462068,0.83633184],"study_design_scores_gemma":[0.0027197166,0.0018939249,0.026138326,0.0040954337,0.00005562371,0.0042833546,0.047245782,0.00041927773,0.014387809,0.0048923525,0.89354086,0.0003275517],"about_ca_topic_score_codex":0.7927438,"about_ca_topic_score_gemma":0.97072715,"teacher_disagreement_score":0.88807875,"about_ca_system_score_codex":0.0017191233,"about_ca_system_score_gemma":0.025157293,"threshold_uncertainty_score":0.98036915},"labels":[],"label_agreement":null},{"id":"W4397007674","doi":"10.51731/cjht.2024.895","title":"Newborn Screening for Congenital Cytomegalovirus","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institute on Deafness and Other Communication Disorders","keywords":"Cytomegalovirus; Medicine; Virology; Cytomegalovirus infections; Pediatrics; Human cytomegalovirus; Virus; Herpesviridae; Viral disease","score_opus":0.07184159967942559,"score_gpt":0.36145888329948683,"score_spread":0.2896172836200612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4397007674","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0896908,0.6083966,0.035500944,0.25822842,0.0018752612,0.0022044452,0.00044868223,0.0007915014,0.0028633992],"genre_scores_gemma":[0.9894333,0.00065743335,0.008859234,0.00059934484,0.00008242753,0.000015413827,0.0000062510217,0.000040294603,0.00030633868],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99830717,0.00002368418,0.00057406584,0.00018249235,0.00022273591,0.0006898279],"domain_scores_gemma":[0.9991165,0.00014466098,0.000113636415,0.00021077845,0.00017160233,0.00024285623],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009766172,0.00014574011,0.00045676786,0.0014196695,0.00025172997,0.00013448062,0.00024207761,0.0001846363,0.000064139305],"category_scores_gemma":[0.00058123167,0.000117887714,0.00020815259,0.00054743874,0.00023690533,0.00016304407,0.000019826963,0.0007189529,0.000020649364],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006083717,0.000008036239,0.00080422335,0.0002849642,0.00012865086,0.0004898256,0.00013601256,0.0000030010845,0.00014047926,0.0013108484,0.02087709,0.97575605],"study_design_scores_gemma":[0.0005523627,0.0008016681,0.0019516828,0.0004375494,0.000030943967,0.0008978032,0.0010737734,0.00022789623,0.00052438054,0.0010909416,0.99230736,0.000103623985],"about_ca_topic_score_codex":0.002703138,"about_ca_topic_score_gemma":0.0033628696,"teacher_disagreement_score":0.9756524,"about_ca_system_score_codex":0.00047269894,"about_ca_system_score_gemma":0.0058261757,"threshold_uncertainty_score":0.99980986},"labels":[],"label_agreement":null},{"id":"W4398208078","doi":"10.51731/cjht.2024.897","title":"2023 Abstracts of the Canadian Association for Population Therapeutics","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Association (psychology); Medicine; Psychology; Psychotherapist","score_opus":0.32982172614975364,"score_gpt":0.4222050936713442,"score_spread":0.09238336752159054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4398208078","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.109921254,0.09279691,0.00049305824,0.7872932,0.0054001748,0.0012919686,0.0013180801,0.00006899808,0.0014163808],"genre_scores_gemma":[0.9964193,0.00016808676,0.0004413642,0.0025860078,0.000049648585,0.000011790295,0.0000076149163,0.000016202868,0.0002999828],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965445,0.00009236909,0.0027375878,0.00014178311,0.00007544095,0.00040836693],"domain_scores_gemma":[0.9966045,0.0004535597,0.0024809996,0.00022259304,0.00014614646,0.0000921849],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0128833,0.00009232312,0.00048688287,0.0008439794,0.00034972938,0.000092113856,0.00033723473,0.0002413925,0.000020564381],"category_scores_gemma":[0.003948966,0.00008961555,0.00013142558,0.00032023937,0.00005095315,0.00021496284,0.0000065710115,0.00030039914,0.000031773085],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007131943,0.000026942147,0.32345536,0.0021959117,0.00048216106,0.000005020822,0.0033502055,0.001393864,0.0000037196028,0.46818343,0.14664115,0.05425512],"study_design_scores_gemma":[0.00019091184,0.00009203281,0.1811863,0.00035520562,0.0000109576085,0.000011245942,0.0011995778,0.00053574046,0.0000128521015,0.09238853,0.72387326,0.0001434058],"about_ca_topic_score_codex":0.4112581,"about_ca_topic_score_gemma":0.7649537,"teacher_disagreement_score":0.88649803,"about_ca_system_score_codex":0.0041377856,"about_ca_system_score_gemma":0.0045734327,"threshold_uncertainty_score":0.99968517},"labels":[],"label_agreement":null},{"id":"W4398238741","doi":"10.51731/cjht.2024.899","title":"Newborn Screening for Congenital Cytomegalovirus in Canada","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cytomegalovirus; Virology; Medicine; Pediatrics; Virus; Herpesviridae; Viral disease","score_opus":0.05442502672261114,"score_gpt":0.33045883323314146,"score_spread":0.27603380651053033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4398238741","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.37772965,0.40280905,0.00478346,0.20899814,0.0016422512,0.0019755259,0.00049083383,0.00021764307,0.0013534472],"genre_scores_gemma":[0.9959687,0.00042760966,0.0028506813,0.0005896675,0.00003398648,0.000013672869,0.0000045690363,0.000027530512,0.0000835575],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99820745,0.000025385349,0.00062920776,0.00017070302,0.00023803831,0.0007292188],"domain_scores_gemma":[0.9992451,0.00015898942,0.000098473196,0.00017359258,0.00010719944,0.0002166263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007471018,0.00013489467,0.00046565582,0.0012502328,0.00012694306,0.00006478255,0.00022914978,0.00011360819,0.000042654658],"category_scores_gemma":[0.0004696261,0.00011494685,0.000097596516,0.0006419995,0.00010938784,0.00011978183,0.000017015618,0.00076308486,0.0000035654357],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005442812,0.0000050420063,0.007887186,0.00025259922,0.000062131025,0.0013287434,0.00009355694,0.000015408985,0.00004017644,0.00036548276,0.013469426,0.9764258],"study_design_scores_gemma":[0.00070517627,0.00036031753,0.014324473,0.00057754933,0.0000143592,0.0005808507,0.0025076384,0.00061352015,0.00026937693,0.00043650842,0.9794903,0.00011995523],"about_ca_topic_score_codex":0.936947,"about_ca_topic_score_gemma":0.9915626,"teacher_disagreement_score":0.97630584,"about_ca_system_score_codex":0.0025996086,"about_ca_system_score_gemma":0.040715273,"threshold_uncertainty_score":0.964723},"labels":[],"label_agreement":null},{"id":"W4398781678","doi":"10.51731/cjht.2024.900","title":"Nabilone for Chronic Non-Cancer Pain","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chronic pain; Medicine; Cancer pain; Cancer; Physical therapy; Internal medicine","score_opus":0.02872035352823543,"score_gpt":0.3403305924569421,"score_spread":0.31161023892870665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4398781678","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04719347,0.68262887,0.025322683,0.24149123,0.0016430045,0.0012582929,0.00008180396,0.00026394485,0.00011668654],"genre_scores_gemma":[0.9948206,0.0016758072,0.0024589985,0.0006668113,0.00005330862,0.00004628263,0.0000028976413,0.00002076931,0.00025452723],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990682,0.000020159314,0.00031405903,0.00011784555,0.00008765814,0.00039205307],"domain_scores_gemma":[0.99948823,0.000071406146,0.000100831145,0.0001375053,0.00009557987,0.00010643161],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009076331,0.000101738624,0.00030618324,0.00047153892,0.00012490425,0.000024909663,0.00010936857,0.00011161509,0.000037402453],"category_scores_gemma":[0.0002797849,0.000074755066,0.00010520787,0.00021917184,0.0000669875,0.0000514987,0.0000053692343,0.0002516843,0.000005880755],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000095225605,0.0000106648295,0.00072839105,0.00064620737,0.00011962015,0.00025670783,0.00008601473,0.0000036467095,0.00017562933,0.0010296857,0.014170758,0.9827632],"study_design_scores_gemma":[0.0014629659,0.004411292,0.0028247426,0.0039923233,0.00011356526,0.0003255809,0.0012217895,0.0007945065,0.0027763767,0.016243849,0.96564424,0.00018879358],"about_ca_topic_score_codex":0.0014897115,"about_ca_topic_score_gemma":0.0022611627,"teacher_disagreement_score":0.98257434,"about_ca_system_score_codex":0.0011881992,"about_ca_system_score_gemma":0.0059316005,"threshold_uncertainty_score":0.9997038},"labels":[],"label_agreement":null},{"id":"W4399260785","doi":"10.51731/cjht.2024.909","title":"Oncology Drug Approvals Under Health Canada’s Notice of Compliance With Conditions Policy: A Retrospective Cohort Analysis","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Notice; Retrospective cohort study; Medicine; Cohort; Compliance (psychology); Drug; Family medicine; Oncology; Internal medicine; Pharmacology; Political science; Psychology; Law","score_opus":0.22660802685067075,"score_gpt":0.43486762120975414,"score_spread":0.2082595943590834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399260785","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04581929,0.07239675,0.008771905,0.86731267,0.00081747485,0.0009973261,0.0024100798,0.00010608802,0.0013684001],"genre_scores_gemma":[0.9886885,0.00051806815,0.0018009543,0.00871102,0.000044036646,0.00002607418,0.000026257667,0.000026763095,0.00015830572],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.99419826,0.00032678354,0.0041556857,0.00042157684,0.00016670744,0.00073099125],"domain_scores_gemma":[0.9942417,0.00062148913,0.0040553375,0.0004867239,0.0003049006,0.00028980794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011042627,0.00021158974,0.0021443784,0.0026466863,0.00037994937,0.000062611194,0.0005029902,0.00015263619,0.0000776377],"category_scores_gemma":[0.0018885324,0.00022430332,0.00015943513,0.0018343399,0.0003931627,0.00027099648,0.000021891483,0.00062194024,0.000020387119],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000018156361,0.00007878727,0.22243127,0.0022012421,0.0031557465,0.00006184379,0.003775326,0.004923304,5.5082666e-7,0.60757536,0.1524644,0.0033140113],"study_design_scores_gemma":[0.00096095423,0.0010623633,0.60272896,0.0016738225,0.00016217063,0.00027126467,0.028876087,0.002366006,0.000009271152,0.06314465,0.29798803,0.00075642735],"about_ca_topic_score_codex":0.90585756,"about_ca_topic_score_gemma":0.95266443,"teacher_disagreement_score":0.94286925,"about_ca_system_score_codex":0.012571847,"about_ca_system_score_gemma":0.045903977,"threshold_uncertainty_score":0.9912187},"labels":[],"label_agreement":null},{"id":"W4399260815","doi":"10.51731/cjht.2024.905","title":"Virtual Medicine Wards and Hospital-at-Home Programs","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Telemedicine and Telehealth Implementation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Hospital medicine; Medical emergency; Medicine; Family medicine","score_opus":0.030115565730325245,"score_gpt":0.33197276797157554,"score_spread":0.3018572022412503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399260815","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.52119017,0.14448398,0.00022621543,0.33214766,0.0010667605,0.0005027871,0.000010270348,0.00023546748,0.0001367054],"genre_scores_gemma":[0.9955771,0.0025234076,0.00040093507,0.0012065697,0.00009156642,0.000010258126,0.000015201612,0.000021521028,0.00015347145],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99831206,0.000028935025,0.0007354264,0.00017685884,0.00025263737,0.00049411383],"domain_scores_gemma":[0.9991451,0.00006104592,0.00021124215,0.00016500743,0.00014013912,0.00027745953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086187257,0.00014611176,0.00046105,0.0009321089,0.00018238189,0.000022623064,0.00012254332,0.000119161734,0.00007496803],"category_scores_gemma":[0.0003362492,0.000102826685,0.000043605593,0.0004648547,0.00040711646,0.00011493042,0.000022781189,0.00046725635,0.0000071467475],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012212334,0.000008911546,0.013677494,0.00039626154,0.000045116452,0.00044790845,0.0013267247,7.727925e-8,0.000015637075,0.0014647678,0.02949522,0.9531097],"study_design_scores_gemma":[0.0014183545,0.010814335,0.04181129,0.0019143933,0.00007746964,0.0026171766,0.014048828,0.000022447524,0.00008422324,0.0025211195,0.92451215,0.00015818927],"about_ca_topic_score_codex":0.0030814991,"about_ca_topic_score_gemma":0.001932863,"teacher_disagreement_score":0.9529515,"about_ca_system_score_codex":0.00055368146,"about_ca_system_score_gemma":0.0022086424,"threshold_uncertainty_score":0.46583253},"labels":[],"label_agreement":null},{"id":"W4399260929","doi":"10.51731/cjht.2024.908","title":"Viewpoint: Reflections on an Analysis of Health Canada’s NOC/c Policy for Oncology Drug Approvals","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Canada","funders":"","keywords":"Drug; Medicine; Drug approval; Oncology; Business; Internal medicine; Pharmacology","score_opus":0.41845352415323434,"score_gpt":0.5129235683561644,"score_spread":0.09447004420293004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399260929","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014502825,0.06360669,0.0056396727,0.9116116,0.0013774696,0.0008441642,0.0016712626,0.00008373828,0.0006625702],"genre_scores_gemma":[0.96661305,0.0011425283,0.0032921818,0.028527033,0.00010860802,0.00006066168,0.00004489575,0.000039937695,0.00017111597],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99271023,0.00043572937,0.0055958894,0.0004082234,0.000104534396,0.00074538396],"domain_scores_gemma":[0.99426764,0.0008762413,0.0038659868,0.0005193314,0.00018528523,0.0002855254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020813689,0.0001968373,0.0020348306,0.005046989,0.00046578413,0.000060065344,0.0005393318,0.00018941921,0.00004327325],"category_scores_gemma":[0.004629315,0.00022070232,0.00026842504,0.00148434,0.00015103369,0.00024709452,0.000015406666,0.00045602137,0.0000125604365],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000016872538,0.00008471182,0.0014712247,0.001618887,0.0010850248,0.000009241584,0.005611895,0.0033196735,9.3110725e-7,0.75457805,0.13946074,0.09274277],"study_design_scores_gemma":[0.00029135015,0.0008538932,0.0035225684,0.00027943988,0.00004084813,0.000026236537,0.011724206,0.002025062,0.000006278421,0.037070923,0.943929,0.00023020642],"about_ca_topic_score_codex":0.87626284,"about_ca_topic_score_gemma":0.96067137,"teacher_disagreement_score":0.95211023,"about_ca_system_score_codex":0.00942971,"about_ca_system_score_gemma":0.039323945,"threshold_uncertainty_score":0.9943729},"labels":[],"label_agreement":null},{"id":"W4399461713","doi":"10.51731/cjht.2024.914","title":"Fidanacogene Elaparvovec (Beqvez)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Drug; Test (biology); Pediatrics; Family medicine; Intensive care medicine; Pharmacology; Health care; Political science; Biology","score_opus":0.023130261508214334,"score_gpt":0.3167561389790502,"score_spread":0.29362587747083585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399461713","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5675709,0.4098992,0.0003866353,0.02092374,0.0005669987,0.00016651684,0.00004989581,0.000060090533,0.00037601727],"genre_scores_gemma":[0.9963318,0.0027057407,0.00021292832,0.00040386955,0.000054198335,0.0000047896524,0.0000074326017,0.000025506271,0.00025374198],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99877286,0.000065868466,0.0003516196,0.00018246875,0.00013851213,0.00048864825],"domain_scores_gemma":[0.9993678,0.000014544357,0.0000906358,0.00029783123,0.00011375556,0.00011543967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073590234,0.00012205024,0.00018844767,0.00045866854,0.00013646451,0.00006097761,0.00047143258,0.00017782356,0.000042191485],"category_scores_gemma":[0.00021183568,0.00010587673,0.00010260348,0.00029127378,0.00019246314,0.0000062655918,0.00003105659,0.0003430405,0.000020573347],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010581368,0.0000115664025,0.0003557297,0.000113474096,0.00015361003,0.00025420438,0.00007218281,0.000082813494,0.042491365,0.000420444,0.04514182,0.910797],"study_design_scores_gemma":[0.0002105194,0.002995515,0.00017415857,0.00012597605,0.0000069421108,0.0003381258,0.0004966291,0.000022077278,0.12057421,0.0013375211,0.87354887,0.00016948118],"about_ca_topic_score_codex":0.00047483103,"about_ca_topic_score_gemma":0.006452686,"teacher_disagreement_score":0.9106275,"about_ca_system_score_codex":0.00014808241,"about_ca_system_score_gemma":0.0041540284,"threshold_uncertainty_score":0.73690677},"labels":[],"label_agreement":null},{"id":"W4399461858","doi":"10.51731/cjht.2024.913","title":"Treosulfan (Trecondyv)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Treosulfan; Medicine; Myelodysplastic syndromes; Fludarabine; Reimbursement; Myeloid leukemia; Hematopoietic stem cell transplantation; Hematopoietic cell; Intensive care medicine; Transplantation; Oncology; Family medicine; Internal medicine; Chemotherapy; Busulfan; Stem cell; Haematopoiesis; Bone marrow; Health care; Political science","score_opus":0.03023603101204567,"score_gpt":0.32433378395190454,"score_spread":0.29409775293985885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399461858","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24051568,0.3793568,0.0014444613,0.3699041,0.001944294,0.0005779876,0.000051786465,0.00064986746,0.005555019],"genre_scores_gemma":[0.99701667,0.00073132926,0.00091618556,0.0005706639,0.000038277798,0.0000034604564,0.000002199817,0.000023544915,0.000697699],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99857205,0.000029737557,0.0004907441,0.00014050714,0.00021988353,0.0005470625],"domain_scores_gemma":[0.99920774,0.0001098245,0.0000958122,0.00023086855,0.00014409548,0.00021167954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065611495,0.000112417256,0.00034571218,0.0013060377,0.000113533235,0.000056698387,0.0002496683,0.00015686855,0.00014811997],"category_scores_gemma":[0.00072808156,0.00008362399,0.00010428659,0.0005572985,0.00026391615,0.00010749898,0.000017419676,0.0007107109,0.00007949477],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014702402,0.000007629601,0.0009356301,0.00034477242,0.00008315159,0.004519364,0.00023827149,0.000001630457,0.00007247043,0.0015505863,0.07331708,0.91891474],"study_design_scores_gemma":[0.0007507206,0.0010400953,0.0027770572,0.0013183183,0.00003321002,0.012176899,0.002520922,0.0002308463,0.00081571285,0.0037003444,0.97450674,0.00012915337],"about_ca_topic_score_codex":0.0023704574,"about_ca_topic_score_gemma":0.0011884538,"teacher_disagreement_score":0.9187856,"about_ca_system_score_codex":0.0019767396,"about_ca_system_score_gemma":0.01819458,"threshold_uncertainty_score":0.9873713},"labels":[],"label_agreement":null},{"id":"W4399583434","doi":"10.51731/cjht.2024.916","title":"Advisory Panel Guidance on Minimum Retesting Intervals for Lab Tests","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Healthcare cost, quality, practices","field":"Health Professions","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Lupus Canada; Strong; Diabetes Canada; Juvenile Diabetes Research Foundation Canada","keywords":"Test (biology); Medicine; Natriuretic peptide; Family medicine; Medical education; Internal medicine","score_opus":0.6766051998361999,"score_gpt":0.5436428878656937,"score_spread":0.13296231197050623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399583434","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19967148,0.17839159,0.0014094926,0.60499364,0.008925433,0.002789886,0.00035239873,0.001232648,0.0022333995],"genre_scores_gemma":[0.98454833,0.0006819493,0.00339541,0.010404894,0.00020528007,0.00011964247,0.0000050043454,0.000073259835,0.0005662551],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99464446,0.0011304866,0.0021230266,0.00038782257,0.0002992262,0.0014149821],"domain_scores_gemma":[0.9913235,0.005806416,0.0012961868,0.0005416024,0.00070673745,0.00032557902],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.009768794,0.00027217114,0.000700699,0.0011246253,0.0012140524,0.00006469035,0.0007808314,0.0005071478,0.000046663317],"category_scores_gemma":[0.030011056,0.00023366527,0.00014505119,0.0006523961,0.00024617038,0.00040166973,0.00006471509,0.0026797256,0.000111544075],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000070982605,0.00002939687,0.0120885465,0.0068900967,0.000082058046,0.00029984015,0.004645836,0.000008419991,0.00009325266,0.0137859015,0.12623397,0.8357717],"study_design_scores_gemma":[0.0005151576,0.0015511214,0.00922818,0.013241386,0.000025240035,0.000106586165,0.016142085,0.00013753619,0.00008197418,0.0196404,0.938993,0.0003373503],"about_ca_topic_score_codex":0.0064168866,"about_ca_topic_score_gemma":0.013054205,"teacher_disagreement_score":0.8354344,"about_ca_system_score_codex":0.0018479471,"about_ca_system_score_gemma":0.014444807,"threshold_uncertainty_score":0.99962115},"labels":[],"label_agreement":null},{"id":"W4399677219","doi":"10.51731/cjht.2024.917","title":"Trifluridine-Tipiracil (Lonsurf)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pharmacological Effects and Toxicity Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chemistry","score_opus":0.0462622084322977,"score_gpt":0.35016247322176103,"score_spread":0.3039002647894633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399677219","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23872949,0.4948916,0.00022662125,0.2626164,0.0013290346,0.00037222088,0.000025172716,0.00040644692,0.0014030029],"genre_scores_gemma":[0.9959151,0.0021264805,0.00025794416,0.001446974,0.00003930923,0.000004513286,7.6714656e-7,0.000011203976,0.00019770314],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99884343,0.000038327922,0.00042670948,0.00012740931,0.0001441343,0.0004199601],"domain_scores_gemma":[0.99938905,0.0001345594,0.000104327264,0.00011549427,0.00011046045,0.0001461117],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006890081,0.00012324554,0.00044671076,0.0006117362,0.0001765909,0.000037396552,0.00014836593,0.000120841345,0.00008060792],"category_scores_gemma":[0.0008449147,0.000081236096,0.00013145822,0.0004493288,0.00023114707,0.00007885809,0.000017158865,0.00067103293,0.000039597104],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000307611,0.000029479213,0.0014255957,0.0005893843,0.00020727396,0.003025173,0.00020999527,0.000004885469,0.0005649642,0.0020396498,0.08356394,0.9083089],"study_design_scores_gemma":[0.00049847335,0.0014025474,0.0048955865,0.0007433959,0.00006153815,0.0013150949,0.000716735,0.00005483848,0.0019612736,0.0025661401,0.9856643,0.00012009109],"about_ca_topic_score_codex":0.00055837474,"about_ca_topic_score_gemma":0.00031839823,"teacher_disagreement_score":0.9081888,"about_ca_system_score_codex":0.00035870454,"about_ca_system_score_gemma":0.0023511534,"threshold_uncertainty_score":0.41708452},"labels":[],"label_agreement":null},{"id":"W4399677806","doi":"10.51731/cjht.2024.919","title":"Ravulizumab (Ultomiris)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Protein Tyrosine Phosphatases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Neuromyelitis optica; Medicine; Family medicine; Political science; Antibody; Immunology; Health care","score_opus":0.01225614560277016,"score_gpt":0.27120583394361875,"score_spread":0.2589496883408486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399677806","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.029694231,0.94854116,0.0019602727,0.018668696,0.0006979921,0.000156026,0.00006803757,0.00007281356,0.00014077684],"genre_scores_gemma":[0.9969642,0.0016094847,0.0009867199,0.00029230092,0.000034499804,0.000004831798,0.000011876909,0.00001688714,0.00007919565],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991048,0.000029264453,0.00031825688,0.00014366701,0.000077100674,0.00032691483],"domain_scores_gemma":[0.99950427,0.000010186149,0.000109512686,0.00022771231,0.000076613884,0.00007171548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036041555,0.00010355394,0.0001608563,0.000263376,0.00010106467,0.0000563485,0.00035256462,0.0001349276,0.000014158543],"category_scores_gemma":[0.0004108809,0.00008903907,0.00007253223,0.00018413387,0.00015526837,0.0000074305967,0.000030115416,0.00022755555,0.000013495309],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001554412,0.0000062434074,0.00032783084,0.00013463458,0.00006653189,0.00023504792,0.00004429542,0.000014772387,0.0025190336,0.007026991,0.106365554,0.8832435],"study_design_scores_gemma":[0.00013142091,0.0003844987,0.00029084377,0.00015063869,0.000005551765,0.00043160297,0.00022789768,0.0000055346795,0.09684318,0.002150722,0.8992718,0.0001062886],"about_ca_topic_score_codex":0.0008339633,"about_ca_topic_score_gemma":0.0010292536,"teacher_disagreement_score":0.96726996,"about_ca_system_score_codex":0.000099503355,"about_ca_system_score_gemma":0.0026786658,"threshold_uncertainty_score":0.47518384},"labels":[],"label_agreement":null},{"id":"W4400088938","doi":"10.51731/cjht.2024.926","title":"Cannabidiol (Epidiolex)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cannabidiol; Medicine; Psychiatry; Cannabis","score_opus":0.029463786262326673,"score_gpt":0.335494869673096,"score_spread":0.30603108341076934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400088938","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.069222935,0.4091412,0.0002081073,0.51851743,0.00097167375,0.00032962105,0.000024339875,0.00022400093,0.0013606959],"genre_scores_gemma":[0.99473923,0.0012165754,0.00014779925,0.00070310384,0.00005659587,0.000008825323,0.0000020161738,0.000024485631,0.0031013528],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984769,0.000036424182,0.00049674266,0.00015319997,0.00024650912,0.00059022],"domain_scores_gemma":[0.9991743,0.000010497214,0.00008991756,0.00024797657,0.00023851603,0.00023877458],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009249565,0.00011956301,0.00038592474,0.0011963372,0.00014728372,0.00007644315,0.00022709448,0.00014876151,0.000111510395],"category_scores_gemma":[0.0005060674,0.000089475696,0.00015603757,0.0006393761,0.00026268058,0.00008950053,0.000017298555,0.00082175364,0.00003059664],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000096932845,0.0000068853747,0.0008247038,0.00037124558,0.000045190067,0.0012806363,0.00015795576,0.000002244926,0.00010339308,0.0019714693,0.37812337,0.6171032],"study_design_scores_gemma":[0.00018798676,0.00060904655,0.004709665,0.0006252026,0.000013790414,0.0023678362,0.0013442063,0.00002432436,0.0006130227,0.0013535784,0.9880695,0.00008185172],"about_ca_topic_score_codex":0.004940296,"about_ca_topic_score_gemma":0.001953934,"teacher_disagreement_score":0.9255163,"about_ca_system_score_codex":0.00076686434,"about_ca_system_score_gemma":0.012695764,"threshold_uncertainty_score":0.9929013},"labels":[],"label_agreement":null},{"id":"W4400378609","doi":"10.51731/cjht.2024.927","title":"National and International Policies on the Use of Biosimilars: An Environmental Scan","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biosimilar; Environmental policy; Business; Medicine; Environmental planning; Environmental science; Internal medicine","score_opus":0.11366115682620082,"score_gpt":0.3321419509867425,"score_spread":0.21848079416054167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400378609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5062826,0.10746413,0.00018209098,0.38252762,0.0019462698,0.00028339436,0.0008843528,0.00008464431,0.0003448867],"genre_scores_gemma":[0.99710983,0.00080052693,0.00036861748,0.0015761388,0.000008722341,0.0000011586654,0.0000037981592,0.000005404636,0.00012581647],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992736,0.00010199738,0.0003007454,0.000096785785,0.000046210935,0.00018067198],"domain_scores_gemma":[0.9995128,0.00022514908,0.00011580166,0.000090683396,0.000034560064,0.00002102284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005395202,0.00008141987,0.00015347161,0.00037716818,0.00012361439,0.00003957123,0.00022914622,0.00013982302,0.00015917247],"category_scores_gemma":[0.00031928872,0.000049305505,0.00004723205,0.00010198529,0.0007099839,0.00010130013,0.000023139039,0.00034139518,0.0000037500872],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005379866,0.00008221168,0.0044660633,0.000051624975,0.00048046737,0.000027024815,0.00068520446,0.000014867709,0.009214126,0.06285041,0.08843045,0.83364373],"study_design_scores_gemma":[0.00017486083,0.0006731779,0.013679184,0.000220523,0.000018222723,0.00033698106,0.0018713465,0.000051530624,0.0077301688,0.0060755285,0.96905327,0.00011519821],"about_ca_topic_score_codex":0.00027864595,"about_ca_topic_score_gemma":0.00028886992,"teacher_disagreement_score":0.8806228,"about_ca_system_score_codex":0.00012673564,"about_ca_system_score_gemma":0.0004228557,"threshold_uncertainty_score":0.26159653},"labels":[],"label_agreement":null},{"id":"W4400498312","doi":"10.51731/cjht.2024.928","title":"Nirmatrelvir-Ritonavir (Paxlovid)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ritonavir; Medicine; Virology; Human immunodeficiency virus (HIV); Antiretroviral therapy; Viral load","score_opus":0.024730642294590738,"score_gpt":0.32302462594105297,"score_spread":0.2982939836464622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400498312","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.48451123,0.47899354,0.0003842725,0.034650985,0.00073544687,0.00019247022,0.00004973775,0.00008793481,0.00039439218],"genre_scores_gemma":[0.9964535,0.0025598973,0.00022676417,0.00042537253,0.000056982637,0.0000049397163,0.000007997038,0.000026538799,0.00023795707],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99876845,0.00007061722,0.00036204894,0.00017566515,0.0001445197,0.00047868615],"domain_scores_gemma":[0.99938524,0.00001663743,0.00008909209,0.00029351472,0.000102940176,0.000112549336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072381034,0.00012314373,0.0001838615,0.0004520334,0.00014470385,0.00006884184,0.00048860215,0.00018514163,0.0000299832],"category_scores_gemma":[0.0001816642,0.00010650185,0.00010208923,0.0002726528,0.00021357235,0.000007920933,0.00003324092,0.0004026842,0.000028334764],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008854325,0.000011129345,0.0004898215,0.00011844942,0.00010188228,0.00022736752,0.0000867018,0.000035891855,0.019774137,0.00032746128,0.052078277,0.92666036],"study_design_scores_gemma":[0.00020480597,0.0028277908,0.00021848304,0.0001476202,0.00000560574,0.00036102883,0.00056849996,0.00001735706,0.057415158,0.0014784588,0.9365946,0.00016059272],"about_ca_topic_score_codex":0.00061961164,"about_ca_topic_score_gemma":0.00552055,"teacher_disagreement_score":0.9264997,"about_ca_system_score_codex":0.00015603479,"about_ca_system_score_gemma":0.004279193,"threshold_uncertainty_score":0.75911045},"labels":[],"label_agreement":null},{"id":"W4400607151","doi":"10.51731/cjht.2024.929","title":"Trends in Public Drug Plan Expenditures for Patients With Crohn Disease and Ulcerative Colitis Initiating Targeted Immune Modulator Therapy","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ulcerative colitis; Medicine; Drug; Disease; Immune system; Crohn's disease; Pharmacotherapy; Immunology; Internal medicine; Pharmacology","score_opus":0.05527035259973597,"score_gpt":0.2868505913691179,"score_spread":0.2315802387693819,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400607151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90152013,0.06935947,0.00006398311,0.026966449,0.00030839856,0.00030073512,0.0012517938,0.000035977453,0.00019309437],"genre_scores_gemma":[0.99822956,0.000969745,0.00014579848,0.00055017025,0.0000192948,0.000027728644,0.000024912675,0.0000187413,0.000014042864],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99877685,0.00001630052,0.00060318905,0.00018188529,0.000019241561,0.0004025319],"domain_scores_gemma":[0.99936444,0.0000711366,0.00027357804,0.00010375631,0.000028042417,0.00015905616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039508432,0.00012431247,0.00035650266,0.0012363724,0.00015108654,0.0001697805,0.00017110766,0.00006200281,0.000039379556],"category_scores_gemma":[0.000116923606,0.00011416279,0.00005359289,0.0001979384,0.00011337976,0.00029479238,0.000012402983,0.00025720836,0.0000015481801],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025714526,0.00009380499,0.14844663,0.000239162,0.0002648471,0.00011175805,0.0026671991,0.00006748493,5.3720254e-7,0.27211425,0.0049207956,0.5708164],"study_design_scores_gemma":[0.0016155285,0.00028011546,0.8053315,0.00013907212,0.000003318063,0.000006093835,0.0005375301,0.0013224997,0.000011851782,0.061759252,0.12871839,0.00027483524],"about_ca_topic_score_codex":0.0012572934,"about_ca_topic_score_gemma":0.0021391516,"teacher_disagreement_score":0.65688485,"about_ca_system_score_codex":0.00030430435,"about_ca_system_score_gemma":0.0004389021,"threshold_uncertainty_score":0.46554235},"labels":[],"label_agreement":null},{"id":"W4400920309","doi":"10.51731/cjht.2024.935","title":"Inebilizumab (Uplizna)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.03787821221735176,"score_gpt":0.354476057902202,"score_spread":0.3165978456848502,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400920309","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2736054,0.4805561,0.00061131804,0.24104737,0.0006867751,0.0005830919,0.00002329337,0.00036276015,0.002523911],"genre_scores_gemma":[0.9976476,0.0011047267,0.0003687291,0.00040697653,0.000017853443,0.000004992802,0.000002167217,0.000021659165,0.00042530586],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986876,0.000034132616,0.000420966,0.00014335771,0.0002351344,0.00047880883],"domain_scores_gemma":[0.99925536,0.00006777246,0.00007416992,0.0002172705,0.00023411607,0.00015130304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005227919,0.0001101434,0.00034437448,0.0012718291,0.00013785064,0.00006446397,0.0002036178,0.00012610308,0.00012305628],"category_scores_gemma":[0.0009539752,0.00008532116,0.000102093094,0.00063225976,0.00027487724,0.000079348894,0.000016656586,0.00061844353,0.00004650201],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033650995,0.000018170487,0.0062454944,0.00054811704,0.00009579095,0.0038608816,0.00047442608,0.000004452804,0.00015901426,0.0033622643,0.028324591,0.9568731],"study_design_scores_gemma":[0.0007178157,0.002057081,0.0029166518,0.0014908295,0.000028589118,0.029526927,0.0065333745,0.0003241363,0.0010725562,0.00939836,0.94573635,0.00019732415],"about_ca_topic_score_codex":0.0017291554,"about_ca_topic_score_gemma":0.0023871653,"teacher_disagreement_score":0.9566758,"about_ca_system_score_codex":0.00092583493,"about_ca_system_score_gemma":0.010976066,"threshold_uncertainty_score":0.99463075},"labels":[],"label_agreement":null},{"id":"W4400921067","doi":"10.51731/cjht.2024.934","title":"Sotorasib (Lumakras)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Business","score_opus":0.01154900914302178,"score_gpt":0.26793361778506275,"score_spread":0.256384608642041,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400921067","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3415549,0.63934296,0.0006195989,0.016540302,0.0008809952,0.00015788298,0.00003200372,0.00006145417,0.00080986525],"genre_scores_gemma":[0.99815196,0.001176792,0.00027922832,0.0002148631,0.000017548316,0.0000029999892,0.000005942656,0.000011719215,0.00013896823],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993569,0.000017187816,0.0002132647,0.00011109788,0.0000532135,0.0002483041],"domain_scores_gemma":[0.9996842,0.000004685964,0.00006734779,0.00014396705,0.000045326193,0.00005446561],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016131846,0.00008258257,0.00012591097,0.00019407512,0.00009374383,0.00004032339,0.00017961877,0.00011620746,0.000010232449],"category_scores_gemma":[0.00007643171,0.000067266286,0.000067781526,0.000120147546,0.00008698126,0.000004343071,0.000013641957,0.0001330925,0.000009571178],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000064670667,0.000020427291,0.006633991,0.00008176428,0.0001579943,0.00020735398,0.00007098252,0.0000067555966,0.0004608119,0.0014658305,0.03829264,0.952595],"study_design_scores_gemma":[0.00026690649,0.0006542839,0.0013925685,0.00012280018,0.000015048299,0.00029821412,0.0007285122,0.0000042955576,0.006332954,0.0033100226,0.986751,0.00012340254],"about_ca_topic_score_codex":0.0007244308,"about_ca_topic_score_gemma":0.0021183325,"teacher_disagreement_score":0.95247155,"about_ca_system_score_codex":0.000048125174,"about_ca_system_score_gemma":0.0015946878,"threshold_uncertainty_score":0.28289077},"labels":[],"label_agreement":null},{"id":"W4400954704","doi":"10.51731/cjht.2024.936","title":"Cannabidiol (Epidiolex)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cannabidiol; Psychology; Medicine; Psychiatry; Cannabis","score_opus":0.029463786262326673,"score_gpt":0.335494869673096,"score_spread":0.30603108341076934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400954704","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.069222935,0.4091412,0.0002081073,0.51851743,0.00097167375,0.00032962105,0.000024339875,0.00022400093,0.0013606959],"genre_scores_gemma":[0.99473923,0.0012165754,0.00014779925,0.00070310384,0.00005659587,0.000008825323,0.0000020161738,0.000024485631,0.0031013528],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984769,0.000036424182,0.00049674266,0.00015319997,0.00024650912,0.00059022],"domain_scores_gemma":[0.9991743,0.000010497214,0.00008991756,0.00024797657,0.00023851603,0.00023877458],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009249565,0.00011956301,0.00038592474,0.0011963372,0.00014728372,0.00007644315,0.00022709448,0.00014876151,0.000111510395],"category_scores_gemma":[0.0005060674,0.000089475696,0.00015603757,0.0006393761,0.00026268058,0.00008950053,0.000017298555,0.00082175364,0.00003059664],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000096932845,0.0000068853747,0.0008247038,0.00037124558,0.000045190067,0.0012806363,0.00015795576,0.000002244926,0.00010339308,0.0019714693,0.37812337,0.6171032],"study_design_scores_gemma":[0.00018798676,0.00060904655,0.004709665,0.0006252026,0.000013790414,0.0023678362,0.0013442063,0.00002432436,0.0006130227,0.0013535784,0.9880695,0.00008185172],"about_ca_topic_score_codex":0.004940296,"about_ca_topic_score_gemma":0.001953934,"teacher_disagreement_score":0.9255163,"about_ca_system_score_codex":0.00076686434,"about_ca_system_score_gemma":0.012695764,"threshold_uncertainty_score":0.9929013},"labels":[],"label_agreement":null},{"id":"W4400983956","doi":"10.51731/cjht.2024.938","title":"Dostarlimab (Jemperli)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Medical History and Research","field":"Arts and Humanities","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.06930665629754058,"score_gpt":0.2910968766942391,"score_spread":0.22179022039669855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400983956","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.027211867,0.7147801,0.00012223628,0.20980309,0.0076735583,0.00025316086,0.00006163358,0.00043953065,0.039654814],"genre_scores_gemma":[0.99567366,0.000544016,0.00003445276,0.00036307878,0.00009201212,0.0000020316968,0.000001041349,0.0000101357555,0.0032796029],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999005,0.000045312045,0.00033158998,0.000085332475,0.00016811778,0.00036461197],"domain_scores_gemma":[0.9995612,0.00006485553,0.00006191276,0.00011125764,0.000092017995,0.00010876997],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008138272,0.00007244694,0.00017983212,0.00066143344,0.00044146457,0.00013064954,0.00030614474,0.000063973,0.0016037608],"category_scores_gemma":[0.00021335737,0.000049654565,0.000068234054,0.000082966886,0.00083345815,0.0001382444,0.000010689399,0.00061629177,0.000094037394],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000027740489,0.0000059972813,0.000017977181,0.00021466873,0.000024767245,0.00048178708,0.010124687,5.0891254e-7,0.0000031659022,0.25493264,0.13083547,0.6033555],"study_design_scores_gemma":[0.000049951737,0.00018191528,0.000013030724,0.00024067261,0.0000029069347,0.00006551235,0.00925311,0.0000074655904,0.000014983621,0.007776568,0.9823414,0.000052496915],"about_ca_topic_score_codex":0.0037794623,"about_ca_topic_score_gemma":0.012801942,"teacher_disagreement_score":0.96846175,"about_ca_system_score_codex":0.00026162047,"about_ca_system_score_gemma":0.0033213699,"threshold_uncertainty_score":0.9993089},"labels":[],"label_agreement":null},{"id":"W4401029234","doi":"10.51731/cjht.2024.939","title":"Drospirenone (Slynd)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Drospirenone; Medicine; Internal medicine","score_opus":0.03349572096903707,"score_gpt":0.35530262858401573,"score_spread":0.32180690761497865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401029234","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1900449,0.5595505,0.00012853272,0.24524611,0.0022071851,0.000287265,0.000020960633,0.0002949065,0.0022196488],"genre_scores_gemma":[0.9966234,0.0016815247,0.00028228277,0.0007729545,0.000040024293,0.0000037642794,0.0000020272003,0.000011894224,0.00058215],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992193,0.000014723537,0.00030058945,0.00008944387,0.000077491786,0.0002984674],"domain_scores_gemma":[0.9996258,0.00003172203,0.00007646329,0.00010308372,0.00005901813,0.00010390758],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024558156,0.00008219159,0.00027041335,0.00059564604,0.00008447341,0.000022115506,0.000097537966,0.00009203182,0.0001712234],"category_scores_gemma":[0.00006145298,0.000062886946,0.000079050136,0.00030604916,0.00013396484,0.000056513374,0.0000064892815,0.00037186232,0.000029124816],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000200262,0.000020516194,0.0038663037,0.00024038074,0.00013460248,0.0019815867,0.00026067806,0.0000013824531,0.00017522964,0.0015194146,0.08387459,0.9079053],"study_design_scores_gemma":[0.0004765189,0.0011668983,0.004397312,0.00041214866,0.000058551006,0.0019006784,0.00046521844,0.000012106848,0.00086413097,0.002543771,0.9876351,0.000067596084],"about_ca_topic_score_codex":0.0018431868,"about_ca_topic_score_gemma":0.0016374977,"teacher_disagreement_score":0.9078377,"about_ca_system_score_codex":0.00052704033,"about_ca_system_score_gemma":0.004145108,"threshold_uncertainty_score":0.7353244},"labels":[],"label_agreement":null},{"id":"W4401127229","doi":"10.51731/cjht.2024.941","title":"Directly Observed Therapy in Correctional Settings","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Possession (linguistics); Methadone; Buprenorphine; Health care; Pharmacotherapy; Psychiatry; Nova scotia; Intensive care medicine; Family medicine; Opioid","score_opus":0.06058462218499515,"score_gpt":0.3275037893453404,"score_spread":0.26691916716034525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401127229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7117286,0.18591312,0.000017049724,0.1013441,0.00053753046,0.00022324623,0.000009750405,0.00010583254,0.00012080958],"genre_scores_gemma":[0.9963973,0.002281776,0.0008919309,0.00029685762,0.000019161802,0.000009321925,0.0000029548078,0.000010941727,0.00008971126],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99903077,0.00003521065,0.00031320064,0.0001096371,0.00015872475,0.00035248345],"domain_scores_gemma":[0.999548,0.00008319974,0.000060007238,0.000109195775,0.00008164534,0.00011791692],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000510789,0.000084724226,0.00024317871,0.000906964,0.000076114295,0.000035908663,0.000104120845,0.00008058778,0.000050723414],"category_scores_gemma":[0.00033654016,0.000060669336,0.00007167994,0.0005014019,0.000093390176,0.00006763297,0.0000060158773,0.00053092424,0.00001182461],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018043099,0.000021104417,0.016688569,0.00006474026,0.00005674845,0.0015657652,0.0001477031,0.0000016238905,0.00003303791,0.0005525948,0.0060595623,0.9746281],"study_design_scores_gemma":[0.006033806,0.0063638124,0.5118937,0.0043032933,0.000026639666,0.0064766095,0.0060571837,0.0002816267,0.004671687,0.018667843,0.4348696,0.00035419376],"about_ca_topic_score_codex":0.0042245626,"about_ca_topic_score_gemma":0.009431379,"teacher_disagreement_score":0.9742739,"about_ca_system_score_codex":0.0007390722,"about_ca_system_score_gemma":0.0063805426,"threshold_uncertainty_score":0.9992524},"labels":[],"label_agreement":null},{"id":"W4401220050","doi":"10.51731/cjht.2024.945","title":"Drug Shortages: A Scoring System to Evaluate and Prioritize the Clinical Importance of Drugs in Canada","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Tolerability; Health care; Economic shortage; Psychological intervention; Population; Risk analysis (engineering); Intensive care medicine; Actuarial science; Business; Adverse effect; Environmental health; Nursing; Pharmacology","score_opus":0.0839966089288163,"score_gpt":0.3449682227445677,"score_spread":0.2609716138157514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401220050","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8445538,0.1081234,0.000016038266,0.045670927,0.00077567424,0.00020250962,0.00010364442,0.000013068421,0.0005408967],"genre_scores_gemma":[0.99734896,0.001667515,0.000106493666,0.00082748575,0.000021705264,0.00000555613,2.4896306e-7,0.000010810587,0.00001122172],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99796665,0.000029594468,0.0014327727,0.00017948869,0.000031997206,0.0003594832],"domain_scores_gemma":[0.99910694,0.00018225166,0.00034950583,0.00019506982,0.000027539074,0.00013870174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00293746,0.000095347954,0.0005093366,0.00042046426,0.00006802605,0.00004715458,0.00034774435,0.00005249554,0.000009568528],"category_scores_gemma":[0.00033395493,0.00008264357,0.00006816836,0.0003068736,0.000097975804,0.00008133321,0.000034791352,0.00044558177,0.0000042739357],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014211873,0.000008641906,0.590525,0.00082099583,0.00012941223,0.0001392113,0.0014575756,0.00018508598,8.5079796e-7,0.20675367,0.009846508,0.19011883],"study_design_scores_gemma":[0.0013630249,0.00036386188,0.31757256,0.0029334691,0.000034536337,0.0003397451,0.02576148,0.010788884,0.000053446347,0.05489549,0.58504134,0.0008521685],"about_ca_topic_score_codex":0.6570575,"about_ca_topic_score_gemma":0.86363685,"teacher_disagreement_score":0.57519484,"about_ca_system_score_codex":0.001177436,"about_ca_system_score_gemma":0.0042411974,"threshold_uncertainty_score":0.7523702},"labels":[],"label_agreement":null},{"id":"W4401220131","doi":"10.51731/cjht.2024.943","title":"Strategies to Reduce Alternate Level of Care","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Geriatric Care and Nursing Homes","field":"Health Professions","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Psychological intervention; Medicine; Health care; Population; Grey literature; Population ageing; Gerontology; Older people; Environmental health; MEDLINE; Nursing","score_opus":0.14059879157591404,"score_gpt":0.44171814601301823,"score_spread":0.3011193544371042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401220131","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.44700888,0.3969831,0.0019932669,0.13474233,0.012089614,0.0010668962,0.0004466124,0.00042569306,0.005243618],"genre_scores_gemma":[0.99802077,0.00054491835,0.0009301513,0.00015464863,0.000059082013,0.000008404132,0.0000027596586,0.000020466861,0.00025879656],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981573,0.00010945481,0.00082448666,0.00014896992,0.00016975851,0.00059001066],"domain_scores_gemma":[0.9987987,0.00013163449,0.00029358474,0.00024728986,0.0003900942,0.00013866788],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006225611,0.0001285954,0.0004312192,0.0011475454,0.00033704517,0.000029758288,0.00042090792,0.00019421455,0.000048543436],"category_scores_gemma":[0.000250442,0.000105876905,0.000092293325,0.00060978864,0.000108409855,0.0001426029,0.000030449904,0.0007584397,0.00003012054],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000040515413,0.000007030255,0.0010714524,0.0025549636,0.00007122294,0.00020274962,0.035518777,0.000044174136,0.00027021454,0.016144367,0.14158134,0.8024932],"study_design_scores_gemma":[0.00027954532,0.0008540207,0.005659257,0.0035981594,0.000027088887,0.00008007505,0.4333828,0.0000028298427,0.0007467867,0.008722898,0.54645544,0.00019112372],"about_ca_topic_score_codex":0.023784084,"about_ca_topic_score_gemma":0.021676509,"teacher_disagreement_score":0.80230206,"about_ca_system_score_codex":0.0006919736,"about_ca_system_score_gemma":0.011204641,"threshold_uncertainty_score":0.99617535},"labels":[],"label_agreement":null},{"id":"W4401596042","doi":"10.51731/cjht.2024.947","title":"Canadian Medical Imaging Inventory 2022–2023: Methods","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Radiation Dose and Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Descriptive statistics; Medical imaging; Unit (ring theory); Per capita; Jurisdiction; Ranking (information retrieval); Population; Medicine; Medical physics; Geography; Nuclear medicine; Computer science; Environmental health; Statistics; Psychology; Radiology; Political science; Artificial intelligence; Mathematics","score_opus":0.025474372200581873,"score_gpt":0.3759987163988628,"score_spread":0.35052434419828093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401596042","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007461416,0.45366865,0.0017503585,0.53057474,0.0025802602,0.0002119497,0.000014658463,0.00020999929,0.0035279412],"genre_scores_gemma":[0.98527265,0.0023144973,0.002297657,0.009334856,0.00013400595,0.000005766213,0.000005463154,0.000038451977,0.0005966306],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981121,0.000106215615,0.0006344176,0.00017686163,0.00031604903,0.00065435533],"domain_scores_gemma":[0.9985694,0.00007634789,0.00012779403,0.00023153477,0.00012548779,0.0008693843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023880817,0.00013806717,0.00037826935,0.0024040712,0.00021509841,0.00008755149,0.0003189449,0.0001693874,0.00072325807],"category_scores_gemma":[0.0020990064,0.00011916182,0.000119932796,0.00074862526,0.00019372246,0.00021175062,0.000015180335,0.0011904857,0.000047911482],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000014654847,0.0000026594303,0.0041119666,0.00010782304,0.00004518317,0.001959795,0.00018873213,0.000001065198,0.000020943296,0.00089860614,0.07805133,0.91461045],"study_design_scores_gemma":[0.0002012942,0.00006755768,0.0019614764,0.00086837984,0.000024878029,0.0032049639,0.0024931787,0.0014627158,0.00019577764,0.0015379259,0.98786753,0.00011430521],"about_ca_topic_score_codex":0.19279812,"about_ca_topic_score_gemma":0.17075458,"teacher_disagreement_score":0.9778113,"about_ca_system_score_codex":0.0017410703,"about_ca_system_score_gemma":0.037045155,"threshold_uncertainty_score":0.9684139},"labels":[],"label_agreement":null},{"id":"W4401596058","doi":"10.51731/cjht.2024.949","title":"Canadian Medical Imaging Inventory 2022–2023: PET-CT and PET-MRI","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Medical Imaging Techniques and Applications","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; PET-CT; Nuclear medicine; Population; Positron emission tomography; Medical physics; Environmental health","score_opus":0.019727449983219063,"score_gpt":0.3240361774305268,"score_spread":0.30430872744730775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401596058","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02884365,0.112776354,0.0005364417,0.85536134,0.00053057895,0.00033638158,0.00003245692,0.0003428954,0.0012398687],"genre_scores_gemma":[0.9883905,0.0041135047,0.001957945,0.0050998633,0.000057021996,0.000014789711,0.0000070730675,0.000027371061,0.00033193338],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982756,0.000035912868,0.0005443997,0.00021744902,0.00033631132,0.000590342],"domain_scores_gemma":[0.99832135,0.00005615041,0.000104640734,0.00026674697,0.00011057727,0.0011405153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011839217,0.0001473419,0.00035555888,0.00114096,0.00024037543,0.000068894115,0.00030612494,0.000037881102,0.0003870133],"category_scores_gemma":[0.00089478696,0.00012234917,0.0000756456,0.00046828174,0.0004522408,0.000094205214,0.000031479696,0.0012488187,0.000018512023],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000025066927,0.000012393543,0.005790383,0.00043370208,0.000052864933,0.027510459,0.00008187035,2.0198785e-7,0.000024122357,0.008151799,0.49230975,0.46562994],"study_design_scores_gemma":[0.00017544857,0.00008095776,0.00055982714,0.0013705912,0.000028290562,0.03678931,0.001052763,0.0015705517,0.000039553965,0.0035211646,0.9546864,0.00012515542],"about_ca_topic_score_codex":0.16392644,"about_ca_topic_score_gemma":0.13622278,"teacher_disagreement_score":0.95954686,"about_ca_system_score_codex":0.00080006645,"about_ca_system_score_gemma":0.01570066,"threshold_uncertainty_score":0.9898794},"labels":[],"label_agreement":null},{"id":"W4401596115","doi":"10.51731/cjht.2024.950","title":"Canadian Medical Imaging Inventory 2022–2023: CT","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Radiation Dose and Imaging","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Population; Computed tomography; Nuclear medicine; Environmental health; Geography; Demography; Radiology","score_opus":0.01575142923157614,"score_gpt":0.3011301623496166,"score_spread":0.28537873311804046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401596115","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04207418,0.3743483,0.00011794865,0.5770578,0.0022527967,0.00020990332,0.000020692698,0.00020909963,0.0037092774],"genre_scores_gemma":[0.9914428,0.0015708997,0.00007811486,0.0063414597,0.000091995156,0.0000032758267,0.000004765903,0.000024358305,0.0004423263],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982165,0.000042589236,0.00057422917,0.0001648208,0.0003586123,0.0006432549],"domain_scores_gemma":[0.9986971,0.000039525283,0.00011369385,0.00021287934,0.000102265236,0.00083452964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011338294,0.00013122793,0.0003285245,0.0021815344,0.00021230469,0.000086499276,0.00029900752,0.0000893641,0.00072610815],"category_scores_gemma":[0.0012101075,0.00011416363,0.0001073672,0.0006456072,0.00018119816,0.00021314966,0.000012794092,0.0010850828,0.0000812045],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000015206448,0.0000034600519,0.013029052,0.00012709308,0.00004606513,0.006520439,0.00015124195,0.0000014080813,0.000008500762,0.0008816325,0.15471256,0.824517],"study_design_scores_gemma":[0.00022550109,0.00006436522,0.003093483,0.0010371804,0.00001980637,0.0058021597,0.0021486718,0.00086582097,0.00008970794,0.00085887575,0.9856829,0.00011150179],"about_ca_topic_score_codex":0.24870746,"about_ca_topic_score_gemma":0.28535214,"teacher_disagreement_score":0.9493686,"about_ca_system_score_codex":0.0017582001,"about_ca_system_score_gemma":0.037606932,"threshold_uncertainty_score":0.96784896},"labels":[],"label_agreement":null},{"id":"W4401596249","doi":"10.51731/cjht.2024.948","title":"Canadian Medical Imaging Inventory 2022–2023: Provincial and Territorial Overview","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Radiology practices and education","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Government of Alberta","keywords":"Staffing; Population; Economic shortage; Workforce; Medical imaging; Medicine; Nuclear medicine; Business; Radiology; Economic growth; Economics; Environmental health; Government (linguistics)","score_opus":0.026829073111530433,"score_gpt":0.3377059065997919,"score_spread":0.31087683348826145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401596249","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.117828645,0.42041823,0.000013822516,0.45379552,0.0072316574,0.00021675834,0.000015406395,0.0000673768,0.0004125796],"genre_scores_gemma":[0.9908649,0.0056580934,0.000112756024,0.0025363094,0.0006467803,0.000005385179,0.0000052961323,0.000016412008,0.00015407286],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99874914,0.00006219932,0.0004128147,0.0001499378,0.00019673686,0.00042920207],"domain_scores_gemma":[0.9990319,0.000054897693,0.00012511495,0.00013171916,0.00008807695,0.0005683094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012353017,0.000102638565,0.0002835303,0.000873328,0.00019771098,0.000060561095,0.00015426819,0.00021792062,0.00017144774],"category_scores_gemma":[0.0014958902,0.00008585769,0.000049800274,0.00024257347,0.0002030656,0.00019405519,0.000011979058,0.00091443956,0.000010020225],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010688448,0.000006825536,0.019676983,0.0003548835,0.000051205076,0.0015184466,0.0004017373,1.4564264e-7,0.000007847803,0.0015762242,0.10160591,0.8747891],"study_design_scores_gemma":[0.00021080422,0.00016369384,0.0073126573,0.00073718565,0.000033773616,0.0043985113,0.0020329838,0.00011035663,0.0000057314364,0.0010850274,0.98382753,0.00008174654],"about_ca_topic_score_codex":0.40485132,"about_ca_topic_score_gemma":0.55289567,"teacher_disagreement_score":0.88222164,"about_ca_system_score_codex":0.0011701176,"about_ca_system_score_gemma":0.035732545,"threshold_uncertainty_score":0.96973395},"labels":[],"label_agreement":null},{"id":"W4401596293","doi":"10.51731/cjht.2024.951","title":"Canadian Medical Imaging Inventory 2022–2023: MRI","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Radiation Dose and Imaging","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Institute for Health Information","funders":"","keywords":"Medicine; Population; Magnetic resonance imaging; Nuclear medicine; Medical imaging; Demography; Radiology; Environmental health","score_opus":0.014169327658130735,"score_gpt":0.2982021297440637,"score_spread":0.28403280208593296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401596293","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017247938,0.3385089,0.00023485454,0.6382221,0.002108414,0.00019866502,0.000019030438,0.00019232994,0.0032677636],"genre_scores_gemma":[0.9898979,0.0021940665,0.00012898052,0.007121266,0.000109426044,0.0000036270721,0.0000052015666,0.000026217094,0.0005133171],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981893,0.000042212458,0.0005827327,0.00016888126,0.000365165,0.00065175607],"domain_scores_gemma":[0.9986578,0.000038764254,0.000115281815,0.00021786959,0.00011714197,0.0008531326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011458005,0.00013221966,0.0003293483,0.002213537,0.00021365657,0.00008791714,0.000305055,0.00015612529,0.0007273674],"category_scores_gemma":[0.0010193927,0.000115414936,0.0001060161,0.0006550345,0.00018599322,0.00021703755,0.000013298494,0.0011016025,0.00008335194],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000020855477,0.000003880739,0.012846017,0.00014146084,0.00005106065,0.0040808734,0.00023476683,0.0000023255852,0.000009822583,0.0010703184,0.2225743,0.7589831],"study_design_scores_gemma":[0.00022480625,0.00007011028,0.002766617,0.0010219389,0.000019605988,0.0032067427,0.002277107,0.0011459804,0.00007411963,0.0009187716,0.9881628,0.000111372705],"about_ca_topic_score_codex":0.20844725,"about_ca_topic_score_gemma":0.28513482,"teacher_disagreement_score":0.97264993,"about_ca_system_score_codex":0.0017476212,"about_ca_system_score_gemma":0.03751214,"threshold_uncertainty_score":0.96794426},"labels":[],"label_agreement":null},{"id":"W4401596315","doi":"10.51731/cjht.2024.953","title":"Canadian Medical Imaging Inventory 2022–2023: The Medical Imaging Team","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Radiation Dose and Imaging","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Staffing; Workforce; Medical imaging; Economic shortage; Business; Service delivery framework; Service (business); Medicine; Nursing; Radiology; Marketing; Political science; Government (linguistics)","score_opus":0.012535751706954389,"score_gpt":0.29933768290074503,"score_spread":0.28680193119379066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401596315","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008387952,0.26246428,0.00020170938,0.7233704,0.0020426034,0.000209843,0.000012035797,0.00016637443,0.0031448107],"genre_scores_gemma":[0.9772981,0.0024687855,0.000044382155,0.019591305,0.00024414776,0.000007704374,0.000005462046,0.00003650759,0.00030361913],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969695,0.00010988771,0.00083733734,0.00023747687,0.0009252365,0.00092052785],"domain_scores_gemma":[0.99794316,0.00013414447,0.00017018705,0.0003508221,0.00015514654,0.0012465413],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0030687288,0.00019458057,0.00040823282,0.0017167162,0.0004745163,0.00015339062,0.00071976916,0.00018471474,0.0011904847],"category_scores_gemma":[0.0037950187,0.00013604522,0.00015503369,0.000822183,0.0005218045,0.00026023612,0.000038418744,0.002190809,0.00007592111],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000002102468,0.0000048123966,0.012979549,0.00008642147,0.000047922662,0.0040512537,0.00029501802,0.000001021984,0.0000038201542,0.0007538429,0.23809692,0.7436773],"study_design_scores_gemma":[0.00032236337,0.000038642982,0.0030489303,0.0015199981,0.00003212443,0.009629356,0.0060297297,0.0059345816,0.000033523298,0.0009795142,0.9722852,0.00014605453],"about_ca_topic_score_codex":0.20253858,"about_ca_topic_score_gemma":0.25132012,"teacher_disagreement_score":0.96891016,"about_ca_system_score_codex":0.0017811123,"about_ca_system_score_gemma":0.050853502,"threshold_uncertainty_score":0.99972254},"labels":[],"label_agreement":null},{"id":"W4401596345","doi":"10.51731/cjht.2024.952","title":"Canadian Medical Imaging Inventory 2022–2023: SPECT and SPECT-CT","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Medical Imaging Techniques and Applications","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Nuclear medicine; Spect imaging; Medicine; Single-photon emission computed tomography; Medical imaging; Radiology; Medical physics","score_opus":0.020609166738610966,"score_gpt":0.3232990369580813,"score_spread":0.30268987021947036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401596345","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.042971216,0.1623149,0.00040803314,0.790557,0.00058146036,0.00035359096,0.00002912275,0.00036045266,0.0024241644],"genre_scores_gemma":[0.9915648,0.0032772315,0.00080999633,0.0039536986,0.000076675926,0.000009518744,0.0000045942857,0.000024342839,0.00027912986],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99836326,0.00003155411,0.0005139926,0.00021037429,0.0003183916,0.0005624204],"domain_scores_gemma":[0.9984953,0.000050254414,0.000095946976,0.00025554394,0.000065032276,0.001037948],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011093196,0.00014077984,0.00035168882,0.0011609668,0.00020570817,0.00006753517,0.00028079917,0.000062298306,0.0004959068],"category_scores_gemma":[0.0009341027,0.00011635813,0.000075298485,0.000506667,0.00042721428,0.00008306778,0.000027545933,0.0012136375,0.000022141221],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000017159763,0.000008323664,0.005650189,0.00023998534,0.000037916274,0.008616766,0.00006915049,6.9738455e-8,0.000029153285,0.0077884644,0.31114504,0.66641325],"study_design_scores_gemma":[0.00016956181,0.000093950875,0.0010339132,0.0013077636,0.000026912925,0.013480217,0.0008740023,0.0005859934,0.00019320575,0.00536788,0.9767427,0.00012391168],"about_ca_topic_score_codex":0.18781099,"about_ca_topic_score_gemma":0.1640599,"teacher_disagreement_score":0.9485936,"about_ca_system_score_codex":0.0009371045,"about_ca_system_score_gemma":0.014307064,"threshold_uncertainty_score":0.9912809},"labels":[],"label_agreement":null},{"id":"W4401643305","doi":"10.51731/cjht.2024.954","title":"Cannabidiol (Epidiolex)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Dravet syndrome; Cannabidiol; Tuberous sclerosis; Medicine; Psychiatry; Lennox–Gastaut syndrome; Epilepsy; Family medicine; Pediatrics; Cannabis; Political science","score_opus":0.03851485464450901,"score_gpt":0.3462713254877497,"score_spread":0.3077564708432407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401643305","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14295211,0.5802077,0.00020972975,0.2736017,0.0006513425,0.00039347017,0.000029105742,0.00026125106,0.0016935413],"genre_scores_gemma":[0.99685603,0.0020181022,0.0003827585,0.00030768977,0.000025492933,0.0000059800564,0.0000022455667,0.000012928749,0.00038878212],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989186,0.000028521485,0.00033393307,0.00010628526,0.00015530949,0.0004573723],"domain_scores_gemma":[0.9993967,0.00003514046,0.000061453764,0.00017902377,0.00011300359,0.00021470974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049171265,0.00008938418,0.00029016566,0.00077192625,0.00010515846,0.000037341742,0.00012965559,0.000088971094,0.000056940447],"category_scores_gemma":[0.0003776683,0.00006205118,0.0000977549,0.00034733146,0.00015107103,0.0000645709,0.000008986614,0.0004950105,0.000045389403],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014300965,0.000014322703,0.013558092,0.0003198998,0.00013554147,0.0043625687,0.00015055714,0.0000013228062,0.00003064248,0.0022330792,0.052541897,0.92663777],"study_design_scores_gemma":[0.00046555744,0.0020007414,0.020098587,0.0013733369,0.000031204305,0.0032747155,0.0015171668,0.000021458573,0.00094458845,0.0046379734,0.9655347,0.00009995551],"about_ca_topic_score_codex":0.004206948,"about_ca_topic_score_gemma":0.0025846036,"teacher_disagreement_score":0.9265378,"about_ca_system_score_codex":0.00067912915,"about_ca_system_score_gemma":0.007784225,"threshold_uncertainty_score":0.9978407},"labels":[],"label_agreement":null},{"id":"W4401836024","doi":"10.51731/cjht.2024.957","title":"Aging in Place","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Health disparities and outcomes","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Aging in place; Gerontology; Medicine","score_opus":0.037708329081717604,"score_gpt":0.3634149897123307,"score_spread":0.3257066606306131,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401836024","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08216833,0.26240057,0.00008096882,0.64999163,0.0020458875,0.00016962714,0.000006669655,0.00017110113,0.0029652435],"genre_scores_gemma":[0.99539435,0.0028114847,0.00016692674,0.0013594697,0.000028347346,0.0000018591991,1.56161e-7,0.0000060293432,0.00023138116],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998721,0.00009341782,0.00037774583,0.00007675423,0.00013186035,0.00059921754],"domain_scores_gemma":[0.9995332,0.00016327399,0.000078314755,0.00007231846,0.00003844011,0.00011449972],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020609125,0.000055742214,0.00018573264,0.00069919054,0.0003215737,0.00010120782,0.00027985912,0.00010323011,0.000043333548],"category_scores_gemma":[0.00080553256,0.00004999857,0.000039593855,0.000529509,0.0001894399,0.00018587883,0.000008012251,0.0004298903,0.000009448562],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000014120536,0.0000038923645,0.029445862,0.0003464752,0.000007930416,0.00045913132,0.010206289,0.00001910059,1.8221938e-7,0.20024483,0.019441409,0.73982346],"study_design_scores_gemma":[0.000048324157,0.0000203687,0.0065288604,0.0005642816,9.616849e-7,0.000013859395,0.026168844,0.000008378234,0.0000023044088,0.006887083,0.95970434,0.000052383384],"about_ca_topic_score_codex":0.15487145,"about_ca_topic_score_gemma":0.38738078,"teacher_disagreement_score":0.9402629,"about_ca_system_score_codex":0.0009581476,"about_ca_system_score_gemma":0.009768521,"threshold_uncertainty_score":0.9958452},"labels":[],"label_agreement":null},{"id":"W4401999141","doi":"10.51731/cjht.2024.960","title":"Infliximab (Remsima SC)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Infliximab; Reimbursement; Medicine; Maintenance therapy; Disease; Crohn's disease; Intensive care medicine; Drug; Family medicine; Surgery; Internal medicine; Pharmacology; Health care; Political science; Chemotherapy","score_opus":0.010920370304103644,"score_gpt":0.25982153471275776,"score_spread":0.24890116440865412,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401999141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.75774705,0.22091511,0.00064478326,0.018126773,0.0012685888,0.00022329121,0.000055520784,0.00012722639,0.00089166267],"genre_scores_gemma":[0.99872214,0.00042777098,0.00028841593,0.0003810412,0.0000422793,0.0000036345348,0.000005396179,0.00001809381,0.00011121594],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99906236,0.00003568022,0.0003360148,0.00013631996,0.00008570489,0.00034394124],"domain_scores_gemma":[0.999457,0.000006876825,0.000104657,0.00023013422,0.00009845608,0.00010287979],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039399462,0.00010619164,0.00013420598,0.00032491566,0.00010897927,0.000054550637,0.00031046147,0.00015130482,0.000017322678],"category_scores_gemma":[0.00029564957,0.000094870695,0.00008779272,0.00015005395,0.00024154813,0.000008254754,0.000026027017,0.00023071507,0.000019631492],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007238364,0.00002399208,0.010431943,0.00053911126,0.00023157432,0.0044186,0.0002679536,0.00013884017,0.0040070186,0.009524651,0.1235545,0.8467894],"study_design_scores_gemma":[0.00026272296,0.00026950194,0.011424923,0.00022466405,0.000012378408,0.00042817908,0.0008462652,0.000030027582,0.0033105507,0.0022611164,0.98072594,0.00020375366],"about_ca_topic_score_codex":0.00028745303,"about_ca_topic_score_gemma":0.0019241857,"teacher_disagreement_score":0.8571714,"about_ca_system_score_codex":0.00011767257,"about_ca_system_score_gemma":0.0037998382,"threshold_uncertainty_score":0.67407495},"labels":[],"label_agreement":null},{"id":"W4402052589","doi":"10.51731/cjht.2024.961","title":"An Inventory of Rare Disease Registries in the Canadian Landscape","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Environmental DNA in Biodiversity Studies","field":"Environmental Science","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Geography","score_opus":0.021789243557623225,"score_gpt":0.24050434204874171,"score_spread":0.21871509849111848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402052589","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91421634,0.04378948,0.0000044929056,0.040567055,0.00024844307,0.0002249512,0.00012107809,0.000031176023,0.0007970087],"genre_scores_gemma":[0.9991545,0.00036321394,0.000118235424,0.00032605015,0.0000043366767,0.000002491922,0.0000032645223,0.0000048968627,0.000023026854],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99899745,0.00007192408,0.00027141202,0.00012779752,0.00020097877,0.00033046506],"domain_scores_gemma":[0.99948084,0.000029980778,0.00010320271,0.00023383767,0.0000057303014,0.00014641078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060437847,0.00009320651,0.00015377128,0.00031689455,0.00027654204,0.0000410532,0.0006387141,0.00006530146,0.00010557398],"category_scores_gemma":[0.00012323767,0.00006879451,0.000044084416,0.00035654166,0.00076606835,0.00019862171,0.000031372812,0.0003006506,0.000019978137],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000003467614,0.00001004271,0.9527855,0.00004628756,0.000008743809,0.00041970427,0.0017184248,0.000102299826,0.0000044427866,0.0002858553,0.023133742,0.021481488],"study_design_scores_gemma":[0.00009079669,0.00016645342,0.8300852,0.0001420983,0.0000102386875,0.000035383324,0.012734997,0.000026677128,0.000024900464,0.0018703793,0.15470402,0.00010882363],"about_ca_topic_score_codex":0.31765437,"about_ca_topic_score_gemma":0.80794805,"teacher_disagreement_score":0.49029365,"about_ca_system_score_codex":0.00091733533,"about_ca_system_score_gemma":0.0005035214,"threshold_uncertainty_score":0.6868894},"labels":[],"label_agreement":null},{"id":"W4402332430","doi":"10.51731/cjht.2024.968","title":"Methoxyflurane Inhalation as an Analgesic for Minor Gynecological, Ambulatory, or Emergency Procedures","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Airway Management and Intubation Techniques","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Methoxyflurane; Analgesic; Ambulatory; Medicine; Inhalation; Anesthesia; Minor (academic); Surgery; Halothane; Art","score_opus":0.06002260778740687,"score_gpt":0.3905191772450101,"score_spread":0.33049656945760325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402332430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7539892,0.0899088,0.016603878,0.12885742,0.0016983139,0.0036569764,0.00004081729,0.0019443672,0.0033002116],"genre_scores_gemma":[0.9901701,0.003377675,0.0041781305,0.00023701876,0.00004755752,0.00005257946,0.0000139942,0.000023323344,0.0018995825],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99859905,0.000039075312,0.000672888,0.00019440617,0.0001526783,0.00034189378],"domain_scores_gemma":[0.99912786,0.000051744006,0.00025009064,0.00018454234,0.00026142484,0.00012433447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008454649,0.00014523731,0.0003561416,0.0011017997,0.00019678276,0.00004545662,0.0002072078,0.00019166281,0.00075328414],"category_scores_gemma":[0.0016711822,0.00010137224,0.00010745543,0.00049921894,0.00010168601,0.00027204427,0.000011246737,0.0002848012,0.0000070359492],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008524993,0.000039099545,0.0009901379,0.0011888974,0.00009746964,0.000046640464,0.00035606156,0.0000032735936,0.00011300825,0.008998696,0.120525345,0.8675561],"study_design_scores_gemma":[0.0006171132,0.019147808,0.009237529,0.0008668511,0.00016788658,0.00016627928,0.005422556,0.00056485337,0.003088105,0.049679235,0.9107019,0.00033989438],"about_ca_topic_score_codex":0.00035283674,"about_ca_topic_score_gemma":0.0016669502,"teacher_disagreement_score":0.8672162,"about_ca_system_score_codex":0.00030818005,"about_ca_system_score_gemma":0.0023808705,"threshold_uncertainty_score":0.8247933},"labels":[],"label_agreement":null},{"id":"W4402393947","doi":"10.51731/cjht.2024.969","title":"The Paige Prostate Suite: Assistive Artificial Intelligence for Prostate Cancer Diagnosis","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Suite; Prostate cancer; Prostate; Medicine; Artificial intelligence; Cancer; Computer science; Internal medicine; Archaeology; Geography","score_opus":0.16458749205818846,"score_gpt":0.4392394186078883,"score_spread":0.27465192654969983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402393947","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10251935,0.28277814,0.0025659832,0.60457087,0.0048659705,0.0022727363,0.00017929684,0.00020752272,0.000040165334],"genre_scores_gemma":[0.9865689,0.01165775,0.0003558528,0.0005598824,0.0001341115,0.00052949454,0.0000059184113,0.000025134748,0.00016292554],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99792266,0.000052546082,0.000980535,0.00020538286,0.00017573038,0.0006631484],"domain_scores_gemma":[0.99805546,0.0006855415,0.00028615707,0.00020799451,0.0006025054,0.00016231435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015403663,0.00014709297,0.0003004239,0.00043464845,0.00071626506,0.00017050204,0.00022407415,0.00014101903,0.000024634699],"category_scores_gemma":[0.0020581142,0.000097113036,0.00011937648,0.0005866111,0.00038524074,0.00013272393,0.000011470953,0.0005810954,0.0000122834235],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058001468,0.000012970744,0.0054934844,0.0003086108,0.000040313764,0.000034448967,0.0016784166,0.00001164521,0.000006322968,0.0032114633,0.009982159,0.97916216],"study_design_scores_gemma":[0.000034158744,0.0019686415,0.0030765072,0.0025164797,0.00008612527,0.00017008586,0.039297022,0.0006719848,0.013437176,0.09119823,0.84728116,0.00026242936],"about_ca_topic_score_codex":0.010581683,"about_ca_topic_score_gemma":0.02294244,"teacher_disagreement_score":0.9788997,"about_ca_system_score_codex":0.0009084889,"about_ca_system_score_gemma":0.0090694465,"threshold_uncertainty_score":0.99654824},"labels":[],"label_agreement":null},{"id":"W4402413658","doi":"10.51731/cjht.2024.970","title":"Drug Shortages and Patient Harms","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Drug; Economic shortage; Medicine; Intensive care medicine; Business; Pharmacology; Government (linguistics)","score_opus":0.05190415301851258,"score_gpt":0.2854990001977715,"score_spread":0.23359484717925894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402413658","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22198825,0.6111461,0.00011664971,0.16235949,0.0011306145,0.00012278091,0.00019260707,0.000071420814,0.0028721022],"genre_scores_gemma":[0.993201,0.004897763,0.00015474779,0.001669707,0.000014182055,0.0000024033948,6.196973e-7,0.000011598118,0.000047987258],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99893594,0.000006891517,0.0005970598,0.00013694185,0.000012861902,0.0003103061],"domain_scores_gemma":[0.9995478,0.000036357433,0.00017775362,0.000107835294,0.00001457558,0.00011571339],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043347047,0.000085917556,0.0002819603,0.0006366892,0.00010213222,0.00012395524,0.0001713684,0.0000634122,0.00007116549],"category_scores_gemma":[0.00011035286,0.00008461013,0.000055780085,0.00014747759,0.00012748322,0.00015289435,0.000020174222,0.0003119702,0.000048648315],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000001950151,0.0000069406556,0.005028225,0.00012099062,0.0000569264,0.00007778012,0.0009990684,0.000012951375,0.0000018189758,0.34735465,0.039361537,0.60697716],"study_design_scores_gemma":[0.00006169984,0.00005984894,0.0010658822,0.000053984804,0.0000015971264,0.000060878447,0.0004100454,0.00020803037,0.00004233465,0.1008058,0.8971401,0.00008983179],"about_ca_topic_score_codex":0.0019581344,"about_ca_topic_score_gemma":0.0007351631,"teacher_disagreement_score":0.85777855,"about_ca_system_score_codex":0.00020144379,"about_ca_system_score_gemma":0.0003570776,"threshold_uncertainty_score":0.34503013},"labels":[],"label_agreement":null},{"id":"W4402488118","doi":"10.51731/cjht.2024.972","title":"Teclistamab (Tecvayli)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Vial; Medicine; Refractory (planetary science); Drug; Multiple myeloma; Subcutaneous injection; Monoclonal antibody; Internal medicine; Pharmacology; Family medicine; Oncology; Antibody; Health care; Immunology; Chemistry; Political science","score_opus":0.045761241313877425,"score_gpt":0.3538396592666456,"score_spread":0.3080784179527682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402488118","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21838942,0.5776585,0.0005601576,0.19811782,0.00092383823,0.00066242414,0.00006503029,0.0005114429,0.0031114141],"genre_scores_gemma":[0.9976639,0.000941583,0.0008215489,0.00019357607,0.000017614142,0.0000048941138,0.0000033220497,0.000014866515,0.00033868145],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988535,0.000024439803,0.00035384597,0.00011434116,0.00018939507,0.0004644832],"domain_scores_gemma":[0.99937546,0.000050427083,0.0000707576,0.00019226214,0.00011366352,0.00019742125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040560486,0.00009672453,0.00028644106,0.0009803622,0.00012494976,0.00005502339,0.00015190608,0.00009974893,0.000083418505],"category_scores_gemma":[0.0005235945,0.0000684026,0.000095519856,0.00039864896,0.00016436393,0.00008354256,0.000011724358,0.0005112158,0.000057047506],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020283143,0.000014657395,0.0047671627,0.0002758866,0.000106009415,0.0039534476,0.00008564744,5.056058e-7,0.000044227258,0.0012878397,0.0114310235,0.97801334],"study_design_scores_gemma":[0.0010525666,0.001339245,0.020937735,0.0013292922,0.000032650016,0.0035780491,0.0014703983,0.000075646094,0.0010871929,0.0038889225,0.9650908,0.00011748838],"about_ca_topic_score_codex":0.0026675793,"about_ca_topic_score_gemma":0.0012641195,"teacher_disagreement_score":0.9778958,"about_ca_system_score_codex":0.0006161206,"about_ca_system_score_gemma":0.0052055735,"threshold_uncertainty_score":0.92344636},"labels":[],"label_agreement":null},{"id":"W4402533840","doi":"10.51731/cjht.2024.975","title":"Measuring and Valuing Health for Children: A Review of the Evidence","year":2024,"lang":"en","type":"review","venue":"Canadian Journal of Health Technologies","topic":"Global Health Care Issues","field":"Health Professions","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Psychology","score_opus":0.3532562923029029,"score_gpt":0.5248495744493564,"score_spread":0.17159328214645353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402533840","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000053072363,0.949425,0.000017689685,0.042517357,0.0020172151,0.0056373347,0.0002743272,0.000085643245,0.000020136838],"genre_scores_gemma":[0.0001622932,0.99661523,0.00049609056,0.002359565,0.00008423499,0.0001592294,0.0000049454125,0.00007237864,0.000046002668],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99222976,0.0014658754,0.0041347174,0.00041300786,0.0004425355,0.0013141241],"domain_scores_gemma":[0.9919329,0.0010931855,0.0052096345,0.00080438383,0.0006629348,0.0002969563],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.009969995,0.00047593316,0.003841554,0.0008662629,0.0011865348,0.000019452593,0.0013353198,0.00058068015,0.000008618353],"category_scores_gemma":[0.008793851,0.00028982988,0.000600626,0.0011227379,0.00031602092,0.00012075336,0.00021453835,0.0029909732,0.000013475309],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[8.601243e-7,0.000001676858,0.00004011977,0.40124875,0.00004615219,0.0000023058337,0.00015366383,2.801897e-8,2.1946733e-9,0.00034926875,0.038511965,0.5596452],"study_design_scores_gemma":[0.000048785412,0.00013291485,0.00005212716,0.4832958,0.0001753168,0.000114910814,0.00033864588,1.1235974e-7,3.4934e-8,0.0003315959,0.515413,0.000096740936],"about_ca_topic_score_codex":0.007069887,"about_ca_topic_score_gemma":0.005458381,"teacher_disagreement_score":0.55954844,"about_ca_system_score_codex":0.0029509827,"about_ca_system_score_gemma":0.048075728,"threshold_uncertainty_score":0.99995536},"labels":[],"label_agreement":null},{"id":"W4402620951","doi":"10.51731/cjht.2024.978","title":"Continuous Diffused Oxygen Therapy for Wound Healing","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Diabetic Foot Ulcer Assessment and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Oxygen therapy; Medicine; Wound care; Intensive care medicine; Wound healing; Health care; Surgery; Internal medicine","score_opus":0.03537621756336913,"score_gpt":0.324699520967545,"score_spread":0.2893233034041759,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402620951","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.26630682,0.34420985,0.009117234,0.37246457,0.0031497017,0.0024979156,0.00003685838,0.00060120755,0.0016158507],"genre_scores_gemma":[0.99487925,0.0013167822,0.0019158184,0.0013563919,0.00004293986,0.00002371505,0.000004930284,0.000024345503,0.00043585678],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988384,0.000016169324,0.00044623628,0.00013456645,0.00013028964,0.0004342851],"domain_scores_gemma":[0.9994283,0.00006587382,0.00012974296,0.00016991288,0.000104105384,0.00010211428],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006966088,0.00011679497,0.00038189566,0.0006723048,0.00012463507,0.00008973715,0.00016957414,0.000089170884,0.00002400788],"category_scores_gemma":[0.00012214958,0.00008930551,0.0001200846,0.0002319162,0.000096649535,0.00007170213,0.00000940822,0.00026065478,0.0000037438965],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030172203,0.000025177722,0.00077646866,0.0004356927,0.00018913881,0.00012970084,0.00025756136,0.0000019548165,0.000072288836,0.005458364,0.03630889,0.95631456],"study_design_scores_gemma":[0.0010690888,0.0014476505,0.0028745867,0.0005780664,0.000034918023,0.00007381853,0.0025413095,0.000069672686,0.00022710398,0.0055292114,0.98545367,0.00010092266],"about_ca_topic_score_codex":0.0006478616,"about_ca_topic_score_gemma":0.0004180012,"teacher_disagreement_score":0.95621365,"about_ca_system_score_codex":0.00034534832,"about_ca_system_score_gemma":0.0020560196,"threshold_uncertainty_score":0.36472905},"labels":[],"label_agreement":null},{"id":"W4402644752","doi":"10.51731/cjht.2024.981","title":"Cemiplimab (Libtayo)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.020648046148322174,"score_gpt":0.26516243236839404,"score_spread":0.24451438622007188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402644752","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07932167,0.889168,0.00073742686,0.027062843,0.0027455902,0.0001275271,0.000020816084,0.0002323531,0.00058377115],"genre_scores_gemma":[0.99860215,0.00083570194,0.00006585661,0.00011706579,0.000007110639,0.0000022328493,0.000006702798,0.000011268865,0.00035193795],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989849,0.00005913789,0.00044941768,0.000107531625,0.000024445077,0.00037457485],"domain_scores_gemma":[0.9995572,0.00005100279,0.00014835542,0.0001607272,0.00006567674,0.000017070362],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049319834,0.00009936184,0.0002570912,0.00062477845,0.00020378143,0.000039486597,0.0002688161,0.00020433491,0.000120340206],"category_scores_gemma":[0.00013836718,0.000078589605,0.00008986566,0.00027047566,0.00020913726,0.0001548571,0.000015717978,0.0004610151,0.0001296501],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000063064263,0.000007732741,0.00032573426,0.00006619111,0.00009240837,0.000039859653,0.0002790005,0.000004488439,0.006818734,0.007986039,0.027679712,0.95669377],"study_design_scores_gemma":[0.0002216142,0.00023893363,0.0028720817,0.00030253298,0.000012527604,0.0007883895,0.00095689076,0.0000053742956,0.014826631,0.003962162,0.9757109,0.00010191261],"about_ca_topic_score_codex":0.000924594,"about_ca_topic_score_gemma":0.00032494782,"teacher_disagreement_score":0.9565919,"about_ca_system_score_codex":0.00025153477,"about_ca_system_score_gemma":0.0017367366,"threshold_uncertainty_score":0.3204791},"labels":[],"label_agreement":null},{"id":"W4402644953","doi":"10.51731/cjht.2024.980","title":"Tralokinumab (Adtralza)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Geology; Geography","score_opus":0.038193925976586225,"score_gpt":0.3464458702473919,"score_spread":0.30825194427080566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402644953","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.26775706,0.5253729,0.00055295567,0.20021532,0.0014987431,0.00056254514,0.000024988256,0.00055260723,0.003462841],"genre_scores_gemma":[0.9974605,0.0009979177,0.000539811,0.00034990849,0.00003632756,0.0000034839177,0.0000015631583,0.000022500773,0.0005879947],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998464,0.000029121173,0.0004882708,0.00014329041,0.00026462926,0.00061069336],"domain_scores_gemma":[0.999261,0.00007773855,0.00008133424,0.00025949915,0.00012374553,0.00019664226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073657633,0.00011036103,0.0003556446,0.0010514705,0.000106277126,0.00006167575,0.00026192176,0.00015818141,0.000100289],"category_scores_gemma":[0.0005120916,0.00008375241,0.00012221019,0.00057644304,0.00027782004,0.00010810832,0.0000141466935,0.0007340212,0.000055955574],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000021889107,0.000011437969,0.00019740869,0.00080093276,0.00010908143,0.0060635577,0.0004231959,0.00000661965,0.00007139707,0.005374188,0.05423248,0.9326878],"study_design_scores_gemma":[0.0021540835,0.0008884469,0.00068095635,0.0016486122,0.00003105559,0.013427184,0.001867235,0.00048667463,0.0012216346,0.004690843,0.97277004,0.00013326402],"about_ca_topic_score_codex":0.0058639217,"about_ca_topic_score_gemma":0.0016043193,"teacher_disagreement_score":0.93255454,"about_ca_system_score_codex":0.013835991,"about_ca_system_score_gemma":0.077052385,"threshold_uncertainty_score":0.9899497},"labels":[],"label_agreement":null},{"id":"W4402663829","doi":"10.51731/cjht.2024.983","title":"Bimekizumab (Bimzelx)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.036952607970333055,"score_gpt":0.3438340482654081,"score_spread":0.306881440295075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402663829","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19477782,0.63416433,0.0005934678,0.16422868,0.0016069859,0.00054299313,0.000021892907,0.00055872597,0.0035050889],"genre_scores_gemma":[0.99724865,0.0012191863,0.0005879022,0.0003791308,0.00003855156,0.0000035835342,0.0000016155387,0.000023675128,0.0004976804],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99845123,0.000030636507,0.00049844483,0.00014776512,0.00027597873,0.0005959551],"domain_scores_gemma":[0.9991738,0.000093411174,0.00009058911,0.00029182568,0.00015297362,0.00019737029],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007658674,0.00011192571,0.0003569519,0.0012365681,0.0001178831,0.0000637418,0.00027070474,0.00016187858,0.00010719639],"category_scores_gemma":[0.0007416573,0.000084311665,0.00011167163,0.0006652828,0.0002913028,0.00010077033,0.000023080254,0.0007310827,0.00009051882],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000018558778,0.000008206923,0.00013366318,0.0005942715,0.00008389999,0.0045684143,0.00023815488,0.0000040317914,0.000036954327,0.0035351173,0.04257377,0.94820493],"study_design_scores_gemma":[0.0020886185,0.0008609231,0.00039265468,0.0016675534,0.000028499458,0.012703964,0.0017599978,0.00072845217,0.0009877998,0.004297881,0.97435737,0.00012629268],"about_ca_topic_score_codex":0.0072274357,"about_ca_topic_score_gemma":0.0014355059,"teacher_disagreement_score":0.9480787,"about_ca_system_score_codex":0.01583756,"about_ca_system_score_gemma":0.091070496,"threshold_uncertainty_score":0.9993835},"labels":[],"label_agreement":null},{"id":"W4402681860","doi":"10.51731/cjht.2024.982","title":"Optimal Team for Diagnostic Imaging Equipment Installation","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Engineering Diagnostics and Reliability","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science; Engineering","score_opus":0.009412333758549628,"score_gpt":0.23984359221717866,"score_spread":0.23043125845862902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402681860","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15151896,0.53666675,0.28189534,0.018909464,0.0076352754,0.0009828273,0.00013567098,0.0017461958,0.00050951453],"genre_scores_gemma":[0.995153,0.0011079325,0.0036403704,0.000024619161,0.000027272845,0.000014031093,0.0000031376453,0.000024567013,0.000005039291],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991479,0.0000056139265,0.00036241952,0.000082611616,0.00006852991,0.0003329582],"domain_scores_gemma":[0.99942654,0.00030579526,0.000035606143,0.000108247295,0.000058285004,0.00006549899],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004009061,0.00010319312,0.00017096823,0.00040950283,0.000077213364,0.000068663416,0.00014931159,0.00006807342,0.000003941213],"category_scores_gemma":[0.00077130104,0.00009264178,0.0000615872,0.0001672413,0.0000509471,0.00009786794,0.0000076130427,0.00026090455,0.0000027854865],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000013619004,0.0000074206937,0.0011767484,0.0012486045,0.000062608684,0.000079446916,0.00035042127,0.32630402,0.0000734346,0.0034478374,0.02137036,0.6458777],"study_design_scores_gemma":[0.0002754943,0.00025354285,0.0027927484,0.001523412,0.000029927887,0.00016243145,0.0008120802,0.14067322,0.00085107615,0.0052757324,0.84699756,0.00035275405],"about_ca_topic_score_codex":0.00013870402,"about_ca_topic_score_gemma":0.00017834008,"teacher_disagreement_score":0.84363407,"about_ca_system_score_codex":0.0004890573,"about_ca_system_score_gemma":0.00048695048,"threshold_uncertainty_score":0.3777822},"labels":[],"label_agreement":null},{"id":"W4402698098","doi":"10.51731/cjht.2024.985","title":"Maralixibat (Livmarli)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Business","score_opus":0.027999714835361657,"score_gpt":0.3060256705592148,"score_spread":0.27802595572385314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402698098","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21178548,0.60242665,0.0003236302,0.1793199,0.002197484,0.00048271928,0.000028673014,0.00054413034,0.002891358],"genre_scores_gemma":[0.9962006,0.0013774764,0.001128659,0.00051830924,0.00003034078,0.0000041462067,0.0000033283584,0.000022077831,0.0007150237],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99878734,0.000022711796,0.00045483778,0.00013522478,0.00015794614,0.00044195258],"domain_scores_gemma":[0.9993651,0.000051114235,0.0001138236,0.00024326536,0.00007717106,0.00014953683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036918765,0.00012485356,0.0003550799,0.00080200017,0.00009744843,0.000034396173,0.00015405592,0.00014074567,0.00016453679],"category_scores_gemma":[0.00027423288,0.00009447259,0.00011121998,0.00037940327,0.0001516685,0.000094516356,0.000012990007,0.00053100736,0.00008609629],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011704436,0.000011895034,0.0033722993,0.00040375447,0.00014855544,0.0033584537,0.00027363742,0.00000255514,0.000034403714,0.0029174124,0.053414155,0.9360512],"study_design_scores_gemma":[0.0006949336,0.00072352414,0.0060395803,0.0015078608,0.000054293327,0.0052619493,0.0013110465,0.00004367262,0.00043694908,0.002196195,0.9816164,0.000113615875],"about_ca_topic_score_codex":0.0036043592,"about_ca_topic_score_gemma":0.00153232,"teacher_disagreement_score":0.9359376,"about_ca_system_score_codex":0.0027360509,"about_ca_system_score_gemma":0.0105159115,"threshold_uncertainty_score":0.9950935},"labels":[],"label_agreement":null},{"id":"W4402815998","doi":"10.51731/cjht.2024.987","title":"Avatrombopag (Doptelet)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Electrolyte and hormonal disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Health Canada","keywords":"Business","score_opus":0.018967762409276518,"score_gpt":0.29302047160474726,"score_spread":0.27405270919547076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402815998","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1561355,0.6314763,0.00028529545,0.20586766,0.00032532756,0.00020486178,0.0000069337602,0.0002765037,0.0054216],"genre_scores_gemma":[0.9959692,0.0024164973,0.00028356613,0.0010565532,0.000021635817,0.0000017877618,0.0000016769071,0.000015029663,0.00023404733],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99901074,0.00001355743,0.0003554565,0.0000974968,0.00012742777,0.0003953298],"domain_scores_gemma":[0.9995725,0.000029877154,0.00007605436,0.00013174597,0.00008335231,0.00010643547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033532517,0.00009169204,0.0002846624,0.00078267505,0.00009824869,0.000035483,0.00014213975,0.00010374653,0.000051154337],"category_scores_gemma":[0.00017288527,0.00007120568,0.00010466264,0.00037633185,0.0001226501,0.000080194906,0.0000059649387,0.00057849364,0.0000342033],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012279196,0.000009255476,0.0008201361,0.00023459396,0.00008516771,0.0009678899,0.0001351097,0.0000013102068,0.00056493393,0.007412824,0.053466756,0.9362897],"study_design_scores_gemma":[0.00032077587,0.0013619692,0.012986958,0.00064104353,0.000040738665,0.0023443133,0.0012947558,0.000026447717,0.0007962508,0.011471013,0.9685977,0.00011801664],"about_ca_topic_score_codex":0.0011328877,"about_ca_topic_score_gemma":0.0011227085,"teacher_disagreement_score":0.9361717,"about_ca_system_score_codex":0.00029120766,"about_ca_system_score_gemma":0.0046000467,"threshold_uncertainty_score":0.81602854},"labels":[],"label_agreement":null},{"id":"W4402848531","doi":"10.51731/cjht.2024.986","title":"Short-Cycle Autoclave Sterilization of Instruments in Same-Day Ophthalmic Surgeries","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Digital Imaging in Medicine","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Sterilization (economics); Medicine; Autoclave; Materials science; Metallurgy; Business","score_opus":0.03181342894197042,"score_gpt":0.3258453124441941,"score_spread":0.2940318835022237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402848531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95684063,0.022740318,0.00013539736,0.018455649,0.00080324605,0.00026350768,0.000017285474,0.000099541125,0.0006444281],"genre_scores_gemma":[0.99895597,0.00039560525,0.0003471801,0.00018418826,0.000011773874,0.000003498093,0.00000658086,0.000019895893,0.0000753375],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99849194,0.000035439774,0.0007874015,0.00013030956,0.00021414329,0.00034077142],"domain_scores_gemma":[0.9993843,0.000055574015,0.00015442578,0.0001951515,0.00011376108,0.000096774726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075718586,0.0001192503,0.00047860102,0.0014533402,0.000033234304,0.000031159805,0.0001628538,0.00010049491,0.000019538596],"category_scores_gemma":[0.0008535407,0.0000999493,0.00005741756,0.00066678436,0.00032628613,0.00024109152,0.00001869791,0.00039482495,0.000002737326],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020134012,0.000024160941,0.11017221,0.0008200666,0.00004711606,0.0008826744,0.00072029425,0.000019412251,0.00020793956,0.00044357742,0.0015942727,0.88504815],"study_design_scores_gemma":[0.0025055695,0.004239618,0.7578815,0.035503823,0.00015035972,0.009311411,0.024194073,0.0019945316,0.010787184,0.019281743,0.13335165,0.00079853024],"about_ca_topic_score_codex":0.0013519509,"about_ca_topic_score_gemma":0.00058576145,"teacher_disagreement_score":0.8842496,"about_ca_system_score_codex":0.0005419037,"about_ca_system_score_gemma":0.0024981552,"threshold_uncertainty_score":0.443162},"labels":[],"label_agreement":null},{"id":"W4402924504","doi":"10.51731/cjht.2024.991","title":"Nivolumab (Opdivo)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Nivolumab; Medicine; Immunology; Immunotherapy; Immune system","score_opus":0.026593800618034187,"score_gpt":0.3047002063446103,"score_spread":0.27810640572657613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402924504","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.102199644,0.7154124,0.00026773685,0.17882282,0.001624999,0.00021611688,0.000016093492,0.00026066133,0.0011795774],"genre_scores_gemma":[0.9960825,0.00223659,0.0003444117,0.00093054445,0.000024458119,0.0000018894958,0.0000010884795,0.000013032081,0.0003654994],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991077,0.000015624133,0.00037652263,0.00008976397,0.000110431676,0.00029994376],"domain_scores_gemma":[0.99958694,0.000023811777,0.00009194314,0.00015477286,0.00006826985,0.0000742724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046237392,0.000081129685,0.00024089457,0.00066745526,0.00009954905,0.000040198895,0.00013866863,0.00010504624,0.00010658065],"category_scores_gemma":[0.000106110754,0.000061737606,0.00011231452,0.000385692,0.00017467952,0.000073316696,0.0000055972496,0.00037635985,0.000015193139],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037732843,0.0000047394615,0.00063294306,0.00017694541,0.00007838321,0.00047188002,0.00016665041,2.790457e-7,0.00016635822,0.0005118225,0.037326615,0.9604257],"study_design_scores_gemma":[0.00041593375,0.0006840576,0.0035711208,0.00090414006,0.000017265042,0.0019323933,0.0014524957,0.000010639897,0.00063998287,0.0011772577,0.9891231,0.00007158982],"about_ca_topic_score_codex":0.003518141,"about_ca_topic_score_gemma":0.0018042212,"teacher_disagreement_score":0.9603541,"about_ca_system_score_codex":0.0005619194,"about_ca_system_score_gemma":0.004960285,"threshold_uncertainty_score":0.8799333},"labels":[],"label_agreement":null},{"id":"W4402924664","doi":"10.51731/cjht.2024.988","title":"Lenvatinib for the Treatment of Hepatocellular Carcinoma After Liver Transplant","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lenvatinib; Hepatocellular carcinoma; Medicine; Liver transplantation; Oncology; Internal medicine; Carcinoma; Sorafenib; Transplantation","score_opus":0.03972847074739106,"score_gpt":0.27603342845020606,"score_spread":0.236304957702815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402924664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5264537,0.4560854,0.00012579291,0.016357422,0.00019285684,0.0005789705,0.00017082311,0.000023369284,0.000011661639],"genre_scores_gemma":[0.98833424,0.011150897,0.00021438867,0.00013327094,0.000021542504,0.00009303618,0.0000056109325,0.000012950421,0.000034048273],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991841,0.000015013357,0.00034983677,0.00010547219,0.00009800695,0.0002476229],"domain_scores_gemma":[0.99941623,0.00014052688,0.00009226315,0.00018271478,0.00008238974,0.0000858903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013117463,0.00011469929,0.00031118913,0.00025536213,0.0000835988,0.000015857591,0.00008850455,0.000065807944,0.000031710162],"category_scores_gemma":[0.000019452356,0.00006165913,0.00022866852,0.00012345008,0.00012445403,0.00003473986,0.0000020232742,0.00008319666,0.0000025307256],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018353105,0.0002449143,0.29433775,0.0010213229,0.0007563424,0.0028372302,0.0028299086,0.0000021335927,0.000013646388,0.0014395188,0.0020612127,0.6942725],"study_design_scores_gemma":[0.0039092894,0.014011181,0.35352996,0.002782029,0.0019649027,0.0009502835,0.0042891726,0.0008931543,0.008781223,0.0015228828,0.60706675,0.0002991349],"about_ca_topic_score_codex":0.0032320311,"about_ca_topic_score_gemma":0.00089907885,"teacher_disagreement_score":0.69397336,"about_ca_system_score_codex":0.00036932027,"about_ca_system_score_gemma":0.0017651306,"threshold_uncertainty_score":0.48858857},"labels":[],"label_agreement":null},{"id":"W4402925364","doi":"10.51731/cjht.2024.989","title":"Cost-Effectiveness of Conjugate Pneumococcal Vaccines in At-Risk Adults Aged 18 to 64 Years","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Public Health Agency; Public Health Agency of Canada","keywords":"Conjugate; Pneumococcal conjugate vaccine; Medicine; Pneumococcal disease; Virology; Streptococcus pneumoniae; Biology; Mathematics; Microbiology; Antibiotics","score_opus":0.03914414147732651,"score_gpt":0.33787295240153004,"score_spread":0.2987288109242035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402925364","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98536026,0.0082359705,0.00005075938,0.0049965866,0.00053813856,0.00063998887,0.00004457079,0.000077519806,0.000056175744],"genre_scores_gemma":[0.99927694,0.00045234308,0.000038463124,0.00015319625,0.000015347085,0.000023838464,0.0000016008106,0.000017331913,0.000020942782],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99865025,0.00015325237,0.00055195316,0.00015964491,0.000116878306,0.00036804107],"domain_scores_gemma":[0.9991665,0.0001821917,0.00016311654,0.00019544153,0.00011686837,0.00017588703],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009957512,0.00012282668,0.00048699978,0.0014156016,0.0000927407,0.000014473404,0.00014776835,0.00015891144,0.000023714754],"category_scores_gemma":[0.0007417365,0.00010133634,0.000100923484,0.000754063,0.000109194334,0.00006482981,0.000023623315,0.0006185326,0.000015135766],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044439136,0.00010383179,0.5562892,0.0024893282,0.00022598299,0.0033235624,0.0017386788,0.00038709794,0.015969604,0.00035237515,0.0022373411,0.4164386],"study_design_scores_gemma":[0.0011394928,0.0014703197,0.9414789,0.003632799,0.000033021373,0.0006912293,0.0011295377,0.000020012074,0.0028653326,0.00044585948,0.046963725,0.00012977066],"about_ca_topic_score_codex":0.003310954,"about_ca_topic_score_gemma":0.013612781,"teacher_disagreement_score":0.41630885,"about_ca_system_score_codex":0.0007339753,"about_ca_system_score_gemma":0.0019508223,"threshold_uncertainty_score":0.75962514},"labels":[],"label_agreement":null},{"id":"W4402925909","doi":"10.51731/cjht.2024.990","title":"Etranacogene Dezaparvovec (Hemgenix)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pulmonary Hypertension Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.04367960532597456,"score_gpt":0.33157483962306206,"score_spread":0.2878952342970875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402925909","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3090449,0.57147884,0.0001353555,0.117488116,0.0005195755,0.00028040443,0.00003266695,0.00019274284,0.0008274136],"genre_scores_gemma":[0.9959074,0.0025671734,0.00062892004,0.0005420432,0.000014252401,0.0000029751752,0.0000037591224,0.00001503598,0.00031841715],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988524,0.000024347528,0.00034015218,0.00012430787,0.00019965516,0.00045918804],"domain_scores_gemma":[0.99934316,0.00003979721,0.000058105932,0.00018234937,0.00012910189,0.00024748492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033377332,0.0001020071,0.00030731532,0.00090924074,0.00012630265,0.000031686068,0.00014553712,0.00010710023,0.00008704613],"category_scores_gemma":[0.00026068446,0.00007170135,0.000110719455,0.00044388132,0.00014500578,0.000081365084,0.000010056869,0.0004437573,0.000064589985],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031528965,0.000041919095,0.0064213024,0.0002690544,0.00024316744,0.031508174,0.000055664445,0.0000011435269,0.0003775329,0.00073086354,0.029873528,0.93044615],"study_design_scores_gemma":[0.00083254505,0.0019070456,0.02049667,0.001228651,0.00007359831,0.017465226,0.0012904654,0.00009160904,0.002730737,0.004197758,0.9495221,0.00016359932],"about_ca_topic_score_codex":0.001728436,"about_ca_topic_score_gemma":0.0007261234,"teacher_disagreement_score":0.93028253,"about_ca_system_score_codex":0.00036053994,"about_ca_system_score_gemma":0.0049971933,"threshold_uncertainty_score":0.8864807},"labels":[],"label_agreement":null},{"id":"W4402939154","doi":"10.51731/cjht.2024.993","title":"Insulin icodec (Awiqli)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Diabetes Management and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Insulin; Medicine; Internal medicine","score_opus":0.041581416693938854,"score_gpt":0.33948135706398647,"score_spread":0.29789994037004763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402939154","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10953791,0.52411675,0.00043280786,0.35496864,0.0014363973,0.00048525445,0.000012610693,0.00042034144,0.00858929],"genre_scores_gemma":[0.99638975,0.0011799627,0.00042780215,0.00047878985,0.00003214539,0.0000026820023,0.0000018455311,0.000014873803,0.0014721618],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988868,0.000022602411,0.00035165725,0.00010511788,0.0001919583,0.00044184865],"domain_scores_gemma":[0.999491,0.000038941333,0.00006797161,0.00017475759,0.00009948887,0.00012787155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081175467,0.000081858525,0.00025768657,0.0013205443,0.000102017984,0.00007074613,0.00021862995,0.00009586123,0.00009227651],"category_scores_gemma":[0.00037556604,0.00005907039,0.00008046227,0.0005638218,0.00017698383,0.00009402337,0.000022669696,0.0005940422,0.00006873292],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000055081086,0.000008384623,0.0014836629,0.00039821208,0.000057557103,0.0006933237,0.00007866352,0.000001710809,0.000015455593,0.0030908152,0.04755351,0.9466132],"study_design_scores_gemma":[0.00026223724,0.00054731406,0.004381128,0.00084857555,0.00001730837,0.000098392586,0.00092766836,0.00009917506,0.0001497074,0.0049616043,0.98763984,0.00006704429],"about_ca_topic_score_codex":0.0004908588,"about_ca_topic_score_gemma":0.00048719186,"teacher_disagreement_score":0.94654614,"about_ca_system_score_codex":0.00030786978,"about_ca_system_score_gemma":0.0028556397,"threshold_uncertainty_score":0.5065782},"labels":[],"label_agreement":null},{"id":"W4403443158","doi":"10.51731/cjht.2024.997","title":"Metreleptin (Myalepta)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Malaria Research and Control","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Political science","score_opus":0.02805504402960337,"score_gpt":0.32141526167126067,"score_spread":0.2933602176416573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403443158","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.020632429,0.43400747,0.0012527306,0.53993887,0.00063503574,0.00035135122,0.000016357526,0.0002628817,0.002902897],"genre_scores_gemma":[0.9975928,0.0007312268,0.0005760932,0.00045234145,0.000029732253,0.000004200945,0.0000010613861,0.0000120255245,0.0006005021],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988589,0.000034743367,0.00035434696,0.000099683275,0.00019140156,0.00046091547],"domain_scores_gemma":[0.9993787,0.00005913739,0.00007046627,0.00017242396,0.00012469916,0.00019457718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079520955,0.000080791506,0.00029296815,0.0010019054,0.00009235241,0.000054621203,0.00018212524,0.00010342018,0.00019080298],"category_scores_gemma":[0.0008824074,0.00005879487,0.00010278887,0.0004418386,0.00013253649,0.00007001136,0.000009803136,0.00069435843,0.000042815464],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017388225,0.0000066136604,0.00074688566,0.00023508031,0.00007720657,0.0015764366,0.00006340607,8.318314e-7,0.00007665528,0.010009704,0.029209241,0.9579806],"study_design_scores_gemma":[0.0005551735,0.001184822,0.0073337294,0.00077359925,0.000028536562,0.0016479399,0.0015635312,0.000106419604,0.0003273315,0.0048683817,0.9815181,0.00009245668],"about_ca_topic_score_codex":0.0019938317,"about_ca_topic_score_gemma":0.0015268425,"teacher_disagreement_score":0.97696036,"about_ca_system_score_codex":0.00035812127,"about_ca_system_score_gemma":0.0065576998,"threshold_uncertainty_score":0.9990742},"labels":[],"label_agreement":null},{"id":"W4403489647","doi":"10.51731/cjht.2024.999","title":"CRISPR Technologies for In Vivo and Ex Vivo Gene Editing","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"CRISPR; Ex vivo; Genome editing; Biology; In vivo; Gene; Genetics; Computational biology","score_opus":0.011123602297740065,"score_gpt":0.3030946579556271,"score_spread":0.29197105565788706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403489647","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.41733214,0.5333783,0.02854811,0.018867295,0.0010644859,0.00042717357,0.00009386587,0.00018040036,0.000108208114],"genre_scores_gemma":[0.99377894,0.0027104842,0.0033355942,0.000060968083,0.00004274619,0.000011845087,0.0000018677906,0.000018439738,0.00003913129],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990306,0.000010018647,0.00034671655,0.00018226352,0.00005142501,0.00037899354],"domain_scores_gemma":[0.99965876,0.000022842929,0.00007351582,0.00015280914,0.000052261326,0.0000397793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040489665,0.00012087693,0.0002024181,0.00045908935,0.00007636072,0.00004482562,0.00020808697,0.00021020416,0.000002197222],"category_scores_gemma":[0.00042084395,0.000111969275,0.000050331244,0.00016847298,0.00011742581,0.0000069782627,0.000036229612,0.00021229303,2.8014637e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021457965,0.000013996346,0.0039386754,0.00079991465,0.00009892147,0.00016934738,0.00035161723,0.00030754315,0.20670733,0.0014284496,0.026174562,0.7599882],"study_design_scores_gemma":[0.00033325874,0.0005244375,0.000373102,0.00033598684,0.000010701053,0.00038210195,0.0047980705,0.00017479967,0.50983167,0.0023308126,0.4806806,0.00022443598],"about_ca_topic_score_codex":0.0002510226,"about_ca_topic_score_gemma":0.0018858234,"teacher_disagreement_score":0.7597638,"about_ca_system_score_codex":0.00006572525,"about_ca_system_score_gemma":0.0004930068,"threshold_uncertainty_score":0.45659745},"labels":[],"label_agreement":null},{"id":"W4403544229","doi":"10.51731/cjht.2024.998","title":"Bimekizumab (Bimzelx)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.036952607970333055,"score_gpt":0.3438340482654081,"score_spread":0.306881440295075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403544229","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19477782,0.63416433,0.0005934678,0.16422868,0.0016069859,0.00054299313,0.000021892907,0.00055872597,0.0035050889],"genre_scores_gemma":[0.99724865,0.0012191863,0.0005879022,0.0003791308,0.00003855156,0.0000035835342,0.0000016155387,0.000023675128,0.0004976804],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99845123,0.000030636507,0.00049844483,0.00014776512,0.00027597873,0.0005959551],"domain_scores_gemma":[0.9991738,0.000093411174,0.00009058911,0.00029182568,0.00015297362,0.00019737029],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007658674,0.00011192571,0.0003569519,0.0012365681,0.0001178831,0.0000637418,0.00027070474,0.00016187858,0.00010719639],"category_scores_gemma":[0.0007416573,0.000084311665,0.00011167163,0.0006652828,0.0002913028,0.00010077033,0.000023080254,0.0007310827,0.00009051882],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000018558778,0.000008206923,0.00013366318,0.0005942715,0.00008389999,0.0045684143,0.00023815488,0.0000040317914,0.000036954327,0.0035351173,0.04257377,0.94820493],"study_design_scores_gemma":[0.0020886185,0.0008609231,0.00039265468,0.0016675534,0.000028499458,0.012703964,0.0017599978,0.00072845217,0.0009877998,0.004297881,0.97435737,0.00012629268],"about_ca_topic_score_codex":0.0072274357,"about_ca_topic_score_gemma":0.0014355059,"teacher_disagreement_score":0.9480787,"about_ca_system_score_codex":0.01583756,"about_ca_system_score_gemma":0.091070496,"threshold_uncertainty_score":0.9993835},"labels":[],"label_agreement":null},{"id":"W4403566031","doi":"10.51731/cjht.2024.1005","title":"Development of an Evaluation Instrument on Artificial Intelligence Search Tools for Evidence Synthesis","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science; Systems engineering; Engineering","score_opus":0.56733717002908,"score_gpt":0.5086916951041844,"score_spread":0.05864547492489558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403566031","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94220346,0.0115149245,0.0067374464,0.037625365,0.00086126063,0.0009775414,0.0000089273935,0.000048635713,0.000022453354],"genre_scores_gemma":[0.98864836,0.00025406788,0.0108569125,0.00011749713,0.000043992844,0.000060804254,0.0000037503382,0.000011247152,0.0000033630938],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980279,0.00007767651,0.0010303247,0.00017486885,0.00035928295,0.0003299168],"domain_scores_gemma":[0.9982091,0.00063216797,0.00019616961,0.00020361049,0.0006332195,0.0001256887],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004043122,0.00009874898,0.00027256028,0.00084243173,0.00020459101,0.00006132351,0.00019007707,0.0001267391,0.000040320745],"category_scores_gemma":[0.0047587026,0.00008265393,0.000060579794,0.0003897917,0.00012457899,0.00025911667,0.0000071884247,0.000292273,0.000009490414],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056169476,0.000028086853,0.000061849525,0.00043666305,0.000019147707,0.0000052128717,0.0022969719,0.00007605455,0.0002035597,0.0019421227,0.00006009985,0.99481404],"study_design_scores_gemma":[0.000034365854,0.004285325,0.0017630586,0.012194041,0.00011834035,0.00016229306,0.098440014,0.008585723,0.830724,0.028740412,0.01464941,0.00030299812],"about_ca_topic_score_codex":0.0011347468,"about_ca_topic_score_gemma":0.0026310182,"teacher_disagreement_score":0.99451107,"about_ca_system_score_codex":0.0012472336,"about_ca_system_score_gemma":0.015970139,"threshold_uncertainty_score":0.9896084},"labels":[],"label_agreement":null},{"id":"W4403566032","doi":"10.51731/cjht.2024.1004","title":"Development of an Evaluation Instrument on Artificial Intelligence Search Tools for Evidence Synthesis","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science; Artificial intelligence","score_opus":0.56733717002908,"score_gpt":0.5086916951041844,"score_spread":0.05864547492489558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403566032","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94220346,0.0115149245,0.0067374464,0.037625365,0.00086126063,0.0009775414,0.0000089273935,0.000048635713,0.000022453354],"genre_scores_gemma":[0.98864836,0.00025406788,0.0108569125,0.00011749713,0.000043992844,0.000060804254,0.0000037503382,0.000011247152,0.0000033630938],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980279,0.00007767651,0.0010303247,0.00017486885,0.00035928295,0.0003299168],"domain_scores_gemma":[0.9982091,0.00063216797,0.00019616961,0.00020361049,0.0006332195,0.0001256887],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004043122,0.00009874898,0.00027256028,0.00084243173,0.00020459101,0.00006132351,0.00019007707,0.0001267391,0.000040320745],"category_scores_gemma":[0.0047587026,0.00008265393,0.000060579794,0.0003897917,0.00012457899,0.00025911667,0.0000071884247,0.000292273,0.000009490414],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056169476,0.000028086853,0.000061849525,0.00043666305,0.000019147707,0.0000052128717,0.0022969719,0.00007605455,0.0002035597,0.0019421227,0.00006009985,0.99481404],"study_design_scores_gemma":[0.000034365854,0.004285325,0.0017630586,0.012194041,0.00011834035,0.00016229306,0.098440014,0.008585723,0.830724,0.028740412,0.01464941,0.00030299812],"about_ca_topic_score_codex":0.0011347468,"about_ca_topic_score_gemma":0.0026310182,"teacher_disagreement_score":0.99451107,"about_ca_system_score_codex":0.0012472336,"about_ca_system_score_gemma":0.015970139,"threshold_uncertainty_score":0.9896084},"labels":[],"label_agreement":null},{"id":"W4403687222","doi":"10.51731/cjht.2024.1006","title":"Osimertinib (Tagrisso)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Osimertinib; Chemistry","score_opus":0.025332631547092532,"score_gpt":0.3596782912347435,"score_spread":0.33434565968765095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403687222","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.077723585,0.6168531,0.00059955736,0.29900876,0.0016596199,0.00039525257,0.000036811616,0.00036093517,0.0033623697],"genre_scores_gemma":[0.99786496,0.00058479985,0.00059316726,0.0005090282,0.00001925568,0.0000040325726,0.000002645391,0.000010672527,0.000411453],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99930465,0.00000984881,0.00028881477,0.00007789435,0.00008263166,0.0002361491],"domain_scores_gemma":[0.9996207,0.000024729863,0.00007394285,0.000113764356,0.0000757196,0.00009119464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016995157,0.000067847075,0.00019422264,0.00048289972,0.0001016061,0.000029037861,0.00007655713,0.00006501302,0.00005604148],"category_scores_gemma":[0.000118232114,0.00004738287,0.0000664644,0.00027480777,0.000077269906,0.000066734065,0.0000040525088,0.0002517004,0.000023154891],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004734663,0.000011075705,0.0032321052,0.00016392913,0.0001538533,0.0007194038,0.00043771425,0.0000029144462,0.000026758846,0.0027083987,0.031726763,0.96081233],"study_design_scores_gemma":[0.00032221037,0.0005262138,0.009125555,0.00075960276,0.000085624015,0.0010683165,0.0018607258,0.00001653087,0.0003683336,0.002521093,0.98328084,0.000064953674],"about_ca_topic_score_codex":0.0023036583,"about_ca_topic_score_gemma":0.00066594966,"teacher_disagreement_score":0.9607474,"about_ca_system_score_codex":0.00047242607,"about_ca_system_score_gemma":0.004707914,"threshold_uncertainty_score":0.83516365},"labels":[],"label_agreement":null},{"id":"W4403687451","doi":"10.51731/cjht.2024.1007","title":"Abemaciclib (Verzenio)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.02564525981457516,"score_gpt":0.3288999898054583,"score_spread":0.30325472999088315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403687451","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.057299446,0.7542902,0.0028155255,0.18231277,0.0015929395,0.00029361848,0.000024735766,0.0005642116,0.0008065006],"genre_scores_gemma":[0.9961571,0.0007010752,0.002027324,0.0008212622,0.00003837718,0.0000035479047,0.0000010985165,0.00002404999,0.00022612861],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989041,0.00001720729,0.00041220052,0.00012139127,0.00014151845,0.00040360182],"domain_scores_gemma":[0.9994075,0.000038789414,0.000120421115,0.00020094895,0.000109684996,0.00012270536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034056342,0.00011197804,0.00033406803,0.00074881176,0.000100196165,0.000033041833,0.0001710434,0.0001020889,0.00007689571],"category_scores_gemma":[0.0001850776,0.000087264045,0.00009356097,0.0004299285,0.00021855684,0.00014042458,0.000009458974,0.0005408228,0.000027891725],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015574344,0.0000045258626,0.000802457,0.00022528722,0.00006096605,0.00071303954,0.00023701722,0.0000044697085,0.00011518825,0.002434906,0.0027240168,0.99266255],"study_design_scores_gemma":[0.0003423339,0.00042421353,0.002525836,0.0010856555,0.000020472968,0.0038576075,0.0017423857,0.000015553402,0.00095910503,0.009755209,0.9791748,0.00009682717],"about_ca_topic_score_codex":0.00069171615,"about_ca_topic_score_gemma":0.00051315565,"teacher_disagreement_score":0.99256575,"about_ca_system_score_codex":0.0006618111,"about_ca_system_score_gemma":0.004273231,"threshold_uncertainty_score":0.7580528},"labels":[],"label_agreement":null},{"id":"W4403732382","doi":"10.51731/cjht.2024.1009","title":"Pembrolizumab (Keytruda)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pembrolizumab; Medicine; Internal medicine; Cancer","score_opus":0.028657323898609394,"score_gpt":0.3193534515525259,"score_spread":0.2906961276539165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403732382","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15032552,0.6221192,0.000091205875,0.22457995,0.001081641,0.0002506074,0.00002107371,0.00021116217,0.0013196713],"genre_scores_gemma":[0.99560815,0.0034454786,0.00025852295,0.0005163749,0.000027650678,0.0000067784877,0.000001481102,0.000013560144,0.00012199195],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99912566,0.000011370419,0.00033158224,0.00010488821,0.00012086633,0.000305653],"domain_scores_gemma":[0.9995327,0.000033997916,0.00008190164,0.0001625879,0.00007214966,0.00011665515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002040981,0.0000905342,0.0002925262,0.00061777415,0.000088535155,0.000040722964,0.000096680924,0.000081709775,0.000083290084],"category_scores_gemma":[0.00010460338,0.00006632716,0.00010797083,0.00028462015,0.00010068102,0.000058497477,0.000006974379,0.00031791642,0.000024724866],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011396862,0.000016548638,0.0050455616,0.00023118581,0.000100118166,0.0016505907,0.00018031118,0.0000018195612,0.0000070327587,0.0038047556,0.037624322,0.9513264],"study_design_scores_gemma":[0.00058068044,0.0010970052,0.016753873,0.0013418215,0.000056249533,0.002660658,0.0010249978,0.000013437741,0.0004621372,0.002734957,0.97319055,0.00008361755],"about_ca_topic_score_codex":0.0036062496,"about_ca_topic_score_gemma":0.0029081274,"teacher_disagreement_score":0.95124274,"about_ca_system_score_codex":0.00085811055,"about_ca_system_score_gemma":0.004707528,"threshold_uncertainty_score":0.8350952},"labels":[],"label_agreement":null},{"id":"W4403850901","doi":"10.51731/cjht.2024.1012","title":"Relugolix (Orgovyx)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Medical Imaging Techniques and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.038491625551458554,"score_gpt":0.3554205771460136,"score_spread":0.31692895159455503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403850901","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.020199448,0.12710467,0.006869247,0.84193397,0.0004047218,0.00033785022,0.000013276641,0.0008606405,0.002276189],"genre_scores_gemma":[0.9878765,0.0011200841,0.009458737,0.0012463039,0.000025576897,0.000006833146,0.0000018006136,0.00001336899,0.0002508039],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99913096,0.000011747937,0.00037568226,0.00009573448,0.000117669944,0.00026817873],"domain_scores_gemma":[0.9994548,0.0000341381,0.00008227398,0.00020595457,0.0000819523,0.00014087123],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046992092,0.00007068219,0.00022351931,0.0004955511,0.00009032735,0.000030885654,0.00016798648,0.00009444308,0.00004700816],"category_scores_gemma":[0.0003546149,0.000052379608,0.000070324495,0.0003711247,0.00019064514,0.000049956576,0.000010293863,0.0005618727,0.000022811275],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000022250076,0.000009806757,0.0003906808,0.00024552474,0.000025882187,0.00046191263,0.00009216684,2.416025e-7,0.00021297522,0.026562292,0.2651923,0.706804],"study_design_scores_gemma":[0.00007837173,0.00017154918,0.0004415588,0.000749972,0.00001453122,0.0013105806,0.0002874008,0.00006607181,0.00078218535,0.007766109,0.9882835,0.00004813968],"about_ca_topic_score_codex":0.0009662059,"about_ca_topic_score_gemma":0.000119977725,"teacher_disagreement_score":0.96767706,"about_ca_system_score_codex":0.00024084651,"about_ca_system_score_gemma":0.002942535,"threshold_uncertainty_score":0.5219931},"labels":[],"label_agreement":null},{"id":"W4403896352","doi":"10.51731/cjht.2024.1014","title":"Review of Guidelines on Bupropion for Depression","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Poisoning and overdose treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Network for Mood and Anxiety Treatments","keywords":"Bupropion; Depression (economics); Medicine; Psychiatry; Psychology; Smoking cessation; Economics","score_opus":0.09958524636766677,"score_gpt":0.4229304188080985,"score_spread":0.3233451724404317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403896352","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008767624,0.92454004,0.00023494642,0.06559078,0.00037419645,0.00030850837,0.000020241776,0.00006034948,0.00010329081],"genre_scores_gemma":[0.86711836,0.12358683,0.0050689285,0.0039432826,0.000041352836,0.000015149097,0.000008992041,0.000023917275,0.00019321512],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991554,0.000012131435,0.00048182995,0.00008311188,0.000090616326,0.00017692671],"domain_scores_gemma":[0.99937284,0.000046515663,0.0001740539,0.00014380408,0.00020531016,0.00005746127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042378748,0.000071691524,0.00032534997,0.0003352634,0.00005305917,0.0000055504743,0.00008468776,0.00006940934,0.000006156488],"category_scores_gemma":[0.0013337971,0.000046821777,0.00009629689,0.00016397581,0.000040618816,0.000031564934,0.0000045282263,0.00015608557,0.000002404408],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001601316,0.0000087128465,0.00052242493,0.006844849,0.00003535482,0.00004844587,0.00002041244,0.0000010414635,0.000027727858,0.00026048854,0.06942218,0.9227924],"study_design_scores_gemma":[0.0005198261,0.0016748874,0.001131271,0.17052408,0.00008052747,0.000379511,0.00018321126,0.000038762442,0.0026194567,0.0012558043,0.8215217,0.00007097698],"about_ca_topic_score_codex":0.00052249205,"about_ca_topic_score_gemma":0.0000876943,"teacher_disagreement_score":0.9227214,"about_ca_system_score_codex":0.00021250414,"about_ca_system_score_gemma":0.0016850043,"threshold_uncertainty_score":0.29891253},"labels":[],"label_agreement":null},{"id":"W4403896689","doi":"10.51731/cjht.2024.1013","title":"Burosumab (Crysvita)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.03131719817347778,"score_gpt":0.29654389724201785,"score_spread":0.2652266990685401,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403896689","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13107137,0.80588025,0.00010392856,0.060527135,0.00127099,0.00016933694,0.000013468825,0.00023249688,0.00073104526],"genre_scores_gemma":[0.99565226,0.0035503989,0.0001436789,0.0004158881,0.000030823718,0.0000023199527,0.0000013308495,0.000014989344,0.00018829574],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99897194,0.000022177564,0.00045471505,0.00010568005,0.0001394935,0.00030600384],"domain_scores_gemma":[0.999434,0.000037952726,0.000113058646,0.00017080318,0.00009637875,0.00014783978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035852919,0.00008953249,0.0002973944,0.0007044885,0.00010266512,0.000045484987,0.00013294371,0.00014622063,0.000051241823],"category_scores_gemma":[0.00033492505,0.0000619101,0.00012233036,0.00036911928,0.00012944815,0.00006475982,0.0000072584994,0.0003902281,0.00003260467],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011745423,0.000015897598,0.0033299467,0.0005646511,0.00014711017,0.0012996745,0.0002819594,0.0000044390767,0.00030024475,0.0026566586,0.07861094,0.9127767],"study_design_scores_gemma":[0.0009791991,0.0012132045,0.022818213,0.016028665,0.00016142869,0.007888324,0.008965665,0.00007940474,0.0009958592,0.0037265234,0.9368859,0.00025763616],"about_ca_topic_score_codex":0.00090838317,"about_ca_topic_score_gemma":0.00013053039,"teacher_disagreement_score":0.9125191,"about_ca_system_score_codex":0.00036105816,"about_ca_system_score_gemma":0.004077787,"threshold_uncertainty_score":0.72338194},"labels":[],"label_agreement":null},{"id":"W4403966203","doi":"10.51731/cjht.2024.1015","title":"Epcoritamab (Epkinly)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.03514424862429699,"score_gpt":0.3569083070650617,"score_spread":0.3217640584407647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403966203","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13079892,0.6100553,0.00012860663,0.25308493,0.0027892352,0.00028857417,0.000022236396,0.0002878589,0.002544336],"genre_scores_gemma":[0.9965377,0.0018500909,0.00031118537,0.0007223465,0.00004811686,0.000003914642,0.000001957876,0.000011950813,0.0005127298],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99920034,0.000016726222,0.00030382336,0.00009192337,0.00007955986,0.00030761198],"domain_scores_gemma":[0.9996097,0.000039124065,0.000074650336,0.00010645154,0.00006697597,0.0001031018],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024149405,0.000084615735,0.00026986457,0.00070065015,0.000082551705,0.000023024737,0.00010407436,0.000096670505,0.0001533035],"category_scores_gemma":[0.00007405889,0.00006448731,0.0000858453,0.00032699748,0.00012034611,0.000061686354,0.0000064161313,0.00040192297,0.000030057236],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021805874,0.000018660965,0.0031559924,0.00024137714,0.00013058148,0.002242108,0.00024029243,0.0000011461804,0.00009364895,0.0025628842,0.091326185,0.89996535],"study_design_scores_gemma":[0.00045060084,0.0010085718,0.0031410088,0.00036306694,0.00005365841,0.0019739137,0.00055401854,0.000011068857,0.0005151766,0.002431696,0.9894365,0.000060695183],"about_ca_topic_score_codex":0.0019295575,"about_ca_topic_score_gemma":0.0015699591,"teacher_disagreement_score":0.8999046,"about_ca_system_score_codex":0.0006005405,"about_ca_system_score_gemma":0.004730148,"threshold_uncertainty_score":0.83910793},"labels":[],"label_agreement":null},{"id":"W4404070843","doi":"10.51731/cjht.2024.1016","title":"Elexacaftor-Tezacaftor-Ivacaftor and Ivacaftor (Trikafta)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ivacaftor; Medicine; Computer science; Internal medicine; Cystic fibrosis","score_opus":0.023704979657390646,"score_gpt":0.33266858670483407,"score_spread":0.3089636070474434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404070843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.615134,0.371145,0.00027246185,0.012411182,0.000081500366,0.00037313876,0.000043402277,0.00024751716,0.0002917742],"genre_scores_gemma":[0.9918792,0.0036790422,0.003614139,0.00032496362,0.00008716013,0.000011578399,0.0000037734337,0.000041602878,0.00035850084],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99761146,0.00006194268,0.0007498364,0.000302808,0.00041977566,0.0008541928],"domain_scores_gemma":[0.99856865,0.00023440148,0.00018240813,0.00033371104,0.0002320424,0.00044877175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009422892,0.00023145399,0.0006372395,0.0014902168,0.00022472841,0.00014490115,0.00032241544,0.0002211468,0.000090687754],"category_scores_gemma":[0.0018467909,0.0001834177,0.00012539883,0.0006603613,0.0005609712,0.0002937914,0.000052498584,0.0010764976,0.00003407367],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000095424206,0.00002556702,0.009563719,0.0015987669,0.00017267204,0.0020068728,0.000032202995,0.000001875614,0.0018174436,0.004031943,0.03358461,0.9470689],"study_design_scores_gemma":[0.00056910043,0.0014643593,0.021973813,0.0017651464,0.000038235365,0.0027474465,0.0014257815,0.000054994063,0.0013587394,0.0029017848,0.96549714,0.00020343575],"about_ca_topic_score_codex":0.0010561618,"about_ca_topic_score_gemma":0.0000430484,"teacher_disagreement_score":0.94686544,"about_ca_system_score_codex":0.00082021224,"about_ca_system_score_gemma":0.0053163846,"threshold_uncertainty_score":0.94310385},"labels":[],"label_agreement":null},{"id":"W4404110461","doi":"10.51731/cjht.2024.1018","title":"Danicopan (Voydeya)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Chemical synthesis and alkaloids","field":"Chemistry","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.019192173322738544,"score_gpt":0.2563885265742544,"score_spread":0.2371963532515159,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404110461","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5140912,0.36326215,0.00011792178,0.11048027,0.00053770863,0.00007099143,0.00005141748,0.0005825841,0.010805753],"genre_scores_gemma":[0.99866885,0.0005630289,0.00031503112,0.00013903204,0.000026128482,0.0000015233501,0.0000013165461,0.000015352463,0.00026973712],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990578,0.000005342526,0.00038309742,0.000116842435,0.00010566665,0.00033121582],"domain_scores_gemma":[0.9995221,0.000053330896,0.000097039236,0.00017806169,0.000043731594,0.000105726016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020561379,0.000097679695,0.0002440973,0.00020764982,0.00009643005,0.00007675588,0.00027545862,0.00014249315,0.00031889722],"category_scores_gemma":[0.0002533674,0.00007800417,0.000112990616,0.0001900459,0.00012302524,0.00006955064,0.000015375068,0.0004902909,0.000014442239],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000021893864,0.0000068668146,0.00039031592,0.00033789754,0.00003141003,0.00024114265,0.000058950693,5.855847e-7,0.00833771,0.0017405406,0.012907401,0.975945],"study_design_scores_gemma":[0.00006909884,0.000037444985,0.00008782105,0.00063254876,0.000009022247,0.0005571276,0.00063859107,0.000016198066,0.054466497,0.004335467,0.9390514,0.000098824676],"about_ca_topic_score_codex":0.0006976555,"about_ca_topic_score_gemma":0.00037109313,"teacher_disagreement_score":0.9758462,"about_ca_system_score_codex":0.000357962,"about_ca_system_score_gemma":0.0016183554,"threshold_uncertainty_score":0.3491701},"labels":[],"label_agreement":null},{"id":"W4404122679","doi":"10.51731/cjht.2024.1021","title":"Sotatercept (Winrevair)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pulmonary Hypertension Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.04567324693324143,"score_gpt":0.33956812718622065,"score_spread":0.2938948802529792,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404122679","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.30777776,0.4606469,0.00010164151,0.22897267,0.0007327946,0.00033567785,0.000028101023,0.00027142605,0.0011330373],"genre_scores_gemma":[0.9969297,0.0016447093,0.00042686387,0.0005257352,0.000012961221,0.0000026808189,0.000002911895,0.000011968125,0.0004424446],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999032,0.00002380426,0.00029312487,0.00010175142,0.0001578716,0.0003914117],"domain_scores_gemma":[0.99946487,0.000031933992,0.00004892298,0.00015422929,0.00010627792,0.0001937519],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029638785,0.00008359454,0.00026208741,0.00078150735,0.000108801985,0.000032715983,0.00011925629,0.000078783014,0.00008079526],"category_scores_gemma":[0.00022495851,0.000056200635,0.00008731305,0.000303266,0.00013625585,0.00008287967,0.000010472157,0.0004008817,0.00008549717],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018566854,0.0000266314,0.007892868,0.00025232005,0.0001241569,0.02734509,0.00007020746,5.681103e-7,0.0000653229,0.00043184753,0.041260965,0.92251146],"study_design_scores_gemma":[0.00055446,0.0017006507,0.02333947,0.0013839763,0.000037900383,0.01350576,0.0017094067,0.000057662863,0.00034471706,0.005710405,0.95154715,0.000108424196],"about_ca_topic_score_codex":0.0012807185,"about_ca_topic_score_gemma":0.00020200686,"teacher_disagreement_score":0.92240304,"about_ca_system_score_codex":0.00031642785,"about_ca_system_score_gemma":0.0038914236,"threshold_uncertainty_score":0.6903218},"labels":[],"label_agreement":null},{"id":"W4404141856","doi":"10.51731/cjht.2024.1020","title":"Eplontersen (Wainua)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.01707836537499913,"score_gpt":0.2876893261619645,"score_spread":0.2706109607869654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404141856","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4358118,0.47294942,0.0007856907,0.08754557,0.0015990998,0.0003248821,0.000081625716,0.00017466012,0.000727247],"genre_scores_gemma":[0.9958527,0.0025995371,0.0005315102,0.00068016996,0.00003468686,0.000009594671,0.000007539963,0.000024103272,0.00026013886],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99892277,0.00004072137,0.00036220206,0.00018401981,0.000088523084,0.00040177262],"domain_scores_gemma":[0.9994182,0.00002239252,0.00013674244,0.0002587956,0.00006644055,0.0000974239],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000307771,0.00014340553,0.00022836265,0.00035846006,0.00011721005,0.00005633167,0.00032877043,0.00017393182,0.000017028391],"category_scores_gemma":[0.0002710176,0.000118650234,0.00013178421,0.00017046281,0.00015864699,0.000008592328,0.000031785163,0.0002145134,0.000019828114],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001916386,0.0000359659,0.028299008,0.00019956654,0.0004664916,0.0007696791,0.00033755164,0.000026588425,0.0023990967,0.0021318966,0.15656658,0.8087484],"study_design_scores_gemma":[0.00029396778,0.00072686886,0.004155489,0.00024356763,0.000026499923,0.00045200033,0.002144892,0.0000053511017,0.011031867,0.0009150924,0.9798033,0.0002010652],"about_ca_topic_score_codex":0.0011033042,"about_ca_topic_score_gemma":0.0032837456,"teacher_disagreement_score":0.82323676,"about_ca_system_score_codex":0.0002041366,"about_ca_system_score_gemma":0.0017475339,"threshold_uncertainty_score":0.48384163},"labels":[],"label_agreement":null},{"id":"W4404163529","doi":"10.51731/cjht.2024.1022","title":"Aflibercept 8 mg/0.07 mL (Eylea HD)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Aflibercept; Medicine; Internal medicine","score_opus":0.03733900008348816,"score_gpt":0.3430989103266301,"score_spread":0.3057599102431419,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404163529","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3018072,0.4884,0.0004835723,0.19967565,0.002183047,0.0008166027,0.000039587278,0.0008051325,0.0057892054],"genre_scores_gemma":[0.9953857,0.0018267351,0.0007057579,0.00071324944,0.00007445996,0.000006339103,0.0000029691657,0.000039655013,0.0012451494],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99781954,0.000048338323,0.00067029725,0.00021968612,0.00039935455,0.0008427839],"domain_scores_gemma":[0.9988161,0.0001350214,0.00013223164,0.0004146432,0.0001874889,0.0003145587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001052218,0.00016572846,0.0005014034,0.0012829825,0.00016847333,0.000084502004,0.00039502842,0.00025051233,0.00031114725],"category_scores_gemma":[0.0009247113,0.00012908457,0.00015033671,0.0006990392,0.0004261845,0.00013922606,0.000039522733,0.0010890326,0.0002625542],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000033232925,0.000017229451,0.00027557314,0.00096875057,0.00013497348,0.0052703903,0.00073103106,0.000008666595,0.000107777414,0.002992646,0.104140446,0.8853193],"study_design_scores_gemma":[0.0023156593,0.0009435206,0.0008891781,0.001811975,0.000039660823,0.009242659,0.0034432062,0.0005636124,0.0006262161,0.0039279247,0.9760136,0.0001827763],"about_ca_topic_score_codex":0.009157328,"about_ca_topic_score_gemma":0.0030575718,"teacher_disagreement_score":0.8851365,"about_ca_system_score_codex":0.018565953,"about_ca_system_score_gemma":0.07706677,"threshold_uncertainty_score":0.99744076},"labels":[],"label_agreement":null},{"id":"W4404186508","doi":"10.51731/cjht.2024.1023","title":"Elranatamab (Elrexfio)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.02548443029172805,"score_gpt":0.3087367537867053,"score_spread":0.28325232349497725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404186508","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.071524225,0.738882,0.00028369704,0.18621607,0.0016182237,0.00021443523,0.000020475625,0.00024277628,0.0009980722],"genre_scores_gemma":[0.9953836,0.0029732343,0.000350226,0.0010224014,0.000026160229,0.0000019466345,0.0000015560556,0.000013911237,0.00022696739],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990579,0.000016678214,0.00040120457,0.00009534829,0.000119372824,0.00030949182],"domain_scores_gemma":[0.99956316,0.000028630882,0.00009386205,0.00016612302,0.00007055156,0.000077645665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005174067,0.00008730246,0.000255871,0.00074769364,0.000100103854,0.00004119905,0.0001503362,0.00010942634,0.00011169904],"category_scores_gemma":[0.00011667177,0.000065092725,0.00011878881,0.00043643994,0.00017649976,0.00008029871,0.000005489566,0.00040587253,0.00001402562],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044712895,0.0000051998986,0.000520561,0.00020885703,0.00009599334,0.00060393487,0.0001726288,3.6198946e-7,0.00018163555,0.00073080894,0.036414847,0.96102047],"study_design_scores_gemma":[0.0004269265,0.0005395197,0.0033741477,0.0008930421,0.000018901226,0.0018867219,0.0014214001,0.000010608215,0.00077424827,0.0011443216,0.98943716,0.00007299445],"about_ca_topic_score_codex":0.0029435367,"about_ca_topic_score_gemma":0.0015328174,"teacher_disagreement_score":0.96094745,"about_ca_system_score_codex":0.0005196596,"about_ca_system_score_gemma":0.0047122478,"threshold_uncertainty_score":0.83593255},"labels":[],"label_agreement":null},{"id":"W4404205526","doi":"10.51731/cjht.2024.1024","title":"Pembrolizumab (Keytruda)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pembrolizumab; Computer science; Medicine; Internal medicine; Cancer","score_opus":0.028657323898609394,"score_gpt":0.3193534515525259,"score_spread":0.2906961276539165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404205526","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15032552,0.6221192,0.000091205875,0.22457995,0.001081641,0.0002506074,0.00002107371,0.00021116217,0.0013196713],"genre_scores_gemma":[0.99560815,0.0034454786,0.00025852295,0.0005163749,0.000027650678,0.0000067784877,0.000001481102,0.000013560144,0.00012199195],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99912566,0.000011370419,0.00033158224,0.00010488821,0.00012086633,0.000305653],"domain_scores_gemma":[0.9995327,0.000033997916,0.00008190164,0.0001625879,0.00007214966,0.00011665515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002040981,0.0000905342,0.0002925262,0.00061777415,0.000088535155,0.000040722964,0.000096680924,0.000081709775,0.000083290084],"category_scores_gemma":[0.00010460338,0.00006632716,0.00010797083,0.00028462015,0.00010068102,0.000058497477,0.000006974379,0.00031791642,0.000024724866],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011396862,0.000016548638,0.0050455616,0.00023118581,0.000100118166,0.0016505907,0.00018031118,0.0000018195612,0.0000070327587,0.0038047556,0.037624322,0.9513264],"study_design_scores_gemma":[0.00058068044,0.0010970052,0.016753873,0.0013418215,0.000056249533,0.002660658,0.0010249978,0.000013437741,0.0004621372,0.002734957,0.97319055,0.00008361755],"about_ca_topic_score_codex":0.0036062496,"about_ca_topic_score_gemma":0.0029081274,"teacher_disagreement_score":0.95124274,"about_ca_system_score_codex":0.00085811055,"about_ca_system_score_gemma":0.004707528,"threshold_uncertainty_score":0.8350952},"labels":[],"label_agreement":null},{"id":"W4404393548","doi":"10.51731/cjht.2024.1025","title":"Overview of Systematic Reviews of ICIs in NSCLC With EGFR, ALK, ROS1, and RET Actionable Driver Mutations","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Health Canada","keywords":"ROS1; Medicine; Cancer research; Oncology; Internal medicine; Cancer; Adenocarcinoma","score_opus":0.07018628142857407,"score_gpt":0.38070954589236666,"score_spread":0.3105232644637926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404393548","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10063212,0.87535924,0.00024646503,0.021274608,0.00018152551,0.001672248,0.000052062078,0.00003566971,0.0005460435],"genre_scores_gemma":[0.9863936,0.0122927055,0.001098731,0.000082722305,0.0000031632399,0.000026994721,0.0000034470236,0.0000083838895,0.00009027653],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9989732,0.000043156142,0.00066011207,0.00008070184,0.000102207094,0.00014061198],"domain_scores_gemma":[0.9992596,0.00008126342,0.00034509244,0.00014123513,0.00012087124,0.00005193249],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039793504,0.00007813195,0.0005831356,0.00058909977,0.000043521384,0.000009623353,0.00005947962,0.000053148953,0.000018915853],"category_scores_gemma":[0.0002657421,0.000049877555,0.00004838339,0.0004637161,0.00011756681,0.00010073186,0.000004615022,0.00016105198,9.351172e-7],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000114539944,0.0002853091,0.049886435,0.47458574,0.001821572,0.0013272106,0.013768486,0.00016237567,0.00033147977,0.028224474,0.013620465,0.41587192],"study_design_scores_gemma":[0.0074773915,0.007790999,0.09451245,0.61458135,0.0031676602,0.0059960517,0.05438775,0.0003494744,0.0016428445,0.01299292,0.19633697,0.00076414144],"about_ca_topic_score_codex":0.0037712548,"about_ca_topic_score_gemma":0.0061823223,"teacher_disagreement_score":0.88576144,"about_ca_system_score_codex":0.00038353947,"about_ca_system_score_gemma":0.0020353564,"threshold_uncertainty_score":0.5701034},"labels":[],"label_agreement":null},{"id":"W4404435811","doi":"10.51731/cjht.2024.1026","title":"Lebrikizumab (Ebglyss)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Psychology","score_opus":0.026680093527297718,"score_gpt":0.3047469040962092,"score_spread":0.27806681056891147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404435811","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.25012907,0.61267614,0.00026395486,0.13198856,0.0014977714,0.00041085432,0.000024952731,0.0005126464,0.0024960295],"genre_scores_gemma":[0.9969627,0.0012732848,0.0008297606,0.00040045357,0.000029863275,0.0000036462357,0.0000029965122,0.000021924898,0.00047537344],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987557,0.000021316506,0.00046866786,0.0001398398,0.00016439485,0.00045010223],"domain_scores_gemma":[0.9993463,0.000046635065,0.0001198835,0.00025168897,0.000085963045,0.00014948794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036034983,0.0001250817,0.00037108627,0.00084502134,0.00010752249,0.000041435444,0.00017375026,0.00014122293,0.0001095624],"category_scores_gemma":[0.00031693658,0.00009598792,0.000116853436,0.00041294238,0.00015511915,0.00009226927,0.000012388201,0.00057204126,0.00007222712],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000111607405,0.000010221655,0.0014556211,0.00030206368,0.00012850671,0.0030657481,0.00021938035,0.0000025363943,0.000029677782,0.0015525434,0.030650355,0.96257216],"study_design_scores_gemma":[0.00092082185,0.0008975934,0.0054435697,0.0016206962,0.000066512745,0.007861689,0.0013308343,0.000056084875,0.0007255383,0.002772404,0.9781773,0.00012696578],"about_ca_topic_score_codex":0.0036090326,"about_ca_topic_score_gemma":0.0015626901,"teacher_disagreement_score":0.9624452,"about_ca_system_score_codex":0.0031185064,"about_ca_system_score_gemma":0.013731207,"threshold_uncertainty_score":0.99186003},"labels":[],"label_agreement":null},{"id":"W4404494745","doi":"10.51731/cjht.2024.1027","title":"Alectinib (Alecensaro)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Alectinib; Medicine; Internal medicine","score_opus":0.03220771378287877,"score_gpt":0.31660962255069,"score_spread":0.2844019087678112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404494745","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.26576322,0.5836792,0.0002565889,0.1441869,0.0019321265,0.00048413326,0.000026635811,0.00058025355,0.00309095],"genre_scores_gemma":[0.9967491,0.0012978865,0.0009381716,0.00046533617,0.00003098207,0.0000035209891,0.0000027386977,0.000021900798,0.0004903738],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987912,0.000022400132,0.00044860694,0.00013834954,0.00015023052,0.00044919612],"domain_scores_gemma":[0.9993641,0.000058562324,0.00011726175,0.00022607704,0.00009203537,0.00014197921],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036533838,0.00012147115,0.00034812783,0.00082914974,0.000112405665,0.000035282086,0.00015267488,0.00013805181,0.0001118825],"category_scores_gemma":[0.00039992787,0.00009425228,0.00010507073,0.00047270357,0.00014555371,0.00008194067,0.000010003994,0.00060132117,0.0000613594],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011578097,0.000012918212,0.003387216,0.00033880142,0.00015130789,0.0028805495,0.00030702283,0.0000022486408,0.00006214947,0.0010874483,0.038622428,0.9531363],"study_design_scores_gemma":[0.0008315347,0.00096130715,0.0052985046,0.0015360654,0.00006031221,0.008123407,0.0012320046,0.000043754066,0.0011501784,0.0021839954,0.97845405,0.00012486144],"about_ca_topic_score_codex":0.0025557831,"about_ca_topic_score_gemma":0.0016927676,"teacher_disagreement_score":0.95301145,"about_ca_system_score_codex":0.0025048647,"about_ca_system_score_gemma":0.012573977,"threshold_uncertainty_score":0.9930238},"labels":[],"label_agreement":null},{"id":"W4404564780","doi":"10.51731/cjht.2024.1028","title":"Avapritinib (Ayvakyt)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Mast cells and histamine","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Systemic mastocytosis; Medicine; Cutaneous Mastocytosis; Internal medicine; Oncology; Bone marrow","score_opus":0.01671379464688355,"score_gpt":0.24949761866987108,"score_spread":0.23278382402298753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404564780","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.032160092,0.9179156,0.0003538116,0.041623663,0.0036250085,0.00014018775,0.000058749556,0.00027529706,0.0038475948],"genre_scores_gemma":[0.99674237,0.0009783461,0.00012349882,0.00022420617,0.000010792447,0.0000019213505,0.000005933877,0.000011997733,0.0019009608],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989544,0.000046649973,0.0004358354,0.00011734885,0.000023129473,0.0004226022],"domain_scores_gemma":[0.99957335,0.00005664785,0.00012145042,0.00015503723,0.00006719532,0.000026329704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048171147,0.00010192286,0.00026538587,0.0006159006,0.0002050326,0.000037078644,0.00030053817,0.00020059376,0.0005664394],"category_scores_gemma":[0.00014376485,0.00008247748,0.00007970438,0.00021919784,0.00030267445,0.00007219598,0.00001562457,0.0005911514,0.0002511653],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000059455583,0.000009437087,0.00027166426,0.00016234194,0.00007617485,0.00026336414,0.00035190495,0.0000013904487,0.0016407198,0.018467128,0.10658636,0.8721636],"study_design_scores_gemma":[0.00014590417,0.00020352135,0.00035403162,0.00020147317,0.0000074495474,0.0007420854,0.0009999961,9.444002e-7,0.001667453,0.0019072379,0.99369174,0.0000781767],"about_ca_topic_score_codex":0.0021757537,"about_ca_topic_score_gemma":0.002276032,"teacher_disagreement_score":0.96458226,"about_ca_system_score_codex":0.00016190471,"about_ca_system_score_gemma":0.001846139,"threshold_uncertainty_score":0.6202114},"labels":[],"label_agreement":null},{"id":"W4404564918","doi":"10.51731/cjht.2024.1029","title":"Ciltacabtagene Autoleucel (Carvykti)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lenalidomide; Medicine; Chimeric antigen receptor; Drug; Refractory (planetary science); Multiple myeloma; Disease; Thalidomide; Internal medicine; Oncology; Intensive care medicine; Pharmacology; Immunotherapy; Cancer","score_opus":0.05463637822091671,"score_gpt":0.35592399706672717,"score_spread":0.30128761884581046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404564918","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.18820117,0.5416071,0.00059701205,0.25998503,0.0018261716,0.0006900982,0.000042691157,0.00070329854,0.006347418],"genre_scores_gemma":[0.99313444,0.0022824595,0.00063200516,0.0006149004,0.000060001734,0.00000519022,0.000002527095,0.000035018864,0.003233444],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983486,0.000044379416,0.0005151528,0.00016703244,0.00030440986,0.00062042824],"domain_scores_gemma":[0.99910897,0.00007329119,0.00009990011,0.0003141703,0.00017694851,0.00022670609],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010132327,0.00013256216,0.0004136001,0.0014013265,0.00013825919,0.00007491403,0.00029507827,0.00018785396,0.00079842686],"category_scores_gemma":[0.00039631347,0.000105961866,0.00015094533,0.000701016,0.00024183815,0.00009394214,0.000021808322,0.0010173527,0.0000570701],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001849464,0.000008928655,0.0007753444,0.00029600054,0.00009413705,0.0018370147,0.00021984408,0.000003157025,0.0024547447,0.0009878151,0.024135703,0.96916884],"study_design_scores_gemma":[0.00034246073,0.00071662024,0.0019153444,0.0006525581,0.00001891708,0.0023988506,0.0011548145,0.00008318967,0.0037026824,0.0019455433,0.9869679,0.00010111599],"about_ca_topic_score_codex":0.002547982,"about_ca_topic_score_gemma":0.0013461785,"teacher_disagreement_score":0.9690677,"about_ca_system_score_codex":0.0010445801,"about_ca_system_score_gemma":0.008545843,"threshold_uncertainty_score":0.9970748},"labels":[],"label_agreement":null},{"id":"W4404639239","doi":"10.51731/cjht.2024.1030","title":"Aflibercept (Eylea HD)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Aflibercept; Reimbursement; Diabetic macular edema; Medicine; Drug; Family medicine; Optometry; Intensive care medicine; Political science; Pharmacology; Surgery; Diabetic retinopathy; Diabetes mellitus; Health care","score_opus":0.025289213416362345,"score_gpt":0.3209214808373789,"score_spread":0.29563226742101656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404639239","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.35752147,0.51878405,0.00013237375,0.11914398,0.00094363093,0.00032051772,0.000040060946,0.000305278,0.0028086072],"genre_scores_gemma":[0.9974329,0.0013432421,0.00036372265,0.00043417752,0.000019243496,0.0000026263776,0.0000029755702,0.000014503688,0.00038662305],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991251,0.00001530085,0.00032218927,0.000101289326,0.00012557351,0.00031049945],"domain_scores_gemma":[0.9995076,0.000023278668,0.00008126052,0.00015199528,0.000067241934,0.00016861354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016598497,0.00009310086,0.0002632928,0.000514523,0.00009333014,0.00003831608,0.00010761391,0.00008096286,0.00009654355],"category_scores_gemma":[0.00014231031,0.00006621459,0.000120044875,0.00026687325,0.0001137784,0.00006894141,0.000007467798,0.0002917923,0.000056665285],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017112101,0.000019431787,0.00821869,0.0002975437,0.0001090916,0.0033245818,0.00014286423,0.0000010912617,0.000010456964,0.0018862302,0.020297911,0.965675],"study_design_scores_gemma":[0.00057790236,0.0016388022,0.0741119,0.0019731538,0.00012269222,0.0031255821,0.0025756592,0.000027685666,0.00013977716,0.008487356,0.907075,0.0001445288],"about_ca_topic_score_codex":0.0016062665,"about_ca_topic_score_gemma":0.00047439386,"teacher_disagreement_score":0.96553046,"about_ca_system_score_codex":0.00037366143,"about_ca_system_score_gemma":0.002923383,"threshold_uncertainty_score":0.5185956},"labels":[],"label_agreement":null},{"id":"W4404639336","doi":"10.51731/cjht.2024.1031","title":"Pembrolizumab (Keytruda)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pembrolizumab; Reimbursement; Medicine; Gemcitabine; Drug; Vial; Audit; Family medicine; Chemotherapy; Medical physics; Internal medicine; Business; Pharmacology; Accounting; Cancer; Political science; Health care; Immunotherapy","score_opus":0.0493223292658819,"score_gpt":0.3740354626978171,"score_spread":0.3247131334319352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404639336","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4480086,0.34640738,0.00072013936,0.1963274,0.00077125395,0.00035829065,0.000012859708,0.00025469172,0.007139375],"genre_scores_gemma":[0.9963884,0.0016474853,0.00087420386,0.00039650447,0.000028785793,0.0000040815753,0.0000012015486,0.0000126830155,0.0006467066],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988255,0.000037937432,0.00041314497,0.0001051104,0.00017230694,0.00044602758],"domain_scores_gemma":[0.99935424,0.000094582756,0.00008071944,0.0001806009,0.00013063362,0.00015924976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007349575,0.00008516469,0.00043642434,0.0009083577,0.00012764783,0.000030501102,0.00017212122,0.00015561096,0.00014572676],"category_scores_gemma":[0.00062819466,0.000062330015,0.00008430173,0.00037163895,0.00028840796,0.00006519581,0.0000121607945,0.00068500655,0.000054640837],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048267655,0.000020689813,0.03968372,0.00068200595,0.00019187755,0.003938719,0.0005178585,8.228607e-7,0.000057402434,0.009977526,0.056929592,0.8879515],"study_design_scores_gemma":[0.000933866,0.0022394427,0.042311065,0.00154042,0.00008836275,0.0085425405,0.0033983728,0.00019542349,0.00017206649,0.010851953,0.9295899,0.00013657362],"about_ca_topic_score_codex":0.0016803328,"about_ca_topic_score_gemma":0.0008349563,"teacher_disagreement_score":0.88781494,"about_ca_system_score_codex":0.00055938365,"about_ca_system_score_gemma":0.011088877,"threshold_uncertainty_score":0.9945173},"labels":[],"label_agreement":null},{"id":"W4404643885","doi":"10.51731/cjht.2024.1032","title":"RapidAI for Stroke Detection and AI Implementation Review","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Vector Institute","keywords":"Stroke (engine); Medicine; Intensive care medicine; Inclusion and exclusion criteria; Systematic review; MEDLINE; Alternative medicine; Pathology","score_opus":0.024362976827991788,"score_gpt":0.35515252006587805,"score_spread":0.3307895432378863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404643885","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010762713,0.73682517,0.011210794,0.23928495,0.0004901545,0.0011140872,0.00004030881,0.00012644705,0.00014535167],"genre_scores_gemma":[0.9684459,0.02600025,0.0015786444,0.0037737451,0.000029920318,0.000032539334,0.000005164027,0.00001534329,0.00011850867],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991867,0.000012444865,0.00038725397,0.000102921644,0.00008729861,0.00022338952],"domain_scores_gemma":[0.99958634,0.000030016263,0.00012981374,0.00010204189,0.00009033539,0.00006144087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058867544,0.00007667357,0.00024226736,0.00045613438,0.0000838083,0.000024149434,0.00006438147,0.000051112795,0.000019032144],"category_scores_gemma":[0.00018418705,0.00006273897,0.00005898748,0.00016449204,0.000053758282,0.000084853324,0.000009750526,0.00021773808,0.0000014174681],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000044992407,0.0000013661576,0.00022005304,0.0022880163,0.00005458599,0.000024310051,0.000035867255,7.9925485e-8,0.00018056932,0.0001479569,0.06968902,0.9273537],"study_design_scores_gemma":[0.00036593425,0.0006034557,0.00085852,0.0022345555,0.00011040525,0.00042191884,0.0015165611,0.000027677906,0.0018349008,0.0002650449,0.9917021,0.000058955153],"about_ca_topic_score_codex":0.0004039967,"about_ca_topic_score_gemma":0.0007361311,"teacher_disagreement_score":0.95768315,"about_ca_system_score_codex":0.00034242944,"about_ca_system_score_gemma":0.00079517876,"threshold_uncertainty_score":0.2558421},"labels":[],"label_agreement":null},{"id":"W4404716728","doi":"10.51731/cjht.2024.1033","title":"Remdesivir (Veklury)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Drug-Induced Hepatotoxicity and Protection","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Virology; Medicine","score_opus":0.1986343850936048,"score_gpt":0.45803941880608745,"score_spread":0.2594050337124827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404716728","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3507589,0.40365958,0.0029779905,0.20713618,0.020652816,0.0011723328,0.0001372988,0.0015286087,0.011976273],"genre_scores_gemma":[0.9968453,0.0013484866,0.00022023743,0.0011813248,0.00006829172,0.000010249444,0.0000016684377,0.000019354342,0.0003050726],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99835074,0.00025314305,0.00055746746,0.00016487596,0.00010849647,0.00056525273],"domain_scores_gemma":[0.9992229,0.000167897,0.00019636088,0.00015027222,0.00010278513,0.00015978249],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019763731,0.00015249614,0.0002900319,0.0008986644,0.00044519434,0.00006352994,0.0003748627,0.0004834765,0.0002058416],"category_scores_gemma":[0.00037737912,0.00013595968,0.000112369555,0.0005551452,0.00025876658,0.00021544218,0.000018526976,0.0020304313,0.00012876294],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013346326,0.000013754131,0.0005714452,0.00017786346,0.00007305789,0.0003981355,0.0004565975,0.000045111763,0.0008016254,0.0070196236,0.017191937,0.9732375],"study_design_scores_gemma":[0.00018426706,0.00021892661,0.00038567215,0.00016411018,0.000020439744,0.0005260653,0.000612017,0.00016829392,0.008533652,0.012705623,0.9763454,0.00013549461],"about_ca_topic_score_codex":0.0012496882,"about_ca_topic_score_gemma":0.0017067564,"teacher_disagreement_score":0.97310203,"about_ca_system_score_codex":0.00052799727,"about_ca_system_score_gemma":0.0028014642,"threshold_uncertainty_score":0.88213265},"labels":[],"label_agreement":null},{"id":"W4404965869","doi":"10.51731/cjht.2024.1036","title":"Artificial Intelligence–Assisted Colonoscopy for Detecting Polyps, Adenomas, Precancerous Lesions, and Colorectal Cancer","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Colonoscopy; Medicine; Colorectal cancer; Randomized controlled trial; Gold standard (test); MEDLINE; Cost effectiveness; Cancer; Internal medicine","score_opus":0.0641731189824856,"score_gpt":0.3514271536074059,"score_spread":0.2872540346249203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404965869","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7143334,0.25578654,0.0062154043,0.021039208,0.0015975316,0.0006683649,0.000053212858,0.00027349294,0.000032843785],"genre_scores_gemma":[0.9964397,0.001192197,0.0020259323,0.00012260953,0.00009764347,0.00006675726,0.0000018900564,0.000024296227,0.000028981469],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986136,0.000033234322,0.00057010713,0.00022684954,0.00012498905,0.00043120404],"domain_scores_gemma":[0.9992006,0.00017407144,0.0002095136,0.00009782621,0.00016859072,0.0001494169],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005594638,0.00014958541,0.00039808394,0.0007208524,0.00036916122,0.0000859381,0.00010904796,0.00019853826,0.000017121285],"category_scores_gemma":[0.0005943628,0.000130216,0.0000947752,0.00051371276,0.00019677558,0.00009596975,0.0000151932845,0.00052832084,0.0000010092573],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006837262,0.000006625565,0.0008242045,0.00028443593,0.000062405976,0.000051079787,0.00030067627,0.000010983428,0.000484063,0.00017463461,0.00032186598,0.9967953],"study_design_scores_gemma":[0.0023739652,0.10449569,0.0754972,0.021217102,0.0012555033,0.016896935,0.04845323,0.01710854,0.32245457,0.030975481,0.35678923,0.0024825654],"about_ca_topic_score_codex":0.008252673,"about_ca_topic_score_gemma":0.029839896,"teacher_disagreement_score":0.99431276,"about_ca_system_score_codex":0.0010022687,"about_ca_system_score_gemma":0.0042249346,"threshold_uncertainty_score":0.99835145},"labels":[],"label_agreement":null},{"id":"W4404998522","doi":"10.51731/cjht.2024.1037","title":"Etrasimod (Velsipity)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Ulcerative colitis; Family medicine; Political science; Health care; Internal medicine","score_opus":0.0116962134788563,"score_gpt":0.2591476059987694,"score_spread":0.2474513925199131,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404998522","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8315715,0.1512266,0.0013408295,0.013086632,0.0013798054,0.00019798148,0.000051988605,0.0001170057,0.001027617],"genre_scores_gemma":[0.99894595,0.00036679613,0.00023428859,0.0002773957,0.000037803453,0.00000274611,0.000004042762,0.00001555567,0.00011544242],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991662,0.000034676475,0.00029214768,0.000125757,0.000073952106,0.00030729602],"domain_scores_gemma":[0.9995349,0.000006526354,0.00008593906,0.00020001961,0.00007878011,0.000093806826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036713568,0.00009367864,0.00011770917,0.00034130024,0.00009801251,0.00004866682,0.00028601842,0.00014488057,0.000015095839],"category_scores_gemma":[0.00026574236,0.000083444815,0.000082947634,0.0001421427,0.00013857719,0.000006627005,0.00001872376,0.00022191642,0.000013677395],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004360039,0.000022487939,0.011735442,0.00055791147,0.000212638,0.0038770956,0.00021090262,0.00008738201,0.004531417,0.010153047,0.081294276,0.8872738],"study_design_scores_gemma":[0.00017959053,0.0002606453,0.019537397,0.00018587873,0.000011748106,0.0003281774,0.00060331204,0.00001647215,0.0037540495,0.0028932628,0.97204286,0.00018659311],"about_ca_topic_score_codex":0.00015707685,"about_ca_topic_score_gemma":0.0015919883,"teacher_disagreement_score":0.8907486,"about_ca_system_score_codex":0.000096937496,"about_ca_system_score_gemma":0.0035383215,"threshold_uncertainty_score":0.62768304},"labels":[],"label_agreement":null},{"id":"W4405076128","doi":"10.51731/cjht.2024.1038","title":"Health System Readiness for Disease-Modifying Therapies for Alzheimer Disease","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Disease; Medicine; Alzheimer's disease; Psychology; Internal medicine","score_opus":0.3957357735027015,"score_gpt":0.44773036010382655,"score_spread":0.05199458660112505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405076128","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028794336,0.5308161,0.030917548,0.4294482,0.0020319454,0.0016422567,0.0020333803,0.00020720168,0.000024007446],"genre_scores_gemma":[0.9896473,0.0009721815,0.0036616004,0.00496884,0.00020226711,0.00035604055,0.0000395959,0.00007210032,0.000080025005],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9944982,0.0001455591,0.0039724875,0.00043850587,0.00008110359,0.0008641687],"domain_scores_gemma":[0.9957779,0.00088076957,0.002211222,0.00044652796,0.00016663993,0.00051696226],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.013364645,0.0002363529,0.0012452295,0.0013123287,0.00068648823,0.00017133595,0.00050609244,0.00012860066,0.000011143292],"category_scores_gemma":[0.0024669007,0.0002529241,0.0002927467,0.00028542214,0.00014378407,0.00045070297,0.000015852325,0.00024800887,0.00004208483],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007974591,0.000036479745,0.008284633,0.014564391,0.00045076796,0.000022203421,0.0022587222,0.00023852591,1.8250695e-7,0.7265566,0.13809223,0.10941554],"study_design_scores_gemma":[0.00072131143,0.00026605168,0.0062389597,0.0025697693,0.000035737157,0.000029066063,0.007495204,0.0062955604,0.0000011109812,0.08280048,0.893114,0.0004327876],"about_ca_topic_score_codex":0.0030806367,"about_ca_topic_score_gemma":0.0011486396,"teacher_disagreement_score":0.9867679,"about_ca_system_score_codex":0.0020751297,"about_ca_system_score_gemma":0.0066457805,"threshold_uncertainty_score":0.9999923},"labels":[],"label_agreement":null},{"id":"W4405323691","doi":"10.51731/cjht.2024.1040","title":"Evolocumab (Repatha)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Evolocumab; Medicine; Reimbursement; Statin; Hyperlipidemia; Internal medicine; Discontinuation; Physical therapy; Endocrinology; Cholesterol; Lipoprotein; Diabetes mellitus; Health care","score_opus":0.019935744332750752,"score_gpt":0.28352586770971805,"score_spread":0.2635901233769673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405323691","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11171389,0.7905327,0.0010446603,0.09346696,0.0012985879,0.00039834343,0.000012576029,0.0003427641,0.0011895087],"genre_scores_gemma":[0.9960039,0.0023288885,0.0008724484,0.00057248725,0.000063459884,0.0000048092916,0.0000014516728,0.000020010732,0.00013251077],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99864334,0.0000392817,0.00047298963,0.00013940076,0.00026508557,0.00043989945],"domain_scores_gemma":[0.99920344,0.000020429146,0.000100454796,0.00036639304,0.00013827842,0.0001710117],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013232254,0.00010760897,0.00043609596,0.0007592315,0.0001330489,0.000040478328,0.00015570364,0.00014971955,0.00004102949],"category_scores_gemma":[0.0003507163,0.00008020286,0.0002366477,0.0004437017,0.00012608503,0.000089766734,0.000011177613,0.0006246139,0.000027998256],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00000570578,0.0000056927615,0.00060622924,0.0004723893,0.00010222938,0.0014091303,0.00013799076,0.0000014516411,0.000011708674,0.00219524,0.009982746,0.9850695],"study_design_scores_gemma":[0.00033412362,0.0007345942,0.004512384,0.0011444081,0.000045494424,0.0059785964,0.0014420879,0.000028846243,0.00027112878,0.0027215641,0.9826871,0.000099678975],"about_ca_topic_score_codex":0.0046845903,"about_ca_topic_score_gemma":0.001031792,"teacher_disagreement_score":0.9849698,"about_ca_system_score_codex":0.000631657,"about_ca_system_score_gemma":0.008452052,"threshold_uncertainty_score":0.9971691},"labels":[],"label_agreement":null},{"id":"W4405389006","doi":"10.51731/cjht.2024.1043","title":"Emerging Antiviral Drugs to Prevent or Treat Influenza","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Randomized controlled trial; Intensive care medicine; Placebo; Drug; Alternative medicine; Pharmacology; Internal medicine; Pathology","score_opus":0.0864022376009829,"score_gpt":0.4259711340832469,"score_spread":0.33956889648226396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405389006","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.51277655,0.3003576,0.00012804901,0.18160138,0.00084916205,0.0012140399,0.00006429416,0.0005332845,0.0024756554],"genre_scores_gemma":[0.99468017,0.0014883425,0.0009023681,0.002101061,0.000050261322,0.000018574538,6.582826e-7,0.000031547057,0.00072702294],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980161,0.00005126111,0.00063699513,0.00019240341,0.00032450736,0.0007786868],"domain_scores_gemma":[0.99910426,0.00009773645,0.00010722042,0.0002584668,0.00021153713,0.00022076623],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008783028,0.0001745942,0.0005055788,0.0017623245,0.00025602395,0.000070008966,0.00026539224,0.00010912171,0.000047758054],"category_scores_gemma":[0.0014950144,0.000117503325,0.00011421731,0.0009176346,0.00019476566,0.00015661799,0.000056780584,0.0007014161,0.000062964486],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000085766755,0.000018004068,0.0013383529,0.00061823876,0.00013254708,0.0012840172,0.0023366546,0.000008437635,0.00011184808,0.00041452475,0.028783012,0.9648686],"study_design_scores_gemma":[0.00036943515,0.0013454742,0.0016138343,0.0020358225,0.000031245883,0.0002482839,0.0067694723,0.000014209095,0.0020497064,0.0004932666,0.98488545,0.00014379744],"about_ca_topic_score_codex":0.002727855,"about_ca_topic_score_gemma":0.0016911668,"teacher_disagreement_score":0.9647248,"about_ca_system_score_codex":0.0010760901,"about_ca_system_score_gemma":0.0056328224,"threshold_uncertainty_score":0.9992385},"labels":[],"label_agreement":null},{"id":"W4405389146","doi":"10.51731/cjht.2024.1042","title":"Fruquintinib (Fruzaqla)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.038644650356632254,"score_gpt":0.35176466344841517,"score_spread":0.31312001309178294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405389146","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24761117,0.56099796,0.0006934767,0.18325052,0.0019242987,0.0005753035,0.000021945172,0.00058496656,0.004340401],"genre_scores_gemma":[0.99727607,0.0010171131,0.0006594083,0.00043634287,0.000044965258,0.0000036229687,0.0000016009075,0.000023522016,0.0005373707],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99842894,0.00003100848,0.00051377,0.00015030369,0.00027590586,0.0006000751],"domain_scores_gemma":[0.9991563,0.00009996621,0.00009693347,0.00028828866,0.00016148725,0.00019702953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009088475,0.00011101372,0.00036234927,0.0010991998,0.000112529946,0.000065805405,0.00027531196,0.00016462294,0.00012036115],"category_scores_gemma":[0.00090555346,0.000084667605,0.000116239586,0.0006040192,0.00030289014,0.00009855168,0.000024451456,0.00076359167,0.00009023743],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000019899406,0.000011031853,0.00038230975,0.0008184829,0.00010761935,0.0051715863,0.00036211804,0.0000044512544,0.00006755144,0.0049803914,0.07137112,0.91670346],"study_design_scores_gemma":[0.001561822,0.0007068452,0.0005762271,0.0015681154,0.00002399694,0.008473778,0.0018468861,0.00044037448,0.0008646646,0.0033294046,0.9804977,0.0001101404],"about_ca_topic_score_codex":0.005460688,"about_ca_topic_score_gemma":0.0013105894,"teacher_disagreement_score":0.9165933,"about_ca_system_score_codex":0.011494265,"about_ca_system_score_gemma":0.07507536,"threshold_uncertainty_score":0.99230045},"labels":[],"label_agreement":null},{"id":"W4405396598","doi":"10.51731/cjht.2024.1045","title":"Atogepant (Qulipta)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Migraine; Family medicine; Medicine; Drug class; Drug; Psychiatry; Political science; Health care","score_opus":0.04343733291579114,"score_gpt":0.33127145157457966,"score_spread":0.2878341186587885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405396598","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06850517,0.6667121,0.00022154348,0.2612711,0.0003135026,0.00019392118,0.000012440135,0.00025400755,0.0025162555],"genre_scores_gemma":[0.9948491,0.002813714,0.0005593282,0.0008082259,0.00003944863,0.0000023115028,9.242262e-7,0.000012537519,0.0009144187],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99901485,0.000014437159,0.0003950881,0.00009712811,0.00011903835,0.0003594567],"domain_scores_gemma":[0.99953115,0.000035562025,0.00008058262,0.0001455648,0.00010484037,0.00010230369],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044443918,0.000093635615,0.00034807005,0.0006700154,0.00013713821,0.000024164754,0.00011195559,0.00008974898,0.000049738504],"category_scores_gemma":[0.00037410937,0.000067079316,0.00011891937,0.00032650484,0.00015674088,0.000055331224,0.000011811929,0.00048626738,0.00002867444],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009542023,0.000010759967,0.005850466,0.0006990499,0.00017756694,0.0016921952,0.0010801489,5.6368447e-7,0.000069890826,0.0070095495,0.53376704,0.4496332],"study_design_scores_gemma":[0.00014242441,0.00044418575,0.0058770333,0.00073733396,0.000028382397,0.0013210265,0.0037039192,0.000010245542,0.00014555169,0.0021306775,0.9853971,0.00006214004],"about_ca_topic_score_codex":0.002175233,"about_ca_topic_score_gemma":0.0038911384,"teacher_disagreement_score":0.9263439,"about_ca_system_score_codex":0.0002651271,"about_ca_system_score_gemma":0.0037852507,"threshold_uncertainty_score":0.6714872},"labels":[],"label_agreement":null},{"id":"W4405500642","doi":"10.51731/cjht.2024.1047","title":"Brentuximab Vedotin (Adcetris)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Brentuximab vedotin; Reimbursement; Dacarbazine; Vinblastine; Medicine; Hodgkin lymphoma; Doxorubicin; Oncology; Internal medicine; Pharmacology; Lymphoma; Chemotherapy; Political science","score_opus":0.0252575892802914,"score_gpt":0.30406359354986845,"score_spread":0.278806004269577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405500642","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22696514,0.598601,0.00007596877,0.17123884,0.001233143,0.0002945966,0.000027466687,0.00027120652,0.00129262],"genre_scores_gemma":[0.9968226,0.002112341,0.00041968506,0.00048638115,0.00002425214,0.000005257044,0.0000025929533,0.000012987275,0.00011392256],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989655,0.00001786092,0.000405285,0.000118714685,0.00013773802,0.00035489566],"domain_scores_gemma":[0.9994528,0.0000533339,0.00010384657,0.0001752896,0.000080014725,0.00013466632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003012521,0.000106972824,0.00033301336,0.00076279946,0.00010170843,0.000050763418,0.00012192081,0.00010173377,0.00005369751],"category_scores_gemma":[0.0002140897,0.00007616156,0.000117490476,0.00038019856,0.0001028453,0.00007070617,0.000009612131,0.00026459762,0.00005024188],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000067832552,0.00003640761,0.011917964,0.00017456815,0.00009924311,0.0021059432,0.00012767325,9.0857e-7,0.000009256744,0.0025108384,0.03330064,0.9497098],"study_design_scores_gemma":[0.0009849928,0.0011694074,0.033796124,0.0014267659,0.000068176785,0.0030592731,0.0011879379,0.000019377621,0.0010669803,0.0020799069,0.9550322,0.00010881214],"about_ca_topic_score_codex":0.002558972,"about_ca_topic_score_gemma":0.0008220603,"teacher_disagreement_score":0.94960093,"about_ca_system_score_codex":0.0008975765,"about_ca_system_score_gemma":0.0045413957,"threshold_uncertainty_score":0.8056241},"labels":[],"label_agreement":null},{"id":"W4405500883","doi":"10.51731/cjht.2024.1046","title":"Venetoclax (Venclexta)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Venetoclax; Obinutuzumab; Medicine; Chronic lymphocytic leukemia; Reimbursement; Ibrutinib; Chlorambucil; Internal medicine; Intensive care medicine; Leukemia; Oncology; Chemotherapy; Health care; Political science","score_opus":0.03855962024480177,"score_gpt":0.35098683390007007,"score_spread":0.3124272136552683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405500883","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23896751,0.6512239,0.00053242804,0.1039183,0.0015066031,0.0005516821,0.000018121578,0.0004576235,0.0028238758],"genre_scores_gemma":[0.9977129,0.0010409385,0.00049342855,0.00033490424,0.000037818423,0.0000037780915,0.0000013479747,0.000020390306,0.00035448885],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986206,0.000027885344,0.00043479016,0.0001322363,0.00024969407,0.0005347595],"domain_scores_gemma":[0.99927807,0.000077113706,0.00008189732,0.00025939225,0.00012554388,0.0001779597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007419001,0.00009686536,0.00031119655,0.0009268778,0.00010600049,0.000052829953,0.0002483366,0.00014469001,0.0000842763],"category_scores_gemma":[0.0005964721,0.00007537968,0.00009863715,0.0005443455,0.00026018528,0.000085150146,0.000020638037,0.00064582314,0.00006890451],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000019763365,0.000006073093,0.00023216958,0.00079697475,0.000093469615,0.005533456,0.00032437465,0.00001937364,0.00008140008,0.0042783637,0.045774132,0.94284046],"study_design_scores_gemma":[0.0014028979,0.0007919367,0.0005886223,0.0016963093,0.000022715189,0.008695841,0.001311416,0.0009871166,0.0008982964,0.0048515964,0.97864413,0.000109134766],"about_ca_topic_score_codex":0.0063015344,"about_ca_topic_score_gemma":0.0012085914,"teacher_disagreement_score":0.9427313,"about_ca_system_score_codex":0.024779579,"about_ca_system_score_gemma":0.1200972,"threshold_uncertainty_score":0.9789641},"labels":[],"label_agreement":null},{"id":"W4405543459","doi":"10.51731/cjht.2024.1048","title":"Enfortumab Vedotin (Padcev)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Internal medicine; Medicine; Computer science","score_opus":0.03084868347907145,"score_gpt":0.3204241996970247,"score_spread":0.28957551621795324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405543459","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14331214,0.6271518,0.00012349298,0.22590923,0.0015235019,0.0003418504,0.000032758235,0.00026103162,0.0013441828],"genre_scores_gemma":[0.9959797,0.0029088538,0.00036173355,0.00056171627,0.000030688403,0.000007580589,0.000002280423,0.000013765859,0.00013366816],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990683,0.000010502336,0.00037770017,0.00010568024,0.0001203362,0.00031747698],"domain_scores_gemma":[0.9995069,0.000040017996,0.00009601877,0.00016461177,0.00007044525,0.00012202425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026345477,0.0000952563,0.00030026826,0.0005950551,0.00008928907,0.00003921062,0.00010072637,0.00008330915,0.00008526127],"category_scores_gemma":[0.00013275622,0.00006999036,0.0001082904,0.0002801021,0.00009992824,0.00006123792,0.000007687396,0.00033215564,0.000025916392],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000006983089,0.000016362806,0.006023886,0.00020402914,0.00009268331,0.0014177838,0.00017119606,0.0000021467133,0.0000059237764,0.0031415445,0.03867527,0.95024216],"study_design_scores_gemma":[0.00041885316,0.0009645778,0.014243161,0.0013895399,0.000050688373,0.0015586052,0.0010518953,0.0000140774255,0.0005643834,0.0019529054,0.97771037,0.0000809746],"about_ca_topic_score_codex":0.005917028,"about_ca_topic_score_gemma":0.003863252,"teacher_disagreement_score":0.9501612,"about_ca_system_score_codex":0.0008926988,"about_ca_system_score_gemma":0.0056773764,"threshold_uncertainty_score":0.9999595},"labels":[],"label_agreement":null},{"id":"W4405573853","doi":"10.51731/cjht.2024.1049","title":"Canadian Trends in Estimated Drug Purchases and Projections: 2024 and 2025","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Audit; Business; Biosimilar; Specialty; Agricultural economics; Medicine; Accounting; Economics; Family medicine","score_opus":0.08836610602824099,"score_gpt":0.3365487014798369,"score_spread":0.2481825954515959,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405573853","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24024144,0.5153702,0.000021368058,0.23760319,0.000966269,0.00017493777,0.0004965801,0.000057165453,0.005068874],"genre_scores_gemma":[0.99268705,0.00610257,0.00013984756,0.0006535093,0.000013259779,0.000005941311,0.0000023267319,0.000011567318,0.00038393188],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988487,0.000009930732,0.00054780504,0.00017672186,0.00001105582,0.00040581502],"domain_scores_gemma":[0.99954253,0.000038787715,0.000112201626,0.00009193166,0.0000134245065,0.00020109938],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060670543,0.0001020942,0.0003052599,0.0031915142,0.0001399332,0.00015271688,0.00012922025,0.000094205396,0.000099577606],"category_scores_gemma":[0.00014505094,0.000109046116,0.000031433417,0.00053272414,0.00013211757,0.0001803229,0.000015002077,0.00039662726,0.000013858499],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000041009407,0.000009830757,0.049273312,0.00019092744,0.000061870094,0.00019194781,0.0009193146,0.00003596236,9.2174236e-7,0.1777246,0.03996275,0.7316245],"study_design_scores_gemma":[0.00026485106,0.000091914306,0.01857855,0.00021698904,0.000004575162,0.00021791502,0.0006475872,0.0033274044,0.000007631679,0.09704435,0.87938774,0.00021047157],"about_ca_topic_score_codex":0.4111923,"about_ca_topic_score_gemma":0.5399578,"teacher_disagreement_score":0.839425,"about_ca_system_score_codex":0.0006318073,"about_ca_system_score_gemma":0.0010455014,"threshold_uncertainty_score":0.5927286},"labels":[],"label_agreement":null},{"id":"W4405641897","doi":"10.51731/cjht.2024.1050","title":"Inclisiran (Leqvio)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Familial hypercholesterolemia; Drug; Syringe; Disease; Intensive care medicine; Family medicine; Internal medicine; Cholesterol; Pharmacology; Political science; Psychiatry","score_opus":0.023971632236052604,"score_gpt":0.29090637191898483,"score_spread":0.26693473968293224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405641897","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.119800694,0.76287293,0.0010740254,0.11262494,0.0013912847,0.00043870177,0.000014649669,0.00034142245,0.0014413717],"genre_scores_gemma":[0.9964597,0.001799407,0.0007296682,0.0008078417,0.00006928128,0.000003727287,0.0000016754587,0.000020195082,0.00010849137],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986639,0.000041506944,0.0004912468,0.00013606621,0.00024071446,0.00042653727],"domain_scores_gemma":[0.99925315,0.000023224016,0.00009401679,0.0003288878,0.00012302911,0.00017767705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014182995,0.000106493964,0.00043213664,0.0007897817,0.00014635055,0.00004642626,0.0001611495,0.00014732432,0.00003838092],"category_scores_gemma":[0.00031164178,0.00007894559,0.00022051457,0.00048373052,0.00012962073,0.000092020186,0.000012484481,0.0006558307,0.000024451703],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004461117,0.000005020464,0.00058564695,0.00042763527,0.000086968466,0.00093980314,0.00014621225,0.0000011052203,0.000011263536,0.0021945934,0.0052722166,0.9903251],"study_design_scores_gemma":[0.00031207292,0.00064306066,0.00480167,0.0010665419,0.000035817007,0.0034604657,0.001267857,0.000013741696,0.00022124001,0.0026227136,0.9854685,0.000086310654],"about_ca_topic_score_codex":0.0050401306,"about_ca_topic_score_gemma":0.0013874854,"teacher_disagreement_score":0.9902388,"about_ca_system_score_codex":0.000506767,"about_ca_system_score_gemma":0.006937589,"threshold_uncertainty_score":0.99869215},"labels":[],"label_agreement":null},{"id":"W4406146809","doi":"10.51731/cjht.25.1054","title":"Ferric Carboxymaltose (Ferinject)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Reimbursement; Anemia; Iron-deficiency anemia; Hypophosphatemia; Pediatrics; Iron deficiency; Drug; Internal medicine; Pharmacology; Health care","score_opus":0.0114566010590819,"score_gpt":0.27536329185759706,"score_spread":0.26390669079851514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406146809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5006777,0.27208185,0.0002773768,0.2147044,0.0013896304,0.00046413002,0.000007031047,0.00022674388,0.010171113],"genre_scores_gemma":[0.99570066,0.0018376991,0.00034185854,0.0016793644,0.0000055629466,0.0000022313043,7.108503e-7,0.000008641626,0.00042330072],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988757,0.000026480622,0.00048273453,0.00010235978,0.00009548831,0.00041725807],"domain_scores_gemma":[0.99932283,0.000028196837,0.00017187592,0.00022203839,0.00014632329,0.00010874753],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033298138,0.00010712724,0.00038418936,0.0010020613,0.00018772349,0.000015674168,0.0001842978,0.00021458193,0.000021613962],"category_scores_gemma":[0.00065183104,0.00008321521,0.00009305783,0.0006702184,0.0001825974,0.000038839466,0.000015151497,0.0006240054,0.000006544666],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039512895,0.000040137093,0.023126185,0.0004013217,0.00015137627,0.0006352452,0.00028281557,0.000025145302,0.00007826819,0.003984898,0.029621106,0.941614],"study_design_scores_gemma":[0.002202494,0.0011943971,0.04576592,0.0018174264,0.00009811489,0.0013566631,0.013629081,0.00004595414,0.0007651706,0.008680726,0.9242066,0.00023743622],"about_ca_topic_score_codex":0.0039016295,"about_ca_topic_score_gemma":0.0014900174,"teacher_disagreement_score":0.94137657,"about_ca_system_score_codex":0.00041912767,"about_ca_system_score_gemma":0.0059545687,"threshold_uncertainty_score":0.99968076},"labels":[],"label_agreement":null},{"id":"W4406146832","doi":"10.51731/cjht.25.1055","title":"Capivasertib (Truqap)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Fulvestrant; Reimbursement; Medicine; Oncology; Metastatic breast cancer; Regimen; Internal medicine; Anastrozole; Cancer; Breast cancer; Tamoxifen; Political science","score_opus":0.01585888414316502,"score_gpt":0.3169227501187481,"score_spread":0.3010638659755831,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406146832","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20674603,0.38522944,0.0054143895,0.39766547,0.0015048463,0.0005820321,0.000019428417,0.00035803436,0.0024803437],"genre_scores_gemma":[0.99391425,0.00031749287,0.0028156003,0.0026007467,0.000011159905,0.000003998662,8.3862426e-7,0.000010236037,0.00032569462],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989451,0.000020734651,0.00044227345,0.00010226759,0.000100339974,0.0003892583],"domain_scores_gemma":[0.9992021,0.000032142558,0.00021893905,0.00026218567,0.0001957329,0.00008890792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027347135,0.000105037376,0.0003867014,0.0008322359,0.00015153899,0.000012461089,0.00021469672,0.00010594918,0.000028169561],"category_scores_gemma":[0.00039159885,0.000086931956,0.0000731662,0.0004513633,0.00023706419,0.00007677359,0.0000123342725,0.0004215844,0.0000052672635],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039650255,0.0000117309855,0.007746908,0.00012868064,0.000066694665,0.00013716365,0.00011099695,0.000007452214,0.00013633164,0.0029691518,0.002604649,0.9860406],"study_design_scores_gemma":[0.001358287,0.00040391827,0.032327767,0.0009915346,0.000028261446,0.00068860356,0.003941304,0.0000044735284,0.00319675,0.016380701,0.9405682,0.0001101627],"about_ca_topic_score_codex":0.0020437376,"about_ca_topic_score_gemma":0.0019775745,"teacher_disagreement_score":0.98593044,"about_ca_system_score_codex":0.00070604467,"about_ca_system_score_gemma":0.0054433537,"threshold_uncertainty_score":0.96562755},"labels":[],"label_agreement":null},{"id":"W4406146939","doi":"10.51731/cjht.25.1053","title":"Exagamglogene autotemcel (Casgevy)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Thalassemia; Medicine; Hematologist; Beta thalassemia; Red Cell; Malignancy; Pediatrics; Hematopoietic stem cell; Hemoglobinopathy; Hematopoietic stem cell transplantation; Internal medicine; Stem cell; Transplantation; Haematopoiesis; Hemolytic anemia; Biology; Genetics; Disease","score_opus":0.014059258815711047,"score_gpt":0.27877952370201586,"score_spread":0.2647202648863048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406146939","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24937189,0.38544783,0.0011046152,0.35099036,0.0016745781,0.0005256646,0.000011800626,0.0002799862,0.010593283],"genre_scores_gemma":[0.9943188,0.0020297258,0.00071359973,0.0022368343,0.0000066807534,0.0000021501878,0.0000013669434,0.000009407512,0.0006814618],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987817,0.000028336632,0.00054338056,0.000110314286,0.00010077946,0.00043550445],"domain_scores_gemma":[0.9992556,0.000025838304,0.00020533471,0.00023910493,0.00016017137,0.0001139353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041906707,0.00011167294,0.00040166188,0.0009523393,0.00020688717,0.000016510585,0.00020037038,0.00025604235,0.000033298467],"category_scores_gemma":[0.00052733184,0.000086747445,0.00010209824,0.00059598405,0.0002191918,0.00004121556,0.000015524485,0.0005834933,0.000009930405],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022876387,0.000031983815,0.009463003,0.0002516601,0.00011837348,0.00044849826,0.00014327002,0.000017014247,0.00011137903,0.003907093,0.0375772,0.9479076],"study_design_scores_gemma":[0.0013150582,0.00058052246,0.017257689,0.0011177011,0.000058577396,0.0008263944,0.005548295,0.000029708855,0.00091497344,0.005277111,0.96693504,0.00013893953],"about_ca_topic_score_codex":0.0021631303,"about_ca_topic_score_gemma":0.00087068725,"teacher_disagreement_score":0.9477687,"about_ca_system_score_codex":0.0003924975,"about_ca_system_score_gemma":0.006254854,"threshold_uncertainty_score":0.99937874},"labels":[],"label_agreement":null},{"id":"W4406146972","doi":"10.51731/cjht.25.1052","title":"Exagamglogene Autotemcel (Casgevy)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Hematologist; Internal medicine; Disease; Transcranial Doppler; Stem cell; Hematopoietic stem cell transplantation; Oncology; Pediatrics; Surgery","score_opus":0.014059258815711047,"score_gpt":0.27877952370201586,"score_spread":0.2647202648863048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406146972","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24937189,0.38544783,0.0011046152,0.35099036,0.0016745781,0.0005256646,0.000011800626,0.0002799862,0.010593283],"genre_scores_gemma":[0.9943188,0.0020297258,0.00071359973,0.0022368343,0.0000066807534,0.0000021501878,0.0000013669434,0.000009407512,0.0006814618],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987817,0.000028336632,0.00054338056,0.000110314286,0.00010077946,0.00043550445],"domain_scores_gemma":[0.9992556,0.000025838304,0.00020533471,0.00023910493,0.00016017137,0.0001139353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041906707,0.00011167294,0.00040166188,0.0009523393,0.00020688717,0.000016510585,0.00020037038,0.00025604235,0.000033298467],"category_scores_gemma":[0.00052733184,0.000086747445,0.00010209824,0.00059598405,0.0002191918,0.00004121556,0.000015524485,0.0005834933,0.000009930405],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022876387,0.000031983815,0.009463003,0.0002516601,0.00011837348,0.00044849826,0.00014327002,0.000017014247,0.00011137903,0.003907093,0.0375772,0.9479076],"study_design_scores_gemma":[0.0013150582,0.00058052246,0.017257689,0.0011177011,0.000058577396,0.0008263944,0.005548295,0.000029708855,0.00091497344,0.005277111,0.96693504,0.00013893953],"about_ca_topic_score_codex":0.0021631303,"about_ca_topic_score_gemma":0.00087068725,"teacher_disagreement_score":0.9477687,"about_ca_system_score_codex":0.0003924975,"about_ca_system_score_gemma":0.006254854,"threshold_uncertainty_score":0.99937874},"labels":[],"label_agreement":null},{"id":"W4406174727","doi":"10.51731/cjht.25.1056","title":"Spesolimab (Spevigo)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Phytochemical Studies and Bioactivities","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Psychology","score_opus":0.00952296609788956,"score_gpt":0.26550730500820074,"score_spread":0.2559843389103112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406174727","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.54742664,0.37491786,0.0017142302,0.06805026,0.0009991578,0.0002728881,0.000039376137,0.000049471797,0.0065301526],"genre_scores_gemma":[0.9972209,0.0014869145,0.00023458147,0.00080626603,0.000017380375,0.0000022867257,0.0000020863085,0.000004172603,0.00022542183],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992956,0.000017283532,0.0002515788,0.00009936326,0.0000469305,0.00028926547],"domain_scores_gemma":[0.9995856,0.000008715105,0.00013456693,0.00015191395,0.000084870415,0.00003428481],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017912214,0.00008463114,0.00018897558,0.00013788146,0.00015320764,0.000015986343,0.00026310972,0.00011243234,0.0000037376585],"category_scores_gemma":[0.00025060607,0.00006906231,0.00007008076,0.00014304464,0.00019915838,0.0000027811213,0.000042345426,0.00015291505,0.0000010911843],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004970477,0.000038996113,0.0095537035,0.00014267396,0.00023205571,0.00003020465,0.00006471869,0.0000069561183,0.021618066,0.0025646565,0.1298186,0.8358797],"study_design_scores_gemma":[0.00022701037,0.0002388332,0.0022397058,0.000083039486,0.000006122486,0.000029993435,0.0011596543,7.325942e-7,0.057278153,0.0025102638,0.93613666,0.00008980847],"about_ca_topic_score_codex":0.0006204438,"about_ca_topic_score_gemma":0.0015358776,"teacher_disagreement_score":0.83578986,"about_ca_system_score_codex":0.00008059051,"about_ca_system_score_gemma":0.0009918603,"threshold_uncertainty_score":0.28162795},"labels":[],"label_agreement":null},{"id":"W4406218158","doi":"10.51731/cjht.25.1057","title":"Remdesivir (Veklury)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Coronavirus disease 2019 (COVID-19); Pneumonia; Family medicine; Intensive care medicine; Political science; Internal medicine; Health care","score_opus":0.059734840009306206,"score_gpt":0.4505808174288163,"score_spread":0.3908459774195101,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406218158","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.021230623,0.078521475,0.0016978708,0.894857,0.0005836485,0.00048935175,0.0000095810465,0.00017418747,0.00243626],"genre_scores_gemma":[0.99072707,0.0025766243,0.0007391954,0.0050833663,0.000011707628,0.0000050344247,4.3790527e-7,0.0000072488538,0.0008493163],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99842393,0.000053894342,0.00065633544,0.00013918531,0.00020389038,0.0005227444],"domain_scores_gemma":[0.9979629,0.0009602943,0.00021464219,0.00033713787,0.00037596992,0.00014905828],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0013339927,0.00010263383,0.0005236062,0.0011105184,0.00023270503,0.00001838093,0.0003230021,0.00013789054,0.000025409956],"category_scores_gemma":[0.051672935,0.0000786803,0.00011959377,0.00070439774,0.00045949416,0.000051624873,0.00005280596,0.0008094054,0.000010817797],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045950488,0.000028186434,0.03077748,0.00065791764,0.00012134923,0.000393299,0.00006376368,0.0000060055036,0.000036734797,0.00379185,0.04645578,0.9176217],"study_design_scores_gemma":[0.00076510315,0.0007135134,0.060052224,0.000996194,0.000025044055,0.00001956736,0.0007719268,0.000013049282,0.00027803602,0.011866945,0.92442334,0.00007503837],"about_ca_topic_score_codex":0.0028748352,"about_ca_topic_score_gemma":0.0015943209,"teacher_disagreement_score":0.9694964,"about_ca_system_score_codex":0.00082939985,"about_ca_system_score_gemma":0.0122528095,"threshold_uncertainty_score":0.9933468},"labels":[],"label_agreement":null},{"id":"W4406285138","doi":"10.51731/cjht.25.1058","title":"Ravulizumab (Ultomiris)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.008815170847852714,"score_gpt":0.2506433297686746,"score_spread":0.24182815892082188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406285138","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0685084,0.90219253,0.0006669011,0.02352694,0.002144724,0.0001617162,0.000010391428,0.00011917286,0.0026692313],"genre_scores_gemma":[0.9978739,0.00060833164,0.000028664384,0.0005938776,2.9577632e-7,0.0000032053686,0.000004217502,0.000005904622,0.00088161265],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986484,0.00009573731,0.0005935956,0.00011754821,0.000022395852,0.0005222937],"domain_scores_gemma":[0.9992476,0.00006034284,0.00030292157,0.0002596883,0.00012529753,0.000004149354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005701854,0.00012595253,0.00036657305,0.0008372354,0.0005092226,0.00002018998,0.0006102555,0.00025026948,0.00008303921],"category_scores_gemma":[0.00047137483,0.00010815153,0.00010143208,0.00044530965,0.00047821502,0.00008628432,0.000027294313,0.00060494797,0.00006171524],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018797515,0.000021194532,0.0004410282,0.000035229536,0.00007882038,0.000012739995,0.00029020788,0.000008427841,0.0010991987,0.007773851,0.0066356556,0.9835848],"study_design_scores_gemma":[0.0007742886,0.00013271463,0.0049575875,0.00018626562,0.000011267353,0.00011463369,0.005639058,7.375076e-7,0.004214376,0.0045251544,0.97933793,0.000106001935],"about_ca_topic_score_codex":0.0029769526,"about_ca_topic_score_gemma":0.00023231418,"teacher_disagreement_score":0.98347884,"about_ca_system_score_codex":0.00018897504,"about_ca_system_score_gemma":0.0029383085,"threshold_uncertainty_score":0.5212433},"labels":[],"label_agreement":null},{"id":"W4406494073","doi":"10.51731/cjht.25.1059","title":"Cabotegravir (Apretude)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Political science","score_opus":0.014424990178748594,"score_gpt":0.2988635952017083,"score_spread":0.2844386050229597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406494073","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20646936,0.1415937,0.0006308665,0.6409851,0.00089063303,0.00064163166,0.000012962125,0.00023786297,0.008537941],"genre_scores_gemma":[0.99079067,0.0005850425,0.002165094,0.0009012906,0.000005364976,0.0000046792584,0.000002668547,0.0000071534732,0.005538044],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990076,0.00002060174,0.00042868167,0.000096804004,0.00010597487,0.0003403478],"domain_scores_gemma":[0.99940574,0.000028320424,0.00015333557,0.00018728833,0.00013383082,0.000091472066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003156457,0.00010741707,0.00036466427,0.0008959611,0.00016625866,0.000016927226,0.00016216295,0.00011177871,0.000027572672],"category_scores_gemma":[0.00026915345,0.000080703205,0.00007258737,0.0004226427,0.00012062889,0.000043804954,0.000011957131,0.0003220562,0.00001305977],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024627945,0.000041407544,0.09011804,0.00015977837,0.00022700394,0.00065632054,0.000400623,0.0000015818231,0.000028273864,0.0058127013,0.076386824,0.8261428],"study_design_scores_gemma":[0.0011917017,0.00021526677,0.043697078,0.00089024124,0.000055148925,0.00028140694,0.003221146,0.0000038524963,0.0009823893,0.004621477,0.9447322,0.00010810421],"about_ca_topic_score_codex":0.0010513249,"about_ca_topic_score_gemma":0.0024166312,"teacher_disagreement_score":0.8683454,"about_ca_system_score_codex":0.0006223694,"about_ca_system_score_gemma":0.0061755353,"threshold_uncertainty_score":0.99945855},"labels":[],"label_agreement":null},{"id":"W4406494084","doi":"10.51731/cjht.25.1060","title":"Cariprazine (Vraylar)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.024610940232256535,"score_gpt":0.332200500069454,"score_spread":0.3075895598371975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406494084","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3306977,0.2377316,0.00034081473,0.42770243,0.0005316768,0.00049419724,0.00001671541,0.00013874925,0.0023461073],"genre_scores_gemma":[0.9962965,0.00071410526,0.0020210736,0.0006287145,0.000006917955,0.0000046670766,0.0000018788257,0.000005332045,0.00032080212],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99905515,0.000026351745,0.0003301849,0.000086682514,0.00012407398,0.00037753317],"domain_scores_gemma":[0.99930274,0.000037087408,0.000108441236,0.00022947996,0.00018473927,0.00013748388],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035401023,0.00008172359,0.00030770354,0.00097539986,0.00014844861,0.000018123697,0.0001610581,0.00008933955,0.000027020367],"category_scores_gemma":[0.00077039265,0.000060094568,0.000072868446,0.0004508864,0.00014678444,0.0000407505,0.000013740111,0.0004041137,0.000011032106],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002062567,0.000029588144,0.02309322,0.00010319827,0.00012878666,0.00089138246,0.00003556067,9.228609e-7,0.000025560332,0.0072113783,0.018381923,0.9498922],"study_design_scores_gemma":[0.0069517684,0.0027851048,0.2867132,0.0015117654,0.000103217615,0.0016635478,0.0033263909,0.000019215335,0.00353005,0.036587562,0.6566099,0.00019824662],"about_ca_topic_score_codex":0.0031348644,"about_ca_topic_score_gemma":0.008064758,"teacher_disagreement_score":0.949694,"about_ca_system_score_codex":0.000590461,"about_ca_system_score_gemma":0.009724489,"threshold_uncertainty_score":0.9958894},"labels":[],"label_agreement":null},{"id":"W4406555837","doi":"10.51731/cjht.25.1061","title":"Virtual Mental Health Counselling","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Digital Mental Health Interventions","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Mental health; Psychology; Applied psychology; Psychotherapist","score_opus":0.03241794645001042,"score_gpt":0.3764964738512954,"score_spread":0.344078527401285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406555837","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06585386,0.3387171,0.006533212,0.5558105,0.019238658,0.0012778718,0.00035658543,0.00047926794,0.011732892],"genre_scores_gemma":[0.9942682,0.00027436993,0.00028209123,0.0034526754,0.00001083621,0.0000117879545,0.000006925166,0.000015324327,0.0016778042],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975306,0.00012911229,0.0012052925,0.00019088665,0.00014385254,0.00080025924],"domain_scores_gemma":[0.99871594,0.0000649146,0.00064185594,0.00029898155,0.000103942824,0.00017439549],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011171079,0.00015499153,0.00043390412,0.0011377403,0.0005132483,0.000053636228,0.00054293836,0.0001393023,0.000098511344],"category_scores_gemma":[0.00009180661,0.00015212558,0.00012808731,0.00056342495,0.0002720344,0.00014382559,0.000016969107,0.0005648391,0.00007084828],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023746661,0.000066797205,0.0005094379,0.00007515653,0.00005753517,0.000027578471,0.000718491,0.0000028157647,6.659982e-7,0.11441524,0.09241182,0.7916907],"study_design_scores_gemma":[0.00076177705,0.0023630273,0.0022938217,0.0013589276,0.0000054782545,0.00025381843,0.014015512,0.000005008045,0.000050297742,0.017693277,0.9610432,0.00015584838],"about_ca_topic_score_codex":0.005840379,"about_ca_topic_score_gemma":0.008713697,"teacher_disagreement_score":0.92841434,"about_ca_system_score_codex":0.000856035,"about_ca_system_score_gemma":0.0031194482,"threshold_uncertainty_score":0.88289446},"labels":[],"label_agreement":null},{"id":"W4406555849","doi":"10.51731/cjht.25.1062","title":"Secukinumab (Cosentyx)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Secukinumab; Medicine; Dermatology","score_opus":0.01896513563315761,"score_gpt":0.31425843574670986,"score_spread":0.29529330011355226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406555849","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3084021,0.12277646,0.00064248085,0.5536599,0.0013086436,0.00067840295,0.000031052896,0.00024313366,0.012257812],"genre_scores_gemma":[0.9982321,0.00025877377,0.00055520347,0.00030175396,0.0000057498974,0.000002934674,0.000002292812,0.000006293992,0.0006348551],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991063,0.000025086854,0.0003797461,0.00008558115,0.00009067695,0.0003126018],"domain_scores_gemma":[0.9994359,0.000026535688,0.0001499714,0.00018296106,0.000120797304,0.00008382399],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000050140126,0.00009228452,0.00033157892,0.00075775885,0.00016678969,0.000016936921,0.00013371711,0.000104692,0.000037430007],"category_scores_gemma":[0.00028252453,0.00007188338,0.00007287095,0.00036542045,0.0001322463,0.00006024555,0.00000920943,0.00030665452,0.000013266129],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030923213,0.000056993253,0.06345796,0.0001733469,0.00020146629,0.0071842778,0.00028200887,4.071453e-7,0.000045292043,0.005966686,0.022544855,0.90005577],"study_design_scores_gemma":[0.004433802,0.0017589052,0.06458125,0.0022621278,0.00013685616,0.019243889,0.0085072825,0.000009045056,0.0037628806,0.020563789,0.8744938,0.0002464164],"about_ca_topic_score_codex":0.0016754637,"about_ca_topic_score_gemma":0.0017730326,"teacher_disagreement_score":0.89980936,"about_ca_system_score_codex":0.00049172377,"about_ca_system_score_gemma":0.0042340034,"threshold_uncertainty_score":0.751094},"labels":[],"label_agreement":null},{"id":"W4406615403","doi":"10.51731/cjht.25.1063","title":"Severity Weighting of Quality-Adjusted Life-Years for Economic Evaluation: What, How, and Where Next?","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Weighting; Quality (philosophy); Quality of life (healthcare); Actuarial science; Psychology; Economics; Medicine; Nursing","score_opus":0.34709072831738885,"score_gpt":0.43675221642879947,"score_spread":0.08966148811141061,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406615403","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.36010718,0.25246528,0.0017781466,0.38254675,0.0015348372,0.0011335906,0.00022187765,0.000042929652,0.00016939105],"genre_scores_gemma":[0.9897889,0.003259658,0.0033025658,0.0034625155,0.000049597944,0.000047751266,0.000007598115,0.000018479068,0.000062951214],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9948318,0.00032258875,0.0039837663,0.00032180845,0.00007271154,0.00046733717],"domain_scores_gemma":[0.99392635,0.0009130518,0.0043872558,0.00039838793,0.00022421377,0.0001507584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.024745608,0.00016471597,0.00130779,0.0011563726,0.00029321053,0.00020875665,0.00041639613,0.00026099762,0.00005122724],"category_scores_gemma":[0.0075728097,0.00020958448,0.00013236234,0.00020476322,0.00022433701,0.0010375043,0.000034062738,0.00028676237,0.00000960628],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006779042,0.00006288478,0.092927285,0.0056525287,0.0005867322,0.0000031442862,0.004160183,0.00044804523,0.000005592707,0.43204188,0.06541032,0.39863363],"study_design_scores_gemma":[0.0045810267,0.0005733259,0.15214227,0.002333418,0.00006163127,0.00003880451,0.09619255,0.0066499305,0.000040508727,0.2358575,0.5007137,0.0008152901],"about_ca_topic_score_codex":0.007187342,"about_ca_topic_score_gemma":0.012061661,"teacher_disagreement_score":0.6296817,"about_ca_system_score_codex":0.0014535941,"about_ca_system_score_gemma":0.0051054945,"threshold_uncertainty_score":0.99942386},"labels":[],"label_agreement":null},{"id":"W4406698363","doi":"10.51731/cjht.25.1064","title":"Ivosidenib (Tibsovo)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.016761126834953326,"score_gpt":0.35869270102917783,"score_spread":0.3419315741942245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406698363","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13155214,0.2970532,0.0015839633,0.54877144,0.0016522687,0.0007324274,0.000027314127,0.00023332356,0.018393915],"genre_scores_gemma":[0.9962605,0.00035870075,0.00091866666,0.0015271415,0.0000060216967,0.000004418155,0.0000015993577,0.000004898229,0.0009180342],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993271,0.000011702855,0.00030375988,0.00006740553,0.000064022,0.00022598928],"domain_scores_gemma":[0.9994877,0.000022811251,0.00013190215,0.0001519893,0.0001431205,0.00006245096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014298227,0.00006453164,0.00023311545,0.00062059675,0.0001506293,0.000014763714,0.00010332817,0.00006967377,0.000025286534],"category_scores_gemma":[0.00024148145,0.000049209695,0.00005615226,0.00031097987,0.000094780786,0.00004652984,0.0000061793057,0.00020707668,0.0000052479436],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014903659,0.000028875365,0.0336228,0.00015100208,0.0002151714,0.00026796525,0.00025629162,0.000005207262,0.000030019468,0.0097383205,0.05341934,0.9022501],"study_design_scores_gemma":[0.0014693264,0.00056508294,0.06296181,0.0009488822,0.0001310616,0.0004032195,0.0044222814,0.000004253272,0.00083467003,0.011086875,0.9170872,0.00008536381],"about_ca_topic_score_codex":0.0037815822,"about_ca_topic_score_gemma":0.002877908,"teacher_disagreement_score":0.90216476,"about_ca_system_score_codex":0.0006168979,"about_ca_system_score_gemma":0.0066630305,"threshold_uncertainty_score":0.99896824},"labels":[],"label_agreement":null},{"id":"W4406907125","doi":"10.51731/cjht.2025.1065","title":"Osimertinib (Tagrisso)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Osimertinib; Medicine; Internal medicine; Receptor","score_opus":0.01814201831550905,"score_gpt":0.3576238266743232,"score_spread":0.33948180835881414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406907125","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14767139,0.28625324,0.00135293,0.5477888,0.0015582574,0.0007328761,0.00002798599,0.00023229863,0.014382207],"genre_scores_gemma":[0.9966142,0.00031398097,0.0007528948,0.001556934,0.0000057427005,0.000004463884,0.00000184101,0.000004640918,0.00074527966],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99931765,0.000011987698,0.00031594533,0.00006665374,0.000060904473,0.0002268805],"domain_scores_gemma":[0.9994958,0.000022276192,0.00014336355,0.00014436967,0.00013158661,0.000062586165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015051341,0.00006382156,0.00023081018,0.00053791626,0.0001512012,0.000011746095,0.000098066615,0.00006923903,0.000024539002],"category_scores_gemma":[0.00023544283,0.00004751668,0.000054887678,0.00031286283,0.00008687081,0.00003953772,0.00000573927,0.00020212683,0.0000050165236],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013414335,0.000027317745,0.03618459,0.000104165134,0.00018439708,0.00013731977,0.0002030037,0.0000044242506,0.000025575842,0.0044950563,0.038123697,0.92049706],"study_design_scores_gemma":[0.001207336,0.0004598329,0.08380111,0.00067045284,0.00011427583,0.000203355,0.0031785995,0.00000484857,0.0008758899,0.004906878,0.90450543,0.000071994036],"about_ca_topic_score_codex":0.0031275954,"about_ca_topic_score_gemma":0.0011803573,"teacher_disagreement_score":0.92042506,"about_ca_system_score_codex":0.0004743897,"about_ca_system_score_gemma":0.0054113334,"threshold_uncertainty_score":0.9599473},"labels":[],"label_agreement":null},{"id":"W4406986856","doi":"10.51731/cjht.2025.1066","title":"Mapping the Landscape of Infusion Care for People Prescribed IV Medicines in Canada","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Healthcare Decision-Making and Restraints","field":"Psychology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Geography","score_opus":0.03165195297929813,"score_gpt":0.32867252413714615,"score_spread":0.297020571157848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406986856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8377906,0.06889931,0.00027497121,0.09002094,0.0019341893,0.00056250783,0.00005224943,0.000018588264,0.00044662977],"genre_scores_gemma":[0.9989189,0.0001934517,0.00013189118,0.0006895496,0.000012436155,0.000015352382,0.000002289934,0.0000067998394,0.000029366805],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.9984157,0.000112368696,0.00077762705,0.0001245411,0.00013462549,0.00043512322],"domain_scores_gemma":[0.9985288,0.0004954707,0.00037249515,0.0002870095,0.0002571103,0.00005911121],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008015923,0.00009810327,0.0004281019,0.0007733756,0.00019681116,0.000007674093,0.00049858796,0.00014090112,0.000018145989],"category_scores_gemma":[0.0013402764,0.00006442819,0.00004800184,0.0006414815,0.00008256415,0.000021219053,0.000019718253,0.000421748,3.0567185e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002962856,0.000006452309,0.040087,0.0003583665,0.000029104664,0.00013297383,0.0072985413,0.000041608164,0.0000040533823,0.0004221257,0.014639457,0.9369507],"study_design_scores_gemma":[0.0010154694,0.00030651462,0.34152138,0.0021450557,0.000008634227,0.00015129407,0.4872467,0.000044008917,0.000020901254,0.0027271213,0.16469558,0.00011735068],"about_ca_topic_score_codex":0.92150295,"about_ca_topic_score_gemma":0.9935627,"teacher_disagreement_score":0.9368333,"about_ca_system_score_codex":0.0005533643,"about_ca_system_score_gemma":0.013854995,"threshold_uncertainty_score":0.9917355},"labels":[],"label_agreement":null},{"id":"W4407006763","doi":"10.51731/cjht.2025.1068","title":"Amivantamab (Rybrevant)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Drug-Induced Hepatotoxicity and Protection","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.13011247310058613,"score_gpt":0.4548316854798537,"score_spread":0.3247192123792676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407006763","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5704671,0.12722783,0.0038911754,0.26084858,0.014421572,0.001517402,0.00010814471,0.00069142465,0.020826764],"genre_scores_gemma":[0.9952246,0.0009927956,0.00021237167,0.0031403278,0.0000225441,0.0000100041325,0.0000014867504,0.000009069408,0.00038680306],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982934,0.00028493427,0.0006326403,0.00014538602,0.000083334584,0.00056031597],"domain_scores_gemma":[0.9990206,0.00015348184,0.00036610244,0.00018330423,0.00016322116,0.00011333815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015529889,0.00015054386,0.0003645407,0.00097226456,0.0006309503,0.00002756367,0.00048202815,0.00047657816,0.000101702484],"category_scores_gemma":[0.0005851522,0.0001405628,0.00009841793,0.00057491555,0.00028988073,0.00012881595,0.000028331771,0.0016685181,0.000036113055],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036019774,0.00003362633,0.0058294055,0.00013509805,0.00009337902,0.000091273345,0.00024159829,0.000059458012,0.00069519447,0.00720881,0.018035384,0.96754074],"study_design_scores_gemma":[0.00064344745,0.00016930257,0.002644612,0.00014349267,0.0000265287,0.0001395334,0.001165318,0.000059539943,0.013837771,0.016129635,0.9649106,0.00013021633],"about_ca_topic_score_codex":0.001526796,"about_ca_topic_score_gemma":0.0028467055,"teacher_disagreement_score":0.96741056,"about_ca_system_score_codex":0.0005552789,"about_ca_system_score_gemma":0.0029074403,"threshold_uncertainty_score":0.7248973},"labels":[],"label_agreement":null},{"id":"W4407006797","doi":"10.51731/cjht.2025.1067","title":"Erdafitinib (Balversa)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Business","score_opus":0.025151317670980115,"score_gpt":0.3267555524490281,"score_spread":0.301604234778048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407006797","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2623742,0.3692587,0.00021322224,0.34105584,0.0014125129,0.0005358479,0.000025105974,0.00017978126,0.024944795],"genre_scores_gemma":[0.996996,0.0009884256,0.00032309216,0.0011973381,0.000006545895,0.000004374313,7.2035294e-7,0.000004043952,0.00047946442],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99925345,0.000012344933,0.00030630556,0.00007855395,0.00007560354,0.00027372548],"domain_scores_gemma":[0.9995135,0.000029210922,0.00013264324,0.00012764249,0.00014256795,0.000054398974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001782296,0.00008088321,0.00033911364,0.000510655,0.00019232616,0.00001175946,0.000103944854,0.00006709527,0.000023212315],"category_scores_gemma":[0.00030225853,0.000060232116,0.00007733153,0.00031987063,0.00015338339,0.000032990458,0.000013030161,0.0002249577,0.000002803357],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004340001,0.000020025082,0.034618117,0.00009997275,0.0001750146,0.00021579291,0.00019445473,8.80214e-7,0.000007797698,0.0025054088,0.033689704,0.9284294],"study_design_scores_gemma":[0.0012605938,0.0010797743,0.121161796,0.00063673925,0.00006422866,0.00021389383,0.0066436194,0.0000021009114,0.00036783764,0.00407173,0.8644158,0.00008185669],"about_ca_topic_score_codex":0.0025074135,"about_ca_topic_score_gemma":0.0041991617,"teacher_disagreement_score":0.9283476,"about_ca_system_score_codex":0.00060409645,"about_ca_system_score_gemma":0.003369543,"threshold_uncertainty_score":0.5977425},"labels":[],"label_agreement":null},{"id":"W4407034836","doi":"10.51731/cjht.2025.1069","title":"Pembrolizumab (Keytruda)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Pembrolizumab; Medicine; Drug; Vial; Chemotherapy; Oncology; Intensive care medicine; Internal medicine; Pharmacology; Cancer; Political science","score_opus":0.020298250381991106,"score_gpt":0.30338636799249236,"score_spread":0.28308811761050123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407034836","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21033311,0.1594774,0.002087645,0.60433674,0.0022767514,0.00069528725,0.000007723439,0.00031075033,0.020474613],"genre_scores_gemma":[0.9952724,0.00056477945,0.000505611,0.0022969202,0.000009933531,0.0000022764416,7.8132257e-7,0.0000055692017,0.001341742],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990752,0.000013772147,0.00039242243,0.000083772204,0.00010648263,0.00032838553],"domain_scores_gemma":[0.999421,0.000022976625,0.00018001022,0.00020362045,0.000109292014,0.00006310378],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002849655,0.000084095445,0.0003403933,0.0011301255,0.00012557644,0.000020035102,0.00020176433,0.000076377946,0.000039731858],"category_scores_gemma":[0.000326497,0.00006887439,0.00008502629,0.00051480735,0.00011400394,0.000050850915,0.000018212373,0.00031059378,0.000005117227],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003146715,0.0000100261195,0.067634284,0.00022388875,0.00008129225,0.00018511979,0.000055525572,0.0000028350644,0.000005799827,0.0076545947,0.07905852,0.84505665],"study_design_scores_gemma":[0.001321052,0.00034459136,0.16574843,0.00039979705,0.000045810004,0.000158258,0.0022775608,0.0000060086672,0.00010398869,0.004102765,0.8254239,0.00006785078],"about_ca_topic_score_codex":0.0018621704,"about_ca_topic_score_gemma":0.0017531625,"teacher_disagreement_score":0.8449888,"about_ca_system_score_codex":0.00046943544,"about_ca_system_score_gemma":0.0030803012,"threshold_uncertainty_score":0.5464322},"labels":[],"label_agreement":null},{"id":"W4407266958","doi":"10.51731/cjht.2025.1072","title":"Abemaciclib (Verzenio)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Oncology; Breast cancer; Internal medicine; Disease; Adjuvant; Human Epidermal Growth Factor Receptor 2; Drug; Cancer; Family medicine; Oestrogen receptor; Gynecology; Pharmacology; Political science; Health care","score_opus":0.016496647619343496,"score_gpt":0.3269568899253435,"score_spread":0.310460242306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407266958","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12795791,0.4636574,0.0074591762,0.3940198,0.0017579932,0.00063973357,0.000022099617,0.00042678817,0.004059053],"genre_scores_gemma":[0.99405897,0.00037936613,0.002592132,0.0025298425,0.000011537714,0.0000039583256,7.704302e-7,0.000010542638,0.0004128648],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989321,0.000020942773,0.0004509282,0.00010388173,0.00010431762,0.00038778034],"domain_scores_gemma":[0.99920183,0.00003493607,0.00023344156,0.00025499234,0.0001905836,0.000084216066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030162235,0.000105336345,0.0003969745,0.0008340875,0.00014908667,0.000013367962,0.00021908205,0.00010872307,0.000033674838],"category_scores_gemma":[0.00036846515,0.0000875104,0.0000772673,0.00048945664,0.00024571596,0.00008319933,0.000013396245,0.00043436498,0.000006045503],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039032348,0.000009874781,0.008006866,0.00012666942,0.00006464873,0.00012047795,0.00009726664,0.0000060024977,0.00009741568,0.0035743373,0.0028943222,0.98496306],"study_design_scores_gemma":[0.0012163002,0.00035162878,0.022428978,0.0009090069,0.00002591852,0.00069807743,0.0028233496,0.000004327627,0.002162296,0.017970031,0.9513083,0.00010179685],"about_ca_topic_score_codex":0.0009394843,"about_ca_topic_score_gemma":0.0009095156,"teacher_disagreement_score":0.9848613,"about_ca_system_score_codex":0.0006645732,"about_ca_system_score_gemma":0.0049113138,"threshold_uncertainty_score":0.871246},"labels":[],"label_agreement":null},{"id":"W4407266966","doi":"10.51731/cjht.2025.1071","title":"Baricitinib (Olumiant)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Family medicine; Political science; Health care","score_opus":0.013385074642773423,"score_gpt":0.29305047799045036,"score_spread":0.2796654033476769,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407266966","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3137169,0.2056726,0.0024104635,0.44454488,0.0011683425,0.0005603635,0.000014588995,0.00029932577,0.031612527],"genre_scores_gemma":[0.9951937,0.00031816863,0.00057260325,0.0036049502,0.000005981906,0.000002072311,0.0000011568461,0.0000058435508,0.0002955234],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99902314,0.000019538767,0.00041191763,0.00008303531,0.00008502987,0.00037735488],"domain_scores_gemma":[0.99940884,0.00003233158,0.00013590693,0.00017844618,0.0001339758,0.00011052045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003303439,0.00008110151,0.00031405844,0.0009286872,0.00015461862,0.000014983187,0.00017116801,0.00012664631,0.00003062172],"category_scores_gemma":[0.0009744069,0.00006808898,0.00007388477,0.0004992404,0.00017427851,0.00004650967,0.000009395121,0.00038762513,0.000008735571],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002734355,0.000021727692,0.041535594,0.00025211094,0.000054980228,0.0002679181,0.00015554776,0.000002686043,0.000022491435,0.012548699,0.055029076,0.8900818],"study_design_scores_gemma":[0.0013529289,0.00053053454,0.03955888,0.00068505225,0.000030044803,0.0003395967,0.008724656,0.000012110282,0.0004340502,0.00963993,0.93858224,0.000109962864],"about_ca_topic_score_codex":0.0023409964,"about_ca_topic_score_gemma":0.0029725886,"teacher_disagreement_score":0.88997185,"about_ca_system_score_codex":0.00023146183,"about_ca_system_score_gemma":0.006781857,"threshold_uncertainty_score":0.9988488},"labels":[],"label_agreement":null},{"id":"W4407408614","doi":"10.51731/cjht.2025.1074","title":"Lebrikizumab (Ebglyss)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.01890364514807176,"score_gpt":0.30303255137561497,"score_spread":0.2841289062275432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407408614","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4562103,0.29132405,0.000584914,0.23895778,0.0013754945,0.0007462408,0.000018570438,0.00032292263,0.010459756],"genre_scores_gemma":[0.9961484,0.0006843315,0.0010546306,0.0012266452,0.000008898146,0.0000040371347,0.0000020873624,0.000009523739,0.0008614674],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99878806,0.000025965199,0.00051274814,0.00011964121,0.000121142475,0.0004324433],"domain_scores_gemma":[0.99915385,0.000042043248,0.00023258127,0.00031945662,0.00014950101,0.000102559774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031910776,0.00011764644,0.00044108368,0.0009413351,0.0001601219,0.000016743019,0.00022264085,0.00015041669,0.000047938523],"category_scores_gemma":[0.00063176634,0.00009625954,0.00009648146,0.00047010052,0.00017435645,0.000054667365,0.000017542476,0.00045915935,0.00001560221],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003078669,0.00002454199,0.015991852,0.00018658105,0.0001497624,0.00056861265,0.0000988462,0.000003747145,0.000027571652,0.0025079555,0.035792463,0.9446173],"study_design_scores_gemma":[0.003723827,0.00084552064,0.054857243,0.0015426455,0.000095671996,0.0016137485,0.0024498722,0.000017719894,0.0018615188,0.005813535,0.927027,0.00015173902],"about_ca_topic_score_codex":0.004903654,"about_ca_topic_score_gemma":0.0027704819,"teacher_disagreement_score":0.9444655,"about_ca_system_score_codex":0.0031310671,"about_ca_system_score_gemma":0.015776383,"threshold_uncertainty_score":0.98980325},"labels":[],"label_agreement":null},{"id":"W4407408699","doi":"10.51731/cjht.2025.1073","title":"Zilucoplan (Zilbrysq)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Amino Acid Enzymes and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.007438099556752454,"score_gpt":0.2584332955643642,"score_spread":0.2509951960076117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407408699","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.43510053,0.51585627,0.0064661354,0.03515977,0.0021003028,0.00026971503,0.000034091012,0.000058562462,0.0049546342],"genre_scores_gemma":[0.99602276,0.0015210181,0.0006667166,0.001144053,0.000021030502,0.000002058996,0.0000045622705,0.0000066314697,0.00061115774],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992145,0.000026900654,0.00030138728,0.000105784566,0.00004879507,0.0003026564],"domain_scores_gemma":[0.9994622,0.000005500699,0.00015869123,0.0002249173,0.00009559527,0.000053125328],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002932977,0.000088294466,0.0001905698,0.00027681093,0.00013323342,0.000016991393,0.0003310783,0.0001546083,0.0000063398634],"category_scores_gemma":[0.00025916213,0.0000765423,0.00006428872,0.00015996268,0.00013031896,0.00000319935,0.000028081255,0.00017352082,0.000002296976],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018285838,0.000014077718,0.005825682,0.0000690181,0.000086008855,0.000033588058,0.0000579668,0.000025135627,0.006329262,0.0073888972,0.123681165,0.8564709],"study_design_scores_gemma":[0.00022104723,0.00012357712,0.003979813,0.000047502905,0.0000061196115,0.000059559705,0.00064508914,0.000001107757,0.01512314,0.0011482108,0.9785735,0.00007132078],"about_ca_topic_score_codex":0.0006014748,"about_ca_topic_score_gemma":0.0016068969,"teacher_disagreement_score":0.8563996,"about_ca_system_score_codex":0.000045108438,"about_ca_system_score_gemma":0.002117818,"threshold_uncertainty_score":0.3756918},"labels":[],"label_agreement":null},{"id":"W4407489911","doi":"10.51731/cjht.2025.1076","title":"Burosumab (Crysvita)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Family medicine; Intensive care medicine; Business; Economic growth; Health care; Economics","score_opus":0.06656303316153739,"score_gpt":0.40391335139295653,"score_spread":0.33735031823141914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407489911","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.037485275,0.32034296,0.0003719477,0.6297846,0.00079410616,0.00022603614,0.0000063663733,0.00009030182,0.010898418],"genre_scores_gemma":[0.9917346,0.0030184076,0.00047820486,0.0045066327,0.000009359891,0.0000018094147,3.213687e-7,0.0000041973185,0.00024646067],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99914736,0.000027554308,0.0003447032,0.00007482412,0.00008707067,0.00031847606],"domain_scores_gemma":[0.99938565,0.00009233365,0.00017446742,0.00013107683,0.00013265805,0.00008379346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004590021,0.00007314553,0.00030134124,0.00036644848,0.00022376228,0.000018293367,0.00015144866,0.00007894784,0.00003498616],"category_scores_gemma":[0.0011912164,0.00005524597,0.000060211412,0.00034701335,0.00016852038,0.00006574605,0.000019062774,0.00048610562,0.0000062747426],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038514107,0.0000186494,0.01020267,0.00016736834,0.000105308536,0.00020340565,0.00005944868,0.0000010580777,0.00004006242,0.0048027732,0.040248048,0.9441127],"study_design_scores_gemma":[0.00045113533,0.00023338893,0.010472012,0.00022243739,0.000033083797,0.00016586315,0.0014233995,0.000004642895,0.00032299134,0.0034127354,0.9832161,0.000042204592],"about_ca_topic_score_codex":0.0013349105,"about_ca_topic_score_gemma":0.00078014436,"teacher_disagreement_score":0.9542493,"about_ca_system_score_codex":0.00027710444,"about_ca_system_score_gemma":0.0021445865,"threshold_uncertainty_score":0.38044044},"labels":[],"label_agreement":null},{"id":"W4407563556","doi":"10.51731/cjht.2025.1075","title":"Momelotinib (Ojjaara)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Myelofibrosis; Medicine; Polycythemia vera; Essential thrombocythemia; Anemia; Drug; Internal medicine; Surgery; Pharmacology; Bone marrow","score_opus":0.02145489802086633,"score_gpt":0.31894452950270036,"score_spread":0.29748963148183405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407563556","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.40491423,0.13978265,0.00040624934,0.4464148,0.0009447339,0.00074590783,0.000022693224,0.00016892499,0.0065997904],"genre_scores_gemma":[0.9955826,0.0010198444,0.0010097303,0.0019819906,0.000008619914,0.000011980081,0.0000019799247,0.000007370484,0.00037588444],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989148,0.000029798564,0.0004789945,0.00011675746,0.000109484026,0.00035018395],"domain_scores_gemma":[0.9992164,0.00006585998,0.00020468865,0.00020845968,0.0002019123,0.00010272338],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031747675,0.00011702856,0.00045491487,0.00084036385,0.00018784261,0.000021298707,0.00014136812,0.000114332186,0.000047739002],"category_scores_gemma":[0.000525624,0.00008740795,0.00009148457,0.00040378625,0.00013529224,0.000045899404,0.000012087862,0.00033268682,0.000009456342],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033996683,0.00008426049,0.2209355,0.00019498664,0.00022425386,0.00047824316,0.00017458784,0.00000522579,0.000021183543,0.017194727,0.041386206,0.71926683],"study_design_scores_gemma":[0.0021439495,0.0014183401,0.23830163,0.0013797315,0.000079681595,0.00052666274,0.0024053352,0.000010008619,0.0045380844,0.0068592597,0.74218804,0.00014927995],"about_ca_topic_score_codex":0.0012216121,"about_ca_topic_score_gemma":0.0019166368,"teacher_disagreement_score":0.7191176,"about_ca_system_score_codex":0.0004893959,"about_ca_system_score_gemma":0.0045011495,"threshold_uncertainty_score":0.7984846},"labels":[],"label_agreement":null},{"id":"W4407593771","doi":"10.51731/cjht.2025.1077","title":"Zolbetuximab for Injection (Vyloy)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Geology","score_opus":0.017664576821286273,"score_gpt":0.31315935413502666,"score_spread":0.2954947773137404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407593771","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2910638,0.37735122,0.015960457,0.30722165,0.0027557614,0.0022642943,0.000064964515,0.00064668484,0.0026711873],"genre_scores_gemma":[0.99675065,0.00014803684,0.0014101824,0.0012008166,0.000010646486,0.000015279558,0.0000031594072,0.000011489689,0.00044974536],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989608,0.000018845469,0.0004821415,0.00010307571,0.000081144055,0.00035400104],"domain_scores_gemma":[0.99911886,0.00006452766,0.00026357253,0.00022730048,0.00026147751,0.00006424386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036269458,0.00009656776,0.00037243392,0.0009910951,0.00022967531,0.000017359303,0.00017962181,0.00013021211,0.000012516814],"category_scores_gemma":[0.0016758185,0.0000841774,0.0001163844,0.00037744988,0.00014977365,0.00005374503,0.000011918475,0.00026257176,0.0000026041728],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000113503076,0.000038678725,0.026439806,0.0005770141,0.00013083107,0.00007312548,0.000108809865,0.000020270892,0.000049238963,0.00610309,0.076433666,0.88991195],"study_design_scores_gemma":[0.0030151377,0.0019485564,0.099396974,0.0016730465,0.00014205882,0.00068271643,0.0051749432,0.00006026996,0.0013725,0.024765417,0.86156905,0.00019931333],"about_ca_topic_score_codex":0.0017831359,"about_ca_topic_score_gemma":0.0009820871,"teacher_disagreement_score":0.88971263,"about_ca_system_score_codex":0.00063560833,"about_ca_system_score_gemma":0.006685254,"threshold_uncertainty_score":0.9989459},"labels":[],"label_agreement":null},{"id":"W4407745846","doi":"10.51731/cjht.2025.1079","title":"Eplontersen (Wainua)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Environmental science","score_opus":0.012324526351937747,"score_gpt":0.2861330350591976,"score_spread":0.27380850870725987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407745846","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.65426105,0.20732582,0.0014248815,0.13270977,0.0013265776,0.0004922201,0.000056403416,0.00010418179,0.0022991095],"genre_scores_gemma":[0.9955469,0.0015046026,0.00065583334,0.0018158082,0.0000119104325,0.000010460343,0.0000054803463,0.000011520512,0.0004375221],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99894357,0.000048496786,0.00039201832,0.00016038184,0.00006765796,0.0003878544],"domain_scores_gemma":[0.99923706,0.000020480225,0.00024507975,0.00031922624,0.00010820061,0.00006992366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027654314,0.00013585557,0.0002659345,0.00039419666,0.00016655074,0.000025357298,0.00040905838,0.00018387657,0.000008225078],"category_scores_gemma":[0.000498033,0.00011894654,0.00011132811,0.00019101158,0.00017572784,0.0000054254774,0.000043133554,0.00017663879,0.0000051283673],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004315193,0.0000716632,0.21045394,0.00012029278,0.00049147283,0.00016050166,0.00015407223,0.000034563003,0.0020698183,0.0029979157,0.16507274,0.6183299],"study_design_scores_gemma":[0.0010057848,0.0006887052,0.031997606,0.00023301292,0.00003640571,0.00011140772,0.003657565,0.0000019395789,0.02517941,0.0017498044,0.9351034,0.00023496478],"about_ca_topic_score_codex":0.0014492003,"about_ca_topic_score_gemma":0.0054349387,"teacher_disagreement_score":0.7700307,"about_ca_system_score_codex":0.00020480924,"about_ca_system_score_gemma":0.0019813841,"threshold_uncertainty_score":0.4850499},"labels":[],"label_agreement":null},{"id":"W4407758786","doi":"10.51731/cjht.2025.1078","title":"Pembrolizumab (Keytruda)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pembrolizumab; Medicine; Internal medicine; Cancer","score_opus":0.018423995163443674,"score_gpt":0.31739819533080416,"score_spread":0.2989742001673605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407758786","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2742569,0.31973705,0.00020119116,0.39870843,0.0009884798,0.00045301914,0.00001560814,0.0001323639,0.005506934],"genre_scores_gemma":[0.9960123,0.0018445333,0.0003270286,0.001573605,0.000008197179,0.000007467875,0.0000010266615,0.000005860353,0.00022003926],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99915093,0.000013850381,0.00036276327,0.00008973298,0.000089060224,0.00029364848],"domain_scores_gemma":[0.9993985,0.000030653857,0.00015891595,0.0002063835,0.00012549266,0.00008003504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001807343,0.00008515157,0.0003477167,0.0006882092,0.0001318548,0.000016453725,0.00012389157,0.000087030174,0.000036440437],"category_scores_gemma":[0.00020857493,0.00006651488,0.0000891459,0.0003240212,0.000113166105,0.000034657915,0.000009876098,0.000255158,0.0000053395256],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030364377,0.000038375354,0.052629065,0.0001379032,0.000112682035,0.0002953898,0.0000784541,0.000002596239,0.000006309693,0.0059334785,0.042438727,0.89829665],"study_design_scores_gemma":[0.0020577114,0.0009052149,0.14220658,0.0011187482,0.00007087042,0.0004772586,0.0016527629,0.0000037186264,0.001038769,0.005022954,0.8453579,0.00008753625],"about_ca_topic_score_codex":0.0049003535,"about_ca_topic_score_gemma":0.005150814,"teacher_disagreement_score":0.8982091,"about_ca_system_score_codex":0.0008615668,"about_ca_system_score_gemma":0.005416469,"threshold_uncertainty_score":0.96085835},"labels":[],"label_agreement":null},{"id":"W4407772294","doi":"10.51731/cjht.2025.1080","title":"Sotatercept (Winrevair)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pulmonary Hypertension Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Political science","score_opus":0.03244276372578249,"score_gpt":0.3376472932874215,"score_spread":0.305204529561639,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407772294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.47287408,0.17425811,0.00018872102,0.34742406,0.00056988385,0.0005142277,0.000017670505,0.00014455176,0.0040086904],"genre_scores_gemma":[0.99616647,0.0008804235,0.00053930026,0.0016009061,0.0000038627268,0.0000029596958,0.0000020186008,0.000005202074,0.0007988696],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990708,0.000028940694,0.00032063387,0.00008710428,0.00011642537,0.00037609466],"domain_scores_gemma":[0.99936336,0.000028725239,0.00009474994,0.00019565051,0.00018445092,0.00013305355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002625401,0.000078651,0.0003113267,0.00087038893,0.0001617079,0.000013258354,0.00015266758,0.00008389013,0.000035425237],"category_scores_gemma":[0.00044701548,0.000056358793,0.000072129806,0.00034528133,0.00015323673,0.000049103295,0.000014833721,0.00032222754,0.00001861781],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052994073,0.000066192355,0.087485634,0.00016197425,0.00015024024,0.0053401506,0.00003291697,8.6947136e-7,0.00006307725,0.00072286493,0.05012295,0.85580015],"study_design_scores_gemma":[0.0021038544,0.001509625,0.21226735,0.0012400796,0.000051388914,0.0026323586,0.0029680827,0.000017197988,0.00083112327,0.011295366,0.7649616,0.00012199906],"about_ca_topic_score_codex":0.0017357407,"about_ca_topic_score_gemma":0.00035759617,"teacher_disagreement_score":0.85567814,"about_ca_system_score_codex":0.00031780681,"about_ca_system_score_gemma":0.0044661253,"threshold_uncertainty_score":0.79227144},"labels":[],"label_agreement":null},{"id":"W4407772423","doi":"10.51731/cjht.2025.1081","title":"Pembrolizumab (Keytruda)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pembrolizumab; Medicine; Internal medicine; Cancer","score_opus":0.018423995163443674,"score_gpt":0.31739819533080416,"score_spread":0.2989742001673605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407772423","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2742569,0.31973705,0.00020119116,0.39870843,0.0009884798,0.00045301914,0.00001560814,0.0001323639,0.005506934],"genre_scores_gemma":[0.9960123,0.0018445333,0.0003270286,0.001573605,0.000008197179,0.000007467875,0.0000010266615,0.000005860353,0.00022003926],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99915093,0.000013850381,0.00036276327,0.00008973298,0.000089060224,0.00029364848],"domain_scores_gemma":[0.9993985,0.000030653857,0.00015891595,0.0002063835,0.00012549266,0.00008003504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001807343,0.00008515157,0.0003477167,0.0006882092,0.0001318548,0.000016453725,0.00012389157,0.000087030174,0.000036440437],"category_scores_gemma":[0.00020857493,0.00006651488,0.0000891459,0.0003240212,0.000113166105,0.000034657915,0.000009876098,0.000255158,0.0000053395256],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030364377,0.000038375354,0.052629065,0.0001379032,0.000112682035,0.0002953898,0.0000784541,0.000002596239,0.000006309693,0.0059334785,0.042438727,0.89829665],"study_design_scores_gemma":[0.0020577114,0.0009052149,0.14220658,0.0011187482,0.00007087042,0.0004772586,0.0016527629,0.0000037186264,0.001038769,0.005022954,0.8453579,0.00008753625],"about_ca_topic_score_codex":0.0049003535,"about_ca_topic_score_gemma":0.005150814,"teacher_disagreement_score":0.8982091,"about_ca_system_score_codex":0.0008615668,"about_ca_system_score_gemma":0.005416469,"threshold_uncertainty_score":0.96085835},"labels":[],"label_agreement":null},{"id":"W4407850244","doi":"10.51731/cjht.2025.1085","title":"Clindamycin Plus Benzoyl Peroxide and Adapalene (Cabtreo)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Adapalene; Benzoyl peroxide; Clindamycin; Dermatology; Chemistry; Medicine; Organic chemistry; Antibiotics","score_opus":0.026654558932749726,"score_gpt":0.3470699517471535,"score_spread":0.3204153928144038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407850244","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6264912,0.20275953,0.000055904544,0.16847359,0.0005798743,0.00030673415,0.000016101341,0.000058532976,0.0012585581],"genre_scores_gemma":[0.9931547,0.003357352,0.00047162414,0.0020710444,0.000017022114,0.000004126127,0.0000018050999,0.000007172516,0.0009151419],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99905336,0.000028874443,0.000398005,0.0001186556,0.00006748744,0.00033359637],"domain_scores_gemma":[0.99941057,0.000059686936,0.00017363833,0.00013680657,0.000104189814,0.00011511433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027623348,0.00010982932,0.00042852957,0.00069110503,0.00014908008,0.00001300781,0.000112259135,0.00013345371,0.000054356806],"category_scores_gemma":[0.00012712661,0.000090312795,0.000056796565,0.00025883925,0.00021339058,0.000045495777,0.000016179216,0.0003905881,0.0000033041977],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000226876,0.000050409777,0.07980317,0.0003762879,0.00027389036,0.0006432234,0.00047696737,0.0000069580774,0.00029954416,0.0016936434,0.06388044,0.8522686],"study_design_scores_gemma":[0.0064679487,0.0024183043,0.13180001,0.0009998003,0.00024622196,0.0011590853,0.0053198584,0.000024360053,0.0039013007,0.004127308,0.84332585,0.0002099419],"about_ca_topic_score_codex":0.0030576275,"about_ca_topic_score_gemma":0.009183651,"teacher_disagreement_score":0.85205865,"about_ca_system_score_codex":0.00061356544,"about_ca_system_score_gemma":0.004713322,"threshold_uncertainty_score":0.83612305},"labels":[],"label_agreement":null},{"id":"W4407967855","doi":"10.51731/cjht.2025.1087","title":"Clascoterone (Winlevi)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Hormonal and reproductive studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.023119683710470604,"score_gpt":0.31215251029477653,"score_spread":0.2890328265843059,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407967855","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21121006,0.3671125,0.00037126648,0.41498378,0.0008689813,0.00028776252,0.0000055546666,0.000102416954,0.005057671],"genre_scores_gemma":[0.9968082,0.001190272,0.00049933506,0.00080603414,0.000017635146,0.000002034268,4.1033826e-7,0.000004602,0.00067149673],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99913067,0.000019518517,0.00037140102,0.000106650186,0.000086877124,0.0002848811],"domain_scores_gemma":[0.9993796,0.000020893074,0.00014106501,0.00018041824,0.00022351087,0.000054565873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037305796,0.00008357671,0.00039457274,0.0006129926,0.00018694541,0.000008148039,0.00012901578,0.00007720867,0.000008212896],"category_scores_gemma":[0.0006455018,0.000057850168,0.00006965826,0.0003565833,0.00029341315,0.000038036836,0.000018415207,0.00037139494,0.0000059054305],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033880653,0.000026312562,0.030650275,0.0002478135,0.00019131115,0.00019374538,0.00023966373,0.0000017431971,0.00016831062,0.0039962856,0.026275363,0.9379753],"study_design_scores_gemma":[0.00064748566,0.00071640254,0.19592725,0.00079112535,0.00004322761,0.00028494175,0.0073945243,0.0000011844502,0.0016159255,0.009518475,0.78296345,0.00009601209],"about_ca_topic_score_codex":0.0010340364,"about_ca_topic_score_gemma":0.0010798364,"teacher_disagreement_score":0.93787926,"about_ca_system_score_codex":0.00027721957,"about_ca_system_score_gemma":0.002496743,"threshold_uncertainty_score":0.44291154},"labels":[],"label_agreement":null},{"id":"W4408026696","doi":"10.51731/cjht.2025.1088","title":"Crushed Buprenorphine-Naloxone Tablets","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Buprenorphine; (+)-Naloxone; Medicine; Anesthesia; Opioid; Internal medicine","score_opus":0.015234740472624573,"score_gpt":0.29161165684631285,"score_spread":0.2763769163736883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408026696","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.33462435,0.3129882,0.0010928169,0.3456875,0.0011361431,0.00083026185,0.000033381057,0.00029488915,0.003312454],"genre_scores_gemma":[0.9946235,0.0011373977,0.0021244641,0.0015660947,0.000008002189,0.00000864874,0.000005011518,0.000012678436,0.00051422894],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986429,0.000029402303,0.0005792766,0.00014055097,0.00013727209,0.00047059596],"domain_scores_gemma":[0.99903524,0.000039969073,0.0002485976,0.00034572033,0.00021168403,0.00011876319],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032397208,0.00014731004,0.00051489274,0.0011337468,0.00018491223,0.000023389925,0.00023336239,0.00014520125,0.000047039393],"category_scores_gemma":[0.00055882777,0.00011905132,0.000095252886,0.00060140376,0.00015017517,0.00006563688,0.000019615289,0.00042669175,0.000012119166],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000085550135,0.00018596846,0.08932304,0.0006720965,0.0004412383,0.0009140755,0.0005696968,0.000015168223,0.00032256372,0.005643039,0.06907092,0.83275664],"study_design_scores_gemma":[0.004426476,0.0021462569,0.1880042,0.0025091376,0.00019810884,0.0007271963,0.007679487,0.000023386381,0.0036291832,0.013706786,0.77663904,0.00031072035],"about_ca_topic_score_codex":0.0060933623,"about_ca_topic_score_gemma":0.002413746,"teacher_disagreement_score":0.8324459,"about_ca_system_score_codex":0.00071168784,"about_ca_system_score_gemma":0.0065596895,"threshold_uncertainty_score":0.9990722},"labels":[],"label_agreement":null},{"id":"W4408113763","doi":"10.51731/cjht.2025.1090","title":"Planning for the Introduction of New CT Services in Rural and Remote Communities in Canada","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Radiology practices and education","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Environmental planning; Business; Medicine; Geography; Computer science","score_opus":0.03175689798182077,"score_gpt":0.326745204668316,"score_spread":0.2949883066864952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408113763","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.77778804,0.05104388,0.000036112542,0.17073797,0.00024927524,0.0001269,0.0000013451472,0.000002582609,0.00001387177],"genre_scores_gemma":[0.9975396,0.0013971417,0.00052214664,0.00050181535,0.000014654075,9.689809e-7,0.0000020364769,0.0000019833935,0.000019684363],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9994807,0.00002990316,0.00028717978,0.000030578645,0.000029695932,0.00014190351],"domain_scores_gemma":[0.9994684,0.00017044875,0.00019619992,0.00010187979,0.000042246334,0.000020825073],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049083785,0.00004011287,0.00018369846,0.00034111354,0.000073905816,0.000005460631,0.00009861277,0.000027986074,0.000001617073],"category_scores_gemma":[0.00022741233,0.000029228879,0.000009355167,0.0001730856,0.00006242835,0.000057639296,0.000005916024,0.00027811667,1.2097099e-8],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055375844,0.0000028578008,0.20539229,0.00025686182,0.000022775563,0.0000072312037,0.0016470887,0.00020519098,0.0000049406776,0.00019434224,0.0036592728,0.7885518],"study_design_scores_gemma":[0.00073243165,0.00019354295,0.5171079,0.0010623555,0.000023209586,0.00029579588,0.36043787,0.00089737267,0.00007134203,0.0025409197,0.11658938,0.000047885864],"about_ca_topic_score_codex":0.98512614,"about_ca_topic_score_gemma":0.9888099,"teacher_disagreement_score":0.7885039,"about_ca_system_score_codex":0.00045341192,"about_ca_system_score_gemma":0.0062184827,"threshold_uncertainty_score":0.99941534},"labels":[],"label_agreement":null},{"id":"W4408164497","doi":"10.51731/cjht.2025.1091","title":"Faricimab (Vabysmo)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Philosophy","score_opus":0.008818780460101457,"score_gpt":0.24638145107353843,"score_spread":0.23756267061343697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408164497","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017819973,0.96268606,0.00060468074,0.014745728,0.0015655129,0.00010823427,0.000007303255,0.00008489781,0.002377613],"genre_scores_gemma":[0.9979369,0.00050703203,0.0000081142125,0.0007138858,4.5274724e-8,0.0000029196933,0.000003845978,0.0000054068496,0.0008218711],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986941,0.00008427837,0.0005661348,0.0001135155,0.00002182698,0.00052010757],"domain_scores_gemma":[0.99928945,0.000056953137,0.00028613093,0.0002500179,0.000116585856,8.810564e-7],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055285136,0.00012215084,0.0003514109,0.0008383013,0.0005102374,0.00001952698,0.00058652007,0.00023926536,0.00006893831],"category_scores_gemma":[0.00042426586,0.00010450611,0.000096487856,0.0004730605,0.00044799902,0.00008094411,0.000028174074,0.00059741974,0.000048735696],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007979677,0.000017229071,0.0000891665,0.000023817573,0.000053180065,0.00000829366,0.00018114416,0.000006528201,0.00073873095,0.0051153796,0.0007124902,0.99304605],"study_design_scores_gemma":[0.0004882687,0.00008294174,0.004555165,0.00013453203,0.000009725895,0.00008327147,0.004020205,5.67269e-7,0.0025351197,0.004126199,0.98387796,0.00008602507],"about_ca_topic_score_codex":0.003310476,"about_ca_topic_score_gemma":0.000034629556,"teacher_disagreement_score":0.99296004,"about_ca_system_score_codex":0.0001727523,"about_ca_system_score_gemma":0.002517819,"threshold_uncertainty_score":0.50044715},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"split"},{"id":"W4408194139","doi":"10.51731/cjht.2025.1092","title":"Alectinib (Alecensaro)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Alectinib; Medicine; Internal medicine","score_opus":0.022852287882387443,"score_gpt":0.31484878507832437,"score_spread":0.2919964971959369,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408194139","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.47075966,0.260031,0.0005502192,0.25316116,0.001721344,0.0008522057,0.000019219351,0.00035443387,0.012550752],"genre_scores_gemma":[0.9957535,0.00070069416,0.0011972261,0.0014311431,0.000009282353,0.000003917161,0.000001916053,0.000009566632,0.0008927426],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99882126,0.000027273321,0.0004907783,0.0001183819,0.00011072403,0.00043158332],"domain_scores_gemma":[0.9991755,0.000052768148,0.000227398,0.00028690838,0.00015998301,0.000097426986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032354696,0.00011425908,0.00041373423,0.00092360773,0.00016731785,0.000014266107,0.00019559296,0.00014703028,0.000048977265],"category_scores_gemma":[0.0007965416,0.000094518655,0.000086763524,0.000538141,0.00016362514,0.000048547536,0.000014167281,0.00048282332,0.000013278902],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032813794,0.00003187038,0.03793718,0.00021522884,0.00018131569,0.0005498393,0.0001423169,0.0000034140633,0.000059383663,0.0018055468,0.046397887,0.9126432],"study_design_scores_gemma":[0.0033731158,0.00090924825,0.05351337,0.0014677474,0.00008711509,0.0016770739,0.0022777454,0.000013886171,0.0029606358,0.004600419,0.92896986,0.00014980522],"about_ca_topic_score_codex":0.0034712292,"about_ca_topic_score_gemma":0.0029990354,"teacher_disagreement_score":0.9124934,"about_ca_system_score_codex":0.0025151426,"about_ca_system_score_gemma":0.0144408485,"threshold_uncertainty_score":0.9911464},"labels":[],"label_agreement":null},{"id":"W4408247275","doi":"10.51731/cjht.2025.1095","title":"Environmental Scan of Genetic and Genomic Biomarker Testing Assessment Frameworks, Processes, and Inventories in Cancer Care","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Biomedical and Engineering Education","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biomarker; Cancer; Genetic testing; Computational biology; Medicine; Genetics; Biology; Internal medicine","score_opus":0.011932026990877725,"score_gpt":0.25361355347762266,"score_spread":0.24168152648674493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408247275","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7905134,0.20764579,0.00036353854,0.0011777101,0.00018998925,0.00006314283,0.000010060095,0.00002042314,0.00001594363],"genre_scores_gemma":[0.99496984,0.00272217,0.0022697563,0.000020854532,0.000003915785,0.0000061560827,6.88751e-7,0.0000054237303,0.0000012106143],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9995062,0.000005852649,0.0002392265,0.000057046935,0.00003922303,0.00015247957],"domain_scores_gemma":[0.99981624,0.000027078459,0.000050941806,0.00004990146,0.000016202579,0.000039638842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000082552426,0.00006382948,0.0001396898,0.00032140745,0.00003561034,0.000010859893,0.000071931485,0.00011058184,0.0000016128257],"category_scores_gemma":[0.0000683684,0.000060387705,0.00000588542,0.00022724956,0.00011109931,0.00003282197,0.0000108958775,0.0002416259,2.3814373e-8],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[7.212222e-7,0.0000039036254,0.26595026,0.0018748142,0.000017127093,0.0000036484867,0.0005011028,0.0004440673,0.0003438482,0.0000255244,0.0001163719,0.7307186],"study_design_scores_gemma":[0.0001545032,0.000049930604,0.9896906,0.0010444575,0.000007922865,0.0000142016215,0.003833862,0.0007769233,0.00020223427,0.00066449435,0.0034746192,0.00008626205],"about_ca_topic_score_codex":0.0019220689,"about_ca_topic_score_gemma":0.0022418392,"teacher_disagreement_score":0.73063236,"about_ca_system_score_codex":0.00040997542,"about_ca_system_score_gemma":0.0007211976,"threshold_uncertainty_score":0.2905606},"labels":[],"label_agreement":null},{"id":"W4408410037","doi":"10.51731/cjht.2025.1096","title":"Virtual Remote Imaging Services: CT and MRI Scanning","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Medical Imaging Techniques and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science; Remote sensing; Computer vision; Radiology; Geology; Medical physics; Medicine","score_opus":0.015620295828686615,"score_gpt":0.32079845710943716,"score_spread":0.30517816128075054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408410037","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.122987844,0.057574075,0.031971183,0.7851793,0.0002448059,0.00046670204,0.000008932082,0.00041875604,0.0011483722],"genre_scores_gemma":[0.9790362,0.0008974015,0.015612459,0.004336953,0.000008746006,0.0000014321143,0.000001654531,0.00000788413,0.00009724359],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99909985,0.00001669277,0.00039018606,0.000119399476,0.00009019383,0.0002836902],"domain_scores_gemma":[0.99933976,0.00003603126,0.00017477447,0.0002151532,0.000109189,0.00012511277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004819396,0.000087307395,0.0002756658,0.0005595669,0.00020987159,0.000030380521,0.00018637165,0.000034411994,0.000007033906],"category_scores_gemma":[0.00018909559,0.00007276061,0.000036185487,0.0003268795,0.00024088917,0.000059800463,0.00003110192,0.00044955,0.0000010332881],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000047666877,0.000007314214,0.0085302,0.00024110626,0.000022755064,0.00018568941,0.00011210742,0.0000010507197,0.0001291268,0.004259532,0.01643962,0.9700667],"study_design_scores_gemma":[0.0008993287,0.00023614957,0.008338966,0.005448952,0.0000690027,0.0025209535,0.008467483,0.002530082,0.0012982535,0.019079901,0.95091903,0.00019189459],"about_ca_topic_score_codex":0.004270809,"about_ca_topic_score_gemma":0.00036511174,"teacher_disagreement_score":0.96987486,"about_ca_system_score_codex":0.00017924728,"about_ca_system_score_gemma":0.0014311322,"threshold_uncertainty_score":0.64562136},"labels":[],"label_agreement":null},{"id":"W4408545865","doi":"10.51731/cjht.2025.1098","title":"Elexacaftor-Tezacaftor-Ivacaftor and Ivacaftor (Trikafta)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ivacaftor; Medicine; Internal medicine; Cystic fibrosis","score_opus":0.016675598816513777,"score_gpt":0.3309302250631296,"score_spread":0.3142546262466158,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408545865","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7946423,0.18565026,0.00045508388,0.017646762,0.00006443804,0.000527394,0.000028650507,0.0001417389,0.0008433308],"genre_scores_gemma":[0.99189013,0.0021683106,0.004432547,0.0008457407,0.000031065207,0.000012646735,0.0000027719109,0.000020464337,0.00059633947],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977026,0.000073264506,0.0008097368,0.00026514797,0.0003235948,0.00082567835],"domain_scores_gemma":[0.998358,0.0002143677,0.000321086,0.00040905533,0.00037197678,0.00032548423],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008495151,0.0002196815,0.0007383597,0.0016338918,0.00031550534,0.00006690732,0.0003982922,0.00023336045,0.000044801218],"category_scores_gemma":[0.0033204562,0.00018385968,0.0001064942,0.0007377042,0.0006200066,0.00018787726,0.00007067405,0.0008928416,0.0000092346245],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023235066,0.000055306096,0.074563235,0.0010865155,0.00020171185,0.0004885198,0.000016720127,0.0000026804614,0.0017503644,0.006218029,0.03932376,0.8760608],"study_design_scores_gemma":[0.0015345172,0.0011397472,0.122617565,0.0013855333,0.000042722153,0.00058268744,0.0019671973,0.000016844653,0.002484527,0.004474957,0.8635598,0.00019393319],"about_ca_topic_score_codex":0.001371391,"about_ca_topic_score_gemma":0.00007020102,"teacher_disagreement_score":0.8758669,"about_ca_system_score_codex":0.000823154,"about_ca_system_score_gemma":0.0059856623,"threshold_uncertainty_score":0.99964947},"labels":[],"label_agreement":null},{"id":"W4408546184","doi":"10.51731/cjht.2025.1097","title":"Comparative Effectiveness of Real-Time Teleultrasound Versus In-Person Ultrasound","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Flow Measurement and Analysis","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ultrasound; Psychology; Medicine; Radiology","score_opus":0.026870403669671576,"score_gpt":0.26901858000114304,"score_spread":0.24214817633147145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408546184","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9788612,0.01745857,0.00022470087,0.00027576924,0.0003588217,0.00015243707,0.000010811872,0.000078092664,0.0025795607],"genre_scores_gemma":[0.9993202,0.00045001315,0.00019950031,0.0000044976327,0.0000030019823,0.0000031315008,0.0000019676309,0.0000067026776,0.000010955807],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9990399,0.00008519895,0.00039009,0.00008400359,0.00010642574,0.00029438545],"domain_scores_gemma":[0.999217,0.00038423148,0.00011633189,0.00014275267,0.00010196966,0.000037765083],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000778157,0.00012139215,0.00055650075,0.00084052555,0.00006347038,0.000016189657,0.000251488,0.000098101315,0.000010386135],"category_scores_gemma":[0.00027163955,0.00011488112,0.00007621311,0.00079721207,0.00012576004,0.00008937076,0.0000033369172,0.0002798453,0.000002482671],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011726071,0.00031542836,0.26100427,0.009007209,0.005791664,0.0003879112,0.0074711274,0.13310525,0.25845498,0.010653305,0.018952329,0.29368392],"study_design_scores_gemma":[0.014078649,0.002771608,0.60989684,0.012495344,0.0005202004,0.000102348,0.05468971,0.0031393245,0.27265847,0.0078101577,0.019751295,0.002086066],"about_ca_topic_score_codex":0.0025916444,"about_ca_topic_score_gemma":0.005434082,"teacher_disagreement_score":0.34889254,"about_ca_system_score_codex":0.00063892803,"about_ca_system_score_gemma":0.0006585856,"threshold_uncertainty_score":0.46847162},"labels":[],"label_agreement":null},{"id":"W4408618859","doi":"10.51731/cjht.2025.1099","title":"Talquetamab (Talvey)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.2889593708010012,"score_gpt":0.42972959860994586,"score_spread":0.14077022780894466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408618859","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0447479,0.22790158,0.008549959,0.7064052,0.002521836,0.0005673745,0.00015028665,0.0001489166,0.009006939],"genre_scores_gemma":[0.98259056,0.0005028562,0.002027224,0.014235789,0.000025995023,0.000013895652,0.000003091593,0.00001507211,0.00058554293],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99486136,0.00014554756,0.004151907,0.00023143289,0.000051048533,0.0005587226],"domain_scores_gemma":[0.99636483,0.00030058992,0.0026754988,0.00042166392,0.00012010724,0.00011727914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011881101,0.00014246504,0.0009975393,0.0018265098,0.00034636457,0.000077143355,0.00060764,0.00021024709,0.000113404116],"category_scores_gemma":[0.0071405433,0.00016869765,0.00013107334,0.0005022062,0.00018869866,0.00030616575,0.000026108615,0.00041251123,0.00022847434],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000005568689,0.0000308957,0.046461053,0.00055826374,0.00013141394,0.000016264154,0.0007039275,0.00006960466,9.633121e-7,0.68067926,0.22795098,0.04339181],"study_design_scores_gemma":[0.00043235105,0.000103569975,0.015981654,0.00028423368,0.0000032205398,0.000030389901,0.0035268941,0.00007485189,0.000012422401,0.14509572,0.8342888,0.00016591902],"about_ca_topic_score_codex":0.009370272,"about_ca_topic_score_gemma":0.0043709846,"teacher_disagreement_score":0.9378426,"about_ca_system_score_codex":0.0015415256,"about_ca_system_score_gemma":0.0035593307,"threshold_uncertainty_score":0.9972264},"labels":[],"label_agreement":null},{"id":"W4408650636","doi":"10.51731/cjht.2025.1101","title":"Danicopan (Voydeya)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Chemical synthesis and alkaloids","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.012827854740274846,"score_gpt":0.25479139510980947,"score_spread":0.24196354036953463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408650636","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6997525,0.11390994,0.00019669144,0.1513944,0.0003717307,0.000097074844,0.000028809396,0.00027628217,0.03397256],"genre_scores_gemma":[0.9983688,0.00030180265,0.00039950863,0.000425091,0.000007768243,0.0000016828184,9.1495946e-7,0.000006654257,0.00048776745],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99907833,0.00000650719,0.0004191239,0.00009996541,0.00007786504,0.0003182158],"domain_scores_gemma":[0.99938905,0.00004807827,0.00018826239,0.00022601319,0.000076055316,0.00007253915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018207956,0.00009187402,0.00029014243,0.0002313326,0.0001435957,0.00003101839,0.00035294835,0.00015176846,0.00013955688],"category_scores_gemma":[0.0005050354,0.00007822487,0.00009329348,0.00021635873,0.00013828508,0.000041206713,0.00002177223,0.00039355093,0.0000031203356],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000062144027,0.000016965038,0.0044352575,0.0002147905,0.000037669663,0.00004596487,0.000027333737,8.902102e-7,0.007980719,0.0028931717,0.015502743,0.9688383],"study_design_scores_gemma":[0.00023392205,0.000029505181,0.00075216725,0.00050364103,0.000010857447,0.00009539578,0.0009835681,0.000004281779,0.11351041,0.007600297,0.87617713,0.000098808676],"about_ca_topic_score_codex":0.00094881875,"about_ca_topic_score_gemma":0.000658467,"teacher_disagreement_score":0.96873945,"about_ca_system_score_codex":0.0003594111,"about_ca_system_score_gemma":0.0018626673,"threshold_uncertainty_score":0.33042917},"labels":[],"label_agreement":null},{"id":"W4408650838","doi":"10.51731/cjht.2025.1100","title":"Tarlatamab (Imdelltra)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.01959808958604087,"score_gpt":0.30008057881005523,"score_spread":0.28048248922401436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408650838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.45681325,0.2875144,0.0010077456,0.2450599,0.0014559138,0.0008009514,0.000027384967,0.00032610202,0.006994379],"genre_scores_gemma":[0.996011,0.00068766554,0.0013776359,0.0012561252,0.00000842919,0.0000034347602,0.0000027029894,0.000009190809,0.00064381864],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988296,0.000022723016,0.000496115,0.00011685629,0.00011753023,0.00041720015],"domain_scores_gemma":[0.9991934,0.000041828658,0.00021702526,0.0003131247,0.00013380879,0.000100834615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031632715,0.00011472319,0.00041261545,0.00087211514,0.00014732353,0.000015412354,0.00022134924,0.00014704042,0.000045716468],"category_scores_gemma":[0.0004933205,0.00009391081,0.000087450106,0.00043847182,0.00017162785,0.00005793952,0.000014773573,0.00046724375,0.000013831378],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031485833,0.000033235097,0.031955946,0.00024614806,0.00018238339,0.00066739396,0.00013577218,0.000007793732,0.000049661438,0.0028904323,0.0426534,0.92114633],"study_design_scores_gemma":[0.0036899454,0.00087653013,0.060908467,0.0015644566,0.000097906675,0.0013463724,0.0021297405,0.00002758141,0.0021986773,0.0054654772,0.92153275,0.00016208015],"about_ca_topic_score_codex":0.004211151,"about_ca_topic_score_gemma":0.0022215184,"teacher_disagreement_score":0.92098427,"about_ca_system_score_codex":0.0024660584,"about_ca_system_score_gemma":0.013985466,"threshold_uncertainty_score":0.9916043},"labels":[],"label_agreement":null},{"id":"W4408838287","doi":"10.51731/cjht.2025.1102","title":"Enfortumab Vedotin (Padcev)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chemistry","score_opus":0.019832781524393564,"score_gpt":0.31844238124807966,"score_spread":0.2986095997236861,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408838287","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2643897,0.3205765,0.0002756898,0.40699375,0.0014345999,0.0006247829,0.000025255624,0.0001711831,0.0055085486],"genre_scores_gemma":[0.9960328,0.0015956489,0.0004560848,0.0016533558,0.000009469455,0.000008332289,0.0000016067662,0.0000061076876,0.00023664434],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990895,0.000012733548,0.00041201257,0.00009084271,0.000089540474,0.0003053948],"domain_scores_gemma":[0.99936867,0.000036315396,0.00018243634,0.00020737585,0.00012048177,0.00008474817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023421379,0.00008975041,0.00035504115,0.00066057657,0.00013144391,0.000016297105,0.00012810639,0.000088565546,0.00003830408],"category_scores_gemma":[0.00025937846,0.00007018282,0.00008995418,0.00031739357,0.00011178738,0.000036955033,0.000010749747,0.0002681867,0.000005849267],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017481727,0.000035807127,0.056334544,0.00011988251,0.00010060103,0.000259301,0.00007407499,0.0000029376574,0.000005160245,0.004684273,0.041979257,0.8963867],"study_design_scores_gemma":[0.0014082008,0.00079015223,0.11263113,0.0011509464,0.000062436906,0.00029027186,0.0016427351,0.0000040097852,0.0012200646,0.0034568633,0.8772597,0.00008353775],"about_ca_topic_score_codex":0.00798013,"about_ca_topic_score_gemma":0.0067226477,"teacher_disagreement_score":0.8963031,"about_ca_system_score_codex":0.00089582504,"about_ca_system_score_gemma":0.0065196278,"threshold_uncertainty_score":0.9991125},"labels":[],"label_agreement":null},{"id":"W4408871724","doi":"10.51731/cjht.2025.1103","title":"2025 Watch List: Artificial Intelligence in Health Care","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Artificial intelligence; Computer science; Psychology","score_opus":0.12810152704414343,"score_gpt":0.4406847268809778,"score_spread":0.31258319983683436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408871724","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12273697,0.15595907,0.003945209,0.71301085,0.002524621,0.0009320089,0.000011495959,0.000112888214,0.0007669041],"genre_scores_gemma":[0.9938473,0.0017489638,0.001154121,0.0030800523,0.000034538465,0.000010780527,0.0000055067526,0.000009754925,0.00010898428],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973409,0.0000971035,0.0015509507,0.0001992166,0.00015586894,0.00065592316],"domain_scores_gemma":[0.99860567,0.00011683622,0.00039673093,0.0003045096,0.00041229135,0.00016398539],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011320832,0.00014122394,0.0005283553,0.0012547055,0.00028154042,0.000033264554,0.00027944843,0.00021567216,0.000041213792],"category_scores_gemma":[0.0014028532,0.00013041295,0.00008105622,0.001202173,0.0002154025,0.00009084972,0.000017272827,0.00085243705,0.000013107],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002820696,0.00002723479,0.012201568,0.00049284374,0.000009255338,0.000039764825,0.0027114765,0.000027536975,0.000004385751,0.0063992743,0.0035820985,0.97447634],"study_design_scores_gemma":[0.00015026021,0.0028245558,0.012505387,0.008399943,0.0000315014,0.00027532174,0.38542745,0.00024594247,0.011402457,0.12714587,0.45109752,0.00049379526],"about_ca_topic_score_codex":0.06435934,"about_ca_topic_score_gemma":0.0876095,"teacher_disagreement_score":0.9739826,"about_ca_system_score_codex":0.0020985794,"about_ca_system_score_gemma":0.018138718,"threshold_uncertainty_score":0.98742753},"labels":[],"label_agreement":null},{"id":"W4408940911","doi":"10.51731/cjht.2025.1104","title":"Venetoclax (Venclexta)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Venetoclax; Philosophy; Medicine; Psychology; Internal medicine; Leukemia","score_opus":0.025457065611933158,"score_gpt":0.36479889377678365,"score_spread":0.3393418281648505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408940911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.35248598,0.32817414,0.00023709497,0.30726966,0.0021411174,0.00058758707,0.000015510002,0.00017229031,0.008916597],"genre_scores_gemma":[0.9961132,0.0008101452,0.0003012859,0.0020556499,0.000012194885,0.000004632261,0.0000012787166,0.000004754507,0.0006968824],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992844,0.000019746176,0.00029765588,0.00007200215,0.00005503457,0.0002711511],"domain_scores_gemma":[0.9995499,0.000028974586,0.00013740282,0.00012572603,0.00009256035,0.00006539145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020417187,0.00007101143,0.00028511675,0.0006245599,0.000116115036,0.000008004878,0.00012581467,0.00009346847,0.0000658012],"category_scores_gemma":[0.000114883354,0.000058857622,0.000064053515,0.0003170547,0.00013287828,0.00003074527,0.000008597319,0.00028267043,0.000005858954],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006282563,0.00002590406,0.026629714,0.00015424239,0.00015181536,0.00036470848,0.00012467093,0.000008177524,0.00016527966,0.0030352226,0.10002298,0.86925447],"study_design_scores_gemma":[0.0011430521,0.0007604949,0.025850618,0.000302066,0.00005424821,0.00026406013,0.00062805053,0.0000060663674,0.0014045787,0.004448767,0.9650825,0.000055442397],"about_ca_topic_score_codex":0.0025034612,"about_ca_topic_score_gemma":0.0023057824,"teacher_disagreement_score":0.86919904,"about_ca_system_score_codex":0.0010283879,"about_ca_system_score_gemma":0.008324998,"threshold_uncertainty_score":0.99729687},"labels":[],"label_agreement":null},{"id":"W4409040539","doi":"10.51731/cjht.2025.1108","title":"Ciltacabtagene Autoleucel (Carvykti)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.04058088739669979,"score_gpt":0.3538447205249171,"score_spread":0.3132638331282173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409040539","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.31192797,0.23805399,0.0011994549,0.4228802,0.001577372,0.0011361281,0.000030452484,0.00042877847,0.022765627],"genre_scores_gemma":[0.99013484,0.0013304652,0.0008255905,0.0018232032,0.000019980933,0.0000059211043,0.0000018783985,0.000016562886,0.005841572],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984155,0.000053559983,0.0005604889,0.00014423583,0.00022858969,0.0005975756],"domain_scores_gemma":[0.99889684,0.00006685955,0.00018616699,0.00039302645,0.00029789325,0.00015924248],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009041038,0.00012510897,0.00048663153,0.0015504792,0.00020130629,0.000031966047,0.00037263226,0.00019935027,0.00036771165],"category_scores_gemma":[0.0007594238,0.00010624508,0.00012609373,0.0007909887,0.00026941588,0.00005763929,0.000030154375,0.00082628755,0.000013432046],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044925582,0.000019034958,0.006936716,0.00017631041,0.00010159456,0.00035263452,0.0000972936,0.0000042714555,0.0021405916,0.0014527361,0.025995184,0.96267873],"study_design_scores_gemma":[0.0010681952,0.0005681099,0.014283395,0.00052323093,0.00002224401,0.00045155708,0.0017072905,0.000023704544,0.0075097485,0.0032455625,0.9704967,0.00010026734],"about_ca_topic_score_codex":0.003416639,"about_ca_topic_score_gemma":0.0023096604,"teacher_disagreement_score":0.9625784,"about_ca_system_score_codex":0.001047831,"about_ca_system_score_gemma":0.009786861,"threshold_uncertainty_score":0.9958267},"labels":[],"label_agreement":null},{"id":"W4409040555","doi":"10.51731/cjht.2025.1105","title":"Iptacopan (Fabhalta)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cardiovascular Syncope and Autonomic Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.011168223352784949,"score_gpt":0.2755146141664529,"score_spread":0.26434639081366795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409040555","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16656896,0.4724282,0.0027830068,0.33119422,0.001985784,0.00062738755,0.000011211917,0.00025651473,0.024144704],"genre_scores_gemma":[0.99670655,0.0007366328,0.0004260907,0.0016363806,0.0000073787724,0.000002218333,0.0000010292205,0.000007088011,0.00047662956],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999109,0.000023355122,0.00039222836,0.00009291973,0.00008146482,0.00030099164],"domain_scores_gemma":[0.9994212,0.000017494222,0.00013312377,0.00025664648,0.00010455654,0.00006701284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050360814,0.00008302005,0.00040935192,0.0007632062,0.000118986776,0.000018529543,0.00017278062,0.000097866236,0.000020764097],"category_scores_gemma":[0.00035791873,0.000071017035,0.00018605603,0.00035453125,0.00013989944,0.000049310074,0.000013346101,0.00031635357,0.000009969257],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008258528,0.000009725151,0.0038577802,0.000097881064,0.0001414247,0.00012415907,0.000057674137,0.000006623674,0.000016083104,0.0021406997,0.022228131,0.97131157],"study_design_scores_gemma":[0.000798831,0.00016599508,0.020648701,0.00043598778,0.000045458146,0.00030741555,0.0030195662,0.0000054017796,0.00039793956,0.0023491485,0.97175574,0.00006983701],"about_ca_topic_score_codex":0.0021038046,"about_ca_topic_score_gemma":0.0013267938,"teacher_disagreement_score":0.9712417,"about_ca_system_score_codex":0.0003483503,"about_ca_system_score_gemma":0.0059270086,"threshold_uncertainty_score":0.9997085},"labels":[],"label_agreement":null},{"id":"W4409070048","doi":"10.51731/cjht.2025.1107","title":"Lisocabtagene Maraleucel (Breyanzi)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.017356380450986045,"score_gpt":0.2815971523766693,"score_spread":0.2642407719256833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409070048","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.27816394,0.14663354,0.0057163658,0.5322913,0.004252068,0.0012099289,0.00001530532,0.00061454705,0.031103013],"genre_scores_gemma":[0.99249595,0.00059618306,0.0007234958,0.002898376,0.00001113446,0.0000033481747,8.5326513e-7,0.0000072784323,0.003263391],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990635,0.000022673556,0.00042036932,0.000096770935,0.00009535253,0.00030136277],"domain_scores_gemma":[0.99937826,0.000020164756,0.0001788511,0.00022204395,0.00011842129,0.000082261664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032858466,0.000088589666,0.00030539144,0.0010648895,0.00015953364,0.00002200162,0.00016065188,0.0001000386,0.00006188069],"category_scores_gemma":[0.00029964084,0.000075899916,0.000081904,0.00041455647,0.00010543541,0.00003343239,0.000018267965,0.00032823233,0.000012360534],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003354036,0.000022923788,0.0048549273,0.0002185729,0.0000978264,0.0006161886,0.000060648792,0.0000062230793,0.00011557145,0.0037222316,0.07368119,0.9165702],"study_design_scores_gemma":[0.0005186668,0.00037999166,0.011948126,0.0002913518,0.000029081775,0.0007898146,0.0017670785,0.000011796214,0.0006764657,0.0017163133,0.9818055,0.0000658291],"about_ca_topic_score_codex":0.0014652505,"about_ca_topic_score_gemma":0.0022969064,"teacher_disagreement_score":0.9165043,"about_ca_system_score_codex":0.00047633256,"about_ca_system_score_gemma":0.0019237796,"threshold_uncertainty_score":0.34127024},"labels":[],"label_agreement":null},{"id":"W4409183810","doi":"10.51731/cjht.2025.1110","title":"Fruquintinib (Fruzaqla)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Geography","score_opus":0.025099684938005035,"score_gpt":0.3499035703777737,"score_spread":0.3248038854397687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409183810","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.42928398,0.23626362,0.0014420486,0.31285343,0.0016710047,0.0009851654,0.000015417563,0.00034800544,0.017137367],"genre_scores_gemma":[0.99627644,0.0005468655,0.0008374448,0.0013357837,0.000013446377,0.0000040171035,0.0000011152307,0.000010257494,0.0009746143],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984914,0.000037725174,0.0005620774,0.00012866194,0.00020345632,0.00057664944],"domain_scores_gemma":[0.99894065,0.00008998858,0.00018783794,0.0003657889,0.00028044905,0.000135277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008050436,0.00010443867,0.0004305009,0.0012242518,0.0001673464,0.000026645399,0.0003525304,0.00017530737,0.00005274146],"category_scores_gemma":[0.0017999447,0.000084906256,0.000096011194,0.00068765355,0.00034057614,0.000058389058,0.000034631972,0.00061355403,0.000019603283],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000059839378,0.000028884282,0.004587431,0.0005528955,0.00013706047,0.0010525105,0.00017858345,0.000007174784,0.00006863079,0.0087745935,0.09125493,0.8932975],"study_design_scores_gemma":[0.006216516,0.00065802457,0.005778687,0.0014742535,0.00003412164,0.0017287408,0.0033619623,0.00013770454,0.0021877703,0.006904718,0.9713875,0.0001300119],"about_ca_topic_score_codex":0.0073971646,"about_ca_topic_score_gemma":0.0023198128,"teacher_disagreement_score":0.89316744,"about_ca_system_score_codex":0.011542716,"about_ca_system_score_gemma":0.08532314,"threshold_uncertainty_score":0.9992127},"labels":[],"label_agreement":null},{"id":"W4409266272","doi":"10.51731/cjht.2025.1111","title":"Spesolimab (Spevigo)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Phytochemical Studies and Bioactivities","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.00952296609788956,"score_gpt":0.26550730500820074,"score_spread":0.2559843389103112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409266272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.54742664,0.37491786,0.0017142302,0.06805026,0.0009991578,0.0002728881,0.000039376137,0.000049471797,0.0065301526],"genre_scores_gemma":[0.9972209,0.0014869145,0.00023458147,0.00080626603,0.000017380375,0.0000022867257,0.0000020863085,0.000004172603,0.00022542183],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992956,0.000017283532,0.0002515788,0.00009936326,0.0000469305,0.00028926547],"domain_scores_gemma":[0.9995856,0.000008715105,0.00013456693,0.00015191395,0.000084870415,0.00003428481],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017912214,0.00008463114,0.00018897558,0.00013788146,0.00015320764,0.000015986343,0.00026310972,0.00011243234,0.0000037376585],"category_scores_gemma":[0.00025060607,0.00006906231,0.00007008076,0.00014304464,0.00019915838,0.0000027811213,0.000042345426,0.00015291505,0.0000010911843],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004970477,0.000038996113,0.0095537035,0.00014267396,0.00023205571,0.00003020465,0.00006471869,0.0000069561183,0.021618066,0.0025646565,0.1298186,0.8358797],"study_design_scores_gemma":[0.00022701037,0.0002388332,0.0022397058,0.000083039486,0.000006122486,0.000029993435,0.0011596543,7.325942e-7,0.057278153,0.0025102638,0.93613666,0.00008980847],"about_ca_topic_score_codex":0.0006204438,"about_ca_topic_score_gemma":0.0015358776,"teacher_disagreement_score":0.83578986,"about_ca_system_score_codex":0.00008059051,"about_ca_system_score_gemma":0.0009918603,"threshold_uncertainty_score":0.28162795},"labels":[],"label_agreement":null},{"id":"W4409268403","doi":"10.51731/cjht.2025.1112","title":"Exagamglogene Autotemcel (Casgevy)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Art","score_opus":0.014059258815711047,"score_gpt":0.27877952370201586,"score_spread":0.2647202648863048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409268403","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24937189,0.38544783,0.0011046152,0.35099036,0.0016745781,0.0005256646,0.000011800626,0.0002799862,0.010593283],"genre_scores_gemma":[0.9943188,0.0020297258,0.00071359973,0.0022368343,0.0000066807534,0.0000021501878,0.0000013669434,0.000009407512,0.0006814618],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987817,0.000028336632,0.00054338056,0.000110314286,0.00010077946,0.00043550445],"domain_scores_gemma":[0.9992556,0.000025838304,0.00020533471,0.00023910493,0.00016017137,0.0001139353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041906707,0.00011167294,0.00040166188,0.0009523393,0.00020688717,0.000016510585,0.00020037038,0.00025604235,0.000033298467],"category_scores_gemma":[0.00052733184,0.000086747445,0.00010209824,0.00059598405,0.0002191918,0.00004121556,0.000015524485,0.0005834933,0.000009930405],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022876387,0.000031983815,0.009463003,0.0002516601,0.00011837348,0.00044849826,0.00014327002,0.000017014247,0.00011137903,0.003907093,0.0375772,0.9479076],"study_design_scores_gemma":[0.0013150582,0.00058052246,0.017257689,0.0011177011,0.000058577396,0.0008263944,0.005548295,0.000029708855,0.00091497344,0.005277111,0.96693504,0.00013893953],"about_ca_topic_score_codex":0.0021631303,"about_ca_topic_score_gemma":0.00087068725,"teacher_disagreement_score":0.9477687,"about_ca_system_score_codex":0.0003924975,"about_ca_system_score_gemma":0.006254854,"threshold_uncertainty_score":0.99937874},"labels":[],"label_agreement":null},{"id":"W4409333523","doi":"10.51731/cjht.2025.1113","title":"Avapritinib (Ayvakyt)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.021525077236918103,"score_gpt":0.31111903087100845,"score_spread":0.28959395363409035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409333523","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.42249128,0.26956034,0.0005122202,0.2894537,0.0014340074,0.00083419174,0.000026244381,0.00035217643,0.015335863],"genre_scores_gemma":[0.99552363,0.0006968969,0.0013290354,0.001571359,0.000010326192,0.000004515814,0.000002296472,0.000009561985,0.00085238455],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987838,0.000026241703,0.0005277928,0.00011755229,0.00011630475,0.00042828673],"domain_scores_gemma":[0.999166,0.000050306284,0.00022136673,0.00030128218,0.00015603552,0.00010500845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035930023,0.000114266615,0.0004229872,0.00087559567,0.00015637325,0.000016265223,0.00021708214,0.00015096502,0.000057871643],"category_scores_gemma":[0.00075371825,0.00009500079,0.00009022067,0.00042182568,0.00018265274,0.000052456307,0.000017159247,0.00047349566,0.000017502527],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025528696,0.000030354013,0.02721229,0.00024807887,0.00014265535,0.0006173337,0.0001062481,0.000002496126,0.000039673017,0.0036882835,0.043265145,0.92462194],"study_design_scores_gemma":[0.0032156126,0.00070641824,0.045182154,0.0016684334,0.00007210899,0.0011755191,0.0025986712,0.000011414814,0.0018202106,0.005828293,0.9375863,0.00013485154],"about_ca_topic_score_codex":0.003132523,"about_ca_topic_score_gemma":0.0020329626,"teacher_disagreement_score":0.92448705,"about_ca_system_score_codex":0.0023655486,"about_ca_system_score_gemma":0.014236989,"threshold_uncertainty_score":0.99135137},"labels":[],"label_agreement":null},{"id":"W4409767758","doi":"10.51731/cjht.2025.1115","title":"Trastuzumab Deruxtecan (Enhertu)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Trastuzumab; Medicine; Internal medicine; Breast cancer; Cancer","score_opus":0.019601184163762185,"score_gpt":0.30275716874635483,"score_spread":0.28315598458259267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409767758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.517793,0.25146335,0.0013265827,0.22010666,0.0013116295,0.00089924585,0.000023586368,0.0003540857,0.006721848],"genre_scores_gemma":[0.9960618,0.0005924825,0.0014249259,0.0012522717,0.000009232357,0.00000562777,0.0000022550898,0.000011798627,0.00063958234],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986729,0.00003097133,0.0005525666,0.00013475773,0.00012987279,0.00047890833],"domain_scores_gemma":[0.99913305,0.00004987763,0.00023524393,0.00031440068,0.00014431545,0.00012311901],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032616907,0.00013665731,0.00047136392,0.0009353974,0.00018027647,0.000018078488,0.00024070358,0.00016294312,0.000051372484],"category_scores_gemma":[0.00057172956,0.00011194573,0.000100118166,0.00049303344,0.00019111623,0.000056494166,0.000014997746,0.00049809803,0.000010678564],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000023428274,0.000028138275,0.010924467,0.00015514922,0.00013919649,0.00039040696,0.0001351596,0.000003293053,0.0000321319,0.0010839979,0.015332621,0.971752],"study_design_scores_gemma":[0.0048949514,0.0015306108,0.0683055,0.0021118799,0.00014253843,0.001848427,0.0056107496,0.00002349696,0.0028189037,0.009132374,0.90334976,0.00023078242],"about_ca_topic_score_codex":0.0053122975,"about_ca_topic_score_gemma":0.005873452,"teacher_disagreement_score":0.9715212,"about_ca_system_score_codex":0.0038962327,"about_ca_system_score_gemma":0.017676314,"threshold_uncertainty_score":0.99992764},"labels":[],"label_agreement":null},{"id":"W4409805181","doi":"10.51731/cjht.2025.1116","title":"Pembrolizumab (Keytruda)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pembrolizumab; Computer science; Medicine; Internal medicine; Cancer","score_opus":0.018423995163443674,"score_gpt":0.31739819533080416,"score_spread":0.2989742001673605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409805181","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2742569,0.31973705,0.00020119116,0.39870843,0.0009884798,0.00045301914,0.00001560814,0.0001323639,0.005506934],"genre_scores_gemma":[0.9960123,0.0018445333,0.0003270286,0.001573605,0.000008197179,0.000007467875,0.0000010266615,0.000005860353,0.00022003926],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99915093,0.000013850381,0.00036276327,0.00008973298,0.000089060224,0.00029364848],"domain_scores_gemma":[0.9993985,0.000030653857,0.00015891595,0.0002063835,0.00012549266,0.00008003504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001807343,0.00008515157,0.0003477167,0.0006882092,0.0001318548,0.000016453725,0.00012389157,0.000087030174,0.000036440437],"category_scores_gemma":[0.00020857493,0.00006651488,0.0000891459,0.0003240212,0.000113166105,0.000034657915,0.000009876098,0.000255158,0.0000053395256],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030364377,0.000038375354,0.052629065,0.0001379032,0.000112682035,0.0002953898,0.0000784541,0.000002596239,0.000006309693,0.0059334785,0.042438727,0.89829665],"study_design_scores_gemma":[0.0020577114,0.0009052149,0.14220658,0.0011187482,0.00007087042,0.0004772586,0.0016527629,0.0000037186264,0.001038769,0.005022954,0.8453579,0.00008753625],"about_ca_topic_score_codex":0.0049003535,"about_ca_topic_score_gemma":0.005150814,"teacher_disagreement_score":0.8982091,"about_ca_system_score_codex":0.0008615668,"about_ca_system_score_gemma":0.005416469,"threshold_uncertainty_score":0.96085835},"labels":[],"label_agreement":null},{"id":"W4409927225","doi":"10.51731/cjht.2025.1118","title":"Ferric Carboxymaltose (Ferinject)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chemistry","score_opus":0.015168506749569223,"score_gpt":0.2923345552259458,"score_spread":0.2771660484763766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409927225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5357671,0.3234773,0.0005262884,0.12776572,0.0015124279,0.0004340176,0.00000966245,0.00019585494,0.010311626],"genre_scores_gemma":[0.99568,0.001010754,0.0006733755,0.002153901,0.000008999003,0.0000026545438,8.068643e-7,0.00000801632,0.00046154304],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989389,0.000028723183,0.00043352548,0.00009976014,0.00010195162,0.00039710614],"domain_scores_gemma":[0.99933165,0.000027844415,0.00016531828,0.00024383763,0.00013210149,0.00009923718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003587991,0.00010324688,0.00039073487,0.0011184692,0.0001532127,0.000015892454,0.00020232266,0.00012803865,0.00002782175],"category_scores_gemma":[0.00081828935,0.000084631494,0.00007932948,0.00056166004,0.00016667166,0.000050653824,0.000014345426,0.00040997163,0.000006608043],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004508409,0.00003472722,0.035635475,0.0005009002,0.00004180847,0.00027036364,0.0002464791,0.000009792413,0.000080031736,0.010845449,0.03275178,0.9195381],"study_design_scores_gemma":[0.0023025535,0.00063483807,0.17813046,0.00061887084,0.000094355804,0.0004888468,0.010163108,0.000008009848,0.00089545717,0.012605032,0.7938433,0.00021512157],"about_ca_topic_score_codex":0.004363766,"about_ca_topic_score_gemma":0.0023973135,"teacher_disagreement_score":0.91932297,"about_ca_system_score_codex":0.00022481562,"about_ca_system_score_gemma":0.0058068703,"threshold_uncertainty_score":0.9998293},"labels":[],"label_agreement":null},{"id":"W4409927674","doi":"10.51731/cjht.2025.1117","title":"Olopatadine Hydrochloride and Mometasone Furoate Nasal Spray (Ryaltris)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Mometasone furoate; Nasal spray; Medicine; Pharmacology; Nasal administration; Internal medicine; Corticosteroid","score_opus":0.014258613155299492,"score_gpt":0.3029630974076635,"score_spread":0.288704484252364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409927674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7396242,0.09777395,0.0010986659,0.15989159,0.00063390343,0.00031923607,0.000017636241,0.00009293462,0.00054787815],"genre_scores_gemma":[0.9936672,0.0034352536,0.0011809097,0.0013298717,0.000019056864,7.632374e-7,0.0000024848441,0.000011950565,0.0003525007],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987439,0.000022729528,0.0005371928,0.0001508188,0.00011575724,0.00042962152],"domain_scores_gemma":[0.99917835,0.00005287698,0.00024044575,0.00020707032,0.00014967064,0.00017161452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005611955,0.00013748894,0.00047377095,0.0010263199,0.00017514265,0.000027834749,0.00018499415,0.0001202601,0.0000146965],"category_scores_gemma":[0.0005292314,0.0001139347,0.000060197082,0.00046437062,0.00025859836,0.000053037616,0.000032578344,0.00056055235,0.0000040546456],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028834102,0.00013518504,0.090418905,0.0011795254,0.0005229081,0.001819028,0.0002822407,0.00004368788,0.0048280093,0.009164303,0.058314208,0.83300364],"study_design_scores_gemma":[0.004568558,0.0017430465,0.11284285,0.0016191264,0.0002631595,0.0016500766,0.0017542781,0.00021915691,0.022689195,0.0043963096,0.84787035,0.00038389914],"about_ca_topic_score_codex":0.0007433763,"about_ca_topic_score_gemma":0.00027352467,"teacher_disagreement_score":0.8326198,"about_ca_system_score_codex":0.00015781046,"about_ca_system_score_gemma":0.0017574424,"threshold_uncertainty_score":0.46461222},"labels":[],"label_agreement":null},{"id":"W4410122503","doi":"10.51731/cjht.2025.1121","title":"Ravulizumab (Ultomiris)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Geography","score_opus":0.008815170847852714,"score_gpt":0.2506433297686746,"score_spread":0.24182815892082188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410122503","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0685084,0.90219253,0.0006669011,0.02352694,0.002144724,0.0001617162,0.000010391428,0.00011917286,0.0026692313],"genre_scores_gemma":[0.9978739,0.00060833164,0.000028664384,0.0005938776,2.9577632e-7,0.0000032053686,0.000004217502,0.000005904622,0.00088161265],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986484,0.00009573731,0.0005935956,0.00011754821,0.000022395852,0.0005222937],"domain_scores_gemma":[0.9992476,0.00006034284,0.00030292157,0.0002596883,0.00012529753,0.000004149354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005701854,0.00012595253,0.00036657305,0.0008372354,0.0005092226,0.00002018998,0.0006102555,0.00025026948,0.00008303921],"category_scores_gemma":[0.00047137483,0.00010815153,0.00010143208,0.00044530965,0.00047821502,0.00008628432,0.000027294313,0.00060494797,0.00006171524],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018797515,0.000021194532,0.0004410282,0.000035229536,0.00007882038,0.000012739995,0.00029020788,0.000008427841,0.0010991987,0.007773851,0.0066356556,0.9835848],"study_design_scores_gemma":[0.0007742886,0.00013271463,0.0049575875,0.00018626562,0.000011267353,0.00011463369,0.005639058,7.375076e-7,0.004214376,0.0045251544,0.97933793,0.000106001935],"about_ca_topic_score_codex":0.0029769526,"about_ca_topic_score_gemma":0.00023231418,"teacher_disagreement_score":0.98347884,"about_ca_system_score_codex":0.00018897504,"about_ca_system_score_gemma":0.0029383085,"threshold_uncertainty_score":0.5212433},"labels":[],"label_agreement":null},{"id":"W4410160242","doi":"10.51731/cjht.2025.1122","title":"Ferric Carboxymaltose (Ferinject)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Internal medicine; Medicine","score_opus":0.015168506749569223,"score_gpt":0.2923345552259458,"score_spread":0.2771660484763766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410160242","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5357671,0.3234773,0.0005262884,0.12776572,0.0015124279,0.0004340176,0.00000966245,0.00019585494,0.010311626],"genre_scores_gemma":[0.99568,0.001010754,0.0006733755,0.002153901,0.000008999003,0.0000026545438,8.068643e-7,0.00000801632,0.00046154304],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989389,0.000028723183,0.00043352548,0.00009976014,0.00010195162,0.00039710614],"domain_scores_gemma":[0.99933165,0.000027844415,0.00016531828,0.00024383763,0.00013210149,0.00009923718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003587991,0.00010324688,0.00039073487,0.0011184692,0.0001532127,0.000015892454,0.00020232266,0.00012803865,0.00002782175],"category_scores_gemma":[0.00081828935,0.000084631494,0.00007932948,0.00056166004,0.00016667166,0.000050653824,0.000014345426,0.00040997163,0.000006608043],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004508409,0.00003472722,0.035635475,0.0005009002,0.00004180847,0.00027036364,0.0002464791,0.000009792413,0.000080031736,0.010845449,0.03275178,0.9195381],"study_design_scores_gemma":[0.0023025535,0.00063483807,0.17813046,0.00061887084,0.000094355804,0.0004888468,0.010163108,0.000008009848,0.00089545717,0.012605032,0.7938433,0.00021512157],"about_ca_topic_score_codex":0.004363766,"about_ca_topic_score_gemma":0.0023973135,"teacher_disagreement_score":0.91932297,"about_ca_system_score_codex":0.00022481562,"about_ca_system_score_gemma":0.0058068703,"threshold_uncertainty_score":0.9998293},"labels":[],"label_agreement":null},{"id":"W4410259368","doi":"10.51731/cjht.2025.1123","title":"Pembrolizumab (Keytruda)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pembrolizumab; Medicine; Internal medicine; Cancer","score_opus":0.018423995163443674,"score_gpt":0.31739819533080416,"score_spread":0.2989742001673605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410259368","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2742569,0.31973705,0.00020119116,0.39870843,0.0009884798,0.00045301914,0.00001560814,0.0001323639,0.005506934],"genre_scores_gemma":[0.9960123,0.0018445333,0.0003270286,0.001573605,0.000008197179,0.000007467875,0.0000010266615,0.000005860353,0.00022003926],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99915093,0.000013850381,0.00036276327,0.00008973298,0.000089060224,0.00029364848],"domain_scores_gemma":[0.9993985,0.000030653857,0.00015891595,0.0002063835,0.00012549266,0.00008003504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001807343,0.00008515157,0.0003477167,0.0006882092,0.0001318548,0.000016453725,0.00012389157,0.000087030174,0.000036440437],"category_scores_gemma":[0.00020857493,0.00006651488,0.0000891459,0.0003240212,0.000113166105,0.000034657915,0.000009876098,0.000255158,0.0000053395256],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030364377,0.000038375354,0.052629065,0.0001379032,0.000112682035,0.0002953898,0.0000784541,0.000002596239,0.000006309693,0.0059334785,0.042438727,0.89829665],"study_design_scores_gemma":[0.0020577114,0.0009052149,0.14220658,0.0011187482,0.00007087042,0.0004772586,0.0016527629,0.0000037186264,0.001038769,0.005022954,0.8453579,0.00008753625],"about_ca_topic_score_codex":0.0049003535,"about_ca_topic_score_gemma":0.005150814,"teacher_disagreement_score":0.8982091,"about_ca_system_score_codex":0.0008615668,"about_ca_system_score_gemma":0.005416469,"threshold_uncertainty_score":0.96085835},"labels":[],"label_agreement":null},{"id":"W4410368827","doi":"10.51731/cjht.2025.1124","title":"Troponin | Point of Care Testing in Rural and Remote Community Health Centres","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Acute Myocardial Infarction Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Point-of-care testing; Medicine; Point of care; Troponin I; Troponin; Rural community; Medical emergency; Business; Cardiology; Nursing; Socioeconomics; Sociology; Pathology; Myocardial infarction","score_opus":0.036374549501811786,"score_gpt":0.3530584278254763,"score_spread":0.3166838783236645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410368827","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.63195133,0.10867228,0.00013983127,0.257374,0.00018246337,0.0006102037,0.000032116066,0.00006320504,0.00097456167],"genre_scores_gemma":[0.99431515,0.0012560559,0.0026877732,0.0017093561,0.000004533059,9.0365074e-7,0.0000025142963,0.000007056687,0.000016652068],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99845344,0.00026565144,0.0006560808,0.00007073166,0.00013618897,0.0004178885],"domain_scores_gemma":[0.99879843,0.00019732265,0.00029691702,0.00025636144,0.000323342,0.0001276397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001179679,0.00009249608,0.00054832496,0.0012767308,0.00024953773,0.000012706628,0.0001937348,0.00010381732,0.0000030274657],"category_scores_gemma":[0.0026356364,0.0000809774,0.00004400745,0.0007123975,0.0003553036,0.00005184232,0.00005372203,0.0012114396,2.9874724e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052927655,0.000013387025,0.07225004,0.000767495,0.00003738998,0.000051214953,0.0010894823,0.0000075507774,0.000052274336,0.00029640846,0.0029710708,0.9224108],"study_design_scores_gemma":[0.0036704435,0.0046351976,0.6377437,0.010642776,0.00003142514,0.0009035139,0.28285766,0.00017529777,0.0012784087,0.0042238403,0.053603414,0.00023433792],"about_ca_topic_score_codex":0.2132184,"about_ca_topic_score_gemma":0.03657987,"teacher_disagreement_score":0.9221764,"about_ca_system_score_codex":0.0011242522,"about_ca_system_score_gemma":0.0058246907,"threshold_uncertainty_score":0.99981135},"labels":[],"label_agreement":null},{"id":"W4410439249","doi":"10.51731/cjht.2025.1125","title":"Pembrolizumab (Keytruda)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pembrolizumab; Medicine; Cancer; Internal medicine","score_opus":0.018423995163443674,"score_gpt":0.31739819533080416,"score_spread":0.2989742001673605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410439249","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2742569,0.31973705,0.00020119116,0.39870843,0.0009884798,0.00045301914,0.00001560814,0.0001323639,0.005506934],"genre_scores_gemma":[0.9960123,0.0018445333,0.0003270286,0.001573605,0.000008197179,0.000007467875,0.0000010266615,0.000005860353,0.00022003926],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99915093,0.000013850381,0.00036276327,0.00008973298,0.000089060224,0.00029364848],"domain_scores_gemma":[0.9993985,0.000030653857,0.00015891595,0.0002063835,0.00012549266,0.00008003504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001807343,0.00008515157,0.0003477167,0.0006882092,0.0001318548,0.000016453725,0.00012389157,0.000087030174,0.000036440437],"category_scores_gemma":[0.00020857493,0.00006651488,0.0000891459,0.0003240212,0.000113166105,0.000034657915,0.000009876098,0.000255158,0.0000053395256],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030364377,0.000038375354,0.052629065,0.0001379032,0.000112682035,0.0002953898,0.0000784541,0.000002596239,0.000006309693,0.0059334785,0.042438727,0.89829665],"study_design_scores_gemma":[0.0020577114,0.0009052149,0.14220658,0.0011187482,0.00007087042,0.0004772586,0.0016527629,0.0000037186264,0.001038769,0.005022954,0.8453579,0.00008753625],"about_ca_topic_score_codex":0.0049003535,"about_ca_topic_score_gemma":0.005150814,"teacher_disagreement_score":0.8982091,"about_ca_system_score_codex":0.0008615668,"about_ca_system_score_gemma":0.005416469,"threshold_uncertainty_score":0.96085835},"labels":[],"label_agreement":null},{"id":"W4410439602","doi":"10.51731/cjht.2025.1126","title":"Voice Prostheses and Heat and Moisture Exchangers for Adults After Total Laryngectomy: An Updated Rapid Review","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Voice and Speech Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Laryngectomy; Voice prosthesis; Moisture; Medicine; Heat exchanger; Environmental science; Meteorology; Surgery; Engineering; Mechanical engineering; Geography; Larynx","score_opus":0.015258366812773197,"score_gpt":0.28932130464229283,"score_spread":0.2740629378295196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410439602","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2853616,0.5779354,0.00002222785,0.13562152,0.00010346563,0.0008338129,0.000030534426,0.000047318103,0.00004412013],"genre_scores_gemma":[0.95632786,0.03427347,0.0005367196,0.008687367,0.0000145165495,0.000040907707,0.00001523864,0.000013526419,0.00009039456],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990541,0.000032653606,0.0003411073,0.0001671344,0.00007406415,0.0003309613],"domain_scores_gemma":[0.99937785,0.000028896791,0.00010234673,0.00017989222,0.00017339803,0.00013762966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038295874,0.00013524623,0.00047258858,0.00039631786,0.0001397883,0.000023682098,0.000088027344,0.00013838538,0.000010060338],"category_scores_gemma":[0.00035638813,0.000104093626,0.000047597066,0.00024320305,0.00017050795,0.00013075705,0.000013783877,0.00028901515,3.6982203e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036262264,0.000042957407,0.015056808,0.007495237,0.0001273508,0.00016359553,0.0007451228,1.778958e-7,0.000044272067,0.00009601398,0.043546513,0.93231934],"study_design_scores_gemma":[0.0048032096,0.0050860485,0.10150698,0.021170145,0.00036774416,0.0013893754,0.015638001,0.000026930715,0.00037786676,0.00166079,0.84750843,0.00046448503],"about_ca_topic_score_codex":0.0014950486,"about_ca_topic_score_gemma":0.007896523,"teacher_disagreement_score":0.93185484,"about_ca_system_score_codex":0.00010105012,"about_ca_system_score_gemma":0.001069128,"threshold_uncertainty_score":0.4406445},"labels":[],"label_agreement":null},{"id":"W4410561918","doi":"10.51731/cjht.2025.1127","title":"Blinatumomab (Blincyto)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Research on Leishmaniasis Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Blinatumomab; Medicine; Internal medicine","score_opus":0.03682501354495821,"score_gpt":0.359285618137245,"score_spread":0.3224606045922868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410561918","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11976002,0.2868912,0.00041877298,0.58256936,0.0006832912,0.0005283721,0.000012041001,0.00019374056,0.008943182],"genre_scores_gemma":[0.9951521,0.0019452176,0.0009188801,0.0012104141,0.000010320133,0.000005466899,7.8822006e-7,0.000008807709,0.0007480127],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985508,0.00004468052,0.00054843904,0.000121912715,0.00019975337,0.0005344243],"domain_scores_gemma":[0.9988584,0.00007920271,0.00019980296,0.00028956332,0.00046458392,0.00010847395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083683175,0.000108662985,0.00048850017,0.001796157,0.00027655484,0.000027899543,0.00031602915,0.00012392859,0.00002238616],"category_scores_gemma":[0.0028022067,0.00008568467,0.00009727267,0.00082386076,0.000343558,0.00007639029,0.000037702022,0.0007258232,0.000010811249],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046082576,0.000039314466,0.04269292,0.00039977834,0.0001790769,0.00075167255,0.0001562965,0.0000015337902,0.000057870348,0.00920176,0.12580206,0.8206716],"study_design_scores_gemma":[0.0014993711,0.0010469372,0.13253473,0.0012490299,0.000035977624,0.0005911101,0.005865812,0.000010467345,0.0014041605,0.011900837,0.84373146,0.00013009187],"about_ca_topic_score_codex":0.0022603455,"about_ca_topic_score_gemma":0.0036183102,"teacher_disagreement_score":0.8753921,"about_ca_system_score_codex":0.0007161276,"about_ca_system_score_gemma":0.007712857,"threshold_uncertainty_score":0.99791247},"labels":[],"label_agreement":null},{"id":"W4410598518","doi":"10.51731/cjht.2025.1129","title":"Urgent Care Centres: A Scan of Models of Care and Literature on Their Effectiveness","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Emergency and Acute Care Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Computer science","score_opus":0.012340006215536695,"score_gpt":0.2851717403605384,"score_spread":0.27283173414500167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410598518","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4246479,0.5705854,0.000022407796,0.0035063159,0.00023056913,0.0002599145,0.00012466729,0.000015514288,0.000607298],"genre_scores_gemma":[0.98762035,0.012145347,0.00008705517,0.0001222134,0.000005276056,0.0000037077114,0.0000043338096,0.0000059164363,0.0000057973575],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.99916047,0.000049141097,0.00037180964,0.00011061113,0.0000926907,0.00021528383],"domain_scores_gemma":[0.9988685,0.000065575594,0.00021035268,0.00018026336,0.00060655357,0.00006875932],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001444865,0.00012147089,0.0005466656,0.00060615013,0.0001075534,0.000004164861,0.00011888455,0.00012050134,0.000001744694],"category_scores_gemma":[0.00033232858,0.00008536286,0.000098651115,0.00036441896,0.00019397691,0.0000373194,0.00002154792,0.00029358122,3.3088494e-8],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046565407,0.000057324993,0.04554137,0.020622222,0.0006440206,0.00021435843,0.03587133,0.0001739399,0.000387564,0.012717919,0.004262928,0.8790414],"study_design_scores_gemma":[0.005080206,0.01058456,0.07666588,0.084294386,0.00038890555,0.00022766834,0.68873185,0.000030679814,0.06434259,0.014519674,0.05455545,0.0005781801],"about_ca_topic_score_codex":0.00092083355,"about_ca_topic_score_gemma":0.0016401133,"teacher_disagreement_score":0.8784632,"about_ca_system_score_codex":0.0002537258,"about_ca_system_score_gemma":0.0016698411,"threshold_uncertainty_score":0.34809965},"labels":[],"label_agreement":null},{"id":"W4410598538","doi":"10.51731/cjht.2025.1130","title":"Daratumumab (Darzalex SC)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Daratumumab; Psychology; Medicine; Internal medicine; Multiple myeloma","score_opus":0.035072396872024375,"score_gpt":0.354769225012068,"score_spread":0.31969682814004363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410598538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.39484134,0.28771183,0.00081699615,0.29639366,0.0010658136,0.0011814749,0.000052332965,0.0002891547,0.017647378],"genre_scores_gemma":[0.99725825,0.0005725385,0.0009953217,0.00051288935,0.0000065949366,0.000004715018,0.0000029702198,0.000006756181,0.00063996954],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988507,0.00003348932,0.00038280303,0.000105739564,0.00015111954,0.00047616693],"domain_scores_gemma":[0.9992077,0.000041562856,0.0001367685,0.0002552089,0.00020192104,0.00015684539],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034622813,0.00009703788,0.00034910368,0.0010797587,0.00025440863,0.000024532606,0.00020609934,0.000108531895,0.000038583836],"category_scores_gemma":[0.0008727453,0.00007373232,0.000077838245,0.0004625019,0.00019680965,0.000058557645,0.00001844732,0.0004488134,0.000015561938],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005627479,0.000033011907,0.05171574,0.0001371157,0.00013007227,0.00083714415,0.000047400372,0.0000010030446,0.000029598823,0.0018576831,0.017594561,0.9275604],"study_design_scores_gemma":[0.0038737503,0.0013650857,0.23973586,0.0013737199,0.000044107055,0.00082322885,0.0021174313,0.000031989213,0.0020493928,0.0055905385,0.74285346,0.00014144518],"about_ca_topic_score_codex":0.003368817,"about_ca_topic_score_gemma":0.0032043068,"teacher_disagreement_score":0.92741895,"about_ca_system_score_codex":0.00063717633,"about_ca_system_score_gemma":0.006285821,"threshold_uncertainty_score":0.9993476},"labels":[],"label_agreement":null},{"id":"W4410598584","doi":"10.51731/cjht.2025.1128","title":"Automated Chest Compression Devices","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Compression (physics); Computer science; Materials science; Composite material","score_opus":0.022884453724203873,"score_gpt":0.3398952993815379,"score_spread":0.317010845657334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410598584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3999128,0.26753613,0.00009913577,0.327818,0.0010113255,0.00056505995,0.000016395143,0.0006548149,0.0023863292],"genre_scores_gemma":[0.9971184,0.0008333963,0.0006587312,0.001303723,0.0000056897848,0.000006370787,0.0000023160078,0.000005495438,0.00006587364],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991919,0.000020291007,0.0003586397,0.000090865775,0.00008494906,0.00025336273],"domain_scores_gemma":[0.99937904,0.00003799864,0.00020272077,0.00017654138,0.0001278361,0.00007588177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001896903,0.00008730481,0.0003312058,0.00050821167,0.00015564442,0.000019104851,0.00013275232,0.00009594199,0.000015613688],"category_scores_gemma":[0.00012992535,0.00006189735,0.00005672199,0.0003012192,0.00009376956,0.0000451367,0.000011816062,0.00021007225,0.000004244383],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027014094,0.00008049907,0.26511675,0.0006740039,0.00020725734,0.0003310297,0.0001348073,0.000013750978,0.000026306427,0.0012731251,0.096279226,0.63583624],"study_design_scores_gemma":[0.0013717827,0.0005722803,0.4834212,0.003754407,0.00007708411,0.00016924445,0.0013135357,0.00007814777,0.0017705215,0.00067995297,0.5067041,0.000087754685],"about_ca_topic_score_codex":0.0037457917,"about_ca_topic_score_gemma":0.003957397,"teacher_disagreement_score":0.6357485,"about_ca_system_score_codex":0.0008144952,"about_ca_system_score_gemma":0.0033044012,"threshold_uncertainty_score":0.5861866},"labels":[],"label_agreement":null},{"id":"W4410644984","doi":"10.51731/cjht.2025.1132","title":"Pemigatinib (Pemazyre)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.03601682565298907,"score_gpt":0.3585972738525122,"score_spread":0.32258044819952314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410644984","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5082622,0.15914978,0.0007177377,0.32056275,0.0006880754,0.0009265955,0.000032735075,0.00021872918,0.009441411],"genre_scores_gemma":[0.99681246,0.00045529363,0.0015385858,0.0006335745,0.00000586368,0.000004959602,0.000002367434,0.0000058692476,0.0005410034],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99894613,0.00003233477,0.00038345705,0.000090887,0.00013342974,0.0004137424],"domain_scores_gemma":[0.99925447,0.000057008736,0.0001415822,0.00021684906,0.00018973558,0.00014034745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038051401,0.000084691885,0.0003235747,0.00083741866,0.00016654491,0.000018237737,0.00017541165,0.000096090014,0.000038564518],"category_scores_gemma":[0.0011751584,0.00006365301,0.000073584044,0.00039239778,0.00017079414,0.00004490332,0.000014455672,0.0003945661,0.000012128962],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003554375,0.000025641368,0.08676213,0.00016494516,0.000107369575,0.000525122,0.00006347073,8.248557e-7,0.00003401282,0.0014895529,0.013145177,0.8976462],"study_design_scores_gemma":[0.004650006,0.0016330832,0.31651807,0.0020743313,0.000055814966,0.00094191014,0.004428106,0.000040563675,0.004027571,0.011803502,0.6536544,0.0001726652],"about_ca_topic_score_codex":0.003297409,"about_ca_topic_score_gemma":0.002172777,"teacher_disagreement_score":0.8974736,"about_ca_system_score_codex":0.00046200148,"about_ca_system_score_gemma":0.0058395597,"threshold_uncertainty_score":0.9997964},"labels":[],"label_agreement":null},{"id":"W4410646231","doi":"10.51731/cjht.2025.1131","title":"Amivantamab (Rybrevant)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Drug-Induced Hepatotoxicity and Protection","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Geology","score_opus":0.13011247310058613,"score_gpt":0.4548316854798537,"score_spread":0.3247192123792676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410646231","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5704671,0.12722783,0.0038911754,0.26084858,0.014421572,0.001517402,0.00010814471,0.00069142465,0.020826764],"genre_scores_gemma":[0.9952246,0.0009927956,0.00021237167,0.0031403278,0.0000225441,0.0000100041325,0.0000014867504,0.000009069408,0.00038680306],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982934,0.00028493427,0.0006326403,0.00014538602,0.000083334584,0.00056031597],"domain_scores_gemma":[0.9990206,0.00015348184,0.00036610244,0.00018330423,0.00016322116,0.00011333815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015529889,0.00015054386,0.0003645407,0.00097226456,0.0006309503,0.00002756367,0.00048202815,0.00047657816,0.000101702484],"category_scores_gemma":[0.0005851522,0.0001405628,0.00009841793,0.00057491555,0.00028988073,0.00012881595,0.000028331771,0.0016685181,0.000036113055],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036019774,0.00003362633,0.0058294055,0.00013509805,0.00009337902,0.000091273345,0.00024159829,0.000059458012,0.00069519447,0.00720881,0.018035384,0.96754074],"study_design_scores_gemma":[0.00064344745,0.00016930257,0.002644612,0.00014349267,0.0000265287,0.0001395334,0.001165318,0.000059539943,0.013837771,0.016129635,0.9649106,0.00013021633],"about_ca_topic_score_codex":0.001526796,"about_ca_topic_score_gemma":0.0028467055,"teacher_disagreement_score":0.96741056,"about_ca_system_score_codex":0.0005552789,"about_ca_system_score_gemma":0.0029074403,"threshold_uncertainty_score":0.7248973},"labels":[],"label_agreement":null},{"id":"W4410646356","doi":"10.51731/cjht.2025.1133","title":"Durvalumab (Imfinzi)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Durvalumab; Medicine; Internal medicine; Cancer","score_opus":0.020596970468108097,"score_gpt":0.31009797314778254,"score_spread":0.28950100267967444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410646356","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22531915,0.39269194,0.00059298094,0.3738513,0.0016995159,0.00045509794,0.000013837761,0.00017929492,0.005196881],"genre_scores_gemma":[0.994768,0.0013454988,0.00044543965,0.002888781,0.000007745305,0.000002363712,8.4714856e-7,0.0000059968534,0.0005352877],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99908173,0.000022517836,0.00043876996,0.000078966135,0.00008767438,0.0002903186],"domain_scores_gemma":[0.99941146,0.000025133799,0.00018693897,0.00020274588,0.00012258918,0.00005112155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049150846,0.00007943733,0.00029911203,0.00075280684,0.00014876139,0.000016316018,0.00017778501,0.0001136128,0.0000463355],"category_scores_gemma":[0.00026353463,0.00006341475,0.000097351265,0.00045852887,0.00020003773,0.000042187054,0.000007812162,0.00030873262,0.000003325551],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011371474,0.000012192795,0.0075268773,0.00011772961,0.000100666664,0.00009596291,0.000079240956,5.982445e-7,0.0001664347,0.0010052852,0.03553923,0.9552421],"study_design_scores_gemma":[0.0014232778,0.00050262694,0.046557654,0.00075650366,0.000022550916,0.0003701732,0.002001002,0.000003049937,0.0014534462,0.0022706876,0.9445645,0.00007451022],"about_ca_topic_score_codex":0.003637112,"about_ca_topic_score_gemma":0.002622017,"teacher_disagreement_score":0.95516753,"about_ca_system_score_codex":0.00056202,"about_ca_system_score_gemma":0.0060324734,"threshold_uncertainty_score":0.9996024},"labels":[],"label_agreement":null},{"id":"W4410706903","doi":"10.51731/cjht.2025.1134","title":"Ruxolitinib (Opzelura)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ruxolitinib; Business; Medicine; Internal medicine; Myelofibrosis; Bone marrow","score_opus":0.022036681065779235,"score_gpt":0.32141706921339325,"score_spread":0.29938038814761403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410706903","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.32978648,0.12349658,0.00033469166,0.534721,0.00086939003,0.0007084862,0.00002894005,0.00016384569,0.009890573],"genre_scores_gemma":[0.9951569,0.0009333462,0.0010343102,0.0024105096,0.000010255925,0.0000121915145,0.0000024570277,0.000007133806,0.00043293694],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99888647,0.000034138808,0.00048408433,0.00011469822,0.00010755739,0.00037307778],"domain_scores_gemma":[0.9991974,0.00007186558,0.0002021726,0.0002095,0.00020982893,0.000109193505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033136632,0.000116494004,0.00044329368,0.0007216039,0.00019234569,0.000022402464,0.00013680974,0.000114428476,0.000048815084],"category_scores_gemma":[0.00057766424,0.00008713464,0.00009286518,0.00033244299,0.00014679323,0.000052413117,0.0000117615455,0.00033360397,0.000011382763],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033794127,0.000081274346,0.17882514,0.00021643723,0.00021167772,0.00053237623,0.000166315,0.0000028807137,0.000017323875,0.03531114,0.05199786,0.7326038],"study_design_scores_gemma":[0.001819708,0.0011133272,0.16638508,0.0012772323,0.0000681083,0.00055690715,0.002734528,0.0000063190614,0.0035389012,0.009326371,0.8130457,0.00012784115],"about_ca_topic_score_codex":0.00145734,"about_ca_topic_score_gemma":0.0017756864,"teacher_disagreement_score":0.7610478,"about_ca_system_score_codex":0.000510549,"about_ca_system_score_gemma":0.0046444917,"threshold_uncertainty_score":0.8239129},"labels":[],"label_agreement":null},{"id":"W4410823174","doi":"10.51731/cjht.2025.1136","title":"Momelotinib (Ojjaara)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Business","score_opus":0.021987287900746253,"score_gpt":0.3110414981013667,"score_spread":0.28905421020062044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410823174","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.48273635,0.22491169,0.00052490196,0.27961344,0.0014965974,0.0008023709,0.000020600231,0.00034117396,0.009552864],"genre_scores_gemma":[0.99616337,0.0005795391,0.0010896138,0.001260595,0.000008773198,0.000004405692,0.0000020237414,0.000009622211,0.0008820345],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987966,0.00002484258,0.00051293464,0.000117299365,0.00011916824,0.00042920274],"domain_scores_gemma":[0.99916714,0.00004701436,0.0002341173,0.00030178763,0.0001458437,0.00010409173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034989585,0.00011567934,0.00043482214,0.0010081913,0.00014914294,0.000015099977,0.00021935132,0.00014616115,0.00004793887],"category_scores_gemma":[0.0006624559,0.000094484145,0.00009024697,0.0005068519,0.00016996636,0.000052174324,0.000016786158,0.00045121822,0.0000128421125],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003047858,0.000034260036,0.03922418,0.00025354198,0.00018241037,0.00057128473,0.00013533956,0.0000055738037,0.00004158203,0.0035037901,0.039013434,0.9170041],"study_design_scores_gemma":[0.0037910342,0.00091839297,0.0837363,0.0016856536,0.000089932124,0.0012035848,0.0028420864,0.000019844563,0.0021609422,0.0060788626,0.897309,0.00016434805],"about_ca_topic_score_codex":0.003025705,"about_ca_topic_score_gemma":0.0017582291,"teacher_disagreement_score":0.9168398,"about_ca_system_score_codex":0.0023233877,"about_ca_system_score_gemma":0.013592431,"threshold_uncertainty_score":0.99199957},"labels":[],"label_agreement":null},{"id":"W4410823711","doi":"10.51731/cjht.2025.1137","title":"Erdafitinib (Balversa)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Business","score_opus":0.025151317670980115,"score_gpt":0.3267555524490281,"score_spread":0.301604234778048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410823711","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2623742,0.3692587,0.00021322224,0.34105584,0.0014125129,0.0005358479,0.000025105974,0.00017978126,0.024944795],"genre_scores_gemma":[0.996996,0.0009884256,0.00032309216,0.0011973381,0.000006545895,0.000004374313,7.2035294e-7,0.000004043952,0.00047946442],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99925345,0.000012344933,0.00030630556,0.00007855395,0.00007560354,0.00027372548],"domain_scores_gemma":[0.9995135,0.000029210922,0.00013264324,0.00012764249,0.00014256795,0.000054398974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001782296,0.00008088321,0.00033911364,0.000510655,0.00019232616,0.00001175946,0.000103944854,0.00006709527,0.000023212315],"category_scores_gemma":[0.00030225853,0.000060232116,0.00007733153,0.00031987063,0.00015338339,0.000032990458,0.000013030161,0.0002249577,0.000002803357],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004340001,0.000020025082,0.034618117,0.00009997275,0.0001750146,0.00021579291,0.00019445473,8.80214e-7,0.000007797698,0.0025054088,0.033689704,0.9284294],"study_design_scores_gemma":[0.0012605938,0.0010797743,0.121161796,0.00063673925,0.00006422866,0.00021389383,0.0066436194,0.0000021009114,0.00036783764,0.00407173,0.8644158,0.00008185669],"about_ca_topic_score_codex":0.0025074135,"about_ca_topic_score_gemma":0.0041991617,"teacher_disagreement_score":0.9283476,"about_ca_system_score_codex":0.00060409645,"about_ca_system_score_gemma":0.003369543,"threshold_uncertainty_score":0.5977425},"labels":[],"label_agreement":null},{"id":"W4410826115","doi":"10.51731/cjht.2025.1138","title":"Zolbetuximab for Injection (Vyloy)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.017664576821286273,"score_gpt":0.31315935413502666,"score_spread":0.2954947773137404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410826115","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2910638,0.37735122,0.015960457,0.30722165,0.0027557614,0.0022642943,0.000064964515,0.00064668484,0.0026711873],"genre_scores_gemma":[0.99675065,0.00014803684,0.0014101824,0.0012008166,0.000010646486,0.000015279558,0.0000031594072,0.000011489689,0.00044974536],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989608,0.000018845469,0.0004821415,0.00010307571,0.000081144055,0.00035400104],"domain_scores_gemma":[0.99911886,0.00006452766,0.00026357253,0.00022730048,0.00026147751,0.00006424386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036269458,0.00009656776,0.00037243392,0.0009910951,0.00022967531,0.000017359303,0.00017962181,0.00013021211,0.000012516814],"category_scores_gemma":[0.0016758185,0.0000841774,0.0001163844,0.00037744988,0.00014977365,0.00005374503,0.000011918475,0.00026257176,0.0000026041728],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000113503076,0.000038678725,0.026439806,0.0005770141,0.00013083107,0.00007312548,0.000108809865,0.000020270892,0.000049238963,0.00610309,0.076433666,0.88991195],"study_design_scores_gemma":[0.0030151377,0.0019485564,0.099396974,0.0016730465,0.00014205882,0.00068271643,0.0051749432,0.00006026996,0.0013725,0.024765417,0.86156905,0.00019931333],"about_ca_topic_score_codex":0.0017831359,"about_ca_topic_score_gemma":0.0009820871,"teacher_disagreement_score":0.88971263,"about_ca_system_score_codex":0.00063560833,"about_ca_system_score_gemma":0.006685254,"threshold_uncertainty_score":0.9989459},"labels":[],"label_agreement":null},{"id":"W4411028159","doi":"10.51731/cjht.2025.1139","title":"Rozanolixizumab (Rystiggo)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.014735107386983273,"score_gpt":0.28782373180523996,"score_spread":0.2730886244182567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411028159","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14035468,0.20035467,0.0021963909,0.6352624,0.0019660343,0.0005421297,0.000019948642,0.0003513235,0.018952364],"genre_scores_gemma":[0.99724644,0.00047520516,0.0005106063,0.0010856481,0.000006834893,0.0000027015992,0.0000017176299,0.000005657018,0.0006651947],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999117,0.000019424333,0.00040655077,0.00007623217,0.00007555323,0.00030519938],"domain_scores_gemma":[0.9993891,0.000029983485,0.00013839269,0.00019556294,0.00015995947,0.00008696836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017072086,0.00007500738,0.0002779529,0.0009681229,0.00020672633,0.0000143380685,0.00015018477,0.00017461437,0.000042945838],"category_scores_gemma":[0.00043153242,0.000058664882,0.00007621688,0.00046807958,0.00019546166,0.000041820203,0.000009255352,0.0005276563,0.000011032978],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000410499,0.000068618225,0.013927417,0.00016893247,0.00090752245,0.0010660291,0.00038190171,0.000016307627,0.00031359363,0.07430605,0.10198151,0.80682105],"study_design_scores_gemma":[0.0025666745,0.0010044924,0.05266718,0.0019722027,0.00047589076,0.002287609,0.0063870447,0.00003802747,0.0021682763,0.048371755,0.8818485,0.00021235696],"about_ca_topic_score_codex":0.0010703098,"about_ca_topic_score_gemma":0.0005919056,"teacher_disagreement_score":0.85689175,"about_ca_system_score_codex":0.0003405738,"about_ca_system_score_gemma":0.0060755857,"threshold_uncertainty_score":0.99955904},"labels":[],"label_agreement":null},{"id":"W4411060929","doi":"10.51731/cjht.2025.1140","title":"Exagamglogene Autotemcel (Casgevy)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.014059258815711047,"score_gpt":0.27877952370201586,"score_spread":0.2647202648863048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411060929","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24937189,0.38544783,0.0011046152,0.35099036,0.0016745781,0.0005256646,0.000011800626,0.0002799862,0.010593283],"genre_scores_gemma":[0.9943188,0.0020297258,0.00071359973,0.0022368343,0.0000066807534,0.0000021501878,0.0000013669434,0.000009407512,0.0006814618],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987817,0.000028336632,0.00054338056,0.000110314286,0.00010077946,0.00043550445],"domain_scores_gemma":[0.9992556,0.000025838304,0.00020533471,0.00023910493,0.00016017137,0.0001139353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041906707,0.00011167294,0.00040166188,0.0009523393,0.00020688717,0.000016510585,0.00020037038,0.00025604235,0.000033298467],"category_scores_gemma":[0.00052733184,0.000086747445,0.00010209824,0.00059598405,0.0002191918,0.00004121556,0.000015524485,0.0005834933,0.000009930405],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022876387,0.000031983815,0.009463003,0.0002516601,0.00011837348,0.00044849826,0.00014327002,0.000017014247,0.00011137903,0.003907093,0.0375772,0.9479076],"study_design_scores_gemma":[0.0013150582,0.00058052246,0.017257689,0.0011177011,0.000058577396,0.0008263944,0.005548295,0.000029708855,0.00091497344,0.005277111,0.96693504,0.00013893953],"about_ca_topic_score_codex":0.0021631303,"about_ca_topic_score_gemma":0.00087068725,"teacher_disagreement_score":0.9477687,"about_ca_system_score_codex":0.0003924975,"about_ca_system_score_gemma":0.006254854,"threshold_uncertainty_score":0.99937874},"labels":[],"label_agreement":null},{"id":"W4411092246","doi":"10.51731/cjht.2025.1141","title":"Efanesoctocog Alfa (ALTUVIIIO)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Connective tissue disorders research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Psychology","score_opus":0.014698170256361148,"score_gpt":0.3238205944217282,"score_spread":0.30912242416536706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411092246","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.48044965,0.40884688,0.0048536537,0.09869088,0.0007882578,0.000839,0.000035449415,0.0000654638,0.005430772],"genre_scores_gemma":[0.99820036,0.0006164194,0.00017722923,0.00044362468,0.000008946202,0.000008947037,0.0000044685544,0.000008206685,0.00053179916],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99902385,0.00006239084,0.00029896968,0.00014316787,0.00008252208,0.0003891238],"domain_scores_gemma":[0.99929637,0.00001823238,0.00012935334,0.00026487047,0.00023435825,0.000056837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004617783,0.0000936313,0.000192476,0.00045863094,0.00018012254,0.000023014622,0.00045598563,0.00015455202,0.000017497267],"category_scores_gemma":[0.001073057,0.00008788222,0.000066485925,0.0003017561,0.00021270233,0.0000037166435,0.000047378075,0.00025509874,0.000004513027],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026995052,0.000017976256,0.011448208,0.00008061118,0.0000817958,0.00003650658,0.000059084174,0.000012748148,0.0032752412,0.0021484701,0.034227535,0.94858485],"study_design_scores_gemma":[0.00047405658,0.00043759713,0.006941677,0.00009489746,0.000004907521,0.000048076312,0.002128048,0.000004188666,0.011150643,0.0041467543,0.9744481,0.00012105737],"about_ca_topic_score_codex":0.001485501,"about_ca_topic_score_gemma":0.007855532,"teacher_disagreement_score":0.9484638,"about_ca_system_score_codex":0.00011336404,"about_ca_system_score_gemma":0.0032688493,"threshold_uncertainty_score":0.5798798},"labels":[],"label_agreement":null},{"id":"W4411093106","doi":"10.51731/cjht.2025.1142","title":"Antiviral Drugs for Post-Exposure Prophylaxis Against Influenza A or Influenza B","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Virology; Medicine; Antiviral treatment; Pre-exposure prophylaxis; Virus; Human immunodeficiency virus (HIV)","score_opus":0.0718018418478302,"score_gpt":0.39860109585627396,"score_spread":0.3267992540084438,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411093106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8352189,0.11524266,0.0001636939,0.044208866,0.00061086024,0.0027843355,0.00021132882,0.00029202664,0.0012673256],"genre_scores_gemma":[0.9819878,0.0006410526,0.0020953002,0.014815518,0.00003448568,0.00008443828,0.0000033686026,0.00003284583,0.00030523876],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99706477,0.00008240715,0.0011545665,0.00027092863,0.0003373418,0.0010900054],"domain_scores_gemma":[0.997117,0.00026064055,0.00046991234,0.00047138418,0.0015087939,0.0001722703],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013052163,0.00028464128,0.00092196744,0.002171776,0.00062765385,0.000069487396,0.0005204446,0.00033032568,0.000009047055],"category_scores_gemma":[0.00700911,0.00020346964,0.00021980223,0.0010667251,0.0006367398,0.00021352086,0.0000815349,0.001024643,0.000008632819],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012172434,0.00006190874,0.029671302,0.001821317,0.00041588396,0.00023537969,0.0011132814,0.000010455779,0.0002856736,0.0010469597,0.012361178,0.9517594],"study_design_scores_gemma":[0.0047063367,0.005760402,0.01901061,0.0019329373,0.000058046164,0.000055667508,0.014563366,0.000012767757,0.0018732061,0.00114483,0.9505897,0.0002920941],"about_ca_topic_score_codex":0.0016188368,"about_ca_topic_score_gemma":0.0025184737,"teacher_disagreement_score":0.95146734,"about_ca_system_score_codex":0.0010482083,"about_ca_system_score_gemma":0.014251585,"threshold_uncertainty_score":0.9913367},"labels":[],"label_agreement":null},{"id":"W4411238587","doi":"10.51731/cjht.2025.1144","title":"Cerliponase Alfa for Pediatric Patients With Neuronal Ceroid Lipofuscinosis Type 2 Disease","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Neuronal ceroid lipofuscinosis; Medicine; Disease; Pediatrics; Internal medicine","score_opus":0.01919168497419601,"score_gpt":0.29307934242704003,"score_spread":0.27388765745284405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411238587","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9238565,0.028648803,0.00017170016,0.04582164,0.00035472808,0.0009296232,0.00007198484,0.00006640229,0.0000786173],"genre_scores_gemma":[0.9981259,0.00035017767,0.00041789707,0.0009070648,0.0000215634,0.000017048029,0.000015446318,0.00001950745,0.00012540846],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99854857,0.000035255474,0.00039992214,0.00018640826,0.00027345368,0.00055640435],"domain_scores_gemma":[0.99842185,0.00008951492,0.00020396599,0.00026146683,0.0007327965,0.00029040972],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024185015,0.00014202279,0.0003485997,0.0011166077,0.00023600097,0.000029371542,0.00028982013,0.000093484836,0.00002382189],"category_scores_gemma":[0.0016339298,0.00010849793,0.00008112658,0.00086630834,0.00015640636,0.000089206515,0.0000257338,0.0004050638,0.0000036869621],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006542155,0.00011851088,0.86113566,0.0006288853,0.000057653517,0.000089805435,0.0000368935,0.000009401445,0.0000021940425,0.00025074914,0.020215422,0.11680063],"study_design_scores_gemma":[0.0031950586,0.002451697,0.9124087,0.00023858661,0.000113582864,0.000010341302,0.00036706962,0.00001847337,0.00003748282,0.0009792236,0.08002424,0.00015551661],"about_ca_topic_score_codex":0.00064581406,"about_ca_topic_score_gemma":0.00087151513,"teacher_disagreement_score":0.11664511,"about_ca_system_score_codex":0.00048778442,"about_ca_system_score_gemma":0.008405533,"threshold_uncertainty_score":0.99721587},"labels":[],"label_agreement":null},{"id":"W4411279283","doi":"10.51731/cjht.2025.1145","title":"Drugs for Adults With Spinal Muscular Atrophy: A Focused Review and Critical Appraisal of Recent Evidence (2021 to 2025) on Nusinersen and Risdiplam","year":2025,"lang":"en","type":"review","venue":"Canadian Journal of Health Technologies","topic":"Neurogenetic and Muscular Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Spinal muscular atrophy; Critical appraisal; Medicine; Atrophy; Progressive muscular atrophy; Physical medicine and rehabilitation; Intensive care medicine; Neuroscience; Psychology; Pathology; Alternative medicine; Disease; Amyotrophic lateral sclerosis","score_opus":0.07669452397681137,"score_gpt":0.4370018286103673,"score_spread":0.3603073046335559,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411279283","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009680334,0.96132874,0.00017565698,0.03581305,0.00009377348,0.0024243267,0.000039189385,0.000010838217,0.000017607035],"genre_scores_gemma":[0.00043617777,0.99680036,0.0022060052,0.0003914355,0.000016178774,0.00010519962,0.000004159349,0.000027248454,0.0000132555015],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99772584,0.00017260853,0.0008650095,0.00039272037,0.00031858374,0.00052524905],"domain_scores_gemma":[0.99777216,0.00056073576,0.00034437497,0.00042401874,0.00056840846,0.00033029972],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008703995,0.00030699314,0.0022713398,0.00094894884,0.00011838601,0.000020545109,0.00026768752,0.00021860798,0.000014041664],"category_scores_gemma":[0.0080314465,0.00021263503,0.00020367652,0.00068133365,0.00038976397,0.000034975375,0.00005459056,0.0007063999,8.552837e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011605906,0.000016643717,0.000005895441,0.14036538,0.000093585775,0.00010149778,0.00002641196,5.0632845e-8,1.331372e-7,0.000094034745,0.0014328506,0.85774744],"study_design_scores_gemma":[0.0005155735,0.0051450115,0.000027638062,0.25940832,0.00077951833,0.00034845213,0.0003235273,4.0587508e-7,0.0000016926734,0.00002469548,0.7332848,0.00014038755],"about_ca_topic_score_codex":0.00032757598,"about_ca_topic_score_gemma":0.00019455666,"teacher_disagreement_score":0.85760707,"about_ca_system_score_codex":0.00018874063,"about_ca_system_score_gemma":0.00801005,"threshold_uncertainty_score":0.9976136},"labels":[],"label_agreement":null},{"id":"W4411307213","doi":"10.51731/cjht.2025.1146","title":"Isatuximab (Sarclisa)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Psychology","score_opus":0.01793494157968234,"score_gpt":0.3010390455350337,"score_spread":0.28310410395535135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411307213","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16168383,0.15246096,0.0015259206,0.6680043,0.0016702904,0.00041770496,0.000018612822,0.00025609296,0.013962324],"genre_scores_gemma":[0.9966202,0.000462008,0.00065092294,0.0016787087,0.0000069413272,0.0000019934441,0.0000017470123,0.0000052242594,0.00057229795],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99917203,0.000019492783,0.00037342467,0.00007136686,0.00007273834,0.00029092503],"domain_scores_gemma":[0.99938756,0.000033057924,0.0001719657,0.00018312296,0.000143788,0.00008051072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001969886,0.000067904766,0.00026652557,0.0008785551,0.0001894556,0.000014072131,0.00014186632,0.00016049853,0.000038640286],"category_scores_gemma":[0.0004492975,0.00005326826,0.00007410416,0.00044405158,0.00021446816,0.00004141377,0.000008814629,0.0005476546,0.000010861529],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003642518,0.000082525854,0.0209743,0.00015621475,0.00078302936,0.0008310691,0.00038041658,0.00000817315,0.0002729886,0.07669815,0.122403204,0.7773735],"study_design_scores_gemma":[0.0025877443,0.0008686451,0.05960035,0.0015613587,0.0004216102,0.0015814888,0.0065173116,0.00003109976,0.0014049693,0.060653884,0.8645897,0.00018186639],"about_ca_topic_score_codex":0.00078872126,"about_ca_topic_score_gemma":0.0005033325,"teacher_disagreement_score":0.8349363,"about_ca_system_score_codex":0.00028622206,"about_ca_system_score_gemma":0.005061638,"threshold_uncertainty_score":0.8979128},"labels":[],"label_agreement":null},{"id":"W4411417714","doi":"10.51731/cjht.2025.1147","title":"Durvalumab (Imfinzi) and Tremelimumab (Imjudo)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Oncology; Chemotherapy; Durvalumab; Gemcitabine; Internal medicine; Lung cancer; Regimen; Immunotherapy; Cancer; Pembrolizumab","score_opus":0.015955109993478225,"score_gpt":0.33904363239080565,"score_spread":0.32308852239732744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411417714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.38070846,0.30846608,0.0004880688,0.3022242,0.00080195384,0.0006264474,0.000030870575,0.0001587728,0.0064951614],"genre_scores_gemma":[0.9965995,0.0010910791,0.00070097,0.0010838937,0.0000060758707,0.00000489994,0.0000018690683,0.0000060642055,0.0005056685],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992576,0.00001628824,0.00032110346,0.000092344686,0.000071130715,0.00024153607],"domain_scores_gemma":[0.9994833,0.000028106653,0.00013679177,0.00014960585,0.00012369333,0.00007852869],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017940805,0.00008173263,0.00028104967,0.00060239376,0.00019618725,0.000020414878,0.00008122255,0.00008034786,0.000014640366],"category_scores_gemma":[0.00022471778,0.00006337218,0.000043246226,0.00026763492,0.0001410973,0.00005411592,0.000009134859,0.00021002791,0.000001871797],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020529367,0.000022299651,0.023067247,0.0001518476,0.00016168701,0.00014003176,0.00028783604,0.0000019780432,0.000018117084,0.004542911,0.011459013,0.9601265],"study_design_scores_gemma":[0.0047821514,0.0013824584,0.20426531,0.001508823,0.0002891979,0.0008889512,0.0089435065,0.000021177955,0.000528243,0.014201609,0.7630059,0.00018267226],"about_ca_topic_score_codex":0.0031101578,"about_ca_topic_score_gemma":0.003158012,"teacher_disagreement_score":0.95994383,"about_ca_system_score_codex":0.00048987725,"about_ca_system_score_gemma":0.0044488953,"threshold_uncertainty_score":0.7892149},"labels":[],"label_agreement":null},{"id":"W4411452762","doi":"10.51731/cjht.2025.1148","title":"Faricimab (Vabysmo)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Retinal and Optic Conditions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Macular edema; Family medicine; Ophthalmology; Political science; Retinal; Health care","score_opus":0.0159759840667287,"score_gpt":0.3057363182005016,"score_spread":0.28976033413377295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411452762","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.072726354,0.5090438,0.0016538147,0.40051132,0.00070777343,0.00030265603,0.000013125952,0.00013595246,0.01490521],"genre_scores_gemma":[0.9970507,0.00027656133,0.00027208257,0.0015928256,0.0000010232939,0.0000023314933,0.0000013020469,0.0000036368415,0.0007995283],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992306,0.000013961502,0.0003584512,0.000067634246,0.0000731889,0.0002561609],"domain_scores_gemma":[0.999497,0.00003454897,0.00013598223,0.0001584868,0.00015844709,0.000015511345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024757517,0.00006576943,0.0002632629,0.00072827045,0.0001654135,0.00001421477,0.00013994983,0.00008394567,0.00004461407],"category_scores_gemma":[0.0005294125,0.00005124734,0.00006940424,0.00040739836,0.00015326019,0.000035959172,0.00000991706,0.00035889132,0.000008002203],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000071397526,0.000011233647,0.0013704232,0.00007562265,0.000030830302,0.00015360955,0.00004478792,0.0000012010403,0.000020810794,0.006678088,0.0037644438,0.9878418],"study_design_scores_gemma":[0.0003991978,0.00022424367,0.044644635,0.0004400376,0.000027073944,0.000462307,0.0016441469,0.0000065542995,0.00020626881,0.010796818,0.9411011,0.000047636084],"about_ca_topic_score_codex":0.0014579585,"about_ca_topic_score_gemma":0.000161622,"teacher_disagreement_score":0.98779416,"about_ca_system_score_codex":0.00026140825,"about_ca_system_score_gemma":0.003834258,"threshold_uncertainty_score":0.6801809},"labels":[],"label_agreement":null},{"id":"W4411470437","doi":"10.51731/cjht.2025.1149","title":"Pembrolizumab (Keytruda)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Carboplatin; Medicine; Endometrial cancer; Paclitaxel; Carcinosarcoma; Oncology; Internal medicine; Stage (stratigraphy); Pembrolizumab; Carcinoma; Cancer; Gynecology; Chemotherapy; Cisplatin; Immunotherapy","score_opus":0.02653310924636881,"score_gpt":0.32487161992958985,"score_spread":0.29833851068322104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411470437","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2940161,0.36743745,0.00063131383,0.3160025,0.001981275,0.000672593,0.00002403628,0.000245412,0.018989341],"genre_scores_gemma":[0.9967309,0.00072018517,0.0003767673,0.0017318411,0.000011431034,0.0000037367167,0.0000011822133,0.000005529466,0.0004184201],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99905485,0.000021457152,0.0004019117,0.00008938431,0.0001135914,0.00031882484],"domain_scores_gemma":[0.99937594,0.00004446178,0.00015959331,0.00017817796,0.00014283652,0.00009898789],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022387317,0.000087447,0.00038791428,0.0009401314,0.00012988852,0.0000138439,0.00016301284,0.00010690741,0.00005756477],"category_scores_gemma":[0.00059056113,0.00006464602,0.00009410382,0.00071201974,0.00011605474,0.000040924995,0.00001187188,0.0003146678,0.0000075569014],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009998602,0.000027825143,0.021877484,0.00015510654,0.00010634179,0.00021200333,0.000042979525,0.000001062229,0.000013319939,0.0042474354,0.0071633495,0.9660531],"study_design_scores_gemma":[0.006121616,0.0019146743,0.09631134,0.001057765,0.00010754857,0.00052843353,0.0020169995,0.0000033994188,0.0016869934,0.019565728,0.8705409,0.00014458588],"about_ca_topic_score_codex":0.003080019,"about_ca_topic_score_gemma":0.0013586769,"teacher_disagreement_score":0.9659085,"about_ca_system_score_codex":0.0006297923,"about_ca_system_score_gemma":0.004120736,"threshold_uncertainty_score":0.73100084},"labels":[],"label_agreement":null},{"id":"W4411506783","doi":"10.51731/cjht.2025.1151","title":"Clascoterone (Winlevi)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Acne; Family medicine; Political science; Dermatology; Health care","score_opus":0.015604395554090792,"score_gpt":0.30535708040542686,"score_spread":0.2897526848513361,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411506783","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.46240112,0.24637942,0.0010472547,0.28378588,0.0011419903,0.00049206556,0.000008844729,0.00014762496,0.0045957984],"genre_scores_gemma":[0.9963317,0.000696769,0.0005004192,0.0017560897,0.0000082180495,0.0000018819909,0.0000012365679,0.0000048196684,0.00069885567],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99928653,0.000016969474,0.0002874868,0.00007189017,0.000061635175,0.00027549898],"domain_scores_gemma":[0.9995551,0.000021015767,0.00012110645,0.00015709407,0.00007582362,0.00006982015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021308953,0.00007926988,0.00031623946,0.00050427404,0.00016545558,0.000012532411,0.000098847406,0.00010782888,0.000016203647],"category_scores_gemma":[0.00016392952,0.000053600274,0.00006679611,0.00024526307,0.00010246298,0.00004112425,0.0000089745845,0.00025365993,0.0000069229136],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025131076,0.00003198794,0.028617464,0.00019257827,0.00013028218,0.00038627317,0.00009339796,0.000001945146,0.00004542129,0.0015864687,0.052065454,0.91682357],"study_design_scores_gemma":[0.0017558329,0.0013752524,0.06410398,0.0014502009,0.00008030365,0.00050216756,0.0018011243,0.000008228701,0.0012535398,0.0033123975,0.92425257,0.00010442548],"about_ca_topic_score_codex":0.0012675817,"about_ca_topic_score_gemma":0.00063216034,"teacher_disagreement_score":0.9167192,"about_ca_system_score_codex":0.00026130266,"about_ca_system_score_gemma":0.0023839683,"threshold_uncertainty_score":0.42290574},"labels":[],"label_agreement":null},{"id":"W4411506827","doi":"10.51731/cjht.2025.1150","title":"Zilucoplan (Zilbrysq)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Myasthenia Gravis and Thymoma","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Myasthenia gravis; Drug; Clinical trial; Thymectomy; Family medicine; Internal medicine; Pharmacology; Political science; Law","score_opus":0.014917105700351152,"score_gpt":0.29620265931650336,"score_spread":0.2812855536161522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411506827","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4481769,0.17928505,0.0010696498,0.3581059,0.0014138384,0.00051817595,0.000020481777,0.00023810078,0.011171917],"genre_scores_gemma":[0.9965548,0.00031181448,0.0007651134,0.0018301227,0.000009933521,0.0000017422884,0.0000013668755,0.0000069848647,0.0005181504],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990083,0.000021516236,0.00044213972,0.00008910197,0.000093434464,0.0003455161],"domain_scores_gemma":[0.9993217,0.00002715464,0.00018281312,0.00023182231,0.00013772609,0.000098761746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039691114,0.000090627254,0.000369364,0.0008672481,0.00015503452,0.000018404085,0.00020080495,0.00012237059,0.00003898104],"category_scores_gemma":[0.00037949384,0.00007040409,0.00007812078,0.0003869252,0.00014065533,0.00003747251,0.000012104449,0.00040572332,0.000009340048],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029675943,0.000019479177,0.03304832,0.00020488196,0.00007360674,0.00043696043,0.00012286314,0.0000010645349,0.000066050045,0.018728375,0.04191666,0.90535206],"study_design_scores_gemma":[0.0008248804,0.00050661893,0.044456538,0.0008202952,0.000027340648,0.0008770058,0.0019624226,0.000006325233,0.00065662444,0.012131092,0.93764424,0.00008662146],"about_ca_topic_score_codex":0.0016487492,"about_ca_topic_score_gemma":0.0016392377,"teacher_disagreement_score":0.90526545,"about_ca_system_score_codex":0.00026219562,"about_ca_system_score_gemma":0.0042080036,"threshold_uncertainty_score":0.7464818},"labels":[],"label_agreement":null},{"id":"W4411625452","doi":"10.51731/cjht.2025.1152","title":"Dostarlimab (Jemperli)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Medical History and Research","field":"Arts and Humanities","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.046075261996101735,"score_gpt":0.2892892159167715,"score_spread":0.24321395392066975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411625452","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.055281896,0.34615263,0.00029113205,0.41250446,0.007677138,0.0004981745,0.000049803177,0.00030084015,0.17724393],"genre_scores_gemma":[0.99242496,0.00029855125,0.000044633824,0.0011341141,0.000028154753,0.0000023013947,7.403577e-7,0.000004523587,0.0060620164],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990348,0.000055068107,0.00036269854,0.000073058996,0.0001240046,0.00035035776],"domain_scores_gemma":[0.9994464,0.000058311216,0.00011986031,0.00014112254,0.00015963434,0.00007470724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007209742,0.00006816733,0.00021359144,0.00073663326,0.0006557505,0.000052982425,0.0003918145,0.000068116315,0.0007040944],"category_scores_gemma":[0.00042367753,0.000049794136,0.000056374825,0.00009446615,0.00093735324,0.00008190654,0.000015142408,0.00049554545,0.00002051251],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000070853785,0.0000133405,0.00018292661,0.0001234323,0.000026839258,0.000083522944,0.00426826,6.971595e-7,0.0000027382468,0.36569968,0.1427665,0.486825],"study_design_scores_gemma":[0.00013662568,0.000116469186,0.00008956282,0.0001555192,0.0000028434965,0.000009185599,0.011567364,0.0000016068101,0.000026046164,0.011072717,0.97677946,0.00004260355],"about_ca_topic_score_codex":0.0051140697,"about_ca_topic_score_gemma":0.022432452,"teacher_disagreement_score":0.9371431,"about_ca_system_score_codex":0.0002627783,"about_ca_system_score_gemma":0.003810119,"threshold_uncertainty_score":0.9954056},"labels":[],"label_agreement":null},{"id":"W4411712991","doi":"10.51731/cjht.2025.1153","title":"Cost-Effectiveness of Antiviral Drugs to Prevent or Treat Influenza A, Influenza B, or Zoonotic Influenza","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Virology; Medicine; Microbiology; Biology","score_opus":0.14469101172175794,"score_gpt":0.4492545859597756,"score_spread":0.3045635742380176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411712991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95422405,0.033218462,0.00017659472,0.006846093,0.00040230085,0.0038922522,0.0001192059,0.00018670816,0.0009343381],"genre_scores_gemma":[0.99306935,0.0004890319,0.0009466712,0.0050179767,0.000021218837,0.00015295291,0.0000015160784,0.00004409167,0.00025716555],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99567986,0.0003943982,0.0017164261,0.00039382975,0.0005528462,0.0012626308],"domain_scores_gemma":[0.99627227,0.00086735626,0.00064633635,0.00075319177,0.0011250247,0.00033581175],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0025190858,0.00043298875,0.0016865238,0.003209363,0.00039811607,0.000053190728,0.00075115793,0.0003408044,0.000039975068],"category_scores_gemma":[0.00893196,0.00029898033,0.00023153631,0.0022665984,0.0007409979,0.00027197594,0.00020019713,0.0010515515,0.000021468597],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01011567,0.00047409674,0.11756757,0.008902974,0.0013334117,0.0009496658,0.003453995,0.0004144043,0.000992213,0.0016184928,0.0074184802,0.846759],"study_design_scores_gemma":[0.013055404,0.011107844,0.18269224,0.019824969,0.00043522747,0.00026163808,0.018649828,0.00002488065,0.050843127,0.0026090315,0.69950783,0.0009879519],"about_ca_topic_score_codex":0.005899981,"about_ca_topic_score_gemma":0.003258133,"teacher_disagreement_score":0.8457711,"about_ca_system_score_codex":0.0022556554,"about_ca_system_score_gemma":0.013943037,"threshold_uncertainty_score":0.99994624},"labels":[],"label_agreement":null},{"id":"W4411713030","doi":"10.51731/cjht.2025.1155","title":"Alternate Level of Care in Canada: Evidence Assessment Report","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Geriatric Care and Nursing Homes","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Psychology; Medicine; History; Political science","score_opus":0.13715368792694693,"score_gpt":0.45040458907630576,"score_spread":0.31325090114935883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411713030","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7223989,0.1688131,0.00045440017,0.09928618,0.0059892917,0.0008332861,0.00009119643,0.000044576,0.0020890767],"genre_scores_gemma":[0.99816376,0.00075613125,0.00057859765,0.00027852447,0.00000966296,0.000009932085,0.0000020942327,0.0000069897396,0.00019433605],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99753135,0.00018928623,0.0013735124,0.00014333728,0.00021155212,0.00055095233],"domain_scores_gemma":[0.99781555,0.00028526055,0.0009772604,0.0003344338,0.0005128722,0.00007460725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011457102,0.00011133292,0.00055971486,0.0008761494,0.00026675328,0.0000048503384,0.00043278196,0.00013773485,0.000018777208],"category_scores_gemma":[0.0010260361,0.00009911723,0.000051811516,0.0006154059,0.00007698806,0.00008197423,0.0000392536,0.00087253645,5.348671e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000032375923,0.000007924457,0.68526304,0.0013890094,0.000035080167,0.0008659807,0.0018254358,0.000045487424,0.000015948839,0.0011715759,0.039859302,0.26948884],"study_design_scores_gemma":[0.000642028,0.00025960492,0.7746498,0.0077641006,0.000022066806,0.00008796925,0.13441335,0.000005683173,0.00016751396,0.0019699116,0.07985664,0.00016131758],"about_ca_topic_score_codex":0.9858306,"about_ca_topic_score_gemma":0.99789137,"teacher_disagreement_score":0.27576485,"about_ca_system_score_codex":0.0067378595,"about_ca_system_score_gemma":0.11444823,"threshold_uncertainty_score":0.9970751},"labels":[],"label_agreement":null},{"id":"W4411713042","doi":"10.51731/cjht.2025.1154","title":"Talquetamab (Talvey)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Philosophy","score_opus":0.2889593708010012,"score_gpt":0.42972959860994586,"score_spread":0.14077022780894466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411713042","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0447479,0.22790158,0.008549959,0.7064052,0.002521836,0.0005673745,0.00015028665,0.0001489166,0.009006939],"genre_scores_gemma":[0.98259056,0.0005028562,0.002027224,0.014235789,0.000025995023,0.000013895652,0.000003091593,0.00001507211,0.00058554293],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99486136,0.00014554756,0.004151907,0.00023143289,0.000051048533,0.0005587226],"domain_scores_gemma":[0.99636483,0.00030058992,0.0026754988,0.00042166392,0.00012010724,0.00011727914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011881101,0.00014246504,0.0009975393,0.0018265098,0.00034636457,0.000077143355,0.00060764,0.00021024709,0.000113404116],"category_scores_gemma":[0.0071405433,0.00016869765,0.00013107334,0.0005022062,0.00018869866,0.00030616575,0.000026108615,0.00041251123,0.00022847434],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000005568689,0.0000308957,0.046461053,0.00055826374,0.00013141394,0.000016264154,0.0007039275,0.00006960466,9.633121e-7,0.68067926,0.22795098,0.04339181],"study_design_scores_gemma":[0.00043235105,0.000103569975,0.015981654,0.00028423368,0.0000032205398,0.000030389901,0.0035268941,0.00007485189,0.000012422401,0.14509572,0.8342888,0.00016591902],"about_ca_topic_score_codex":0.009370272,"about_ca_topic_score_gemma":0.0043709846,"teacher_disagreement_score":0.9378426,"about_ca_system_score_codex":0.0015415256,"about_ca_system_score_gemma":0.0035593307,"threshold_uncertainty_score":0.9972264},"labels":[],"label_agreement":null},{"id":"W4411749003","doi":"10.51731/cjht.2025.1157","title":"Trends in CT Exam Volumes Between 2007 and 2022–2023 in Canada","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Advanced X-ray and CT Imaging","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Nuclear medicine; Medicine; Medical physics; Environmental science","score_opus":0.009899713950787196,"score_gpt":0.2395912448993541,"score_spread":0.2296915309485669,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411749003","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82979447,0.1566114,0.0004890397,0.011192983,0.00069594546,0.000099330166,0.00003497293,0.00007942313,0.0010024457],"genre_scores_gemma":[0.99886465,0.00071579206,0.00023352224,0.00010578134,0.0000055798973,0.0000023579705,0.0000011772255,0.000007902997,0.00006326478],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9989967,0.000017323362,0.00041216274,0.00008258613,0.00006077147,0.00043047723],"domain_scores_gemma":[0.999706,0.00005170348,0.000059994887,0.00010629031,0.000016568332,0.00005946977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002483615,0.00010065428,0.00029343597,0.0012918367,0.000055483764,0.000012826751,0.00018926254,0.000041931966,0.0000099517265],"category_scores_gemma":[0.00009391745,0.000106071035,0.000015022004,0.00074388005,0.000049391285,0.000108495515,0.000012594134,0.0005477438,2.9475873e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[6.4730216e-7,7.0044956e-7,0.1948313,0.000045776236,0.0000075827697,0.00014983374,0.000035233,0.0012290747,0.000001915705,0.000059053433,0.0032917035,0.80034715],"study_design_scores_gemma":[0.00072626997,0.000050542236,0.80819684,0.000844669,0.000008039806,0.00007036151,0.008742358,0.001171571,0.0002356409,0.0037448339,0.17588884,0.0003200079],"about_ca_topic_score_codex":0.7725,"about_ca_topic_score_gemma":0.9862341,"teacher_disagreement_score":0.8000272,"about_ca_system_score_codex":0.001366457,"about_ca_system_score_gemma":0.0018010933,"threshold_uncertainty_score":0.43254513},"labels":[],"label_agreement":null},{"id":"W4411749041","doi":"10.51731/cjht.2025.1156","title":"Tarlatamab (Imdelltra)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Cancer Care Ontario","keywords":"Computer science","score_opus":0.01959808958604087,"score_gpt":0.30008057881005523,"score_spread":0.28048248922401436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411749041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.45681325,0.2875144,0.0010077456,0.2450599,0.0014559138,0.0008009514,0.000027384967,0.00032610202,0.006994379],"genre_scores_gemma":[0.996011,0.00068766554,0.0013776359,0.0012561252,0.00000842919,0.0000034347602,0.0000027029894,0.000009190809,0.00064381864],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988296,0.000022723016,0.000496115,0.00011685629,0.00011753023,0.00041720015],"domain_scores_gemma":[0.9991934,0.000041828658,0.00021702526,0.0003131247,0.00013380879,0.000100834615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031632715,0.00011472319,0.00041261545,0.00087211514,0.00014732353,0.000015412354,0.00022134924,0.00014704042,0.000045716468],"category_scores_gemma":[0.0004933205,0.00009391081,0.000087450106,0.00043847182,0.00017162785,0.00005793952,0.000014773573,0.00046724375,0.000013831378],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031485833,0.000033235097,0.031955946,0.00024614806,0.00018238339,0.00066739396,0.00013577218,0.000007793732,0.000049661438,0.0028904323,0.0426534,0.92114633],"study_design_scores_gemma":[0.0036899454,0.00087653013,0.060908467,0.0015644566,0.000097906675,0.0013463724,0.0021297405,0.00002758141,0.0021986773,0.0054654772,0.92153275,0.00016208015],"about_ca_topic_score_codex":0.004211151,"about_ca_topic_score_gemma":0.0022215184,"teacher_disagreement_score":0.92098427,"about_ca_system_score_codex":0.0024660584,"about_ca_system_score_gemma":0.013985466,"threshold_uncertainty_score":0.9916043},"labels":[],"label_agreement":null},{"id":"W4412048074","doi":"10.51731/cjht.2025.1159","title":"Semaglutide (Wegovy)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Semaglutide; Medicine; Endocrinology","score_opus":0.02301648044997576,"score_gpt":0.35637882620294414,"score_spread":0.33336234575296836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412048074","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.32250255,0.24447557,0.00018144377,0.4236061,0.0016136549,0.0004419455,0.000014378045,0.00016103653,0.0070033115],"genre_scores_gemma":[0.9948557,0.0006935634,0.00043042735,0.0028212902,0.000012128825,0.000004049695,0.0000011089487,0.000005208677,0.001176496],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99921477,0.000021452146,0.00033195864,0.00007647232,0.0000576717,0.0002976801],"domain_scores_gemma":[0.9994917,0.00004741775,0.00014878353,0.0001326742,0.000106352345,0.00007306144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022768325,0.00007861363,0.00031707092,0.0007270835,0.00012189616,0.0000080853,0.00012583543,0.000093436276,0.000068462745],"category_scores_gemma":[0.00021548639,0.00006339084,0.000069592636,0.00035450078,0.00014275084,0.00002402907,0.000009182168,0.00031097996,0.0000064528363],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059377817,0.000042070744,0.055865947,0.00017895877,0.00017668144,0.00046523687,0.00012214342,0.0000033785545,0.00015399934,0.002796503,0.14617085,0.79396486],"study_design_scores_gemma":[0.0012546219,0.00061629113,0.0346908,0.00030390808,0.00006560564,0.00034370506,0.0008229221,0.0000031182242,0.0016359845,0.0032175104,0.9569859,0.000059658178],"about_ca_topic_score_codex":0.002898864,"about_ca_topic_score_gemma":0.0039191092,"teacher_disagreement_score":0.81081504,"about_ca_system_score_codex":0.0005842311,"about_ca_system_score_gemma":0.00543191,"threshold_uncertainty_score":0.9635975},"labels":[],"label_agreement":null},{"id":"W4412117824","doi":"10.51731/cjht.2025.1163","title":"Trends in MRI Exam Volumes Between 2007 and 2022–2023 in Canada","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Advanced MRI Techniques and Applications","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Environmental science; Medicine","score_opus":0.02081533778254828,"score_gpt":0.3241183519524455,"score_spread":0.3033030141698972,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412117824","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.497228,0.1376387,0.0047579994,0.356602,0.00030494193,0.0007622538,0.000111057896,0.00012579063,0.0024692628],"genre_scores_gemma":[0.9948024,0.0013555913,0.0029988408,0.0005362057,0.0000064194196,0.000011556841,0.000003945974,0.0000062255945,0.00027880014],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99899745,0.000015482741,0.0004687647,0.00011665162,0.00007197772,0.00032969707],"domain_scores_gemma":[0.999524,0.00004649033,0.00013781196,0.00016571794,0.000044677796,0.00008129857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027684553,0.00008502842,0.00035495794,0.00126933,0.000069033566,0.000006013075,0.00013789455,0.000091364505,0.000014271849],"category_scores_gemma":[0.00011986601,0.00007931225,0.000019550536,0.0008919103,0.000092064125,0.000042819236,0.000017709683,0.0005039499,2.1635877e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000030959984,0.0000040635,0.24140471,0.000029315373,0.000003809111,0.000077059914,0.000020281064,0.000010005489,0.0000033373185,0.0004897033,0.015395055,0.74255955],"study_design_scores_gemma":[0.0005790495,0.00013580774,0.69602436,0.0006043269,0.000010096713,0.000058605667,0.003049028,0.000051602525,0.00015992273,0.0053478675,0.29387075,0.00010861387],"about_ca_topic_score_codex":0.8603571,"about_ca_topic_score_gemma":0.98094976,"teacher_disagreement_score":0.74245095,"about_ca_system_score_codex":0.0014031735,"about_ca_system_score_gemma":0.005297953,"threshold_uncertainty_score":0.9398341},"labels":[],"label_agreement":null},{"id":"W4412158966","doi":"10.51731/cjht.2025.1165","title":"Hourly MRI Exam Volumes Across Canada in 2022–2023","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Environmental science","score_opus":0.009638817110730492,"score_gpt":0.3077956371914655,"score_spread":0.298156820080735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412158966","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.55631804,0.073441,0.0005894715,0.36707795,0.0014690422,0.00025315356,0.000025354608,0.00005984817,0.0007661103],"genre_scores_gemma":[0.99413574,0.0008094856,0.00059414806,0.0037636193,0.000017164697,0.000003272535,0.000003122641,0.000011033026,0.00066242996],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998396,0.000048965187,0.0006052432,0.00014316059,0.0001870171,0.0006196438],"domain_scores_gemma":[0.9992077,0.00008401169,0.0002209157,0.00022185907,0.000111846435,0.00015367758],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010260775,0.0001183231,0.00047727535,0.00041904743,0.00018673371,0.000029328137,0.00031042512,0.00012018311,0.000018907847],"category_scores_gemma":[0.0019146642,0.00010312575,0.000051341805,0.0006590578,0.00019867875,0.000052661093,0.000026491338,0.0012358243,0.0000011904204],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011949714,0.000011065638,0.14621933,0.00016443008,0.000037624155,0.0010180181,0.00016491959,0.00006649495,0.00001400952,0.0002493036,0.10681083,0.74523205],"study_design_scores_gemma":[0.0012909177,0.00020711448,0.18961366,0.0014229596,0.000015862546,0.00044117254,0.00689781,0.00053787185,0.00009499658,0.0011969203,0.79812485,0.00015589417],"about_ca_topic_score_codex":0.869268,"about_ca_topic_score_gemma":0.9384367,"teacher_disagreement_score":0.7450761,"about_ca_system_score_codex":0.0011943507,"about_ca_system_score_gemma":0.011593045,"threshold_uncertainty_score":0.9940103},"labels":[],"label_agreement":null},{"id":"W4412159003","doi":"10.51731/cjht.2025.1164","title":"Hourly CT Exam Volumes Across Canada in 2022–2023","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Radiation Dose and Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Environmental science","score_opus":0.014067817810169195,"score_gpt":0.3049822047060123,"score_spread":0.2909143868958431,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412159003","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7681607,0.07103608,0.000049609618,0.15895256,0.00081377296,0.00020121668,0.000034856304,0.000041435746,0.00070974336],"genre_scores_gemma":[0.9956707,0.00059340225,0.00009123462,0.0029183745,0.000011706516,0.000003318559,0.0000028511884,0.000007669388,0.0007007784],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986394,0.00003285124,0.0005540635,0.00011580683,0.00014471215,0.00051313575],"domain_scores_gemma":[0.9993351,0.000050702256,0.0002095357,0.00020670582,0.000093949144,0.00010402208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054657593,0.00010020532,0.0003740087,0.00049039006,0.00016527197,0.00002982796,0.00023474233,0.000054715183,0.000022293072],"category_scores_gemma":[0.0008957198,0.000092069466,0.00004207397,0.0007685105,0.000100741396,0.00010365304,0.0000148590125,0.0005733858,0.0000020827367],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000064655246,0.000006762449,0.17567715,0.00008032742,0.00002755642,0.00069287175,0.000117714764,0.000018823861,0.000009911645,0.000100610036,0.093391255,0.72987056],"study_design_scores_gemma":[0.0009500483,0.00013001927,0.3515573,0.0007378169,0.000010629274,0.00036579077,0.0102638,0.00007656431,0.00063162186,0.00053398905,0.63462,0.0001223631],"about_ca_topic_score_codex":0.874153,"about_ca_topic_score_gemma":0.97141856,"teacher_disagreement_score":0.7297482,"about_ca_system_score_codex":0.0014297322,"about_ca_system_score_gemma":0.0142834075,"threshold_uncertainty_score":0.9913047},"labels":[],"label_agreement":null},{"id":"W4412200300","doi":"10.51731/cjht.2025.1167","title":"MRI Service Delivery in Canada: Units, Exam Volumes, and Medical Radiation Technologist Staffing","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Radiation Dose and Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Staffing; Medical physics; Service (business); Medicine; Service delivery framework; Nuclear medicine; Radiology; Business; Nursing","score_opus":0.013955953458555118,"score_gpt":0.2562306730184207,"score_spread":0.24227471955986557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412200300","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.65033937,0.09359457,0.00019363168,0.25514114,0.00026737023,0.00021868927,0.000008678906,0.0000628312,0.00017374296],"genre_scores_gemma":[0.9915663,0.0042592883,0.00019672266,0.003930484,0.000008098163,0.0000034595944,0.000004317333,0.000007539187,0.000023774286],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998591,0.000042889355,0.000617987,0.0001407924,0.00021756433,0.00038975506],"domain_scores_gemma":[0.9991777,0.000079437676,0.00023894674,0.00018269276,0.00018806959,0.00013312983],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006434361,0.00011260882,0.00037533467,0.0012357477,0.0001498878,0.000023665332,0.00023997959,0.00016836691,0.000014199451],"category_scores_gemma":[0.0016032308,0.000105650775,0.000015414726,0.0013387491,0.00011031172,0.00013422701,0.000028711478,0.0007257391,6.425271e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008018508,0.000005289832,0.17263994,0.00011790607,0.00002313602,0.00024011984,0.000069453534,0.000026447924,0.000005421726,0.00039981992,0.006598152,0.8198663],"study_design_scores_gemma":[0.0033608053,0.00027806338,0.4469545,0.00316976,0.00005361657,0.0009396963,0.030699665,0.005105414,0.00081066944,0.0010442544,0.5072331,0.0003504779],"about_ca_topic_score_codex":0.89501137,"about_ca_topic_score_gemma":0.97215146,"teacher_disagreement_score":0.8195158,"about_ca_system_score_codex":0.0021579757,"about_ca_system_score_gemma":0.04042706,"threshold_uncertainty_score":0.96501285},"labels":[],"label_agreement":null},{"id":"W4412200350","doi":"10.51731/cjht.2025.1166","title":"MRI Usage Patterns by Clinical Specialty Across Canada: Geographic and Temporal Trends","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Radiology practices and education","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Specialty; Geography; Cartography; Data science; Medicine; Computer science; Family medicine","score_opus":0.033633275085445204,"score_gpt":0.38137493116195026,"score_spread":0.34774165607650503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412200350","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.78232706,0.025849383,0.00004856612,0.19058335,0.0009391896,0.00007551936,0.00004275646,0.000019014387,0.00011514408],"genre_scores_gemma":[0.99413973,0.00307185,0.00016894314,0.0023074748,0.000040118382,0.0000019822858,0.000010333617,0.000005850893,0.00025369207],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99859136,0.000080287144,0.0006653034,0.00015564091,0.00009217745,0.00041521594],"domain_scores_gemma":[0.9990009,0.00011300407,0.00041604953,0.00020083471,0.00009524514,0.00017393698],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011091802,0.00010420607,0.00043431952,0.00026495947,0.00026891186,0.000025996798,0.00016270271,0.0001965227,0.000020980446],"category_scores_gemma":[0.0005298672,0.00008671083,0.000055292705,0.0003078137,0.00028724223,0.00008483428,0.000015434834,0.00071493693,3.1894186e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001252205,0.000010369531,0.64874053,0.00003096464,0.000037495698,0.000051220664,0.000039470087,1.3514492e-7,5.271109e-7,0.000027925718,0.05728135,0.29376748],"study_design_scores_gemma":[0.00035607564,0.00021349767,0.58471256,0.00009337298,0.00001862978,0.00017739662,0.0024352237,0.000002774078,0.00000910358,0.00008522278,0.41184995,0.000046210276],"about_ca_topic_score_codex":0.686641,"about_ca_topic_score_gemma":0.9213214,"teacher_disagreement_score":0.3545686,"about_ca_system_score_codex":0.00034333387,"about_ca_system_score_gemma":0.005568415,"threshold_uncertainty_score":0.9878129},"labels":[],"label_agreement":null},{"id":"W4412360437","doi":"10.51731/cjht.2025.1162","title":"Elafibranor (Iqirvo)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Connective tissue disorders research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.013830898907577311,"score_gpt":0.31496099364087377,"score_spread":0.30113009473329644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412360437","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5623111,0.35207757,0.0049080504,0.07490871,0.0006327119,0.0004375872,0.000025981644,0.000047597194,0.0046506636],"genre_scores_gemma":[0.99820274,0.00064290233,0.00022373012,0.00036621917,0.0000069803236,0.0000041793837,0.0000030918472,0.0000069598927,0.0005431842],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991627,0.00005199216,0.0002588716,0.000120859855,0.00006730641,0.00033829286],"domain_scores_gemma":[0.9994216,0.0000149407515,0.00010463204,0.00023147117,0.00017909113,0.000048284735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003914069,0.00007801878,0.00016352208,0.00044889192,0.00015249495,0.000020619345,0.0004027465,0.00013039043,0.000016218952],"category_scores_gemma":[0.00093197747,0.000073314564,0.000058840236,0.00027422176,0.00018140506,0.0000034263078,0.00003859404,0.00021081227,0.000003774325],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033058823,0.000016924298,0.014250434,0.00008595605,0.000095507916,0.000032977092,0.000057853376,0.000015853733,0.0074866787,0.0029155626,0.037266254,0.93774295],"study_design_scores_gemma":[0.00042463423,0.00042197207,0.008437557,0.000087654626,0.000004201875,0.000047726648,0.0016910733,0.0000034351322,0.021214629,0.003919898,0.963641,0.000106207925],"about_ca_topic_score_codex":0.0011867095,"about_ca_topic_score_gemma":0.005855829,"teacher_disagreement_score":0.93763673,"about_ca_system_score_codex":0.00009172336,"about_ca_system_score_gemma":0.003289827,"threshold_uncertainty_score":0.5836012},"labels":[],"label_agreement":null},{"id":"W4412427405","doi":"10.51731/cjht.2025.1168","title":"Ferric Carboxymaltose (Ferinject)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Internal medicine; Medicine","score_opus":0.015168506749569223,"score_gpt":0.2923345552259458,"score_spread":0.2771660484763766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412427405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5357671,0.3234773,0.0005262884,0.12776572,0.0015124279,0.0004340176,0.00000966245,0.00019585494,0.010311626],"genre_scores_gemma":[0.99568,0.001010754,0.0006733755,0.002153901,0.000008999003,0.0000026545438,8.068643e-7,0.00000801632,0.00046154304],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989389,0.000028723183,0.00043352548,0.00009976014,0.00010195162,0.00039710614],"domain_scores_gemma":[0.99933165,0.000027844415,0.00016531828,0.00024383763,0.00013210149,0.00009923718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003587991,0.00010324688,0.00039073487,0.0011184692,0.0001532127,0.000015892454,0.00020232266,0.00012803865,0.00002782175],"category_scores_gemma":[0.00081828935,0.000084631494,0.00007932948,0.00056166004,0.00016667166,0.000050653824,0.000014345426,0.00040997163,0.000006608043],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004508409,0.00003472722,0.035635475,0.0005009002,0.00004180847,0.00027036364,0.0002464791,0.000009792413,0.000080031736,0.010845449,0.03275178,0.9195381],"study_design_scores_gemma":[0.0023025535,0.00063483807,0.17813046,0.00061887084,0.000094355804,0.0004888468,0.010163108,0.000008009848,0.00089545717,0.012605032,0.7938433,0.00021512157],"about_ca_topic_score_codex":0.004363766,"about_ca_topic_score_gemma":0.0023973135,"teacher_disagreement_score":0.91932297,"about_ca_system_score_codex":0.00022481562,"about_ca_system_score_gemma":0.0058068703,"threshold_uncertainty_score":0.9998293},"labels":[],"label_agreement":null},{"id":"W4412495459","doi":"10.51731/cjht.2025.1171","title":"Naloxegol","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Traditional medicine; Medicine","score_opus":0.025132346049566018,"score_gpt":0.33082840259772517,"score_spread":0.3056960565481591,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412495459","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09265086,0.38137642,0.00049750856,0.5098762,0.0002244013,0.00032029863,0.0000069424495,0.00013763472,0.014909754],"genre_scores_gemma":[0.9939228,0.0009578306,0.0006718071,0.002430308,0.000009536499,0.0000021458773,5.1803505e-7,0.000004320573,0.0020007186],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99917495,0.0000148988065,0.00037763463,0.00006845989,0.000074487994,0.0002895441],"domain_scores_gemma":[0.99944955,0.000031313702,0.00013293955,0.00015491043,0.00017497041,0.000056300545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003357984,0.00007381356,0.0003514633,0.0007488942,0.00017718493,0.000008692586,0.00012523847,0.000083128296,0.000019991807],"category_scores_gemma":[0.00071790244,0.000056573623,0.00008257719,0.00034990834,0.00015186246,0.00002982396,0.0000122954825,0.00035976263,0.0000053865624],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020183601,0.000019748946,0.04947062,0.00037165437,0.00015932255,0.00023284688,0.00041287445,6.720342e-7,0.000039854327,0.010542759,0.56400806,0.37472144],"study_design_scores_gemma":[0.00042605647,0.0003055033,0.03605554,0.0005135378,0.000026217016,0.00020820918,0.004891416,0.0000017291785,0.0002505395,0.0049187792,0.9523524,0.000050089773],"about_ca_topic_score_codex":0.002336138,"about_ca_topic_score_gemma":0.0051791323,"teacher_disagreement_score":0.90127194,"about_ca_system_score_codex":0.00022022195,"about_ca_system_score_gemma":0.003940186,"threshold_uncertainty_score":0.69897205},"labels":[],"label_agreement":null},{"id":"W4412525820","doi":"10.51731/cjht.2025.1172","title":"Pembrolizumab (Keytruda)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pembrolizumab; Medicine; Internal medicine; Cancer","score_opus":0.018423995163443674,"score_gpt":0.31739819533080416,"score_spread":0.2989742001673605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412525820","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2742569,0.31973705,0.00020119116,0.39870843,0.0009884798,0.00045301914,0.00001560814,0.0001323639,0.005506934],"genre_scores_gemma":[0.9960123,0.0018445333,0.0003270286,0.001573605,0.000008197179,0.000007467875,0.0000010266615,0.000005860353,0.00022003926],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99915093,0.000013850381,0.00036276327,0.00008973298,0.000089060224,0.00029364848],"domain_scores_gemma":[0.9993985,0.000030653857,0.00015891595,0.0002063835,0.00012549266,0.00008003504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001807343,0.00008515157,0.0003477167,0.0006882092,0.0001318548,0.000016453725,0.00012389157,0.000087030174,0.000036440437],"category_scores_gemma":[0.00020857493,0.00006651488,0.0000891459,0.0003240212,0.000113166105,0.000034657915,0.000009876098,0.000255158,0.0000053395256],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030364377,0.000038375354,0.052629065,0.0001379032,0.000112682035,0.0002953898,0.0000784541,0.000002596239,0.000006309693,0.0059334785,0.042438727,0.89829665],"study_design_scores_gemma":[0.0020577114,0.0009052149,0.14220658,0.0011187482,0.00007087042,0.0004772586,0.0016527629,0.0000037186264,0.001038769,0.005022954,0.8453579,0.00008753625],"about_ca_topic_score_codex":0.0049003535,"about_ca_topic_score_gemma":0.005150814,"teacher_disagreement_score":0.8982091,"about_ca_system_score_codex":0.0008615668,"about_ca_system_score_gemma":0.005416469,"threshold_uncertainty_score":0.96085835},"labels":[],"label_agreement":null},{"id":"W4412557774","doi":"10.51731/cjht.2025.1173","title":"Lazertinib and Amivantamab (Lazcluze and Rybrevant)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.014318388167044858,"score_gpt":0.2930609854070025,"score_spread":0.27874259723995765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412557774","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7032254,0.19786364,0.000056410045,0.09753202,0.00020111298,0.00029373317,0.00000952556,0.00007247199,0.00074573845],"genre_scores_gemma":[0.99440277,0.0034543045,0.0008870149,0.0009591036,0.000006060501,0.0000026889304,0.000001124721,0.000008190669,0.00027871705],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99902797,0.000024026896,0.00040056062,0.00013466725,0.00008089081,0.0003319113],"domain_scores_gemma":[0.9993745,0.00006707573,0.00017467946,0.00018687097,0.000077013035,0.00011985559],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002859442,0.00011658544,0.00040537099,0.00058290677,0.00015645208,0.000021370246,0.00009599912,0.0001226357,0.000009412166],"category_scores_gemma":[0.00052794407,0.0000928544,0.000032135267,0.0002151042,0.0002740681,0.000056788154,0.000027787375,0.0003574822,0.0000016143813],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042567197,0.000015859176,0.06367069,0.00039319406,0.00011641508,0.00039513418,0.00018195916,3.5947858e-7,0.00006658053,0.0014331173,0.007558607,0.9261255],"study_design_scores_gemma":[0.0086065065,0.0020655345,0.32941988,0.0035760303,0.0002174405,0.0053762244,0.006479236,0.000054732027,0.0018434961,0.010139055,0.6319186,0.00030324864],"about_ca_topic_score_codex":0.002406092,"about_ca_topic_score_gemma":0.0023945416,"teacher_disagreement_score":0.92582226,"about_ca_system_score_codex":0.0007658196,"about_ca_system_score_gemma":0.004045656,"threshold_uncertainty_score":0.717682},"labels":[],"label_agreement":null},{"id":"W4412612589","doi":"10.51731/cjht.2025.1174","title":"Leuprolide Mesylate (Camcevi)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Mesylate; Medicine; Medical physics; Chemistry","score_opus":0.024821458400973634,"score_gpt":0.36169274152501346,"score_spread":0.3368712831240398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412612589","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.34572148,0.27163386,0.00020325472,0.37149405,0.0019172162,0.0005790671,0.000014845555,0.0001853621,0.008250865],"genre_scores_gemma":[0.9944186,0.0012682033,0.0003405866,0.0027951268,0.000014874449,0.0000056632202,0.0000014726128,0.000006413873,0.00114904],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990981,0.00002572075,0.00038757361,0.00008955287,0.00006432843,0.00033472962],"domain_scores_gemma":[0.9994321,0.000035291945,0.0001823668,0.00014927395,0.0001188819,0.00008208376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027864764,0.0000922656,0.00037263933,0.0007750878,0.00013332929,0.000011474508,0.00014830202,0.00010775006,0.00006878034],"category_scores_gemma":[0.00015862499,0.00007334144,0.000080505044,0.00035473032,0.00014648745,0.000044354096,0.000010985876,0.00035685734,0.0000075689313],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010073083,0.00004303064,0.04768485,0.00021304858,0.00024301205,0.0005321626,0.00014688092,0.000005215605,0.00016913355,0.0027824363,0.10581467,0.84226483],"study_design_scores_gemma":[0.0016321683,0.00077696226,0.027777558,0.00036146055,0.00008741288,0.00038904688,0.00063540955,0.0000054839725,0.0020576098,0.004553489,0.9616468,0.00007659313],"about_ca_topic_score_codex":0.002894991,"about_ca_topic_score_gemma":0.0032783789,"teacher_disagreement_score":0.85583216,"about_ca_system_score_codex":0.0006036838,"about_ca_system_score_gemma":0.0052846656,"threshold_uncertainty_score":0.937477},"labels":[],"label_agreement":null},{"id":"W4412632527","doi":"10.51731/cjht.2025.1175","title":"Polatuzumab Vedotin (Polivy)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine","score_opus":0.012518927495771085,"score_gpt":0.29539388877317135,"score_spread":0.28287496127740025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412632527","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.28324756,0.52841187,0.00048373666,0.18062858,0.0010732634,0.00053448824,0.000016647542,0.00036201623,0.005241866],"genre_scores_gemma":[0.9964707,0.00048319,0.00063276413,0.0018738203,0.0000092657465,0.0000031678096,0.0000017664615,0.000012664318,0.0005126685],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986563,0.000035242403,0.0005971593,0.000116366005,0.00012888048,0.00046609336],"domain_scores_gemma":[0.9989846,0.000051277035,0.00029836205,0.0003569975,0.00019366549,0.00011513681],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002800886,0.00012581285,0.00046416017,0.0012432653,0.00021673024,0.000021565695,0.00031637697,0.00014921962,0.000043138505],"category_scores_gemma":[0.0015265662,0.00010793527,0.00011831771,0.00054155005,0.00026465082,0.00005486512,0.000026703667,0.0004997337,0.0000136029585],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000818519,0.000080971884,0.058062106,0.00054452196,0.00021944249,0.00085949426,0.0002923507,0.000010281076,0.000116559335,0.0142111,0.09583608,0.8296852],"study_design_scores_gemma":[0.0014481711,0.00067152694,0.20693104,0.0019302405,0.00008623231,0.0007367004,0.005351514,0.00001469963,0.0008825986,0.011619764,0.770146,0.00018150295],"about_ca_topic_score_codex":0.004787347,"about_ca_topic_score_gemma":0.0010578185,"teacher_disagreement_score":0.8295037,"about_ca_system_score_codex":0.00081368577,"about_ca_system_score_gemma":0.012301819,"threshold_uncertainty_score":0.9932975},"labels":[],"label_agreement":null},{"id":"W4412632949","doi":"10.51731/cjht.2025.1176","title":"Pasireotide (Signifor LAR)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pasireotide; Environmental science; Psychology; Medicine; Internal medicine; Acromegaly","score_opus":0.017207793994875185,"score_gpt":0.29169148275675866,"score_spread":0.27448368876188345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412632949","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3641214,0.32405874,0.0016867921,0.29469618,0.0011048529,0.00078018795,0.00003887596,0.00023573574,0.01327723],"genre_scores_gemma":[0.99698323,0.00060684304,0.00058095827,0.0014419066,0.00000409142,0.000002903344,0.0000028114223,0.000004869781,0.000372409],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99922127,0.000014654773,0.0003198648,0.000078303754,0.00006933832,0.00029655412],"domain_scores_gemma":[0.9995302,0.00002291381,0.00012347459,0.00015948075,0.00008509185,0.00007885387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001851736,0.00008328593,0.00029878155,0.0005720404,0.00014899606,0.000011386127,0.000117613556,0.000078419485,0.000017938868],"category_scores_gemma":[0.000250238,0.00006103704,0.00007133634,0.00026254996,0.00008971043,0.000046917394,0.00000817727,0.00020988837,0.0000064093097],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037782756,0.000060684382,0.23135333,0.00016394957,0.00016548757,0.00070388085,0.00007705415,0.0000022116644,0.000007797634,0.0040450897,0.03124366,0.73213905],"study_design_scores_gemma":[0.00431147,0.0014944075,0.22618268,0.0011798592,0.00012373495,0.0006460315,0.0047404934,0.00000949229,0.0006291608,0.051575508,0.7089222,0.00018493463],"about_ca_topic_score_codex":0.0028526778,"about_ca_topic_score_gemma":0.0027560517,"teacher_disagreement_score":0.73195416,"about_ca_system_score_codex":0.00021858106,"about_ca_system_score_gemma":0.003071158,"threshold_uncertainty_score":0.54481024},"labels":[],"label_agreement":null},{"id":"W4412633024","doi":"10.51731/cjht.2025.1177","title":"Iptacopan (Fabhalta)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cardiovascular Syncope and Autonomic Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Geography","score_opus":0.011168223352784949,"score_gpt":0.2755146141664529,"score_spread":0.26434639081366795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412633024","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16656896,0.4724282,0.0027830068,0.33119422,0.001985784,0.00062738755,0.000011211917,0.00025651473,0.024144704],"genre_scores_gemma":[0.99670655,0.0007366328,0.0004260907,0.0016363806,0.0000073787724,0.000002218333,0.0000010292205,0.000007088011,0.00047662956],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999109,0.000023355122,0.00039222836,0.00009291973,0.00008146482,0.00030099164],"domain_scores_gemma":[0.9994212,0.000017494222,0.00013312377,0.00025664648,0.00010455654,0.00006701284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050360814,0.00008302005,0.00040935192,0.0007632062,0.000118986776,0.000018529543,0.00017278062,0.000097866236,0.000020764097],"category_scores_gemma":[0.00035791873,0.000071017035,0.00018605603,0.00035453125,0.00013989944,0.000049310074,0.000013346101,0.00031635357,0.000009969257],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008258528,0.000009725151,0.0038577802,0.000097881064,0.0001414247,0.00012415907,0.000057674137,0.000006623674,0.000016083104,0.0021406997,0.022228131,0.97131157],"study_design_scores_gemma":[0.000798831,0.00016599508,0.020648701,0.00043598778,0.000045458146,0.00030741555,0.0030195662,0.0000054017796,0.00039793956,0.0023491485,0.97175574,0.00006983701],"about_ca_topic_score_codex":0.0021038046,"about_ca_topic_score_gemma":0.0013267938,"teacher_disagreement_score":0.9712417,"about_ca_system_score_codex":0.0003483503,"about_ca_system_score_gemma":0.0059270086,"threshold_uncertainty_score":0.9997085},"labels":[],"label_agreement":null},{"id":"W4412697740","doi":"10.51731/cjht.2025.1178","title":"Omaveloxolone (Skyclarys)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Drug-Induced Ocular Toxicity","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.01966521098273077,"score_gpt":0.30985834869944173,"score_spread":0.29019313771671096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412697740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.60828656,0.0846194,0.0014298981,0.2965924,0.0012283335,0.00054238655,0.0000133967815,0.0002831919,0.0070044184],"genre_scores_gemma":[0.99491554,0.00023328874,0.0020267586,0.0024331266,0.00001093023,0.0000025604525,0.000001431127,0.0000108424265,0.00036549594],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986512,0.000041665684,0.00056052784,0.00013162242,0.00014496312,0.00046999604],"domain_scores_gemma":[0.9990225,0.000037594917,0.00025566327,0.00034467314,0.00020971555,0.0001298922],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006713192,0.00012266904,0.00047789243,0.0012071066,0.00018535387,0.00001932568,0.00029164803,0.00021365835,0.000016616212],"category_scores_gemma":[0.0012795137,0.000105511106,0.00010342488,0.00063429173,0.00021508997,0.00007227434,0.000024818626,0.00072897796,0.000012976997],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018309842,0.000038009453,0.021427777,0.00024643433,0.00012447918,0.0008239747,0.00014011316,0.000003978992,0.0005453721,0.0045940094,0.015323414,0.95671415],"study_design_scores_gemma":[0.001934841,0.000567063,0.16984859,0.0016562495,0.000080206875,0.001553467,0.0035930865,0.000020632957,0.012796032,0.012391297,0.79531276,0.00024574023],"about_ca_topic_score_codex":0.0022369379,"about_ca_topic_score_gemma":0.0024718607,"teacher_disagreement_score":0.9564684,"about_ca_system_score_codex":0.00073897385,"about_ca_system_score_gemma":0.0067735673,"threshold_uncertainty_score":0.9988571},"labels":[],"label_agreement":null},{"id":"W4412788885","doi":"10.51731/cjht.2025.1181","title":"Fidaxomicin","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Fidaxomicin; Biology","score_opus":0.06982554547290536,"score_gpt":0.40967264471255066,"score_spread":0.3398470992396453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412788885","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06943315,0.27979004,0.00028175084,0.63960165,0.00065253,0.00019649364,0.0000045426323,0.000068183544,0.009971624],"genre_scores_gemma":[0.99182945,0.0024750296,0.00043352673,0.0050205276,0.0000075040457,0.0000011152823,2.4185158e-7,0.0000030762026,0.00022950346],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99927855,0.000023235212,0.00031457303,0.000059612386,0.00006219072,0.0002618686],"domain_scores_gemma":[0.99949074,0.000085594234,0.00015116179,0.00010530946,0.00010062241,0.00006655059],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004429952,0.000059674043,0.0002669956,0.00033234115,0.00017163205,0.000012525699,0.00012346345,0.00006638078,0.00003509721],"category_scores_gemma":[0.000970648,0.000044198117,0.000049425427,0.00028259208,0.00012999377,0.000049231472,0.000014172462,0.00041423712,0.0000058986275],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033214837,0.000013018627,0.017306695,0.00013409716,0.00008597416,0.00012904457,0.00005634802,9.655159e-7,0.00003431295,0.0025661208,0.045429435,0.9342108],"study_design_scores_gemma":[0.0003842887,0.00018107117,0.016014798,0.00023221625,0.000026903934,0.00012149784,0.0014421582,0.000004888458,0.00047820222,0.0022336806,0.9788464,0.00003389862],"about_ca_topic_score_codex":0.0017156848,"about_ca_topic_score_gemma":0.000990834,"teacher_disagreement_score":0.93417686,"about_ca_system_score_codex":0.0002332339,"about_ca_system_score_gemma":0.0019385548,"threshold_uncertainty_score":0.3438913},"labels":[],"label_agreement":null},{"id":"W4412789017","doi":"10.51731/cjht.2025.1179","title":"Fidaxomicin","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Clostridium difficile and Clostridium perfringens research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Fidaxomicin; Geology","score_opus":0.03065298352446918,"score_gpt":0.33521955252870417,"score_spread":0.304566569004235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412789017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.73213273,0.09010427,0.0001597853,0.17252932,0.00041460936,0.00029543595,0.000010148687,0.0000872003,0.004266507],"genre_scores_gemma":[0.9974406,0.0008382099,0.000216318,0.0007715389,0.000011318711,0.000002291944,0.0000014120047,0.0000073072165,0.00071105623],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99879026,0.000027914415,0.00048663176,0.000106601095,0.00014436089,0.00044421677],"domain_scores_gemma":[0.9992058,0.00005278325,0.00013615518,0.00025941632,0.00024213802,0.000103687154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049171527,0.00009397706,0.00037693436,0.0011957615,0.00016757839,0.000022895407,0.00023646059,0.00013516305,0.000049152757],"category_scores_gemma":[0.00093320676,0.00007724412,0.000097333075,0.000641818,0.00018690029,0.000035715282,0.000021683109,0.0005872359,0.000013156522],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006347051,0.000040936226,0.013964743,0.00028952945,0.00009533486,0.0003932049,0.00008674046,0.0000044813573,0.0012861779,0.0021710347,0.0686069,0.9129974],"study_design_scores_gemma":[0.0016397109,0.000944413,0.019530717,0.0011848082,0.00004307569,0.0006088482,0.00445355,0.000021695974,0.052031245,0.0018575843,0.9175362,0.00014812418],"about_ca_topic_score_codex":0.0027848762,"about_ca_topic_score_gemma":0.0011189872,"teacher_disagreement_score":0.9128493,"about_ca_system_score_codex":0.0006341398,"about_ca_system_score_gemma":0.008193673,"threshold_uncertainty_score":0.99742895},"labels":[],"label_agreement":null},{"id":"W4412789053","doi":"10.51731/cjht.2025.1180","title":"Olopatadine Hydrochloride and Mometasone Furoate Nasal Spray (Ryaltris)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Allergic Rhinitis and Sensitization","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Mometasone furoate; Nasal spray; Medicine; Dermatology; Pharmacology; Nasal administration; Internal medicine; Corticosteroid","score_opus":0.01495177589674096,"score_gpt":0.271694093505273,"score_spread":0.25674231760853206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412789053","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.75565636,0.08034628,0.002148878,0.16001505,0.0005582089,0.00029678908,0.000013102907,0.00010511148,0.000860246],"genre_scores_gemma":[0.9944499,0.0028099495,0.0009771303,0.0013611866,0.000015608737,0.0000015501594,0.000004845335,0.000009045148,0.00037079802],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99889916,0.000030307248,0.0005111316,0.00012951872,0.00011179183,0.00031811828],"domain_scores_gemma":[0.9992442,0.000046308807,0.0002471619,0.00017251461,0.00017473436,0.000115060495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048629424,0.000111949405,0.00043295283,0.0008861416,0.00019046641,0.000024972076,0.00010391928,0.00012863116,0.000012693761],"category_scores_gemma":[0.0006967187,0.00009290092,0.000044869983,0.00040027767,0.00017826854,0.0000834984,0.000016507587,0.00038615282,0.0000025686818],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023786428,0.00006476836,0.058226682,0.00067498424,0.0003837532,0.002602321,0.0006308904,0.00004148515,0.0012191333,0.015482374,0.042503,0.8779327],"study_design_scores_gemma":[0.005754725,0.0025471868,0.17269601,0.0027867442,0.00019591456,0.0058265724,0.0074228244,0.00035362944,0.0076902388,0.015301363,0.77889335,0.00053145125],"about_ca_topic_score_codex":0.0012596177,"about_ca_topic_score_gemma":0.0012868076,"teacher_disagreement_score":0.8774013,"about_ca_system_score_codex":0.00020303698,"about_ca_system_score_gemma":0.0018159989,"threshold_uncertainty_score":0.37883893},"labels":[],"label_agreement":null},{"id":"W4412825568","doi":"10.51731/cjht.2025.1182","title":"Naloxegol","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.018251024890165442,"score_gpt":0.29671374668066547,"score_spread":0.2784627217905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412825568","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.40789118,0.101944715,0.0038602094,0.47776982,0.00063421344,0.00041064055,0.0000072877833,0.00019642855,0.0072855093],"genre_scores_gemma":[0.9963396,0.00008471388,0.0016739973,0.0016878706,0.0000029755247,0.0000011318067,5.9301436e-7,0.0000035223404,0.0002055716],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992089,0.000018615463,0.00035287603,0.00007109314,0.00007166278,0.00027680994],"domain_scores_gemma":[0.9994486,0.00003281934,0.00013043085,0.0001573132,0.00015674205,0.00007407709],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031395492,0.00006775523,0.0002575246,0.0006544666,0.00011502775,0.000011659682,0.0001442704,0.00006693783,0.000018719695],"category_scores_gemma":[0.0013895452,0.00005660098,0.000066337634,0.00033654837,0.0001798184,0.000039559523,0.000008689333,0.00037191823,0.000005180666],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045672303,0.000038381102,0.18506494,0.0003493665,0.000047647194,0.00025820147,0.0001025057,0.0000067894257,0.000038477738,0.0064597484,0.023415595,0.78417265],"study_design_scores_gemma":[0.0019790863,0.0017535926,0.43261427,0.0025411588,0.000060309732,0.002121294,0.011656765,0.000024660563,0.00048027132,0.039401013,0.50722015,0.00014742251],"about_ca_topic_score_codex":0.0020952434,"about_ca_topic_score_gemma":0.0022187065,"teacher_disagreement_score":0.78402525,"about_ca_system_score_codex":0.00020655735,"about_ca_system_score_gemma":0.00412289,"threshold_uncertainty_score":0.731383},"labels":[],"label_agreement":null},{"id":"W4412825923","doi":"10.51731/cjht.2025.1183","title":"Trastuzumab Deruxtecan (Enhertu)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Trastuzumab; Medicine; Internal medicine; Breast cancer; Cancer","score_opus":0.021606057420086727,"score_gpt":0.3036627743687614,"score_spread":0.2820567169486746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412825923","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17792594,0.18182844,0.0055618766,0.61863613,0.0023077733,0.0008978251,0.000010900526,0.00036978524,0.012461304],"genre_scores_gemma":[0.9949079,0.00053139764,0.0008858592,0.0024628083,0.000010318176,0.0000031352495,9.807295e-7,0.0000069739976,0.0011906303],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989693,0.000017101565,0.00044226064,0.00009682247,0.000110063476,0.00036445368],"domain_scores_gemma":[0.9993956,0.000028567432,0.00018865835,0.00020461118,0.00010747861,0.00007508322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033653592,0.000098373726,0.00037470783,0.0011044949,0.00014223756,0.000022843671,0.00021929892,0.00008337099,0.00004218575],"category_scores_gemma":[0.0003227144,0.000080630234,0.00009202774,0.0005681742,0.00012621621,0.000053786855,0.000015983487,0.0003352091,0.0000041563944],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015359448,0.000010327178,0.029448327,0.00014365777,0.00007287033,0.00012362511,0.00006122201,0.0000023307234,0.000005996843,0.0020938052,0.03883363,0.92918885],"study_design_scores_gemma":[0.0011195887,0.00045713375,0.14141549,0.00046898556,0.000058668582,0.00014230801,0.0040339716,0.000005766023,0.00017071785,0.0046365876,0.8474049,0.00008588164],"about_ca_topic_score_codex":0.0027190172,"about_ca_topic_score_gemma":0.0043107714,"teacher_disagreement_score":0.92910296,"about_ca_system_score_codex":0.0006576339,"about_ca_system_score_gemma":0.0035304218,"threshold_uncertainty_score":0.6262817},"labels":[],"label_agreement":null},{"id":"W4412973990","doi":"10.51731/cjht.2025.1184","title":"Dupilumab (Dupixent)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dupilumab; Psychology; Dermatology; Medicine; Atopic dermatitis","score_opus":0.01494595144243069,"score_gpt":0.30183851782731863,"score_spread":0.2868925663848879,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412973990","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.27849132,0.38301793,0.000471848,0.32612142,0.0012994164,0.00037570414,0.000013854331,0.00022860536,0.009979896],"genre_scores_gemma":[0.996232,0.0004075254,0.00026337366,0.0027138758,0.000004392341,0.000002407087,0.0000013197998,0.0000044785043,0.0003706585],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991205,0.000028897206,0.00039668198,0.000078774756,0.000069619105,0.00030555693],"domain_scores_gemma":[0.9993848,0.00004148663,0.00015638657,0.00020045802,0.0001286945,0.00008813931],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022243951,0.000077614546,0.00033623294,0.00077756046,0.00017209168,0.000011793665,0.00018374922,0.00013014761,0.000040797673],"category_scores_gemma":[0.0008062751,0.000063646694,0.00007972389,0.0003074015,0.00024490245,0.000048733953,0.000011797897,0.0003359311,0.000011370523],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059262005,0.000046916542,0.18857318,0.00035170474,0.0001371825,0.0012211156,0.000088069326,0.000002244729,0.000010611336,0.006163537,0.3558499,0.4474963],"study_design_scores_gemma":[0.0012380296,0.00020798498,0.18147156,0.000879079,0.000058848316,0.0015009968,0.002356596,0.0000060942743,0.00055075594,0.014819801,0.79681104,0.00009921492],"about_ca_topic_score_codex":0.00047250403,"about_ca_topic_score_gemma":0.00070185243,"teacher_disagreement_score":0.71774065,"about_ca_system_score_codex":0.00021025137,"about_ca_system_score_gemma":0.005429927,"threshold_uncertainty_score":0.9632457},"labels":[],"label_agreement":null},{"id":"W4413006781","doi":"10.51731/cjht.2025.1185","title":"Nivolumab","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Nivolumab; Computer science; Medicine; Internal medicine; Cancer; Immunotherapy","score_opus":0.017837409268314727,"score_gpt":0.3032496467341336,"score_spread":0.2854122374658189,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413006781","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20986685,0.43464628,0.0006964072,0.34752172,0.0014763774,0.0003752419,0.000009542309,0.00015582569,0.0052517736],"genre_scores_gemma":[0.9955683,0.0010401808,0.00041241726,0.0024079538,0.000005712865,0.0000015697299,5.485055e-7,0.000004486149,0.0005588808],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992629,0.00001512913,0.00035384583,0.00006245678,0.0000660502,0.00023956847],"domain_scores_gemma":[0.9995259,0.000017501367,0.00015002761,0.00016496546,0.000101019505,0.000040566087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034705523,0.00006207761,0.00024369425,0.0006592807,0.00012327064,0.000012834578,0.00014501739,0.00009256697,0.00003502332],"category_scores_gemma":[0.00018199344,0.000049896247,0.0000778288,0.000389813,0.00016707517,0.000035285604,0.0000058724445,0.00025372903,0.0000023642656],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007985959,0.0000081902335,0.005785979,0.00008265994,0.00006867276,0.00006486128,0.00005656628,3.0217907e-7,0.0001258801,0.000715892,0.03402064,0.9589905],"study_design_scores_gemma":[0.0012104932,0.00047112218,0.029660773,0.00064206717,0.000016289914,0.00029685404,0.0019512209,0.0000023245118,0.0013100072,0.0019159855,0.96246576,0.000057091802],"about_ca_topic_score_codex":0.003952862,"about_ca_topic_score_gemma":0.0026720995,"teacher_disagreement_score":0.9589334,"about_ca_system_score_codex":0.0004935394,"about_ca_system_score_gemma":0.0053537264,"threshold_uncertainty_score":0.9497281},"labels":[],"label_agreement":null},{"id":"W4413041529","doi":"10.51731/cjht.2025.1186","title":"Dupilumab (Dupixent)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Sinusitis and nasal conditions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Dupilumab; Nasal polyps; Chronic rhinosinusitis; Refractory (planetary science); Nasal administration; Internal medicine; Nose; Sinusitis; Dermatology; Surgery; Asthma; Immunology","score_opus":0.018571479739598322,"score_gpt":0.31258562199054946,"score_spread":0.2940141422509511,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413041529","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6725368,0.13404226,0.0009007589,0.18264079,0.0012909684,0.00040712816,0.00003202648,0.00020841898,0.00794085],"genre_scores_gemma":[0.99690485,0.00018911897,0.00043419347,0.0020031093,0.000008157507,0.0000022335948,0.0000021645617,0.000005105019,0.00045107817],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991977,0.000017753311,0.00036801765,0.000071533555,0.000077802135,0.00026718326],"domain_scores_gemma":[0.99940616,0.000031456326,0.00014462607,0.00017209233,0.00017066443,0.000075024145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025859312,0.00006778083,0.0002720302,0.000903652,0.00020140085,0.000016823824,0.00013695066,0.00009779844,0.000060592705],"category_scores_gemma":[0.00048577908,0.000057142868,0.00007287338,0.00043294253,0.00014432786,0.000048875347,0.000009567979,0.00034837957,0.000008703061],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031582866,0.000044933233,0.06541021,0.0002273701,0.000135146,0.0007907507,0.0001375723,0.0000026567839,0.00011786137,0.028483534,0.17588562,0.72873276],"study_design_scores_gemma":[0.0014371079,0.0007125218,0.31638083,0.001236579,0.00005386981,0.0010419611,0.0031823555,0.0000061805363,0.00079658953,0.007191679,0.66783845,0.000121892306],"about_ca_topic_score_codex":0.0016311534,"about_ca_topic_score_gemma":0.002212707,"teacher_disagreement_score":0.7286109,"about_ca_system_score_codex":0.00038406186,"about_ca_system_score_gemma":0.0047223414,"threshold_uncertainty_score":0.8377231},"labels":[],"label_agreement":null},{"id":"W4413057309","doi":"10.51731/cjht.2025.1169","title":"Technologies to Address Wait Times in the Emergency Department","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Emergency and Acute Care Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Triage; Vital signs; Emergency department; Medical emergency; Telemedicine; Medicine; Patient safety; Computer science; Health care; Nursing","score_opus":0.024786946572379835,"score_gpt":0.3290218648300725,"score_spread":0.30423491825769267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413057309","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12632553,0.28091708,0.000095140655,0.58499897,0.0010999767,0.0009870143,0.000029622333,0.00022197982,0.0053246636],"genre_scores_gemma":[0.9910852,0.007003096,0.00026719083,0.0014015489,0.000008633287,0.00004487802,0.000001779795,0.0000070048764,0.00018071439],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998435,0.000046819034,0.0006833469,0.00015700748,0.00016554355,0.00051225245],"domain_scores_gemma":[0.9991937,0.00004819095,0.00016754649,0.00035754486,0.00019251172,0.000040452003],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006590384,0.00015584483,0.0004375152,0.0011349723,0.00026002573,0.000011355358,0.00054761145,0.00013946157,0.00002552326],"category_scores_gemma":[0.0013371026,0.00009982211,0.00009699793,0.0012109296,0.00016377814,0.000053707354,0.000054234126,0.0005333366,0.0000065280274],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003791067,0.00006160451,0.044585742,0.00027723474,0.0001517234,0.0003843355,0.0011994544,0.0000084767125,0.00003563589,0.01602086,0.45511216,0.48212487],"study_design_scores_gemma":[0.00053128373,0.0008568288,0.0466459,0.0009836527,0.000055578315,0.00013972292,0.05514595,0.0000029882601,0.000908663,0.015899513,0.87863773,0.00019217221],"about_ca_topic_score_codex":0.0010983164,"about_ca_topic_score_gemma":0.009100943,"teacher_disagreement_score":0.8647596,"about_ca_system_score_codex":0.00029432634,"about_ca_system_score_gemma":0.0011743022,"threshold_uncertainty_score":0.507854},"labels":[],"label_agreement":null},{"id":"W4413118800","doi":"10.51731/cjht.2025.1187","title":"Crovalimab (Piasky)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.01764724544898367,"score_gpt":0.36121228104006936,"score_spread":0.3435650355910857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413118800","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14540508,0.2765523,0.0018442735,0.5525817,0.001685103,0.0007277357,0.000032025288,0.00024289846,0.02092883],"genre_scores_gemma":[0.99602395,0.00033936376,0.0011078047,0.0016431175,0.000005531096,0.000004295769,0.0000017598126,0.0000049348196,0.0008692205],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99933785,0.000011548541,0.00029477544,0.000066828885,0.00006203756,0.00022693406],"domain_scores_gemma":[0.99949807,0.000019434521,0.00012960748,0.00015256906,0.00014336767,0.000056955363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014953101,0.00006347889,0.00023233371,0.00060552947,0.00015647872,0.000015134464,0.000099895486,0.000066994915,0.00002078087],"category_scores_gemma":[0.00020456218,0.000048302238,0.000056713216,0.00032485818,0.00009709374,0.00004318711,0.000006032568,0.00019438493,0.000004252675],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014384912,0.00003027348,0.021057643,0.00014465126,0.00019683469,0.0002163537,0.0002209378,0.0000046074456,0.00001993401,0.008198774,0.036233764,0.9336618],"study_design_scores_gemma":[0.0014514107,0.00049784756,0.044159763,0.0006735635,0.00011446065,0.00030572538,0.0034668187,0.00000418775,0.0005866521,0.006694408,0.9419739,0.00007125323],"about_ca_topic_score_codex":0.003025308,"about_ca_topic_score_gemma":0.0017604375,"teacher_disagreement_score":0.9335906,"about_ca_system_score_codex":0.0006145155,"about_ca_system_score_gemma":0.0067581176,"threshold_uncertainty_score":0.99887264},"labels":[],"label_agreement":null},{"id":"W4413118804","doi":"10.51731/cjht.2025.1188","title":"Cipaglucosidase Alfa (Pombiliti) With Miglustat (Opfolda)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Enzyme Production and Characterization","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.0068652297927767865,"score_gpt":0.2434365113207348,"score_spread":0.236571281527958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413118804","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86446345,0.0425975,0.0056503443,0.08576478,0.00063123053,0.0002883737,0.000023636032,0.000055776505,0.0005249259],"genre_scores_gemma":[0.9973166,0.00049815717,0.00059175026,0.0011557686,0.000012058329,0.000004487241,0.0000141715045,0.000007605009,0.00039938997],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992818,0.00003099976,0.00026355853,0.00013530774,0.000057587746,0.00023073333],"domain_scores_gemma":[0.99936813,0.000004466263,0.00017566307,0.00022072754,0.00018290922,0.000048107122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022508907,0.000086755834,0.00014269984,0.00025773598,0.00014006783,0.000023576904,0.00018856551,0.00010865433,0.000009846023],"category_scores_gemma":[0.0001993767,0.000071983384,0.000033398836,0.00021212264,0.00013856606,0.000006933567,0.000014894241,0.00014949817,0.0000012292595],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003237444,0.00014951886,0.0468764,0.0006025079,0.0004017914,0.00011458913,0.00056853244,0.00022137452,0.11397254,0.0068678083,0.09166766,0.73823357],"study_design_scores_gemma":[0.00055406906,0.0006293985,0.0071388646,0.00014557605,0.000011900307,0.00012894801,0.0020161674,0.000004050972,0.13915415,0.0005692643,0.84949785,0.00014975705],"about_ca_topic_score_codex":0.00028249295,"about_ca_topic_score_gemma":0.0014033379,"teacher_disagreement_score":0.7578302,"about_ca_system_score_codex":0.00005816022,"about_ca_system_score_gemma":0.0016492243,"threshold_uncertainty_score":0.2935397},"labels":[],"label_agreement":null},{"id":"W4413127968","doi":"10.51731/cjht.2025.1189","title":"Quizartinib (Vanflyta)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.022377522746083685,"score_gpt":0.3158917955807999,"score_spread":0.2935142728347162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413127968","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4949171,0.20502599,0.000582465,0.28669783,0.0014238801,0.00075887196,0.000018002886,0.00032703124,0.010248834],"genre_scores_gemma":[0.99618435,0.00043674465,0.0010731259,0.0015103603,0.000008804011,0.000004150194,0.0000017610797,0.000009209353,0.00077147473],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998781,0.00002722116,0.00053286727,0.00011482738,0.00011633498,0.00042770393],"domain_scores_gemma":[0.9991564,0.000047417296,0.0002449104,0.00030395002,0.00014463035,0.00010265177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003767941,0.00011189013,0.00041417344,0.00084193115,0.00015234012,0.00001521443,0.00020412386,0.00013941027,0.000045967197],"category_scores_gemma":[0.00080248376,0.000091229245,0.00008735696,0.00045368637,0.00017313981,0.000054651187,0.000016679161,0.00042173144,0.00001584387],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003166573,0.00003251701,0.03418955,0.00021805971,0.00015455295,0.0005266087,0.00014871973,0.0000049801333,0.00005653462,0.0030559385,0.045745507,0.9158354],"study_design_scores_gemma":[0.00295113,0.000771727,0.04363069,0.0013657508,0.00007482749,0.0008650048,0.0025574125,0.000016784705,0.0022520071,0.0052561485,0.94012785,0.00013069512],"about_ca_topic_score_codex":0.0027053184,"about_ca_topic_score_gemma":0.0024348332,"teacher_disagreement_score":0.91570467,"about_ca_system_score_codex":0.0021439914,"about_ca_system_score_gemma":0.013436183,"threshold_uncertainty_score":0.99215674},"labels":[],"label_agreement":null},{"id":"W4413345437","doi":"10.51731/cjht.2025.1190","title":"Nivolumab","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.017837409268314727,"score_gpt":0.3032496467341336,"score_spread":0.2854122374658189,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413345437","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20986685,0.43464628,0.0006964072,0.34752172,0.0014763774,0.0003752419,0.000009542309,0.00015582569,0.0052517736],"genre_scores_gemma":[0.9955683,0.0010401808,0.00041241726,0.0024079538,0.000005712865,0.0000015697299,5.485055e-7,0.000004486149,0.0005588808],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992629,0.00001512913,0.00035384583,0.00006245678,0.0000660502,0.00023956847],"domain_scores_gemma":[0.9995259,0.000017501367,0.00015002761,0.00016496546,0.000101019505,0.000040566087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034705523,0.00006207761,0.00024369425,0.0006592807,0.00012327064,0.000012834578,0.00014501739,0.00009256697,0.00003502332],"category_scores_gemma":[0.00018199344,0.000049896247,0.0000778288,0.000389813,0.00016707517,0.000035285604,0.0000058724445,0.00025372903,0.0000023642656],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007985959,0.0000081902335,0.005785979,0.00008265994,0.00006867276,0.00006486128,0.00005656628,3.0217907e-7,0.0001258801,0.000715892,0.03402064,0.9589905],"study_design_scores_gemma":[0.0012104932,0.00047112218,0.029660773,0.00064206717,0.000016289914,0.00029685404,0.0019512209,0.0000023245118,0.0013100072,0.0019159855,0.96246576,0.000057091802],"about_ca_topic_score_codex":0.003952862,"about_ca_topic_score_gemma":0.0026720995,"teacher_disagreement_score":0.9589334,"about_ca_system_score_codex":0.0004935394,"about_ca_system_score_gemma":0.0053537264,"threshold_uncertainty_score":0.9497281},"labels":[],"label_agreement":null},{"id":"W4413412436","doi":"10.51731/cjht.2025.1197","title":"Daratumumab (Darzalex SC)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Daratumumab; Medicine; Internal medicine; Multiple myeloma; Lenalidomide","score_opus":0.035072396872024375,"score_gpt":0.354769225012068,"score_spread":0.31969682814004363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413412436","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.39484134,0.28771183,0.00081699615,0.29639366,0.0010658136,0.0011814749,0.000052332965,0.0002891547,0.017647378],"genre_scores_gemma":[0.99725825,0.0005725385,0.0009953217,0.00051288935,0.0000065949366,0.000004715018,0.0000029702198,0.000006756181,0.00063996954],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988507,0.00003348932,0.00038280303,0.000105739564,0.00015111954,0.00047616693],"domain_scores_gemma":[0.9992077,0.000041562856,0.0001367685,0.0002552089,0.00020192104,0.00015684539],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034622813,0.00009703788,0.00034910368,0.0010797587,0.00025440863,0.000024532606,0.00020609934,0.000108531895,0.000038583836],"category_scores_gemma":[0.0008727453,0.00007373232,0.000077838245,0.0004625019,0.00019680965,0.000058557645,0.00001844732,0.0004488134,0.000015561938],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005627479,0.000033011907,0.05171574,0.0001371157,0.00013007227,0.00083714415,0.000047400372,0.0000010030446,0.000029598823,0.0018576831,0.017594561,0.9275604],"study_design_scores_gemma":[0.0038737503,0.0013650857,0.23973586,0.0013737199,0.000044107055,0.00082322885,0.0021174313,0.000031989213,0.0020493928,0.0055905385,0.74285346,0.00014144518],"about_ca_topic_score_codex":0.003368817,"about_ca_topic_score_gemma":0.0032043068,"teacher_disagreement_score":0.92741895,"about_ca_system_score_codex":0.00063717633,"about_ca_system_score_gemma":0.006285821,"threshold_uncertainty_score":0.9993476},"labels":[],"label_agreement":null},{"id":"W4413429415","doi":"10.51731/cjht.2025.1198","title":"Trofinetide (Daybue)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Language, Linguistics, Cultural Analysis","field":"Arts and Humanities","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Environmental science","score_opus":0.02364859590659034,"score_gpt":0.2541799723220076,"score_spread":0.23053137641541727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413429415","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10686301,0.30535105,0.0015816321,0.42169282,0.01011855,0.00072702754,0.0002294887,0.0009314171,0.152505],"genre_scores_gemma":[0.99346584,0.00011916695,0.0002474647,0.0012232388,0.00007065993,0.0000018097434,0.0000027131452,0.0000063813072,0.004862754],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99889755,0.000033326483,0.0005327562,0.00009742164,0.000094103816,0.0003448312],"domain_scores_gemma":[0.9990921,0.000043705004,0.0002948067,0.00018149112,0.00033605783,0.000051825773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032103618,0.00011085912,0.00033344596,0.0006764354,0.00044674514,0.00012319452,0.00041259482,0.00006027957,0.00031423417],"category_scores_gemma":[0.0010146763,0.00007891275,0.00010987322,0.00013685085,0.00034421682,0.000070905066,0.000018318431,0.0003091008,0.000018367069],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000050528824,0.000012406741,0.0010865689,0.000107761516,0.00015610064,0.00013140068,0.005657147,0.000013948636,0.0000068574004,0.6957853,0.08389401,0.21314348],"study_design_scores_gemma":[0.00013436991,0.00006746519,0.00033908253,0.00014300947,0.000029552657,0.000010735042,0.021103853,0.0000066886637,0.00006607192,0.036343403,0.94166374,0.00009200781],"about_ca_topic_score_codex":0.023087436,"about_ca_topic_score_gemma":0.1048082,"teacher_disagreement_score":0.8866028,"about_ca_system_score_codex":0.00024630182,"about_ca_system_score_gemma":0.0010089511,"threshold_uncertainty_score":0.9834179},"labels":[],"label_agreement":null},{"id":"W4413684499","doi":"10.51731/cjht.2025.1204","title":"Ruxolitinib (Opzelura)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ruxolitinib; Computer science; Medicine; Internal medicine; Myelofibrosis; Bone marrow","score_opus":0.022036681065779235,"score_gpt":0.32141706921339325,"score_spread":0.29938038814761403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413684499","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.32978648,0.12349658,0.00033469166,0.534721,0.00086939003,0.0007084862,0.00002894005,0.00016384569,0.009890573],"genre_scores_gemma":[0.9951569,0.0009333462,0.0010343102,0.0024105096,0.000010255925,0.0000121915145,0.0000024570277,0.000007133806,0.00043293694],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99888647,0.000034138808,0.00048408433,0.00011469822,0.00010755739,0.00037307778],"domain_scores_gemma":[0.9991974,0.00007186558,0.0002021726,0.0002095,0.00020982893,0.000109193505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033136632,0.000116494004,0.00044329368,0.0007216039,0.00019234569,0.000022402464,0.00013680974,0.000114428476,0.000048815084],"category_scores_gemma":[0.00057766424,0.00008713464,0.00009286518,0.00033244299,0.00014679323,0.000052413117,0.0000117615455,0.00033360397,0.000011382763],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033794127,0.000081274346,0.17882514,0.00021643723,0.00021167772,0.00053237623,0.000166315,0.0000028807137,0.000017323875,0.03531114,0.05199786,0.7326038],"study_design_scores_gemma":[0.001819708,0.0011133272,0.16638508,0.0012772323,0.0000681083,0.00055690715,0.002734528,0.0000063190614,0.0035389012,0.009326371,0.8130457,0.00012784115],"about_ca_topic_score_codex":0.00145734,"about_ca_topic_score_gemma":0.0017756864,"teacher_disagreement_score":0.7610478,"about_ca_system_score_codex":0.000510549,"about_ca_system_score_gemma":0.0046444917,"threshold_uncertainty_score":0.8239129},"labels":[],"label_agreement":null},{"id":"W4413684526","doi":"10.51731/cjht.2025.1205","title":"Pemigatinib (Pemazyre)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.03601682565298907,"score_gpt":0.3585972738525122,"score_spread":0.32258044819952314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413684526","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5082622,0.15914978,0.0007177377,0.32056275,0.0006880754,0.0009265955,0.000032735075,0.00021872918,0.009441411],"genre_scores_gemma":[0.99681246,0.00045529363,0.0015385858,0.0006335745,0.00000586368,0.000004959602,0.000002367434,0.0000058692476,0.0005410034],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99894613,0.00003233477,0.00038345705,0.000090887,0.00013342974,0.0004137424],"domain_scores_gemma":[0.99925447,0.000057008736,0.0001415822,0.00021684906,0.00018973558,0.00014034745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038051401,0.000084691885,0.0003235747,0.00083741866,0.00016654491,0.000018237737,0.00017541165,0.000096090014,0.000038564518],"category_scores_gemma":[0.0011751584,0.00006365301,0.000073584044,0.00039239778,0.00017079414,0.00004490332,0.000014455672,0.0003945661,0.000012128962],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003554375,0.000025641368,0.08676213,0.00016494516,0.000107369575,0.000525122,0.00006347073,8.248557e-7,0.00003401282,0.0014895529,0.013145177,0.8976462],"study_design_scores_gemma":[0.004650006,0.0016330832,0.31651807,0.0020743313,0.000055814966,0.00094191014,0.004428106,0.000040563675,0.004027571,0.011803502,0.6536544,0.0001726652],"about_ca_topic_score_codex":0.003297409,"about_ca_topic_score_gemma":0.002172777,"teacher_disagreement_score":0.8974736,"about_ca_system_score_codex":0.00046200148,"about_ca_system_score_gemma":0.0058395597,"threshold_uncertainty_score":0.9997964},"labels":[],"label_agreement":null},{"id":"W4413745708","doi":"10.51731/cjht.2025.1210","title":"Durvalumab (Imfinzi)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Durvalumab; Medicine; Immunology; Immune system","score_opus":0.020596970468108097,"score_gpt":0.31009797314778254,"score_spread":0.28950100267967444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413745708","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22531915,0.39269194,0.00059298094,0.3738513,0.0016995159,0.00045509794,0.000013837761,0.00017929492,0.005196881],"genre_scores_gemma":[0.994768,0.0013454988,0.00044543965,0.002888781,0.000007745305,0.000002363712,8.4714856e-7,0.0000059968534,0.0005352877],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99908173,0.000022517836,0.00043876996,0.000078966135,0.00008767438,0.0002903186],"domain_scores_gemma":[0.99941146,0.000025133799,0.00018693897,0.00020274588,0.00012258918,0.00005112155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049150846,0.00007943733,0.00029911203,0.00075280684,0.00014876139,0.000016316018,0.00017778501,0.0001136128,0.0000463355],"category_scores_gemma":[0.00026353463,0.00006341475,0.000097351265,0.00045852887,0.00020003773,0.000042187054,0.000007812162,0.00030873262,0.000003325551],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011371474,0.000012192795,0.0075268773,0.00011772961,0.000100666664,0.00009596291,0.000079240956,5.982445e-7,0.0001664347,0.0010052852,0.03553923,0.9552421],"study_design_scores_gemma":[0.0014232778,0.00050262694,0.046557654,0.00075650366,0.000022550916,0.0003701732,0.002001002,0.000003049937,0.0014534462,0.0022706876,0.9445645,0.00007451022],"about_ca_topic_score_codex":0.003637112,"about_ca_topic_score_gemma":0.002622017,"teacher_disagreement_score":0.95516753,"about_ca_system_score_codex":0.00056202,"about_ca_system_score_gemma":0.0060324734,"threshold_uncertainty_score":0.9996024},"labels":[],"label_agreement":null},{"id":"W4413753339","doi":"10.51731/cjht.2025.1209","title":"Portable CT for Use in the Hospital","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Advanced X-ray and CT Imaging","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Medical physics","score_opus":0.01357242150678052,"score_gpt":0.25108548720778257,"score_spread":0.23751306570100206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413753339","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6649974,0.18077631,0.074679546,0.07373469,0.0028508287,0.0012646052,0.00006338349,0.00048506344,0.0011481744],"genre_scores_gemma":[0.9974999,0.00023442625,0.0019258742,0.0002985076,0.0000042741167,0.000009910254,6.297125e-7,0.0000062930476,0.000020200858],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99935126,0.000008288742,0.00025846498,0.000046090605,0.000036594858,0.00029929116],"domain_scores_gemma":[0.9996967,0.000074920616,0.000054026266,0.00012489362,0.00003163418,0.000017824279],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002905524,0.00006460231,0.00014378874,0.00032970423,0.000100246885,0.00003336889,0.0002608588,0.000028898517,0.0000011559134],"category_scores_gemma":[0.00023469231,0.000049742797,0.000032706655,0.00026880152,0.000046713725,0.00016843619,0.0000040558843,0.00027687152,3.87973e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000045001857,0.00001482111,0.02258849,0.00027073617,0.000041547446,0.00022682724,0.0005904821,0.009166042,0.00001506723,0.013206496,0.032072812,0.92180216],"study_design_scores_gemma":[0.00064162264,0.00016916334,0.014382422,0.00051264453,0.000011515629,0.000112345675,0.016250165,0.0011194388,0.00055196474,0.034387823,0.9316343,0.00022656466],"about_ca_topic_score_codex":0.00069527724,"about_ca_topic_score_gemma":0.0040161298,"teacher_disagreement_score":0.9215756,"about_ca_system_score_codex":0.00017007785,"about_ca_system_score_gemma":0.00038039056,"threshold_uncertainty_score":0.22410949},"labels":[],"label_agreement":null},{"id":"W4413927988","doi":"10.51731/cjht.2025.1211","title":"Relugolix–Estradiol–Norethindrone Acetate (Myfembree)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chemistry; Environmental chemistry; Chromatography","score_opus":0.029234205271672614,"score_gpt":0.34878129655109763,"score_spread":0.31954709127942504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413927988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.47980642,0.19422352,0.00018810766,0.31736922,0.0014193031,0.0005585409,0.000022035068,0.00019301969,0.0062198304],"genre_scores_gemma":[0.99352825,0.0021434915,0.0005940578,0.0024131434,0.000019825424,0.0000063630705,0.0000032174812,0.000010160013,0.0012814961],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99877876,0.0000426059,0.00050773454,0.00013043177,0.000094201314,0.00044629123],"domain_scores_gemma":[0.999243,0.00005362032,0.00025080267,0.00021316185,0.0001144219,0.00012498451],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038741573,0.00013249602,0.0004973613,0.0008717956,0.00017689278,0.000015124492,0.00021343266,0.00017540008,0.00006647209],"category_scores_gemma":[0.00017020665,0.00010949448,0.00010258501,0.00044329846,0.0002743007,0.00006238996,0.000013459866,0.0006281636,0.0000075654793],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019176256,0.000089306726,0.027617676,0.00040511225,0.00048580253,0.0014596282,0.0005328215,0.0000137353745,0.0006411563,0.004708093,0.13162753,0.8322274],"study_design_scores_gemma":[0.004171786,0.0019818987,0.055613663,0.0008932933,0.00022289949,0.0018248151,0.0018144052,0.000015696934,0.004683284,0.011492873,0.9170811,0.00020428636],"about_ca_topic_score_codex":0.0034564328,"about_ca_topic_score_gemma":0.002961941,"teacher_disagreement_score":0.8320231,"about_ca_system_score_codex":0.00075961417,"about_ca_system_score_gemma":0.0065272795,"threshold_uncertainty_score":0.9991048},"labels":[],"label_agreement":null},{"id":"W4413952869","doi":"10.51731/cjht.2025.1213","title":"Blinatumomab (Blincyto)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Research on Leishmaniasis Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Blinatumomab; Medicine; Internal medicine","score_opus":0.03682501354495821,"score_gpt":0.359285618137245,"score_spread":0.3224606045922868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413952869","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11976002,0.2868912,0.00041877298,0.58256936,0.0006832912,0.0005283721,0.000012041001,0.00019374056,0.008943182],"genre_scores_gemma":[0.9951521,0.0019452176,0.0009188801,0.0012104141,0.000010320133,0.000005466899,7.8822006e-7,0.000008807709,0.0007480127],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985508,0.00004468052,0.00054843904,0.000121912715,0.00019975337,0.0005344243],"domain_scores_gemma":[0.9988584,0.00007920271,0.00019980296,0.00028956332,0.00046458392,0.00010847395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083683175,0.000108662985,0.00048850017,0.001796157,0.00027655484,0.000027899543,0.00031602915,0.00012392859,0.00002238616],"category_scores_gemma":[0.0028022067,0.00008568467,0.00009727267,0.00082386076,0.000343558,0.00007639029,0.000037702022,0.0007258232,0.000010811249],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046082576,0.000039314466,0.04269292,0.00039977834,0.0001790769,0.00075167255,0.0001562965,0.0000015337902,0.000057870348,0.00920176,0.12580206,0.8206716],"study_design_scores_gemma":[0.0014993711,0.0010469372,0.13253473,0.0012490299,0.000035977624,0.0005911101,0.005865812,0.000010467345,0.0014041605,0.011900837,0.84373146,0.00013009187],"about_ca_topic_score_codex":0.0022603455,"about_ca_topic_score_gemma":0.0036183102,"teacher_disagreement_score":0.8753921,"about_ca_system_score_codex":0.0007161276,"about_ca_system_score_gemma":0.007712857,"threshold_uncertainty_score":0.99791247},"labels":[],"label_agreement":null},{"id":"W4413952983","doi":"10.51731/cjht.2025.1212","title":"Risperidone (Longavo)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Risperidone; Psychology; Psychiatry; Schizophrenia (object-oriented programming)","score_opus":0.025301566400228324,"score_gpt":0.3330000398480029,"score_spread":0.30769847344777457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413952983","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.43418106,0.21140084,0.00033725222,0.35125124,0.0005177667,0.00042915522,0.000012574598,0.00012628417,0.0017438419],"genre_scores_gemma":[0.9962481,0.0008411749,0.0020460084,0.00054873416,0.000007860964,0.000004660247,0.0000013607414,0.0000054256957,0.00029662182],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99905896,0.00002679426,0.0003258021,0.00008689937,0.00012207731,0.0003794941],"domain_scores_gemma":[0.9993425,0.000039176906,0.00010706934,0.00021955575,0.00015806945,0.00013360291],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033344387,0.000080808044,0.00030815482,0.00092262396,0.00016351315,0.00001863807,0.0001605706,0.00008552648,0.00003691207],"category_scores_gemma":[0.0006575973,0.000059640523,0.00007464464,0.00042573156,0.00016923365,0.000039842358,0.00001354529,0.00040316896,0.0000126716495],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027078803,0.000032732023,0.024603598,0.000103571256,0.00013084286,0.0007785097,0.00004353493,9.419358e-7,0.00002247243,0.0068762866,0.01765975,0.94947696],"study_design_scores_gemma":[0.008388076,0.0031620513,0.38272202,0.0019830754,0.00010354359,0.0019070845,0.0050891927,0.000024298257,0.005738535,0.038808383,0.55183274,0.00024097154],"about_ca_topic_score_codex":0.0028800264,"about_ca_topic_score_gemma":0.005764699,"teacher_disagreement_score":0.949236,"about_ca_system_score_codex":0.0005608856,"about_ca_system_score_gemma":0.008198429,"threshold_uncertainty_score":0.9974242},"labels":[],"label_agreement":null},{"id":"W4413986548","doi":"10.51731/cjht.2025.1214","title":"CT and MRI Services in Urban, Rural, and Remote Settings: 24-Hour and Weekend Operations","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Radiology practices and education","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Geography; Computer science; Medical emergency; Optometry; Medicine","score_opus":0.014142590530189831,"score_gpt":0.30925975100834924,"score_spread":0.2951171604781594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413986548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.70647967,0.090515465,0.000011875873,0.20265484,0.0001269681,0.000117865166,0.0000022474255,0.000013638372,0.00007742491],"genre_scores_gemma":[0.9841115,0.012143659,0.0016809849,0.0019498849,0.000010867177,0.0000012458052,0.0000016892626,0.0000041983126,0.000095982134],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99933356,0.000037995087,0.00029409488,0.00009653289,0.000034241195,0.0002035897],"domain_scores_gemma":[0.9995903,0.00006145263,0.00011919995,0.00009941509,0.000055751043,0.00007390395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048723578,0.00007252314,0.00023600995,0.00054166315,0.00019101685,0.000040927942,0.000058902922,0.00006600599,0.0000025499062],"category_scores_gemma":[0.0002668228,0.000061002673,0.000009712915,0.00018673595,0.0001474049,0.00016508314,0.000013681029,0.00035681674,2.6401347e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003458061,0.000018886647,0.27435142,0.0007716237,0.00007067223,0.00015255962,0.0022929802,0.000009768358,0.00009003887,0.0009744817,0.00957099,0.711662],"study_design_scores_gemma":[0.001682943,0.0007659532,0.5505624,0.0027665552,0.00009178875,0.00451376,0.0809419,0.00081673806,0.00010923462,0.003462723,0.35408646,0.00019955571],"about_ca_topic_score_codex":0.009731936,"about_ca_topic_score_gemma":0.015457258,"teacher_disagreement_score":0.71146244,"about_ca_system_score_codex":0.000103979495,"about_ca_system_score_gemma":0.00091356516,"threshold_uncertainty_score":0.99686235},"labels":[],"label_agreement":null},{"id":"W4414016490","doi":"10.51731/cjht.2025.1215","title":"Ruxolitinib (Opzelura)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ruxolitinib; Medicine; Internal medicine; Myelofibrosis","score_opus":0.022036681065779235,"score_gpt":0.32141706921339325,"score_spread":0.29938038814761403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414016490","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.32978648,0.12349658,0.00033469166,0.534721,0.00086939003,0.0007084862,0.00002894005,0.00016384569,0.009890573],"genre_scores_gemma":[0.9951569,0.0009333462,0.0010343102,0.0024105096,0.000010255925,0.0000121915145,0.0000024570277,0.000007133806,0.00043293694],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99888647,0.000034138808,0.00048408433,0.00011469822,0.00010755739,0.00037307778],"domain_scores_gemma":[0.9991974,0.00007186558,0.0002021726,0.0002095,0.00020982893,0.000109193505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033136632,0.000116494004,0.00044329368,0.0007216039,0.00019234569,0.000022402464,0.00013680974,0.000114428476,0.000048815084],"category_scores_gemma":[0.00057766424,0.00008713464,0.00009286518,0.00033244299,0.00014679323,0.000052413117,0.0000117615455,0.00033360397,0.000011382763],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033794127,0.000081274346,0.17882514,0.00021643723,0.00021167772,0.00053237623,0.000166315,0.0000028807137,0.000017323875,0.03531114,0.05199786,0.7326038],"study_design_scores_gemma":[0.001819708,0.0011133272,0.16638508,0.0012772323,0.0000681083,0.00055690715,0.002734528,0.0000063190614,0.0035389012,0.009326371,0.8130457,0.00012784115],"about_ca_topic_score_codex":0.00145734,"about_ca_topic_score_gemma":0.0017756864,"teacher_disagreement_score":0.7610478,"about_ca_system_score_codex":0.000510549,"about_ca_system_score_gemma":0.0046444917,"threshold_uncertainty_score":0.8239129},"labels":[],"label_agreement":null},{"id":"W4414036123","doi":"10.51731/cjht.2025.1216","title":"Pembrolizumab (Keytruda)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.02653310924636881,"score_gpt":0.32487161992958985,"score_spread":0.29833851068322104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414036123","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2940161,0.36743745,0.00063131383,0.3160025,0.001981275,0.000672593,0.00002403628,0.000245412,0.018989341],"genre_scores_gemma":[0.9967309,0.00072018517,0.0003767673,0.0017318411,0.000011431034,0.0000037367167,0.0000011822133,0.000005529466,0.0004184201],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99905485,0.000021457152,0.0004019117,0.00008938431,0.0001135914,0.00031882484],"domain_scores_gemma":[0.99937594,0.00004446178,0.00015959331,0.00017817796,0.00014283652,0.00009898789],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022387317,0.000087447,0.00038791428,0.0009401314,0.00012988852,0.0000138439,0.00016301284,0.00010690741,0.00005756477],"category_scores_gemma":[0.00059056113,0.00006464602,0.00009410382,0.00071201974,0.00011605474,0.000040924995,0.00001187188,0.0003146678,0.0000075569014],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009998602,0.000027825143,0.021877484,0.00015510654,0.00010634179,0.00021200333,0.000042979525,0.000001062229,0.000013319939,0.0042474354,0.0071633495,0.9660531],"study_design_scores_gemma":[0.006121616,0.0019146743,0.09631134,0.001057765,0.00010754857,0.00052843353,0.0020169995,0.0000033994188,0.0016869934,0.019565728,0.8705409,0.00014458588],"about_ca_topic_score_codex":0.003080019,"about_ca_topic_score_gemma":0.0013586769,"teacher_disagreement_score":0.9659085,"about_ca_system_score_codex":0.0006297923,"about_ca_system_score_gemma":0.004120736,"threshold_uncertainty_score":0.73100084},"labels":[],"label_agreement":null},{"id":"W4414089718","doi":"10.51731/cjht.2025.1220","title":"Guselkumab (Tremfya)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Drug; Crohn disease; Public health; Disease; Crohn's disease","score_opus":0.01239833022196209,"score_gpt":0.28669265546221623,"score_spread":0.27429432524025416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414089718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6109658,0.27619064,0.0011173643,0.107426375,0.0012418871,0.00046136105,0.00005603365,0.00010809814,0.0024324767],"genre_scores_gemma":[0.9951084,0.0022197068,0.0007282728,0.0014559955,0.000012551925,0.000011551674,0.0000064767833,0.000012322877,0.00044469468],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99886036,0.00004773655,0.00042758,0.00017255679,0.00007646455,0.00041530386],"domain_scores_gemma":[0.99914974,0.000022073866,0.00026341373,0.00036464375,0.00012770577,0.00007244183],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027287976,0.00014702817,0.00028295306,0.00044267462,0.00020298874,0.000028993396,0.00046306534,0.00021033257,0.000011728905],"category_scores_gemma":[0.0005661609,0.00012926622,0.00011481449,0.00024614093,0.0001836359,0.000005667924,0.000044895056,0.00019860426,0.0000065232716],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003475547,0.000086180655,0.12876087,0.00012427979,0.00046494324,0.000116310286,0.000107280866,0.000041815707,0.0024256578,0.0036169589,0.15999489,0.7042261],"study_design_scores_gemma":[0.0009315481,0.000626195,0.026763782,0.00019245489,0.000038236005,0.00010345289,0.0020798221,0.0000015938919,0.041252438,0.0020202552,0.9257641,0.0002261476],"about_ca_topic_score_codex":0.001395852,"about_ca_topic_score_gemma":0.004879092,"teacher_disagreement_score":0.7657692,"about_ca_system_score_codex":0.00022398957,"about_ca_system_score_gemma":0.0025465726,"threshold_uncertainty_score":0.52713233},"labels":[],"label_agreement":null},{"id":"W4414125020","doi":"10.51731/cjht.2025.1221","title":"Trabectedin","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Trabectedin; Reimbursement; Doxorubicin; Drug; Clinical Practice; Soft tissue sarcoma","score_opus":0.02697847165995515,"score_gpt":0.314905090837416,"score_spread":0.2879266191774609,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414125020","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.41558763,0.2820306,0.000121099605,0.2990059,0.0005394891,0.00029010256,0.000007310855,0.000108943845,0.0023089102],"genre_scores_gemma":[0.9971906,0.00079927297,0.000580609,0.001315996,0.0000047025906,0.000004645425,8.2562684e-7,0.0000042819506,0.00009909068],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992863,0.000015245935,0.0003193249,0.00006846237,0.000066339184,0.00024435946],"domain_scores_gemma":[0.9995266,0.000040084018,0.000119638695,0.00014842635,0.000101662576,0.00006356897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019722868,0.0000691645,0.00028627654,0.00067640404,0.00010437246,0.000011676019,0.000104256505,0.00008058837,0.000022041275],"category_scores_gemma":[0.00032590298,0.000051522093,0.000070121314,0.00033290827,0.00008710239,0.00002694511,0.000005557997,0.00022072274,0.000004390459],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007125347,0.000036811605,0.12239644,0.00004991461,0.000055560053,0.00033639424,0.000045675624,5.587471e-7,0.0000071971212,0.0025541673,0.020451784,0.8540584],"study_design_scores_gemma":[0.0013341885,0.0005391872,0.41489586,0.0009049169,0.00006246677,0.00056053454,0.002137733,0.0000032951218,0.0013131176,0.0053984164,0.5727735,0.00007675284],"about_ca_topic_score_codex":0.0021286726,"about_ca_topic_score_gemma":0.002011373,"teacher_disagreement_score":0.8539816,"about_ca_system_score_codex":0.0004228646,"about_ca_system_score_gemma":0.003069537,"threshold_uncertainty_score":0.5445227},"labels":[],"label_agreement":null},{"id":"W4414239951","doi":"10.51731/cjht.2025.1224","title":"Osimertinib (Tagrisso)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lung cancer; Osimertinib; Exon; Disease; Cancer; Drug; T790M","score_opus":0.01814201831550905,"score_gpt":0.3576238266743232,"score_spread":0.33948180835881414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414239951","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14767139,0.28625324,0.00135293,0.5477888,0.0015582574,0.0007328761,0.00002798599,0.00023229863,0.014382207],"genre_scores_gemma":[0.9966142,0.00031398097,0.0007528948,0.001556934,0.0000057427005,0.000004463884,0.00000184101,0.000004640918,0.00074527966],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99931765,0.000011987698,0.00031594533,0.00006665374,0.000060904473,0.0002268805],"domain_scores_gemma":[0.9994958,0.000022276192,0.00014336355,0.00014436967,0.00013158661,0.000062586165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015051341,0.00006382156,0.00023081018,0.00053791626,0.0001512012,0.000011746095,0.000098066615,0.00006923903,0.000024539002],"category_scores_gemma":[0.00023544283,0.00004751668,0.000054887678,0.00031286283,0.00008687081,0.00003953772,0.00000573927,0.00020212683,0.0000050165236],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013414335,0.000027317745,0.03618459,0.000104165134,0.00018439708,0.00013731977,0.0002030037,0.0000044242506,0.000025575842,0.0044950563,0.038123697,0.92049706],"study_design_scores_gemma":[0.001207336,0.0004598329,0.08380111,0.00067045284,0.00011427583,0.000203355,0.0031785995,0.00000484857,0.0008758899,0.004906878,0.90450543,0.000071994036],"about_ca_topic_score_codex":0.0031275954,"about_ca_topic_score_gemma":0.0011803573,"teacher_disagreement_score":0.92042506,"about_ca_system_score_codex":0.0004743897,"about_ca_system_score_gemma":0.0054113334,"threshold_uncertainty_score":0.9599473},"labels":[],"label_agreement":null},{"id":"W4414240310","doi":"10.51731/cjht.2025.1223","title":"Abemaciclib (Verzenio)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Fulvestrant; Metastatic breast cancer; Breast cancer; Crizotinib; Cancer; Population; Drug; Chemotherapy","score_opus":0.016496647619343496,"score_gpt":0.3269568899253435,"score_spread":0.310460242306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414240310","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12795791,0.4636574,0.0074591762,0.3940198,0.0017579932,0.00063973357,0.000022099617,0.00042678817,0.004059053],"genre_scores_gemma":[0.99405897,0.00037936613,0.002592132,0.0025298425,0.000011537714,0.0000039583256,7.704302e-7,0.000010542638,0.0004128648],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989321,0.000020942773,0.0004509282,0.00010388173,0.00010431762,0.00038778034],"domain_scores_gemma":[0.99920183,0.00003493607,0.00023344156,0.00025499234,0.0001905836,0.000084216066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030162235,0.000105336345,0.0003969745,0.0008340875,0.00014908667,0.000013367962,0.00021908205,0.00010872307,0.000033674838],"category_scores_gemma":[0.00036846515,0.0000875104,0.0000772673,0.00048945664,0.00024571596,0.00008319933,0.000013396245,0.00043436498,0.000006045503],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039032348,0.000009874781,0.008006866,0.00012666942,0.00006464873,0.00012047795,0.00009726664,0.0000060024977,0.00009741568,0.0035743373,0.0028943222,0.98496306],"study_design_scores_gemma":[0.0012163002,0.00035162878,0.022428978,0.0009090069,0.00002591852,0.00069807743,0.0028233496,0.000004327627,0.002162296,0.017970031,0.9513083,0.00010179685],"about_ca_topic_score_codex":0.0009394843,"about_ca_topic_score_gemma":0.0009095156,"teacher_disagreement_score":0.9848613,"about_ca_system_score_codex":0.0006645732,"about_ca_system_score_gemma":0.0049113138,"threshold_uncertainty_score":0.871246},"labels":[],"label_agreement":null},{"id":"W4414258520","doi":"10.51731/cjht.2025.1222","title":"Pertuzumab","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Eosinophilic Disorders and Syndromes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pertuzumab; Reimbursement; Trastuzumab; Cancer; Breast cancer","score_opus":0.01588028164398096,"score_gpt":0.29660047442051346,"score_spread":0.2807201927765325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414258520","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24691507,0.27345377,0.00041581877,0.4651797,0.0007568096,0.0002942947,0.000005955441,0.00013044185,0.012848121],"genre_scores_gemma":[0.99633807,0.00065477623,0.0004428923,0.0019459979,0.000003339913,0.0000014643892,6.6479066e-7,0.0000048947713,0.00060792087],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99921185,0.000014592579,0.00035438375,0.00007235747,0.00007756104,0.00026927906],"domain_scores_gemma":[0.9994978,0.000022607659,0.00012135425,0.0001799499,0.000117213094,0.00006109822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002670354,0.000070696165,0.00032188263,0.0007360405,0.0001332945,0.000014577411,0.0001590576,0.00009702895,0.00003152109],"category_scores_gemma":[0.00046712699,0.000054765733,0.000069942405,0.00032030453,0.00015282338,0.000029638495,0.000009069883,0.0002862337,0.000004390009],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011021035,0.000017574239,0.017450487,0.00017611236,0.000059937654,0.0002220081,0.00014515473,0.0000011562647,0.000014139211,0.012046553,0.036840893,0.933015],"study_design_scores_gemma":[0.0010178328,0.00077427423,0.05428101,0.0009495644,0.000030818006,0.0009392129,0.006312283,0.000010272165,0.00015363564,0.026727917,0.9086998,0.00010336822],"about_ca_topic_score_codex":0.0016111988,"about_ca_topic_score_gemma":0.0010552178,"teacher_disagreement_score":0.9329116,"about_ca_system_score_codex":0.0002645569,"about_ca_system_score_gemma":0.0046906658,"threshold_uncertainty_score":0.83210397},"labels":[],"label_agreement":null},{"id":"W4414282985","doi":"10.51731/cjht.2025.1226","title":"Abemaciclib (Verzenio)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Metastatic breast cancer; Breast cancer; Drug; Chemotherapy; Aromatase; Cancer","score_opus":0.016496647619343496,"score_gpt":0.3269568899253435,"score_spread":0.310460242306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414282985","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12795791,0.4636574,0.0074591762,0.3940198,0.0017579932,0.00063973357,0.000022099617,0.00042678817,0.004059053],"genre_scores_gemma":[0.99405897,0.00037936613,0.002592132,0.0025298425,0.000011537714,0.0000039583256,7.704302e-7,0.000010542638,0.0004128648],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989321,0.000020942773,0.0004509282,0.00010388173,0.00010431762,0.00038778034],"domain_scores_gemma":[0.99920183,0.00003493607,0.00023344156,0.00025499234,0.0001905836,0.000084216066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030162235,0.000105336345,0.0003969745,0.0008340875,0.00014908667,0.000013367962,0.00021908205,0.00010872307,0.000033674838],"category_scores_gemma":[0.00036846515,0.0000875104,0.0000772673,0.00048945664,0.00024571596,0.00008319933,0.000013396245,0.00043436498,0.000006045503],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039032348,0.000009874781,0.008006866,0.00012666942,0.00006464873,0.00012047795,0.00009726664,0.0000060024977,0.00009741568,0.0035743373,0.0028943222,0.98496306],"study_design_scores_gemma":[0.0012163002,0.00035162878,0.022428978,0.0009090069,0.00002591852,0.00069807743,0.0028233496,0.000004327627,0.002162296,0.017970031,0.9513083,0.00010179685],"about_ca_topic_score_codex":0.0009394843,"about_ca_topic_score_gemma":0.0009095156,"teacher_disagreement_score":0.9848613,"about_ca_system_score_codex":0.0006645732,"about_ca_system_score_gemma":0.0049113138,"threshold_uncertainty_score":0.871246},"labels":[],"label_agreement":null},{"id":"W4414283050","doi":"10.51731/cjht.2025.1225","title":"Amivantamab (Rybrevant)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Exon; Lung cancer; Pemetrexed; Carboplatin; Drug; Disease; Mutation; Epidermal growth factor receptor","score_opus":0.014489350832959812,"score_gpt":0.3545799191784978,"score_spread":0.34009056834553797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414283050","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12785241,0.30414283,0.0017891343,0.5482637,0.0016681826,0.000776892,0.000038100537,0.0002384648,0.015230263],"genre_scores_gemma":[0.99637985,0.0005739397,0.0009184953,0.0014174469,0.000005728756,0.0000037145032,0.0000019967931,0.0000051075217,0.000693738],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99931115,0.000012285025,0.00031101817,0.00006982679,0.00006396816,0.00023173493],"domain_scores_gemma":[0.99949664,0.0000228254,0.0001366163,0.00015550245,0.00012897988,0.000059459533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001427348,0.000067357614,0.00024835736,0.00060566596,0.00014998567,0.00001339147,0.00010424254,0.00006524356,0.000019924422],"category_scores_gemma":[0.00020235743,0.000050709816,0.00005675093,0.00030438375,0.000096159405,0.000044333945,0.000006487149,0.0002058683,0.0000052416963],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014044346,0.00002645069,0.02375067,0.00015309785,0.00017719845,0.00023113529,0.00017751881,0.0000034324191,0.000022877888,0.0052051228,0.040594306,0.92964417],"study_design_scores_gemma":[0.0014713855,0.0005208782,0.054498825,0.0008915771,0.00012275006,0.0003971545,0.0037379314,0.0000051326433,0.00054804777,0.0067270286,0.93100303,0.00007625271],"about_ca_topic_score_codex":0.0021817603,"about_ca_topic_score_gemma":0.0017467036,"teacher_disagreement_score":0.9295679,"about_ca_system_score_codex":0.0006417844,"about_ca_system_score_gemma":0.0061325193,"threshold_uncertainty_score":0.99950176},"labels":[],"label_agreement":null},{"id":"W4414327544","doi":"10.51731/cjht.2025.1227","title":"Antihemophilic Factor VIII (Recombinant, B-Domain Deleted), Fc-VWF-XTEN Fusion Protein (Altuviiio)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Drug; Perioperative; Hemostasis; Clinical Practice","score_opus":0.028186656899974665,"score_gpt":0.31714906017491484,"score_spread":0.28896240327494016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414327544","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8288707,0.027030744,0.000065885164,0.14142554,0.00038593417,0.0010466775,0.000023480474,0.00013654397,0.0010144914],"genre_scores_gemma":[0.9961163,0.0010692133,0.0008194939,0.0004891512,0.000020343712,0.000019324096,0.000009006416,0.00002275849,0.0014344204],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99760216,0.000106808875,0.00079667417,0.00026221498,0.0003194075,0.000912732],"domain_scores_gemma":[0.9986016,0.000060465776,0.0002987715,0.0004506706,0.00031414969,0.0002743032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066626846,0.0002393882,0.0007306009,0.0018338971,0.0005177571,0.000042362026,0.0004314602,0.00033604912,0.000080963626],"category_scores_gemma":[0.00066661456,0.0001777944,0.00018035418,0.0009602232,0.00034533202,0.00011492743,0.000056800905,0.0009592034,0.000032894597],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018794762,0.0001812046,0.02990871,0.0007557784,0.0002220523,0.0014951231,0.00039038286,8.0283104e-7,0.00309636,0.0027184803,0.008107925,0.9529352],"study_design_scores_gemma":[0.008640132,0.0071969996,0.09034667,0.006653158,0.00010050774,0.0013568322,0.007096228,0.000045512297,0.019192863,0.02044124,0.83821267,0.0007171659],"about_ca_topic_score_codex":0.0028968945,"about_ca_topic_score_gemma":0.0036303354,"teacher_disagreement_score":0.95221806,"about_ca_system_score_codex":0.0008911194,"about_ca_system_score_gemma":0.008031665,"threshold_uncertainty_score":0.99759185},"labels":[],"label_agreement":null},{"id":"W4414351418","doi":"10.51731/cjht.2025.1228","title":"Isatuximab (Sarclisa)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Sanofi","keywords":"Reimbursement; Drug approval; Drug; MEDLINE","score_opus":0.01793494157968234,"score_gpt":0.3010390455350337,"score_spread":0.28310410395535135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414351418","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16168383,0.15246096,0.0015259206,0.6680043,0.0016702904,0.00041770496,0.000018612822,0.00025609296,0.013962324],"genre_scores_gemma":[0.9966202,0.000462008,0.00065092294,0.0016787087,0.0000069413272,0.0000019934441,0.0000017470123,0.0000052242594,0.00057229795],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99917203,0.000019492783,0.00037342467,0.00007136686,0.00007273834,0.00029092503],"domain_scores_gemma":[0.99938756,0.000033057924,0.0001719657,0.00018312296,0.000143788,0.00008051072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001969886,0.000067904766,0.00026652557,0.0008785551,0.0001894556,0.000014072131,0.00014186632,0.00016049853,0.000038640286],"category_scores_gemma":[0.0004492975,0.00005326826,0.00007410416,0.00044405158,0.00021446816,0.00004141377,0.000008814629,0.0005476546,0.000010861529],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003642518,0.000082525854,0.0209743,0.00015621475,0.00078302936,0.0008310691,0.00038041658,0.00000817315,0.0002729886,0.07669815,0.122403204,0.7773735],"study_design_scores_gemma":[0.0025877443,0.0008686451,0.05960035,0.0015613587,0.0004216102,0.0015814888,0.0065173116,0.00003109976,0.0014049693,0.060653884,0.8645897,0.00018186639],"about_ca_topic_score_codex":0.00078872126,"about_ca_topic_score_gemma":0.0005033325,"teacher_disagreement_score":0.8349363,"about_ca_system_score_codex":0.00028622206,"about_ca_system_score_gemma":0.005061638,"threshold_uncertainty_score":0.8979128},"labels":[],"label_agreement":null},{"id":"W4414565348","doi":"10.51731/cjht.2025.1232","title":"Mirikizumab (Omvoh)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Drug; Public health; Disease; Pharmacotherapy","score_opus":0.010457072088659793,"score_gpt":0.2574572150895341,"score_spread":0.24700014300087433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414565348","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7263254,0.21424712,0.0049952054,0.04363326,0.0019586158,0.00032523708,0.000037716916,0.000068422494,0.00840905],"genre_scores_gemma":[0.9978394,0.00041335123,0.0005463101,0.0007324093,0.000013608332,0.0000025935435,0.0000042896277,0.0000058104897,0.00044226286],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992312,0.000030896677,0.00029878636,0.00010597315,0.00004740337,0.000285705],"domain_scores_gemma":[0.9994616,0.000006612962,0.00015246471,0.00023122985,0.000098394885,0.00004972567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027968566,0.00008265047,0.00016887262,0.00028634488,0.0001369211,0.000016671045,0.00032919078,0.00015538721,0.0000068187996],"category_scores_gemma":[0.0003081524,0.00007309176,0.00006186049,0.000145386,0.00011280687,0.0000026739642,0.000026564772,0.00016018812,0.0000033672527],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004820863,0.000021204123,0.004960842,0.000121689285,0.000096455435,0.0000837066,0.000067461195,0.000011420316,0.008599854,0.0090608625,0.13404904,0.84287924],"study_design_scores_gemma":[0.0002609115,0.0003229702,0.004110535,0.00007230993,0.0000049402906,0.000090338996,0.00059246615,0.0000012121377,0.025048941,0.0024424312,0.9669723,0.000080635764],"about_ca_topic_score_codex":0.00059113605,"about_ca_topic_score_gemma":0.002330655,"teacher_disagreement_score":0.8427986,"about_ca_system_score_codex":0.000064926375,"about_ca_system_score_gemma":0.0026762043,"threshold_uncertainty_score":0.47474718},"labels":[],"label_agreement":null},{"id":"W4414657396","doi":"10.51731/cjht.2025.1234","title":"Odevixibat (Bylvay)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Diverse Scientific and Economic Studies","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Drug; Alagille syndrome; Cholestasis; Liver transplantation; Nice","score_opus":0.046098280041625375,"score_gpt":0.23217355328673686,"score_spread":0.18607527324511147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414657396","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019627362,0.4581264,0.0024719355,0.07933397,0.01290769,0.0003266578,0.00030592925,0.00015466208,0.42674538],"genre_scores_gemma":[0.9756727,0.0010935841,0.000435847,0.0008306318,0.0000075026555,0.000002710418,6.4805494e-7,0.000005587424,0.021950772],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987862,0.0000063098873,0.00069526705,0.00015340491,0.000013978603,0.00034484887],"domain_scores_gemma":[0.9992372,0.000023626477,0.00044569667,0.00020603133,0.000046207675,0.000041232728],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088716287,0.00008274117,0.00040919852,0.001030708,0.00025169158,0.000060260336,0.0004118543,0.000077285855,0.00041853136],"category_scores_gemma":[0.0003953497,0.00008629343,0.000085965985,0.00034130033,0.00020835185,0.00013234428,0.000032899716,0.00017940396,0.00059672375],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000002302234,0.00000897452,0.016799195,0.000043576536,0.00007864691,0.00001223832,0.0002725556,0.000019988533,2.9670719e-7,0.45605305,0.45828995,0.068419226],"study_design_scores_gemma":[0.00016547414,0.000027660055,0.0028174005,0.00004725556,0.0000017348366,0.00000546722,0.0021032894,0.000012684835,0.0000116752135,0.057146225,0.9375913,0.00006983714],"about_ca_topic_score_codex":0.0023701042,"about_ca_topic_score_gemma":0.0007996479,"teacher_disagreement_score":0.9560453,"about_ca_system_score_codex":0.0003634909,"about_ca_system_score_gemma":0.0005341185,"threshold_uncertainty_score":0.76698756},"labels":[],"label_agreement":null},{"id":"W4414695975","doi":"10.51731/cjht.2025.1246","title":"Myoelectric and Microprocessor-Enabled Prostheses","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Muscle activation and electromyography studies","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"MEDLINE; Rehabilitation; Quality of life (healthcare); Clinical effectiveness; Evidence-based medicine; Prosthesis","score_opus":0.007813723457086306,"score_gpt":0.21795934282737145,"score_spread":0.21014561937028514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414695975","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.455903,0.50778085,0.0019372524,0.030356346,0.00038386378,0.00031385178,0.0000047661188,0.0005037858,0.0028162866],"genre_scores_gemma":[0.99630517,0.0032361445,0.00021522227,0.00019654284,0.000002540435,0.000004853279,1.8586968e-7,0.000005930393,0.00003343641],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993643,0.000009575086,0.00024231037,0.000058201545,0.00004001128,0.00028560995],"domain_scores_gemma":[0.99972856,0.000028822096,0.00006288805,0.00007315237,0.00007725997,0.000029319548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015788175,0.00008170222,0.00019637555,0.00093272637,0.00017464334,0.000031693708,0.00012673369,0.000061940475,0.0000022587951],"category_scores_gemma":[0.00015194813,0.000071420334,0.000024028277,0.0006871224,0.000077503275,0.00007467507,0.0000056485596,0.00022986183,1.7622725e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000022510276,0.0000028226234,0.004357794,0.00021191705,0.0000620654,0.0000059209374,0.00013163757,0.00001902916,0.00030523486,0.0013872841,0.0092885755,0.98422545],"study_design_scores_gemma":[0.0010383467,0.00051903585,0.128525,0.00084186223,0.00003765167,0.00017770912,0.0057125413,0.00018743933,0.023874914,0.029217457,0.8093586,0.0005094359],"about_ca_topic_score_codex":0.00032472442,"about_ca_topic_score_gemma":0.0007714359,"teacher_disagreement_score":0.983716,"about_ca_system_score_codex":0.00012595653,"about_ca_system_score_gemma":0.00041343985,"threshold_uncertainty_score":0.29124367},"labels":[],"label_agreement":null},{"id":"W4414696025","doi":"10.51731/cjht.2025.1245","title":"Venetoclax (Venclexta)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ibrutinib; Venetoclax; Mantle cell lymphoma; Drug; Lymphoma; Public health","score_opus":0.025457065611933158,"score_gpt":0.36479889377678365,"score_spread":0.3393418281648505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414696025","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.35248598,0.32817414,0.00023709497,0.30726966,0.0021411174,0.00058758707,0.000015510002,0.00017229031,0.008916597],"genre_scores_gemma":[0.9961132,0.0008101452,0.0003012859,0.0020556499,0.000012194885,0.000004632261,0.0000012787166,0.000004754507,0.0006968824],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992844,0.000019746176,0.00029765588,0.00007200215,0.00005503457,0.0002711511],"domain_scores_gemma":[0.9995499,0.000028974586,0.00013740282,0.00012572603,0.00009256035,0.00006539145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020417187,0.00007101143,0.00028511675,0.0006245599,0.000116115036,0.000008004878,0.00012581467,0.00009346847,0.0000658012],"category_scores_gemma":[0.000114883354,0.000058857622,0.000064053515,0.0003170547,0.00013287828,0.00003074527,0.000008597319,0.00028267043,0.000005858954],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006282563,0.00002590406,0.026629714,0.00015424239,0.00015181536,0.00036470848,0.00012467093,0.000008177524,0.00016527966,0.0030352226,0.10002298,0.86925447],"study_design_scores_gemma":[0.0011430521,0.0007604949,0.025850618,0.000302066,0.00005424821,0.00026406013,0.00062805053,0.0000060663674,0.0014045787,0.004448767,0.9650825,0.000055442397],"about_ca_topic_score_codex":0.0025034612,"about_ca_topic_score_gemma":0.0023057824,"teacher_disagreement_score":0.86919904,"about_ca_system_score_codex":0.0010283879,"about_ca_system_score_gemma":0.008324998,"threshold_uncertainty_score":0.99729687},"labels":[],"label_agreement":null},{"id":"W4414798455","doi":"10.51731/cjht.2025.1247","title":"Canada’s Early Experiences With Low-Field MRI: Insights From a Cross-Country Survey","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Advanced MRI Techniques and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Staffing; Respondent; Context (archaeology); Health care; Agency (philosophy); Survey data collection; Patient experience","score_opus":0.013614347841877513,"score_gpt":0.31233735750632247,"score_spread":0.2987230096644449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414798455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9460308,0.016934503,0.011608765,0.024069572,0.0001893202,0.0003649737,0.000065103864,0.00010705525,0.00062992214],"genre_scores_gemma":[0.995278,0.00017573053,0.002236018,0.0021784964,0.000008554008,0.000025132385,0.00000676773,0.000008641171,0.00008267932],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989375,0.000019021314,0.0004256576,0.00015807158,0.00015152556,0.00030826053],"domain_scores_gemma":[0.99893963,0.000113912276,0.00025424204,0.000310528,0.000266939,0.00011473982],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013061987,0.00012208085,0.0003464545,0.00027767374,0.0002700124,0.00003564677,0.00029314496,0.00012868148,0.000013000255],"category_scores_gemma":[0.0003068243,0.00008986011,0.00002545491,0.00048246936,0.00021588075,0.00009200993,0.000015662126,0.0004429736,4.1937113e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059837004,0.00016305872,0.53006727,0.0003426625,0.0002660787,0.00147997,0.004393292,0.00012559368,0.000254694,0.02026376,0.12511028,0.31693497],"study_design_scores_gemma":[0.0014600164,0.0014651901,0.5382651,0.00208283,0.000039302293,0.00016406736,0.025880227,0.000027975126,0.015382505,0.007733692,0.40704182,0.00045729624],"about_ca_topic_score_codex":0.9229514,"about_ca_topic_score_gemma":0.96735966,"teacher_disagreement_score":0.31647766,"about_ca_system_score_codex":0.00049373455,"about_ca_system_score_gemma":0.017317109,"threshold_uncertainty_score":0.9882538},"labels":[],"label_agreement":null},{"id":"W4414853065","doi":"10.51731/cjht.2025.1250","title":"Dostarlimab (Jemperli)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Medical History and Research","field":"Arts and Humanities","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Carboplatin; Drug; Paclitaxel; Drug approval","score_opus":0.046075261996101735,"score_gpt":0.2892892159167715,"score_spread":0.24321395392066975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414853065","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.055281896,0.34615263,0.00029113205,0.41250446,0.007677138,0.0004981745,0.000049803177,0.00030084015,0.17724393],"genre_scores_gemma":[0.99242496,0.00029855125,0.000044633824,0.0011341141,0.000028154753,0.0000023013947,7.403577e-7,0.000004523587,0.0060620164],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990348,0.000055068107,0.00036269854,0.000073058996,0.0001240046,0.00035035776],"domain_scores_gemma":[0.9994464,0.000058311216,0.00011986031,0.00014112254,0.00015963434,0.00007470724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007209742,0.00006816733,0.00021359144,0.00073663326,0.0006557505,0.000052982425,0.0003918145,0.000068116315,0.0007040944],"category_scores_gemma":[0.00042367753,0.000049794136,0.000056374825,0.00009446615,0.00093735324,0.00008190654,0.000015142408,0.00049554545,0.00002051251],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000070853785,0.0000133405,0.00018292661,0.0001234323,0.000026839258,0.000083522944,0.00426826,6.971595e-7,0.0000027382468,0.36569968,0.1427665,0.486825],"study_design_scores_gemma":[0.00013662568,0.000116469186,0.00008956282,0.0001555192,0.0000028434965,0.000009185599,0.011567364,0.0000016068101,0.000026046164,0.011072717,0.97677946,0.00004260355],"about_ca_topic_score_codex":0.0051140697,"about_ca_topic_score_gemma":0.022432452,"teacher_disagreement_score":0.9371431,"about_ca_system_score_codex":0.0002627783,"about_ca_system_score_gemma":0.003810119,"threshold_uncertainty_score":0.9954056},"labels":[],"label_agreement":null},{"id":"W4414853071","doi":"10.51731/cjht.2025.1249","title":"Cabozantinib","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Cabozantinib; Drug; Compassionate Use; Drug approval","score_opus":0.02085405706881028,"score_gpt":0.31206519005522676,"score_spread":0.2912111329864165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414853071","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.49920815,0.24345043,0.00047122157,0.2428029,0.0014115155,0.00067163835,0.000018077766,0.00026967868,0.011696372],"genre_scores_gemma":[0.9964726,0.0005620864,0.0010217376,0.0011678197,0.0000070253463,0.0000028224024,0.0000015183723,0.0000072949633,0.0007570733],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989835,0.000020056115,0.00044278282,0.000095733776,0.00009448323,0.0003634255],"domain_scores_gemma":[0.999292,0.000036995745,0.00020083766,0.0002560582,0.00013345317,0.00008065576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029886843,0.00009458261,0.00036977077,0.000808406,0.00013063551,0.000012447245,0.00017504518,0.00012217666,0.000036630874],"category_scores_gemma":[0.00059400557,0.00007585599,0.000073388896,0.0004151651,0.00014871251,0.000042618787,0.000013051248,0.0003806224,0.000011048891],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022424427,0.00002424586,0.04035926,0.00019595925,0.00013429881,0.00055847876,0.000106723855,0.0000024791657,0.00003637931,0.0037389048,0.0353369,0.91948396],"study_design_scores_gemma":[0.0025225237,0.00048808954,0.05460554,0.0011466886,0.000055121214,0.00089864363,0.0019304116,0.000008820919,0.0014918548,0.0028481383,0.93390864,0.00009553105],"about_ca_topic_score_codex":0.0040654573,"about_ca_topic_score_gemma":0.0022389577,"teacher_disagreement_score":0.9193884,"about_ca_system_score_codex":0.0014470415,"about_ca_system_score_gemma":0.0142207155,"threshold_uncertainty_score":0.99136776},"labels":[],"label_agreement":null},{"id":"W4414937175","doi":"10.51731/cjht.2025.1251","title":"Rozanolixizumab (Rystiggo)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Drug; Drug approval; Antibody therapy; Tyrosine kinase","score_opus":0.014735107386983273,"score_gpt":0.28782373180523996,"score_spread":0.2730886244182567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414937175","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14035468,0.20035467,0.0021963909,0.6352624,0.0019660343,0.0005421297,0.000019948642,0.0003513235,0.018952364],"genre_scores_gemma":[0.99724644,0.00047520516,0.0005106063,0.0010856481,0.000006834893,0.0000027015992,0.0000017176299,0.000005657018,0.0006651947],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999117,0.000019424333,0.00040655077,0.00007623217,0.00007555323,0.00030519938],"domain_scores_gemma":[0.9993891,0.000029983485,0.00013839269,0.00019556294,0.00015995947,0.00008696836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017072086,0.00007500738,0.0002779529,0.0009681229,0.00020672633,0.0000143380685,0.00015018477,0.00017461437,0.000042945838],"category_scores_gemma":[0.00043153242,0.000058664882,0.00007621688,0.00046807958,0.00019546166,0.000041820203,0.000009255352,0.0005276563,0.000011032978],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000410499,0.000068618225,0.013927417,0.00016893247,0.00090752245,0.0010660291,0.00038190171,0.000016307627,0.00031359363,0.07430605,0.10198151,0.80682105],"study_design_scores_gemma":[0.0025666745,0.0010044924,0.05266718,0.0019722027,0.00047589076,0.002287609,0.0063870447,0.00003802747,0.0021682763,0.048371755,0.8818485,0.00021235696],"about_ca_topic_score_codex":0.0010703098,"about_ca_topic_score_gemma":0.0005919056,"teacher_disagreement_score":0.85689175,"about_ca_system_score_codex":0.0003405738,"about_ca_system_score_gemma":0.0060755857,"threshold_uncertainty_score":0.99955904},"labels":[],"label_agreement":null},{"id":"W4415195696","doi":"10.51731/cjht.2025.1254","title":"Durvalumab (Imfinzi), Carboplatin, Paclitaxel","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Durvalumab; Reimbursement; Paclitaxel; Drug; Cancer; Carboplatin","score_opus":0.020214382825669973,"score_gpt":0.31799889678956045,"score_spread":0.2977845139638905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415195696","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.31487575,0.34963518,0.00013957148,0.32876694,0.0011389718,0.00059974164,0.00003560914,0.00014997362,0.004658263],"genre_scores_gemma":[0.9959557,0.0017578235,0.0005085113,0.0015109222,0.000011423737,0.000011752044,0.0000019982438,0.000008394905,0.00023347196],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99887383,0.000024079565,0.0005003019,0.00012110941,0.0001189246,0.00036177144],"domain_scores_gemma":[0.9991814,0.00005501259,0.00022603535,0.00026671062,0.00016808593,0.00010276416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031466762,0.000114858325,0.00044789122,0.0006958571,0.00016298694,0.000020839041,0.00013852226,0.000115944,0.000034334967],"category_scores_gemma":[0.00040521153,0.00009110286,0.000112252026,0.00038746218,0.00014169779,0.000041636133,0.00001321246,0.000325815,0.0000055301316],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002696512,0.0000554796,0.08445755,0.00019543727,0.0001862842,0.00037893056,0.00015582873,0.000005106683,0.000012033484,0.0044863685,0.045721274,0.8643187],"study_design_scores_gemma":[0.002847536,0.0013956148,0.26308918,0.001958283,0.00014000479,0.00048742033,0.0037285492,0.000009997899,0.0013018611,0.0075265295,0.7173432,0.00017180022],"about_ca_topic_score_codex":0.010069222,"about_ca_topic_score_gemma":0.009867226,"teacher_disagreement_score":0.86414695,"about_ca_system_score_codex":0.0010713962,"about_ca_system_score_gemma":0.005683438,"threshold_uncertainty_score":0.9999534},"labels":[],"label_agreement":null},{"id":"W4415314362","doi":"10.51731/cjht.2025.1255","title":"Semaglutide (Wegovy)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Weight loss; Comorbidity; Body mass index; Type 2 diabetes; Clinical Practice; Body weight","score_opus":0.025126934297497214,"score_gpt":0.35846029367518983,"score_spread":0.3333333593776926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415314362","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.043074403,0.6648703,0.00012389534,0.28234318,0.005212281,0.0005644656,0.000045146266,0.00007864877,0.0036876402],"genre_scores_gemma":[0.9786951,0.013009006,0.00026786534,0.00431424,0.0000614726,0.000009343009,0.0000026576333,0.00002029293,0.0036200043],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99687696,0.00014431067,0.0013952916,0.00026073103,0.00018002564,0.0011426714],"domain_scores_gemma":[0.9978829,0.00023308204,0.00082345103,0.00040923306,0.00038426078,0.00026709825],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00096282654,0.0003205703,0.0011467631,0.0024591405,0.0005089374,0.00004418994,0.00055223354,0.00043471178,0.0004421341],"category_scores_gemma":[0.00090644805,0.0002881606,0.00025600183,0.0012335059,0.0007350296,0.0000796339,0.000043458516,0.0013166685,0.00003599948],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000116863215,0.00009713396,0.026224865,0.0006372683,0.0006109905,0.00097427267,0.00035598563,0.000009442671,0.000058658043,0.0027879216,0.16219202,0.8059346],"study_design_scores_gemma":[0.0028960374,0.0019095846,0.017221842,0.0021099132,0.00039234606,0.00041509586,0.0043376097,0.000012356325,0.0012198024,0.004362296,0.96493053,0.00019261132],"about_ca_topic_score_codex":0.0131136775,"about_ca_topic_score_gemma":0.014653033,"teacher_disagreement_score":0.9356207,"about_ca_system_score_codex":0.002849082,"about_ca_system_score_gemma":0.03297763,"threshold_uncertainty_score":0.999957},"labels":[],"label_agreement":null},{"id":"W4415350852","doi":"10.51731/cjht.2025.1257","title":"Pembrolizumab (Keytruda)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chemoradiotherapy; Cervical cancer; Pembrolizumab; Stage (stratigraphy); Cancer; Adenosquamous carcinoma; Radiation therapy","score_opus":0.020116704277312342,"score_gpt":0.3193127526401548,"score_spread":0.29919604836284247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415350852","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.035496462,0.69679725,0.0001369467,0.2609319,0.003123149,0.0005686477,0.000048140388,0.00006321934,0.0028342668],"genre_scores_gemma":[0.9624278,0.034278374,0.00019909027,0.0023628452,0.000040875613,0.000017198345,0.0000024379547,0.000022621261,0.0006487405],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99666184,0.00009277713,0.0015294629,0.00030708595,0.0002800127,0.0011288488],"domain_scores_gemma":[0.99757886,0.0001489224,0.00088202604,0.00064133276,0.00045532835,0.00029355413],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00076328113,0.00034822122,0.0012611698,0.0023298347,0.0005523297,0.00009111966,0.0005444828,0.00040514182,0.00023406072],"category_scores_gemma":[0.0008719463,0.00030313773,0.00032966456,0.001128129,0.0005823367,0.00011680507,0.00004688405,0.0010795523,0.000029695268],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000074476346,0.00010969134,0.030943256,0.00061178056,0.00048431655,0.0007692662,0.00028469256,0.000009031685,0.0000028671805,0.0074699824,0.059921697,0.89931893],"study_design_scores_gemma":[0.0043052286,0.0025178404,0.065168366,0.0070857895,0.0003812329,0.00052046415,0.007891806,0.000013358634,0.00069451047,0.00617349,0.9049927,0.00025518163],"about_ca_topic_score_codex":0.022210646,"about_ca_topic_score_gemma":0.019198202,"teacher_disagreement_score":0.9269314,"about_ca_system_score_codex":0.004226993,"about_ca_system_score_gemma":0.03296106,"threshold_uncertainty_score":0.99994206},"labels":[],"label_agreement":null},{"id":"W4415403106","doi":"10.51731/cjht.2025.1258","title":"Acalabrutinib (Calquence)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Bendamustine; Mantle cell lymphoma; Debulking; Rituximab; Lymphoma; Primary central nervous system lymphoma","score_opus":0.028257548079617105,"score_gpt":0.35518305201837175,"score_spread":0.32692550393875464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415403106","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.049060524,0.70623565,0.00093995733,0.23211567,0.0037895376,0.0011239736,0.000044047538,0.00014503532,0.00654558],"genre_scores_gemma":[0.98251486,0.012355801,0.0005272873,0.0023188358,0.000054052543,0.00000793327,0.0000023536252,0.00003305888,0.0021858215],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9941917,0.00026126934,0.0023070981,0.00042925263,0.00062898535,0.0021816986],"domain_scores_gemma":[0.99608594,0.00046091896,0.00093531905,0.0010330452,0.000965191,0.00051955873],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0033523547,0.00040316794,0.0014523818,0.003485073,0.00068687747,0.00013114723,0.0015685265,0.0008648399,0.00030846114],"category_scores_gemma":[0.008440004,0.00035588077,0.00030434644,0.0024772342,0.0021032547,0.00019449528,0.00015025798,0.0027582853,0.000094446616],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00010997868,0.000057156267,0.0018660518,0.001792299,0.00035126682,0.0023718167,0.0004488666,0.000022110251,0.00003035747,0.009830204,0.062195707,0.9209242],"study_design_scores_gemma":[0.013186816,0.0018620327,0.0028997178,0.010837575,0.00017190045,0.002340335,0.014353694,0.000660094,0.0018809267,0.012743767,0.93865305,0.00041007288],"about_ca_topic_score_codex":0.038387142,"about_ca_topic_score_gemma":0.0069814622,"teacher_disagreement_score":0.93345433,"about_ca_system_score_codex":0.06350645,"about_ca_system_score_gemma":0.4100721,"threshold_uncertainty_score":0.9999123},"labels":[],"label_agreement":null},{"id":"W4415438746","doi":"10.51731/cjht.2025.1261","title":"Nivolumab Plus Ipilimumab (Opdivo Plus Yervoy)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ipilimumab; Nivolumab; Colorectal cancer; Microsatellite instability; Drug; Metastatic melanoma; Systemic therapy; Disease","score_opus":0.024514835644645905,"score_gpt":0.30273002263953375,"score_spread":0.27821518699488784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415438746","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.036131073,0.7716913,0.0008075512,0.18088555,0.0060358327,0.0010866384,0.0000867602,0.0001765499,0.003098744],"genre_scores_gemma":[0.9684234,0.022892468,0.00034262842,0.0044599427,0.00008055366,0.000013738741,0.0000050017125,0.00004704012,0.0037352187],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99464595,0.00020253594,0.0024779735,0.00047066624,0.00045691043,0.0017459472],"domain_scores_gemma":[0.9964507,0.00017549406,0.0014403249,0.000994908,0.00059825805,0.00034027136],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0020412495,0.0005445104,0.0017319742,0.0032088237,0.0009690822,0.00015432529,0.0012893671,0.0008460782,0.0004068838],"category_scores_gemma":[0.0010521811,0.00050524075,0.0005295792,0.002091069,0.001443902,0.00024734554,0.00008613549,0.0020253884,0.000031963384],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0015176369,0.000050825125,0.0014303668,0.0012590368,0.00084893504,0.00066236255,0.00093054184,0.00003323968,0.00009171468,0.0013938824,0.0661473,0.92563415],"study_design_scores_gemma":[0.012729748,0.0027581386,0.006779752,0.009676116,0.00023935291,0.00076807255,0.023762716,0.00014500723,0.00087807083,0.0023077964,0.93942696,0.0005282419],"about_ca_topic_score_codex":0.035187677,"about_ca_topic_score_gemma":0.02550165,"teacher_disagreement_score":0.93229234,"about_ca_system_score_codex":0.010238504,"about_ca_system_score_gemma":0.068845116,"threshold_uncertainty_score":0.99973994},"labels":[],"label_agreement":null},{"id":"W4415438756","doi":"10.51731/cjht.2025.1260","title":"Asciminib (Scemblix)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Myeloid leukemia; Cancer; Disease; Drug; Public health; Cancer treatment","score_opus":0.026783171320781837,"score_gpt":0.31906480387779484,"score_spread":0.292281632557013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415438756","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06255317,0.71722853,0.00036884757,0.20695774,0.0052875597,0.0009917399,0.00006040713,0.00015062767,0.00640135],"genre_scores_gemma":[0.98276496,0.01138161,0.00076305645,0.0022825778,0.00004573417,0.000009638265,0.000004689232,0.00003557131,0.002712144],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9953046,0.00016796119,0.0021213454,0.00040260397,0.0003826641,0.0016208539],"domain_scores_gemma":[0.9965972,0.00023481814,0.0012639326,0.00097001,0.0005476543,0.00038640533],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015206479,0.00046651743,0.0015178842,0.0035735932,0.0006425043,0.000093603354,0.0009869435,0.0007044271,0.00030275542],"category_scores_gemma":[0.0029955653,0.00041815662,0.0003274437,0.0017778574,0.0009128873,0.00018803781,0.00008140066,0.0018775263,0.000085459265],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00006478106,0.00007753611,0.008695667,0.0008622678,0.0005862316,0.0018901424,0.0004081126,0.000010401857,0.000015117483,0.0031959545,0.063537404,0.9206564],"study_design_scores_gemma":[0.0059932675,0.0022157677,0.015457873,0.008334932,0.00041171748,0.0014846028,0.012048648,0.000049260125,0.0011136737,0.0057518277,0.9467745,0.00036395682],"about_ca_topic_score_codex":0.013451727,"about_ca_topic_score_gemma":0.008564414,"teacher_disagreement_score":0.92029244,"about_ca_system_score_codex":0.012086548,"about_ca_system_score_gemma":0.093339466,"threshold_uncertainty_score":0.999827},"labels":[],"label_agreement":null},{"id":"W4415438775","doi":"10.51731/cjht.2025.1259","title":"Pembrolizumab (Keytruda)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pembrolizumab; Radiation therapy; Head and neck; Cancer; Stage (stratigraphy); Head and neck cancer; Disease; Basal cell","score_opus":0.020116704277312342,"score_gpt":0.3193127526401548,"score_spread":0.29919604836284247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415438775","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.035496462,0.69679725,0.0001369467,0.2609319,0.003123149,0.0005686477,0.000048140388,0.00006321934,0.0028342668],"genre_scores_gemma":[0.9624278,0.034278374,0.00019909027,0.0023628452,0.000040875613,0.000017198345,0.0000024379547,0.000022621261,0.0006487405],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99666184,0.00009277713,0.0015294629,0.00030708595,0.0002800127,0.0011288488],"domain_scores_gemma":[0.99757886,0.0001489224,0.00088202604,0.00064133276,0.00045532835,0.00029355413],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00076328113,0.00034822122,0.0012611698,0.0023298347,0.0005523297,0.00009111966,0.0005444828,0.00040514182,0.00023406072],"category_scores_gemma":[0.0008719463,0.00030313773,0.00032966456,0.001128129,0.0005823367,0.00011680507,0.00004688405,0.0010795523,0.000029695268],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000074476346,0.00010969134,0.030943256,0.00061178056,0.00048431655,0.0007692662,0.00028469256,0.000009031685,0.0000028671805,0.0074699824,0.059921697,0.89931893],"study_design_scores_gemma":[0.0043052286,0.0025178404,0.065168366,0.0070857895,0.0003812329,0.00052046415,0.007891806,0.000013358634,0.00069451047,0.00617349,0.9049927,0.00025518163],"about_ca_topic_score_codex":0.022210646,"about_ca_topic_score_gemma":0.019198202,"teacher_disagreement_score":0.9269314,"about_ca_system_score_codex":0.004226993,"about_ca_system_score_gemma":0.03296106,"threshold_uncertainty_score":0.99994206},"labels":[],"label_agreement":null},{"id":"W4415517288","doi":"10.51731/cjht.2025.1264","title":"Pembrolizumab (Keytruda)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pembrolizumab; Reimbursement; Drug; Lung cancer; Chemotherapy; Stage (stratigraphy); Compassionate Use","score_opus":0.020116704277312342,"score_gpt":0.3193127526401548,"score_spread":0.29919604836284247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415517288","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.035496462,0.69679725,0.0001369467,0.2609319,0.003123149,0.0005686477,0.000048140388,0.00006321934,0.0028342668],"genre_scores_gemma":[0.9624278,0.034278374,0.00019909027,0.0023628452,0.000040875613,0.000017198345,0.0000024379547,0.000022621261,0.0006487405],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99666184,0.00009277713,0.0015294629,0.00030708595,0.0002800127,0.0011288488],"domain_scores_gemma":[0.99757886,0.0001489224,0.00088202604,0.00064133276,0.00045532835,0.00029355413],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00076328113,0.00034822122,0.0012611698,0.0023298347,0.0005523297,0.00009111966,0.0005444828,0.00040514182,0.00023406072],"category_scores_gemma":[0.0008719463,0.00030313773,0.00032966456,0.001128129,0.0005823367,0.00011680507,0.00004688405,0.0010795523,0.000029695268],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000074476346,0.00010969134,0.030943256,0.00061178056,0.00048431655,0.0007692662,0.00028469256,0.000009031685,0.0000028671805,0.0074699824,0.059921697,0.89931893],"study_design_scores_gemma":[0.0043052286,0.0025178404,0.065168366,0.0070857895,0.0003812329,0.00052046415,0.007891806,0.000013358634,0.00069451047,0.00617349,0.9049927,0.00025518163],"about_ca_topic_score_codex":0.022210646,"about_ca_topic_score_gemma":0.019198202,"teacher_disagreement_score":0.9269314,"about_ca_system_score_codex":0.004226993,"about_ca_system_score_gemma":0.03296106,"threshold_uncertainty_score":0.99994206},"labels":[],"label_agreement":null},{"id":"W4415619201","doi":"10.51731/cjht.2025.1265","title":"Elafibranor (Iqirvo)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ursodeoxycholic acid; Reimbursement; Drug; Clinical trial; Compassionate Use; Clinical Practice","score_opus":0.018665533839666907,"score_gpt":0.2979552200978029,"score_spread":0.279289686258136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415619201","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10028036,0.74166775,0.0003292245,0.15076102,0.0032927357,0.00055107975,0.00008173801,0.00008722402,0.0029488476],"genre_scores_gemma":[0.98269975,0.013029788,0.00022686357,0.0028195353,0.00003239026,0.0000033061915,0.0000034372897,0.000019926103,0.0011650301],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967907,0.0001856009,0.0014686302,0.0002206526,0.00023167439,0.0011027383],"domain_scores_gemma":[0.9974388,0.0001346276,0.0008079107,0.0007285844,0.000530609,0.00035949133],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010954441,0.00030232157,0.0010349917,0.002150639,0.00076407596,0.00009482579,0.00088584493,0.0004152238,0.00031021226],"category_scores_gemma":[0.0017417431,0.00026899457,0.00032962777,0.0012343449,0.00080723315,0.00023238172,0.00007509584,0.0015423209,0.0000370785],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000110243316,0.00009794345,0.051236935,0.00142696,0.0005153897,0.00043470017,0.0004147245,0.000005203807,0.00002445019,0.0058109397,0.052495703,0.8874268],"study_design_scores_gemma":[0.0024273738,0.0019125852,0.1614226,0.006697955,0.000393073,0.0002853362,0.021224504,0.000027147122,0.0004838989,0.009277838,0.79553753,0.0003101412],"about_ca_topic_score_codex":0.016073758,"about_ca_topic_score_gemma":0.001567634,"teacher_disagreement_score":0.8871167,"about_ca_system_score_codex":0.001488025,"about_ca_system_score_gemma":0.03544312,"threshold_uncertainty_score":0.9999762},"labels":[],"label_agreement":null},{"id":"W4415619203","doi":"10.51731/cjht.2025.1266","title":"Durvalumab (Imfinzi) and Tremelimumab (Imjudo)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Durvalumab; Tremelimumab; Vinorelbine; Epidermal growth factor receptor; Drug; Clinical Oncology; Reimbursement; Lymphoma; Discontinuation","score_opus":0.020021908016387844,"score_gpt":0.2969294342109829,"score_spread":0.276907526194595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415619203","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08774944,0.74057305,0.00015671625,0.16750143,0.0023518906,0.0005112237,0.000038960647,0.0000654639,0.0010518171],"genre_scores_gemma":[0.9442743,0.051545512,0.00022264774,0.0030653537,0.000033460463,0.0000054166867,0.0000018288795,0.000024381166,0.00082707644],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99649155,0.0001545159,0.0017078787,0.00033180424,0.000262658,0.0010515965],"domain_scores_gemma":[0.9978263,0.00014695675,0.0009081951,0.0005403959,0.000351856,0.00022628874],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018887677,0.00036548264,0.0011460634,0.0023130097,0.0006877704,0.000117314295,0.0005331032,0.0005248937,0.00014405831],"category_scores_gemma":[0.0009082657,0.00032529497,0.00023745987,0.0011920183,0.0012807882,0.00016597316,0.00004886639,0.0011801765,0.000005724611],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004638985,0.000035155936,0.0060028457,0.00069862045,0.00045227195,0.00022396939,0.00049603794,9.854085e-7,0.00013136401,0.0010050979,0.018620893,0.9718689],"study_design_scores_gemma":[0.0074193534,0.0028531183,0.05753404,0.0070259375,0.0002491947,0.0009721464,0.018950647,0.00003316996,0.0010786288,0.0043776217,0.89909786,0.00040828015],"about_ca_topic_score_codex":0.01430227,"about_ca_topic_score_gemma":0.011811309,"teacher_disagreement_score":0.9714606,"about_ca_system_score_codex":0.0017757135,"about_ca_system_score_gemma":0.019128524,"threshold_uncertainty_score":0.9999199},"labels":[],"label_agreement":null},{"id":"W4415619222","doi":"10.51731/cjht.2025.1270","title":"Daridorexant (Quviviq)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Sleep and Wakefulness Research","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Insomnia; Placebo; Sleep (system call); Sleep disorder; Drug treatment; Clinical trial","score_opus":0.0507086726703228,"score_gpt":0.34454736222711513,"score_spread":0.2938386895567923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415619222","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16552858,0.41977623,0.0035003899,0.38889942,0.011757445,0.0013930233,0.00016840083,0.0002634511,0.008713049],"genre_scores_gemma":[0.99319094,0.004025673,0.00010450742,0.0018814219,0.000021348302,0.0000066460643,4.2217246e-7,0.000022654633,0.0007464072],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9950998,0.0004337331,0.0015905657,0.00047054808,0.0005524841,0.0018529064],"domain_scores_gemma":[0.9971296,0.0004738189,0.00081045454,0.00081512565,0.00045583973,0.0003151439],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0023165718,0.00033902586,0.0008846057,0.0040152487,0.0015137219,0.0004590478,0.002567718,0.00045404473,0.00014617726],"category_scores_gemma":[0.008081007,0.00030430433,0.00022693958,0.0030560598,0.001826951,0.00034005826,0.00017518262,0.0022971553,0.00004910619],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031319047,0.000052053038,0.0032242083,0.00030845602,0.000048920443,0.0007942402,0.0003174943,0.000026403435,0.00021505718,0.019877765,0.020183705,0.95492035],"study_design_scores_gemma":[0.0012794599,0.0011062493,0.006173044,0.0022408168,0.00004093259,0.00049744314,0.010026876,0.00014470755,0.03820795,0.020264622,0.91954935,0.00046853037],"about_ca_topic_score_codex":0.007561227,"about_ca_topic_score_gemma":0.0041827275,"teacher_disagreement_score":0.95445186,"about_ca_system_score_codex":0.0013979353,"about_ca_system_score_gemma":0.029183643,"threshold_uncertainty_score":0.99994093},"labels":[],"label_agreement":null},{"id":"W4415665454","doi":"10.51731/cjht.2025.1273","title":"Polatuzumab Vedotin (Polivy)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Drug; Clinical trial; Anticancer drug; Drug approval","score_opus":0.0167420741400342,"score_gpt":0.3023423456240574,"score_spread":0.28560027148402317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415665454","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07977595,0.72689694,0.00007417066,0.18625985,0.0029328368,0.00058630237,0.00004309778,0.00008149147,0.0033493566],"genre_scores_gemma":[0.9805372,0.015777959,0.00036101034,0.0026347928,0.00004014939,0.00001126593,0.0000033125968,0.00002286231,0.00061146927],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962976,0.00013298387,0.0017031971,0.00032059647,0.000280399,0.0012652181],"domain_scores_gemma":[0.9973578,0.00019854802,0.0009779151,0.00067872216,0.00042569422,0.00036132624],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000740817,0.0003983651,0.0012976774,0.002688708,0.00065264676,0.00010468655,0.0006399433,0.0005145932,0.00011750883],"category_scores_gemma":[0.0014766869,0.00033475782,0.00033505235,0.0012337085,0.0006056205,0.00013520377,0.000059662725,0.00089068303,0.000054138247],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000047388734,0.00017510646,0.056263242,0.0005000511,0.0005662067,0.0011730767,0.00040689867,0.0000056798413,0.000006847949,0.015069354,0.041085444,0.8847007],"study_design_scores_gemma":[0.004702856,0.002645872,0.1350895,0.0073097516,0.00040616945,0.00063727616,0.012462526,0.000022848984,0.0013292016,0.007820668,0.8272441,0.00032925562],"about_ca_topic_score_codex":0.026124,"about_ca_topic_score_gemma":0.008424911,"teacher_disagreement_score":0.90076125,"about_ca_system_score_codex":0.005393479,"about_ca_system_score_gemma":0.038975894,"threshold_uncertainty_score":0.9999105},"labels":[],"label_agreement":null},{"id":"W4415665455","doi":"10.51731/cjht.2025.1272","title":"Belantamab Mafodotin, Pomalidomide, Dexamethasone","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pomalidomide; Dexamethasone; Regimen; Multiple myeloma; Refractory (planetary science); Combination therapy","score_opus":0.03492998391048633,"score_gpt":0.34642810840904276,"score_spread":0.3114981244985564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415665455","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15544926,0.6821288,0.0007555485,0.15482873,0.0021790247,0.0014152995,0.00015755468,0.00012829877,0.0029575196],"genre_scores_gemma":[0.9821482,0.0132214185,0.0017485445,0.0010722036,0.000037875205,0.000014707064,0.000009476566,0.000035810197,0.0017118058],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99477434,0.00036099204,0.001893605,0.0004190848,0.0005169522,0.002035016],"domain_scores_gemma":[0.99635226,0.00045912268,0.0009731781,0.0008165048,0.0007596879,0.0006392567],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002218038,0.00046217543,0.0015723206,0.0038501183,0.0008071329,0.00013247856,0.00095339323,0.00058188284,0.00028380338],"category_scores_gemma":[0.0058772108,0.00039341114,0.00033760775,0.0017223734,0.00096302415,0.00019378454,0.000107733824,0.0019541879,0.00008345246],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002940325,0.00013557858,0.09739064,0.0008386064,0.0009139415,0.0032456848,0.0001812711,0.0000041934236,0.000040321193,0.0018585187,0.01735954,0.8777377],"study_design_scores_gemma":[0.022298919,0.006889278,0.30592227,0.014887298,0.0006882119,0.0032146864,0.021098292,0.00017687623,0.0062102964,0.011632358,0.6061002,0.00088133005],"about_ca_topic_score_codex":0.024211774,"about_ca_topic_score_gemma":0.0108548375,"teacher_disagreement_score":0.8768563,"about_ca_system_score_codex":0.0028236338,"about_ca_system_score_gemma":0.029116826,"threshold_uncertainty_score":0.99985176},"labels":[],"label_agreement":null},{"id":"W4415665469","doi":"10.51731/cjht.2025.1274","title":"Mirvetuximab Soravtansine (Elahere)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Fallopian tube; Cancer; Disease; Fallopian tube cancer; Primary care; Drug; First line","score_opus":0.028885706885149767,"score_gpt":0.3440581177649768,"score_spread":0.31517241087982706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415665469","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013539576,0.6408998,0.0026414082,0.33366495,0.0048238174,0.0006667139,0.00010618588,0.00014501979,0.0035125543],"genre_scores_gemma":[0.9779794,0.012461622,0.0011006339,0.006882795,0.00007982535,0.000010246544,0.000005062574,0.000045084224,0.0014353344],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9951721,0.00023661788,0.002386765,0.00038567904,0.00040316422,0.0014156834],"domain_scores_gemma":[0.9961999,0.00018244227,0.0014401209,0.0008550036,0.0009736961,0.00034883866],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0020216478,0.00045212827,0.0015248491,0.0032994214,0.0006622125,0.00010440166,0.0008704488,0.0007242947,0.0004887805],"category_scores_gemma":[0.0013545371,0.00043541356,0.0003266519,0.0020702116,0.0012625675,0.00022492715,0.0000413646,0.0021914735,0.000054258544],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00018954325,0.00010238393,0.004132659,0.00085281406,0.00048009946,0.0006744633,0.0005126016,0.00002438641,0.00014496311,0.008587321,0.12700477,0.85729396],"study_design_scores_gemma":[0.0050877086,0.0015997362,0.004811669,0.008455426,0.00014729638,0.00073279656,0.0071532535,0.000034896693,0.0028366658,0.01949068,0.9492883,0.0003615802],"about_ca_topic_score_codex":0.006565027,"about_ca_topic_score_gemma":0.0051049166,"teacher_disagreement_score":0.9644398,"about_ca_system_score_codex":0.003951386,"about_ca_system_score_gemma":0.03980915,"threshold_uncertainty_score":0.99987227},"labels":[],"label_agreement":null},{"id":"W4415701669","doi":"10.51731/cjht.2025.1279","title":"Leuprolide Mesylate (Camcevi)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Mesylate; Drug; Prostate cancer; Clinical Practice; Patient care","score_opus":0.023287962214125102,"score_gpt":0.3173228180496364,"score_spread":0.2940348558355113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415701669","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.029826526,0.7350394,0.00023101311,0.2290394,0.0031197763,0.00083560194,0.00007301387,0.00007703467,0.0017582336],"genre_scores_gemma":[0.940774,0.05487799,0.0003510334,0.0032279238,0.00003700285,0.000027292119,0.000004020927,0.000027939239,0.0006727535],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99607444,0.00012554842,0.0018325092,0.00036232403,0.0002683968,0.0013367566],"domain_scores_gemma":[0.997135,0.00015148651,0.0011306399,0.00067478156,0.00055944757,0.00034864713],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012426112,0.00041310702,0.0014164661,0.002141472,0.000574623,0.00011184562,0.0006167985,0.00040992108,0.00012487939],"category_scores_gemma":[0.0010952061,0.00034634658,0.00031513724,0.0011642944,0.0006377095,0.00018346167,0.000058944046,0.0012026092,0.000033602362],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0000600686,0.00008167922,0.0416059,0.00077685784,0.0005784017,0.0010013911,0.0002838523,0.000012691405,0.000005954323,0.0040691523,0.037031066,0.91449296],"study_design_scores_gemma":[0.002937702,0.002565255,0.032631002,0.008889939,0.0003696357,0.00031065525,0.005019464,0.000018095647,0.0022019134,0.009803463,0.9349588,0.0002940353],"about_ca_topic_score_codex":0.010650426,"about_ca_topic_score_gemma":0.006190591,"teacher_disagreement_score":0.91419894,"about_ca_system_score_codex":0.0040602293,"about_ca_system_score_gemma":0.030011175,"threshold_uncertainty_score":0.99989885},"labels":[],"label_agreement":null},{"id":"W4415701678","doi":"10.51731/cjht.2025.1277","title":"Pasireotide (Signifor LAR)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pasireotide; Acromegaly; Drug; Reimbursement; Clinical trial","score_opus":0.0184588778501626,"score_gpt":0.29283037601966344,"score_spread":0.27437149816950085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415701678","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03928809,0.78200424,0.0009454275,0.16868012,0.0026350927,0.00076895277,0.00009144178,0.00009094124,0.005495699],"genre_scores_gemma":[0.98571557,0.010605172,0.00037080393,0.0021833384,0.000019479843,0.0000065357735,0.0000066379885,0.000018152603,0.0010743241],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99707884,0.00009144962,0.0012783471,0.0002556899,0.00020810305,0.0010875935],"domain_scores_gemma":[0.9982104,0.000104586325,0.00064202567,0.00047330683,0.00029234047,0.0002773671],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007404468,0.00032325657,0.001031165,0.0018454884,0.00059641036,0.000058801525,0.00048868265,0.00034455323,0.000107044485],"category_scores_gemma":[0.000996582,0.00026276565,0.000250167,0.00087011256,0.00043451827,0.00015174792,0.000036525238,0.00084211817,0.00003338619],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007590504,0.00014192176,0.1197526,0.0005829524,0.0005718692,0.0015259876,0.00022510823,0.0000061802057,0.0000030614024,0.004236876,0.036801994,0.83607554],"study_design_scores_gemma":[0.0077105514,0.003532429,0.09264525,0.0061005824,0.0005484271,0.00061513146,0.01900784,0.000028663795,0.000367573,0.05671001,0.8122788,0.00045471618],"about_ca_topic_score_codex":0.01226588,"about_ca_topic_score_gemma":0.009889774,"teacher_disagreement_score":0.94642746,"about_ca_system_score_codex":0.0009981937,"about_ca_system_score_gemma":0.017635902,"threshold_uncertainty_score":0.9999825},"labels":[],"label_agreement":null},{"id":"W4415739209","doi":"10.51731/cjht.2025.1280","title":"CT and MRI Examination Volumes in Canada: National Performance Insights","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Radiology practices and education","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Workload; Computed tomography; Rural area; Mri scan; Medical imaging","score_opus":0.021320663810881987,"score_gpt":0.28460327527161977,"score_spread":0.2632826114607378,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415739209","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7513605,0.16932295,0.000014355155,0.07717348,0.0013454111,0.00021257008,0.000004742092,0.0000068708778,0.00055911666],"genre_scores_gemma":[0.9795485,0.0190695,0.00012754506,0.0010254998,0.000023471719,0.0000056113518,0.0000037671673,0.000006625426,0.00018947426],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9980503,0.00015462238,0.0009292554,0.0001909704,0.00021132393,0.00046357277],"domain_scores_gemma":[0.9984304,0.0002306747,0.00068771886,0.00014697948,0.00039382593,0.00011040357],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001403413,0.00015894124,0.00047724615,0.0017424929,0.00033572552,0.000031919393,0.00021907326,0.000111266294,0.000018090035],"category_scores_gemma":[0.0017195772,0.00015147359,0.00002386788,0.00073311775,0.0002617469,0.00036022157,0.000017043718,0.00089600653,0.0000012234618],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000017862985,0.000019739264,0.2902474,0.00041675757,0.00005958646,0.000105609295,0.0005446323,0.00008867087,0.0000036231456,0.0010416935,0.0074245087,0.7000299],"study_design_scores_gemma":[0.0006661433,0.00026859643,0.87242603,0.0012320683,0.000028948964,0.00048626555,0.016971061,0.0016835097,0.000055375196,0.0007943304,0.105270684,0.00011698365],"about_ca_topic_score_codex":0.83242005,"about_ca_topic_score_gemma":0.96674865,"teacher_disagreement_score":0.6999129,"about_ca_system_score_codex":0.0063692518,"about_ca_system_score_gemma":0.08785357,"threshold_uncertainty_score":0.9974451},"labels":[],"label_agreement":null},{"id":"W4415739231","doi":"10.51731/cjht.2025.1278","title":"Belantamab Mafodotin (Blenrep), Bortezomib, Dexamethasone","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dexamethasone; Bortezomib; Multiple myeloma; Refractory (planetary science); Drug","score_opus":0.034661680369379236,"score_gpt":0.3464443294400952,"score_spread":0.31178264907071596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415739231","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13062948,0.69158405,0.0011765587,0.16820796,0.0025635678,0.0017846694,0.0001993812,0.00017527718,0.0036790585],"genre_scores_gemma":[0.97866935,0.016420646,0.002138383,0.0009377852,0.000040849984,0.00001783987,0.00001255482,0.00004014506,0.0017224657],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99437463,0.00035262998,0.0020170745,0.0004827521,0.0005696299,0.0022032808],"domain_scores_gemma":[0.99615306,0.00042871787,0.0010374178,0.0009446645,0.00073377456,0.00070235715],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0023291602,0.00050421496,0.0016467506,0.0038164787,0.0008512955,0.00013532239,0.0010006342,0.0006355167,0.00028756438],"category_scores_gemma":[0.0050772736,0.00043409242,0.00034874774,0.0017924759,0.00095942814,0.00020809821,0.00011411198,0.0021947366,0.0000866706],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024698168,0.00012530216,0.07667623,0.00085738866,0.0009168677,0.003125607,0.0002003895,0.00000468444,0.000041429557,0.0015751213,0.015547537,0.90068245],"study_design_scores_gemma":[0.02052365,0.007862079,0.34124866,0.015762415,0.0007925316,0.0030169804,0.025285304,0.00022131363,0.006101716,0.016190607,0.561981,0.0010137166],"about_ca_topic_score_codex":0.026443634,"about_ca_topic_score_gemma":0.012556538,"teacher_disagreement_score":0.89966875,"about_ca_system_score_codex":0.0031423366,"about_ca_system_score_gemma":0.034135956,"threshold_uncertainty_score":0.9998111},"labels":[],"label_agreement":null},{"id":"W4415877972","doi":"10.51731/cjht.2025.1282","title":"Risankizumab (Skyrizi)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ulcerative colitis; Drug; Population; Disease; Orphan drug; Tofacitinib","score_opus":0.008277496548169965,"score_gpt":0.2622596702949909,"score_spread":0.25398217374682097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415877972","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3469604,0.5878081,0.0016455095,0.052165326,0.0046083834,0.0008376431,0.00019178483,0.00007050337,0.005712342],"genre_scores_gemma":[0.99382526,0.0037342582,0.00031850315,0.0014759196,0.00004181239,0.0000070602714,0.00000869504,0.00002632352,0.0005621453],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969438,0.00021439976,0.0013054836,0.00035023896,0.00016920039,0.0010169116],"domain_scores_gemma":[0.99764323,0.00002282613,0.0008737114,0.00078563945,0.0004409846,0.00023360786],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010145848,0.00034433356,0.00054615183,0.001054406,0.0005755144,0.00010230502,0.0011595351,0.00068644236,0.000047794285],"category_scores_gemma":[0.0013205061,0.00035550442,0.00029340276,0.00044743222,0.00077303976,0.000014305556,0.00011506884,0.0007379786,0.000015316125],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002293803,0.00006830185,0.018787453,0.0008290745,0.00050127564,0.0014606455,0.0001570208,0.0000865379,0.00037670563,0.005378586,0.08202372,0.8901013],"study_design_scores_gemma":[0.0012718457,0.00047070108,0.02542013,0.0007852631,0.00007843507,0.0001640257,0.0031219376,0.000015787944,0.0024720824,0.0042859702,0.96151483,0.00039898223],"about_ca_topic_score_codex":0.0008457448,"about_ca_topic_score_gemma":0.0050817425,"teacher_disagreement_score":0.8897023,"about_ca_system_score_codex":0.0006156562,"about_ca_system_score_gemma":0.027519464,"threshold_uncertainty_score":0.9998897},"labels":[],"label_agreement":null},{"id":"W4415877993","doi":"10.51731/cjht.2025.1281","title":"Ibrutinib","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ibrutinib; Reimbursement; Cancer; Antineoplastic Drugs; Cancer drugs; Drug","score_opus":0.02848752115301347,"score_gpt":0.3536033925155721,"score_spread":0.32511587136255865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415877993","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03266925,0.7580184,0.00062827073,0.1956814,0.0037077344,0.00090006104,0.000034279954,0.00011686178,0.008243754],"genre_scores_gemma":[0.9849773,0.01005466,0.0004224365,0.0018896158,0.00004931789,0.000006268848,0.0000020259977,0.000030164343,0.002568208],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9949184,0.00021319924,0.0020558352,0.0003543186,0.00052435725,0.0019339108],"domain_scores_gemma":[0.9965583,0.00038711666,0.00086270715,0.0009576798,0.00081070483,0.00042350226],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0030033716,0.0003485277,0.0013174785,0.0036553934,0.000624529,0.00011749964,0.0013034504,0.0006835221,0.0002652364],"category_scores_gemma":[0.0066827647,0.00031126768,0.00028388604,0.0021495258,0.0015377279,0.00015767492,0.00012833717,0.002172374,0.00008633458],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00010025363,0.00004771821,0.0015947067,0.0017152518,0.00036249025,0.0019510112,0.00042630703,0.000017166114,0.000015227961,0.008442501,0.08906258,0.8962648],"study_design_scores_gemma":[0.011474279,0.0014173603,0.0019208168,0.0075706504,0.00013032548,0.0017435929,0.012665262,0.00039111736,0.0011420342,0.007692214,0.95357424,0.0002781263],"about_ca_topic_score_codex":0.031988394,"about_ca_topic_score_gemma":0.0066744606,"teacher_disagreement_score":0.95230806,"about_ca_system_score_codex":0.05812175,"about_ca_system_score_gemma":0.42700884,"threshold_uncertainty_score":0.99993396},"labels":[],"label_agreement":null},{"id":"W4415963750","doi":"10.51731/cjht.2025.1283","title":"Darolutamide (Nubeqa)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Enzalutamide; Prostate cancer; Androgen deprivation therapy; Abiraterone acetate; Abiraterone; Placebo","score_opus":0.032991687298584586,"score_gpt":0.357982561488245,"score_spread":0.3249908741896604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415963750","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.033526633,0.7035656,0.00020673749,0.2560055,0.0024283226,0.0006492794,0.000050777166,0.00006866153,0.003498498],"genre_scores_gemma":[0.9629435,0.03131777,0.00022717757,0.001267617,0.00003609764,0.000010055458,0.0000042469533,0.000023070374,0.0041704914],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99635035,0.00015178965,0.00135436,0.00029365145,0.00035625868,0.0014935982],"domain_scores_gemma":[0.99769235,0.0001499646,0.0006129743,0.00058319984,0.0006229027,0.00033861172],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015855586,0.00031260564,0.001076719,0.0031206813,0.0007153296,0.0000994899,0.0007589969,0.00044658882,0.00014401472],"category_scores_gemma":[0.0014353588,0.00025250972,0.00023957767,0.0015771686,0.0011222516,0.00016640121,0.00006963653,0.0016960307,0.00003463945],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001465753,0.000059833976,0.017938891,0.0009364994,0.0004768112,0.0012120534,0.00035192366,0.0000062884333,0.000051597053,0.0021628407,0.04576395,0.9308927],"study_design_scores_gemma":[0.0049729166,0.0028425262,0.03499157,0.008088119,0.00023654968,0.00039964556,0.017599087,0.000040215677,0.0037266563,0.013283455,0.91348755,0.00033170867],"about_ca_topic_score_codex":0.008234777,"about_ca_topic_score_gemma":0.0047931084,"teacher_disagreement_score":0.930561,"about_ca_system_score_codex":0.0036522727,"about_ca_system_score_gemma":0.049087558,"threshold_uncertainty_score":0.9999927},"labels":[],"label_agreement":null},{"id":"W4416122867","doi":"10.51731/cjht.2025.1284","title":"Tofacitinib","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tofacitinib; Reimbursement; Psoriatic arthritis; Drug; Rheumatoid arthritis; Tocilizumab; Alternative medicine; Cancer; Plaque psoriasis","score_opus":0.029908767246662703,"score_gpt":0.33742750736823446,"score_spread":0.30751874012157177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416122867","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.033770327,0.7570944,0.00057729287,0.19483314,0.0016609424,0.00062540395,0.00003336295,0.00008065027,0.011324483],"genre_scores_gemma":[0.98116684,0.014397564,0.00013852994,0.0014460245,0.000015433592,0.0000063371176,0.0000030430654,0.000020662263,0.0028055406],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959894,0.00016908022,0.0019696967,0.00023263863,0.0003293668,0.0013098501],"domain_scores_gemma":[0.9975863,0.000115029274,0.0007965815,0.00062112155,0.000673584,0.000207369],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002230048,0.00027279233,0.0011934774,0.0031145888,0.00070474326,0.00009144953,0.0008788617,0.00050371874,0.00048252725],"category_scores_gemma":[0.0033035025,0.00024765104,0.00025555716,0.0014228565,0.0010764624,0.00019866333,0.00007244143,0.0019801508,0.000065076514],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004242046,0.00003379776,0.015147961,0.0008624599,0.00021100078,0.00040822,0.0003498311,0.0000043175983,0.00002354372,0.0068121282,0.045543827,0.93056047],"study_design_scores_gemma":[0.0014738032,0.000794891,0.015334863,0.003072766,0.000046064863,0.00016231647,0.021247884,0.000022957342,0.000534956,0.004918298,0.9522276,0.00016360368],"about_ca_topic_score_codex":0.004615177,"about_ca_topic_score_gemma":0.0015751623,"teacher_disagreement_score":0.9473965,"about_ca_system_score_codex":0.0011260404,"about_ca_system_score_gemma":0.050682575,"threshold_uncertainty_score":0.99999756},"labels":[],"label_agreement":null},{"id":"W4416187047","doi":"10.51731/cjht.2025.1285","title":"Guselkumab (Tremfya)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Drug; Population; Disease; Ulcerative colitis; Public health; Orphan drug","score_opus":0.008829841954949316,"score_gpt":0.260861636096316,"score_spread":0.2520317941413667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416187047","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3620258,0.5642067,0.001301809,0.062011182,0.004207655,0.00079274754,0.00017433226,0.00007205218,0.005207711],"genre_scores_gemma":[0.9938228,0.0037445545,0.0002920873,0.0014156655,0.000037758695,0.000006724664,0.000008103599,0.000026261163,0.00064603746],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970666,0.00019605234,0.0012480973,0.00033971976,0.00016372374,0.0009857628],"domain_scores_gemma":[0.9976145,0.00002117486,0.0008122363,0.0007944751,0.00052845804,0.0002291692],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009788625,0.00033253268,0.000522877,0.0010799901,0.0005594551,0.00010116459,0.0011491396,0.0006474943,0.000039722432],"category_scores_gemma":[0.0013781358,0.0003442903,0.00028190602,0.00045668863,0.0007102526,0.000013961114,0.000108329215,0.00067993836,0.00001623313],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019732774,0.00008314662,0.018883066,0.00091656717,0.0005815552,0.001539681,0.00016773745,0.00009783089,0.00071941275,0.0059133326,0.09418263,0.8767177],"study_design_scores_gemma":[0.0011562047,0.00043223682,0.022234622,0.0007791055,0.00007975619,0.00015162522,0.0029482527,0.000013906166,0.0035469553,0.0032368726,0.9650339,0.00038655018],"about_ca_topic_score_codex":0.0007084833,"about_ca_topic_score_gemma":0.0064621433,"teacher_disagreement_score":0.87633115,"about_ca_system_score_codex":0.0005934899,"about_ca_system_score_gemma":0.02664858,"threshold_uncertainty_score":0.99990094},"labels":[],"label_agreement":null},{"id":"W4416247422","doi":"10.51731/cjht.2025.1286","title":"Belzutifan (Welireg)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Drug approval; MEDLINE; Drug; Clinical trial","score_opus":0.02073411329293563,"score_gpt":0.3122605198815232,"score_spread":0.2915264065885876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416247422","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018083444,0.7137969,0.000387107,0.26071557,0.004270312,0.00045361114,0.000031573585,0.000071024755,0.0021904453],"genre_scores_gemma":[0.9676023,0.025222732,0.0003133842,0.005248791,0.000039589584,0.00000488771,0.0000022751453,0.00002209289,0.0015439207],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99649256,0.00012749975,0.0017579731,0.00026401322,0.00025168862,0.0011062598],"domain_scores_gemma":[0.99753433,0.00011027359,0.000982061,0.0006178151,0.00055929687,0.0001962307],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018100342,0.00031849561,0.0010251999,0.0024695424,0.0006595084,0.00008572845,0.00077658123,0.0005333355,0.00023904338],"category_scores_gemma":[0.0011247927,0.00028163203,0.0002957043,0.0019914284,0.001052798,0.00013600162,0.000037278383,0.0012818855,0.000015129099],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002463654,0.000034144112,0.005499676,0.00052474975,0.00044639513,0.00019406127,0.00033685687,0.0000015730324,0.00011502613,0.0014962229,0.04852746,0.9425775],"study_design_scores_gemma":[0.0022639188,0.0012856851,0.018438505,0.0050552697,0.00011699776,0.00034439703,0.010113916,0.000006389498,0.0011489228,0.0024460924,0.95856553,0.00021436755],"about_ca_topic_score_codex":0.017960893,"about_ca_topic_score_gemma":0.01170799,"teacher_disagreement_score":0.94951886,"about_ca_system_score_codex":0.0022986606,"about_ca_system_score_gemma":0.035836466,"threshold_uncertainty_score":0.9999636},"labels":[],"label_agreement":null},{"id":"W4416333304","doi":"10.51731/cjht.2025.1287","title":"Quetiapine for Insomnia","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Sleep and related disorders","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quetiapine; Quetiapine Fumarate; Insomnia; Atypical antipsychotic; Antipsychotic; Schizophrenia (object-oriented programming); Bipolar disorder","score_opus":0.020782159443599214,"score_gpt":0.3343337592579555,"score_spread":0.31355159981435626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416333304","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0053344457,0.72111523,0.0032411057,0.25663474,0.00733919,0.0009458083,0.00005459029,0.00010017574,0.005234722],"genre_scores_gemma":[0.98297775,0.011379131,0.00060913124,0.003242194,0.000029137214,0.000027183502,0.0000042824595,0.000036218888,0.0016949667],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964402,0.00017100963,0.0016584588,0.00032895745,0.00011947017,0.0012819492],"domain_scores_gemma":[0.9976125,0.00024252517,0.0010311665,0.0005553328,0.0003869172,0.00017159131],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013094803,0.00032485035,0.0008744231,0.0029848658,0.0007295717,0.00007073872,0.001058197,0.0011170119,0.00014938103],"category_scores_gemma":[0.0013092033,0.0003025841,0.00031379593,0.0012419587,0.00079248,0.00008075316,0.000031624484,0.0013797751,0.000029701447],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000081707636,0.00008414934,0.0012508641,0.00027427357,0.000826493,0.000058724116,0.0007047102,0.000021214715,0.0000033599379,0.047741704,0.19537668,0.7535761],"study_design_scores_gemma":[0.0031493085,0.0010007935,0.0009103587,0.0009192138,0.0001637977,0.00009401611,0.01467966,0.000015830828,0.000050766383,0.03645259,0.9423368,0.0002268904],"about_ca_topic_score_codex":0.008348547,"about_ca_topic_score_gemma":0.009074983,"teacher_disagreement_score":0.9776433,"about_ca_system_score_codex":0.0006783846,"about_ca_system_score_gemma":0.010467712,"threshold_uncertainty_score":0.9999426},"labels":[],"label_agreement":null},{"id":"W4416333309","doi":"10.51731/cjht.2025.1289","title":"Talazoparib (Talzenna)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Enzalutamide; Prostate cancer; Androgen receptor; Drug; Prostate; Cancer","score_opus":0.0350540873413844,"score_gpt":0.3577037633705603,"score_spread":0.32264967602917594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416333309","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02114425,0.7237735,0.00019518651,0.2476508,0.0026453568,0.00067089475,0.0000491719,0.00006792737,0.0038029288],"genre_scores_gemma":[0.9661069,0.028115928,0.0001875111,0.00096211716,0.000033669745,0.000010766452,0.00000555991,0.00002270431,0.004554863],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964851,0.00013520378,0.0012748833,0.00029173237,0.0003401069,0.0014729645],"domain_scores_gemma":[0.9977227,0.00012398261,0.00061973475,0.0005559745,0.0006344492,0.0003431513],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014560759,0.00031558034,0.0010502909,0.002899749,0.0007134188,0.00010717752,0.00072217296,0.00045428186,0.00016409012],"category_scores_gemma":[0.001223892,0.00025506222,0.00024270911,0.0015887413,0.0011406562,0.00016749508,0.00007298431,0.0016549125,0.000038258528],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013459501,0.00007746575,0.021210039,0.0009812802,0.00049508945,0.0012720801,0.00032233936,0.0000043475347,0.000045201818,0.0038904063,0.057324085,0.91424304],"study_design_scores_gemma":[0.0041596415,0.0025685064,0.019032743,0.006263385,0.00019376968,0.00040499886,0.013425426,0.000031894655,0.0026678883,0.010696045,0.9402637,0.0002920116],"about_ca_topic_score_codex":0.0064490004,"about_ca_topic_score_gemma":0.0034692248,"teacher_disagreement_score":0.9449626,"about_ca_system_score_codex":0.0031673678,"about_ca_system_score_gemma":0.0421326,"threshold_uncertainty_score":0.99999017},"labels":[],"label_agreement":null},{"id":"W4416422277","doi":"10.51731/cjht.2025.1290","title":"Asynchronous Teleultrasound and In-Person Ultrasound: Comparing Diagnostic Accuracy","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Ultrasound in Clinical Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Comparability; Asynchronous communication; Economic shortage; Health care; Quality (philosophy); Variety (cybernetics); Ultrasound","score_opus":0.042321628627171835,"score_gpt":0.34297256021545847,"score_spread":0.30065093158828665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416422277","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.67702043,0.26906246,0.0014095155,0.049238633,0.0010138565,0.0011462601,0.000044363154,0.00008540642,0.0009790678],"genre_scores_gemma":[0.97251695,0.024407536,0.0015631184,0.0013445141,0.000044081127,0.000033842243,0.000007732173,0.00003303089,0.00004916788],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9951489,0.00020662906,0.00246637,0.0005427927,0.00028583928,0.0013494638],"domain_scores_gemma":[0.98172665,0.015443899,0.0012885017,0.00076133275,0.00036646987,0.000413158],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00215241,0.00045639547,0.0016514978,0.002052081,0.0006646997,0.00019544324,0.000856639,0.0006199352,0.0000789747],"category_scores_gemma":[0.056134317,0.0004456068,0.00017193932,0.001679865,0.0016965427,0.00028704864,0.000048628972,0.0028394114,0.000020383826],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004978481,0.00018387711,0.73632044,0.00082064635,0.00020083015,0.00014172107,0.0008029031,0.000054838198,0.00010659235,0.0037055612,0.0024400994,0.2551727],"study_design_scores_gemma":[0.003111431,0.0010277235,0.8886375,0.0072279074,0.0002560002,0.0012020996,0.024041675,0.000054862816,0.00025418968,0.015428073,0.058245048,0.0005135108],"about_ca_topic_score_codex":0.011950504,"about_ca_topic_score_gemma":0.026604308,"teacher_disagreement_score":0.29549652,"about_ca_system_score_codex":0.0022935115,"about_ca_system_score_gemma":0.011260791,"threshold_uncertainty_score":0.99979955},"labels":[],"label_agreement":null},{"id":"W4416504022","doi":"10.51731/cjht.2025.1291","title":"Flexible Dentures for Edentulism","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Dental materials and restorations","field":"Dentistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Edentulism; Dentures; Removable partial denture; Clinical trial; Randomized controlled trial; Prosthodontics","score_opus":0.027524304142649624,"score_gpt":0.33960887139606766,"score_spread":0.31208456725341804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416504022","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.18271413,0.6658803,0.008519562,0.10057975,0.038037516,0.0018996655,0.0009178259,0.00023276407,0.0012184513],"genre_scores_gemma":[0.9929364,0.0026882072,0.00060290523,0.0007345534,0.00006992205,0.000022140803,0.0000073358656,0.000024523015,0.002914044],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99705344,0.000103154256,0.0015469021,0.00024887323,0.00019567383,0.0008519672],"domain_scores_gemma":[0.9979198,0.000118576514,0.0010486232,0.00042758405,0.00033437772,0.00015102494],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00095747283,0.00027191837,0.00074358005,0.0015109257,0.0011731588,0.0004641122,0.0010032399,0.0005146731,0.00009304714],"category_scores_gemma":[0.0010639806,0.00025067438,0.00027051283,0.0005989306,0.00043410208,0.0002441676,0.000064406835,0.000518976,0.000029474375],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011225652,0.0001228411,0.0022887278,0.0016814106,0.00049035373,0.00033400365,0.00037451534,0.00019553574,0.0006483332,0.07360794,0.3602754,0.5598687],"study_design_scores_gemma":[0.001088253,0.0004340405,0.0094947815,0.0014849993,0.00007500263,0.00026604455,0.006039354,0.000009280469,0.004360893,0.03967513,0.93681854,0.00025366235],"about_ca_topic_score_codex":0.004616266,"about_ca_topic_score_gemma":0.014283781,"teacher_disagreement_score":0.8102222,"about_ca_system_score_codex":0.000904164,"about_ca_system_score_gemma":0.008524277,"threshold_uncertainty_score":0.9999946},"labels":[],"label_agreement":null},{"id":"W4416744877","doi":"10.51731/cjht.2025.1292","title":"Quetiapine for Major Depressive Disorder","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Treatment of Major Depression","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Science and Technology Department of Zhejiang Province; National Laboratory of Pattern Recognition; U.S. Department of Defense; Canadian Network for Mood and Anxiety Treatments; China Postdoctoral Science Foundation; U.S. Department of Veterans Affairs; West China Hospital, Sichuan University; Department of Science and Technology of Sichuan Province; National Natural Science Foundation of China","keywords":"Quetiapine; Atypical antipsychotic; Major depressive disorder; Guideline; Quetiapine Fumarate; Anxiety; Schizophrenia (object-oriented programming); Bipolar disorder","score_opus":0.018287283221420477,"score_gpt":0.31778504392077667,"score_spread":0.2994977606993562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416744877","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02244967,0.7125898,0.006328586,0.2537595,0.0022186032,0.0019734325,0.000116677795,0.00012336002,0.00044037536],"genre_scores_gemma":[0.9881086,0.006347324,0.0023587816,0.0011931278,0.00005140641,0.00007188281,0.000013315302,0.000049992097,0.0018055899],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99613976,0.0001297773,0.0017038254,0.0004300892,0.00028881704,0.001307744],"domain_scores_gemma":[0.99650735,0.00036924682,0.0013451696,0.00075926044,0.00071954133,0.0002994057],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008884104,0.00045912332,0.0013599945,0.002420282,0.0008810036,0.000080530015,0.00079289725,0.0006525592,0.00007794426],"category_scores_gemma":[0.0036415095,0.00038195282,0.00036524932,0.0007968243,0.0006086942,0.00020085958,0.00007566883,0.0010200231,0.000010539825],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026565965,0.00016035573,0.03719088,0.0015676833,0.0006220169,0.00026344653,0.00022407479,0.000023713126,0.000051909974,0.0035272539,0.055265043,0.90083796],"study_design_scores_gemma":[0.014017494,0.0037206353,0.037888873,0.011710654,0.0008763122,0.0003441452,0.006622588,0.00008035175,0.003268124,0.020680914,0.90030307,0.00048683787],"about_ca_topic_score_codex":0.006573052,"about_ca_topic_score_gemma":0.0091118775,"teacher_disagreement_score":0.9656589,"about_ca_system_score_codex":0.0015499454,"about_ca_system_score_gemma":0.014547147,"threshold_uncertainty_score":0.99986327},"labels":[],"label_agreement":null},{"id":"W4416744889","doi":"10.51731/cjht.2025.1295","title":"Injectable Opioid Agonist Treatment for Patients With Opioid Use Disorder: An Updated Review of Clinical and Cost-Effectiveness","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Hydromorphone; Opioid; Adverse effect; Agonist; Opioid use disorder; Disease","score_opus":0.04495310668926925,"score_gpt":0.37513746105256024,"score_spread":0.33018435436329097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416744889","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.52903765,0.45327136,0.0003498573,0.0066506625,0.00085005123,0.008839833,0.00092522136,0.000053320673,0.000022033848],"genre_scores_gemma":[0.8091954,0.18792857,0.0015601004,0.0006309605,0.000013841224,0.00024501755,0.00031261373,0.000055584118,0.000057925117],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9949235,0.00052012806,0.0026700823,0.0006188512,0.00029230904,0.0009751804],"domain_scores_gemma":[0.9948969,0.0005609423,0.001819306,0.00089421554,0.0013984033,0.00043024647],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001529543,0.00060009165,0.0029092873,0.0009761797,0.00051217404,0.000074708,0.00041703923,0.00042709554,0.00002254172],"category_scores_gemma":[0.0017767596,0.00044102143,0.00028999086,0.0008909829,0.0010231402,0.00035970256,0.00005096671,0.0005824408,9.237006e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007624492,0.0011263023,0.4994414,0.009341545,0.00069222064,0.000025053225,0.0001644794,0.0000034686789,4.8330895e-7,0.00026204987,0.0007528584,0.4874277],"study_design_scores_gemma":[0.023631243,0.0508249,0.55855554,0.057362832,0.0020798857,0.00003896953,0.0033817762,0.000042079315,0.00016007427,0.00066712743,0.30269048,0.00056509697],"about_ca_topic_score_codex":0.015046379,"about_ca_topic_score_gemma":0.007536404,"teacher_disagreement_score":0.4868626,"about_ca_system_score_codex":0.001259376,"about_ca_system_score_gemma":0.019400941,"threshold_uncertainty_score":0.99980414},"labels":[],"label_agreement":null},{"id":"W4416817506","doi":"10.51731/cjht.2025.1296","title":"Omaveloxolone (Skyclarys)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Drug; MEDLINE; Clinical Practice; Drug approval","score_opus":0.03355986091341648,"score_gpt":0.301689674879214,"score_spread":0.2681298139657975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416817506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.59422016,0.25760564,0.0012792043,0.13897227,0.0057713888,0.00079029746,0.00016691799,0.00013822214,0.0010559302],"genre_scores_gemma":[0.9900366,0.0040892605,0.0003710464,0.0048555615,0.000017711267,0.000006411585,7.165144e-7,0.000028354125,0.00059435575],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.995444,0.0005530367,0.0016807811,0.00056578225,0.0003731387,0.0013832656],"domain_scores_gemma":[0.99698156,0.00028563425,0.001162964,0.0008074899,0.00045822875,0.00030414932],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00088247494,0.00042512093,0.0009021022,0.0027005728,0.0011280804,0.00022303777,0.0019348474,0.00032130166,0.0000950715],"category_scores_gemma":[0.00662527,0.00041991528,0.0002518745,0.0021441905,0.0015451269,0.00022176241,0.00013774967,0.0012209235,0.000037561458],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000073928284,0.0002138485,0.012248253,0.0008351428,0.00012109303,0.0016019811,0.0007845072,0.00039131165,0.012454226,0.01881871,0.057886813,0.8945702],"study_design_scores_gemma":[0.0016379703,0.0016573097,0.043551818,0.0019298984,0.000119925884,0.0005084332,0.006402137,0.00007906163,0.561997,0.016964812,0.36438066,0.0007709983],"about_ca_topic_score_codex":0.0016998134,"about_ca_topic_score_gemma":0.002451777,"teacher_disagreement_score":0.8937992,"about_ca_system_score_codex":0.0007954685,"about_ca_system_score_gemma":0.02360834,"threshold_uncertainty_score":0.99982524},"labels":[],"label_agreement":null},{"id":"W4416864806","doi":"10.51731/cjht.2025.1298","title":"Delgocitinib (Anzupgo)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Contact Dermatitis and Allergies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Drug; Clinical trial; Public health; Pharmacotherapy; MEDLINE","score_opus":0.01991656212034417,"score_gpt":0.29696586819643467,"score_spread":0.2770493060760905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416864806","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03404412,0.66421205,0.00076175225,0.28835568,0.003904407,0.0005263608,0.000054232725,0.000112267706,0.008029129],"genre_scores_gemma":[0.96930766,0.024438769,0.00041372865,0.0044937935,0.000041444226,0.0000052519954,0.0000027337503,0.000021774145,0.001274845],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963127,0.00012046167,0.0019226879,0.00024135035,0.00026515903,0.0011376733],"domain_scores_gemma":[0.9973845,0.00017641453,0.0010267709,0.00055524707,0.0006093486,0.00024771897],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010996724,0.0003340891,0.0012457825,0.0023972988,0.0006587194,0.00014153567,0.0007379428,0.00043925658,0.00026861337],"category_scores_gemma":[0.0020338027,0.00030386806,0.000296077,0.0010081645,0.0005950368,0.00021383996,0.000060749462,0.0014409606,0.000029849703],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021848087,0.00002967446,0.008390531,0.00070961163,0.00026932042,0.00076758466,0.00040041667,0.000004514223,0.00001821687,0.01551065,0.057844833,0.9160328],"study_design_scores_gemma":[0.0015757679,0.0007144445,0.03188063,0.0065264944,0.00010282859,0.0005253857,0.013187113,0.000028477769,0.00037857966,0.008832985,0.9360082,0.00023905195],"about_ca_topic_score_codex":0.011829475,"about_ca_topic_score_gemma":0.016052183,"teacher_disagreement_score":0.9352635,"about_ca_system_score_codex":0.0012181515,"about_ca_system_score_gemma":0.024751954,"threshold_uncertainty_score":0.99994135},"labels":[],"label_agreement":null},{"id":"W4416917498","doi":"10.51731/cjht.2025.1299","title":"Fecal Microbiota (Rebyota)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Clostridium difficile and Clostridium perfringens research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Clostridioides; Antibiotics; Antibiotic therapy; Drug; Public health; Pharmacotherapy","score_opus":0.02828175753638394,"score_gpt":0.3278995271824078,"score_spread":0.2996177696460238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416917498","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22622336,0.541803,0.00015304411,0.22520639,0.0028895058,0.0008096364,0.00013473348,0.00009184111,0.0026884684],"genre_scores_gemma":[0.98095083,0.015423037,0.00018573621,0.0011981868,0.000076514225,0.0000058298588,0.000007395206,0.000037619513,0.0021148573],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9946352,0.00022861401,0.0021471402,0.00046741677,0.000464391,0.0020571926],"domain_scores_gemma":[0.9965841,0.0002541907,0.00077981275,0.000939311,0.0009657536,0.00047678786],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0020637994,0.0004730864,0.0015048013,0.0038665992,0.0008337156,0.00017047711,0.0012868351,0.0008373266,0.00033941082],"category_scores_gemma":[0.0032767945,0.0004389018,0.0004429884,0.0024286304,0.0012808158,0.00012364471,0.00016295984,0.0030541029,0.000098649296],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016722248,0.0001617024,0.0045900047,0.0014449019,0.0004795635,0.0012330755,0.00025381113,0.000008686018,0.0032107215,0.0019091541,0.13568208,0.8508591],"study_design_scores_gemma":[0.0029612726,0.002050206,0.006433346,0.006062688,0.00021562105,0.00093247567,0.011639992,0.0000383969,0.03611585,0.0009251761,0.932189,0.00043595873],"about_ca_topic_score_codex":0.010593299,"about_ca_topic_score_gemma":0.004527466,"teacher_disagreement_score":0.8504231,"about_ca_system_score_codex":0.0035438347,"about_ca_system_score_gemma":0.046995014,"threshold_uncertainty_score":0.9998063},"labels":[],"label_agreement":null},{"id":"W4417044153","doi":"10.51731/cjht.2025.1301","title":"Vanzacaftor-Tezacaftor-Deutivacaftor (Alyftrek)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cystic fibrosis; Drug; Mutation; Cystic fibrosis transmembrane conductance regulator; Public health","score_opus":0.02383383768169574,"score_gpt":0.3518872957391622,"score_spread":0.3280534580574665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417044153","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06484376,0.8346023,0.0019369124,0.09163158,0.0019468202,0.0014385524,0.00018049053,0.00022149638,0.0031981037],"genre_scores_gemma":[0.9798372,0.013218656,0.0027699396,0.0014348889,0.00011134935,0.000022572847,0.00000670715,0.00006307006,0.0025356587],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9922087,0.0004005667,0.0030063298,0.000659773,0.00092537166,0.0027992653],"domain_scores_gemma":[0.99421334,0.00075166236,0.0015359039,0.0012695397,0.0014057562,0.00082379504],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0029709458,0.00068428024,0.002173786,0.005261527,0.0010466578,0.00021783756,0.0019265285,0.00082901015,0.00048298438],"category_scores_gemma":[0.01254598,0.0006183819,0.0004954478,0.0029364456,0.002190781,0.00049814995,0.00020585448,0.0033381188,0.0001105759],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00028686982,0.00011995673,0.01866634,0.0021632044,0.00057266623,0.000990666,0.000112071844,0.000021038433,0.00041574694,0.005584708,0.079629876,0.8914369],"study_design_scores_gemma":[0.0023959845,0.0022875129,0.027550356,0.008232737,0.00016495341,0.00041226335,0.009939555,0.000046944388,0.0021002516,0.008720334,0.93771785,0.00043124642],"about_ca_topic_score_codex":0.007114431,"about_ca_topic_score_gemma":0.0013031237,"teacher_disagreement_score":0.9149934,"about_ca_system_score_codex":0.005069156,"about_ca_system_score_gemma":0.04775485,"threshold_uncertainty_score":0.99962676},"labels":[],"label_agreement":null},{"id":"W4417197298","doi":"10.51731/cjht.2025.1302","title":"Tofersen (Qalsody)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Amyotrophic lateral sclerosis; Weakness; Public health; Agency (philosophy); Multidisciplinary approach; Riluzole","score_opus":0.03730431379994192,"score_gpt":0.3499477317441295,"score_spread":0.3126434179441876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417197298","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08989271,0.41111997,0.00044471322,0.4906358,0.002694226,0.0009050934,0.000035074412,0.000109462795,0.004162929],"genre_scores_gemma":[0.98285824,0.012059503,0.00041307785,0.0022004044,0.000048982165,0.000006845243,0.0000018375525,0.000028543598,0.0023825695],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9952478,0.0002722432,0.0018362238,0.00034232615,0.0005108124,0.001790638],"domain_scores_gemma":[0.99702704,0.00018551193,0.0007502911,0.00077174185,0.00081867864,0.0004467179],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0022659416,0.00034432096,0.0012822184,0.0031245225,0.0006715472,0.00012810131,0.0011509389,0.0006688303,0.00043987934],"category_scores_gemma":[0.0035539705,0.00028863756,0.00027184997,0.0019128186,0.0011872866,0.00020683628,0.00012524643,0.0024874115,0.0000776712],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008469676,0.000050811428,0.0141794095,0.00076831965,0.0003342325,0.0007838723,0.00033065057,0.000011410468,0.0001799781,0.0046150843,0.0624009,0.91626066],"study_design_scores_gemma":[0.0026202486,0.002277819,0.14318989,0.008203318,0.00013180354,0.00038028666,0.009270404,0.00007920857,0.0006257848,0.010550424,0.8222941,0.00037671384],"about_ca_topic_score_codex":0.016489485,"about_ca_topic_score_gemma":0.005192018,"teacher_disagreement_score":0.9158839,"about_ca_system_score_codex":0.003418541,"about_ca_system_score_gemma":0.034043472,"threshold_uncertainty_score":0.99995655},"labels":[],"label_agreement":null},{"id":"W4417278693","doi":"10.51731/cjht.2025.1303","title":"Vorasidenib (Voranigo)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Oligodendroglioma; Reimbursement; IDH2; Astrocytoma; Grading (engineering); IDH1; Radiation therapy; Quality of life (healthcare)","score_opus":0.02169489955527991,"score_gpt":0.3092425360839617,"score_spread":0.28754763652868176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417278693","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08148097,0.6537638,0.00015077367,0.259627,0.0028125078,0.0006207849,0.0000355368,0.00007128185,0.0014373587],"genre_scores_gemma":[0.9862141,0.011062234,0.0004421916,0.0019285233,0.000028266746,0.000012138395,0.0000023703064,0.000023703808,0.00028648807],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963994,0.0001374556,0.0017086826,0.00030587442,0.0002877104,0.0011608475],"domain_scores_gemma":[0.99731946,0.00019404806,0.00094398425,0.0006545787,0.0005728005,0.00031513063],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011323978,0.0003704005,0.0013036091,0.0030691554,0.0006080239,0.00011297011,0.0006123338,0.00047183433,0.00014853377],"category_scores_gemma":[0.0018161092,0.00031341283,0.00032635155,0.0014554643,0.0005698947,0.0001405321,0.00004571668,0.0010500782,0.0000529677],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039151273,0.00016058318,0.07048488,0.00053971424,0.0005774142,0.002620003,0.0002967988,0.000011582717,0.000027173059,0.00846117,0.049030207,0.8677513],"study_design_scores_gemma":[0.00518167,0.0026107233,0.0895998,0.009366905,0.0006016764,0.0010254624,0.016116852,0.000025502011,0.0035957978,0.0150886355,0.8563792,0.0004077406],"about_ca_topic_score_codex":0.015128748,"about_ca_topic_score_gemma":0.0132739125,"teacher_disagreement_score":0.9047331,"about_ca_system_score_codex":0.0021143754,"about_ca_system_score_gemma":0.021525543,"threshold_uncertainty_score":0.9999318},"labels":[],"label_agreement":null},{"id":"W4417329605","doi":"10.51731/cjht.2025.1306","title":"Inavolisib (Itovebi)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Breast cancer; Metastatic breast cancer; Regimen; Reimbursement; Cancer; Fulvestrant; Palbociclib","score_opus":0.017625129350615592,"score_gpt":0.3259197549193014,"score_spread":0.3082946255686858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417329605","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016261518,0.776894,0.0037541003,0.19649626,0.004618406,0.0005828826,0.000049317845,0.00013408571,0.0012094465],"genre_scores_gemma":[0.9867579,0.006568175,0.0015138136,0.004066436,0.00007547603,0.000008833424,0.0000017546763,0.000039606002,0.0009680182],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959003,0.00013983536,0.0018440955,0.00034297357,0.00032382744,0.0014490165],"domain_scores_gemma":[0.99667674,0.00017762258,0.0012854123,0.00079672015,0.00076297985,0.00030053724],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012853859,0.0004223195,0.0014168737,0.0030250316,0.0006188756,0.0000753345,0.0009845877,0.0005255117,0.00014845062],"category_scores_gemma":[0.002015026,0.0003866177,0.00026036645,0.0017762247,0.0012449845,0.00028551396,0.00007185559,0.0019916615,0.000024555105],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001179815,0.000034522724,0.006299204,0.0006766989,0.00028120383,0.00035788555,0.00062344497,0.000028162187,0.000049999428,0.006166577,0.005790116,0.9795742],"study_design_scores_gemma":[0.0023088607,0.0010150464,0.016091213,0.006834184,0.00011721202,0.0006424751,0.0143849915,0.000013288385,0.0011409008,0.025367802,0.93180084,0.0002831865],"about_ca_topic_score_codex":0.0074909185,"about_ca_topic_score_gemma":0.004841347,"teacher_disagreement_score":0.979291,"about_ca_system_score_codex":0.0036039324,"about_ca_system_score_gemma":0.032450076,"threshold_uncertainty_score":0.99985856},"labels":[],"label_agreement":null},{"id":"W4417329610","doi":"10.51731/cjht.2025.1305","title":"Federal Policies and Public Reimbursement of Pediatric Medicines in Canada","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Formulary; Medical prescription; Public health; Off-label use; Orphan drug; Prescription drug; MEDLINE","score_opus":0.06434924540929551,"score_gpt":0.3681667365483332,"score_spread":0.30381749113903767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417329610","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24633189,0.4394327,0.000007636389,0.31275216,0.0007837479,0.0002320967,0.00001721125,0.0000056669105,0.00043690501],"genre_scores_gemma":[0.89222085,0.10455775,0.000057198813,0.0030781224,0.000042181877,0.0000036087367,6.1033967e-7,0.000007768869,0.00003191952],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996654,0.00016052145,0.0016590628,0.00019606818,0.00034022765,0.0009901399],"domain_scores_gemma":[0.9976193,0.00051133515,0.0010077475,0.00021096467,0.00035123716,0.00029942364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013843386,0.00024206963,0.0011001369,0.0015262539,0.00034016036,0.000035651643,0.00036401345,0.00015360524,0.000044825825],"category_scores_gemma":[0.0036493798,0.00019766249,0.000057198835,0.0013220088,0.00047822727,0.00014993967,0.00009196548,0.0010881914,2.643905e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045449906,0.000033355846,0.6118306,0.0012825652,0.00018049957,0.00020217698,0.00028433322,0.0000033919796,0.0000034495354,0.0010643075,0.01681983,0.36825004],"study_design_scores_gemma":[0.0031926667,0.0011764314,0.48037615,0.0019931328,0.0003105524,0.00016626042,0.103284605,0.00006351123,0.00012039861,0.0020562173,0.40695524,0.00030482223],"about_ca_topic_score_codex":0.97480524,"about_ca_topic_score_gemma":0.99075025,"teacher_disagreement_score":0.6458889,"about_ca_system_score_codex":0.0023141135,"about_ca_system_score_gemma":0.045087468,"threshold_uncertainty_score":0.960326},"labels":[],"label_agreement":null},{"id":"W4417434215","doi":"10.51731/cjht.2025.1307","title":"Lazertinib and Amivantamab (Lazcluze and Rybrevant)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Lung cancer; Drug; Clinical Practice; Cancer","score_opus":0.012612102283990068,"score_gpt":0.3396914984257826,"score_spread":0.32707939614179254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417434215","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10196356,0.691217,0.00015971875,0.20403813,0.0008933566,0.0005171434,0.000057514877,0.000042865926,0.0011107197],"genre_scores_gemma":[0.9688008,0.028422162,0.00050700735,0.0015259848,0.000016777733,0.000006134326,0.0000022344582,0.000014660601,0.0007042496],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99808985,0.00006201532,0.0008698427,0.0002427406,0.00012443248,0.0006111405],"domain_scores_gemma":[0.9986716,0.00013249984,0.00047073816,0.00026051397,0.00022386976,0.00024078652],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004753458,0.00023493638,0.00072223286,0.0011494913,0.00056401757,0.00008573056,0.00016935283,0.00023303229,0.000024137027],"category_scores_gemma":[0.00066784886,0.00019389567,0.00006339276,0.00045782077,0.00068518537,0.00013839501,0.00004216507,0.0006026844,0.0000023284433],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041894033,0.00003230905,0.033413608,0.000774727,0.00040219803,0.00029324566,0.00087697647,0.000001104219,0.000014643444,0.0038589472,0.008188566,0.95210177],"study_design_scores_gemma":[0.0061303554,0.0029218774,0.14556426,0.007510296,0.0010008215,0.0014374322,0.031158974,0.000046952566,0.00033032132,0.013152837,0.790383,0.00036292002],"about_ca_topic_score_codex":0.0065718587,"about_ca_topic_score_gemma":0.006257247,"teacher_disagreement_score":0.95173883,"about_ca_system_score_codex":0.00074658793,"about_ca_system_score_gemma":0.009426466,"threshold_uncertainty_score":0.9961892},"labels":[],"label_agreement":null},{"id":"W4417434479","doi":"10.51731/cjht.2025.1308","title":"Dupilumab (Dupixent)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dupilumab; Reimbursement; Medical prescription; Drug; Disease; Syringe","score_opus":0.019273028663953005,"score_gpt":0.31211856573767205,"score_spread":0.292845537073719,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417434479","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.036176078,0.57796806,0.0004121161,0.37456644,0.0039972817,0.0008467317,0.00007997388,0.00011520812,0.005838128],"genre_scores_gemma":[0.9908401,0.0057560545,0.0003911088,0.00045216602,0.00002671693,0.000007697568,0.0000054273028,0.000024870698,0.0024958786],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99634665,0.00016706574,0.0016716828,0.00029591058,0.00029055332,0.0012281545],"domain_scores_gemma":[0.9976616,0.00013470848,0.0008492104,0.0005828221,0.0004511739,0.00032048495],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022293358,0.00037890903,0.0012293541,0.0025846388,0.00077677757,0.000099994766,0.0006198782,0.0004864671,0.00027645187],"category_scores_gemma":[0.001452075,0.00032953164,0.00027389615,0.0012615866,0.000750783,0.00022013867,0.000045146375,0.0012932945,0.000088199966],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000061290586,0.00012446872,0.03872988,0.000572206,0.00063059764,0.012127339,0.00067627884,9.662631e-7,0.0000140461725,0.0054693767,0.024785982,0.9168076],"study_design_scores_gemma":[0.0072517507,0.003979422,0.033806328,0.010954481,0.0005646802,0.013487725,0.027238604,0.000020654052,0.001437565,0.013373901,0.88735306,0.00053183985],"about_ca_topic_score_codex":0.0072635747,"about_ca_topic_score_gemma":0.006132441,"teacher_disagreement_score":0.954664,"about_ca_system_score_codex":0.0025078873,"about_ca_system_score_gemma":0.027912814,"threshold_uncertainty_score":0.99991566},"labels":[],"label_agreement":null},{"id":"W4417464386","doi":"10.51731/cjht.2025.1309","title":"Darolutamide (Nubeqa)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Enzalutamide; Agency (philosophy); Drug; Drug approval","score_opus":0.032991687298584586,"score_gpt":0.357982561488245,"score_spread":0.3249908741896604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417464386","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.033526633,0.7035656,0.00020673749,0.2560055,0.0024283226,0.0006492794,0.000050777166,0.00006866153,0.003498498],"genre_scores_gemma":[0.9629435,0.03131777,0.00022717757,0.001267617,0.00003609764,0.000010055458,0.0000042469533,0.000023070374,0.0041704914],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99635035,0.00015178965,0.00135436,0.00029365145,0.00035625868,0.0014935982],"domain_scores_gemma":[0.99769235,0.0001499646,0.0006129743,0.00058319984,0.0006229027,0.00033861172],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015855586,0.00031260564,0.001076719,0.0031206813,0.0007153296,0.0000994899,0.0007589969,0.00044658882,0.00014401472],"category_scores_gemma":[0.0014353588,0.00025250972,0.00023957767,0.0015771686,0.0011222516,0.00016640121,0.00006963653,0.0016960307,0.00003463945],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001465753,0.000059833976,0.017938891,0.0009364994,0.0004768112,0.0012120534,0.00035192366,0.0000062884333,0.000051597053,0.0021628407,0.04576395,0.9308927],"study_design_scores_gemma":[0.0049729166,0.0028425262,0.03499157,0.008088119,0.00023654968,0.00039964556,0.017599087,0.000040215677,0.0037266563,0.013283455,0.91348755,0.00033170867],"about_ca_topic_score_codex":0.008234777,"about_ca_topic_score_gemma":0.0047931084,"teacher_disagreement_score":0.930561,"about_ca_system_score_codex":0.0036522727,"about_ca_system_score_gemma":0.049087558,"threshold_uncertainty_score":0.9999927},"labels":[],"label_agreement":null},{"id":"W4417464387","doi":"10.51731/cjht.2025.1311","title":"Dupilumab (Dupixent)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Sinusitis and nasal conditions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dupilumab; Reimbursement; Nasal administration; Drug; Chronic rhinosinusitis; Syringe; Drug injection","score_opus":0.020277960162260522,"score_gpt":0.3144775969370887,"score_spread":0.2941996367748282,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417464387","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1248959,0.69249064,0.00082825386,0.17005119,0.005405272,0.0006736443,0.00013126142,0.00013167574,0.0053921533],"genre_scores_gemma":[0.9915388,0.0036203999,0.00027504726,0.00311493,0.000041994816,0.000005231091,0.0000053413946,0.000020317459,0.001377945],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967976,0.00011999818,0.0015611621,0.00024520047,0.00024519852,0.0010308359],"domain_scores_gemma":[0.99760205,0.00015361416,0.00080655573,0.0005356086,0.00062560226,0.0002765519],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011024375,0.00027764202,0.000987807,0.0030847376,0.00085458765,0.00009368678,0.0006051906,0.0004579245,0.00039471476],"category_scores_gemma":[0.0020637026,0.00026125167,0.00027015465,0.0015218538,0.0007506961,0.00016639219,0.00004561039,0.0014870629,0.00004888773],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005000733,0.00008317818,0.0249597,0.0006550959,0.00037589826,0.0013479715,0.0003238673,0.0000059727263,0.000035827983,0.023643686,0.15955697,0.7889618],"study_design_scores_gemma":[0.0029316582,0.0019422739,0.14624882,0.007707157,0.00028360807,0.0011294852,0.015053142,0.0000220127,0.0005179964,0.008650296,0.8151632,0.0003503297],"about_ca_topic_score_codex":0.00734487,"about_ca_topic_score_gemma":0.0082028,"teacher_disagreement_score":0.8666429,"about_ca_system_score_codex":0.0018758101,"about_ca_system_score_gemma":0.028978782,"threshold_uncertainty_score":0.99998397},"labels":[],"label_agreement":null},{"id":"W7092477290","doi":"10.51731/cjht.2025.1256","title":"Glofitamab (Columvi)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Oxaliplatin; Gemcitabine; Refractory (planetary science); Lymphoma; Drug; Chemotherapy; Diffuse large B-cell lymphoma","score_opus":0.0406180561604166,"score_gpt":0.3553585270236323,"score_spread":0.3147404708632157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7092477290","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.037663367,0.63014287,0.0004506971,0.3146594,0.003821993,0.001307657,0.000049761085,0.00013870717,0.0117655955],"genre_scores_gemma":[0.96906686,0.015890565,0.00039661088,0.002303218,0.000070130496,0.000011633036,0.0000021942626,0.00004414886,0.012214641],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9949108,0.00027867084,0.0019317513,0.0003853828,0.0005597314,0.0019336626],"domain_scores_gemma":[0.99650466,0.0002805648,0.00079766725,0.0010031188,0.00094620977,0.00046777548],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0031200633,0.0003818092,0.0014204368,0.0041709393,0.0007275847,0.00016367379,0.0013325637,0.0007094966,0.002305758],"category_scores_gemma":[0.0031810326,0.00036778144,0.00036407102,0.0024886942,0.0013247795,0.00017206105,0.00010508289,0.0028830355,0.00006778003],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00013111763,0.000055158478,0.008538809,0.0007618598,0.0003623947,0.0008260594,0.0002872741,0.000005612654,0.0003166235,0.002435342,0.04880955,0.9374702],"study_design_scores_gemma":[0.0025003876,0.0020291551,0.010827104,0.0036055874,0.000095331176,0.0005358975,0.011293873,0.000043932832,0.0017150557,0.0063721,0.96072245,0.0002591138],"about_ca_topic_score_codex":0.018266972,"about_ca_topic_score_gemma":0.014826883,"teacher_disagreement_score":0.9372111,"about_ca_system_score_codex":0.004537081,"about_ca_system_score_gemma":0.049583577,"threshold_uncertainty_score":0.9998774},"labels":[],"label_agreement":null},{"id":"W7115022452","doi":"10.51731/cjht.2025.1304","title":"Nivolumab Plus Ipilimumab (Opdivo Plus Yervoy)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Durvalumab; Nivolumab; Ipilimumab; Sorafenib; Lenvatinib; Immunotherapy; Clinical trial; Sunitinib","score_opus":0.06552939086128179,"score_gpt":0.28578960532171566,"score_spread":0.22026021446043387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7115022452","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1585059,0.69941443,0.0006838633,0.13227467,0.003236549,0.0016151647,0.000086998974,0.00021985473,0.0039625545],"genre_scores_gemma":[0.98619944,0.008664886,0.00060054165,0.0014298261,0.00007330183,0.000027539516,0.0000131032075,0.000054315824,0.0029370429],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9944645,0.00028907208,0.0022959989,0.0005409131,0.00047994853,0.0019295525],"domain_scores_gemma":[0.9963509,0.00021950963,0.0011909056,0.0009960323,0.00068872166,0.0005539748],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016454275,0.00064640475,0.0020336246,0.0034906105,0.0010178327,0.00016807283,0.0010766713,0.00093784044,0.00032581517],"category_scores_gemma":[0.0013272313,0.00059650687,0.0005911735,0.0019108803,0.00090306497,0.0002601433,0.00011226156,0.0019672827,0.000100001096],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00032643697,0.00010890632,0.11824735,0.0018024236,0.0010139091,0.003979069,0.0012283036,0.00001533645,0.000016949096,0.0034500642,0.032746937,0.8370643],"study_design_scores_gemma":[0.016526598,0.005764492,0.014922695,0.012770466,0.0012440404,0.0012380406,0.024071518,0.0016360803,0.002038504,0.0059031127,0.9128301,0.0010543648],"about_ca_topic_score_codex":0.019164486,"about_ca_topic_score_gemma":0.010338131,"teacher_disagreement_score":0.88008314,"about_ca_system_score_codex":0.007474329,"about_ca_system_score_gemma":0.05241032,"threshold_uncertainty_score":0.99964863},"labels":[],"label_agreement":null},{"id":"W7116080493","doi":"10.51731/cjht.2025.1312","title":"Abemaciclib (Verzenio)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Fulvestrant; Reimbursement; Disease; Drug; Breast cancer; Metastatic breast cancer; Cancer","score_opus":0.018015218389356564,"score_gpt":0.32893630027680315,"score_spread":0.3109210818874466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7116080493","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01158076,0.7765502,0.003941523,0.20141459,0.0041528237,0.000598984,0.000051040115,0.00015448974,0.0015556463],"genre_scores_gemma":[0.98604816,0.0070509017,0.0016573342,0.003879658,0.00005865959,0.000009154208,0.000001857946,0.000041605424,0.0012526512],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99579763,0.00014016494,0.0018929355,0.00035416443,0.00032702892,0.0014880685],"domain_scores_gemma":[0.99674946,0.00016908342,0.0012930189,0.00079068815,0.0006905805,0.00030719658],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012765208,0.00042959722,0.0014348273,0.0028143153,0.00062078383,0.00007338253,0.0009654376,0.0005050949,0.00021450236],"category_scores_gemma":[0.0015442912,0.000397878,0.00028346703,0.001702258,0.0012668596,0.000282018,0.00006352726,0.0018396684,0.0000336739],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001226485,0.000035526056,0.005875684,0.000721014,0.00035399653,0.00039827486,0.0004538256,0.000027077025,0.000059506496,0.005756513,0.005193824,0.9810021],"study_design_scores_gemma":[0.0026014878,0.0009914611,0.0101541085,0.0059105246,0.00014152692,0.0007857034,0.013906201,0.000015994094,0.0015146928,0.022964517,0.9407075,0.0003062776],"about_ca_topic_score_codex":0.004216227,"about_ca_topic_score_gemma":0.0033333052,"teacher_disagreement_score":0.98069584,"about_ca_system_score_codex":0.003235739,"about_ca_system_score_gemma":0.029728003,"threshold_uncertainty_score":0.9998473},"labels":[],"label_agreement":null},{"id":"W7116123103","doi":"10.51731/cjht.2025.1310","title":"Pembrolizumab (Keytruda)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Occupational and environmental lung diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pembrolizumab; Reimbursement; Pemetrexed; Drug; Compassionate Use; Clinical Practice","score_opus":0.013036716158886795,"score_gpt":0.2886499990016752,"score_spread":0.2756132828427884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7116123103","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15769805,0.6882389,0.00024293276,0.1462964,0.0024671522,0.0005063585,0.00012869076,0.00007558052,0.004345889],"genre_scores_gemma":[0.990507,0.0057872212,0.00019112809,0.0023305642,0.000031281576,0.0000044612457,0.000007038379,0.000015674417,0.0011256082],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99754393,0.00007770038,0.0011160276,0.00021908985,0.00028636627,0.000756878],"domain_scores_gemma":[0.99856764,0.00008858662,0.0005684209,0.00037102972,0.00013822364,0.0002661243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046248766,0.0002524284,0.000702341,0.0014022758,0.0004876219,0.000045829187,0.00046862793,0.000280974,0.00032522302],"category_scores_gemma":[0.0007930703,0.00022541768,0.00022337014,0.0006271884,0.0007450517,0.00014157569,0.000047694237,0.0007535947,0.000056292556],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020683657,0.000119544835,0.17877653,0.00089280657,0.0002755981,0.00038796526,0.00013614315,0.00003290176,0.000018792343,0.0064068497,0.036621727,0.7761243],"study_design_scores_gemma":[0.0018454334,0.0012313647,0.5185639,0.0031256964,0.00020778572,0.00024259785,0.0058708824,0.000028028879,0.00023133428,0.009470703,0.45896077,0.00022145531],"about_ca_topic_score_codex":0.0037694366,"about_ca_topic_score_gemma":0.0012767179,"teacher_disagreement_score":0.832809,"about_ca_system_score_codex":0.001741644,"about_ca_system_score_gemma":0.012810732,"threshold_uncertainty_score":0.9927857},"labels":[],"label_agreement":null},{"id":"W7116849294","doi":"10.51731/cjht.2025.1315","title":"Abemaciclib (Verzenio)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Fulvestrant; Breast cancer; Metastatic breast cancer; Chemotherapy; Reimbursement; Regimen; Cancer; Aromatase","score_opus":0.018015218389356564,"score_gpt":0.32893630027680315,"score_spread":0.3109210818874466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7116849294","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01158076,0.7765502,0.003941523,0.20141459,0.0041528237,0.000598984,0.000051040115,0.00015448974,0.0015556463],"genre_scores_gemma":[0.98604816,0.0070509017,0.0016573342,0.003879658,0.00005865959,0.000009154208,0.000001857946,0.000041605424,0.0012526512],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99579763,0.00014016494,0.0018929355,0.00035416443,0.00032702892,0.0014880685],"domain_scores_gemma":[0.99674946,0.00016908342,0.0012930189,0.00079068815,0.0006905805,0.00030719658],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012765208,0.00042959722,0.0014348273,0.0028143153,0.00062078383,0.00007338253,0.0009654376,0.0005050949,0.00021450236],"category_scores_gemma":[0.0015442912,0.000397878,0.00028346703,0.001702258,0.0012668596,0.000282018,0.00006352726,0.0018396684,0.0000336739],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001226485,0.000035526056,0.005875684,0.000721014,0.00035399653,0.00039827486,0.0004538256,0.000027077025,0.000059506496,0.005756513,0.005193824,0.9810021],"study_design_scores_gemma":[0.0026014878,0.0009914611,0.0101541085,0.0059105246,0.00014152692,0.0007857034,0.013906201,0.000015994094,0.0015146928,0.022964517,0.9407075,0.0003062776],"about_ca_topic_score_codex":0.004216227,"about_ca_topic_score_gemma":0.0033333052,"teacher_disagreement_score":0.98069584,"about_ca_system_score_codex":0.003235739,"about_ca_system_score_gemma":0.029728003,"threshold_uncertainty_score":0.9998473},"labels":[],"label_agreement":null},{"id":"W7116912364","doi":"10.51731/cjht.2025.1314","title":"Cipaglucosidase Alfa (Pombiliti) With Miglustat (Opfolda)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Disease; Reimbursement; Drug; Clinical Practice; Pharmacotherapy; Clinical trial","score_opus":0.02304819863146158,"score_gpt":0.31699144196907564,"score_spread":0.29394324333761407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7116912364","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16004612,0.55784595,0.00094317656,0.27585572,0.0010681561,0.0016144746,0.00007686954,0.00013929067,0.00241026],"genre_scores_gemma":[0.9882382,0.006788242,0.00080541294,0.0025197063,0.000023269191,0.000025488283,0.0000061427186,0.00005887855,0.0015346535],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9940124,0.0002956622,0.0018521036,0.0005771048,0.00084025756,0.0024224366],"domain_scores_gemma":[0.99547285,0.00032904395,0.00091218867,0.001111652,0.0014720245,0.0007022394],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0021036358,0.0005561491,0.0016272116,0.0040523517,0.0009557681,0.00018386682,0.0013666071,0.00065307465,0.00038899743],"category_scores_gemma":[0.003836019,0.00045383614,0.00027103297,0.0030272573,0.0021237172,0.00032528836,0.000119923134,0.0028284816,0.00004020754],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069587835,0.00029596206,0.050390895,0.0034051002,0.000971415,0.005889453,0.001843493,0.000054786302,0.000075755976,0.003660866,0.041092187,0.8916242],"study_design_scores_gemma":[0.0107050985,0.011483902,0.033886075,0.013961836,0.00043137625,0.0020343782,0.10348913,0.0001815339,0.0027064586,0.0071515017,0.81292665,0.0010420567],"about_ca_topic_score_codex":0.028395593,"about_ca_topic_score_gemma":0.026719902,"teacher_disagreement_score":0.89058214,"about_ca_system_score_codex":0.0031395615,"about_ca_system_score_gemma":0.04971932,"threshold_uncertainty_score":0.9997913},"labels":[],"label_agreement":null},{"id":"W7117159139","doi":"10.51731/cjht.2025.1316","title":"Quizartinib (Vanflyta)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cytarabine; Myeloid leukemia; Reimbursement; Drug; Food and drug administration","score_opus":0.024026374837483006,"score_gpt":0.3171629694084499,"score_spread":0.2931365945709669,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117159139","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06827554,0.7122403,0.00041638146,0.20762771,0.004682773,0.000993738,0.000057738554,0.00016417664,0.005541643],"genre_scores_gemma":[0.9862629,0.008292438,0.0006797499,0.00230895,0.000044756187,0.000009646174,0.000004298763,0.00003641495,0.0023608573],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9951608,0.00018364968,0.0022493543,0.0003931126,0.00036613134,0.0016469316],"domain_scores_gemma":[0.99655914,0.00023124905,0.0013622025,0.00094698,0.00052399957,0.00037645467],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016044594,0.00045814484,0.0015022439,0.0028501211,0.00063733826,0.00008394618,0.0009011678,0.00065164274,0.00029515376],"category_scores_gemma":[0.0034050357,0.0004164475,0.00032211732,0.0015820762,0.0008928712,0.00018485055,0.00007956831,0.0017912916,0.000089465655],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0000681858,0.00008169053,0.017542282,0.000858218,0.00058799965,0.0012189435,0.00047909687,0.000015400467,0.000023373115,0.0033788998,0.05763973,0.9181062],"study_design_scores_gemma":[0.0056957733,0.0019687775,0.01780885,0.0079825455,0.0003706945,0.0008745273,0.011292256,0.00005659035,0.0014030631,0.0059615336,0.9462327,0.00035269494],"about_ca_topic_score_codex":0.012238087,"about_ca_topic_score_gemma":0.009037965,"teacher_disagreement_score":0.91798735,"about_ca_system_score_codex":0.010571383,"about_ca_system_score_gemma":0.07921841,"threshold_uncertainty_score":0.99982876},"labels":[],"label_agreement":null},{"id":"W7133200569","doi":"10.51731/cjht.2025.1360","title":"Dihydropyrimidine Dehydrogenase Deficiency Testing for Patients Treated With 5-Fluorouracil and Capecitabine","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"DPYD; Dihydropyrimidine dehydrogenase; Capecitabine; Genotyping; Adverse effect; Genetic testing; Glucose-6-phosphate dehydrogenase deficiency","score_opus":0.024465994639906945,"score_gpt":0.27863339870557463,"score_spread":0.2541674040656677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7133200569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.74405414,0.2431784,0.000078322395,0.010648058,0.00025377664,0.0012148537,0.00012788063,0.000052230807,0.00039235112],"genre_scores_gemma":[0.99611825,0.0023756558,0.001009289,0.0002652524,0.000014878819,0.000050985593,0.000007947281,0.000026824893,0.00013089894],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9972931,0.0000481505,0.0010759543,0.00037809214,0.00020989776,0.0009947888],"domain_scores_gemma":[0.99730176,0.00032916066,0.0007668474,0.00026934192,0.0011074513,0.0002254642],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00044184676,0.00041898547,0.0011254424,0.001079628,0.0011136094,0.00006596217,0.00022609695,0.0001940984,0.000007676694],"category_scores_gemma":[0.0022253126,0.00029864028,0.00009932777,0.0011255918,0.0006219819,0.00013581182,0.000045618253,0.00042775637,6.065361e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036987895,0.00017354605,0.38804653,0.0008164636,0.00031913328,0.00012491192,0.00031017014,0.0000071146687,0.000015534517,0.00015417542,0.0007424444,0.6089201],"study_design_scores_gemma":[0.04257193,0.118996635,0.7009556,0.020718062,0.0038170838,0.00094288203,0.027934097,0.00083580776,0.0031431676,0.0034062332,0.07469579,0.001982662],"about_ca_topic_score_codex":0.0077555557,"about_ca_topic_score_gemma":0.008881615,"teacher_disagreement_score":0.6069374,"about_ca_system_score_codex":0.0015948015,"about_ca_system_score_gemma":0.0054488056,"threshold_uncertainty_score":0.9999466},"labels":[],"label_agreement":null},{"id":"W7160716020","doi":"10.51731/cjht.2025.1437","title":"Appropriate Use of Antipsychotics in Long-Term Care: Expert Panel Guidance","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Geriatric Care and Nursing Homes","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Long-term care; Excellence; Antipsychotic; Quality (philosophy); Pro forma; Action (physics); Quality of life (healthcare)","score_opus":0.09185841985435168,"score_gpt":0.38397619332025684,"score_spread":0.2921177734659052,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7160716020","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.45039886,0.49438846,0.0009482094,0.043729577,0.009069533,0.0012223902,0.000103998755,0.000066538225,0.000072422416],"genre_scores_gemma":[0.96841204,0.029195951,0.0014350121,0.00065560406,0.000044690594,0.000011930037,0.0000067430924,0.000037558228,0.00020044378],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9934492,0.0006864516,0.0034899637,0.0004254399,0.0003305606,0.0016183876],"domain_scores_gemma":[0.9952477,0.000437132,0.0020289477,0.00097246515,0.0010812536,0.00023246456],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0015141101,0.00042951028,0.0016390801,0.0034563337,0.0007067401,0.000059893373,0.0011066314,0.0011008251,0.000033641212],"category_scores_gemma":[0.0018748925,0.00041453147,0.0002571027,0.0022482888,0.0007065023,0.00030118914,0.000098841134,0.0023712944,0.000005608818],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000308903,0.00012273659,0.18688883,0.0047725937,0.00011862555,0.00028400714,0.018918728,0.000055629956,0.00004675634,0.00082077214,0.01887064,0.7687918],"study_design_scores_gemma":[0.0036568006,0.0012509396,0.78072995,0.029954111,0.000102336395,0.00007194831,0.12091698,0.000022874558,0.00051168434,0.0022929513,0.05979702,0.00069238344],"about_ca_topic_score_codex":0.035767842,"about_ca_topic_score_gemma":0.0590197,"teacher_disagreement_score":0.76809937,"about_ca_system_score_codex":0.0023241378,"about_ca_system_score_gemma":0.020488268,"threshold_uncertainty_score":0.99993026},"labels":[],"label_agreement":null}]}